PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ehrsson, HH; Spence, C; Passingham, RE				Ehrsson, HH; Spence, C; Passingham, RE			That's my hand! Activity in premotor cortex reflects feeling of ownership of a limb	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; REPRESENTATION; MOTOR; SELF; ARM; ORGANIZATION; PERCEPTION	When we look at our hands, we immediately know that they are part of our own body. This feeling of ownership of our limbs is a fundamental aspect of self-consciousness. We have studied the neuronal counterparts of this experience. A perceptual illusion was used to manipulate feelings of ownership of a rubber hand presented in front of healthy subjects while brain activity was measured by functional magnetic resonance imaging. The neural activity in the premotor cortex reflected the feeling of ownership of the hand. This suggests that multisensory integration in the premotor cortex provides a mechanism for bodily self-attribution.	Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Ehrsson, HH (corresponding author), Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	h.ehrsson@fil.ion.ucl.ac.uk						Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; CRITCHLE.M, 1974, MT SINAI J MED, V41, P82; Critchley M., 1953, PARIETAL LOBES; DUFFY FH, 1971, SCIENCE, V172, P273, DOI 10.1126/science.172.3980.273; EHRSSON HH, UNPUB; Feinberg TE, 1997, SEMIN NEUROL, V17, P129, DOI 10.1055/s-2008-1040922; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Macaluso Emiliano, 2003, Adv Neurol, V93, P219; Meador KJ, 2000, NEUROLOGY, V55, P816, DOI 10.1212/WNL.55.6.816; MITCHELL RW, 2003, SELF SOUL BRAIN, P39; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2	30	903	914	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					875	877		10.1126/science.1097011	http://dx.doi.org/10.1126/science.1097011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15232072				2022-12-01	WOS:000223104900052
J	Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL				Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL			DksA: A critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP	CELL			English	Article							RATE-DEPENDENT CONTROL; ESCHERICHIA-COLI; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; NUCLEOSIDE TRIPHOSPHATE; IN-VITRO; MUTANTS; 5'-DIPHOSPHATE; POLYMERASE; PROTEASE	Ribosomal RNA (rRNA) transcription is regulated primarily at the level of initiation from rRNA promoters. The unusual kinetic properties of these promoters result in their specific regulation by two small molecule signals, ppGpp and the initiating NTP, that bind to RNA polymerase (RNAP) at all promoters. We show here that DksA, a protein previously unsuspected as a transcription factor, is absolutely required for rRNA regulation. InDeltadksA mutants, rRNA promoters are unresponsive to changes in amino acid availability, growth rate, or growth phase. In vitro, DksA binds to RNAP, reduces open complex lifetime, inhibits rRNA promoter activity, and amplifies effects of ppGpp and the initiating NTP on rRNA transcription, explaining the dksA requirement in vivo. These results expand our molecular understanding of rRNA transcription regulation, may explain previously described pleiotropic effects of dksA, and illustrate how transcription factors that do not bind DNA can nevertheless potentiate RNAP for regulation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of Wisconsin System; University of Wisconsin Madison; University of South Alabama	Gourse, RL (corresponding author), Univ Wisconsin, Dept Bacteriol, 420 Henry Mall, Madison, WI 53706 USA.	rgourse@bact.wisc.edu		Schneider, David/0000-0003-0635-5091	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048, R01GM037048] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM037048, R01 GM37048] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BOKAL AJ, 1995, J MOL BIOL, V245, P197, DOI 10.1006/jmbi.1994.0016; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Murray HD, 2004, MOL MICROBIOL, V52, P1375, DOI 10.1111/j.1365-2958.2004.04060.x; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Murray HD, 2003, J BACTERIOL, V185, P28, DOI 10.1128/JB.185.1.28-34.2003; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; SANDS MK, 1952, J BACTERIOL, V63, P505, DOI 10.1128/JB.63.4.505-511.1952; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; Schneider DA, 2003, J BACTERIOL, V185, P6185, DOI 10.1128/JB.185.20.6185-6191.2003; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	39	368	378	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					311	322		10.1016/j.cell.2004.07.009	http://dx.doi.org/10.1016/j.cell.2004.07.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294157	Bronze			2022-12-01	WOS:000223353100008
J	Denver, DR; Morris, K; Lynch, M; Thomas, WK				Denver, DR; Morris, K; Lynch, M; Thomas, WK			High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome	NATURE			English	Article							DROSOPHILA-MELANOGASTER; DNA-SEQUENCES; EVOLUTION; SELECTION; NUCLEOTIDE; GENES	Mutations have pivotal functions in the onset of genetic diseases and are the fundamental substrate for evolution. However, present estimates of the spontaneous mutation rate and spectrum are derived from indirect and biased measurements. For instance, mutation rate estimates for Caenorhabditis elegans are extrapolated from observations on a few genetic loci with visible phenotypes and vary over an order of magnitude(1). Alternative approaches in mammals, relying on phylogenetic comparisons of pseudogene loci(2) and fourfold degenerate codon positions(3), suffer from uncertainties in the actual number of generations separating the compared species and the inability to exclude biases associated with natural selection. Here we provide a direct and unbiased estimate of the nuclear mutation rate and its molecular spectrum with a set of C. elegans mutation-accumulation lines that reveal a mutation rate about tenfold higher than previous indirect estimates and an excess of insertions over deletions. Because deletions dominate patterns of C. elegans pseudogene variation(4,5), our observations indicate that natural selection might be significant in promoting small genome size, and challenge the prevalent assumption that pseudogene divergence accurately reflects the spontaneous mutation spectrum.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire	Denver, DR (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ddenver@bio.indiana.edu						Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Charlesworth B, 1996, NATURE, V384, P315, DOI 10.1038/384315a0; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Denver DR, 2004, J MOL EVOL, V58, P584, DOI 10.1007/s00239-004-2580-4; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Drake JW, 1998, GENETICS, V148, P1667; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hill F, 2000, EMBO REP, V1, P29, DOI 10.1093/embo-reports/kvd015; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Keightley PD, 1998, GENETICS, V148, P753; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LANGLEY CH, 1976, MUTAT RES, V36, P385, DOI 10.1016/0027-5107(76)90248-7; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; Nachman MW, 2000, GENETICS, V156, P297; NACLERIO G, 1992, J MOL BIOL, V226, P159, DOI 10.1016/0022-2836(92)90131-3; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; SEIN LD, 2003, PLOS BIOL, V1, P166; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	29	266	275	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					679	682		10.1038/nature02697	http://dx.doi.org/10.1038/nature02697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295601				2022-12-01	WOS:000223085400046
J	Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ				Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ			Loss of Smad3 in acute T-cell lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TGF-BETA; P27(KIP1); EXPRESSION; INHIBITOR; LYMPHOMAS; GROWTH; MICE	BACKGROUND: The receptors for transforming growth factor (beta) (TGF-(beta)) and their signaling intermediates make up an important tumor-suppressor pathway. The role of one of these intermediates -- Smad3 -- in the pathogenesis of lymphoid neoplasia is unknown. METHODS: We measured Smad3 messenger RNA (mRNA) and protein in leukemia cells obtained at diagnosis from 19 children with acute leukemia, including 10 with T-cell acute lymphoblastic leukemia (ALL), 7 with pre-B-cell ALL, and 2 with acute nonlymphoblastic leukemia (ANLL). All nine exons of the SMAD3 gene (MADH3) were sequenced. Mice in which one or both alleles of Smad3 were inactivated were used to evaluate the role of Smad3 in the response of normal T cells to TGF-(beta) and in the susceptibility to spontaneous leukemogenesis in mice in which both alleles of the tumor suppressor p27(sup Kip1) were deleted. RESULTS: Smad3 protein was absent in T-cell ALL but present in pre-B-cell ALL and ANLL. No mutations were found in the MADH3 gene in T-cell ALL, and Smad3 mRNA was present in T-cell ALL and normal T cells at similar levels. In mice, the loss of one allele for Smad3 impairs the inhibitory effect of TGF-(beta) on the proliferation of normal T cells and works in tandem with the homozygous inactivation of p27(sup Kip1) to promote T-cell leukemogenesis. CONCLUSIONS: Loss of Smad3 protein is a specific feature of pediatric T-cell ALL. A reduction in Smad3 expression and the loss of p27(sup Kip1) work synergistically to promote T-cell leukemogenesis in mice.	NCI, LCRC, CCR, NIH, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, CCR, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA; Linkoping Univ Hosp, Fac Hlth Sci, Div Oncol, Dept Biomed & Surg, S-58185 Linkoping, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Linkoping University	Letterio, JJ (corresponding author), NCI, LCRC, CCR, NIH, Bldg 41,Rm C629,41 Lib Dr, Bethesda, MD 20892 USA.	letterij@mail.nih.gov	Aplan, Peter D/K-9064-2016	Mamura, Mizuko/0000-0003-4531-0144; Balis, Frank/0000-0002-8117-6926	DIVISION OF BASIC SCIENCES - NCI [Z01BC010049, Z01BC005051] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC006880, ZIASC010378, ZIASC006880, Z01SC010378] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chervinsky DS, 1999, MOL CELL BIOL, V19, P5025; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2001, NAT GENET, V29, P351; Flanders KC, 2001, DEV DYNAM, V220, P141, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.3.CO;2-W; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Komuro Hiroaki, 1999, Neoplasia (New York), V1, P253, DOI 10.1038/sj.neo.7900033; Lin ZS, 2003, BRIT J HAEMATOL, V121, P739, DOI 10.1046/j.1365-2141.2003.04354.x; Margolin J.F., 2002, PRINCIPLES PRACTICE, P489; MOROSETTI R, 1995, BLOOD, V86, P1924, DOI 10.1182/blood.V86.5.1924.bloodjournal8651924; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	13	121	130	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					552	559		10.1056/NEJMoa031197	http://dx.doi.org/10.1056/NEJMoa031197			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295048				2022-12-01	WOS:000223069900008
J	Zeitlin, P				Zeitlin, P			Can curcumin cure cystic fibrosis?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CFTR FUNCTION		Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Zeitlin, P (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA.			Zeitlin, Pamela/0000-0002-2719-1834				Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Yerxa BR, 2002, J PHARMACOL EXP THER, V302, P871, DOI 10.1124/jpet.102.035485; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	5	32	34	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					606	608		10.1056/NEJMcibr041584	http://dx.doi.org/10.1056/NEJMcibr041584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295056				2022-12-01	WOS:000223069900017
J	Rouse, GW; Goffredi, SK; Vrijenhoek, RC				Rouse, GW; Goffredi, SK; Vrijenhoek, RC			Osedax: Bone-eating marine worms with dwarf males	SCIENCE			English	Article							MOLECULAR EVIDENCE; VESTIMENTIFERA; POGONOPHORANS; WHALES; VENT	We describe a new genus, Osedax, and two new species of annelids with females that consume the bones of dead whales via ramifying roots. Molecular and morphological evidence revealed that Osedax belongs to the Siboglinidae, which includes pogonophoran and vestimentiferan worms from deep-sea vents, seeps, and anoxic basins. Osedax has skewed sex ratios with numerous dwarf (paedomorphic) males that live in the tubes of females. DNA sequences reveal that the two Osedax species diverged about 42 million years ago and currently maintain large populations ranging from 10(5) to 10(6) adult females.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; S Australian Museum, Adelaide, SA 5000, Australia; Univ Adelaide, Adelaide, SA 5005, Australia	Monterey Bay Aquarium Research Institute; University of Adelaide	Vrijenhoek, RC (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	vrijen@mbari.org	Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263				Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GOFFREDI SK, UNPUB; GOFFREDI SK, IN PRESS DEEP SEA RE, V1; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; Julian D, 1999, J EXP BIOL, V202, P2245; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pilger J., 1978, P103; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Southward EC, 1999, HYDROBIOLOGIA, V402, P185, DOI 10.1023/A:1003796626851; Southward Eve C., 1993, P327; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD, P411	17	244	250	3	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					668	671		10.1126/science.1098650	http://dx.doi.org/10.1126/science.1098650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286372	Green Submitted			2022-12-01	WOS:000222992100048
J	Walker, FO; Raymond, LA				Walker, FO; Raymond, LA			Targeting energy metabolism in Huntington's disease	LANCET			English	Editorial Material							DIETARY RESTRICTION; MUTANT MICE; MOUSE MODEL; PROGRESSION		Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Winston Salem, NC 27157 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	Wake Forest University; Wake Forest Baptist Medical Center; University of British Columbia	Walker, FO (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	fwalker@wfubmc.edu	Raymond, Lynn A/A-6664-2010; Raymond, Lynn A./R-6707-2016; Longo, Kenneth A/A-5631-2010	Raymond, Lynn A/0000-0002-8610-1042; Raymond, Lynn A./0000-0002-8610-1042; Walker, Francis/0000-0002-7817-9421				Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Kieburtz K, 2001, NEUROLOGY, V57, P397; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Zeron MM, 2004, MOL CELL NEUROSCI, V25, P469, DOI 10.1016/j.mcn.2003.11.014	7	12	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					312	313		10.1016/S0140-6736(04)16739-1	http://dx.doi.org/10.1016/S0140-6736(04)16739-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276373				2022-12-01	WOS:000222853300008
J	Roger, VL; Weston, SA; Redfield, MA; Hellermann-Homan, JP; Killian, J; Yawn, BP; Jacobsen, SJ				Roger, VL; Weston, SA; Redfield, MA; Hellermann-Homan, JP; Killian, J; Yawn, BP; Jacobsen, SJ			Trends in heart failure incidence and survival in a community-based population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; OLMSTED COUNTY; CASE-FATALITY; DISEASE; MINNESOTA; MANAGEMENT; ROCHESTER; MORBIDITY; MORTALITY; PROJECT	Context The epidemic of heart failure has yet to be fully investigated, and data on incidence, survival, and sex-specific temporal trends in community-based populations are limited. Objective To test the hypothesis that the incidence of heart failure has declined and survival after heart failure diagnosis has improved over time but that secular trends have diverged by sex. Design, Setting, and Participants Population-based cohort study using the resources of the Rochester Epidemiology Project conducted in Olmsted County, Minnesota. Patients were 4537 Olmsted County residents (57% women; mean [SD] age, 74 [14] years) with a diagnosis of heart failure between 1979 and 2000. Framingham criteria and clinical criteria were used to validate the diagnosis Main Outcome Measures Incidence of heart failure and survival after heart failure diagnosis. Results The incidence of heart failure was higher among men (378/100000 persons; 95% confidence interval [Cl], 361-395 for men; 289/100000 persons; 95% Cl, 277-300 for women) and did not change over time among men or women. After a mean follow-up of 4.2 years (range, 0-23.8 years), 3347 deaths occurred, including 1930 among women and 1417 among men. Survival after heart failure diagnosis was worse among men than women (relative risk, 1.33; 95% Cl, 1.24-1.43) but overall improved over time (5-year age-adjusted survival, 43% in 1979-1984 vs 52% in 19962000, P<.001). However, men and younger persons experienced larger survival gains, contrasting with less or no improvement for women and elderly persons. Conclusion In this community-based cohort, the incidence of heart failure has not declined during 2 decades, but survival after onset of heart failure has increased over-all, with less improvement among women and elderly persons.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Olmsted Med Ctr, Dept Res, Rochester, MN USA	Mayo Clinic; Olmsted Medical Center	Roger, VL (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55095 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [R01 HL 72435] Funding Source: Medline; NIAMS NIH HHS [R01 AR30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ASSAF AR, 1993, NEW ENGL J MED, V329, P931, DOI 10.1056/NEJM199309233291307; BERGSTRAHL E, 1992, CALCULATING INCIDENC; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Croft JB, 1997, J AM GERIATR SOC, V45, P270, DOI 10.1111/j.1532-5415.1997.tb00939.x; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; KENNEDY JW, 1981, CIRCULATION, V63, P793, DOI 10.1161/01.CIR.63.4.793; Kurland LT, 1970, COMMUNITY EPIDEMIOLO, P47; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Levy D, 1998, NEW ENGL J MED, V339, P915, DOI 10.1056/NEJM199809243391309; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; MCMURRY M, 1992, POPULATION NOTES, P1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Morrison AS, 1998, MODERN EPIDEMIOLOGY, P499; Psaty BM, 1999, AM J CARDIOL, V84, P108, DOI 10.1016/S0002-9149(99)00205-2; PSATY BM, 1999, AM J CARDIOL, V84, pA9, DOI DOI 10.1016/S0002-9149(99)00205-2; RODEHEFFER RJ, 1993, MAYO CLIN PROC, V68, P1143, DOI 10.1016/S0025-6196(12)60063-9; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P1417, DOI 10.1016/0735-1097(95)00341-X; Stewart S, 2001, EUR HEART J, V22, P693, DOI 10.1053/euhj.2000.2511; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0	33	1080	1128	0	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2004	292	3					344	350		10.1001/jama.292.3.344	http://dx.doi.org/10.1001/jama.292.3.344			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838DL	15265849	Bronze			2022-12-01	WOS:000222693500019
J	Watkins, D; McCarron, P; Murray, L; Cran, G; Boreham, C; Robson, P; McGartland, C; Smith, GD; Savage, M				Watkins, D; McCarron, P; Murray, L; Cran, G; Boreham, C; Robson, P; McGartland, C; Smith, GD; Savage, M			Trends in blood pressure over 10 years in adolescents: analyses of cross sectional surveys in the Northern Ireland Young Hearts project	BRITISH MEDICAL JOURNAL			English	Article							CORONARY RISK-FACTORS; SECULAR TRENDS; BIRTH-WEIGHT; ADULTHOOD; HYPERTENSION; POPULATION; CHILDHOOD; SCHOOLCHILDREN; MORTALITY; CHILDREN	Objective To examine secular trends in blood pressure over a 10 year period between two representative cohorts of adolescents from Northern Ireland. Design Repeat cross sectional study. Setting Randomly selected post-primary schools from Northern Ireland. Participants 10 15 adolescents studied between 1989 and 1990, and 2017 adolescents studied between 1999 and 2001. Participants were aged 12 or 15 years. Main outcome measures Systolic and diastolic blood pressure measured by one observer in each study. Results The four groups for sex and age showed decreases in both systolic blood pressure (mean decrease 7.7 mm Hg to 10.0 mm Hg) and diastolic blood pressure (8.8 mm Hg to 11.0 mm Hg). These decreases were not accounted for by adjustment for potential confounders including age, height, body mass index, smoking, physical activity, aerobic fitness, and stratification. The findings were not altered by additional adjustment for social class, pubertal status, birth weight, and infant feeding. No evidence was found of systematic variation between observers. Conclusions Substantial decreases in systolic and diastolic blood pressure over the past decade in adolescents from Northern Ireland are likely to have important benefits to public health and may help offset the increasing risk of cardiovascular disease due to increases in obesity.	Queens Univ Belfast, Royal Victoria Hosp, Inst Clin Sci, Dept Child Hlth, Belfast BT12 6JB, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; Univ Ulster, Dept Appl Med Sci & Sports Studies, Newtownabbey BT37 0QB, Antrim, North Ireland; Univ Ulster, No Ireland Ctr Diet & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Queens University Belfast; Queens University Belfast; Ulster University; Ulster University; University of Bristol	Watkins, D (corresponding author), Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England.	david.watkins@stockport-tr.nwest.nhs.uk	Robson, Paula J/Q-3351-2017; Davey Smith, George/A-7407-2013	Robson, Paula J/0000-0003-4640-1371; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768				BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Berenson GS, 1996, PUBLIC HEALTH REP, V111, P3; BOREHAM C, 1993, ARCH DIS CHILD, V68, P182, DOI 10.1136/adc.68.2.182; BOREHAM CAG, 1990, J SPORT MED PHYS FIT, V30, P19; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; *DEP HLTH, 2002, HLTH SURV ENGL TREND; DESWIET M, 1989, BRIT MED J, V299, P497, DOI 10.1136/bmj.299.6697.497; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; KOTCHEN JM, 1989, J CLIN EPIDEMIOL, V42, P735; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAUER RM, 1989, PEDIATRICS, V84, P633; Luepker RV, 1999, J PEDIATR-US, V134, P668, DOI 10.1016/S0022-3476(99)70279-9; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; McCarron P, 2002, J HUM HYPERTENS, V16, P677, DOI 10.1038/sj.jhh.1001471; McCarron P, 2001, BMJ-BRIT MED J, V322, P885, DOI 10.1136/bmj.322.7291.885; ROBERTS J, 1978, VITAL HLTH STAT 11, V166; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; THOM TJ, 1989, INT J EPIDEMIOL, V18, pS20; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Walton KA, 2000, EUR J EPIDEMIOL, V16, P793, DOI 10.1023/A:1007625030509; WRIGHT BM, 1970, LANCET, V1, P337	26	49	53	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 17	2004	329	7458					139	141		10.1136/bmj.38149.510139.7C	http://dx.doi.org/10.1136/bmj.38149.510139.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840BP	15226191	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000222832300017
J	Gray, JM; Karow, DS; Lu, H; Chang, AJ; Chang, JS; Ellis, RE; Marletta, MA; Bargmann, CI				Gray, JM; Karow, DS; Lu, H; Chang, AJ; Chang, JS; Ellis, RE; Marletta, MA; Bargmann, CI			Oxygen sensation and social feeding mediated by a C-elegans guanylate cyclase homologue	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; NITRIC-OXIDE; RESPONSES; HYPOXIA; ACTIVATION; BEHAVIOR; PATHWAYS; NEURONS; STATES	Specialized oxygen-sensing cells in the nervous system generate rapid behavioural responses to oxygen. We show here that the nematode Caenorhabditis elegans exhibits a strong behavioural preference for 5-12% oxygen, avoiding higher and lower oxygen levels. 3',5'-cyclic guanosine monophosphate (cGMP) is a common second messenger in sensory transduction and is implicated in oxygen sensation. Avoidance of high oxygen levels by C. elegans requires the sensory cGMP-gated channel tax-2/tax-4 and a specific soluble guanylate cyclase homologue, gcy-35. The GCY-35 haem domain binds molecular oxygen, unlike the haem domains of classical nitric-oxide-regulated guanylate cyclases. GCY-35 and TAX-4 mediate oxygen sensation in four sensory neurons that control a naturally polymorphic social feeding behaviour in C. elegans. Social feeding and related behaviours occur only when oxygen exceeds C. elegans' preferred level, and require gcy-35 activity. Our results suggest that GCY-35 is regulated by molecular oxygen, and that social feeding can be a behavioural strategy for responding to hyperoxic environments.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; Univ Med & Dent New Jersey, Sch Osteopath Med, Stratford, NJ 08084 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	marletta@berkeley.edu; cori@itsa.ucsf.edu		Lu, Hang/0000-0002-6881-660X; Bargmann, Cornelia/0000-0002-8484-0618				ANDERSON GL, 1977, J NEMATOL, V9, P253; BARAK R, 1982, J BACTERIOL, V152, P643; CHEUNG BHH, IN PRESS CURR BIOL; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; DIIORIO EE, 1981, HEMOGLOBINS, P57; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; DUSENBERY DB, 1980, J COMP PHYSIOL, V136, P333, DOI 10.1007/BF00657353; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; HIEB WF, 1970, SCIENCE, V168, P143, DOI 10.1126/science.168.3927.143; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; KAROW DS, IN PRESS BIOCHEMISTR; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lopez-Barneo J, 2003, CURR OPIN NEUROBIOL, V13, P493, DOI 10.1016/S0959-4388(03)00093-X; MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Morton DB, 1999, CURR BIOL, V9, pR546, DOI 10.1016/S0960-9822(99)80349-2; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sylvia D.M., 1998, PRINCIPLES APPL SOIL; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Wannamaker CM, 2000, J EXP MAR BIOL ECOL, V249, P145, DOI 10.1016/S0022-0981(00)00160-X; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x	33	412	447	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					317	322		10.1038/nature02714	http://dx.doi.org/10.1038/nature02714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15220933	Green Published			2022-12-01	WOS:000222631200032
J	Heil, M; Greiner, S; Meimberg, H; Kruger, R; Noyer, JL; Heubl, G; Linsenmair, KE; Boland, W				Heil, M; Greiner, S; Meimberg, H; Kruger, R; Noyer, JL; Heubl, G; Linsenmair, KE; Boland, W			Evolutionary change from induced to constitutive expression of an indirect plant resistance	NATURE			English	Article							PHYLOGENETIC RECONSTRUCTION; NECTAR PRODUCTION; INDUCED RESPONSES; DEFENSES; FABACEAE; MATK; BIOSYNTHESIS; MIMOSOIDEAE; INDUCTION; HERBIVORY	Induced plant resistance traits are expressed in response to attack and occur throughout the plant kingdom(1,2). Despite their general occurrence, the evolution of such resistances has rarely been investigated(3). Here we report that extrafloral nectar, a usually inducible trait, is constitutively secreted by Central American Acacia species that are obligately inhabited by ants. Extrafloral nectar is secreted as an indirect resistance(4), attracting ants that defend plants against herbivores(5). Leaf damage induces extrafloral nectar secretion in several plant species(6-8); among these are various Acacia species and other Fabaceae investigated here. In contrast, Acacia species obligately inhabited by symbiotic ants(9) nourish these ants by secreting extrafloral nectar constitutively at high rates that are not affected by leaf damage. The phylogeny of the genus Acacia and closely related genera indicate that the inducibility of extrafloral nectar is the plesiomorphic or 'original' state, whereas the constitutive extrafloral nectar flow is derived within Acacia. A constitutive resistance trait has evolved from an inducible one, obviously in response to particular functional demands.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; Biozentrum, Lehrstuhl Zool 3, D-94074 Wurzburg, Germany; Ludwig Maximilians Univ Munchen, Dept Biol 1, Sect Biodivers Res, D-80638 Munich, Germany; CIRAD, UMR 1096, PIA, F-34398 Montpellier 5, France	Max Planck Society; University of Wurzburg; University of Munich; CIRAD	Heil, M (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Hans Knoll Str 8,Beutenberg Campus, D-07745 Jena, Germany.	Heil_Martin@web.de	Heil, Martin/T-3960-2019; Boland, Wilhelm/K-7762-2012; Linsenmair, Karl Eduard/Q-2268-2018; Heil, Martin/AAC-2730-2022; Heil, Martin/I-1797-2012	Heil, Martin/0000-0001-8036-8697; Boland, Wilhelm/0000-0001-6784-2534; Linsenmair, Karl Eduard/0000-0002-2132-8721; Noyer, Jean-Louis/0000-0002-7389-5621; Meimberg, Harald/0000-0001-6696-2649				Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Baldwin IT, 1997, PLANTA, V201, P397, DOI 10.1007/s004250050082; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CUCUROU C, 1991, BIOCHEMISTRY-US, V30, P8964, DOI 10.1021/bi00101a008; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2004, CHEMOECOLOGY, V14, P45, DOI 10.1007/s00049-003-0257-x; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Janzen DH, 1974, SWOLLEN THORN ACACIA; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Karban R., 2007, INDUCED RESPONSES HE; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; Meimberg H, 2001, PLANT BIOLOGY, V3, P164, DOI 10.1055/s-2001-12897; Miller JT, 2003, SYST BOT, V28, P558; Miller JT, 2003, AUST SYST BOT, V16, P27, DOI 10.1071/SB01035; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Siemens DH, 1998, ECOLOGY, V79, P632, DOI 10.1890/0012-9658(1998)079[0632:EOPIDI]2.0.CO;2; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thaler JS, 1997, AM NAT, V149, P1139, DOI 10.1086/286042; Wackers FL, 2001, ANN BOT-LONDON, V87, P365, DOI 10.1006/anbo.2000.1342; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112	30	110	119	8	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					205	208		10.1038/nature02703	http://dx.doi.org/10.1038/nature02703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241414				2022-12-01	WOS:000222470600043
J	Taylor, HS				Taylor, HS			Endometrial cells derived from donor stem cells in bone marrow transplant recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADULT MICE; IN-VIVO; HEPATOCYTES; EXPRESSION; BRAIN; DIFFERENTIATE; MUSCLE; BLOOD	Context Regeneration of the endometrium in each menstrual cycle is required for reproduction. Endogenous endometrial stem cells reside in the basalis layer and serve as a source of cells that differentiate to form the endometrium. Bone marrow-derived cells have been shown to take on functions outside the hematopoietic system. Objective To investigate the possibility that cells of extrauterine origin could re-populate the endometrium. Design, Setting, and Patients Endometrium from 4 HLA-mismatched bone marrow transplant recipients (1998-2002) was evaluated for donor HLA expression. Each recipient had a bone marrow donor with an HLA type that enabled determination of the origin of any cell. Endometrial biopsies also were obtained from 4 healthy control women. Main Outcome Measure HLA type was determined by immunohistochemistry and by reverse transcription-polymerase chain reaction. Results Donor-derived endometrial cells were detected in endometrial biopsy samples from all bone marrow recipients and accounted for 0.2% to 48% of epithelial cells and 0.3% to 52% of stromal cells. None of the controls demonstrated HLA mismatch in endometrial samples. Conclusion These findings demonstrate that endometrial cells can originate from donor-derived bone marrow cells and suggest that nonuterine stem cells contribute to the regeneration of endometrial tissue.	Yale Univ, Sch Med, Div Reprod Endocrinol, New Haven, CT 06520 USA	Yale University	Taylor, HS (corresponding author), Yale Univ, Sch Med, Div Reprod Endocrinol, 333 Cedar St,POB 208063, New Haven, CT 06520 USA.	hugh.taylor@yale.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD036887, R01HD036887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 36887] Funding Source: Medline; NIEHS NIH HHS [ES 10610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; BEGOVICH AB, 1995, JAMA-J AM MED ASSOC, V273, P586, DOI 10.1001/jama.273.7.586; Bettinotti MP, 1997, J IMMUNOTHER, V20, P425, DOI 10.1097/00002371-199711000-00001; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Kumar S, 1998, J CLIN ENDOCR METAB, V83, P4443, DOI 10.1210/jc.83.12.4443; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pyo CW, 2001, TISSUE ANTIGENS, V58, P190, DOI 10.1034/j.1399-0039.2001.580309.x; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rier SE, 1997, SEMIN REPROD ENDOCR, V15, P209, DOI 10.1055/s-2008-1068750; Robertson SA, 2000, REV REPROD, V5, P164, DOI 10.1530/revreprod/5.3.164; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; SIDELL N, 2002, ANN NY ACAD SCI, V95, P159; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Unger JB, 1996, AM J OBSTET GYNECOL, V175, P1432, DOI 10.1016/S0002-9378(96)70086-8; Vinatier D, 2001, EUR J OBSTET GYN R B, V96, P21, DOI 10.1016/S0301-2115(00)00405-X	27	339	375	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2004	292	1					81	85		10.1001/jama.292.1.81	http://dx.doi.org/10.1001/jama.292.1.81			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834YZ	15238594	Bronze			2022-12-01	WOS:000222448100030
J	Han, JDJ; Bertin, N; Hao, T; Goldberg, DS; Berriz, GF; Zhang, LV; Dupuy, D; Walhout, AJM; Cusick, ME; Roth, FP; Vidal, M				Han, JDJ; Bertin, N; Hao, T; Goldberg, DS; Berriz, GF; Zhang, LV; Dupuy, D; Walhout, AJM; Cusick, ME; Roth, FP; Vidal, M			Evidence for dynamically organized modularity in the yeast protein-protein interaction network	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME; SCALE; IDENTIFICATION; ROBUSTNESS; MAP	In apparently scale-free protein-protein interaction networks, or 'interactome' networks(1,2), most proteins interact with few partners, whereas a small but significant proportion of proteins, the 'hubs', interact with many partners. Both biological and nonbiological scale-free networks are particularly resistant to random node removal but are extremely sensitive to the targeted removal of hubs(1). A link between the potential scale-free topology of interactome networks and genetic robustness(3,4) seems to exist, because knockouts of yeast genes(5,6) encoding hubs are approximately threefold more likely to confer lethality than those of non-hubs(1). Here we investigate how hubs might contribute to robustness and other cellular properties for protein protein interactions dynamically regulated both in time and in space. We uncovered two types of hub: 'party' hubs, which interact with most of their partners simultaneously, and 'date' hubs, which bind their different partners at different times or locations. Both in silico studies of network connectivity and genetic interactions described in vivo support a model of organized modularity in which date hubs organize the proteome, connecting biological processes-or modules(7)-to each other, whereas party hubs function inside modules.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Syst Biol, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Bertin, Nicolas/O-9602-2019; Roth, Frederick P/H-6308-2011; Dupuy, Denis/M-7299-2014; Bertin, Nicolas/C-3025-2008	Walhout, Marian/0000-0001-5587-3608; Dupuy, Denis/0000-0002-4781-5595; Han, Jing-Dong J./0000-0002-9270-7139; Bertin, Nicolas/0000-0002-9835-9606; Roth, Frederick/0000-0002-6628-649X				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Le Pont F, 2003, SEX TRANSM DIS, V30, P6, DOI 10.1097/00007435-200301000-00002; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	1285	1332	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					88	93		10.1038/nature02555	http://dx.doi.org/10.1038/nature02555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15190252				2022-12-01	WOS:000222356800049
J	Walker, N; Grassly, NC; Garnett, GP; Stanecki, KA; Ghys, PD				Walker, N; Grassly, NC; Garnett, GP; Stanecki, KA; Ghys, PD			Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic?	LANCET			English	Article							IMPACT; END	The validity of UNAIDS/WHO estimates of the burden of HIV/AIDS is rightly questioned by politicians, scientists, and activists-especially since the 2003 estimates to be released in July, 2004, will show substantial drops in the burden of HIV/AIDS in several countries, and increases in others. However, the estimates are based on an explicit attempt to meet criteria we believe should guide the generation of international morbidity and mortality figures. These criteria extend beyond the quality of the input data to include features of the estimation process such as transparency and participation. The 2003 estimates now include plausible ranges for estimates rather than a single best estimate. This reduces the chance that insignificant differences in estimates from different sources are given importance. Here, we describe the levels of uncertainty associated with the UNAIDS/WHO estimates of HIV/AIDS. We explain the reason for moving to the use of plausibility bounds, the factors that determine the width of the bounds, and the implications for policy makers and programme managers.	UNICEF, New York, NY 10017 USA; UNAIDS, United Nations Joint Programme HIV AIDS, Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	UNICEF; UNAIDS; Imperial College London	Walker, N (corresponding author), UNICEF, 3 UN Plaza, New York, NY 10017 USA.	nwalker@unicef.org	Garnett, Geoffrey P/A-9312-2008; Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507				Artzrouni M, 2002, AIDS, V16, pW1; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Burton AH, 1998, INT J EPIDEMIOL, V27, P101, DOI 10.1093/ije/27.1.101; Feeney G, 2001, POPUL DEV REV, V27, P771, DOI 10.1111/j.1728-4457.2001.00771.x; GARCIACALLEJA JM, IN PRESS SEX TRANSM; GHYS PD, IN PRESS SEX TRANSM; GRASSLY NC, IN PRESS SEX TRANSM; GRASSLY NC, 2004, POPULATION STUDIES, V55, P207; *NAT AIDS COUNC, 2002, ANC SENT SURV HIV SY; *NAT AIDS PROGR ZI, 2002, NAT SURV HIV SYPH PR; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; STOVER J, IN PRESS SEX TRANSM; TIMAEUS IM, 2001 ANN M FIN PROGR; *UNAIDS, 2000, REP GLOB HIV EP; *UNAIDS, 2002, REP GLOB HIV EP; *UNAIDS, 2004, IN PRESS REP GLOB HI; *UNAIDS, 1998, REP GLOB HIV EP; *UNAIDS, 2000, GUID 2 GEN SURV GEN; *UNAIDS, 2000, MEAS EV; UNICEF, 2004, STAT WORLDS CHILDR 2; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; Walker N, 2001, AIDS, V15, P1545, DOI 10.1097/00002030-200108170-00012; WALKER N, IN PRESS SEX TRANSM; *WHO UNAIDS, 1999, 11 WHOUNAIDS; World Health Organization, 1998, WORLD HLTH REP 1997; World Health Organization, 1999, WORLD HLTH REP 1999; World Health Organization, 2000, WORLD HLTH REP 2000	28	57	60	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 26	2004	363	9427					2180	2185		10.1016/S0140-6736(04)16511-2	http://dx.doi.org/10.1016/S0140-6736(04)16511-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832LF	15220043				2022-12-01	WOS:000222268300024
J	Grantham, BA; Chan, F; Nielsen, KJ; Fox, DS; Barth, JA; Huyer, A; Lubchenco, J; Menge, BA				Grantham, BA; Chan, F; Nielsen, KJ; Fox, DS; Barth, JA; Huyer, A; Lubchenco, J; Menge, BA			Upwelling-driven nearshore hypoxia signals ecosystem and oceanographic changes in the northeast Pacific	NATURE			English	Article							CALIFORNIA CURRENT; ART.; OREGON; OCEAN; CHLOROPHYLL; SHELF	Seasonal development of dissolved-oxygen deficits (hypoxia) represents an acute system-level perturbation to ecological dynamics and fishery sustainability in coastal ecosystems around the globe(1-3). Whereas anthropogenic nutrient loading has increased the frequency and severity of hypoxia in estuaries and semi-enclosed seas(3,4), the occurrence of hypoxia in open-coast upwelling systems reflects ocean conditions that control the delivery of oxygen-poor and nutrient-rich deep water onto continental shelves(1). Upwelling systems support a large proportion of the world's fisheries(5), therefore understanding the links between changes in ocean climate, upwelling-driven hypoxia and ecological perturbations is critical. Here we report on the unprecedented development of severe inner-shelf (<70 m) hypoxia and resultant mass die-offs of fish and invertebrates within the California Current System. In 2002, cross-shelf transects revealed the development of abnormally low dissolved-oxygen levels as a response to anomalously strong flow of subarctic water into the California Current System. Our findings highlight the sensitivity of inner-shelf ecosystems to variation in ocean conditions, and the potential impacts of climate change on marine communities.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Washington State Dept Ecol, Coastal & Estuarine Assessment Unit, Olympia, WA 98504 USA; Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR 97365 USA	Oregon State University; Oregon State University; California State University System; Sonoma State University	Chan, F (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	chanft@science.oregonstate.edu	Menge, Bruce/I-6571-2012; Nielsen, Karina Johanne/AAQ-6430-2020	Nielsen, Karina/0000-0002-7438-0240				BAILEY GW, 1985, S AFRICAN J MARINE S, V3, P197; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barth JA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017511; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; DILLMAN T, 2002, ABUNDANCE FISH AREA; FLEISCHBEIN J, 2003, US GLOBEC; FOX DS, 2000, OREGON DEP FISH WILD; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; HUYER A, 1974, Tethys, V6, P391; KAMYKOWSKI D, 1990, DEEP-SEA RES, V37, P1861, DOI 10.1016/0198-0149(90)90082-7; Kosro PM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017436; Morales CE, 1999, J MAR RES, V57, P909, DOI 10.1357/002224099321514097; Murphree T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017303; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; *NAT MAR FISH SERV, 1999, NMFSFSPO41 NOAA US D; *NAT RES COUNC, 2000, COAST WAT UND RED EF; Oke PR, 2002, J PHYS OCEANOGR, V32, P1360, DOI 10.1175/1520-0485(2002)032<1360:AMSOTT>2.0.CO;2; OMALLEY R, 2003, SEASOAR OBSERVATIONS; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Rabalais NN, 2001, COAST EST S, V58, P1; REELAND HJ, 2003, GEOPHYS RES LETT, V30, P1141, DOI DOI 10.1029/2002GL016663; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Strub PT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017513; Thomas AC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017409; Wheeler PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017395	27	399	414	9	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					749	754		10.1038/nature02605	http://dx.doi.org/10.1038/nature02605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201908				2022-12-01	WOS:000222059900036
J	Picard, F; Kurtev, M; Chung, NJ; Topark-Ngarm, A; Senawong, T; de Oliveira, RM; Leid, M; McBurney, MW; Guarente, L				Picard, F; Kurtev, M; Chung, NJ; Topark-Ngarm, A; Senawong, T; de Oliveira, RM; Leid, M; McBurney, MW; Guarente, L			Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma	NATURE			English	Article							CEREVISIAE LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; RECEPTOR; DIFFERENTIATION; ADIPOGENESIS	Calorie restriction extends lifespan in organisms ranging from yeast to mammals(1). In yeast, the SIR2 gene mediates the life-extending effects of calorie restriction(2). Here we show that the mammalian SIR2 orthologue, Sirt1 (sirtuin 1), activates a critical component of calorie restriction in mammals; that is, fat mobilization in white adipocytes. Upon food withdrawal Sirt1 protein binds to and represses genes controlled by the fat regulator PPAR-gamma (peroxisome proliferator-activated receptor-gamma), including genes mediating fat storage. Sirt1 represses PPAR-gamma by docking with its cofactors NCoR (nuclear receptor co-repressor) and SMRT ( silencing mediator of retinoid and thyroid hormone receptors). Mobilization of fatty acids from white adipocytes upon fasting is compromised in Sirt1(+/-) mice. Repression of PPAR-gamma by Sirt1 is also evident in 3T3-L1 adipocytes, where overexpression of Sirt1 attenuates adipogenesis, and RNA interference of Sirt1 enhances it. In differentiated fat cells, upregulation of Sirt1 triggers lipolysis and loss of fat. As a reduction in fat is sufficient to extend murine lifespan(3), our results provide a possible molecular pathway connecting calorie restriction to life extension in mammals.	MIT, Dept Biol, Cambridge, MA 02139 USA; Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Mol Pharmacol Lab, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; Univ Porto, ICBAS, Grad Program Basic & Appl Biol, P-4099003 Oporto, Portugal; Univ Ottawa, Ottawa Reg Canc Ctr, Ottawa, ON K1H 1C4, Canada; Univ Ottawa, Dept Med, Ottawa, ON K1H 1C4, Canada	Massachusetts Institute of Technology (MIT); Oregon State University; Oregon State University; Universidade do Porto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	de Oliveira, Rita M/E-9696-2015	de Oliveira, Rita M/0000-0002-0970-4501	NIGMS NIH HHS [R01 GM060852, R01 GM060852-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gabriely I, 2001, MECH AGEING DEV, V122, P1565, DOI 10.1016/S0047-6374(01)00287-1; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MARETTE A, 1991, AM J PHYSIOL, V261, pE204, DOI 10.1152/ajpendo.1991.261.2.E204; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Miles PDG, 2003, AM J PHYSIOL-ENDOC M, V284, pE618, DOI 10.1152/ajpendo.00312.2002; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Weindruch R., 1988, RETARDATION AGING DI	30	1541	1669	5	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					771	776		10.1038/nature02583	http://dx.doi.org/10.1038/nature02583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15175761	Green Accepted			2022-12-01	WOS:000222059900041
J	Bayliss, R				Bayliss, R			The arrogance of youth	LANCET			English	Editorial Material											Bayliss, R (corresponding author), 61 Onslow Sq, London SW7 3LS, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 29	2004	363	9423					1793	1793		10.1016/S0140-6736(04)16306-X	http://dx.doi.org/10.1016/S0140-6736(04)16306-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824SD	15172779				2022-12-01	WOS:000221705800022
J	West, J; Logan, RFA; Smith, CJ; Hubbard, RB; Card, TR				West, J; Logan, RFA; Smith, CJ; Hubbard, RB; Card, TR			Malignancy and mortality in people with coeliac disease: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; RISK; CANCER; DEATH	Objective To quantify the risks of malignancy and mortality in people with coeliac disease compared with the general population. Design Population based cohort study. Setting General practice research database. Participants 4732 people with coeliac disease and 23 620 matched controls. Main outcome measures Hazard ratios for malignancy and mortality. Results Of the 4732 people with coeliac disease, 134 (2.8%) had at least one malignancy and 237 (5.0%) died. The overall hazard ratios were: for any malignancy 1.29 (95% confidence interval 1.06 to 1.55), for mortality 1.31 (1.13 to 1.51), for gastrointestinal cancer 1.85 (1.22 to 2.81), for breast cancer 0.35 (0.17 to 0.72), for lung cancer 0.34 (0.13 to 0.95), and for lymphoproliferative disease 4.80 (2.71 to 8.50). The increased risk was primarily in the first year after diagnosis, with only the risk for lymphoproliferative disease remaining significantly raised thereafter. After excluding events in the year after diagnosis, the hazard ratio for malignancy was 1.10 (0.87 to 1.39) and for mortality was 1.17 (0.98 to 1.38), giving absolute excess rates of 6 and 17 per 10 000 person years, respectively. Conclusions People with coeliac disease have modest increases in overall risks of malignancy and mortality. Most of this excess risk occurs in the first year after diagnosis. People with coeliac disease also have a noticeably reduced risk of breast cancer. The mechanism of this merits further attention as it may provide insights into the cause of this common malignancy.	Univ Nottingham, Queens Med Ctr, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England; Univ Nottingham, City Hosp Nottingham, Sch Med & Surg Sci, Nottingham NG5 1PB, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	West, J (corresponding author), Univ Nottingham, Queens Med Ctr, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England.	joe.west@nottinghani.ac.uk	West, Joe/I-6637-2012; West, Joe/M-3867-2019; Card, Tim/J-8651-2013	West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Card, Tim/0000-0003-2555-2250				Askling J, 2002, GASTROENTEROLOGY, V123, P1428, DOI 10.1053/gast.2002.36585; Catassi C, 2002, JAMA-J AM MED ASSOC, V287, P1413, DOI 10.1001/jama.287.11.1413; COOPER BT, 1980, MEDICINE, V59, P249, DOI 10.1097/00005792-198007000-00002; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Cottone M, 1999, DIGEST DIS SCI, V44, P2538, DOI 10.1023/A:1026655609906; Faggiano F, 1997, IARC Sci Publ, P65; HOHNES GK, 1989, GUT, V30, P333; Hollowell J, 1997, Popul Trends, P36; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lo WS, 2003, DIGEST DIS SCI, V48, P395, DOI 10.1023/A:1021956200382; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Sanders DS, 2002, POSTGRAD MED J, V78, P31, DOI 10.1136/pmj.78.915.31; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960	21	257	267	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 25	2004	329	7468					716	718A		10.1136/bmj.38169.486701.7C	http://dx.doi.org/10.1136/bmj.38169.486701.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15269095	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000224210300018
J	MacMahon, E; Brown, LJ; Bexley, S; Snashall, DC; Patel, D				MacMahon, E; Brown, LJ; Bexley, S; Snashall, DC; Patel, D			Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study	BRITISH MEDICAL JOURNAL			English	Article							ZOSTER-VIRUS; INFECTION		Guys & St Thomas NHS Trust, Dept Infect, London SE1 7EH, England; Guys & St Thomas NHS Trust, Dept Occupat Hlth, London SE1 7EH, England; Guys Kings & St Thomas Sch Med, Dept Occupat Hlth, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	MacMahon, E (corresponding author), Guys & St Thomas NHS Trust, Dept Infect, London SE1 7EH, England.	eithne.macmahon@gstt.sthames.nhs.uk						BUCHANAN J, 2000, BRIT MED J, P1067; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; ROGERS J, 1997, BMJ S, V315, pS2; Vandersmissen G, 2000, OCCUP ENVIRON MED, V57, P621, DOI 10.1136/oem.57.9.621	4	24	26	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 4	2004	329	7465					551	552		10.1136/bmj.38170.691956.AE	http://dx.doi.org/10.1136/bmj.38170.691956.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853DE	15273160	Green Published, Bronze			2022-12-01	WOS:000223805800024
J	Prandoni, P; Bernardi, E; Marchiori, A; Lensing, AWA; Prins, MH; Villalta, S; Bagatella, P; Sartor, D; Piccioli, A; Simioni, P; Pagnan, A; Girolami, A				Prandoni, P; Bernardi, E; Marchiori, A; Lensing, AWA; Prins, MH; Villalta, S; Bagatella, P; Sartor, D; Piccioli, A; Simioni, P; Pagnan, A; Girolami, A			The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOSIS		Univ Hosp Padua, Dept Med & Surg Sci, Chair Internal Med 2, I-35128 Padua, Italy; Univ Amsterdam, Acad Med Ctr, Ctr Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Maastricht, Dept Clin Epidemiol & Technol Assessment, NL-6202 AZ Maastricht, Netherlands	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Prandoni, P (corresponding author), Univ Hosp Padua, Dept Med & Surg Sci, Chair Internal Med 2, Via Osped Civile 105, I-35128 Padua, Italy.	paoloprandoni@tin.it	SIMIONI, PAOLO/AAC-5438-2022; Simioni, Paolo/AAC-5416-2022	SIMIONI, PAOLO/0000-0002-6744-383X; 				Hirsh J, 2002, BLOOD, V99, P3102, DOI 10.1182/blood.V99.9.3102; Kahn SR, 2002, ARCH INTERN MED, V162, P1144, DOI 10.1001/archinte.162.10.1144; Kommareddy A, 2002, SEMIN THROMB HEMOST, V28, P89, DOI 10.1055/s-2002-20567; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001	5	117	119	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					484	485		10.1136/bmj.38167.684444.3A	http://dx.doi.org/10.1136/bmj.38167.684444.3A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15256419	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000223684600013
J	Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB				Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB			The avian nature of the brain and inner ear of Archaeopteryx	NATURE			English	Article							EVOLUTION; ORIGIN; SIZE	Archaeopteryx, the earliest known flying bird (avialan) from the Late Jurassic period, exhibits many shared primitive characters with more basal coelurosaurian dinosaurs ( the clade including all theropods more bird- like than Allosaurus)(1), such as teeth, a long bony tail and pinnate feathers(2). However, Archaeopteryx possessed asymmetrical flight feathers on its wings and tail, together with a wing feather arrangement shared with modern birds. This suggests some degree of powered flight capability(3) but, until now, little was understood about the extent to which its brain and special senses were adapted for flight. We investigated this problem by computed tomography scanning and three-dimensional reconstruction of the braincase of the London specimen of Archaeopteryx. Here we show the reconstruction of the braincase from which we derived endocasts of the brain and inner ear. These suggest that Archaeopteryx closely resembled modern birds in the dominance of the sense of vision and in the possession of expanded auditory and spatial sensory perception in the ear. We conclude that Archaeopteryx had acquired the derived neurological and structural adaptations necessary for flight. An enlarged forebrain suggests that it had also developed enhanced somatosensory integration with these special senses demanded by a lifestyle involving flying ability(4).	Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Complutense Madrid, Dept Paleontol, E-28040 Madrid, Spain; Univ Texas, High Resolut Xray CT Facil, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	Natural History Museum London; Complutense University of Madrid; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Hertfordshire	Milner, AC (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	A.Milner@nhm.ac.uk	Ketcham, Richard/B-5431-2011; Domínguez Alonso, Patricio/C-2679-2013	Ketcham, Richard/0000-0002-2748-0409; 				BROCHU CA, 2003, MEMOIR SOC VERTEBRAT, V7, P1, DOI DOI 10.2307/3889334; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; DUBBELDAM JL, 1998, CENTRAL NERVOUS SYST, V3, P1525; Elzanowski A., 1991, Journal of Vertebrate Paleontology, V11, P90; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Elzanowski Andrzej, 2002, P129; Franzosa J.W., 2004, THESIS U TEXAS; Gleich O, 2000, SPR HDB AUD, V13, P70; Gray A.A., 1908, LABYRINTH ANIMALS IN, VII; Hopson J.A., 1979, P39; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; JERISON HJ, 1968, NATURE, V219, P1381, DOI 10.1038/2191381a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PALTEL R, 1979, BIOL REPTILIA, V9, P147; PEARSON R, 1972, AVIAN BRAIN; Shimizu Toru, 2001, P135; STARCK D, 1979, BIOL REPTILIA, V9, P1; Walker A., 1985, P123; Wever E.G., 1978, REPTILE EAR ITS STRU; WHETSTONE K N, 1983, Journal of Vertebrate Paleontology, V2, P439; Whybrow P.J., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1982, P184; Witmer L.M., 1997, ENCY DINOSAURS PP, P151; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x	29	141	149	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					666	669		10.1038/nature02706	http://dx.doi.org/10.1038/nature02706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295597				2022-12-01	WOS:000223085400042
J	Aspholm-Hurtig, M; Dailide, G; Lahmann, M; Kalia, A; Ilver, D; Roche, N; Vikstrom, S; Sjostrom, R; Linden, S; Backstrom, A; Lundberg, C; Arnqvist, A; Mahdavi, J; Nilsson, UJ; Velapatino, B; Gilman, RH; Gerhard, M; Alarcon, T; Lopez-Brea, M; Nakazawa, T; Fox, JG; Correa, P; Dominguez-Bello, MG; Perez-Perez, GI; Blaser, MJ; Normark, S; Carlstedt, I; Oscarson, S; Teneberg, S; Berg, DE; Boren, T				Aspholm-Hurtig, M; Dailide, G; Lahmann, M; Kalia, A; Ilver, D; Roche, N; Vikstrom, S; Sjostrom, R; Linden, S; Backstrom, A; Lundberg, C; Arnqvist, A; Mahdavi, J; Nilsson, UJ; Velapatino, B; Gilman, RH; Gerhard, M; Alarcon, T; Lopez-Brea, M; Nakazawa, T; Fox, JG; Correa, P; Dominguez-Bello, MG; Perez-Perez, GI; Blaser, MJ; Normark, S; Carlstedt, I; Oscarson, S; Teneberg, S; Berg, DE; Boren, T			Functional adaptation of BabA, the H-pylori ABO blood group antigen binding adhesin	SCIENCE			English	Article							EXPRESSION; INFECTION	Adherence by Helicobacter pylori increases the risk of gastric disease. Here, we report that more than 95% of strains that bind fucosylated blood group antigen bind A, B, and O antigens ( generalists), whereas 60% of adherent South American Amerindian strains bind blood group O antigens best ( specialists). This specialization coincides with the unique predominance of blood group O in these Amerindians. Strains differed about 1500-fold in binding affinities, and diversifying selection was evident in babA sequences. We propose that cycles of selection for increased and decreased bacterial adherence contribute to babA diversity and that these cycles have led to gradual replacement of generalist binding by specialist binding in blood group O - dominant human populations.	Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Umea Univ, Dept Odontol, Sect Oral Microbiol, SE-90187 Umea, Sweden; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Gothenburg, Dept Chem, SE-41296 Gothenburg, Sweden; Lund Univ, Dept Cell & Mol Biol, SE-22184 Lund, Sweden; Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; Lund Univ, SE-22100 Lund, Sweden; Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; Tech Univ Munich, Klinikum Rechts Isar, Dept Med, DE-81675 Munich, Germany; Hosp Princesa, Dept Microbiol, Madrid 28006, Spain; Yamaguchi Univ, Sch Med, Dept Microbiol, Ube, Yamaguchi 7558505, Japan; MIT, Div Comparat Med, Cambridge, MA 02139 USA; Louisiana State Univ, Med Ctr, New Orleans, LA 70112 USA; Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Karolinska Inst, MTC, SE-17177 Stockholm, Sweden; Stockholm Univ, Arrhenius Lab, Dept Organ Chem, SE-10691 Stockholm, Sweden; Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	University of Gothenburg; Umea University; Washington University (WUSTL); University of Gothenburg; Lund University; Umea University; Lund University; Universidad Peruana Cayetano Heredia; Technical University of Munich; Hospital de La Princesa; Yamaguchi University; Massachusetts Institute of Technology (MIT); Louisiana State University System; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; New York University; Karolinska Institutet; Stockholm University; Umea University	Teneberg, S (corresponding author), Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se; Berg@borcim.wustl.edu; Thomas.Boren@medchem.umu.se	Lahmann, Martina/A-3090-2010; Gerhard, Markus/P-8996-2019; Gerhard, Markus/N-3387-2014; Lindén, Sara K/A-3271-2011; Nilsson, Ulf J./L-3219-2014; Aspholm, Marina/ABB-5298-2020; Perez, Guillermo Perez/AAJ-3761-2020	Lahmann, Martina/0000-0002-8513-1952; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Lindén, Sara K/0000-0002-7751-9586; Nilsson, Ulf J./0000-0001-5815-9522; Aspholm, Marina/0000-0003-3175-6022; Kalia, Awdhesh/0000-0001-5365-1702; Oscarson, Stefan/0000-0002-8273-4918; Perez Perez, Guillermo/0000-0002-0131-5798; Ilver, Dag/0000-0002-3618-9496	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI049161, R01AI038166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041, P30DK052574, R01DK053727] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI38166, R03 AI49161] Funding Source: Medline; NIDDK NIH HHS [P30 DK52574, R01 DK53727, R01 DK63041] Funding Source: Medline; NIGMS NIH HHS [R0IGM62370] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASPHOLMHURTIG M, UNPUB; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; CLARKE CA, 1955, BRIT MED J, V2, P643, DOI 10.1136/bmj.2.4940.643; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; DAILIDE G, UNPUB; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mourant AE., 1976, DISTRIBUTION HUMAN B; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pride DT, 2002, J MOL BIOL, V316, P629, DOI 10.1006/jmbi.2001.5311; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100	15	293	306	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					519	522		10.1126/science.1098801	http://dx.doi.org/10.1126/science.1098801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273394				2022-12-01	WOS:000222828900040
J	Shu, DG; Morris, SC; Han, J; Zhang, ZF; Liu, JN				Shu, DG; Morris, SC; Han, J; Zhang, ZF; Liu, JN			Ancestral echinoderms from the Chengjiang deposits of China	NATURE			English	Article							DEUTEROSTOME EVOLUTION; ORIGIN; SOLUTE; FOSSIL; HEMICHORDATE; EXPRESSION; PHYLOGENY; SEQUENCE; TUNICATE; ANATOMY	Deuterostomes are a remarkably diverse super-phylum, including not only the chordates ( to which we belong) but groups as disparate as the echinoderms and the hemichordates. The phylogeny of deuterostomes is now achieving some degree of stability, especially on account of new molecular data, but this leaves as conjectural the appearance of extinct intermediate forms that would throw light on the sequence of evolutionary events leading to the extant groups. Such data can be supplied from the fossil record, notably those deposits with exceptional soft-part preservation. Excavations near Kunming in southwestern China have revealed a variety of remarkable early deuterostomes, including the vetulicolians and yunnanozoans. Here we describe a new group, the vetulocystids. They appear to have similarities not only to the vetulicolians but also to the homalozoans, a bizarre group of primitive echinoderms whose phylogenetic position has been highly controversial.	China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	China University of Geosciences; Northwest University Xi'an; Northwest University Xi'an; University of Cambridge	Shu, DG (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	elidgshu@nwu.edu.cn	Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				Babcock Loren E., 2001, Palaeoworld, V13, P66; BEAVER HH, 1967, TREATISE INVERTEBR S, V2, pS300; Bromham LD, 1999, EVOL DEV, V1, P166, DOI 10.1046/j.1525-142x.1999.99026.x; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; CASTER KE, 1967, TREATISE INVERTEB S, V2, pS581; Chen AL, 2003, ACTA GEOL SIN-ENGL, V77, P281; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; Daley PEJ, 1996, ZOOL J LINN SOC-LOND, V117, P405; Daley PEJ, 1995, GEOBIOS-LYON, V28, P585, DOI 10.1016/S0016-6995(95)80214-2; DALEY PEJ, 1992, ZOOL J LINN SOC-LOND, V105, P353, DOI 10.1111/j.1096-3642.1992.tb01233.x; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; Dominguez P., 1999, P269; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dominguez-Alonso P., 1999, P263; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gee H., 1996, BACKBONE VIEWS ORIGI; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Holland LZ, 1997, DEVELOPMENT, V124, P1723; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101, DOI 10.1111/j.1463-6395.1996.tb01256.x; Jefferies RPS, 1997, LETHAIA, V30, P1; JOLLIE M, 1982, ZOOL J LINN SOC-LOND, V75, P167, DOI 10.1111/j.1096-3642.1982.tb01946.x; Kesling R.V., 1967, TREATISE INVERTEBRAT, V1, pS85; Lacalli TC, 2002, BIOESSAYS, V24, P208, DOI 10.1002/bies.10064; Lefebvre B, 2003, PALAEONTOLOGY, V46, P511, DOI 10.1111/1475-4983.00309; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Parsley R. L., 1999, P369; PARSLEY RL, 1994, ECHINODERMS THROUGH TIME, P167; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 2003, CHINESE SCI BULL, V48, P725, DOI 10.1360/03wd0026; Shu DG, 2003, SCIENCE, V299, P1380, DOI 10.1126/science.1079846; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Sly BJ, 2002, EVOL DEV, V4, P189, DOI 10.1046/j.1525-142X.2002.02002.x; Smith MP, 2001, SYST ASSOC SPEC VOL, V61, P67; SPRINKLE J, 1978, TREATISE INVERTEBR T, V3, pT998; UBAGHS G, 1967, TREATISE INVERTEBR S, V2, pS495; UBAGHS G, 1967, TREATISE INVERTEBR S, V2, pS455; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Wray GA, 2000, SYST BIOL, V49, P28, DOI 10.1080/10635150050207375; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	45	78	97	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					422	428		10.1038/nature02648	http://dx.doi.org/10.1038/nature02648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269760				2022-12-01	WOS:000222801400034
J	Pikitch, EK; Santora, C; Babcock, EA; Bakun, A; Bonfil, R; Conover, DO; Dayton, P; Doukakis, P; Fluharty, D; Heneman, B; Houde, ED; Link, J; Livingston, PA; Mangel, M; McAllister, MK; Pope, J; Sainsbury, KJ				Pikitch, EK; Santora, C; Babcock, EA; Bakun, A; Bonfil, R; Conover, DO; Dayton, P; Doukakis, P; Fluharty, D; Heneman, B; Houde, ED; Link, J; Livingston, PA; Mangel, M; McAllister, MK; Pope, J; Sainsbury, KJ			Ecosystem-based fishery management	SCIENCE			English	Editorial Material							FISHING MORTALITY; STRATEGIES; IMPACTS; MODELS		Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Pew Inst Ocean Sci, New York, NY 10022 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Wildlife Conservat Soc, Bronx, NY 10460 USA; SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Washington, Sch Marine Affairs, Seattle, WA 98105 USA; Commonweal Ocean Policy Program, Bolinas, CA 94924 USA; Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; NOAA, Natl Marine Fisheries Serv, NE Fishery Sci Ctr, Food Web Dynam Program, Woods Hole, MA 02543 USA; Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, London SW7 2BP, England; Natl Res Council Europe Ltd, Norfolk NR34 OBT, England; CSIRO, Div Marine Res, Hobart, Tas 7001, Australia	University of Miami; Wildlife Conservation Society; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Center for Environmental Science; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; Imperial College London; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pikitch, EK (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Pew Inst Ocean Sci, New York, NY 10022 USA.	epikitch@rsmas.miami.edu	Babcock, Elizabeth A/E-7753-2013; Bonfil, Ramón/K-1226-2012; Houde, Edward/D-8498-2012	Bakun, Andrew/0000-0002-4366-3846; Link, Jason/0000-0003-2740-7161; Babcock, Elizabeth A/0000-0002-2279-6762; Bonfil, Ramon/0000-0002-5753-464X				Alverson DL, 1997, AM FISH S S, V20, P115; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; *EC PRINC ADV PAN, 1999, EC FISH MAN REP C EC; *FAO FISH DEP, 2002, STAT WORLD FISH AQ; *FAO FISH DEP, 2003, 4 FAO S2; Gislason H, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P255, DOI 10.1079/9780851996332.0255; *HL, 1996, 25 HL; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; KAUFMAN L, IN PRESS B MAR SCI; Latour RJ, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:TEFM]2.0.CO;2; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Major P, 1997, AM FISH S S, V20, P264; *MIN ENV, 1997, INT MIN M INT FISH E; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; National Research Council, 1999, SUST MAR FISH; Pew Oceans Commission, 2003, AM LIV OC CHART COUR; Pope JG, 2000, ICES J MAR SCI, V57, P689, DOI 10.1006/jmsc.2000.0729; Rice JC, 2000, ICES J MAR SCI, V57, P682, DOI 10.1006/jmsc.2000.0735; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Sainsbury KJ, 1997, AM FISH S S, V20, P107; Smith ADM, 1999, ICES J MAR SCI, V56, P967, DOI 10.1006/jmsc.1999.0540; U.S. Commission on Ocean Policy, 2004, PREL REP US COMM OC; Whipple SJ, 2000, FISH FISH, V1, P22, DOI 10.1046/j.1467-2979.2000.00007.x; Witherell D, 2000, ICES J MAR SCI, V57, P771, DOI 10.1006/jmsc.2000.0719	25	1501	1557	9	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					346	347		10.1126/science.1098222	http://dx.doi.org/10.1126/science.1098222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256658				2022-12-01	WOS:000222662400022
J	Sisneros, JA; Forlano, PM; Deitcher, DL; Bass, AH				Sisneros, JA; Forlano, PM; Deitcher, DL; Bass, AH			Steroid-dependent auditory plasticity leads to adaptive coupling of sender and receiver	SCIENCE			English	Article							RELEVANT ACOUSTIC-SIGNALS; PHASE-LOCKING; SENSORY EXPLOITATION; PLAINFIN MIDSHIPMAN; SEASONAL PLASTICITY; ESTROGEN-RECEPTORS; SEXUAL SELECTION; ALLIGATOR LIZARD; COCHLEAR NERVE; TELEOST FISH	For seasonally breeding vertebrates, reproductive cycling is often coupled with changes in vocalizations that function in courtship and territoriality. Less is known about changes in auditory sensitivity to those vocalizations. Here, we show that nonreproductive female midshipman fish treated with either testosterone or 17beta-estradiol exhibit an increase in the degree of temporal encoding of the frequency content of male vocalizations by the inner ear that mimics the reproductive female's auditory phenotype. This sensory plasticity provides an adaptable mechanism that enhances coupling between sender and receiver in vocal communication.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Sisneros, JA (corresponding author), Univ Washington, Dept Psychol, Guthrie Hall,Box 351525, Seattle, WA 98195 USA.	sisneros@u.washington.edu; ahb3@cornell.edu	Sisneros, Joseph/AAU-9965-2020; Deitcher, David/K-6538-2019	Forlano, Paul/0000-0003-4258-5708; Deitcher, David/0000-0002-8512-8868; Sisneros, Joseph/0000-0002-3114-773X	NIDCD NIH HHS [1F32DC00445, DC00092] Funding Source: Medline; NIMH NIH HHS [5T32MH15793] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000445] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bass AH, 2003, SPR HDB AUD, V16, P15; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; ELKINDHIRSCH KE, 1994, OTOLARYNG HEAD NECK, V110, P46, DOI 10.1016/S0194-5998(94)70791-X; FAY RR, 1978, NATURE, V275, P320, DOI 10.1038/275320a0; FINE ML, 1983, COMP BIOCHEM PHYS A, V76, P225, DOI 10.1016/0300-9629(83)90319-5; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Haggard M, 1978, Br J Audiol, V12, P105, DOI 10.3109/03005367809078862; Hauser MD., 1996, EVOLUTION COMMUNICAT; Hultcrantz M, 2000, HEARING RES, V143, P182, DOI 10.1016/S0378-5955(00)00042-3; JAVEL E, 1988, HEARING RES, V34, P275, DOI 10.1016/0378-5955(88)90008-1; Koppl C, 1997, J NEUROSCI, V17, P3312; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; McFadden D, 1998, DEV NEUROPSYCHOL, V14, P261, DOI 10.1080/87565649809540712; McKibben JR, 1999, J COMP PHYSIOL A, V184, P563, DOI 10.1007/s003590050356; McKibben JR, 2001, J COMP PHYSIOL A, V187, P271, DOI 10.1007/s003590100199; NARINS PM, 1976, SCIENCE, V192, P378, DOI 10.1126/science.1257772; NELSON RJ, 2000, BEHAV NEUROENDOCRINO; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Ramanathan K, 2002, BIOPHYS J, V82, P64, DOI 10.1016/S0006-3495(02)75374-5; ROSE C, 1988, HEARING RES, V33, P151, DOI 10.1016/0378-5955(88)90028-7; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; SHAW K, 1995, TRENDS ECOL EVOL, V10, P117, DOI 10.1016/S0169-5347(00)89005-9; Sisneros JA, 2004, GEN COMP ENDOCR, V136, P101, DOI 10.1016/j.ygcen.2003.12.007; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Stenberg AE, 2001, HEARING RES, V157, P87, DOI 10.1016/S0378-5955(01)00280-5; Stenberg AE, 1999, HEARING RES, V136, P29, DOI 10.1016/S0378-5955(99)00098-2; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; WEISS TF, 1988, HEARING RES, V33, P167, DOI 10.1016/0378-5955(88)90029-9; YOVANOF S, 1983, NEUROSCI LETT, V36, P291, DOI 10.1016/0304-3940(83)90015-0; Zar JH., 1999, BIOSTAT ANAL	33	177	181	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					404	407		10.1126/science.1097218	http://dx.doi.org/10.1126/science.1097218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256672				2022-12-01	WOS:000222662400041
J	Marko, PB; Lee, SC; Rice, AM; Gramling, JM; Fitzhenry, TM; McAlister, JS; Harper, GR; Moran, AL				Marko, PB; Lee, SC; Rice, AM; Gramling, JM; Fitzhenry, TM; McAlister, JS; Harper, GR; Moran, AL			Mislabelling of a depleted reef fish	NATURE			English	Editorial Material									Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Marko, PB (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA.	pmarko@unc.edu	Lee, Sarah/Q-3372-2017; Rice, Amber/F-3410-2011; Moran, Amy/F-7072-2011; Rice, Amber/AHB-1530-2022	Rice, Amber/0000-0002-5475-8226; Rice, Amber/0000-0002-5475-8226; Moran, Amy/0000-0002-0604-5096				*GULF MEX FISH MAN, 1994, REEF FISH ASS PAN RE; HUANG TS, 1995, J AGR FOOD CHEM, V43, P2301, DOI 10.1021/jf00056a063; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; MORAN D, 1988, EL824 TR NAT WETL RE; *NAT MAR FISH SERV, 2002, ATL BILLF RES PLAN; *NAT MAR FISH SERV, 2001, MAR FISH STOCK ASS I; *OC PROJ, 1999, REV EX PUBL OP DAT O; PORCH CE, 2001, SFD0102129 SE FISH S; Sarver SK, 1996, COPEIA, P715, DOI 10.2307/1447537; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050	11	193	202	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					309	310		10.1038/430309b	http://dx.doi.org/10.1038/430309b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254528				2022-12-01	WOS:000222631200028
J	Wong, TY; Shankar, A; Klein, R; Klein, BEK; Hubbard, LD				Wong, TY; Shankar, A; Klein, R; Klein, BEK; Hubbard, LD			Prospective cohort study of retinal vessel diameters and risk of hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATHEROSCLEROSIS RISK; VISUAL-ACUITY; ABNORMALITIES; POPULATION	Objective To examine the relation between diameters of the retinal artcrioles and 10 year incidence of hypertension. Design Population based prospective cohort study. Setting Beaver Dam eye study. Participants 2451 normotensive people aged 43 to 84 years. Main outcome measures Diameters of retinal arterioles and venules measured from digitised photographs of the retina taken at baseline. Measurements summarised as the arteriole:venule ratio, with a lower ratio indicating smaller arteriolar diameters. Incident hypertension, defined as systolic blood pressure greater than or equal to 140 mm Hg, diastolic blood pressure greater than or equal to 90 mm Hg, or use of antihypertensive drugs during follow tip. Results 72 1 participants developed hypertension over a 10 year period. Those with lower arteriole:venule ratios had a higher cumulative incidence of hypertension (incidences of 17.4%, 24.1%, 31.0%, and 45.1%, respectively, for decreasing quarters of distribution of arteriole:venule ratio). After adjustment for age and sex, participants with arteriole:venule ratios in the lowest quarter had a threefold higher risk of hypertension (odds ratio 2.95, 95% confidence interval 2.77 to 3.88) than those with ratios in the highest quarter. This association remained significant after further adjustment for baseline systolic and diastolic blood pressure and other risk factors (1.82, 1.39 to 2.40, for lowest versus highest ratio quarters). Conclusions Narrowed retinal arterioles are associated with long term risk of hypertension, suggesting that structural alterations of the microvasculature may be linked to the development of hypertension.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Univ Wisconsin, Dept Ophthalmol, Madison, WI 53726 USA; Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI USA	Centre for Eye Research Australia; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066018] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beevers G, 2001, BRIT MED J, V322, P912, DOI 10.1136/bmj.322.7291.912; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; KLEIN R, PB91149823 NTIS; KLEIN R, 1991, PB91149823 NTIS; KLEIN R, 2000, ARTERIOSCLER THROMB, V20, P44; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158; Mulrow CD, 2001, BMJ-BRIT MED J, V322, P1107, DOI 10.1136/bmj.322.7294.1107; Mulvany MJ, 1996, HYPERTENSION, V28, P505; MULVANY MJ, 1991, HYPERTENSION, V18, P52, DOI 10.1161/01.HYP.18.3_Suppl.I52; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; NORRELUND H, 1994, HYPERTENSION, V24, P301, DOI 10.1161/01.HYP.24.3.301; Pries AR, 1999, HYPERTENSION, V33, P153, DOI 10.1161/01.HYP.33.1.153; Rizzoni D, 2003, CIRCULATION, V108, P2230, DOI 10.1161/01.CIR.0000095031.51492.C5; RIZZONI D, 1994, AM J HYPERTENS, V7, P193, DOI 10.1093/ajh/7.2.193; The hypertension detection and follow-up program. Hypertension detetection and follow-up program cooperative group, 1976, PREV MED, V5, P207; THYBO NK, 1995, HYPERTENSION, V25, P474, DOI 10.1161/01.HYP.25.4.474; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079	26	189	195	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2004	329	7457					79	82A		10.1136/bmj.38124.682523.55	http://dx.doi.org/10.1136/bmj.38124.682523.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837ON	15175230	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000222645000017
J	Zhan, XC; Dravid, G; Ye, ZH; Hammond, H; Shamblott, M; Gearhart, J; Cheng, LZ				Zhan, XC; Dravid, G; Ye, ZH; Hammond, H; Shamblott, M; Gearhart, J; Cheng, LZ			Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro	LANCET			English	Article							DENDRITIC CELLS; HEMATOPOIETIC DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; LINES	Background Differentiated cells derived from pluripotent human embryonic stem (hES) cells offer the opportunity for new transplantation therapies. However, hES cells and their differentiated progeny express highly polymorphic MHC molecules that serve as major graft rejection antigens to the immune system of allogeneic hosts. To achieve sustained engraftment of donor cells, strategies must be developed to overcome graft rejection without broadly suppressing host immunity. One approach entails induction of donor-specific immune tolerance by establishing chimeric engraftment in hosts with haemopoietic cells derived from an existing hES cell line. We aimed to develop methods to efficiently differentiate hES cells to haemopoietic cells, including immune-modulating leucocytes, a prerequisite of the tolerance induction strategies applying to hES cell-mediated transplantation. Methods We developed a method to generate a broad range of haemopoietic cells from hES-generated embryonic bodies in the absence of murine stromal feeder cells, Embryonic bodies were further cultured in the presence of haemopoietic cytokines. In addition to flow cytometric analyses of haemopoietic cell markers, we analysed the hES cell-derived haemopoietic cells by colony-forming assays (for erythroid and myeloid progenitor cells), cytochemical staining, and mixed leucocyte reactions to determine the functional capacity of the generated antigen-presenting cells. Findings 12 independent experiments were done. When selected growth factors were added, leucocytes expressing CD45 were generated and released into culture media for 6-7 weeks. Under the condition used, both erythroid and myeloid progenitor cells were generated. About 25% of the generated leucocytes acquired MHC class II and costimulatory molecule expression. These hES-derived, MHC class II+ leucocytes resembled dendritic cells and macrophages, and they functioned as antigen-presenting cells capable of eliciting allogeneic CD4 and CD8 T-cell responses in culture. Interpretation The hES cell-derived antigen-presenting cells could be used to regulate alloreactive T cells and induce immune tolerance for improvement of the transplant acceptance of hES-cell derivatives.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Broadway Res Bldg,Room 747,733 N Broadway, Baltimore, MD 21205 USA.	lcheng@welch.jhu.edu	Dravid, Gautam/E-3531-2010	Ye, Zhaohui/0000-0001-5272-9168	NHLBI NIH HHS [R01HL67195, R01HL73781] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067195, R01HL073781] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodmer JG, 1999, HUM IMMUNOL, V60, P361; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Crawford K, 1999, J IMMUNOL, V163, P5920; Crawford K, 2003, BLOOD, V102, P1745, DOI 10.1182/blood-2002-07-2206; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Fairchild PJ, 2000, CURR BIOL, V10, P1515, DOI 10.1016/S0960-9822(00)00824-1; Fairchild PJ, 2000, CURR OPIN IMMUNOL, V12, P528, DOI 10.1016/S0952-7915(00)00134-5; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kaufman DS, 2002, J ANAT, V200, P243, DOI 10.1046/j.1469-7580.2002.00028.x; Keller G, 1999, NAT MED, V5, P151, DOI 10.1038/5512; Li F, 2001, BLOOD, V98, P335, DOI 10.1182/blood.V98.2.335; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trounson A, 2002, NAT BIOTECHNOL, V20, P237, DOI 10.1038/nbt0302-237; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	26	114	132	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2004	364	9429					163	171		10.1016/S0140-6736(04)16629-4	http://dx.doi.org/10.1016/S0140-6736(04)16629-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246729				2022-12-01	WOS:000222612200027
J	Li, KS; Guan, Y; Wang, J; Smith, GJD; Xu, KM; Duan, L; Rahardjo, AP; Puthavathana, P; Buranathai, C; Nguyen, TD; Estoepangestie, ATS; Chaisingh, A; Auewarakul, P; Long, HT; Hanh, NTH; Webby, RJ; Poon, LLM; Chen, H; Shortridge, KF; Yuen, KY; Webster, RG; Peiris, JSM				Li, KS; Guan, Y; Wang, J; Smith, GJD; Xu, KM; Duan, L; Rahardjo, AP; Puthavathana, P; Buranathai, C; Nguyen, TD; Estoepangestie, ATS; Chaisingh, A; Auewarakul, P; Long, HT; Hanh, NTH; Webby, RJ; Poon, LLM; Chen, H; Shortridge, KF; Yuen, KY; Webster, RG; Peiris, JSM			Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia	NATURE			English	Article							AVIAN INFLUENZA; A VIRUS; H9N2; EVOLUTION; POULTRY; CHINA	A highly pathogenic avian influenza virus, H5N1, caused disease outbreaks in poultry in China and seven other east Asian countries between late 2003 and early 2004; the same virus was fatal to humans in Thailand and Vietnam(1). Here we demonstrate a series of genetic reassortment events traceable to the precursor of the H5N1 viruses that caused the initial human outbreak in Hong Kong in 1997 (refs 2-4) and subsequent avian outbreaks in 2001 and 2002 ( refs 5, 6). These events gave rise to a dominant H5N1 genotype (Z) in chickens and ducks that was responsible for the regional outbreak in 2003-04. Our findings indicate that domestic ducks in southern China had a central role in the generation and maintenance of this virus, and that wild birds may have contributed to the increasingly wide spread of the virus in Asia. Our results suggest that H5N1 viruses with pandemic potential have become endemic in the region and are not easily eradicable. These developments pose a threat to public and veterinary health in the region and potentially the world, and suggest that long-term control measures are required.	Shantou Univ, Coll Med, Joint Influenza Res Ctr, SUMC,HKU, Guangdong 515031, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Airlangga, Fak Kedokteran Hewan, Surabaya 60115, Indonesia; Sriraj Hosp, Dept Microbiol, Bangkok 10700, Thailand; Natl Inst Anim Hlth, Dept Livestock Dev, Bangkok 10900, Thailand; Minist Agr & Rural Dev, Natl Inst Vet Res, Dept Virol, Hanoi, Vietnam; Natl Inst Hyg & Epidemiol, Dept Virol, Hanoi, Vietnam; St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	Shantou University; University of Hong Kong; University of Hong Kong; Airlangga University; National Institute of Hygiene & Epidemiology (NIHE); St Jude Children's Research Hospital	Guan, Y (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr, SUMC,HKU, Guangdong 515031, Peoples R China.	yguan@hkucc.hku.hk	Auewarakul, Prasert/D-6015-2011; Webby, Richard J/N-5657-2018; Xu, Kemin/G-2825-2011; Chen, Honglin/C-4224-2009; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Yuen, Kwok Yung/C-4465-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Chen, Honglin/0000-0001-5108-8338; Poon, Leo Lit Man/0000-0002-9101-7953; Li, Kangsheng/0000-0002-6981-9263; Yuen, Kwok-yung/0000-0002-2083-1552; Guan, Yi/0000-0001-6057-9243; Smith, Gavin JD/0000-0001-5031-468X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				[Anonymous], 2004, Wkly Epidemiol Rec, V79, P65; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HOLSINGER LJ, 1995, J VIROL, V69, P1219, DOI 10.1128/JVI.69.2.1219-1225.1995; Iwatsuki-Horimoto K, 2004, J GEN VIROL, V85, P1001, DOI 10.1099/vir.0.19519-0; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Sims LD, 2003, AVIAN DIS, V47, P832, DOI 10.1637/0005-2086-47.s3.832; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Thomas JM, 1998, VIROLOGY, V252, P54, DOI 10.1006/viro.1998.9384; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	26	980	1222	3	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					209	213		10.1038/nature02746	http://dx.doi.org/10.1038/nature02746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241415				2022-12-01	WOS:000222470600044
J	Martinez, E; Milinkovic, A; de Lazzari, E; Ravasi, G; Blanco, JL; Larrousse, M; Mallolas, J; Garcia, F; Miro, JM; Gatell, JM				Martinez, E; Milinkovic, A; de Lazzari, E; Ravasi, G; Blanco, JL; Larrousse, M; Mallolas, J; Garcia, F; Miro, JM; Gatell, JM			Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults	LANCET			English	Article								The rise in didanosine concentrations in plasma when given with tenofovir raises concern for a high risk of toxic effects. Recommendations to reduce didanosine dose have been issued, but only for adults weighing more than 60 kg. We reviewed cases of pancreatitis in patients receiving didanosine plus tenofovir, didanosine alone, and tenofovir alone to assess the incidence of and risk factors for pancreatitis. Between Aug 1, 2001, and Nov 30, 2003, five of 185 (2.7%) patients receiving didanosine plus tenofovir, one of 182 (0.5%) on didanosine without tenofovir, and none of 208 on tenofovir without didanosine developed pancreatitis (p=0.016). Co-administration of both drugs versus each of them individually was an independent risk factor for pancreatitis (crude hazard ratio 10.666, 95% CI 1.246-91.294, p=0.031). These results suggest that the risk of pancreatitis is heightened when didanosine and tenofovir are given together.	Univ Barcelona, Hosp Clin, Infect Dis Unit, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Martinez, E (corresponding author), Univ Barcelona, Hosp Clin, Infect Dis Unit, Calle Villarroel 170, E-08036 Barcelona, Spain.	esteban@fundsoriano.es	Gatell, Jose M/ABC-3607-2020; , Felipe/F-4242-2014	, Felipe/0000-0001-7658-5832; De Lazzari, Elisa/0000-0003-2614-6545; Mallolas Masferrer, Josep/0000-0002-8365-141X; Milinkovic, Ana/0000-0002-7732-9168				Becher F, 2004, AIDS, V18, P181, DOI 10.1097/00002030-200401230-00006; Blanchard JN, 2003, CLIN INFECT DIS, V37, pE57, DOI 10.1086/376991; FLAHERTY J, 2001, 41 INT C ANT AG CHEM; KAUL S, 2003, 4 INT WORKSH CLIN PH; KEARNEY BP, 2001, 1 IAS C HIV PATH TRE	5	45	47	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					65	67		10.1016/S0140-6736(04)16591-4	http://dx.doi.org/10.1016/S0140-6736(04)16591-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234858				2022-12-01	WOS:000222392900033
J	Buffetaut, E; Martill, D; Escuillie, F				Buffetaut, E; Martill, D; Escuillie, F			Pterosaurs as part of a spinosaur diet - A rare fossilized action snapshot captures a mortal tussle with a hungry predator	NATURE			English	Article									CNRS, F-75013 Paris, France; Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; Eldonia, F-03800 Gannat, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Portsmouth	Buffetaut, E (corresponding author), CNRS, 16 Cour Liegat, F-75013 Paris, France.	eric.buffetaut@wanadoo.fr		Martill, David/0000-0002-3208-5702				Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; HOLZ TR, 1998, SCIENCE, V282, P1276; Kellner Alexander W.A., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P151; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; KITCHENER A, 1987, NATURE, V325, P114, DOI 10.1038/325114a0; MARTILL DM, 1993, POSSILS SANTANA CRAT; Mazin Jean-Michel, 2003, Geological Society Special Publication, V217, P283, DOI 10.1144/GSL.SP.2003.217.01.17; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; WELLNHOFER P, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V215, P43	10	58	61	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					33	33		10.1038/430033a	http://dx.doi.org/10.1038/430033a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229562	Bronze			2022-12-01	WOS:000222356800031
J	Thomas, DJ				Thomas, DJ			Evidence for deep-water production in the North Pacific Ocean during the early Cenozoic warm interval	NATURE			English	Article							RESIDENCE TIME; NEODYMIUM; ND; ATLANTIC; SR	The deep-ocean circulation is responsible for a significant component of global heat transport. In the present mode of circulation, deep waters formin the North Atlantic and Southern oceans where surface water becomes sufficiently cold and dense to sink. Polar temperatures during the warmest climatic interval of the Cenozoic era (similar to65 to 40 million years (Myr) ago) were significantly warmer than today, and this may have been a consequence of enhanced oceanic heat transport(1). However, understanding the relationship between deep-ocean circulation and ancient climate is complicated by differences in oceanic gateways(2), which affect where deep waters form and how they circulate. Here I report records of neodymium isotopes from two cores in the Pacific Ocean that indicate a shift in deep-water production from the Southern Ocean to the North Pacific similar to65 Myr ago. The source of deep waters reverted back to the Southern Ocean 40 Myr ago. The relative timing of changes in the neodymium and oxygen isotope records indicates that changes in Cenozoic deep-water circulation patterns were the consequence, not the cause, of extreme Cenozoic warmth.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Thomas, DJ (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	dthomas@ocean.tamu.edu						Bice KL, 1997, GEOLOGY, V25, P951, DOI 10.1130/0091-7613(1997)025<0951:CRAECB>2.3.CO;2; BOYLE EA, 1981, EARTH PLANET SC LETT, V53, P11, DOI 10.1016/0012-821X(81)90022-4; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; BRALOWER TJ, 2002, P ODP INIT REP, V198; BROECKER W, 1960, J GEOPHYS RES, V65, P2903, DOI 10.1029/JZ065i009p02903; DEPAOLO DJ, 1976, GEOPHYS RES LETT, V3, P249, DOI 10.1029/GL003i005p00249; ELDHOLM O, 1993, EARTH PLANET SC LETT, V117, P319, DOI 10.1016/0012-821X(93)90087-P; FRAKES LA, 1972, NATURE, V240, P97, DOI 10.1038/240097a0; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V87, P249, DOI 10.1016/0012-821X(88)90013-1; HALLIDAY AN, 1992, GEOPHYS RES LETT, V19, P761, DOI 10.1029/92GL00393; JONES CE, 1994, EARTH PLANET SC LETT, V127, P55, DOI 10.1016/0012-821X(94)90197-X; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3645, DOI 10.1130/0016-7606(1972)83[3645:WCOMMA]2.0.CO;2; Levitus S., 1982, 13 NOAA; Martin EE, 2004, EARTH PLANET SC LETT, V220, P25, DOI 10.1016/S0012-821X(04)00030-5; PIEPGRAS DJ, 1988, GEOCHIM COSMOCHIM AC, V52, P1373, DOI 10.1016/0016-7037(88)90208-6; Reynard B, 1999, CHEM GEOL, V155, P233, DOI 10.1016/S0009-2541(98)00169-7; Rutberg RL, 2000, NATURE, V405, P935, DOI 10.1038/35016049; Saunders A.D., 1997, GEOPH MONOG SERIES, P45; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; STAUDIGEL H, 1985, EARTH PLANET SC LETT, V76, P45, DOI 10.1016/0012-821X(85)90147-5; Tachikawa K, 1999, EARTH PLANET SC LETT, V170, P433, DOI 10.1016/S0012-821X(99)00127-2; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; Thomas DJ, 2003, EARTH PLANET SC LETT, V209, P309, DOI 10.1016/S0012-821X(03)00096-7; THOMAS DJ, IN PRESS GSA SPEC PU; Tomczak M., 1994, REGIONAL OCEANOGRAPH, DOI 10.1016/B978-0-08-041021-0.50003-5; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	28	98	103	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					65	68		10.1038/nature02639	http://dx.doi.org/10.1038/nature02639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229597				2022-12-01	WOS:000222356800042
J	Krupa, DJ; Wiest, MC; Shuler, MG; Laubach, M; Nicolelis, MAL				Krupa, DJ; Wiest, MC; Shuler, MG; Laubach, M; Nicolelis, MAL			Layer-specific somatosensory cortical activation during active tactile discrimination	SCIENCE			English	Article							RECEPTIVE-FIELDS; VISUAL-CORTEX; BARREL FIELD; AWAKE RATS; ORGANIZATION; SI; VIBRISSA; STIMULI; NEURONS; INFORMATION	Ensemble neuronal activity was recorded in each layer of the whisker area of the primary somatosensory cortex (SI) while rats performed a whisker-dependent tactile discrimination task. Comparison of this activity with SI activity evoked by similar passive whisker stimulation revealed fundamental differences in tactile signal processing during active and passive stimulation. Moreover, significant layer specific functional differences in SI activity were observed during active discrimination. These differences could not be explained solely by variations in ascending thalamocortical input to SI. Instead, these results suggest that top-down influences during active discrimination may alter the overall functional nature of SI as well as layer-specific mechanisms of tactile processing.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; John B Pierce Lab, New Haven, CT 06519 USA	Duke University; Yale University; The John B Pierce Laboratory, Inc	Krupa, DJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	krupa@neuro.duke.edu	Wiest, Michael/ABC-8101-2020	Laubach, Mark/0000-0002-2403-4497	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451, R01DE013810] Funding Source: NIH RePORTER; NIDCR NIH HHS [5RO1DE11451, 5RO1DE13810] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; CHAPIN JK, 1986, EXP BRAIN RES, V62, P549; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jackson ME, 1998, NEUROREPORT, V9, P3379, DOI 10.1097/00001756-199810260-00008; KORALEK KA, 1990, J COMP NEUROL, V299, P133, DOI 10.1002/cne.902990202; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; POWELL TPS, 1959, B JOHNS HOPKINS HOSP, V105, P133; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sachdev RNS, 2000, J NEUROPHYSIOL, V84, P1497, DOI 10.1152/jn.2000.84.3.1497; Shuler MG, 2002, CEREB CORTEX, V12, P86, DOI 10.1093/cercor/12.1.86; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; Zhang ZW, 1998, CEREB CORTEX, V8, P428, DOI 10.1093/cercor/8.5.428	21	153	159	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2004	304	5679					1989	1992		10.1126/science.1093318	http://dx.doi.org/10.1126/science.1093318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218154				2022-12-01	WOS:000222241600052
J	Norman, C				Norman, C			A time for action	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2004	304	5679					1931	1931		10.1126/science.304.5679.1931	http://dx.doi.org/10.1126/science.304.5679.1931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218137				2022-12-01	WOS:000222241600032
J	Irigoien, X; Huisman, J; Harris, RP				Irigoien, X; Huisman, J; Harris, RP			Global biodiversity patterns of marine phytoplankton and zooplankton	NATURE			English	Article							PRODUCTIVITY; DIVERSITY; COMPETITION; RESOURCES; GROWTH	Although the oceans cover 70% of the Earth's surface, our knowledge of biodiversity patterns in marine phytoplankton and zooplankton is very limited compared to that of the biodiversity of plants and herbivores in the terrestrial world. Here, we present biodiversity data for marine plankton assemblages from different areas of the world ocean. Similar to terrestrial vegetation(1-3), marine phytoplankton diversity is a unimodal function of phytoplankton biomass, with maximum diversity at intermediate levels of phytoplankton biomass and minimum diversity during massive blooms. Contrary to expectation, we did not find a relation between phytoplankton diversity and zooplankton diversity. Zooplankton diversity is a unimodal function of zooplankton biomass. Most strikingly, these marine biodiversity patterns show a worldwide consistency, despite obvious differences in environmental conditions of the various oceanographic regions. These findings may serve as a new benchmark in the search for global biodiversity patterns of plants and herbivores.	AZTI, Arrantza Elikaigintzarako Inst Teknol, Harrera Kaia Portualdea, Pasaia 20110, Spain; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	AZTI; University of Amsterdam; Plymouth Marine Laboratory	Irigoien, X (corresponding author), AZTI, Arrantza Elikaigintzarako Inst Teknol, Harrera Kaia Portualdea, Pasaia 20110, Spain.	xirigoien@pas.azti.es	Huisman, Jef/A-1089-2013; Irigoien, Xabier/B-8171-2009	Huisman, Jef/0000-0001-9598-3211; Irigoien, Xabier/0000-0002-5411-6741	Natural Environment Research Council [NER/O/S/2001/00680] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hillebrand H, 2003, OIKOS, V100, P592, DOI 10.1034/j.1600-0706.2003.12045.x; HOLLIGAN PM, 1977, J MAR BIOL ASSOC UK, V57, P1075, DOI 10.1017/S002531540002614X; Huisman J, 1999, AM NAT, V154, P46, DOI 10.1086/303220; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.2307/176991; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Joint I, 2000, J EXP MAR BIOL ECOL, V250, P233, DOI 10.1016/S0022-0981(00)00199-4; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kirk JTO., 1994, LIGHT PHOTOSYNTHESIS, V2nd ed; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Mauchline, 1998, BIOL CALANOID COPEPO; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Strom S, 2003, LIMNOL OCEANOGR, V48, P217, DOI 10.4319/lo.2003.48.1.0217; Tilman D., 1982, Monographs in Population Biology, pi; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WILLIAMS LG, 1964, ECOLOGY, V45, P809, DOI 10.2307/1934927; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	30	293	305	17	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					863	867		10.1038/nature02593	http://dx.doi.org/10.1038/nature02593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215862				2022-12-01	WOS:000222213000039
J	Karlson, RH; Cornell, HV; Hughes, TP				Karlson, RH; Cornell, HV; Hughes, TP			Coral communities are regionally enriched along an oceanic biodiversity gradient	NATURE			English	Article							SPECIES RICHNESS; DIVERSITY; PATTERNS; SCALE; REEFS	Ecological communities are influenced by processes operating at multiple scales(1-5). Thus, a better understanding of how broad- as well as local-scale processes affect species diversity and richness is increasingly becoming a central focus in modern community ecology(6-9). Here, in a study of unprecedented geographical scope, we show significant regional and local variation in the species richness of coral assemblages across an oceanic biodiversity gradient. The gradient that we sampled extends 10,000 km eastwards from the world's richest coral biodiversity hotspot in the central Indo-Pacific(10). Local richness and the size of regional species pools decline significantly across 15 islands spanning the gradient. In addition, richness declines across three adjacent habitats ( reef slopes, crests and flats). In each habitat, a highly consistent linear relationship between local and regional species richness indicates strong regional enrichment. Thus, even on the most diverse coral reefs in the world, local coral assemblages are profoundly affected by regional-scale processes. Understanding these historical and biogeographical influences is essential for the effective management and preservation of these endangered communities.	Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia	University of Delaware; James Cook University	Karlson, RH (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	rkarlson@udel.edu	Hughes, Terry P/L-4721-2013	Hughes, Terry P/0000-0002-5257-5063				[Anonymous], 1982, AUSTR I MARINE SCI M; [Anonymous], 1997, SPATIAL ECOLOGY ROLE; Buzas MA, 1997, SURVEYING NATURAL PO, V2nd; Caley MJ, 1997, ECOLOGY, V78, P70; Caswell Hal, 1993, P99; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cornell HV, 1996, J ANIM ECOL, V65, P233, DOI 10.2307/5726; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Elton C.S., 1933, ECOLOGY ANIMALS; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Holt Robert D., 1997, P149, DOI 10.1016/B978-012323445-2/50010-9; Holt Robert D., 1993, P77; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Karlson RH, 1998, ECOL MONOGR, V68, P259, DOI 10.1890/0012-9615(1998)068[0259:SDVILV]2.0.CO;2; Karlson RH, 2002, ECOLOGY, V83, P452, DOI 10.2307/2680027; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; PACALA SW, 1990, ECOL MONOGR, V60, P113, DOI 10.2307/1943028; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Roughgarden J, 1989, PERSPECTIVES ECOLOGI; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, AUSTR I MARINE SCI M, P77; Wallace C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Yodzis P., 1989, INTRO THEORETICAL EC	30	111	116	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2004	429	6994					867	870		10.1038/nature02685	http://dx.doi.org/10.1038/nature02685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15201847				2022-12-01	WOS:000222213000040
J	Loewen, CJR; Gaspar, ML; Jesch, SA; Delon, C; Ktistakis, NT; Henry, SA; Levine, TP				Loewen, CJR; Gaspar, ML; Jesch, SA; Delon, C; Ktistakis, NT; Henry, SA; Levine, TP			Phospholipid metabolism regulated by a transcription factor sensing phosphatidic acid	SCIENCE			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; GENETIC-REGULATION; BINDING DOMAIN; YEAST; MEMBRANE; PROTEIN; BIOSYNTHESIS; EXPRESSION	Cells regulate the biophysical properties of their membranes by coordinated synthesis of different classes of lipids. Here, we identified a highly dynamic feedback mechanism by which the budding yeast Saccharomyces cerevisiae can regulate phospholipid biosynthesis. Phosphatidic acid on the endoplasmic reticulum directly bound to the soluble transcriptional repressor Opi1p to maintain it as inactive outside the nucleus. After the addition of the lipid precursor inositol, this phosphatidic acid was rapidly consumed, releasing Opi1p from the endoplasmic reticulum and allowing its nuclear translocation and repression of target genes. Thus, phosphatidic acid appears to be both an essential ubiquitous metabolic intermediate and a signaling lipid.	Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Babraham Inst, Signalling Programme, Cambridge CB2 4AT, England	University of London; University College London; Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Levine, TP (corresponding author), Inst Ophthalmol, Div Cell Biol, Bath St, London EC1V 9EL, England.	tim.levine@ucl.ac.uk	Henry, Susan/K-5464-2014	Levine, Timothy/0000-0002-7231-0775; Delon, Christine/0000-0001-5163-1716	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019629, R37GM019629] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000F969] Funding Source: Medline; NIGMS NIH HHS [GM-19629] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; NIKAWA J, 1984, EUR J BIOCHEM, V143, P251, DOI 10.1111/j.1432-1033.1984.tb08366.x; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Rudge SA, 1998, J CELL BIOL, V140, P81, DOI 10.1083/jcb.140.1.81; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WHITE MJ, 1991, J BIOL CHEM, V266, P863	28	351	363	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1644	1647		10.1126/science.1096083	http://dx.doi.org/10.1126/science.1096083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192221				2022-12-01	WOS:000221934300042
J	Gatfield, D; Izaurralde, E				Gatfield, D; Izaurralde, E			Nonsense-mediated messenger RNA decay is initiated by endonucleolytic cleavage in Drosophila	NATURE			English	Article							GENE-EXPRESSION; DEGRADATION; CODON; PATHWAY; YEAST; CELLS; ENDORIBONUCLEASE; IDENTIFICATION; DEADENYLATION; SURVEILLANCE	In eukaryotic cells, messenger RNAs harbouring premature termination codons (PTCs) are rapidly degraded by a conserved post-transcriptional mechanism referred to as nonsense-mediated mRNA decay (NMD)(1,2), which prevents the synthesis of truncated proteins that could be deleterious for the cell(1,2). Studies in yeast and mammals indicate that degradation by means of this pathway can occur from both the 5' end of the message (involving decapping and 5'-to-3' exonucleolytic digestion by XRN1) or the 3' end (through accelerated deadenylation and exosome-mediated 3'-to-5' decay)(3-9). Here we show that, contrary to expectation, degradation of PTC-containing messages in Drosophila is initiated by endonucleolytic cleavage(s) in the vicinity of the nonsense codon. The resulting 5' fragment is rapidly degraded by exonucleolytic digestion by the exosome, whereas the 3' fragment is degraded by XRN1. This decay route is shown for several PTC-containing reporters, as well as an endogenous mRNA that is naturally regulated by NMD. We conclude that, despite conservation in the NMD machinery, PTC-containing transcripts are degraded in Drosophila by a mechanism that differs considerably from those described in yeast and mammals(3,6,7).	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Izaurralde, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	izaurralde@embl-heidelberg.de	Gatfield, David/C-2354-2011; Izaurralde, Elisa/G-3239-2012	Gatfield, David/0000-0001-5114-2824; Izaurralde, Elisa/0000-0001-7365-2649				BINDER R, 1989, J BIOL CHEM, V264, P16910; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; BROWN BD, 1990, GENE DEV, V4, P1925, DOI 10.1101/gad.4.11.1925; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Cao D, 2003, CELL, V113, P533, DOI 10.1016/S0092-8674(03)00353-2; Chen CYA, 2003, MOL CELL BIOL, V23, P4805, DOI 10.1128/MCB.23.14.4805-4813.2003; Chernokalskaya E, 1998, RNA, V4, P1537, DOI 10.1017/S1355838298980451; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; Ivanov IP, 1998, MOL CELL BIOL, V18, P1553, DOI 10.1128/MCB.18.3.1553; Lee CH, 1998, J BIOL CHEM, V273, P25261, DOI 10.1074/jbc.273.39.25261; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; REMER KA, 2003, RNA, V9, P1157; SCHEPER W, 1995, MOL CELL BIOL, V15, P235, DOI 10.1128/MCB.15.1.235; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Van Dijk EL, 1998, RNA, V4, P1623, DOI 10.1017/S1355838298981316; Wagner E, 2002, J CELL SCI, V115, P3033; Wang ZR, 2000, EMBO J, V19, P295, DOI 10.1093/emboj/19.2.295; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	30	177	185	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					575	578		10.1038/nature02559	http://dx.doi.org/10.1038/nature02559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175755				2022-12-01	WOS:000221767700043
J	Martens, JA; Laprade, L; Winston, F				Martens, JA; Laprade, L; Winston, F			Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene	NATURE			English	Article							RNA-POLYMERASE-II; PROMOTER; INTERFERENCE; YEAST; TERMINATION; COMPONENTS; BINDING; SWI/SNF; FORMS	Transcription by RNA polymerase II in Saccharomyces cerevisiae and in humans is widespread, even in genomic regions that do not encode proteins(1-6). The purpose of such intergenic transcription is largely unknown, although it can be regulatory(7,8). We have discovered a role for one case of intergenic transcription by studying the S. cerevisiae SER3 gene. Our previous results demonstrated that transcription of SER3 is tightly repressed during growth in rich medium(9). We now show that the regulatory region of this gene is highly transcribed under these conditions and produces a non-protein-coding RNA (SRG1). Expression of the SRG1 RNA is required for repression of SER3. Additional experiments have demonstrated that repression occurs by a transcription-interference mechanism in which SRG1 transcription across the SER3 promoter interferes with the binding of activators. This work identifies a previously unknown class of transcriptional regulatory genes.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Winston, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	winston@genetics.med.harvard.edu						ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Andersen AA, 2003, CURR OPIN CELL BIOL, V15, P281, DOI 10.1016/S0955-0674(03)00041-3; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; Dudley AM, 1999, GENETICS, V151, P1365; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HAUSLER B, 1979, J MOL BIOL, V127, P353, DOI 10.1016/0022-2836(79)90335-8; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; HIRSCHMAN JE, 1988, MOL CELL BIOL, V8, P4608, DOI 10.1128/MCB.8.11.4608; Hurowitz EH, 2004, GENOME BIOL, V5; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Valerius O, 2002, J BIOL CHEM, V277, P21440, DOI 10.1074/jbc.M201841200; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000	30	459	479	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					571	574		10.1038/nature02538	http://dx.doi.org/10.1038/nature02538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175754				2022-12-01	WOS:000221767700042
J	Bentley, DR				Bentley, DR			Genomes for medicine	NATURE			English	Review							DNA-SEQUENCE; REGULATORY NETWORKS; GENE; CHROMOSOME; SUSCEPTIBILITY; PATHOGENESIS; ANNOTATION; REGIONS; BIOLOGY	We have the human genome sequence. It is freely available, accurate and nearly complete. But is the genome ready for medicine? The new resource is already changing genetic research strategies to find information of medical value. Now we need high-quality annotation of all the functionally important sequences and the variations within them that contribute to health and disease. To achieve this, we need more genome sequences, systematic experimental analyses, and extensive information on human phenotypes. Flexible and user-friendly access to well-annotated genomes will create an environment for innovation, and the potential for unlimited use of sequencing in biomedical research and practice.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bentley, DR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	drb@sanger.ac.uk						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aiuti A, 2003, CURR OPIN ALLERGY CL, V3, P461, DOI 10.1097/01.all.0000104453.09202.d5; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bentley DR, 1996, SCIENCE, V274, P533, DOI 10.1126/science.274.5287.533; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Druker BJ, 2003, SEMIN HEMATOL, V40, P50, DOI 10.1053/shem.2003.50000; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Georgiou-Karistianis N, 2003, BRAIN RES BULL, V59, P331, DOI 10.1016/S0361-9230(02)00877-8; Golub TR, 2001, CURR OPIN HEMATOL, V8, P252, DOI 10.1097/00062752-200107000-00012; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Guyer M, 1998, GENOME RES, V8, P413; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Novik K. L., 2002, Current Issues in Molecular Biology, V4, P111; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; *RAT GEN PROJ SEQ, 1920, NATURE, V428, P493; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROGERS J, IN PRESS COLD SPRING, V68; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH T, IN PRESS TARGETS; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Treasure T, 2004, BMJ-BRIT MED J, V328, P237, DOI 10.1136/bmj.328.7434.237; van Dellen A, 2004, NEUROGENETICS, V5, P9, DOI 10.1007/s10048-003-0169-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	60	49	52	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					440	445		10.1038/nature02622	http://dx.doi.org/10.1038/nature02622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164068				2022-12-01	WOS:000221644600045
J	Singer, LT; Minnes, S; Short, E; Arendt, R; Farkas, K; Lewis, B; Klein, N; Russ, S; Min, MO; Kirchner, HL				Singer, LT; Minnes, S; Short, E; Arendt, R; Farkas, K; Lewis, B; Klein, N; Russ, S; Min, MO; Kirchner, HL			Cognitive with outcomes of preschool children prenatal cocaine exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSYCHOLOGICAL DISTRESS; MECONIUM; INFANTS; GROWTH	Context Because of methodological limitations, the results of the few prospective studies assessing long-term cognitive effects of prenatal cocaine exposure are inconsistent. Objective To assess effects of prenatal cocaine exposure and quality of caregiving environment on 4-year cognitive outcomes. Design Longitudinal, prospective, masked comparison cohort study from birth (September 1994-June 1996) to 4 years. Setting Research laboratory of a US urban county teaching hospital. Participants A total of 415 consecutively enrolled infants identified from a high-risk population screened for drug use through clinical interview, urine, and meconium screens. Ninety-three percent retention for surviving participants at 4 years of age resulted in 376 children (190 cocaine-exposed and 186 nonexposed). Main Outcome Measure The Wechsler Preschool and Primary Scales of Intelligence-Revised. Results After control for covariates, prenatal cocaine exposure was not related to lower full-scale IQ (cocaine exposed [80.7] vs nonexposed [82.9]; P=.09) scores or summary verbal (cocaine exposed [79.9] vs nonexposed [81.9]; P=.11) or performance (cocaine exposed [85.5] vs nonexposed [87.5]; P=.18) IQ scores at age 4 years. However, prenatal cocaine exposure was related to small but significant deficits on several subscales (mean [SE]): visual-spatial skills (cocaine exposed [7.3 (0.22)] vs nonexposed [8.2 (0.22)]; P=.01), general knowledge (cocaine exposed [6.1 (0.18)] vs nonexposed [6.7 (0.17)]; P=.04), and arithmetic skills (cocaine exposed [6.2 (0.20)] vs nonexposed [6.8 (0.20)]; P=.05). Prenatal cocaine exposure was also associated with a lower likelihood of achievement of IQ above normative means (odds ratio, 0.26 [95% confidence interval, 0.10-0.65]; P=.004). The quality of the caregiving environment was the strongest independent predictor of outcomes. Cocaine-exposed children placed in nonrelative foster or adoptive care lived in homes with more stimulating environments and had caregivers with better vocabulary scores, and they attained full-scale and performance IQ scores (83 and 87, respectively) similar to nonexposed children in biological maternal or relative care (full-scale IQ, 82; performance IQ, 88) and higher than cocaine-exposed children in biological maternal or relative care (full-scale IQ, 79; performance IQ, 84). Conclusions Prenatal cocaine exposure was not associated with lower full-scale, verbal, or performance IQ scores but was associated with an increased risk for specific cognitive impairments and lower likelihood of IQ above the normative mean at 4 years. A better home environment was associated with IQ scores for cocaine-exposed children that are similar to scores in nonexposed children.	Case Western Reserve Univ, Sch Med, Dept Gen Med Sci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Mandel Sch Appl Social Sci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Educ, Cleveland, OH 44115 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; University System of Ohio; Ohio State University	Singer, LT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Gen Med Sci, Triangle Bldg,11400 Euclid Ave,Suite 250-A, Cleveland, OH 44106 USA.	Lynn.Singer@case.edu	Singer, Lynn/Q-2045-2019	Singer, Lynn/0000-0003-2950-9460; Min, Meeyoung/0000-0003-3584-6690	NCRR NIH HHS [RR00080] Funding Source: Medline; NIDA NIH HHS [R01 DA007957] Funding Source: Medline; PHS HHS [R01-07259, 07957] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007957] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alessandri SM, 1998, DEV PSYCHOL, V34, P565, DOI 10.1037/0012-1649.34.3.565; Appelbaum M, 1999, DEV PSYCHOL, V35, P1297; Arendt R, 1999, PEDIATRICS, V103, P86, DOI 10.1542/peds.103.1.86; Arendt RE, 1999, J DRUG ISSUES, V29, P203, DOI 10.1177/002204269902900203; Bandstra ES, 2001, PEDIATRICS, V108, P1309, DOI 10.1542/peds.108.6.1309; BARBABAN SC, 1997, J NEUROPHYSIOL, V77, P126; Bennett DS, 2002, DEV PSYCHOL, V38, P648, DOI 10.1037//0012-1649.38.5.648; Caldwell B.M., 1984, HOME OBSERVATION MEA; COLES CD, 1992, NEUROTOXICOL TERATOL, V14, P23, DOI 10.1016/0892-0362(92)90025-6; Derogatis L. R., 1992, CLIN PSYCHOMETRIC RE; DOWEDWARDS D, 1995, MOTHERS BABIES COCAI, P1; DOWEDWARDS DL, 1993, DEV BRAIN RES, V72, P309, DOI 10.1016/0165-3806(93)90198-J; Dunn L., 1981, PEABODY PICTURE VOCA; Eyler FD, 1998, PEDIATRICS, V101, P237, DOI 10.1542/peds.101.2.237; HOBEL CJ, 1973, AM J OBSTET GYNECOL, V117, P1; Hurt H, 2001, J DEV BEHAV PEDIATR, V22, P27, DOI 10.1097/00004703-200102000-00005; Hurt H, 1997, ARCH PEDIAT ADOL MED, V151, P1237, DOI 10.1001/archpedi.1997.02170490063011; HURT H, 1995, J DEV BEHAV PEDIATR, V16, P29, DOI 10.1097/00004703-199502000-00005; Inman-Wood SL, 2000, NEUROTOXICOL TERATOL, V22, P547, DOI 10.1016/S0892-0362(00)00084-2; JACOBSON SH, 1991, POLYM PREPR, V32, P390; Jacobson SW, 1996, J PEDIATR-US, V129, P581, DOI 10.1016/S0022-3476(96)70124-5; KANDEL D, 1998, DRUG ADDICTIONS RES; Koren G, 1998, ANN NY ACAD SCI, V846, P306, DOI 10.1111/j.1749-6632.1998.tb09747.x; Lester BM, 1998, SCIENCE, V282, P633, DOI 10.1126/science.282.5389.633; LEWIS DE, 1994, J TOXICOL-CLIN TOXIC, V32, P697, DOI 10.3109/15563659409017976; Melnick SM, 2001, NEUROTOXICOL TERATOL, V23, P445, DOI 10.1016/S0892-0362(01)00157-X; OSTREA EM, 1989, J PEDIATR-US, V115, P474, DOI 10.1016/S0022-3476(89)80860-1; Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P627, DOI 10.1016/S0892-0362(96)00121-3; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; Singer L, 1997, DEV PSYCHOPATHOL, V9, P473, DOI 10.1017/S0954579497001259; Singer LT, 1999, J DRUG ISSUES, V29, P253, DOI 10.1177/002204269902900207; Singer LT, 2000, NEUROTOXICOL TERATOL, V22, P653, DOI 10.1016/S0892-0362(00)00092-1; Singer LT, 2002, NEUROTOXICOL TERATOL, V24, P127, DOI 10.1016/S0892-0362(01)00208-2; SINGER LT, 1991, J PEDIATR-US, V119, P667, DOI 10.1016/S0022-3476(05)82426-6; Singer LT, 2002, JAMA-J AM MED ASSOC, V287, P1952, DOI 10.1001/jama.287.15.1952; Singer LT, 2001, PEDIATRICS, V107, P1057, DOI 10.1542/peds.107.5.1057; SINGER LT, 2001, BIOBEHAVIORAL ASSESS, P15; Smeriglio VL, 1999, CLIN PERINATOL, V26, P1; Snow DM, 2001, NEUROTOXICOL TERATOL, V23, P225, DOI 10.1016/S0892-0362(01)00137-4; THADANI PV, 1995, NIDA RES MONOGRAPH, V158; Van Beveren TT, 2000, AM J HUM BIOL, V12, P417; VOLPE JJ, 1992, NEW ENGL J MED, V327, P399, DOI 10.1056/NEJM199208063270607; Vorhees C., 1986, HDB BEHAV TERATOLOGY, P23; Wechsler D., 1999, WECHSLER PRESCHOOL P; Wechsler D, 1989, WECHSLER ADULT INTEL; WOODS JR, 1987, JAMA-J AM MED ASSOC, V257, P957, DOI 10.1001/jama.257.7.957; ZUCKERMAN B, 1989, NEW ENGL J MED, V320, P762, DOI 10.1056/NEJM198903233201203	47	164	168	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2004	291	20					2448	2456		10.1001/jama.291.20.2448	http://dx.doi.org/10.1001/jama.291.20.2448			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823HB	15161895	Bronze			2022-12-01	WOS:000221599700027
J	Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ				Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ			Small interfering RNA-induced transcriptional gene silencing in human cells	SCIENCE			English	Article							NOVO DNA METHYLATION; ELONGATION FACTOR-1-ALPHA; NUCLEAR EXPORT; HAIRPIN RNAS; METHYLTRANSFERASES; HETEROCHROMATIN; MAINTENANCE; DROSOPHILA; MICRORNAS; MECHANISM	Small interfering RNA (siRNA) and rnicroRNA silence genes at the transcriptional, posttranscriptional, and/or translational level. Using human tissue culture cells, we show that promoter-directed siRNA inhibits transcription of an integrated, proviral, elongation factor 1 alpha (EF1A) promoter-green fluorescent protein reporter gene and of endogenous EF1A. Silencing was associated with DNA methylation of the targeted sequence, and it required either active transport of siRNA into the nucleus or permeabilization of the nuclear envelope by lentiviral transduction. These results demonstrate that siRNA-directed transcriptional silencing is conserved in mammals, providing a means to inhibit mammalian gene function.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; VA San Diego Healthcare Syst, Infect Dis, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Morris, KV (corresponding author), Beckman Res Inst, Div Mol Biol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	kmorris@coh.org	morris, kevin v/B-5481-2011	Morris, Kevin/0000-0002-0157-0553	NIAID NIH HHS [P01 AI45992, P30 AI36214, AI07384] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045992, P30AI036214] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, MOL THER, V10, P181, DOI 10.1016/j.ymthe.2004.03.019; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	31	745	843	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2004	305	5688					1289	1292		10.1126/science.1101372	http://dx.doi.org/10.1126/science.1101372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15297624				2022-12-01	WOS:000223624600041
J	Smith, GCS; Pell, JP; Pasupathy, D; Dobbie, R				Smith, GCS; Pell, JP; Pasupathy, D; Dobbie, R			Factors predisposing to perinatal death related to uterine rupture during attempted vaginal birth after caesarean section: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							DELIVERY; RISK; LABOR; WOMEN	Objective To determine the factors associated with an increased risk of perinatal death related to uterine rupture during attempted vaginal birth after caesarean section. Design Population based retrospective cohort study. Setting Data from the linked Scottish Morbidity Record and Stillbirth and Infant Death Survey of births in Scotland, 1985-98. Participants All women with one previous caesarean delivery who gave birth to a singleton infant at term by a means other than planned repeat caesarean section (n = 35 854). Main outcome measures All intrapartum uterine rupture and uterine rupture resulting in perinatal death (that is, death of the fetus or neonate). Results The overall proportion of vaginal births was 74.2% and of uterine rupture was 0.35%. The risk of intrapartum uterine rupture was higher among women who had not previously given birth vaginally (adjusted odds ratio 2.5, 95% confidence interval 1.6 to 3.9, P < 0.001) and those whose labour was induced with prostaglandin (2.9, 2.0 to 4.3, P < 0.001). Both factors were also associated with an increased risk of perinatal death due to uterine rupture. Delivery in a hospital with < 3000 births a year did not increase the overall risk of uterine rupture (1.1, 0.8 to 1.5, P = 0.67). However, the risk of perinatal death due to uterine rupture was significantly higher in hospitals with < 3000 births a year (one per 1300 births) than in hospitals with greater than or equal to3000 births a year (one per 4700; 3.4, 1.0 to 14.3, P = 0.04). Conclusion Women who have not previously given birth vaginally and those whose labour is induced with prostaglandin are at increased risk of uterine rupture when attempting vaginal birth after caesarean section. The risk of consequent death of the infant is higher in units with lower annual numbers of births.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Addenbrookes NHS Trust, Dept Obstet, Cambridge CB2 2SW, England; Addenbrookes NHS Trust, Dept Gynaecol, Cambridge CB2 2SW, England; Common Serv Agcy, Informat & Stat Div, Edinburgh EH5 3SE, Midlothian, Scotland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008; Pasupathy, Dharmintra/N-9586-2019	Smith, Gordon/0000-0003-2124-0997; Pasupathy, Dharmintra/0000-0002-6722-1006; Pell, Jill/0000-0002-8898-7035				COLE SK, 1980, PERINATAL AUDIT SURV, P39; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Flamm BL, 2001, BEST PRACT RES CL OB, V15, P81, DOI 10.1053/beog.2000.0150; Gregory KD, 1999, OBSTET GYNECOL, V94, P985, DOI 10.1016/S0029-7844(99)00422-6; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; MILLER DA, 1994, OBSTET GYNECOL, V84, P255; Oster RA, 2002, AM STAT, V56, P235, DOI 10.1198/00031300274; Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Zelop CM, 2000, AM J OBSTET GYNECOL, V183, P1184, DOI 10.1067/mob.2000.109048	13	81	86	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 14	2004	329	7462					375	377		10.1136/bmj.38160.634352.55	http://dx.doi.org/10.1136/bmj.38160.634352.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15262772	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000223433600016
J	Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E				Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E			Multiplex detection of RNA expression in Drosophila embryos	SCIENCE			English	Article							HYBRIDIZATION		Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Mol Probes Inc, Eugene, OR 97402 USA	University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ebier@ucsd.edu			NINDS NIH HHS [NS29870] Funding Source: Medline; PHS HHS [28315] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029870] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Hughes SC, 1998, BIOTECHNIQUES, V24, P530, DOI 10.2144/98244bm01; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0	8	276	304	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					846	846		10.1126/science.1099247	http://dx.doi.org/10.1126/science.1099247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297669				2022-12-01	WOS:000223104900042
J	Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M				Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M			The semaphorin 4D receptor plexin-B1 is a GTPase activating protein for R-Ras	SCIENCE			English	Article							ACTIVE RAC; RHO; SIGNALS; RND1; FAMILY	Plexins are cell surface receptors for semaphorin molecules, and their interaction governs cell adhesion and migration in a variety of tissues. We report that the Semaphorin 4D (Sema4D) receptor Plexin-B1 directly stimulates the intrinsic guanosine triphosphatase ( GTPase) activity of R-Ras, a member of the Ras superfamily of small GTP-binding proteins that has been implicated in promoting cell adhesion and neurite outgrowth. This activity required the interaction of Plexin-B1 with Rnd1, a small GTP-binding protein of the Rho family. Down-regulation of R-Ras activity by the Plexin-B1-Rnd1 complex was essential for the Sema4D-induced growth cone collapse in hippocampal neurons. Thus, Plexin-B1 mediates Sema4D-induced repulsive axon guidance signaling by acting as a GTPase activating protein for R-Ras.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Goshima Y, 2002, J CLIN INVEST, V109, P993, DOI 10.1172/JCI200215467; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; RHOM B, 2000, FEBS LETT, V486, P68; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	26	309	324	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					862	865		10.1126/science.1097545	http://dx.doi.org/10.1126/science.1097545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297673				2022-12-01	WOS:000223104900048
J	Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D				Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D			Vigorous exchange between the Indian and Atlantic oceans at the end of the past five glacial periods	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SOUTH-ATLANTIC; OVERTURNING CIRCULATION; RECORD; COMMUNICATION; FLUCTUATIONS; OCEANOGRAPHY; SECTOR; HEAT	The magnitude of heat and salt transfer between the Indian and Atlantic oceans through 'Agulhas leakage' is considered important for balancing the global thermohaline circulation(1-3). Increases or reductions of this leakage lead to strengthening or weakening of the Atlantic meridional overturning and associated variation of North Atlantic Deep Water formation(4-6). Here we show that modern Agulhas waters, which migrate into the south Atlantic Ocean in the form of an Agulhas ring, contain a characteristic assemblage of planktic foraminifera. We use this assemblage as a modern analogue to investigate the Agulhas leakage history over the past 550,000 years from a sediment record in the Cape basin. Our reconstruction indicates that Indian - Atlantic water exchange was highly variable: enhanced during present and past interglacials and largely reduced during glacial intervals. Coherent variability of Agulhas leakage with northern summer insolation suggests a teleconnection to the monsoon system. The onset of increased Agulhas leakage during late glacial conditions took place when glacial ice volume was maximal, suggesting a crucial role for Agulhas leakage in glacial terminations, timing of interhemispheric climate change(7) and the resulting resumption of the Atlantic meridional overturning circulation(6).	Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, NL-1081 HV Amsterdam, Netherlands; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Texel, Netherlands; Univ Edinburgh, Grant Inst Geol, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Fac Phys & Astron, NL-3584 CC Utrecht, Netherlands; Univ Bordeaux 1, Dept Geol & Oceanog, CNRS, UMR EPOC 5805, F-33405 Talence, France	Vrije Universiteit Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Edinburgh; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Peeters, FJC (corresponding author), Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	frank.peeters@falw.vu.nl	de Ruijter, Wilhelmus/I-2541-2016; Brummer, Gerard J/I-1187-2014	Peeters, Frank J.C./0000-0002-5678-9288; Ufkes, E./0000-0003-3257-0203				Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; Bu A., 1971, MICROPALEONTOLOGY OC, P105; Chen MT, 2002, MAR GEOL, V180, P163, DOI 10.1016/S0025-3227(01)00212-2; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; de Ruijter WPM, 2004, DEEP-SEA RES PT I, V51, P383, DOI 10.1016/j.dsr.2003.10.011; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Garzoli SL, 1996, J GEOPHYS RES-OCEANS, V101, P897, DOI 10.1029/95JC03221; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Gordon AL, 1996, NATURE, V382, P399, DOI 10.1038/382399a0; Hodell DA, 2000, GLOBAL PLANET CHANGE, V24, P7, DOI 10.1016/S0921-8181(99)00069-7; Howard WR, 1992, PALEOCEANOGRAPHY, V7, P79, DOI 10.1029/91PA02994; Imbrie J., 1984, MILANKOVITCH CLIMA 1, P269; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Kunz-Pirrung M, 2002, PALAEOGEOGR PALAEOCL, V182, P305, DOI 10.1016/S0031-0182(01)00501-6; Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125; LUTJEHARMS JRE, 2000, S AFR J SCI, V96; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; Rau AJ, 2002, MAR GEOL, V180, P183, DOI 10.1016/S0025-3227(01)00213-4; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Schneider RR, 1999, RECONSTRUCTING OCEAN HISTORY, P33; Schouten MW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014542; Ufkes E, 2000, MAR MICROPALEONTOL, V40, P23, DOI 10.1016/S0377-8398(00)00030-X; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Weijer W, 2001, J PHYS OCEANOGR, V31, P2385, DOI 10.1175/1520-0485(2001)031<2385:SOTAOC>2.0.CO;2; Winter A, 1990, PALEOCEANOGRAPHY, V5, P479, DOI 10.1029/PA005i004p00479; Wunsch C, 2003, QUATERNARY SCI REV, V22, P1631, DOI 10.1016/S0277-3791(03)00152-5	31	278	281	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					661	665		10.1038/nature02785	http://dx.doi.org/10.1038/nature02785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295596	Green Published			2022-12-01	WOS:000223085400041
J	Trotter, CL; Andrews, NJ; Kaczmarski, EB; Miller, E; Ramsay, ME				Trotter, CL; Andrews, NJ; Kaczmarski, EB; Miller, E; Ramsay, ME			Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction	LANCET			English	Article							ENGLAND	The meningococcal serogroup C conjugate (MCC) vaccine programme in England has successfully controlled the incidence of serogroup C disease, as a result of high short-term vaccine effectiveness and substantial herd immunity. However, the long-term effectiveness of the vaccine remains unknown. We assessed surveillance data from the 4 years since introduction of the programme. Vaccine effectiveness remained high in children vaccinated in the catch-up campaign (aged 5 months to 18 years). However, for children vaccinated in the routine infant immunisation programme, the effectiveness of the MCC vaccine fell to low levels after only 1 year. The number of individuals in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Hlth Protect Agcy, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Stat Econ & Modelling Dept, London NW9 5EQ, England; Manchester Royal Infirm, Hlth Protect Agcy, Meningococcal Reference Unit, Manchester M13 9WL, Lancs, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency; University of Manchester	Ramsay, ME (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, 61 Colindale Ave, London NW9 5EQ, England.	mary.ramsay@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Trotter, Caroline/0000-0003-4000-2708; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; *COVER PROGR CHILD, Q COMM DIS REP COVER; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7	6	437	456	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					365	367		10.1016/S0140-6736(04)16725-1	http://dx.doi.org/10.1016/S0140-6736(04)16725-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276396				2022-12-01	WOS:000222853300035
J	Umemori, H; Linhoff, MW; Ornitz, DM; Sanes, JR				Umemori, H; Linhoff, MW; Ornitz, DM; Sanes, JR			FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; CULTURED NEURONS; STOP SIGNAL; RECEPTOR; DIFFERENTIATION; SPECIFICITY; INDUCTION; BINDING; CELLS; LIMB	Target-derived cues promote local differentiation of axons into nerve terminals at sites of synaptic contact. Using clustering of synaptic vesicles in cultured neurons as an assay, we purified putative target-derived presynaptic organizing molecules from mouse brain and identified FGF22 as a major active species. FGF7 and FGF10, the closest relatives of FGF22, share this activity; other FGFs have distinct effects. FGF22 is expressed by cerebellar granule cells during the period when they receive synapses. Its receptor, FGFR2, is expressed by pontine and vestibular neurons when their axons (mossy fibers) are making synapses on granule cells. Neutralization of FGF7, -10, and -22 inhibits presynaptic differentiation of mossy fibers at sites of contact with granule cells in vivo. Inactivation of FGFR2 has similar effects. These results indicate that FGF22 and its relatives are presynaptic organizing molecules in the mammalian brain and suggest new functions for this family of signaling molecules.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@mcb.harvard.edu		Ornitz, David/0000-0003-1592-7629; Umemori, Hisashi/0000-0001-7198-2062				Altman J., 1997, DEV CEREBELLAR SYSTE; BAIRD DH, 1992, J NEUROSCI, V12, P619; Belluardo N, 1997, J COMP NEUROL, V379, P226; Bellusci S, 1997, DEVELOPMENT, V124, P4867; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Beyer TA, 2003, EXP CELL RES, V287, P228, DOI 10.1016/S0014-4827(03)00139-3; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; DAI ZS, 1995, J NEUROSCI, V15, P5466; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HENDERSON CE, 2003, MOL CELL NEUROSCI, V22, P430; Li AJ, 2002, EUR J NEUROSCI, V16, P1313, DOI 10.1046/j.1460-9568.2002.02193.x; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakatake Y, 2001, BBA-GENE STRUCT EXPR, V1517, P460, DOI 10.1016/S0167-4781(00)00302-X; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Post M, 1996, DEVELOPMENT, V122, P3107; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WERLE MJ, 1991, RES NEUROL, V5, P269; Xu XL, 1998, DEVELOPMENT, V125, P753; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; YUZAKI M, 1992, J NEUROSCI, V12, P4253	42	206	213	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					257	270		10.1016/j.cell.2004.06.025	http://dx.doi.org/10.1016/j.cell.2004.06.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260994	Bronze			2022-12-01	WOS:000222966000013
J	Backwell, PRY; Jennions, MD				Backwell, PRY; Jennions, MD			Coalition among male fiddler crabs	NATURE			English	Editorial Material							NEIGHBORS		Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	Australian National University	Backwell, PRY (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	pat.backwell@anu.edu.au	Jennions, Michael D/C-7560-2009; Backwell, Patricia RY/C-8883-2009	Jennions, Michael D/0000-0001-9221-2788; 				Backwell PRY, 2000, P ROY SOC B-BIOL SCI, V267, P719, DOI 10.1098/rspb.2000.1062; CRANE JA, 1976, FIDDLER CRABS WORLD; Dugatkin LA., 1997, COOPERATION ANIMALS; Elfstrom ST, 1997, ANIM BEHAV, V54, P535, DOI 10.1006/anbe.1996.0492; GETTY T, 1987, AM ZOOL, V27, P327; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; Morrell LJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P385, DOI 10.1007/s00265-003-0663-7; Stamps JA, 2001, AM NAT, V157, P154, DOI 10.1086/318634; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	9	60	61	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					417	417		10.1038/430417a	http://dx.doi.org/10.1038/430417a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269757				2022-12-01	WOS:000222801400030
J	Ninomiya, H; Elinson, RP; Winklbauer, R				Ninomiya, H; Elinson, RP; Winklbauer, R			Antero-posterior tissue polarity links mesoderm convergent extension to axial patterning	NATURE			English	Article							MORPHOGEN GRADIENT; CELL POLARIZATION; XENOPUS HOMOLOG; WNT PATHWAY; GASTRULATION; MOVEMENTS; ACTIVIN; EXPRESSION; DROSOPHILA; ORGANIZER	Remodelling its shape, or morphogenesis, is a fundamental property of living tissue. It underlies much of embryonic development and numerous pathologies. Convergent extension (CE) of the axial mesoderm of vertebrates is an intensively studied model for morphogenetic processes that rely on cell rearrangement. It involves the intercalation of polarized cells perpendicular to the antero-posterior (AP) axis, which narrows and lengthens the tissue(1,2). Several genes have been identified that regulate cell behaviour underlying CE in zebrafish and Xenopus. Many of these are homologues of genes that control epithelial planar cell polarity in Drosophila(1-5). However, elongation of axial mesoderm must be also coordinated with the pattern of AP tissue specification to generate a normal larval morphology. At present, the long-range control that orients CE with respect to embryonic axes is not understood. Here we show that the chordamesoderm of Xenopus possesses an intrinsic AP polarity that is necessary for CE, functions in parallel to Wnt/planar cell polarity signalling, and determines the direction of tissue elongation. The mechanism that establishes AP polarity involves graded activin-like signalling and directly links mesoderm AP patterning to CE.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA	University of Toronto; Duquesne University	Winklbauer, R (corresponding author), Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada.	winklbauer@zoo.utoronto.ca						Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gurdon JB, 1999, DEVELOPMENT, V126, P5309; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; GWANTKA V, 1992, DEVELOPMENT, V115, P595; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 1988, DEVELOPMENT, V103, P193; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Ninomiya H, 1999, DEV GROWTH DIFFER, V41, P391; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; SOKOL SY, 1995, DEVELOPMENT, V121, P1637; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Tada M, 2000, DEVELOPMENT, V127, P2227; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	30	121	123	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					364	367		10.1038/nature02620	http://dx.doi.org/10.1038/nature02620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254540				2022-12-01	WOS:000222631200044
J	Chen, JY; Bottjer, DJ; Oliveri, P; Dornbos, SQ; Gao, F; Ruffins, S; Chi, HM; Li, CW; Davidson, EH				Chen, JY; Bottjer, DJ; Oliveri, P; Dornbos, SQ; Gao, F; Ruffins, S; Chi, HM; Li, CW; Davidson, EH			Small bilaterian fossils from 40 to 55 million years before the Cambrian	SCIENCE			English	Article							NEOPROTEROZOIC SNOWBALL EARTH; DOUSHANTUO FORMATION; CONSTRAINTS; CHINA; PLATYHELMINTHES; PHOSPHORITES; EVOLUTION; EMBRYOS; MEMBERS; AGE	Ten phosphatized specimens of a small (<180 micrometers) animal displaying clear bilaterian features have been recovered from the Doushantuo Formation, China, dating from 40 to 55 million years before the Cambrian. Seen in sections, this animal (Vernanimalcula guizhouena gen. et sp. nov.) had paired coeloms extending the length of the gut; paired external pits that could be sense organs; bilateral, anterior-posterior organization; a ventrally directed anterior mouth with thick walled pharynx; and a triploblastic structure. The structural complexity is that of an adult rather than a larval form. These fossils provide the first evidence confirming the phylogenetic inference that Bilateria arose well before the Cambrian.	Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China; Nanjing Univ, Coll Life Sci, Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; SE Univ, Dept Biol Sci & Med Engn, Nanjing 210096, Peoples R China; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Nanjing University; University of Southern California; California Institute of Technology; Southeast University - China; National Tsing Hua University	Chen, JY (corresponding author), Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China.	chenjunyuan@163.net; dbottjer@usc.edu	Gao, Fremont/AFQ-0003-2022	Gao, Fremont/0000-0001-8764-1107; Oliveri, Paola/0000-0002-3477-8529				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Baguna J, 2001, INT J DEV BIOL, V45, pS133; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Brusca R. C., 2003, INVERTEBRATES; Chen DF, 2003, CHEM GEOL, V201, P103, DOI 10.1016/S0009-2541(03)00235-3; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Chen JY, 2000, P NATL ACAD SCI USA, V97, P4457, DOI 10.1073/pnas.97.9.4457; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Davidson EH, 2001, GENOMIC REGULATORY S; DORNBOS SQ, 2002, GSA ABSTR PROG, V34, P75; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; GAO F, 2003, GSA ABSTR PROG, V35, P187; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; HALANYCH KM, 1995, SCIENCE, V267, P1642; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Jondelius U, 2002, ZOOL SCR, V31, P201, DOI 10.1046/j.1463-6409.2002.00090.x; KIMURA H, 2003, GSA ABSTR PROG, V35, P187; Knoll AH, 2003, LIFE YOUNG PLANET 1; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Runnegar B, 2000, NATURE, V405, P403, DOI 10.1038/35013168; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Yuan X.L., 2002, DOUSHANTUO FOSSILS L, P1; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1; ZHAO Z, 1988, CHINA U GEOL PRESS, P1	29	150	188	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2004	305	5681					218	222		10.1126/science.1099213	http://dx.doi.org/10.1126/science.1099213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15178752				2022-12-01	WOS:000222501000045
J	Verma, R; Oania, R; Graumann, J; Deshaies, RJ				Verma, R; Oania, R; Graumann, J; Deshaies, RJ			Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; DEPENDENT DEGRADATION; PROTEIN-DEGRADATION; BINDING PROTEIN; UBA DOMAIN; DNA-REPAIR; SUBUNIT; RECOGNITION; RAD23; COMPLEX	Recruitment of ubiquitinated proteins to the 26S proteasome lies at the heart of the ubiquitin-proteasome system (UPS). Genetic studies suggest a role for the multiubiquitin chain binding proteins (MCBPs) Rad23 and Rpn10 in recruitment, but biochemical studies implicate the Rpt5 ATPase. We addressed this issue by analyzing degradation of the ubiquitinated Cdk inhibitor Sic1 (UbSic1) in vitro. Mutant rpn10Delta and rad23Delta proteasomes failed to bind or degrade UbSic1. Although Rpn10 or Rad23 restored UbSic1 recruitment to either mutant, rescue of degradation by Rad23 uncovered a requirement for the VWA domain of Rpn10. In vivo analyses confirmed that Rad23 and the multiubiquitin binding domain of Rpn10 contribute to Sic1 degradation. Turnover studies of multiple UPS substrates uncovered an unexpected degree of specificity in their requirements for MCBPs. We propose that recruitment of substrates to the proteasome by MCBPs provides an additional layer of substrate selectivity in the UPS.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Graumann, Johannes/C-5241-2008; Deshaies, Raymond/B-8354-2014	Graumann, Johannes/0000-0002-3015-5850; Deshaies, Raymond/0000-0002-3671-9354				Amerik AY, 1997, EMBO J, V16, P4826; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lambertson D, 1999, GENETICS, V153, P69; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169	57	354	363	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2004	118	1					99	110		10.1016/j.cell.2004.06.014	http://dx.doi.org/10.1016/j.cell.2004.06.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242647	Bronze			2022-12-01	WOS:000222626800011
J	Field, MG				Field, MG			Global health - HIV and AIDS in the former Soviet Bloc	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Davis Ctr Russian & Eurasian Studies, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Field, MG (corresponding author), Harvard Univ, Davis Ctr Russian & Eurasian Studies, Cambridge, MA 02138 USA.							EBERSTADT N, 2004, WASHINGTON POST 0213, pA27; FESHBACH M, 2003, NY TIMES        0531, pA15; POWELL DE, 2000, RUSSIAS TORN SAFETY, P123; *UN DEV PROGR, 2004, HIV AIDS E EUR COMM; 2004, MOSCOW TIMES    0218, P42	5	26	28	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2004	351	2					117	120		10.1056/NEJMp048066	http://dx.doi.org/10.1056/NEJMp048066			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835GM	15247350				2022-12-01	WOS:000222470700002
J	Lu, XW; Borchers, AGM; Jolicoeur, C; Rayburn, H; Baker, JC; Tessier-Lavigne, M				Lu, XW; Borchers, AGM; Jolicoeur, C; Rayburn, H; Baker, JC; Tessier-Lavigne, M			PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates	NATURE			English	Article							NEURAL-TUBE CLOSURE; CONVERGENT EXTENSION; DROSOPHILA; MOUSE; MECHANISMS; POLARIZATION; CIRCLETAIL; MOLECULE; ENCODES; DEFECTS	In addition to the apical-basal polarity pathway operating in epithelial cells, a planar cell polarity (PCP) pathway establishes polarity within the plane of epithelial tissues and is conserved from Drosophila to mammals. In Drosophila, a 'core' group of PCP genes including frizzled (fz), flamingo/starry night, dishevelled (dsh), Van Gogh/strabismus and prickle, function to regulate wing hair, bristle and ommatidial polarity(1-3). In vertebrates, the PCP pathway regulates convergent extension movements and neural tube closure(3-5), as well as the orientation of stereociliary bundles of sensory hair cells in the inner ear(6). Here we show that a mutation in the mouse protein tyrosine kinase 7 (PTK7) gene, which encodes an evolutionarily conserved transmembrane protein with tyrosine kinase homology, disrupts neural tube closure and stereociliary bundle orientation, and shows genetic interactions with a mutation in the mouse Van Gogh homologue vangl(2). We also show that PTK7 is dynamically localized during hair cell polarization, and that the Xenopus homologue of PTK7 is required for neural convergent extension and neural tube closure. These results identify PTK7 as a novel regulator of PCP in vertebrates.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com	Borchers, Annette/AAF-8126-2021					Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Borchers AGM, 2002, DEV BIOL, V251, P395, DOI 10.1006/dbio.2002.0814; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.0.CO;2-K; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; MOSSIE K, 1995, ONCOGENE, V11, P2179; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Park SK, 1996, J BIOCHEM, V119, P235; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9	24	360	370	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					93	98		10.1038/nature02677	http://dx.doi.org/10.1038/nature02677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229603				2022-12-01	WOS:000222356800050
J	Schuit, SCE; Oei, HHS; Witteman, JCM; van Kessel, CHG; van Meurs, JBJ; Nijhuis, RL; van Leeuwen, JPTM; de Jong, FH; Zillikens, MC; Hofman, A; Pols, HAP; Uitterlinden, AG				Schuit, SCE; Oei, HHS; Witteman, JCM; van Kessel, CHG; van Meurs, JBJ; Nijhuis, RL; van Leeuwen, JPTM; de Jong, FH; Zillikens, MC; Hofman, A; Pols, HAP; Uitterlinden, AG			Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; POSTMENOPAUSAL WOMEN; ASSOCIATION; ESTRADIOL; HAPLOTYPE; HEALTHY; MEN; PREMENOPAUSAL; REPLACEMENT	Context The role of estrogens in ischemic heart disease (IHD) is uncertain. Evidence suggests that genetic variations in the estrogen receptor alpha (ESR1) gene may influence IHD risk, but the role of common sequence variations in the ESR1 gene is unclear. Objective To determine whether the ESR1 haplotype created by the c.454-397T>C (Pvull) and c.454-351A>G (Xbal) polymorphisms is associated with myocardial infarction (MI) and IHD risk. Design, Setting, and Participants In 2617 men and 3791 postmenopausal women from The Rotterdam Study (enrollment between 1989-1993 and follow-up to January 2000), a population-based, prospective cohort study of participants aged 55 years and older, ESR1 c.454-397T>C and c.454-351A>G haplotypes were determined. Detailed interviews and physical examinations were performed, blood samples were obtained, and cardiovascular risk factors were assessed. Main Outcome Measure The primary outcome was MI and IHD defined as MIs, revascularization procedures, and IHD mortality. Results Approximately 29% of women and 28.2% of men were homozygous carriers of the ESR1 haplotype 1 (-397 T and -351 A) allele, 49% of women and 50% of men were heterozygous carriers, and 22% of women and 21.4% of men were noncarriers. During a mean follow-up of 7.0 years, 285 participants (115 women; 170 men) had MI, and 440 (168 women; 272 men) had an IHD event, of which 97 were fatal. After adjustment for known cardiovascular risk factors, female heterozygous carriers of haplotype 1 had an increased risk of MI (event rate, 2.8%; relative risk [RR], 2.23; 95% confidence interval [CI], 1.13-4.43) compared with noncarriers (event rate, 1.3%), whereas homozygous carriers had an increased risk (event rate, 3.2%; RR, 2.48; 950/c Cl, 1.22-5.03). For IHD events, we observed a similar association. In women, the effect of haplotype 1 on fatal IHD was larger than on nonfatal IHD. In men, the ESR1 haplotypes were not associated with an increased risk of MI (event rate, 5.7%; RR, 0.93; 95% Cl, 0.59-1.46 for heterozygous carriers; and event rate, 5.1%; RR, 0.82; 95% Cl, 0.49-1.38 for homozygous carriers) compared with noncarriers (event rate, 5.8%) and were not associated with an increased risk of IHD. Conclusions In this population-based, prospective cohort study, postmenopausal women who carry ESR1 haplotype 1 (c.454-397 T allele and c.454-351 A allele) have an increased risk of MI and IHD, independent of known cardiovascular risk factors. in men, no association was observed.	Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pols, HAP (corresponding author), Erasmus MC, Dept Internal Med, POB 1738, NL-3000 DR Rotterdam, Netherlands.	h.pols@erasmusmc.nl	van Leeuwen, Johannes/D-5015-2014; De Jong, Frank H/A-9876-2011	van Leeuwen, Johannes/0000-0002-2282-4006; De Jong, Frank H/0000-0003-3578-1065; van Meurs, Joyce/0000-0001-6245-2123				Albagha OME, 2001, J BONE MINER RES, V16, P128, DOI 10.1359/jbmr.2001.16.1.128; ANDERSEN TI, 1994, HUM GENET, V94, P665; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1992, INT CLASS DIS 10 REV; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Brouchet L, 2001, CIRCULATION, V103, P423; BRUYNE MC, 1997, J CLIN EPIDEMIOL, V50, P947; BRUYNE MC, 1997, EPIDEMIOLOGY, V8, P495; Chalmers J, 1999, J HYPERTENS, V17, P151; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Deng HW, 2000, J CLIN ENDOCR METAB, V85, P2748, DOI 10.1210/jc.85.8.2748; Fricker J, 1999, MOL MED TODAY, V5, P505, DOI 10.1016/S1357-4310(99)01617-2; GENT CM, 1977, CLIN CHIM ACTA, V75, P243; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Hedges YK, 1999, CIRCULATION, V99, P2688, DOI 10.1161/01.CIR.99.20.2688; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; HISHIKAWA K, 1995, FEBS LETT, V360, P291, DOI 10.1016/0014-5793(95)00124-R; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kunnas TA, 2000, BRIT MED J, V321, P273, DOI 10.1136/bmj.321.7256.273; Langdahl BL, 2000, J BONE MINER RES, V15, P2222, DOI 10.1359/jbmr.2000.15.11.2222; LEHRER S, 1993, HYPERTENSION, V21, P439, DOI 10.1161/01.HYP.21.4.439; Lehtimaki T, 2002, EUR J CLIN INVEST, V32, P400, DOI 10.1046/j.1365-2362.2002.01010.x; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Maxwell SRJ, 1998, BASIC RES CARDIOL, V93, P79; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McNeill AM, 1999, STROKE, V30, P2186, DOI 10.1161/01.STR.30.10.2186; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Schuit SCE, 2004, J CLIN ENDOCR METAB, V89, P303, DOI 10.1210/jc.2003-031095; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sudhir K, 1997, CIRCULATION, V96, P3774; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Venkov CD, 1996, CIRCULATION, V94, P727, DOI 10.1161/01.CIR.94.4.727; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146; *WHO, 1985, TECHN REP SER, V727; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445	47	194	197	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2004	291	24					2969	2977		10.1001/jama.291.24.2969	http://dx.doi.org/10.1001/jama.291.24.2969			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831HD	15213208	Bronze			2022-12-01	WOS:000222184600026
J	Levasseur-Regourd, AC				Levasseur-Regourd, AC			Cometary dust unveiled	SCIENCE			English	Editorial Material							COMA; FRAGMENTS; 1P/HALLEY		Univ Paris 06, F-91371 Verrieres Le Buisson, France; Univ Paris 06, F-91371 Verrieres Le Buisson, France; Aeron CNRS, IPSL, F-91371 Verrieres Le Buisson, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Levasseur-Regourd, AC (corresponding author), Univ Paris 06, BP 3, F-91371 Verrieres Le Buisson, France.	anny-chantal.levasseur@aerov.jussieu.fr						Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; CLARK BC, UNPUB; Desvoivres E, 2000, ICARUS, V144, P172, DOI 10.1006/icar.1999.6272; Fulle M, 2000, ASTRON J, V119, P1968, DOI 10.1086/301285; Greenberg J., 1982, COMETS, P131; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; KISSEL J, 1986, NATURE, V321, P336, DOI 10.1038/321336a0; Levasseur-Regourd AC, 1999, ASTRON ASTROPHYS, V348, P636; McBride N, 1997, MON NOT R ASTRON SOC, V289, P535, DOI 10.1093/mnras/289.3.535; MCDONNELL JAM, 1987, ASTRON ASTROPHYS, V187, P719; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; Tuzzolino AJ, 2004, SCIENCE, V304, P1776, DOI 10.1126/science.1098759; Weaver HA, 2004, SCIENCE, V304, P1760	13	19	20	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1762	1763		10.1126/science.1100601	http://dx.doi.org/10.1126/science.1100601			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205523				2022-12-01	WOS:000222089500034
J	Klein, S; Fontana, L; Young, VL; Coggan, AR; Kilo, C; Patterson, BW; Mohammed, BS				Klein, S; Fontana, L; Young, VL; Coggan, AR; Kilo, C; Patterson, BW; Mohammed, BS			Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE-VOLUME LIPOSUCTION; TUMOR-NECROSIS-FACTOR; FREE FATTY-ACIDS; WEIGHT-LOSS; ADIPOSE-TISSUE; OBESE WOMEN; LIPID-METABOLISM; GLUCOSE-METABOLISM; WHOLE-BODY; REDUCTION	Background: Liposuction has been proposed as a potential treatment for the metabolic complications of obesity. We evaluated the effect of large-volume abdominal liposuction on metabolic risk factors for coronary heart disease in women with abdominal obesity. Methods: We evaluated the insulin sensitivity of liver, skeletal muscle, and adipose tissue (with a euglycemic-hyperinsulinemic clamp procedure and isotope-tracer infusions) as well as levels of inflammatory mediators and other risk factors for coronary heart disease in 15 obese women before and 10 to 12 weeks after abdominal liposuction. Eight of the women had normal glucose tolerance (mean [+/-SD] body-mass index, 35.1+/-2.4), and seven had type 2 diabetes (body-mass index, 39.9+/-5.6). Results: Liposuction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects with normal glucose tolerance and 28 percent in those with diabetes; those with normal oral glucose tolerance lost 9.1+/-3.7 kg of fat (18+/-3 percent decrease in total fat, P=0.002), and those with type 2 diabetes lost 10.5+/-3.3 kg of fat (19+/-2 percent decrease in total fat, P<0.001). Liposuction did not significantly alter the insulin sensitivity of muscle, liver, or adipose tissue (assessed by the stimulation of glucose disposal, the suppression of glucose production, and the suppression of lipolysis, respectively); did not significantly alter plasma concentrations of C-reactive protein, interleukin-6, tumor necrosis factor (alpha), and adiponectin; and did not significantly affect other risk factors for coronary heart disease (blood pressure and plasma glucose, insulin, and lipid concentrations) in either group. Conclusions: Abdominal liposuction does not significantly improve obesity-associated metabolic abnormalities. Decreasing adipose tissue mass alone will not achieve the metabolic benefits of weight loss.	Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; Ist Super Sanita, Div Food Sci Human Nutr & Hlth, I-00161 Rome, Italy	Washington University (WUSTL); Istituto Superiore di Sanita (ISS)	Klein, S (corresponding author), Washington Univ, Sch Med, Ctr Human Nutr, 660 S Euclid Ave,Campus Box 8031, St Louis, MO 63110 USA.		Fontana, Luigi/K-4773-2013; Fontana, Luigi/A-8371-2013; Coggan, Andrew R/B-2117-2010	Coggan, Andrew R/0000-0002-7723-8872; Patterson, Bruce W/0000-0001-9261-0233; Fontana, Luigi/0000-0001-8500-5537	NCRR NIH HHS [RR-00954, RR-00036] Funding Source: Medline; NICHD NIH HHS [HD 01459] Funding Source: Medline; NIDDK NIH HHS [DK 56341, DK 37948] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037948, P30DK056341] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; American Society for Aesthetic Plastic Surgery, COSM SURG NAT DAT BA; BALLOR DL, 1994, INT J OBESITY, V18, P35; Berntorp E, 1998, J INTERN MED, V243, P197; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Commons GW, 2001, PLAST RECONSTR SURG, V108, P1753, DOI 10.1097/00006534-200111000-00050; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Giese SY, 2001, PLAST RECONSTR SURG, V108, P510, DOI 10.1097/00006534-200108000-00035; Gonzalez-Ortiz M, 2002, HORM METAB RES, V34, P446, DOI 10.1055/s-2002-33603; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Horowitz JF, 2001, AM J CLIN NUTR, V73, P517; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE278, DOI 10.1152/ajpendo.1999.276.2.E278; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Klein S, 2002, GASTROENTEROLOGY, V123, P882, DOI 10.1053/gast.2002.35514; Klein S, 2002, GASTROENTEROLOGY, V123, P1752; Klein S, 1996, AM J PHYSIOL-ENDOC M, V270, pE739; KNITTLE JL, 1972, DIABETES, V21, P754, DOI 10.2337/diab.21.6.754; Krssak M, 1999, DIABETOLOGIA, V42, P386; LAMBERT EV, 1991, AESTHET PLAST SURG, V15, P105, DOI 10.1007/BF02273842; Matarasso A, 2001, JAMA-J AM MED ASSOC, V285, P266, DOI 10.1001/jama.285.3.266; Matarasso A, 1998, PLAST RECONSTR SURG, V102, P1686, DOI 10.1097/00006534-199810000-00057; MLADICK RA, 1990, PLAST RECONSTR SURG, V86, P84, DOI 10.1097/00006534-199007000-00013; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Purnell JQ, 2000, J CLIN ENDOCR METAB, V85, P977, DOI 10.1210/jc.85.3.977; SAMDAL F, 1995, AESTHET PLAST SURG, V19, P131, DOI 10.1007/BF00450248; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Tiikkainen M, 2003, DIABETES, V52, P701, DOI 10.2337/diabetes.52.3.701; Trott SA, 1998, PLAST RECONSTR SURG, V102, P2220, DOI 10.1097/00006534-199811000-00063; Uusitupa M, 2003, DIABETES, V52, P2532, DOI 10.2337/diabetes.52.10.2532; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; YANG WS, 2002, J CLIN ENDOCR METAB, V87, P1626; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	42	521	552	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2004	350	25					2549	2557		10.1056/NEJMoa033179	http://dx.doi.org/10.1056/NEJMoa033179			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829NE	15201411				2022-12-01	WOS:000222054700005
J	Pouille, F; Scanziani, M				Pouille, F; Scanziani, M			Routing of spike series by dynamic circuits in the hippocampus	NATURE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; SYNAPTIC ORGANIZATION; TOTAL NUMBER; CA1 AREA; INTERNEURONS; NEURONS; INHIBITION; SYNAPSES; RECEPTOR	Recurrent inhibitory loops are simple neuronal circuits found in the central nervous system, yet little is known about the physiological rules governing their activity. Here we use simultaneous somatic and dendritic recordings in rat hippocampal slices to show that during a series of action potentials in pyramidal cells recurrent inhibition rapidly shifts from their soma to the apical dendrites. Two distinct inhibitory circuits are sequentially recruited to produce this shift: one, time-locked with submillisecond precision to the onset of the action potential series, transiently inhibits the somatic and perisomatic regions of pyramidal cells; the other, activated in proportion to the rate of action potentials in the series, durably inhibits the distal apical dendrites. These two operating modes result from the synergy between pre- and postsynaptic properties of excitatory synapses onto recurrent inhibitory neurons with distinct projection patterns. Thus, the onset of a series of action potentials and the rate of action potentials in the series are selectively captured and transformed into different spatial patterns of recurrent inhibition.	Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu						Adrian E. D. A., 1928, BASIS SENSATION ACTI; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; Dayan P., 2001, THEORETICAL NEUROSCI; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gulyas AI, 1999, J NEUROSCI, V19, P10082; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rieke F., 1997, SPIKES EXPLORING NEU; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000	31	311	345	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					717	723		10.1038/nature02615	http://dx.doi.org/10.1038/nature02615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15170216				2022-12-01	WOS:000222059900028
J	Zhu, Z; Zheng, T; Homer, RJ; Kim, YK; Chen, NY; Cohn, L; Hamid, Q; Elias, JA				Zhu, Z; Zheng, T; Homer, RJ; Kim, YK; Chen, NY; Cohn, L; Hamid, Q; Elias, JA			Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation	SCIENCE			English	Article							PARASITE CHITINASE; ALLERGY; IDENTIFICATION	Chitin is a surface component of parasites and insects, and chitinases are induced in lower life forms during infections with these agents. Although chitin itself does not exist in humans, chitinases are present in the human genome. We show here that acidic mammalian chitinase (AMCase) is induced via a T helper-2 (Th2) specific, interleukin-13 (IL-13) -mediated pathway in epithelial cells and macrophages in an aeroallergen asthma model and expressed in exaggerated quantities in human asthma. AMCase neutralization ameliorated Th2 inflammation and airway hyperresponsiveness, in part by inhibiting IL-13 pathway activation and chemokine induction. AMCase may thus be an important mediator of IL-13-induced responses in Th2-dominated disorders such as asthma.	Yale Univ, Sch Med, Dept Internal Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; VA CT Hlth Care Syst, Pathol & Lab Med Serv, West Haven, CT 06516 USA; McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; McGill University	Elias, JA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Pulm & Crit Care Med Sect, 300 Cedar St,TAC S-441, New Haven, CT 06520 USA.	jack.elias@yale.edu	homer, robert/P-3884-2019	homer, robert/0000-0002-2055-5885	NHLBI NIH HHS [P50-HL-56, R01-HL-61904, R01-HL-074095, R01-HL-64242, R01-HL-66571] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061904, R01HL064242, R01HL066571, R01HL074095] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Herrera-Estrella A, 1999, EXS, V87, P171; Holt PG, 2000, LANCET, V356, P1699, DOI 10.1016/S0140-6736(00)03198-6; Holt PG, 1996, TOXICOL LETT, V86, P205, DOI 10.1016/0378-4274(96)03692-2; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Palli Sr, 1999, EXS, V87, P85; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Seferian PG, 2000, VACCINE, V19, P661, DOI 10.1016/S0264-410X(00)00248-6; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; Shahabuddin M, 1999, EXS, V87, P223; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Spindler KD, 1997, ARCH INSECT BIOCHEM, V36, P223, DOI 10.1002/(SICI)1520-6327(1997)36:3<223::AID-ARCH6>3.0.CO;2-U; Spindler KD, 1999, EXS, V87, P201; Strong P, 2002, CLIN EXP ALLERGY, V32, P1794, DOI 10.1046/j.1365-2222.2002.01551.x; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	18	641	688	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1678	1682		10.1126/science.1095336	http://dx.doi.org/10.1126/science.1095336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192232				2022-12-01	WOS:000221934300053
J	Borodinsky, LN; Root, CM; Cronin, JA; Sann, SB; Gu, XN; Spitzer, NC				Borodinsky, LN; Root, CM; Cronin, JA; Sann, SB; Gu, XN; Spitzer, NC			Activity-dependent homeostatic specification of transmitter expression in embryonic neurons	NATURE			English	Article							CULTURED SYMPATHETIC NEURONS; SPONTANEOUS CA2+ TRANSIENTS; HOMEODOMAIN PROTEIN; SPINAL NEURONS; GENE-EXPRESSION; MOTOR-NEURONS; TRANSCRIPTION FACTORS; MESSENGER-RNAS; GROWTH CONES; DIFFERENTIATION	Neurotransmitters are essential for interneuronal signalling, and the specification of appropriate transmitters in differentiating neurons has been related to intrinsic neuronal identity and to extrinsic signalling proteins. Here we show that altering the distinct patterns of Ca2+ spike activity spontaneously generated by different classes of embryonic spinal neurons in vivo changes the transmitter that neurons express without affecting the expression of markers of cell identity. Regulation seems to be homeostatic: suppression of activity leads to an increased number of neurons expressing excitatory transmitters and a decreased number of neurons expressing inhibitory transmitters; the reverse occurs when activity is enhanced. The imposition of specific spike frequencies in vitro does not affect labels of cell identity but again specifies the expression of transmitters that are inappropriate for the markers they express, during an early critical period. The results identify a new role of patterned activity in development of the central nervous system.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Borodinsky, LN (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	lborodin@biomail.ucsd.edu		Spitzer, Nicholas/0000-0002-3523-1103				Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BIXBY JL, 1984, J PHYSIOL-LONDON, V353, P143, DOI 10.1113/jphysiol.1984.sp015328; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Chub N, 1998, J NEUROSCI, V18, P294; Defazio RA, 2000, NEUROSCIENCE, V99, P297, DOI 10.1016/S0306-4522(00)00191-3; DIEFENBACH TJ, 1995, DEV BIOL, V167, P282, DOI 10.1006/dbio.1995.1023; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GROVES AK, 1995, DEVELOPMENT, V121, P887; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; HARTENSTEIN V, 1993, J COMP NEUROL, V328, P213, DOI 10.1002/cne.903280205; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; Li WC, 2001, J COMP NEUROL, V441, P248, DOI 10.1002/cne.1410; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; Milner LD, 1999, J NEUROSCI, V19, P3007; NAWA H, 1990, NEURON, V4, P269, DOI 10.1016/0896-6273(90)90101-K; Okada T, 2002, DEV BIOL, V244, P278, DOI 10.1006/dbio.2002.0585; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; RAO MS, 1992, DEV BIOL, V150, P281, DOI 10.1016/0012-1606(92)90242-9; RIBERA AB, 1989, NEURON, V2, P1055, DOI 10.1016/0896-6273(89)90229-8; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Somasekhar T, 1997, DEV BRAIN RES, V99, P208, DOI 10.1016/S0165-3806(97)00011-4; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; TAIRA M, 1993, DEV BIOL, V159, P245, DOI 10.1006/dbio.1993.1237; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WALICKE PA, 1981, J NEUROSCI, V1, P343; Watt SD, 2000, MOL CELL NEUROSCI, V16, P376, DOI 10.1006/mcne.2000.0871; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	50	297	304	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					523	530		10.1038/nature02518	http://dx.doi.org/10.1038/nature02518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175743				2022-12-01	WOS:000221767700030
J	Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U				Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U			Effect of trace metal availability on coccolithophorid calcification	NATURE			English	Article							SUB-ARCTIC PACIFIC; CADMIUM CONCENTRATIONS; MARINE-PHYTOPLANKTON; GREENLAND ICE; CARBONIC-ACID; ZINC; SEAWATER; IRON; DISSOCIATION; COMPLEXATION	The deposition of atmospheric dust into the ocean has varied considerably over geological time(1,2). Because some of the trace metals contained in dust are essential plant nutrients which can limit phytoplankton growth in parts of the ocean, it has been suggested that variations in dust supply to the surface ocean might influence primary production(3,4). Whereas the role of trace metal availability in photosynthetic carbon fixation has received considerable attention, its effect on biogenic calcification is virtually unknown. The production of both particulate organic carbon and calcium carbonate (CaCO3) drives the ocean's biological carbon pump. The ratio of particulate organic carbon to CaCO3 export, the so-called rain ratio, is one of the factors determining CO2 sequestration in the deep ocean. Here we investigate the influence of the essential trace metals iron and zinc on the prominent CaCO3-producing microalga Emiliania huxleyi. We show that whereas at low iron concentrations growth and calcification are equally reduced, low zinc concentrations result in a de-coupling of the two processes. Despite the reduced growth rate of zinc-limited cells, CaCO3 production rates per cell remain unaffected, thus leading to highly calcified cells. These results suggest that changes in dust deposition can affect biogenic calcification in oceanic regions characterized by trace metal limitation, with possible consequences for CO2 partitioning between the atmosphere and the ocean.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Leibniz Inst Marine Sci IFM GEOMAR, D-24105 Kiel, Germany; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Schulz, KG (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.	kschulz@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Schulz, Kai/AEZ-9073-2022; Schulz, Kai G./Q-5608-2017	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; timmermans, klaas/0000-0002-3214-4354; Riebesell, Ulf/0000-0002-9442-452X				Boyd P.W., 2000, CHANGING OCEAN CARBO, p[61, 107]; Broecker W., 1982, TRACERS SEA; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; BRULAND KW, 1989, LIMNOL OCEANOGR, V34, P269, DOI 10.4319/lo.1989.34.2.0269; CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989; COALE KH, 1991, LIMNOL OCEANOGR, V36, P1851, DOI 10.4319/lo.1991.36.8.1851; CONKRIGHT ME, 1994, 1 NOAA NESDIS US DEP, V1; Crawford DW, 2003, LIMNOL OCEANOGR, V48, P1583, DOI 10.4319/lo.2003.48.4.1583; Dickson A.G., 1994, HDB METHODS ANAL VAR; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Ellwood MJ, 2001, MAR CHEM, V75, P33, DOI 10.1016/S0304-4203(01)00024-X; Hong SM, 1997, ATMOS ENVIRON, V31, P2235, DOI 10.1016/S1352-2310(97)00029-0; Hong SM, 1996, EARTH PLANET SC LETT, V143, P233, DOI 10.1016/0012-821X(96)00137-9; Kremling K, 2001, DEEP-SEA RES PT I, V48, P2541, DOI 10.1016/S0967-0637(01)00036-X; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lohan MC, 2002, DEEP-SEA RES PT II, V49, P5793, DOI 10.1016/S0967-0645(02)00215-1; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Millero FJ, 1998, AQUAT GEOCHEM, V4, P153, DOI 10.1023/A:1009656023546; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pettit L. D., 2001, IUPAC STABILITY CONS; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda WG, 1995, LIMNOL OCEANOGR, V40, P1404, DOI 10.4319/lo.1995.40.8.1404; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	30	76	79	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					673	676		10.1038/nature02631	http://dx.doi.org/10.1038/nature02631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295599	Green Published			2022-12-01	WOS:000223085400044
J	Veugelers, M; Bressan, M; McDermott, DA; Weremowicz, S; Morton, CC; Mabry, CC; Lefaivre, JF; Zunamon, A; Destree, A; Chaudron, JM; Basson, CT				Veugelers, M; Bressan, M; McDermott, DA; Weremowicz, S; Morton, CC; Mabry, CC; Lefaivre, JF; Zunamon, A; Destree, A; Chaudron, JM; Basson, CT			Mutation of perinatal myosin heavy chain associated with a Carney complex variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL CARDIAC MYXOMAS; HOLT-ORAM-SYNDROME; SKELETAL-MUSCLE; DUTCH-KENTUCKY; EXPRESSION; GENE; TRISMUS; HEART; PHOSPHORYLATION; IDENTIFICATION	BACKGROUND: Familial cardiac myxomas occur in the hereditary syndrome Carney complex. Although PRKAR1A mutations can cause the Carney complex, the disorder is genetically heterogeneous. To identify the cause of a Carney complex variant associated with distal arthrogryposis (the trismus-pseudocamptodactyly syndrome), we performed clinical and genetic studies. METHODS: A large family with familial cardiac myxomas and the trismus-pseudocamptodactyly syndrome (Family 1) was identified and clinically evaluated along with two families with trismus and pseudocamptodactyly. Genetic linkage analyses were performed with the use of microsatellite polymorphisms to determine a locus for this Carney complex variant. Positional cloning and mutational analyses of candidate genes were performed to identify the genetic cause of disease in the family with the Carney complex as well as in the families with the trismus-pseudocamptodactyly syndrome. RESULTS: Clinical evaluations demonstrated that the Carney complex cosegregated with the trismus-pseudocamptodactyly syndrome in Family 1, and genetic analyses demonstrated linkage of the disease to chromosome 17p12-p13.1 (maximum multipoint lod score, 4.39). Sequence analysis revealed a missense mutation (Arg674Gln) in the perinatal myosin heavy-chain gene (MYH8). The same mutation was also found in the two families with the trismus-pseudocamptodactyly syndrome. Arg674 is highly conserved evolutionarily, localizes to the actin-binding domain of the perinatal myosin head, and is close to the ATP-binding site. We identified nonsynonymous MYH8 polymorphisms in patients with cardiac myxoma syndromes but without arthrogryposis. CONCLUSIONS: We describe a novel heart-hand syndrome involving familial cardiac myxomas and distal arthrogryposis and demonstrate that these disorders are caused by a founder mutation in the MYH8 gene. Our findings demonstrate novel roles for perinatal myosin in both the development of skeletal muscle and cardiac tumorigenesis.	Cornell Univ, Weill Med Coll, Dept Med, Greenberg Cardiol Div,Mol Cardiol Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Univ Kentucky, Coll Med, Dept Pediat, Div Endocrinol & Metab, Lexington, KY USA; Univ S Carolina, Sch Med, Dept Surg, Div Plast Surg, Columbia, SC USA; Evanston NW Healthcare, Div Cardiol, Evanston, IL USA; Inst Pathol & Genet, Ctr Genet Humaine, Loverval, Belgium; Jolimont Hosp, Dept Cardiol, Jolimont, Belgium	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Kentucky; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; NorthShore University Health System; Groupe Jolimont	Basson, CT (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Greenberg Cardiol Div,Mol Cardiol Lab, 525 E 68th St, New York, NY 10021 USA.	ctbasson@med.cornell.edu	Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211	NATIONAL CANCER INSTITUTE [R01CA078895] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061785] Funding Source: NIH RePORTER; NCI NIH HHS [CA78895] Funding Source: Medline; NHLBI NIH HHS [R01-HL61785] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKOU S, 2001, BASIC APPL MYOL, V11, P13; BANDMAN E, 1985, SCIENCE, V227, P780, DOI 10.1126/science.3969567; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; CARNEY JA, 1985, MEDICINE, V64, P270, DOI 10.1097/00005792-198507000-00007; Casey M, 2001, J CLIN INVEST, V107, P235, DOI 10.1172/JCI10841C1; Casey M, 1998, CIRCULATION, V98, P2560, DOI 10.1161/01.CIR.98.23.2560; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; CHAUDRON JM, 1992, EUR HEART J, V13, P569, DOI 10.1093/oxfordjournals.eurheartj.a060216; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; FEGHALI R, 1989, J CELL BIOL, V108, P1791, DOI 10.1083/jcb.108.5.1791; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; He J, 2004, AM J MED GENET A, V126A, P93, DOI 10.1002/ajmg.a.20487; HECHT F, 1969, Birth Defects Original Article Series, V5, P96; *HUM GEN PROJ, 2004, UCSC GEN BROWS; KARSCHMIZRACHI I, 1990, GENE, V89, P289, DOI 10.1016/0378-1119(90)90020-R; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lefaivre JF, 2003, ANN PLAS SURG, V50, P310, DOI 10.1097/01.SAP.0000046787.17899.83; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; MABRY CC, 1974, J PEDIATR-US, V85, P503, DOI 10.1016/S0022-3476(74)80453-1; Machida S, 2000, DEV DYNAM, V217, P37, DOI 10.1002/(SICI)1097-0177(200001)217:1<37::AID-DVDY4>3.3.CO;2-V; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Rombouts J J, 1992, Ann Chir Main Memb Super, V11, P333, DOI 10.1016/S0753-9053(05)80481-8; Sacks LD, 2003, DEVELOPMENT, V130, P3391, DOI 10.1242/dev.00541; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Stratakis CA, 1996, J CLIN INVEST, V97, P699, DOI 10.1172/JCI118467; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; VAGHADIA H, 1988, CAN J ANAESTH, V35, P80, DOI 10.1007/BF03010551; VEUGELERS M, 2002, GENETIC BASIS HUMAN, P635; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; WILSON R V, 1969, Birth Defects Original Article Series, V5, P99; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	40	87	89	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					460	469		10.1056/NEJMoa040584	http://dx.doi.org/10.1056/NEJMoa040584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282353				2022-12-01	WOS:000222939700009
J	Florio, P; Michetti, F; Bruschettini, M; Lituania, M; Bruschettini, P; Severi, FM; Petraglia, F; Gazzolo, D				Florio, P; Michetti, F; Bruschettini, M; Lituania, M; Bruschettini, P; Severi, FM; Petraglia, F; Gazzolo, D			Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death	LANCET			English	Article							GESTATIONAL-AGE; FETUSES	Fetal death in the mid-trimester of pregnancy is unexplained and no reliable markers are available to identify at-risk women. We aimed to assess use of a fetoprotein and S100B concentrations in amniotic fluid as markers. We did a case-control study in 758 healthy women undergoing amniocentesis at mid-gestation, of whom 12 had a spontaneous intrauterine fetal death before 28 weeks, and 746 matched controls. Concentrations were corrected for gestational age by conversion to multiples of median (MoM) of healthy controls of the same gestational age. Concentrations of S100B, but not alpha fetoprotein, were significantly higher (p<0.0001) in women who later had spontaneous fetal death (median 4.431 MoM [95%CI 3.605-6.197]) than in controls (1.000 MoM [1.062-1.121]). Sensitivity, specificity, and positive and negative predictive values of S100B as a diagnostic test were 100%, suggesting that measurement of this protein at amniocentesis could be useful to identify at-risk women.	Univ Siena, Policlin Le Scotte, Dept Paediat Obstet & Reprod Med, I-53100 Siena, Italy; Univ Sacred Heart, Inst Anat & Cell Biol, I-00168 Rome, Italy; Univ Genoa, G Gaslini Childrens Hosp, Dept Paediat, I-16126 Genoa, Italy; Univ Genoa, G Gaslini Childrens Hosp, Dept Obstet & Gynaecol, I-16126 Genoa, Italy	University of Siena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Petraglia, F (corresponding author), Univ Siena, Policlin Le Scotte, Dept Paediat Obstet & Reprod Med, Viale Bracci, I-53100 Siena, Italy.	petraglia@unisi.it	matteo, bruschettini/J-6030-2019; Petraglia, Felice/D-4373-2019; SEVERI, Filiberto Maria/K-6586-2016	matteo, bruschettini/0000-0002-4775-872X; Petraglia, Felice/0000-0002-8851-625X; SEVERI, Filiberto Maria/0000-0002-0892-4561				Gazzolo D, 2001, CLIN CHEM, V47, P954; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Goldenberg RL, 1997, CLIN OBSTET GYNECOL, V40, P704, DOI 10.1097/00003081-199712000-00004; Incerpi MH, 1998, AM J OBSTET GYNECOL, V178, P1121, DOI 10.1016/S0002-9378(98)70311-4; Michetti F, 2002, CLIN CHEM, V48, P2097; Reis FM, 2002, ENDOCR REV, V23, P230, DOI 10.1210/er.23.2.230; SINDIC CJM, 1984, PRENATAL DIAG, V4, P297, DOI 10.1002/pd.1970040409	7	36	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2004	364	9430					270	272		10.1016/S0140-6736(04)16677-4	http://dx.doi.org/10.1016/S0140-6736(04)16677-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15262105				2022-12-01	WOS:000222784900030
J	Marquez, V; Wilson, DN; Tate, WP; Triana-Alonso, F; Nierhaus, KH				Marquez, V; Wilson, DN; Tate, WP; Triana-Alonso, F; Nierhaus, KH			Maintaining the ribosomal reading frame: The influence of the E site during translational regulation of release factor 2	CELL			English	Article							ESCHERICHIA-COLI; TRANSFER-RNA; FACTOR-II; MESSENGER-RNA; BINDING; TERMINATION; ELONGATION; GENE	Maintenance of the translation reading frame is one of the most remarkable achievements of the ribosome while decoding the information of an mRNA. Loss of the reading frame through spontaneous frameshifting occurs with a frequency of one in 30,000 amino acid incorporations. However, at many recoding sites, the mechanism that controls reading frame maintenance is switched off. One such example is the programmed + 1 frameshift site of the prfB gene encoding the termination factor RF2, in which slippage into the forward frame by one nucleotide can attain an efficiency of similar to100%, namely, four orders of magnitude higher than normally observed. Here, using the RF2 frameshift window, we demonstrate that premature release of the E site tRNA from the ribosome is coupled with high-level frameshifting. Consistently, in a minimal system, the presence of the E site tRNA prevents the + 1 frameshift event, illustrating the importance of the E site for reading-frame maintenance.	AG Ribosomen, Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Otago, Dept Biochem, Dunedin, New Zealand; Univ Carabobo, Fac Ciencias Salud, Maracay, Venezuela	Max Planck Society; University of Otago	Nierhaus, KH (corresponding author), AG Ribosomen, Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	nierhaus@molgen.mpg.de	Wilson, Daniel/AAE-8504-2019	Wilson, Daniel/0000-0003-3816-3828				ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Atkins JF, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P369; BARANOV P, 2002, EMBO REP, V3, P1; BELITSINA NV, 1981, FEBS LETT, V131, P289, DOI 10.1016/0014-5793(81)80387-0; BELITSINA NV, 1982, BIOSYSTEMS, V15, P233, DOI 10.1016/0303-2647(82)90008-9; Blaha G, 2000, METHOD ENZYMOL, V317, P292; Blaha G, 2001, COLD SPRING HARB SYM, V66, P135, DOI 10.1101/sqb.2001.66.135; CURRAN JF, 1988, J MOL BIOL, V203, P75, DOI 10.1016/0022-2836(88)90092-7; CURRAN JF, 1993, NUCLEIC ACIDS RES, V21, P1837, DOI 10.1093/nar/21.8.1837; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DONLY BC, 1990, NUCLEIC ACIDS RES, V18, P6517, DOI 10.1093/nar/18.22.6517; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Major LL, 1996, NUCLEIC ACIDS RES, V24, P2673, DOI 10.1093/nar/24.14.2673; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; RHEINBERGER HJ, 1988, METHOD ENZYMOL, V164, P658; Triana-Alonso FJ, 2000, METHOD ENZYMOL, V317, P261; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wilson DN, 2003, ANGEW CHEM INT EDIT, V42, P3464, DOI 10.1002/anie.200200544; Wilson DN, 2000, RNA, V6, P1704, DOI 10.1017/S135583820000131X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZANIEWSKI R, 1984, J BIOL CHEM, V259, P1651	25	89	89	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2004	118	1					45	55		10.1016/j.cell.2004.06.012	http://dx.doi.org/10.1016/j.cell.2004.06.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242643	Bronze			2022-12-01	WOS:000222626800007
J	Mariathasan, S; Newton, K; Monack, DM; Vucic, D; French, DM; Lee, WP; Roose-Girma, M; Erickson, S; Dixit, VM				Mariathasan, S; Newton, K; Monack, DM; Vucic, D; French, DM; Lee, WP; Roose-Girma, M; Erickson, S; Dixit, VM			Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf	NATURE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; KAPPA-B ACTIVATION; MACROPHAGE APOPTOSIS; RECRUITMENT DOMAIN; MICE DEFICIENT; PROTEIN; ICE; IDENTIFICATION; MONOCYTES; REGULATOR	Specific adaptors regulate the activation of initiator caspases; for example, FADD and Apaf-1 engage caspases 8 and 9, respectively(1). The adaptors ASC, Ipaf and RIP2 have each been proposed to regulate caspase-1 ( also called interleukin (IL)-1 converting enzyme), which is activated within the 'inflammasome', a complex comprising several adaptors(2). Here we show the impact of ASC-, Ipaf- or RIP2-deficiency on inflammasome function. ASC was essential for extracellular ATP-driven activation of caspase-1 in toll-like receptor (TLR)-stimulated macrophages. Accordingly, ASC- deficient macrophages exhibited defective maturation of IL-1beta and IL-18, and ASC-null mice were resistant to lipopoly-saccharide-induced endotoxic shock. Furthermore, activation of caspase-1 in response to an intracellular pathogen (Salmonella typhimurium) was abrogated severely in ASC- null macrophages. Unexpectedly, Ipaf- deficient macrophages activated caspase-1 in response to TLR plus ATP stimulation but not S. typhimurium. Caspase-1 activation was not compromised by loss of RIP2. These data show that whereas ASC is key to caspase-1 activation within the inflammasome, Ipaf provides a special conduit to the inflammasome for signals triggered by intracellular pathogens. Notably, cell death triggered by stimuli that engage caspase-1 was ablated in macrophages lacking either ASC or Ipaf, suggesting a coupling between the inflammatory and cell death pathways.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Monack, Denise/0000-0003-3804-2209				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Conway KE, 2000, CANCER RES, V60, P6236; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Gumucio DL, 2002, CLIN EXP RHEUMATOL, V20, pS45; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Srinivasula SM, 2002, J BIOL CHEM, V19, P19; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200	30	1354	1411	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					213	218		10.1038/nature02664	http://dx.doi.org/10.1038/nature02664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15190255				2022-12-01	WOS:000222470600045
J	Khosrotehrani, K; Johnson, KL; Cha, DH; Salomon, RN; Bianchi, DW				Khosrotehrani, K; Johnson, KL; Cha, DH; Salomon, RN; Bianchi, DW			Transfer of fetal cells with multilineage potential to maternal tissue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; SYSTEMIC-SCLEROSIS; PERIPHERAL-BLOOD; PROGENITOR CELLS; HEALTHY WOMEN; MALE DNA; MICROCHIMERISM; CIRCULATION; PREGNANCY; LONG	Context During pregnancy, fetal CD34(+) cells enter the maternal circulation, persist for decades, and create a state of physiologic microchimerism. Many studies have confirmed the residual presence of fetal cells in maternal blood and tissues following pregnancy. Fetal cells may respond to maternal injury by developing multilineage capacity in maternal organs. Objective To verify that fetal microchimeric cells express markers of epithelial, leukocyte, and hepatocyte differentiation within maternal organs. Design, Setting, and Patients Archived paraffin-embedded tissue section specimens from 10 women who had male offspring and were previously found to have high numbers of microchimeric cells, and 11 control women who had no prior male pregnancies. Male cells were identified by fluorescence in situ hybridization, using X and Y chromosome-specific probes, followed by histologic and immunochemical studies using anticytokeratin (AE1/AE3) as a marker of epithelial cells, anti-CD45 as a leukocyte marker, and heppar-1 as a hepatocyte marker. Main Outcome Measure Percentage of microchimeric cells expressing nonhematopoietic markers. Results A total of 701 male (XY+) microchimeric cells were identified (mean [SD], 227 [128] XY+ cells per million maternal cells). In maternal epithelial tissues (thyroid, cervix, intestine, and gallbladder), 14% to 60% of XY+ cells expressed cytokeratin. Conversely, in hematopoietic tissues, such as lymph nodes and spleen, 90% of XY+ cells expressed CD45. In 1 liver sample, 4% of XY+ cells expressed heppar-1. Histologic and immunochemical evidence of differentiation, as assessed by independent observers, was highly concordant (kappa = 0.72). Conclusion The detection of microchimeric male cells, bearing epithelial, leukocyte, or hepatocyte markers, in a variety of maternal tissue specimens suggests the presence of fetal cells that may have multilineage capacity.	Tufts Univ, New England Med Ctr, Dept Pediat, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Pathol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Bianchi, DW (corresponding author), Tufts Univ, New England Med Ctr, Dept Pediat, Box 394,750 Washington St, Boston, MA 02111 USA.	dbianchi@tufts-nemc.org	Khosrotehrani, Kiarash/M-8025-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; Cha, Dong Hyun/0000-0003-0722-1714				Adams KM, 2003, BLOOD, V102, P3845, DOI 10.1182/blood-2003-05-1570; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Artlett CM, 2002, CLIN IMMUNOL, V103, P303, DOI 10.1006/clim.2002.5222; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cha D, 2003, OBSTET GYNECOL, V102, P774, DOI 10.1016/S0029-7844(03)00615-X; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Fanning PA, 2000, J HEPATOL, V33, P690, DOI 10.1016/S0168-8278(00)80297-4; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Hollander M., 1999, NONPARAMETRIC STAT M, P190; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Johnson KL, 2001, ARTHRITIS RHEUM, V44, P2107, DOI 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9; Johnson KL, 2002, HEPATOLOGY, V36, P1295, DOI 10.1053/jhep.2002.35622; Johnson KL, 2001, ARTHRITIS RHEUM-US, V44, P1848, DOI 10.1002/1529-0131(200108)44:8<1848::AID-ART323>3.0.CO;2-L; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Khosrotehrani K, 2003, BIOTECHNIQUES, V34, P242, DOI 10.2144/03342bm01; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; Lee TH, 1999, BLOOD, V93, P3127; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; Osada H, 2001, TRANSFUSION, V41, P499, DOI 10.1046/j.1537-2995.2001.41040499.x; Scaletti C, 2002, ARTHRITIS RHEUM, V46, P445, DOI 10.1002/art.10049; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; vanWijk IJ, 1996, AM J OBSTET GYNECOL, V174, P871, DOI 10.1016/S0002-9378(96)70315-0; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531	29	190	197	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2004	292	1					75	80		10.1001/jama.292.1.75	http://dx.doi.org/10.1001/jama.292.1.75			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834YZ	15238593	Bronze			2022-12-01	WOS:000222448100029
J	Chow, SS; Wilke, CO; Ofria, C; Lenski, RE; Adami, C				Chow, SS; Wilke, CO; Ofria, C; Lenski, RE; Adami, C			Adaptive radiation from resource competition in digital organisms	SCIENCE			English	Article							DIVERSITY PATTERNS; ESCHERICHIA-COLI; PRODUCTIVITY; EVOLUTION	Species richness often peaks at intermediate productivity and decreases as resources become more or less abundant. The mechanisms that produce this pattern are not completely known, but several previous studies have suggested environmental heterogeneity as a cause. In experiments with evolving digital organisms and populations of fixed size, maximum species richness emerges at intermediate productivity, even in a spatially homogeneous environment, owing to frequency-dependent selection to exploit an influx of mixed resources. A diverse pool of limiting resources is sufficient to cause adaptive radiation, which is manifest by the origin and maintenance of phenotypically and phylogenetically distinct groups of organisms.	CALTECH, Digital Life Lab 136 93, Pasadena, CA 91125 USA; Keck Grad Inst, Claremont, CA 91711 USA; Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	California Institute of Technology; Claremont Colleges; Keck Graduate Institute; Michigan State University; Michigan State University	Adami, C (corresponding author), CALTECH, Digital Life Lab 136 93, Pasadena, CA 91125 USA.	adami@caltech.edu	Adami, Chris/A-9675-2011; Wilke, Claus O./B-4643-2008; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; Ofria, Charles/0000-0003-2924-1732; Wilke, Claus/0000-0002-7470-9261; Lenski, Richard/0000-0002-1064-8375				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; COOPER TF, 2003, ARTIF LIFE, V8, P227; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; HELLING RB, 1987, GENETICS, V116, P349; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kimura M., 1983, NEUTRAL THEORY MOL E; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin PJ, 2000, NATURE, V406, P463, DOI 10.1038/35020160; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rosenzweig Michael L., 1993, P52; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wilke CO, 2002, TRENDS ECOL EVOL, V17, P528, DOI 10.1016/S0169-5347(02)02612-5; ZUCKERKANDL E, 1965, EVOLVING GENES PROTE, V5, P97	28	87	90	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					84	86		10.1126/science.1096307	http://dx.doi.org/10.1126/science.1096307			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232105				2022-12-01	WOS:000222386000040
J	Doll, R; Peto, R; Boreham, J; Sutherland, I				Doll, R; Peto, R; Boreham, J; Sutherland, I			Mortality in relation to smoking: 50 years' observations on male British doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; TOBACCO; STATISTICS; COHORT; DEATHS; INDIA	Objective To compare the hazards of cigarette smoking in men who formed their habits at different periods, and the extent of the reduction in risk when cigarette smoking is stopped at different ages. Design Prospective study that has continued from 1951 to 2001. Setting United Kingdom. Participants 34 439 male British doctors. Information about their smoking habits was obtained in 1951, and periodically thereafter; cause specific mortality was monitored for 50 years. Main outcome measures Overall mortality by smoking habit, considering separately men born in different periods. Results The excess mortality associated with smoking chiefly involved vascular, neoplastic, and respiratory diseases that can be caused by smoking. Men born in 1900-1930 who smoked only cigarettes mid continued smoking died on average about 10 years younger than lifelong non-smokers. Cessation at age 60, 50, 40, or 30 years gained respectively, about 3, 6, 9, or 10 years of life expectancy. The excess mortality associated with cigarette smoking was less for men born in the 19th century and was greatest for men born in the 1920s. The cigarette smoker versus non-smoker probabilities of dying in middle age (35-69) were 42% v 24% (a twofold death rate ratio) for those born in 1900-1909, but were 43% v 15% (a threefold death rate ratio) for those born in the 1920s. At older acres, the cigarette smoker versus non-smoker probabilities Of surviving from age 70 to 90 were 10% v 12% at the death rates of the 1950s (that is, among men born around the 1870s) but were 7% v 33% (again a threefold death rate ratio) at the death rates of the 1990s (that is, among men born around the 1910s). Conclusion A substantial progressive decrease in the mortality rates among non-smokers over the past half century (due to prevention and improved treatment of disease) has been wholly outweighed, among cigarette smokers, by a progressive increase in the smoker v non-smoker death rate ratio due to earlier and more intensive use of cigarettes. Among the men born around 1920, prolonged cigarette smoking from early adult life tripled age specific mortality rates, but cessation at age 50 halved the hazard, and cessation at age 30 avoided almost all of it.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit CTSU, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	Doll, R (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.	secretary@ctsu.ox.ac.uk						DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; DOLL R, 1964, BMJ-BRIT MED J, V1, P1460, DOI 10.1136/bmj.1.5396.1460; DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Doll R, 1999, J URBAN HEALTH, V76, P289, DOI 10.1007/BF02345669; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; Doll R, 1954, BRIT MED J, V228, P151; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1193; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; Harris JE, 2004, BMJ-BRIT MED J, V328, P72, DOI 10.1136/bmj.37936.585382.44; Kaplan S., 2004, IARC MONOGRAPHS EVAL, V83, P33; LAM TH, 2001, BRIT MED J, V323, P1; LEVIN ML, 1950, JAMA-J AM MED ASSOC, V143, P336, DOI 10.1001/jama.1950.02910390008002; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; LOPEZ A, 1997, TOBACCO HLTH GLOBAL; *MED RES COUNC, 1957, BMJ-BRIT MED J, V1, P1523; MILLS CA, 1950, CANCER RES, V10, P539; MULLER F. H., 1939, ZEITSCHR KREBSJORSCH, V49, P57; NICOLAIDESBOUMA.A, 1993, INT SMOKING STAT; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 1994, MORTALITY SMOKING DE; Peto R, 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441; Royal College of Physicians, 1962, SMOK HLTH; SCHAIRER E, 1943, Z KREBSFORSCH, V54, P261; SHREK R, 1950, CANCER RES, V10, P49; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; US Department of Health and Human Services, 1989, DHHS PUBL; VINEIS P, 2001, J NATL CANCER I, V96, P99; WASSINK W. F., 1948, NEDERLANDSCH TIJDSCHR GENEESK, V92, P3732; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; ZARIDZE D, 1986, IARC SCI PUBLICATION, V74	38	2042	2095	6	156	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2004	328	7455					1519	1528		10.1136/bmj.38142.554479.AE	http://dx.doi.org/10.1136/bmj.38142.554479.AE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DV	15213107	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000222392700015
J	Jia, ST; Noma, K; Grewal, SIS				Jia, ST; Noma, K; Grewal, SIS			RNAi-independent heterochromatin nucleation by the stress-activated ATF/CREB family proteins	SCIENCE			English	Article							ATF1 TRANSCRIPTION FACTOR; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; HISTONE H3; SEXUAL DEVELOPMENT; METHYLATION; GENOME; LOCALIZATION; EXPRESSION; ENCODES	At the silent mating-type interval of fission yeast, the RNA interference (RNAi) machinery cooperates with cenH, a DNA element homologous to centromeric repeats, to initiate heterochromatin formation. However, in RNAi mutants, heterochromatin assembly can still occur at low efficiency. Here, we report that Atf1 and Pcr1, two ATF/CREB family proteins, act in a parallel mechanism to the RNAi pathway for heterochromatin nucleation. Deletion of atf1 or pcr1 alone has little effect on silencing at the mating-type region, but when combined with RNAi mutants, double mutants fail to nucleate heterochromatin assembly. Moreover, deletion of atf1 or pcr1 in combination with cenH deletion causes loss of silencing and heterochromatin formation. Furthermore, Atf1 and Pcr1 bind to the mating-type region and target histone H3 lysine-9 methylation and the Swi6 protein essential for heterochromatin assembly. These analyses link ATF/CREB family proteins, involved in cellular response to environmental stresses, to nucleation of constitutive heterochromatin.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Ayoub N, 1999, GENETICS, V152, P495; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Gowen JW, 1933, SCIENCE, V77, P312, DOI 10.1126/science.77.1995.312; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.3.CO;2-4; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Thon G, 1999, GENETICS, V151, P945; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	23	233	242	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1971	1976		10.1126/science.1099035	http://dx.doi.org/10.1126/science.1099035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218150				2022-12-01	WOS:000222241600047
J	Motose, H; Sugiyama, M; Fukuda, H				Motose, H; Sugiyama, M; Fukuda, H			A proteoglycan mediates inductive interaction during plant vascular development	NATURE			English	Article							LOCAL INTERCELLULAR COMMUNICATION; TRACHEARY ELEMENT DIFFERENTIATION; LIPID-TRANSFER PROTEINS; ARABINOGALACTAN-PROTEIN; MESOPHYLL-CELLS; MEMBRANE; ANCHOR	Inductive cell-cell interactions are essential for controlling cell fate determination in both plants and animals(1); however, the chemical basis of inductive signals in plants remains little understood. A proteoglycan-like factor named xylogen mediates local and inductive cell-cell interactions required for xylem differentiation in Zinnia cells cultured in vitro(2,)3. Here we describe the purification of xylogen and cloning of its complementary DNA, and present evidence for its role in planta. The polypeptide backbone of xylogen is a hybrid-type molecule with properties of both arabinogalactan proteins and nonspecific lipid-transfer proteins. Xylogen predominantly accumulates in the meristem, procambium and xylem. In the xylem, xylogen has a polar localization in the cell walls of differentiating tracheary elements. Double knockouts of Arabidopsis lacking both genes that encode xylogen proteins show defects in vascular development: discontinuous veins, improperly interconnected vessel elements and simplified venation. Our results suggest that the polar secretion of xylogen draws neighbouring cells into the pathway of vascular differentiation to direct continuous vascular development, thereby identifying a molecule that mediates an inductive cell cell interaction involved in plant tissue differentiation.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 1120001, Japan; RIKEN, Plant Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; RIKEN	Motose, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hmotose@ucdavis.edu	MOTOSE, Hiroyasu/B-1474-2011; SUGIYAMA, MUNETAKA/G-4922-2014	Motose, Hiroyasu/0000-0001-5038-6640				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANDERSON RL, 1977, AUST J PLANT PHYSIOL, V4, P143, DOI 10.1071/PP9770143; Berleth T, 2000, CURR OPIN PLANT BIOL, V3, P406, DOI 10.1016/S1369-5266(00)00104-7; Carland FM, 2002, PLANT CELL, V14, P2045, DOI 10.1105/tpc.003939; FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Ito M, 1998, PLANT CELL, V10, P331; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Koizumi K, 2000, DEVELOPMENT, V127, P3197; KOMALAVILAS P, 1991, J BIOL CHEM, V266, P15956; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Motose H, 2001, PLANTA, V213, P121, DOI 10.1007/s004250000482; Motose H, 2001, PLANT CELL PHYSIOL, V42, P129, DOI 10.1093/pcp/pce014; Nishitani C, 2001, PLANT CELL PHYSIOL, V42, P1210, DOI 10.1093/pcp/pce156; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oxley D, 1999, P NATL ACAD SCI USA, V96, P14246, DOI 10.1073/pnas.96.25.14246; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; SOJAR HT, 1987, METHOD ENZYMOL, V138, P341; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Svetek J, 1999, J BIOL CHEM, V274, P14724, DOI 10.1074/jbc.274.21.14724; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; YAMADA M, 1992, PLANT CELL PHYSIOL, V33, P1; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; Youl JJ, 1998, P NATL ACAD SCI USA, V95, P7921, DOI 10.1073/pnas.95.14.7921	25	247	261	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					873	878		10.1038/nature02613	http://dx.doi.org/10.1038/nature02613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215864				2022-12-01	WOS:000222213000042
J	Mount, AM; Mwapasa, V; Elliott, SR; Beeson, JG; Tadesse, E; Lema, VM; Molyneux, ME; Meshnick, SR; Rogerson, SJ				Mount, AM; Mwapasa, V; Elliott, SR; Beeson, JG; Tadesse, E; Lema, VM; Molyneux, ME; Meshnick, SR; Rogerson, SJ			Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection	LANCET			English	Article							VARIANT SURFACE-ANTIGENS; PLACENTAL MALARIA; ACQUIRED-IMMUNITY; WOMEN; ANTIBODIES; ADULTS; ERYTHROCYTES; RESPONSES; ABNORMALITIES; DETERMINANTS	Background HIV infection increases the risk of malaria infection in pregnant women. Antibodies to variant surface antigens (VSA) on infected erythrocytes might protect against malaria in pregnancy. We postulated that HIV-induced impairment of humoral immunity to VSA mediates the increased susceptibility to malaria. Methods We compared serum concentrations of antibodies to VSA by flow cytometry or agglutination, and to merozoite proteins AMA-1 and MSP1(19), by ELISA, in 298 pregnant Malawian women, and related the findings to malaria and HIV infection, CD4-positive T-cell count, and HIV-1 viral load. Findings Concentrations of IgG to placental type VSA were lower in HIV-infected women than in HIV-uninfected women (median 8 units [IQR 4-23] vs 20 [12-30]; p<0.0001), among women with malaria (p=0.009) and those without malaria (p=0.0062). The impairment was greatest in first pregnancy. Agglutinating antibodies to placental VSA were present in a lower proportion of HIV-infected than HIV-uninfected women (58 [35.1%] of 165 vs 50 [53.8%] of 93, p<0.001). The degree of antibody binding by flow cytometry was correlated with CD4-positive T-cell count (r=0.16, p=0.019) and inversely with HIV-1 viral load (r=-0.16, p=0.030). Concentrations of antibodies to AMA-1 were lower in HIV infection (p<0.0001) but were not correlated with CD4-positive T-cell count or viral load. Responses to MSP1(19) were little affected by HIV infection. In multivariate analyses, HIV was negatively associated with amount of antibody to both VSA and AMA-1 (p<0.001 for each) but not MSP1(19). Interpretation HIV infection impairs antimalarial immunity, especially responses to placental type VSA. The impairment is greatest in the most immunosuppressed women and could explain the increased susceptibility to malaria seen in pregnant women with HIV infection.	Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Obstet & Gynaecol, Blantyre, Malawi; Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	Royal Melbourne Hospital; University of Melbourne; University of Michigan System; University of Michigan; University of Malawi; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogerson, SJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, PO Royal Melbourne Hosp, Parkville, Vic 3050, Australia.	sroger@unimelb.edu.au		Mwapasa, Victor/0000-0002-2748-8902; Rogerson, Stephen/0000-0003-4287-1982	NIAID NIH HHS [AI 49084] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049084] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayisi JG, 2003, J INFECTION, V46, P164, DOI 10.1053/jinf.2002.1088; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BRABIN BJ, 1991, APPL FIELD RES MALAR, P1; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Kashamuka M, 2003, AM J TROP MED HYG, V68, P376, DOI 10.4269/ajtmh.2003.68.376; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Kroon FP, 1998, AIDS, V12, pF217, DOI 10.1097/00002030-199817000-00002; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Moore JM, 2000, J INFECT DIS, V182, P960, DOI 10.1086/315755; MWAPASA V, IN PRESS AIDS; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Van Eijk AM, 2001, AM J TROP MED HYG, V65, P623, DOI 10.4269/ajtmh.2001.65.623; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6	28	109	110	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2004	363	9424					1860	1867		10.1016/S0140-6736(04)16354-X	http://dx.doi.org/10.1016/S0140-6736(04)16354-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15183624				2022-12-01	WOS:000221822300010
J	Bazykin, GA; Kondrashov, FA; Ogurtsov, AY; Sunyaev, S; Kondrashov, AS				Bazykin, GA; Kondrashov, FA; Ogurtsov, AY; Sunyaev, S; Kondrashov, AS			Positive selection at sites of multiple amino acid replacements since rat-mouse divergence	NATURE			English	Article							PROTEIN EVOLUTION; MAXIMUM-LIKELIHOOD; GENOME; NUCLEOTIDE; DROSOPHILA; SEQUENCE; HUMANS; GENES; MODEL	New alleles become fixed owing to random drift of nearly neutral mutations or to positive selection of substantially advantageous mutations(1-3). After decades of debate, the fraction of fixations driven by selection remains uncertain(4-9). Within 9,390 genes, we analysed 28,196 codons at which rat and mouse differ from each other at two nucleotide sites and 1,982 codons with three differences. At codons where rat-mouse divergence involved two non-synonymous substitutions, both of them occurred in the same lineage, either rat or mouse, in 64% of cases; however, independent substitutions would occur in the same lineage with a probability of only 50%. All three non-synonymous substitutions occurred in the same lineage for 46% of codons, instead of the 25% expected. Furthermore, comparison of 12 pairs of prokaryotic genomes also shows clumping of multiple nonsynonymous substitutions in the same lineage. This pattern cannot be explained by correlated mutation or episodes of relaxed negative selection, but instead indicates that positive selection acts at many sites of rapid, successive amino acid replacement.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA	Princeton University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bazykin, GA (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	gbazykin@princeton.edu	Kondrashov, Fyodor Alexeevich/H-6331-2015; Bazykin, Georgii/E-4601-2012	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Bazykin, Georgii/0000-0003-2334-2751	NATIONAL LIBRARY OF MEDICINE [Z01LM000095] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2003, GENETICS, V164, P1229; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2002, MOL BIOL EVOL, V19, P110, DOI 10.1093/oxfordjournals.molbev.a003975; Eyre-Walker A, 2002, GENETICS, V162, P2017; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gillespie J.H., 1991, CAUSES MOL EVOLUTION; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Huelsenbeck JP, 2002, MOL BIOL EVOL, V19, P698, DOI 10.1093/oxfordjournals.molbev.a004128; Kimura M., 1983, NEUTRAL THEORY MOL E; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Nachman MW, 2000, GENETICS, V156, P297; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILBUR WJ, 1985, MOL BIOL EVOL, V2, P434; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	25	57	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2004	429	6991					558	562		10.1038/nature02601	http://dx.doi.org/10.1038/nature02601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175752				2022-12-01	WOS:000221767700039
J	Jang, HH; Lee, KO; Chi, YH; Jung, BG; Park, SK; Park, JH; Lee, JR; Lee, SS; Moon, JC; Yun, JW; Choi, YO; Kim, WY; Kang, JS; Cheong, GW; Yun, DJ; Rhee, SG; Cho, MJ; Lee, SY				Jang, HH; Lee, KO; Chi, YH; Jung, BG; Park, SK; Park, JH; Lee, JR; Lee, SS; Moon, JC; Yun, JW; Choi, YO; Kim, WY; Kang, JS; Cheong, GW; Yun, DJ; Rhee, SG; Cho, MJ; Lee, SY			Two enzymes in one: Two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function	CELL			English	Article							CYSTEINE-SULFINIC ACID; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; THIOL PEROXIDASE; 2-CYS PEROXIREDOXIN; PROTEIN; INACTIVATION; PROTEASES; REDUCTASE; DEFENSE	Although a great deal is known biochemically about peroxiredoxins (Prxs), little is known about their real physiological function. We show here that two cytosolic yeast Prxs, cPrxI and II, which display diversity in structure and apparent molecular weights (MW), can act alternatively as peroxidases and molecular chaperones. The peroxidase function predominates in the lower MW forms, whereas the chaperone function predominates in the higher MW complexes. Oxidative stress and heat shock exposure of yeasts causes the protein structures of cPrxI and II to shift from low MW species to high MW complexes. This triggers a peroxidase-to-chaperone functional switch. These in vivo changes are primarily guided by the active peroxidase site residue, Cys(47), which serves as an efficient "H2O2-sensor" in the cells. The chaperone function of these proteins enhances yeast resistance to heat shock.	Gyeongsang Natl Univ, Div Appl Life Sci, Chinju 660701, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Chinju 660701, South Korea; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA	Gyeongsang National University; Gyeongsang National University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, SY (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Chinju 660701, South Korea.	sylee@gsnu.ac.kr	Cho, Moo Je/F-1649-2010	LEE, JUNG RO/0000-0002-9596-3330; Yun, Dae-Jin/0000-0002-3638-6043				Baier M, 1999, PLANT PHYSIOL, V119, P1407, DOI 10.1104/pp.119.4.1407; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Butterfield DA, 1999, METHOD ENZYMOL, V309, P746; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DEMPLE B, 1991, CELL, V67, P837, DOI 10.1016/0092-8674(91)90355-3; DURR R, 1991, ULTRAMICROSCOPY, V38, P135, DOI 10.1016/0304-3991(91)90114-L; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HERGEL R, 1996, J STRUCT BIOL, V116, P30; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jaschke A, 1998, J MOL BIOL, V277, P763, DOI 10.1006/jmbi.1998.1644; KEM R, 2003, BIOCHEM J, V371, P965; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim KS, 2002, FREE RADICAL BIO MED, V32, P544, DOI 10.1016/S0891-5849(02)00741-4; Manna T, 2001, J BIOL CHEM, V276, P39742, DOI 10.1074/jbc.M104061200; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Schroder E, 1998, PROTEIN SCI, V7, P2465, DOI 10.1002/pro.5560071125; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; Wang CC, 2002, METHOD ENZYMOL, V348, P66, DOI 10.1016/S0076-6879(02)48627-2; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	37	590	623	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					625	635		10.1016/j.cell.2004.05.002	http://dx.doi.org/10.1016/j.cell.2004.05.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163410	Bronze			2022-12-01	WOS:000221857900009
J	Norbury, CC; Basta, S; Donohue, KB; Tscharke, DC; Princiotta, MF; Berglund, P; Gibbs, J; Bennink, JR; Yewdell, JW				Norbury, CC; Basta, S; Donohue, KB; Tscharke, DC; Princiotta, MF; Berglund, P; Gibbs, J; Bennink, JR; Yewdell, JW			CD8(+)T cell cross-priming via transfer of proteasome substrates	SCIENCE			English	Article							ANTIGEN-PRESENTING CELLS; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; GENE-PRODUCTS; CTL RESPONSES; CUTTING EDGE; PEPTIDES; VIVO; GENERATION; MECHANISMS	"Cross-priming" describes the activation of naive CD8(+) T cells by professional antigen-presenting cells that have acquired viral or tumor antigens from "donor" cells. Antigen transfer is believed to be mediated by donor cell-derived molecular chaperones bearing short peptide ligands generated by proteasome degradation of protein antigens. We show here that cross-priming is based on the transfer of proteasome substrates rather than peptides. These findings are potentially important for the rational design of vaccines that elicit CD8(+) T cell responses.	NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Penn State Univ Huck Inst Life Sci, Integrat Biosci Grad Program, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@niaid.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Tscharke, David/C-9133-2009	Tscharke, David/0000-0001-6825-9172	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056094, Z01AI000814, R56AI056094] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-056094-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Anton LC, 1997, J IMMUNOL, V158, P2535; ARCEGOMEZ B, 1978, TISSUE ANTIGENS, V11, P96, DOI 10.1111/j.1399-0039.1978.tb01233.x; Bellone M, 1997, J IMMUNOL, V159, P5391; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; FENTEANY G, 1994, P NATL ACAD SCI USA, V91, P3358, DOI 10.1073/pnas.91.8.3358; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell J, 1999, IMMUNOL REV, V172, P97, DOI 10.1111/j.1600-065X.1999.tb01359.x; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	22	238	241	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1318	1321		10.1126/science.1096378	http://dx.doi.org/10.1126/science.1096378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166379				2022-12-01	WOS:000221669600053
J	Piccirillo, JF; Tierney, RM; Costas, I; Grove, L; Spitznagel, EL				Piccirillo, JF; Tierney, RM; Costas, I; Grove, L; Spitznagel, EL			Prognostic importance of Comorbidity in a hospital-based cancer registry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CO-MORBIDITY; SURVIVAL; IMPACT; DISEASE; AGE; CLASSIFICATION; CARCINOMA; INDEX; WOMEN; RISK	Context Patients with cancer often have other medical ailments, referred to as comorbidity. Comorbidity may impact treatment decision-making, prognosis, and quality of care assessment. Objective To assess whether comorbidity information can provide important prognostic information in a hospital-based cancer registry. Design, Setting, and Participants An observational prospective cohort study using comorbidity data collected by trained hospital-based cancer registrars. Comorbidity was obtained through medical record review using the Adult Comorbidity Evaluation 27, a validated chart-based comorbidity instrument. A total of 17712 patients receiving care between January 1, 1995, and January 31, 2001, for the primary diagnosis of new cancer of the prostate, lung (nonsmall cell), breast, digestive system, gynecological, urinary system, or head and neck were included. Main Outcome Measure Duration in months of overall survival. Results A total of 19268 patients were included in the study; median duration of follow-up was 31 months. Of these patients, 1556 (8.0%) were excluded due to missing or unknown data. Severity of comorbidity strongly influenced survival in a dose-dependent fashion and the impact of comorbidity was independent of cancer stage. Compared with patients without comorbidity, the adjusted hazard ratio associated with mild comorbidity was 1.21 (95% confidence interval [Cl], 1.13-1.30), moderate comorbidity was 1.86 (95% Cl, 1.73-2.00), and severe comorbidity was 2.56 (95% Cl, 2.35-2.81). Adjusted Kaplan-Meier survival curves revealed that at any point in time the patients with more severe levels of comorbidity had worse survival (partial chi(3)(2) due to comorbidity, 523.54; P<.001). Model discrimination ranged from 0.71 for head and neck to 0.86 for prostate cancers. Conclusions Comorbidity is an important independent prognostic factor for patients with cancer. The inclusion of comorbidity in hospital-based cancer registries will increase the value and use of observational research.	Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA; Washington Univ, Barnes Jewish Hosp, Oncol Data Serv, St Louis, MO USA; Washington Univ, Siteman Canc Ctr, St Louis, MO USA; Washington Univ, Dept Math, St Louis, MO 63130 USA	Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Campus Box 8115,660 S Euclid Ave, St Louis, MO 63110 USA.	piccirij@msnotes.wustl.edu			NATIONAL CANCER INSTITUTE [R25CA068304] Funding Source: NIH RePORTER; NCI NIH HHS [R25CA68304-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertsen PC, 1996, J UROLOGY, V156, P127, DOI 10.1016/S0022-5347(01)65964-0; *CANC DAT PROJ, PIL LESS LEARN REP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *COMM CANC, 1999, REG OP DAT STAND ROA, V2; Committee to Advise on Tropical Medicine and Travel, 2003, SECT ON CAS EL CANC, P1; CONCATO J, 1990, T ASSOC AM PHYSICIAN, V103, P90; Desch CE, 1996, MED CARE, V34, P152, DOI 10.1097/00005650-199602000-00007; DesHarnais S, 2000, J AM COLL SURGEONS, V11, P2; DiSilvestro P, 1997, J CLIN EPIDEMIOL, V50, P501, DOI 10.1016/S0895-4356(97)00002-4; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Extermann M, 2000, CRIT REV ONCOL HEMAT, V35, P181, DOI 10.1016/S1040-8428(00)00090-1; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fleming ST, 1999, MED CARE, V37, P601, DOI 10.1097/00005650-199906000-00009; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Hall SF, 2000, HEAD NECK-J SCI SPEC, V22, P317, DOI 10.1002/1097-0347(200007)22:4<317::AID-HED1>3.0.CO;2-0; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Iezzoni L., 2012, RISK ADJUSTMENT MEAS; Iezzoni L I, 1994, Am J Med Qual, V9, P43, DOI 10.1177/0885713X9400900202; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Jeffe D, 2003, J REGISTRY MANAG, V30, P8; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Kattan MW, 1997, J GEN INTERN MED, V12, P299, DOI 10.1007/s11606-006-5066-9; Kieszak SM, 1999, J CLIN EPIDEMIOL, V52, P137, DOI 10.1016/S0895-4356(98)00154-1; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; MALENKA DJ, 1994, J CLIN EPIDEMIOL, V47, P1027, DOI 10.1016/0895-4356(94)90118-X; Miller DC, 2003, J UROLOGY, V169, P105, DOI 10.1016/S0022-5347(05)64046-3; Newschaffer CJ, 1996, ARCH INTERN MED, V156, P85, DOI 10.1001/archinte.156.1.85; PICCIRILLO J, 2001, J REGISTRY MANAGE, V28, P172; Piccirillo J F, 1995, Oncology (Williston Park), V9, P831; Piccirillo JF, 1996, CANCER, V77, P834, DOI 10.1002/(SICI)1097-0142(19960301)77:5<834::AID-CNCR5>3.0.CO;2-E; PICCIRILLO JF, 1994, ANN OTO RHINOL LARYN, V103, P83, DOI 10.1177/000348949410300201; Piccirillo JF, 2000, LARYNGOSCOPE, V110, P593, DOI 10.1097/00005537-200004000-00011; *PRACT MAN INF COR, 1996, INT CLASS DIS; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SATARIANO WA, 2000, BAS CLIN ON, V23, P477; Schrijvers CTM, 1997, CANCER-AM CANCER SOC, V80, P1482; *STAT CORP, 2001, STAT STAT SOFTW REL, P394; van Spronsen DJ, 1999, ANN HEMATOL, V78, P315, DOI 10.1007/s002770050521; WELLS CK, 1984, ARCH INTERN MED, V144, P2004, DOI 10.1001/archinte.144.10.2004; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.3.CO;2-N; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yancik R, 2001, J CLIN ONCOL, V19, P1147, DOI 10.1200/JCO.2001.19.4.1147; Yates JW, 2001, CA-CANCER J CLIN, V51, P329, DOI 10.3322/canjclin.51.6.329; Zequeira R, 1999, J REGISTRY MANAGEMEN, V26, P66; NATL DEATH INDEX	46	860	879	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2004	291	20					2441	2447		10.1001/jama.291.20.2441	http://dx.doi.org/10.1001/jama.291.20.2441			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823HB	15161894				2022-12-01	WOS:000221599700026
J	Wood, JG; Rogina, B; Lavu, S; Howitz, K; Helfand, SL; Tatar, M; Sinclair, D				Wood, JG; Rogina, B; Lavu, S; Howitz, K; Helfand, SL; Tatar, M; Sinclair, D			Sirtuin activators mimic caloric restriction and delay ageing in metazoans	NATURE			English	Article							LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; SIR2 PROTEIN; LONGEVITY; DEACETYLASE; YEAST; NAD; SELECTION; NUTRITION	Caloric restriction extends lifespan in numerous species. In the budding yeast Saccharomyces cerevisiae this effect requires Sir2 (ref. 1), a member of the sirtuin family of NAD(+)-dependent deacetylases(2,3). Sirtuin activating compounds (STACs) can promote the survival of human cells and extend the replicative lifespan of yeast(4). Here we show that resveratrol and other STACs activate sirtuins from Caenorhabditis elegans and Drosophila melanogaster, and extend the lifespan of these animals without reducing fecundity. Lifespan extension is dependent on functional Sir2, and is not observed when nutrients are restricted. Together these data indicate that STACs slow metazoan ageing by mechanisms that may be related to caloric restriction.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; BIOMOL Res Labs Inc, Plymouth Meeting, PA 19462 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Harvard University; Harvard Medical School; University of Connecticut; Brown University	Sinclair, D (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	shelfand@neuron.uchc.edu; marc_tatar@brown.edu; david_sinclair@hms.harvard.edu		Tatar, Marc/0000-0003-3232-6884; Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [R01 AG028730, RF1 AG024353, R37 AG016667] Funding Source: Medline; NIDDK NIH HHS [R01 DK100263] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024353, R37AG016667] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Guarente L, 2000, GENE DEV, V14, P1021; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693	24	1443	1511	7	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					686	689		10.1038/nature02789	http://dx.doi.org/10.1038/nature02789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15254550				2022-12-01	WOS:000223085400048
J	Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A				Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A			Ethical review of research into rare genetic disorders	BRITISH MEDICAL JOURNAL			English	Article								Although some work on rare diseases is clearly clinical investigation and some clearly research, much activity falls uneasily between the two. Where should we draw the line and how can we ensure research gets appropriate ethical review?	Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ London Imperial Coll Sci Technol & Med, Med Eth Unit, London W6 8RP, England; Genet Interest Grp, London N1 3QP, England	University of Oxford; University of Oxford; Imperial College London	Parker, M (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	Michael.parker@ethox.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				*DEP HLTH, 2003, RES GOV FRAM HLTH SO; *DEP HLTH, GOOD PRACT CONS IMPL; *GEN MED COUNC, 2000, CONF PROT PROV INF	3	29	29	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					288	289		10.1136/bmj.329.7460.288	http://dx.doi.org/10.1136/bmj.329.7460.288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284160	Green Published, Green Submitted			2022-12-01	WOS:000223133300029
J	Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH				Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH			APOBEC-mediated editing of viral RNA	SCIENCE			English	Article							ENZYMES; DEAMINATION		Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk		Malim, Michael/0000-0002-7699-2064				Anant S, 2003, TRENDS MOL MED, V9, P147, DOI 10.1016/S1471-4914(03)00032-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BISHOP KN, 2004, IN PRESS CARR BIOL; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	7	187	206	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					645	645		10.1126/science.1100658	http://dx.doi.org/10.1126/science.1100658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286366				2022-12-01	WOS:000222992100039
J	Lengronne, A; Katou, Y; Mori, S; Yokobayashi, S; Kelly, GP; Itoh, T; Watanabe, Y; Shirahige, K; Uhlmann, F				Lengronne, A; Katou, Y; Mori, S; Yokobayashi, S; Kelly, GP; Itoh, T; Watanabe, Y; Shirahige, K; Uhlmann, F			Cohesin relocation from sites of chromosomal loading to places of convergent transcription	NATURE			English	Article							SISTER-CHROMATID COHESION; YEAST COHESIN; ATP HYDROLYSIS; PROTEINS; CENTROMERES; IDENTIFICATION; ASSOCIATION; REQUIREMENT; SEPARATION; COMPLEX	Sister chromatids, the products of eukaryotic DNA replication, are held together by the chromosomal cohesin complex after their synthesis. This allows the spindle in mitosis to recognize pairs of replication products for segregation into opposite directions(1-6). Cohesin forms large protein rings that may bind DNA strands by encircling them(7), but the characterization of cohesin binding to chromosomes in vivo has remained vague. We have performed high resolution analysis of cohesin association along budding yeast chromosomes III - VI. Cohesin localizes almost exclusively between genes that are transcribed in converging directions. We find that active transcription positions cohesin at these sites, not the underlying DNA sequence. Cohesin is initially loaded onto chromosomes at separate places, marked by the Scc2/Scc4 cohesin loading complex(8), from where it appears to slide to its more permanent locations. But even after sister chromatid cohesion is established, changes in transcription lead to repositioning of cohesin. Thus the sites of cohesin binding and therefore probably sister chromatid cohesion, a key architectural feature of mitotic chromosomes, display surprising flexibility. Cohesin localization to places of convergent transcription is conserved in fission yeast, suggesting that it is a common feature of eukaryotic chromosomes.	Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Computat Genome Anal Lab, London WC2A 3PX, England; Riken Genom Sci Ctr, Human Genome Res Grp, Genome Informat Team, Yokohama, Kanagawa 2300045, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Div Gene Res, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, Kanagawa 2300045, Japan; Tokai Univ, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Chiyoda Ku, Tokyo 1008141, Japan; Japan Sci & Technol Agcy, SORST, Tokyo 1130032, Japan	Cancer Research UK; Cancer Research UK; The Genome Analysis Centre (TGAC); RIKEN; Tokyo Institute of Technology; Tokyo Institute of Technology; Yokohama City University; Tokai University; Mitsubishi Research Institute; Japan Science & Technology Agency (JST)	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, Lincolns Inn Fields Labs,44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Itoh, Takehiko/E-8873-2014; Kelly, Gavin/ABG-2715-2021	Itoh, Takehiko/0000-0002-6113-557X; Kelly, Gavin/0000-0001-7219-560X; Shirahige, Katsuhiko/0000-0002-7862-1144; Watanabe, Yoshinori/0000-0002-5488-4812; Uhlmann, Frank/0000-0002-3527-6619	Cancer Research UK [A3592] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Filipski J, 2002, GENE, V300, P63, DOI 10.1016/S0378-1119(02)00848-X; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Jacq C, 1997, NATURE, V387, P75, DOI 10.1038/387s075; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Megee PC, 1999, SCIENCE, V285, P254, DOI 10.1126/science.285.5425.254; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; Reid RJD, 2002, YEAST, V19, P319, DOI 10.1002/yea.817; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030	30	416	422	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					573	578		10.1038/nature02742	http://dx.doi.org/10.1038/nature02742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15229615	Green Accepted			2022-12-01	WOS:000222946100051
J	Irish, JM; Hovland, R; Krutzik, PO; Perez, OD; Bruserud, O; Gjertsen, BT; Nolan, GP				Irish, JM; Hovland, R; Krutzik, PO; Perez, OD; Bruserud, O; Gjertsen, BT; Nolan, GP			Single cell profiling of potentiated phospho-protein networks in cancer cells	CELL			English	Article							ACUTE MYELOGENOUS LEUKEMIA; INTERNAL TANDEM DUPLICATION; SIGNAL TRANSDUCER; CONSTITUTIVE ACTIVATION; MYELOID DIFFERENTIATION; TRANSCRIPTION PROTEINS; MOLECULAR TARGETS; STAT PROTEINS; MAP KINASE; AML BLASTS	Altered growth factor responses in phospho-protein-driven signaling networks are crucial to cancer cell survival and pathology. Profiles of cancer cell signaling networks might therefore identify mechanisms by which such cells interpret environmental cues for continued growth. Using multiparameter flow cytometry, we monitored phospho-protein responses to environmental cues in acute myeloid leukemia at the single cell level. By exposing cancer cell signaling networks to potentiating inputs, rather than relying upon the basal levels of protein phosphorylation alone, we could discern unique cancer network profiles that correlated with genetics and disease outcome. Strikingly, individual cancers manifested multiple cell subsets with unique network profiles, reflecting cancer heterogeneity at the level of signaling response. The results revealed a dramatic remodeling of signaling networks in cancer cells. Thus, single cell measurements of phospho-protein responses reveal shifts in signaling potential of a phospho-protein network, allowing for categorizing of cell network phenotypes by multidimensional molecular profiles of signaling.	Stanford Univ, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Bergen, Ctr Med Genet & Mol Med, Haukeland Univ Hosp, Bergen, Norway; Univ Bergen, Ctr Med Genet & Mol Med, Proteom Unit, Bergen, Norway; Haukeland Hosp, Haematol Sect, Dept Internal Med, N-5021 Bergen, Norway; Univ Bergen, Inst Med, Haematol Sect, Bergen, Norway	Stanford University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Nolan, GP (corresponding author), Stanford Univ, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Irish, Jonathan M/E-1180-2013; Gjertsen, Bjorn T/O-1542-2015; Gjertsen, Bjørn T/AAP-3281-2020	Irish, Jonathan M/0000-0001-9428-8866; Gjertsen, Bjorn T/0000-0001-9358-9704; Gjertsen, Bjørn T/0000-0001-9358-9704; Nolan, Garry/0000-0002-8862-9043	NHLBI NIH HHS [N01-HV-28183I] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bruserud O, 2003, HAEMATOLOGICA, V88, P416; Bruserud O, 2000, J HEMATOTH STEM CELL, V9, P923, DOI 10.1089/152581600750062372; Buettner R, 2002, CLIN CANCER RES, V8, P945; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Kiyoi H, 2002, ONCOGENE, V21, P2555, DOI 10.1038/sj.onc.1205332; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; McCubrey JA, 2000, LEUKEMIA, V14, P9, DOI 10.1038/sj.leu.2401657; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Namikawa R, 1999, EXP HEMATOL, V27, P1029, DOI 10.1016/S0301-472X(99)00034-X; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pallis M, 2003, LEUKEMIA RES, V27, P803, DOI 10.1016/S0145-2126(03)00012-2; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Tilstone C, 2003, NATURE, V424, P610, DOI 10.1038/424610a; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x; Xia Z, 1998, CANCER RES, V58, P3173	36	546	590	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					217	228		10.1016/j.cell.2004.06.028	http://dx.doi.org/10.1016/j.cell.2004.06.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260991	Bronze			2022-12-01	WOS:000222966000010
J	Cohen, HY; Miller, C; Bitterman, KJ; Wall, NR; Hekking, B; Kessler, B; Howitz, KT; Gorospe, M; de Cabo, R; Sinclair, DA				Cohen, HY; Miller, C; Bitterman, KJ; Wall, NR; Hekking, B; Kessler, B; Howitz, KT; Gorospe, M; de Cabo, R; Sinclair, DA			Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase	SCIENCE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; AGING PROCESS; APOPTOSIS; P53; SENESCENCE; LONGEVITY; KU70; NAD; BAX	A major cause of aging is thought to result from the cumulative effects of cell loss over time. In yeast, caloric restriction (CR) delays aging by activating the Sir2 deacetylase. Here we show that expression of mammalian Sir2 (SIRT1) is induced in CR rats as well as in human cells that are treated with serum from these animals. Insulin and insulin-like growth factor 1 (IGF-1) attenuated this response. SIRT1 deacetylates the DNA repair factor Ku70, causing it to sequester the proapoptotic factor Bax away from mitochondria, thereby inhibiting stress-induced apoptotic cell death. Thus, CR could extend life-span by inducing SIRT1 expression and promoting the long-term survival of irreplaceable cells.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; BIOMOL Res Labs, Plymouth Meeting, PA 19462 USA; NIA, Cellular & Mol Biol Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; NIA, Lab Expt Gerontol, Gerontol Res Ctr, Baltimore, MD 21224 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Wall, Nathan R./H-7368-2015; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; Kessler, Benedikt/AAY-8614-2021; de Cabo, Rafael/J-5230-2016	Wall, Nathan R./0000-0002-3235-4386; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; Kessler, Benedikt/0000-0002-8160-2446; Sinclair, David/0000-0002-9936-436X; de Cabo, Rafael/0000-0002-3354-2442; Cohen, Haim Y./0000-0002-6613-8710	NATIONAL CANCER INSTITUTE [F32CA097802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000368, Z01AG000511, P01AG027916, R01AG019719, R01AG028730, R01AG019972, R37AG028730] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA097802] Funding Source: Medline; NIA NIH HHS [R01 AG028730, R01 AG019719, P01 AG027916, R01 AG019972, R37 AG028730, AG19719-03, AG19972-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRUNET A, 2004, SCIENCE, V203, P530; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; COHEN HT, UNPUB; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; ECABO R, 2003, EXP GERONTOL, V38, P631; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9	24	1512	1610	2	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					390	392		10.1126/science.1099196	http://dx.doi.org/10.1126/science.1099196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15205477				2022-12-01	WOS:000222662400036
J	Jaeger, J; Surkova, S; Blagov, M; Janssens, H; Kosman, D; Kozlov, KN; Manu; Myasnikova, E; Vanario-Alonso, CE; Samsonova, M; Sharp, DH; Reinitz, J				Jaeger, J; Surkova, S; Blagov, M; Janssens, H; Kosman, D; Kozlov, KN; Manu; Myasnikova, E; Vanario-Alonso, CE; Samsonova, M; Sharp, DH; Reinitz, J			Dynamic control of positional information in the early Drosophila embryo	NATURE			English	Article							MORPHOGEN GRADIENT; SEGMENTATION; PROTEIN; PATTERN; EMBRYOGENESIS; HUNCHBACK; MODEL; GENES	Morphogen gradients contribute to pattern formation by determining positional information in morphogenetic fields(1,2). Interpretation of positional information is thought to rely on direct, concentration-threshold-dependent mechanisms for establishing multiple differential domains of target gene expression(1,3,4). In Drosophila, maternal gradients establish the initial position of boundaries for zygotic gap gene expression, which in turn convey positional information to pair-rule and segment-polarity genes, the latter forming a segmental prepattern by the onset of gastrulation(5-7). Here we report, on the basis of quantitative gene expression data, substantial anterior shifts in the position of gap domains after their initial establishment. Using a data-driven mathematical modelling approach(8-11), we show that these shifts are based on a regulatory mechanism that relies on asymmetric gap-gap cross-repression and does not require the diffusion of gap proteins. Our analysis implies that the threshold-dependent interpretation of maternal morphogen concentration is not sufficient to determine shifting gap domain boundary positions, and suggests that establishing and interpreting positional information are not independent processes in the Drosophila blastoderm.	SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; St Petersburg State Polytech Univ, Ctr Adv Studies, Dept Computat Biol, St Petersburg 195251, Russia; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; Los Alamos Natl Lab, Div Appl Phys, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Peter the Great St. Petersburg Polytechnic University; University of California System; University of California San Diego; Universidade Federal do Rio de Janeiro; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Reinitz, J (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	reinitz@odd.bio.sunysb.edu	Myasnikova, Ekaterina/I-2711-2017; Kozlov, Konstantin/N-6748-2013	Kozlov, Konstantin/0000-0001-6765-236X; Jaeger, Johannes/0000-0002-2568-2103; Surkova, Svetlana/0000-0002-9016-4732	NCRR NIH HHS [R01 RR007801] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007801] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKAM M, 1987, DEVELOPMENT, V101, P1; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FOE VE, 1983, J CELL SCI, V61, P31; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JAEGER J, IN PRESS GENETICS; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LEWIS J, 1977, J THEOR BIOL, V65, P579, DOI 10.1016/0022-5193(77)90216-8; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MEINHARDT H, 1978, J THEOR BIOL, V74, P307, DOI 10.1016/0022-5193(78)90078-4; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Press W., 1992, NUMERICAL RECIPES, V2nd; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Reinitz J, 1998, DEV GENET, V23, P11, DOI 10.1002/(SICI)1520-6408(1998)23:1<11::AID-DVG2>3.0.CO;2-9; REINITZ J, 1995, J EXP ZOOL, V271, P47, DOI 10.1002/jez.1402710106; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; TSAI CC, 1994, DEVELOPMENT, V120, P1671; WADDINGTON CH, 1940, ORGS GENES; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	27	410	424	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					368	371		10.1038/nature02678	http://dx.doi.org/10.1038/nature02678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254541				2022-12-01	WOS:000222631200045
J	Autran, B; Carcelain, G; Combadiere, B; Debre, P				Autran, B; Carcelain, G; Combadiere, B; Debre, P			Therapeutic Vaccines for chronic infections	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL; HUMAN-PAPILLOMAVIRUS; RESPONSES; SAFETY; IMMUNOGENICITY; AIDS; HIV; LYMPHOCYTES; EVOLUTION	Therapeutic vaccines aim to prevent severe complications of a chronic infection by reinforcing host defenses when some immune control, albeit insufficient, can already be demonstrated and when a conventional antimicrobial therapy either is not available or has limited efficacy. We focus on the rationale and challenges behind this still controversial strategy and provide examples from three major chronic infectious diseases-human immunodeficiency virus, hepatitis B virus, and human papillomavirus-for which the efficacy of therapeutic vaccines is currently being evaluated.	Univ Paris 06, Ctr Hosp Univ Pitie Salpetriere, Lab Immunol Cellulaire, F-75013 Paris, France; Univ Paris 06, Ctr Hosp Univ Pitie Salpetriere, INSERM, U543, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Autran, B (corresponding author), Univ Paris 06, Ctr Hosp Univ Pitie Salpetriere, Lab Immunol Cellulaire, F-75013 Paris, France.	brigitte.autran@psl.ap-hop-paris.fr	Combadiere, Behazine/S-8054-2019; Combadiere, Behazine/G-3881-2013	Combadiere, Behazine/0000-0002-2353-4406; 				Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Autran B, 2000, SCIENCE, V290, P946, DOI 10.1126/science.290.5493.946; Autran B, 1996, CURR OPIN IMMUNOL, V8, P546, DOI 10.1016/S0952-7915(96)80045-8; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BARTHOLOMEW JS, 1994, EUR J IMMUNOL, V24, P3175, DOI 10.1002/eji.1830241239; BOFFETTA P, 1994, CA-CANCER J CLIN, V44, P81, DOI 10.3322/canjclin.44.2.81; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Carcelain G, 2001, CURR OPIN IMMUNOL, V13, P483, DOI 10.1016/S0952-7915(00)00245-4; Dahmen A, 2002, J MED VIROL, V66, P452, DOI 10.1002/jmv.2165; Dalod M, 1998, J INFECT DIS, V178, P61, DOI 10.1086/515587; Debre P, 1995, L PASTEUR; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dikici B, 2003, PEDIATR INFECT DIS J, V22, P345; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Hanazaki Kazuhiro, 2004, Current Drug Targets - Inflammation and Allergy, V3, P63, DOI 10.2174/1568010043483908; HEL Z, 2003, NAT MED, V6, P1140; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jin X, 2002, J VIROL, V76, P2206, DOI 10.1128/JVI.76.5.2206-2216.2002; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lacey CJN, 1999, J INFECT DIS, V179, P612, DOI 10.1086/314616; LEVY J, 1998, BLOOD, V92, P3105; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Pol S, 2001, J HEPATOL, V34, P917, DOI 10.1016/S0168-8278(01)00028-9; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; TUBIANA R, 2003, 10 C RETR OPP INF BO; Yalcin K, 2003, INFECTION, V31, P221, DOI 10.1007/s15010-003-3187-1	34	106	120	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					205	208		10.1126/science.1100600	http://dx.doi.org/10.1126/science.1100600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247470				2022-12-01	WOS:000222501000041
J	Eberl, G; Littman, DR				Eberl, G; Littman, DR			Thymic origin of intestinal alpha beta T cells revealed by fate mapping of ROR gamma t(+) cells	SCIENCE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; LYMPHOID PROGENITORS; GUT CRYPTOPATCHES; TRANSGENIC MICE; ROR-GAMMA; EXPRESSION; GENERATION; IDENTIFICATION; LYMPHOPOIESIS; PRECURSORS	Intestinal intraepithelial T lymphocytes (IELs) are likely to play a key role in host mucosal immunity and, unlike other T cells, have been proposed to differentiate from local precursors rather than from thymocytes. We show here that IELs expressing the alphabeta T cell receptor are derived from precursors that express RORgammat, an orphan nuclear hormone receptor detected only in immature CD4(+) CD8(+) thymocytes, fetal lymphoid tissue-inducer (LTi) cells, and LTi-like cells in crypto-patches within the adult intestinal lamina propria. Using cell fate mapping, we found that all intestinal alphabeta T cells are progeny of CD4(+) CD8(+) thymocytes, indicating that the adult intestine is not a significant site for alphabeta T cell development. Our results suggest that intestinal RORgammat(+) cells are local organizers of mucosal lymphoid tissue.	NYU, Sch Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Eberl, G (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	geberl@adarc.org; littman@saturn.med.nyu.edu	Eberl, Gerard/A-1160-2013	Eberl, Gerard/0000-0002-1119-5638				Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; EBERL G, UNPUB; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Guy-Grand D, 2002, CURR OPIN IMMUNOL, V14, P255, DOI 10.1016/S0952-7915(02)00330-8; Guy-Grand D, 2001, EUR J IMMUNOL, V31, P2593, DOI 10.1002/1521-4141(200109)31:9<2593::AID-IMMU2593>3.0.CO;2-X; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Lefrancois L, 1997, J IMMUNOL, V159, P538; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; LIN T, 1994, EUR J IMMUNOL, V24, P1785, DOI 10.1002/eji.1830240810; LIN T, 1994, EUR J IMMUNOL, V24, P1080, DOI 10.1002/eji.1830240511; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Spahn TW, 2002, AM J PATHOL, V161, P2273, DOI 10.1016/S0002-9440(10)64503-8; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2000, IMMUNITY, V13, P691, DOI 10.1016/S1074-7613(00)00068-6; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yeung MMW, 2000, GUT, V47, P215, DOI 10.1136/gut.47.2.215; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	26	388	407	8	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2004	305	5681					248	251		10.1126/science.1096472	http://dx.doi.org/10.1126/science.1096472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247480				2022-12-01	WOS:000222501000054
J	Leist, M; Ghezzi, P; Grasso, G; Bianchi, R; Villa, P; Fratelli, M; Savino, C; Bianchi, M; Nielsen, J; Gerwien, J; Kallunki, P; Larsen, AK; Helboe, L; Christensen, S; Pedersen, LO; Nielsen, M; Torup, L; Sager, T; Sfacteria, A; Erbayraktar, S; Erbayraktar, Z; Gokmen, N; Yilmaz, O; Cerami-Hand, C; Xie, QW; Coleman, T; Cerami, A; Brines, M				Leist, M; Ghezzi, P; Grasso, G; Bianchi, R; Villa, P; Fratelli, M; Savino, C; Bianchi, M; Nielsen, J; Gerwien, J; Kallunki, P; Larsen, AK; Helboe, L; Christensen, S; Pedersen, LO; Nielsen, M; Torup, L; Sager, T; Sfacteria, A; Erbayraktar, S; Erbayraktar, Z; Gokmen, N; Yilmaz, O; Cerami-Hand, C; Xie, QW; Coleman, T; Cerami, A; Brines, M			Derivatives of erythropoietin that are tissue protective but not erythropoietic	SCIENCE			English	Article							BIOLOGICAL-ACTIVITY; IN-VIVO; NEUROPROTECTION; RECEPTOR; INVITRO; NEURONS	Erythropoietin (EPO) is both hematopoietic and tissue protective, putatively through interaction with different receptors. We generated receptor subtype selective ligands allowing the separation of EPO's bioactivities at the cellular level and in animals. Carbamylated EPO (CEPO) or certain EPO mutants did not bind to the classical EPO receptor ( EPOR) and did not show any hematopoietic activity in human cell signaling assays or upon chronic dosing in different animal species. Nevertheless, CEPO and various nonhematopoietic mutants were cytoprotective in vitro and conferred neuroprotection against stroke, spinal cord compression, diabetic neuropathy, and experimental autoimmune encephalomyelitis at a potency and efficacy comparable to EPO.	Kenneth S Warren Inst, Ossining, NY 10562 USA; H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Univ Messina, I-98122 Messina, Italy; CNR, Inst Neurosci, I-20129 Milan, Italy; Dokuz Eylul Univ, Sch Med, TR-35340 Izmir, Turkey; Warren Pharmaceut Inc, Ossining, NY 10562 USA	Lundbeck Corporation; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Messina; Consiglio Nazionale delle Ricerche (CNR); Dokuz Eylul University	Cerami, A (corresponding author), Kenneth S Warren Inst, Ossining, NY 10562 USA.	acerami@kswi.org	Ghezzi, Pietro/A-4995-2010; Brinesd, Michael/AAE-6072-2020; Leist, Marcel/D-2133-2010; Gökmen, Necati/J-9761-2019; grasso, giovanni/K-3774-2018; Gokmen, Necati/B-1775-2008; Fratelli, Maddalena/AAA-6446-2020; Erbayraktar, Zübeyde/P-4575-2019; Sfacteria, Alessandra/AAK-1839-2020; YILMAZ, Osman/V-3632-2019	Leist, Marcel/0000-0002-3778-8693; Gökmen, Necati/0000-0002-3225-7666; grasso, giovanni/0000-0001-5362-0092; Gokmen, Necati/0000-0002-3225-7666; Fratelli, Maddalena/0000-0002-1769-3427; Erbayraktar, Zübeyde/0000-0002-0316-1462; YILMAZ, Osman/0000-0001-7817-7576; Gokmen, Necati/0000-0003-1835-4133; Christensen, Soren/0000-0003-2500-0085; Cerami, Carla/0000-0002-7634-0955; Ghezzi, Pietro/0000-0003-0911-8358; Nielsen, Jacob/0000-0001-9842-2276; Brines, Michael/0000-0003-4151-4449	NIAID NIH HHS [R56 AI085201] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085201] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Campana WM, 1998, INT J MOL MED, V1, P235; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Eid Tore, 2002, Clin Breast Cancer, V3 Suppl 3, pS109, DOI 10.3816/CBC.2002.s.021; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; GRODBERG J, 1993, EUR J BIOCHEM, V218, P597, DOI 10.1111/j.1432-1033.1993.tb18413.x; Grodberg J, 1996, ARCH BIOCHEM BIOPHYS, V333, P427, DOI 10.1006/abbi.1996.0411; HANAZONO Y, 1995, BIOCHEM BIOPH RES CO, V208, P1060, DOI 10.1006/bbrc.1995.1442; JUBLINSKY PT, 1997, BLOOD, V90, P1867; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mun KC, 2000, BLOOD PURIFICAT, V18, P13, DOI 10.1159/000014403; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; SATAKE R, 1990, BIOCHIM BIOPHYS ACTA, V1038, P125, DOI 10.1016/0167-4838(90)90020-G; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Yousef GM, 2001, BIOCHEM BIOPH RES CO, V284, P900, DOI 10.1006/bbrc.2001.5053	22	639	723	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					239	242		10.1126/science.1098313	http://dx.doi.org/10.1126/science.1098313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247477	Green Submitted			2022-12-01	WOS:000222501000051
J	Costanzo, M; Nishikawa, JL; Tang, XL; Millman, JS; Schub, O; Breitkreuz, K; Dewar, D; Rupes, I; Andrews, B; Tyers, M				Costanzo, M; Nishikawa, JL; Tang, XL; Millman, JS; Schub, O; Breitkreuz, K; Dewar, D; Rupes, I; Andrews, B; Tyers, M			CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; CELL-CYCLE; RETINOBLASTOMA PROTEIN; SYSTEMATIC IDENTIFICATION; CLN2 TRANSCRIPTION; MASS-SPECTROMETRY; GENETIC-ANALYSIS; G(1) CONTROL; FACTOR SWI6; S-PHASE	Cyclin-dependent kinase (CDK) activity initiates the eukaryotic cell division cycle by turning on a suite of gene expression in late G1 phase. In metazoans, CDK-dependent phosphorylation of the retinoblastoma tumor suppressor protein (Rb) alleviates repression of E2F and thereby activates G1/S transcription. However, in yeast, an analogous G1 phase target of CDK activity has remained elusive. Here we show that the cell size regulator Whi5 inhibits G1/S transcription and that this inhibition is relieved by CDK-mediated phosphorylation. Deletion of WH15 bypasses the requirement for upstream activators of the G1/S transcription factors SBF/MBF and thereby accelerates the G1/S transition. Whi5 is recruited to G1/S promoter elements via its interaction with SBF/MBF in vivo and in vitro. In late G1 phase, CDK-dependent phosphorylation dissociates Whi5 from SBF and drives Whi5 out of the nucleus. Elimination of CDK activity at the end of mitosis allows Whi5 to reenter the nucleus to again repress G1/S transcription. These findings harmonize G1/S control in eukaryotes.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Tyers, M (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	tyers@mshri.on.ca	Tyers, Michael/ABE-3194-2021	Millman, Jonathan/0000-0002-1766-2348				AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Breeden L, 1996, CURR TOP MICROBIOL, V208, P95; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrington LA, 1996, NUCLEIC ACIDS RES, V24, P558, DOI 10.1093/nar/24.4.558; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; Hinds PW, 2003, CANCER CELL, V3, P305, DOI 10.1016/S1535-6108(03)00084-9; Ho W, 1999, MOL CELL BIOL, V19, P5267; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; JOHNSTON GC, 1979, J BACTERIOL, V137, P1; Johnston JB, 1902, J COMP NEUROL, V12, P1, DOI 10.1002/cne.910120102; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Macpherson N, 2000, GENETICS, V154, P1561; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Sidorova JM, 2002, GENETICS, V160, P123; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Wijnen H, 1999, GENETICS, V153, P1131; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	63	321	326	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					899	913		10.1016/j.cell.2004.05.024	http://dx.doi.org/10.1016/j.cell.2004.05.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210111	Bronze			2022-12-01	WOS:000222300200008
J	Feinstein, P; Mombaerts, P				Feinstein, P; Mombaerts, P			A contextual model for axonal sorting into glomeruli in the mouse olfactory system	CELL			English	Article							ODORANT RECEPTOR EXPRESSION; SENSORY NEURONS; GENE-EXPRESSION; BULB; MICE; VOMERONASAL; PROJECTIONS; EPITHELIUM; MAP; ORGANIZATION	No models fully account for how odorant receptors (ORs) function in the guidance of axons of olfactory sensory neurons (OSNs) to glomeruli in the olfactory bulb. Here, we use gene targeting in mice to demonstrate that the OR amino acid sequence imparts OSN axons with an identity that allows them to coalesce into glomeruli. Replacements between the coding regions of the M71 and M72 OR genes reroute axons to their respective glomeruli. A series of M71-M72 hybrid ORs uncover a spectrum of glomerular phenotypes, leading to the concept that the identity of OSN axons is revealed depending on what other axons are present. Naturally occurring amino acid polymorphisms in other ORs also produce distinct axonal identities. These critical amino acid residues are distributed throughout the protein and reside predominantly within transmembrane domains. We propose a contextual model for axon guidance in which ORs mediate homotypic interactions between like axons.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Feinstein, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	feinstp@rockefeller.edu; peter@rockefeller.edu	Zufall, Frank/AAE-5290-2021	Zufall, Frank/0000-0002-4383-8618				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.97.7.3684; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P828; Conzelmann S, 2001, EUR J NEUROSCI, V14, P1623, DOI 10.1046/j.0953-816x.2001.01788.x; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Royal SJ, 1999, J NEUROSCI, V19, P9856; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	40	237	239	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					817	831		10.1016/j.cell.2004.05.011	http://dx.doi.org/10.1016/j.cell.2004.05.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186781	Bronze			2022-12-01	WOS:000222048400013
J	Kingston, T; Rossiter, SJ				Kingston, T; Rossiter, SJ			Harmonic-hopping in Wallacea's bats	NATURE			English	Article							GREATER HORSESHOE BATS; RHINOLOPHUS-FERRUMEQUINUM; SPECIATION	Evolutionary divergence between species is facilitated by ecological shifts, and divergence is particularly rapid when such shifts also promote assortative mating(1-3). Horseshoe bats are a diverse OldWorld family ( Rhinolophidae) that have undergone a rapid radiation in the past 5 million years(4). These insectivorous bats use a predominantly pure-tone echolocation call matched to an auditory fovea ( an over-representation of the pure-tone frequency in the cochlea and inferior colliculus(5,6)) to detect the minute changes in echo amplitude and frequency generated when an insect flutters its wings(7). The emitted signal is the accentuated second harmonic of a series in which the fundamental and remaining harmonics are filtered out(8). Here we show that three distinct, sympatric size morphs of the large-eared horseshoe bat (Rhinolophus philippinensis) echolocate at different harmonics of the same fundamental frequency. These morphs have undergone recent genetic divergence, and this process has occurred in parallel more than once(9). We suggest that switching harmonics creates a discontinuity in the bats' perception of available prey that can initiate disruptive selection(1). Moreover, because call frequency in horseshoe bats has a dual function in resource acquisition and communication, ecological selection on frequency might lead to assortative mating and ultimately reproductive isolation and speciation, regardless of external barriers to gene flow(1-3).	Boston Univ, Dept Geog, Boston, MA 02215 USA; Univ London, Sch Biol Sci, London E1 4NS, England; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	Boston University; University of London; University of Bristol	Kingston, T (corresponding author), Boston Univ, Dept Geog, Boston, MA 02215 USA.	tigga@bu.edu	Rossiter, Stephen J/E-2111-2011	Kingston, Tigga/0000-0003-3552-5352; Rossiter, Stephen/0000-0002-3881-4515	Natural Environment Research Council [NER/I/S/2002/00732] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andrews MM, 2003, ACTA CHIROPTEROL, V5, P221, DOI 10.3161/001.005.0212; [Anonymous], 2008, AUSTR BATS; BRUNS V, 1976, J COMP PHYSIOL, V106, P77, DOI 10.1007/BF00606573; Cooper SJB, 1998, AUST J ZOOL, V46, P203, DOI 10.1071/ZO97056; Dawson K., 2000, Journal of Computing in Teacher Education, V17, P4; Fenton M.B., 1985, COMMUNICATION CHIROP; Francis Charles M., 1998, P169; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; Houston R, 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Jones G., 2004, ECHOLOCATION BATS DO, P345; KOBER R, 1990, J ACOUST SOC AM, V87, P882, DOI 10.1121/1.398898; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; LONG GR, 1975, J COMP PHYSIOL, V100, P211, DOI 10.1007/BF00614531; MATSUMURA S, 1981, J MAMMAL, V62, P20, DOI 10.2307/1380474; *NATO ADV STUD I M, 1966, COURS ET OTAN SYST S, V2, P939; Nichols RA, 2001, MOL ECOL, V10, P593, DOI 10.1046/j.1365-294x.2001.01204.x; Pye J. David, 1993, Bioacoustics, V4, P271; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rossiter SJ, 1999, MOL ECOL, V8, P1959, DOI 10.1046/j.1365-294x.1999.00778-2.x; RUBSAMEN R, 1990, J COMP PHYSIOL A, V167, P771; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHNITZLER HU, 1987, RECENT ADV STUDY BAT, P226; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; SERVENT AG, 2003, HORSESHOE BATS WORLD, pR12; SIMMONS NB, IN PRESS MAMMAL SPEC; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; Vater Marianne, 2000, P137, DOI 10.1017/CBO9780511541872.005; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; WILKINSON GS, 1991, GENETICS, V128, P607	30	127	139	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					654	657		10.1038/nature02487	http://dx.doi.org/10.1038/nature02487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190351				2022-12-01	WOS:000221912600039
J	Recker, M; Nee, S; Bull, PC; Kinyanjui, S; Marsh, K; Newbold, C; Gupta, S				Recker, M; Nee, S; Bull, PC; Kinyanjui, S; Marsh, K; Newbold, C; Gupta, S			Transient cross-reactive immune responses can orchestrate antigenic variation in malaria	NATURE			English	Article							VARIANT SURFACE-ANTIGENS; PLASMODIUM-FALCIPARUM INFECTIONS; MATHEMATICAL-MODEL; ANTIBODY-RESPONSES; CHILDREN; ERYTHROCYTES; DYNAMICS; TRYPANOSOMES; PROTECTION; SELECTION	The malaria parasite Plasmodium falciparum has evolved to prolong its duration of infection by antigenic variation of a major immune target on the surface of the infected red blood cell. This immune evasion strategy depends on the sequential, rather than simultaneous, appearance of immunologically distinct variants. Although the molecular mechanisms by which a single organism switches between variants are known in part(1-3), it remains unclear how an entire population of parasites within the host can synchronize expression to avoid rapidly exhausting the variant repertoire. Here we show that short-lived, partially cross-reactive immune responses to parasite-infected erythrocyte surface antigens can produce a cascade of sequentially dominant antigenic variants, each of which is the most immunologically distinct from its preceding types. This model reconciles several previously unexplained and apparently conflicting epidemiological observations by demonstrating that individuals with stronger cross-reactive immune responses can, paradoxically, be more likely to sustain chronic infections. Antigenic variation has always been seen as an adaptation of the parasite to evade host defence: we show that the coordination necessary for the success of this strategy might be provided by the host.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Edinburgh, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 9DS, England; Kenya Govt Med Res Ctr, Kilifi, Kenya	University of Oxford; University of Edinburgh; University of Oxford; Kenya Medical Research Institute	Gupta, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sunetra.gupta@zoology.ox.ac.uk		Bull, Peter/0000-0002-7674-6752; Recker, Mario/0000-0001-9489-1315				AGUR Z, 1989, P NATL ACAD SCI USA, V86, P9626, DOI 10.1073/pnas.86.23.9626; Antia R, 1996, P NATL ACAD SCI USA, V93, P985, DOI 10.1073/pnas.93.3.985; Beck HP, 1997, J INFECT DIS, V175, P921, DOI 10.1086/513991; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Frank SA, 1999, P ROY SOC B-BIOL SCI, V266, P1397, DOI 10.1098/rspb.1999.0793; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Haraguchi Y, 1997, PHILOS T R SOC B, V352, P11, DOI 10.1098/rstb.1997.0002; Kinyanjui SM, 2003, J INFECT DIS, V187, P667, DOI 10.1086/373994; KOSINSKI RJ, 1980, PARASITOLOGY, V80, P343, DOI 10.1017/S0031182000000809; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Molineaux L, 1980, THE GARKI PROJECT; Newbold CI, 1999, CURR OPIN MICROBIOL, V2, P420, DOI 10.1016/S1369-5274(99)80074-5; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Tebo AE, 2002, AM J TROP MED HYG, V67, P597, DOI 10.4269/ajtmh.2002.67.597	28	130	132	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					555	558		10.1038/nature02486	http://dx.doi.org/10.1038/nature02486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175751				2022-12-01	WOS:000221767700038
J	Collins, FS				Collins, FS			The case for a US prospective cohort study of genes and environment	NATURE			English	Editorial Material							ASSOCIATION; DISEASE	Information from the Human Genome Project will be vital for defining the genetic and environmental factors that contribute to health and disease. Well-designed case-control studies of people with and without a particular disease are essential for this, but rigorous and unbiased conclusions about the causes of diseases and their population-wide impact will require a representative population to be monitored over time ( a prospective cohort study). The time is right for the United States to consider such a project.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Collins, FS (corresponding author), NHGRI, NIH, Bldg 31,Room 4B09,MSC 2152,31 Ctr Dr, Bethesda, MD 20892 USA.	fc23a@nih.gov						Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; FEINSTEIN AR, 1985, J CHRON DIS, V38, P127, DOI 10.1016/0021-9681(85)90085-2; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordis L., 2000, EPIDEMIOLOGY, V2; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Shi Michael M, 2002, Am J Pharmacogenomics, V2, P197, DOI 10.2165/00129785-200202030-00005; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1123; van den Oord EJCG, 1999, AM J EPIDEMIOL, V150, P1179; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weaver VM, 1998, ENVIRON HEALTH PERSP, V106, P827, DOI 10.2307/3434197	14	177	184	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					475	477		10.1038/nature02628	http://dx.doi.org/10.1038/nature02628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164074				2022-12-01	WOS:000221644600051
J	Mitchell, JF; Stoner, GR; Reynolds, JH				Mitchell, JF; Stoner, GR; Reynolds, JH			Object-based attention determines dominance in binocular rivalry	NATURE			English	Article							SELECTIVE ATTENTION; SURFACES; MOTION; SYNCHRONY; FEATURES	A question of long-standing interest to philosophers, psychologists and neuroscientists is how the brain selects which signals enter consciousness(1,2). Binocular rivalry and attention both involve selection of visual stimuli, but affect perception quite differently. During binocular rivalry, awareness alternates between two different stimuli presented to the two eyes. In contrast, attending to one of two different stimuli impairs discrimination of the ignored stimulus, but without causing it to disappear from consciousness. Here we show that despite this difference, attention and rivalry rely on shared object-based selection mechanisms. We cued attention to one of two superimposed transparent surfaces and then deleted the image of one surface from each eye, resulting in rivalry. Observers usually reported seeing only the cued surface. They were also less accurate in judging unpredictable changes in the features of the uncued surface. Our design ensured that selection of the cued surface could not have resulted from spatial, ocular or feature-based mechanisms. Rather, attention was drawn to one surface, and this caused the other surface to be perceptually suppressed during rivalry. These results raise the question of how object representations compete during these two forms of perceptual selection, even as the features of those objects change unpredictably over time.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Reynolds, JH (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545				Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Diaz-Caneja E, 1928, ANN OCUL, V165, P721; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; James W., 1890, INDIAN J PSYCHOL SCI, pJan; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; KULIKOWSKI JJ, 1992, OPHTHAL PHYSL OPT, V12, P168, DOI 10.1111/j.1475-1313.1992.tb00283.x; Lack L.C., 1978, SELECTIVE ATTENTION; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Mitchell JF, 2003, VISION RES, V43, P1323, DOI 10.1016/S0042-6989(03)00123-8; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; Ooi TL, 2003, PERCEPTION, V32, P155, DOI 10.1068/p3467; Pinilla T, 2001, VISION RES, V41, P1619, DOI 10.1016/S0042-6989(01)00039-6; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reynolds JH, 2003, VISION RES, V43, P59, DOI 10.1016/S0042-6989(02)00403-0; Sasaki H, 2002, PERCEPTION, V31, P409, DOI 10.1068/p3255; Schoenfeld MA, 2003, P NATL ACAD SCI USA, V100, P11806, DOI 10.1073/pnas.1932820100; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sobel KV, 2002, PERCEPTION, V31, P813, DOI 10.1068/p3279; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Valdes-Sosa M, 2000, J EXP PSYCHOL HUMAN, V26, P488, DOI 10.1037/0096-1523.26.2.488; VONNHELMHOLTZ H, 1909, HDB PHYSL OPTIK; WHITTLE P, 1968, PERCEPT PSYCHOPHYS, V4, P183, DOI 10.3758/BF03210465	30	182	184	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					410	413		10.1038/nature02584	http://dx.doi.org/10.1038/nature02584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164062	Green Accepted			2022-12-01	WOS:000221644600038
J	Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L				Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L			Crystal structure of argonaute and its implications for RISC slicer activity	SCIENCE			English	Article							PAZ DOMAIN; RNA; DROSOPHILA; COMPLEX; INTEGRASE; SIRNAS; CORE; TRANSPOSITION; INTERFERENCE; RECOGNITION	Argonaute proteins and small interfering RNAs (siRNAs) are the known signature components of the RNA interference effector complex RNA-induced silencing complex (RISC). However, the identity of "Slicer," the enzyme that cleaves the messenger RNA (mRNA) as directed by the siRNA, has not been resolved. Here, we report the crystal structure of the Argonaute protein from Pyrococcus furiosus at 2.25 angstrom resolution. The structure reveals a crescent-shaped base made up of the amino-terminal, middle, and PIWI domains. The Piwi Argonaute Zwille (PAZ) domain is held above the base by a "stalk"-like region. The PIWI domain (named for the protein piwi) is similar to ribonuclease H, With a conserved active site aspartate-aspartate-glutamate motif, strongly implicating Argonaute as "Slicer." The architecture of the molecule and the placement of the PAZ and PIWI domains define a groove for substrate binding and suggest a mechanism for siRNA-guided mRNA cleavage.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Song, Ji-Joon/C-1721-2011; Hannon, Gregory/AAB-3568-2019	Goldsmith, Stephanie/0000-0002-5010-1657; Joshua-Tor, Leemor/0000-0001-8185-8049				ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	29	1035	1142	6	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1434	1437		10.1126/science.1102514	http://dx.doi.org/10.1126/science.1102514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284453				2022-12-01	WOS:000223761900039
J	Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G				Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G			Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands	ANNALS OF INTERNAL MEDICINE			English	Article							LAST RESORT; UNCONTROLLED SYMPTOMS; CAREFUL CONVERSATION; PALLIATIVE OPTIONS; ASSISTED SUICIDE; END; CANCER; LIFE	Background: Terminal sedation in patients nearing death is an important issue related to end-of-life care. Objective: To describe the practice of terminal sedation in the Netherlands. Design: Face-to-face interviews. Setting: The Netherlands. Participants: Nationwide stratified sample of 482 physicians; 410 responded and 211 of these reported characteristics of their most recent terminal sedation case. Measurements: Physician reports of frequency of terminal sedation (defined as the administration of drugs to keep the patient in deep sedation or coma until death, without giving artificial nutrition or hydration), characteristics of the decision-making process, drugs used, the estimated life-shortening effect, and frequency of euthanasia discussions. Results: Of respondents, 52% (95% CI, 48% to 57%) had ever used terminal sedation. Of the 211 most recent cases, physicians used terminal sedation to alleviate severe pain in 51% of patients (CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and dyspnea in 38% (CI, 32% to 45%). Physicians reported discussing with patients the decision to use deep sedation in 59% of the 211 most recent cases (CI, 52% to 66%) and the decision to forgo artificial nutrition or hydration in 34% (CI, 28% to 41%). Hastening death was partly the intention of the physician in 47% (CI, 41% to 54%) of cases and the explicit intention in 17% (CI, 13% to 22%) of cases. Limitations: The generalizability of physician reports about their most recent cases to all terminal sedation cases is uncertain. In addition, the findings are subject to recall bias and may not apply to other geographic settings. Conclusions: Terminal sedation precedes a substantial number of deaths in the Netherlands. In about two thirds of most recently reported cases, physicians indicated that in addition to alleviating symptoms, they intended to hasten death.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Rietjens, JAC (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.rietjens@erasmusmc.nl						Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Chater S, 1998, PALLIATIVE MED, V12, P255, DOI 10.1191/026921698671831786; Cherny N I, 1994, J Palliat Care, V10, P31; Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; Coyle N, 1990, J Pain Symptom Manage, V5, P83; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fainsinger RL, 1998, J PAIN SYMPTOM MANAG, V16, P145, DOI 10.1016/S0885-3924(98)00066-9; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Kvasnicka John H, 2002, Ann Intern Med, V137, pW2; Letvak R, 1998, JAMA-J AM MED ASSOC, V279, P1065, DOI 10.1001/jama.279.14.1065; LETVAK R, 1998, JAMA-J AM MED ASSOC, V279, P1066; Loewy EH, 2001, ARCH INTERN MED, V161, P329, DOI 10.1001/archinte.161.3.329; Morita T, 2003, J PAIN SYMPTOM MANAG, V25, P357, DOI 10.1016/S0885-3924(02)00684-X; Morita T, 2002, J CLIN ONCOL, V20, P758, DOI 10.1200/JCO.2002.20.3.758; Morita T, 2001, LANCET, V358, P335, DOI 10.1016/S0140-6736(01)05515-5; Morita Tatsuya, 2002, Ann Intern Med, V137, pW1; Muller-Busch H Christof, 2003, BMC Palliat Care, V2, P2, DOI 10.1186/1472-684X-2-2; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00026; Rousseau P, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00027; Sasser CG, 2002, ANN INTERN MED, V137, P1008, DOI 10.7326/0003-4819-137-12-200212170-00025; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; Sulmasy DP, 2000, ANN INTERN MED, V133, P562, DOI 10.7326/0003-4819-133-7-200010030-00023; Sulmasy DP, 2000, ANN INTERN MED, V133, P560, DOI 10.7326/0003-4819-133-7-200010030-00021; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; VANDERWAL G, 2003, MED BESLUITVORMING L; Ventafridda V, 1990, J Palliat Care, V6, P7; 2004, STAT NETHERLANDS CEN	35	133	134	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					178	185		10.7326/0003-4819-141-3-200408030-00006	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289214	Green Published			2022-12-01	WOS:000223068600002
J	Greenstein, RJ; Collins, MT				Greenstein, RJ; Collins, MT			Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?	LANCET			English	Editorial Material							CROHNS-DISEASE; BIOPSY SPECIMENS; NOD2		Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison	Greenstein, RJ (corresponding author), Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA.	BGAxis@aol.com						Behr MA, 2004, LANCET INFECT DIS, V4, P136, DOI 10.1016/S1473-3099(04)00935-1; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Collins MT, 2000, J CLIN MICROBIOL, V38, P4373, DOI 10.1128/JCM.38.12.4373-4381.2000; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; GREEN JP, 2002, DRAFT GUIDANCE CONTR; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Sechi LA, 2001, J CLIN MICROBIOL, V39, P4514, DOI 10.1128/JCM.39.12.4514-4517.2001	11	62	63	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					396	397		10.1016/S0140-6736(04)16781-0	http://dx.doi.org/10.1016/S0140-6736(04)16781-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288721				2022-12-01	WOS:000222998600007
J	Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G				Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G			The complete genome sequence of Propionibacterium acnes, a commensal of human skin	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HYALURONATE LYASE; ANTIGENS; PROTEINS; CLONING; LEPRAE	Propionibacterium acnes is a major inhabitant of adult human skin, where it resides within sebaceous follicles, usually as a harmless commensal although it has been implicated in acne vulgaris formation. The entire genome sequence of this Gram-positive bacterium encodes 2333 putative genes and revealed numerous gene products involved in degrading host molecules, including sialidases, neuraminidases, endoglycoceramidases, lipases, and pore-forming factors. Surface-associated and other immunogenic factors have been identified, which might be involved in triggering acne inflammation and other P. acnes-associated diseases.	Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; Univ Ulm, Dept Microbiol & Biotechnol, D-89069 Ulm, Germany	University of Gottingen; Ulm University	Bruggemann, H (corresponding author), Inst Pasteur, Lab Genom Microbial Pathogens, 28 Rue Dr Roux, F-75724 Paris, France.	hbruegg@pasteur.fr; ggottsc@gwdg.de		Liesegang, Heiko/0000-0003-1792-2047; Bruggemann, Holger/0000-0001-7433-0190				BOOTH RJ, 1993, INFECT IMMUN, V61, P1509, DOI 10.1128/IAI.61.4.1509-1515.1993; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Csukas Z, 2004, MICROB PATHOGENESIS, V36, P171, DOI 10.1016/j.micpath.2003.09.002; Farrar MD, 2000, FEMS MICROBIOL LETT, V191, P183, DOI 10.1016/S0378-1097(00)00387-6; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; HERMANS PWM, 1995, INFECT IMMUN, V63, P954, DOI 10.1128/IAI.63.3.954-960.1995; Holland KT, 1998, DERMATOLOGY, V196, P67, DOI 10.1159/000017870; HUJER S, UNPUB; Ingham E, 1999, CURR OPIN INFECT DIS, V12, P191, DOI 10.1097/00001432-199906000-00006; Jakab E, 1996, YALE J BIOL MED, V69, P477; Jappe U, 2002, BRIT J DERMATOL, V146, P202, DOI 10.1046/j.1365-2133.2002.04602.x; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Makris G, 2004, MICROBIOL-SGM, V150, P2005, DOI 10.1099/mic.0.26942-0; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Steiner B, 1997, CAN J MICROBIOL, V43, P315, DOI 10.1139/m97-044; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243	19	306	409	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					671	673		10.1126/science.1100330	http://dx.doi.org/10.1126/science.1100330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286373				2022-12-01	WOS:000222992100049
J	Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD				Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD			Neurons compute internal models of the physical laws of motion	NATURE			English	Article							APERTURE PROBLEM; PROJECTIONS; HUMANS; MONKEY; CEREBELLUM; DYNAMICS; AFFERENT; THALAMUS; NUCLEI; CUES	A critical step in self-motion perception and spatial awareness is the integration of motion cues from multiple sensory organs that individually do not provide an accurate representation of the physical world. One of the best-studied sensory ambiguities is found in visual processing, and arises because of the inherent uncertainty in detecting the motion direction of an untextured contour moving within a small aperture(1-4). A similar sensory ambiguity arises in identifying the actual motion associated with linear accelerations sensed by the otolith organs in the inner ear(5,6). These internal linear accelerometers respond identically during translational motion ( for example, running forward) and gravitational accelerations experienced as we reorient the head relative to gravity ( that is, head tilt). Using new stimulus combinations, we identify here cerebellar and brainstem motion-sensitive neurons that compute a solution to the inertial motion detection problem. We show that the firing rates of these populations of neurons reflect the computations necessary to construct an internal model representation of the physical equations of motion.	Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu						ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ANGAUT P, 1970, BRAIN RES, V24, P49, DOI 10.1016/0006-8993(70)90273-8; Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2003, J NEUROSCI, V23, P2971; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; ASAMURA C, 1983, BRAIN RES REV, V5, P237; BATTON RR, 1977, J COMP NEUROL, V174, P281, DOI 10.1002/cne.901740206; CARLETON SC, 1984, BRAIN RES, V294, P281, DOI 10.1016/0006-8993(84)91040-0; Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002; Draper N.R., 1998, APPL REGRESSION ANAL, V326; Einstein A., 1907, JAHRB RADIOAKT ELEKT, V4, P411, DOI DOI 10.1007/978-3-322-83770-7_6; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Goldstein H., 2002, CLASSICAL MECH; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KOTCHABHAKDI N, 1978, BRAIN RES, V142, P142, DOI 10.1016/0006-8993(78)90183-X; LANG W, 1979, BRAIN RES, V177, P3, DOI 10.1016/0006-8993(79)90914-4; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; NEWLANDS SD, 2004, SEMICIRCULAR CANAL I; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Zupan LH, 2000, J NEUROPHYSIOL, V84, P2001, DOI 10.1152/jn.2000.84.4.2001	30	223	227	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					560	564		10.1038/nature02754	http://dx.doi.org/10.1038/nature02754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282606				2022-12-01	WOS:000222946100048
J	Comas, D; Petit, F; Preat, T				Comas, D; Petit, F; Preat, T			Drosophila long-term memory formation involves regulation of cathepsin activity	NATURE			English	Article							CONSOLIDATED MEMORY; GLIAL-CELLS; GENES	Whereas short-term memory lasts from minutes to hours, long-term memory (LTM) can last for days or even an entire lifetime. LTM generally forms after spaced repeated training sessions and involves the regulation of gene expression(1,2), thereby implicating transcription factors in the initial steps of LTM establishment(3). However, the direct participation of effector genes in memory formation has been rarely documented, and many of the mechanisms involved in LTM formation remain to be understood. Here we describe a Drosophila melanogaster mutant, crammer (cer), which shows a specific LTM defect. The cer gene encodes an inhibitor of a subfamily of cysteine proteinases, named cathepsins, some of which might be involved in human Alzheimer's disease(4). The Cer peptide was found in the mushroom bodies (MBs), the Drosophila olfactory memory centre and in glial cells around the MBs. The overexpression of cer in glial cells but not in MB neurons induces a decrease in LTM, suggesting that Cer might have a role in glia and that the concentration of the Cer peptide is critical for LTM. In wild-type flies, cer expression transiently decreases after LTM conditioning, indicating that cysteine proteinases are activated early in LTM formation.	CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr		Preat, Thomas/0000-0001-9976-1763				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Boquet I, 2000, J NEUROBIOL, V42, P33; Callahan LM, 1998, NEUROBIOL AGING, V19, pS99, DOI 10.1016/S0197-4580(98)00044-X; Comas D, 1999, INSECT BIOCHEM MOLEC, V29, P821, DOI 10.1016/S0965-1748(99)00058-2; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; DELARIA K, 1994, J BIOL CHEM, V269, P25172; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Epstein HT, 2003, NEUROBIOL LEARN MEM, V79, P127, DOI 10.1016/S1074-7427(02)00020-5; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Igaz LM, 2002, J NEUROSCI, V22, P6781; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Ito K, 1997, DEVELOPMENT, V124, P761; Kurata M, 2001, J BIOCHEM, V130, P857, DOI 10.1093/oxfordjournals.jbchem.a003058; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wiederanders B, 2000, ADV EXP MED BIOL, V477, P261	25	68	72	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					460	463		10.1038/nature02726	http://dx.doi.org/10.1038/nature02726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269770				2022-12-01	WOS:000222801400045
J	Stone, EM; Braun, TA; Russell, SR; Kuehn, MH; Lotery, AJ; Moore, PA; Eastman, CG; Casavant, TL; Sheffield, VC				Stone, EM; Braun, TA; Russell, SR; Kuehn, MH; Lotery, AJ; Moore, PA; Eastman, CG; Casavant, TL; Sheffield, VC			Missense variations in the fibulin 5 gene and age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALATTIA LEVENTINESE; ALLELIC VARIATION; VISUAL IMPAIRMENT; STARGARDT-DISEASE; MUTATION; ABCR; MACULOPATHY; POPULATION; PREVALENCE; BLINDNESS	Background: Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world. The study of a rare mendelian form of macular degeneration implicated fibulin genes in the pathogenesis of more common forms of this disease. We evaluated five fibulin genes in a large series of patients with AMD. Methods: We studied 402 patients with AMD and 429 control subjects from the same clinic population. Patients were examined by means of indirect ophthalmoscopy, slit-lamp microscopy, and fundus photography to establish the presence and phenotypic pattern of AMD. DNA samples were screened for sequence variations in five members of the fibulin gene family. Results: Amino acid-altering sequence variations were found in all five fibulin genes, many of which were observed only in patients with AMD. Several of the altered residues have been conserved during evolution. Seven of the 402 patients with AMD had amino acid-altering sequence variations in the fibulin 5 gene, whereas none were observed among 429 control subjects (P<0.01). In addition, these seven patients all had small, circular drusen, which are commonly referred to as basal laminar or cuticular drusen. Conclusions: Missense mutations in the fibulin 5 gene were found in 1.7 percent of patients with AMD. Many variations in other fibulin genes were also found in these patients, and the evolutionary conservation of the affected residues suggests that several of these variations may also be involved in AMD.	Univ Iowa, Carver Coll Med, Ctr Macular Degenerat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Southampton, Dept Ophthalmol, Southampton, Hants, England	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Southampton	Stone, EM (corresponding author), Univ Iowa, Carver Coll Med, Ctr Macular Degenerat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	edwin-stone@uiowa.edu		Stone, Edwin M./0000-0003-3343-4414; Lotery, Andrew/0000-0001-5541-4305; Sheffield, Val/0000-0002-6282-0835; Kuehn, Markus/0000-0003-3940-198X; Russell, Stephen/0000-0003-3776-1367				Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gass JD., 1977, STEREOSCOPIC ATLAS M, V2; GASS JDM, 1985, AM J OPHTHALMOL, V99, P445; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heon E, 1996, ARCH OPHTHALMOL-CHIC, V114, P193, DOI 10.1001/archopht.1996.01100130187014; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; TIELSCH JM, 1995, NEW ENGL J MED, V332, P1205, DOI 10.1056/NEJM199505043321806; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Vogel BE, 2001, DEVELOPMENT, V128, P883; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	30	247	259	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					346	353		10.1056/NEJMoa040833	http://dx.doi.org/10.1056/NEJMoa040833			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269314				2022-12-01	WOS:000222801200008
J	Wilson, JF				Wilson, JF			Angiogenesis therapy moves beyond cancer	ANNALS OF INTERNAL MEDICINE			English	Article												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	11	16	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2004	141	2					165	168		10.7326/0003-4819-141-2-200407200-00027	http://dx.doi.org/10.7326/0003-4819-141-2-200407200-00027			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839BL	15262679				2022-12-01	WOS:000222758200018
J	Peto, J; Gilham, C; Fletcher, O; Matthews, FE				Peto, J; Gilham, C; Fletcher, O; Matthews, FE			The cervical cancer epidemic that screening has prevented in the UK	LANCET			English	Article							CARCINOMA IN-SITU; HUMAN-PAPILLOMAVIRUS; UTERINE CERVIX; ENGLAND; MORTALITY; WOMEN; RATES; ADENOCARCINOMA; CLEARANCE; BEHAVIOR	Background Recent reports suggest that the reduction in mortality achieved by the UK national cervical screening programme is too small to justify its financial and psychosocial costs, except perhaps in a few high-risk women. Methods We analysed trends in mortality before 1988, when the British national screening programme was launched, to estimate what future trends in cervical cancer mortality would have been without any screening. Findings Cervical cancer mortality in England and Wales in women younger than 35 years rose three-fold from 1967 to 1987. By 1988, incidence in this age-range was among the highest in the world despite substantial opportunistic screening. Since national screening was started in 1988, this rising trend has been reversed. Interpretation Cervical screening has prevented an epidemic that would have killed about one in 65 of all British women born since 1910 and culminated in about 6110 deaths per year in this country. However, these estimates are subject to substantial uncertainty, particularly in relation to the effects of oral contraceptives and changes in sexual behaviour. 80% or more of these deaths (up to 5000 deaths per year) are likely to be prevented by screening, which means that about 100 000 (one in 80) of the 8 million British women born between 1951 and 1970 will be saved from premature death by the cervical screening programme at a cost per life saved of about pound36 000. The birth cohort trends also provide strong evidence that the death rate throughout life is substantially lower in women who were first screened when they were younger.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Inst Canc Res, Sutton, Surrey, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; MRC Biostatistics Unit; University of Cambridge	Peto, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	julian.peto@lshtm.ac.uk	Matthews, Fiona/O-6932-2015	Matthews, Fiona/0000-0002-1728-2388; Fletcher, Olivia/0000-0001-9387-7116				Akker-van Marle MEV, 2003, BRIT J CANCER, V88, P1054, DOI 10.1038/sj.bjc.6600843; [Anonymous], 1986, Br Med J (Clin Res Ed), V293, P659; Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.3.CO;2-E; Botting B, 2000, Popul Trends, P32; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Department of Health, 1994, CERV CYT 1992 93 SUM; Dillner J, 2000, J CLIN VIROL, V19, P7, DOI 10.1016/S1386-6532(00)00126-8; Elfgren K, 2002, OBSTET GYNECOL, V100, P965, DOI 10.1016/S0029-7844(02)02280-9; Green J, 2003, BRIT J CANCER, V89, P2078, DOI 10.1038/sj.bjc.6601296; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Johnson AM, 1994, SEXUAL ATTITUDES LIF; KINLEN LJ, 1978, LANCET, V2, P463; KITCHENER HC, 2004, 21 INT PAP C 2004 FE; KOSS LG, 1963, CANCER, V16, P1160, DOI 10.1002/1097-0142(196309)16:9<1160::AID-CNCR2820160910>3.0.CO;2-4; LEA R, 2000, HEALTHCARE UK NEED R; Levi F, 2000, EUR J CANCER, V36, P2266, DOI 10.1016/S0959-8049(00)00346-4; MCINDOE WA, 1984, OBSTET GYNECOL, V64, P451; Miller AB, 2002, EUR J CANCER, V38, P321, DOI 10.1016/S0959-8049(01)00374-4; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; *OFF NAT STAT, 1984, SOC TRENDS; *OFF NAT STAT, 2001, STAT B DEP HLTH; *OFF NAT STAT, 2002, SOC TRENDS; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; PARKIN DM, 2000, IARC SCI PUBLICATION, V143; PETO J, IN PRESS BR J CANC; Peyton CL, 1998, J CLIN MICROBIOL, V36, P3248, DOI 10.1128/JCM.36.11.3248-3254.1998; *PHLS DHSS PS SCOT, 1995, SEX TRANSM INF UK NE; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Raffle AE, 2003, BRIT MED J, V326, P901, DOI 10.1136/bmj.326.7395.901; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; Redburn JC, 2001, BRIT J OBSTET GYNAEC, V108, P388; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Sasieni P, 1999, BRIT MED J, V318, P1244; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Simms I, 1997, GENITOURIN MED, V73, P365; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Swerdlow A, 2001, CANC INCIDENCE MORTA; van Ballegooijen M, 2000, EUR J CANCER, V36, P2177, DOI 10.1016/S0959-8049(00)00330-0; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, WHO STAT INF SYST WH	42	546	565	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2004	364	9430					249	256		10.1016/S0140-6736(04)16674-9	http://dx.doi.org/10.1016/S0140-6736(04)16674-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15262102				2022-12-01	WOS:000222784900027
J	Farr, MA; Basson, CT				Farr, MA; Basson, CT			Sparking the failing heart	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHANNEL RYANODINE RECEPTOR; FAILURE		Cornell Univ, Weill Med Coll, Mol Cardiol Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Congest Heart Failure Ctr, Greenberg Cardiol Div,Dept Med, New York, NY USA	Cornell University; Cornell University	Farr, MA (corresponding author), Cornell Univ, Weill Med Coll, Mol Cardiol Lab, New York, NY 10021 USA.							Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Priori SG, 2001, CIRCULATION, V103, P196; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE	5	15	25	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2004	351	2					185	187		10.1056/NEJMcibr041466	http://dx.doi.org/10.1056/NEJMcibr041466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835GM	15247360				2022-12-01	WOS:000222470700015
J	ter Meulen, J; Bakker, ABH; van den Brink, EN; Weverling, GJ; Martina, BEE; Haagmans, BL; Kuiken, T; de Kruif, J; Preiser, W; Spaan, W; Gelderblom, HR; Goudsmit, J; Osterhaus, ADME				ter Meulen, J; Bakker, ABH; van den Brink, EN; Weverling, GJ; Martina, BEE; Haagmans, BL; Kuiken, T; de Kruif, J; Preiser, W; Spaan, W; Gelderblom, HR; Goudsmit, J; Osterhaus, ADME			Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets	LANCET			English	Article								SARS coronavirus continues to cause sporadic cases of severe acute respiratory syndrome (SARS) in China. No active or passive immunoprophylaxis for disease induced by SARS coronavirus is available. We investigated prophylaxis of SARS coronavirus infection with a neutralising human monoclonal antibody in ferrets, which can be readily infected with the virus. Prophylactic administration of the monoclonal antibody at 10 mg/kg reduced replication of SARS coronavirus in the lungs of infected ferrets by 3.3 logs (95% Cl 2.6-4.0 logs; p<0.001), completely prevented the development of SARS coronavirus-induced macroscopic lung pathology (p=0.013), and abolished shedding of virus in pharyngeal secretions. The data generated in this animal model show that administration of a human monoclonal antibody might offer a feasible and effective prophylaxis for the control of human SARS coronavirus infection.	Crucell Holland BV, NL-2301 CA Leiden, Netherlands; Univ Frankfurt, Inst Med Virol, D-6000 Frankfurt, Germany; Robert Koch Inst, D-1000 Berlin, Germany; Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands	Johnson & Johnson; Goethe University Frankfurt; Robert Koch Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	ter Meulen, J (corresponding author), Crucell Holland BV, POB 2048, NL-2301 CA Leiden, Netherlands.	j.termeulen@crucell.com	Bakker, Arnold B./F-8494-2010; Preiser, Wolfgang/J-4875-2016; Haagmans, Bart/E-9791-2015	Bakker, Arnold B./0000-0003-1489-1847; Preiser, Wolfgang/0000-0002-0254-7910; Haagmans, Bart/0000-0001-6221-2015; Osterhaus, Albert/0000-0002-6074-1172				Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Parnes C, 2003, PEDIATR PULM, V35, P484, DOI 10.1002/ppul.10288; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tsang OTY, 2003, EMERG INFECT DIS, V9, P1381, DOI 10.3201/eid0911.030400	5	202	217	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 26	2004	363	9427					2139	2141		10.1016/S0140-6736(04)16506-9	http://dx.doi.org/10.1016/S0140-6736(04)16506-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832LF	15220038	Green Published, Bronze			2022-12-01	WOS:000222268300013
J	Ebel, C; Mariconti, L; Gruissem, W				Ebel, C; Mariconti, L; Gruissem, W			Plant retinoblastoma homologues control nuclear proliferation in the female gametophyte	NATURE			English	Article							GEMINIVIRUS REPLICATION PROTEIN; SEED DEVELOPMENT; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GENE; RB; FERTILIZATION; PATHWAY; MEDEA; DIFFERENTIATION	Haploid spores of plants divide mitotically to form multicellular gametophytes. The female spore ( megaspore) of most flowering plants develops by means of a well-defined programme into the mature megagametophyte consisting of the egg apparatus and a central cell(1,2). We investigated the role of the Arabidopsis retino-blastoma(3,4) protein homologue and its function as a negative regulator of cell proliferation during megagametophyte development. Here we show that three mutant alleles of the gene for the Arabidopsis retinoblastoma-related protein, RBR1 (ref. 4), are gametophytic lethal. In heterozygous plants 50% of the ovules are aborted when the mutant allele is maternally inherited. The mature unfertilized mutant megagametophyte fails to arrest mitosis and undergoes excessive nuclear proliferation in the embryo sac. Supernumerary nuclei are present at the micropylar end of the megagametophyte, which develops into the egg apparatus and central cell. The central cell nucleus, which gives rise to the endosperm after fertilization, initiates autonomous endosperm development reminiscent of fertilization-independent seed (fis) mutants(5). Thus, RBR1 has a novel and previously unrecognized function in cell cycle control during gametogenesis and in the repression of autonomous endosperm development.	Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gruissem, W (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Plant Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	wilhelm.gruissem@ipw.biol.ethz.ch	Gruissem, Wilhelm/H-1752-2013	Gruissem, Wilhelm/0000-0002-1872-2998				Ach RA, 1997, MOL CELL BIOL, V17, P5077, DOI 10.1128/MCB.17.9.5077; Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Durfee T, 2000, PLANT MOL BIOL, V43, P635, DOI 10.1023/A:1006426808185; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Grossniklaus U, 2001, CURR OPIN PLANT BIOL, V4, P21, DOI 10.1016/S1369-5266(00)00130-8; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Howden R, 1998, GENETICS, V149, P621; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kong LJ, 2000, EMBO J, V19, P3485, DOI 10.1093/emboj/19.13.3485; Kwee HS, 2003, PLANT J, V36, P853, DOI 10.1046/j.1365-313X.2003.01925.x; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li Y, 2003, BIOINFORMATICS, V19, P1441, DOI 10.1093/bioinformatics/btg170; LIN BY, 1978, CAN J GENET CYTOL, V20, P249, DOI 10.1139/g78-028; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yan W, 2001, ONCOGENE, V20, P1343, DOI 10.1038/sj.onc.1204254	30	195	214	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					776	780		10.1038/nature02637	http://dx.doi.org/10.1038/nature02637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201912				2022-12-01	WOS:000222059900042
J	Kaminski, J; Call, J; Fischer, J				Kaminski, J; Call, J; Fischer, J			Word learning in a domestic dog: Evidence for "fast mapping"	SCIENCE			English	Article							CANIS-FAMILIARIS; COMPREHENSION; COGNITION; CHILDREN; LANGUAGE; STIMULI; ABILITY; HUMANS	During speech acquisition, children form quick and rough hypotheses about the meaning of a new word after only a single exposure - a process dubbed "fast mapping." Here we provide evidence that a border collie, Rico, is able to fast map. Rico knew the labels of over 200 different items. He inferred the names of novel items by exclusion learning and correctly retrieved those items right away as well as 4 weeks after the initial exposure. Fast mapping thus appears to be mediated by general learning and memory mechanisms also found in other animals and not by a language acquisition device that is special to humans.	Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany	Max Planck Society	Fischer, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, D-04103 Leipzig, Germany.	scher@eva.mpg.de	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074; Call Balaguer, Josep/0000-0002-8597-8336; Kaminski, Juliane/0000-0002-3437-3484				BALDWIN DA, 1993, DEV PSYCHOL, V29, P832, DOI 10.1037/0012-1649.29.5.832; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bloom P., 2000, CHILDREN LEARN MEANI; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; CAREY S, 1978, CHILD LANG DEV, V15, P29; Coppinger R, 1995, DOMESTIC DOG ITS EVO; Fischer J, 2004, ANIM BEHAV, V67, P655, DOI 10.1016/j.anbehav.2003.08.006; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEIBECK TH, 1987, CHILD DEV, V58, P1021, DOI 10.1111/j.1467-8624.1987.tb01438.x; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; MERVIS CB, 1994, CHILD DEV, V65, P1662; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miles HWL, 1994, HOMINID CULTURE PRIM; SCHUSTERMAN RJ, 1984, PSYCHOL REC, V34, P3, DOI 10.1007/BF03394849; Tomasello M., 2003, CONSTRUCTING LANGUAG; Warden CJ, 1928, Q REV BIOL, V3, P1, DOI 10.1086/394292; Wilkinson KM, 1998, PSYCHOL REC, V48, P407, DOI 10.1007/BF03395281; YOUNG CA, 1991, APPL ANIM BEHAV SCI, V32, P75, DOI 10.1016/S0168-1591(05)80165-0	20	371	384	7	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1682	1683		10.1126/science.1097859	http://dx.doi.org/10.1126/science.1097859			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827WL	15192233				2022-12-01	WOS:000221934300054
J	Shykind, BM; Rohani, SC; O'Donnell, S; Nemes, A; Mendelsohn, M; Sun, YH; Axel, R; Barnea, G				Shykind, BM; Rohani, SC; O'Donnell, S; Nemes, A; Mendelsohn, M; Sun, YH; Axel, R; Barnea, G			Gene switching and the stability of odorant receptor gene choice	CELL			English	Article							MAMMALIAN OLFACTORY-BULB; TOPOGRAPHIC MAP; TRANSGENIC MICE; MOUSE; EXPRESSION; EPITHELIUM; ORGANIZATION; DEFICIENT; GLOMERULI; EXCISION	Individual olfactory sensory neurons express only a single odorant receptor from a large family of genes, and this singularity is an essential feature in models of olfactory perception. We have devised a genetic strategy to examine the stability of receptor choice. We observe that immature olfactory sensory neurons that express a given odorant receptor can switch receptor expression, albeit at low frequency. Neurons that express a mutant receptor gene switch receptor transcription with significantly greater probability, suggesting that the expression of a functional odorant receptor elicits a feedback signal that terminates switching (Lewcock and Reed, 2004; Serizawa et al., 2003). This process of receptor gene switching assures that a neuron will ultimately express a functional receptor and that the choice of this receptor will remain stable for the life of the cell.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NCI NIH HHS [2P01CA23767] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNEA G, 2004, IN PRESS SCIENCE; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Iwema CL, 2003, J COMP NEUROL, V459, P209, DOI 10.1002/cne.10583; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Poole AM, 2003, BIOSYSTEMS, V69, P163, DOI 10.1016/S0303-2647(02)00131-4; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schwob JE, 1999, J COMP NEUROL, V412, P439, DOI 10.1002/(SICI)1096-9861(19990927)412:3<439::AID-CNE5>3.0.CO;2-H; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	39	179	182	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					801	815		10.1016/j.cell.2004.05.015	http://dx.doi.org/10.1016/j.cell.2004.05.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186780	Bronze			2022-12-01	WOS:000222048400012
J	Lin, JC; Wang, WY; Chen, KY; Wei, YH; Liang, WM; Jan, JS; Jiang, RS				Lin, JC; Wang, WY; Chen, KY; Wei, YH; Liang, WM; Jan, JS; Jiang, RS			Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIPHERAL-BLOOD CELLS; IN-SITU HYBRIDIZATION; QUANTITATIVE-ANALYSIS; PHASE-III; RADIOTHERAPY; CHEMOTHERAPY; EXPRESSION; MARKER; CANCER; TUMOR	BACKGROUND We investigated the clinical significance of plasma concentrations of Epstein - Barr virus (EBV) DNA in patients with advanced nasopharyngeal carcinoma. METHODS Ninety-nine patients with biopsy-proven stage III or IV nasopharyngeal carcinoma and no evidence of metastasis (M0) received 10 weekly chemotherapy treatments followed by radiotherapy. Plasma samples from the patients were subjected to a real-time quantitative polymerase-chain-reaction assay. EBV genotypes of paired samples from plasma and primary tumor were compared. RESULTS Plasma EBV DNA was detectable before treatment in 94 of the 99 patients, but not in 40 healthy controls or 20 cured patients. The median concentrations of plasma EBV DNA were 681 copies per milliliter among 25 patients with stage III disease, 1703 copies per milliliter among 74 patients with stage IV disease, and 291,940 copies per milliliter among 19 control patients with distant metastasis (P< 0.001). Patients with relapse had a significantly higher plasma EBV DNA concentration before treatment than those who did not have a relapse ( median, 3035 vs. 1202 copies per milliliter; P=0.02). The consistent genotyping of EBV DNA between paired samples of plasma and primary tumor suggested that the circulating cell-free EBV DNA may originate from the primary tumor. Unlike the rebound of plasma EBV DNA concentrations in the patients who had a relapse, the plasma EBV DNA concentration was persistently low or undetectable in patients with a complete clinical remission. Overall survival ( P< 0.001) and relapse-free survival ( P=0.02) were significantly lower among patients with pretreatment plasma EBV DNA concentrations of at least 1500 copies per milliliter than among those with concentrations of less than 1500 copies per milliliter. Patients with persistently detectable plasma EBV DNA had significantly worse overall survival ( P< 0.001) and relapse-free survival ( P< 0.001) than patients with undetectable EBV DNA one week after the completion of radiotherapy. CONCLUSIONS Quantification of plasma EBV DNA is useful for monitoring patients with nasopharyngeal carcinoma and predicting the outcome of treatment.	Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung 407, Taiwan; Taichung Vet Gen Hosp, Dept Otorhinolaryngol, Taichung 407, Taiwan; Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Life Sci, Dept Biochem, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Life Sci, Ctr Cellular & Mol Biol, Taipei 112, Taiwan; Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan 70428, Taiwan; China Med Univ, Sch Med, Dept Med, Taichung, Taiwan; China Med Univ, Dept Publ Hlth, Taichung, Taiwan; Hung Kuang Univ, Dept Basic Med, Taichung, Taiwan; Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; China Medical University Taiwan; Hungkuang University; Taipei Veterans General Hospital	Lin, JC (corresponding author), Taichung Vet Gen Hosp, Dept Radiat Oncol, Taiwan 160,Sec 3,Taichung Kang Rd, Taichung 407, Taiwan.	jclin@vghtc.gov.tw	Wei, Yau-Huei/ABA-6841-2021	Wei, Yau-Huei/0000-0002-6429-2546; Jiang, Rong-San/0000-0002-8280-6029				Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2003, CANCER RES, V63, P2028; Chang JTC, 2000, RADIOTHER ONCOL, V54, P135, DOI 10.1016/S0167-8140(99)00177-2; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; Chao TY, 1996, CANCER-AM CANCER SOC, V78, P24, DOI 10.1002/(SICI)1097-0142(19960701)78:1<24::AID-CNCR5>3.0.CO;2-H; CHEN CL, 1993, INTERVIROLOGY, V36, P91, DOI 10.1159/000150327; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Fleming ID, 1997, AJCC CANC STAGING MA, P31; Hsiao JR, 2002, CANCER, V94, P723, DOI 10.1002/cncr.10251; Lee WY, 2000, HEAD NECK-J SCI SPEC, V22, P336, DOI 10.1002/1097-0347(200007)22:4<336::AID-HED4>3.0.CO;2-T; Leung TW, 2000, INT J RADIAT ONCOL, V48, P1331, DOI 10.1016/S0360-3016(00)00776-8; Lin JC, 2003, HEAD NECK-J SCI SPEC, V25, P438, DOI 10.1002/hed.10238; Lin JC, 2003, BRIT J CANCER, V88, P187, DOI 10.1038/sj.bjc.6600716; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin JC, 2001, J CLIN ONCOL, V19, P2607, DOI 10.1200/JCO.2001.19.10.2607; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Lo YMD, 2000, CANCER RES, V60, P6878; Lo YMD, 2000, ANN NY ACAD SCI, V906, P99; MACDONALD MR, 1995, HEAD NECK-J SCI SPEC, V17, P487, DOI 10.1002/hed.2880170606; Mutirangura A, 1998, CLIN CANCER RES, V4, P665; Ngan RKC, 2001, ANN NY ACAD SCI, V945, P73; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Shotelersuk K, 2000, CLIN CANCER RES, V6, P1046; Teo PML, 1998, INT J RADIAT ONCOL, V40, P897, DOI 10.1016/S0360-3016(97)00854-7; Tsai ST, 1996, CANCER, V77, P231, DOI 10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P; Wang WY, 2002, CLIN CANCER RES, V8, P2586; WU TC, 1991, AM J PATHOL, V138, P1461; YEUNG WM, 1993, INT J CANCER, V53, P746, DOI 10.1002/ijc.2910530507	32	608	638	2	44	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2004	350	24					2461	2470		10.1056/NEJMoa032260	http://dx.doi.org/10.1056/NEJMoa032260			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	827GH	15190138				2022-12-01	WOS:000221887200005
J	Hwangbo, DS; Gersham, B; Tu, MP; Palmer, M; Tatar, M				Hwangbo, DS; Gersham, B; Tu, MP; Palmer, M; Tatar, M			Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body	NATURE			English	Article							RECEPTOR; GROWTH; HOMOLOG; MUTANT; DOWNSTREAM; EXPRESSION; LONGEVITY; DAF-16; SYSTEM; GENE	In Drosophila melanogaster, ageing is slowed when insulin-like signalling is reduced: life expectancy is extended by more than 50% when the insulin-like receptor (InR) or its receptor substrate (chico) are mutated, or when insulin-producing cells are ablated(1-3). But we have yet to resolve when insulin affects ageing, or whether insulin signals regulate ageing directly or indirectly through secondary hormones. Caenorhabditis elegans lifespan is also extended when insulin signalling is inhibited in certain tissues, or when repressed in adult worms(4,5), and this requires the forkhead transcription factor (FOXO) encoded by daf-16 (ref. 6). The D. melanogaster insulin-like receptor mediates phosphorylation of dFOXO, the equivalent of nematode daf-16 and mammalian FOXO3a(7,8). We demonstrate here that dFOXO regulates D. melanogaster ageing when activated in the adult pericerebral fat body. We further show that this limited activation of dFOXO reduces expression of the Drosophila insulin-like peptide dilp-2 synthesized in neurons, and represses endogenous insulin-dependent signalling in peripheral fat body. These findings suggest that autonomous and non-autonomous roles of insulin signalling combine to control ageing.	Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Brown University	Tatar, M (corresponding author), Brown Univ, Div Biol & Med, Box G-W, Providence, RI 02912 USA.	Marc_Tatar@brown.edu	Gimenez, Luis E Diaz/D-9291-2011	Tatar, Marc/0000-0003-3232-6884				Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dobens LL, 1997, MECH DEVELOP, V65, P197, DOI 10.1016/S0925-4773(97)00080-4; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Jia KL, 2002, DEVELOPMENT, V129, P221; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	26	700	737	5	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					562	566		10.1038/nature02549	http://dx.doi.org/10.1038/nature02549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175753				2022-12-01	WOS:000221767700040
J	Weiss, R; Dziura, J; Burgert, TS; Tamborlane, WV; Taksali, SE; Yeckel, CW; Allen, K; Lopes, M; Savoye, M; Morrison, J; Sherwin, RS; Caprio, S				Weiss, R; Dziura, J; Burgert, TS; Tamborlane, WV; Taksali, SE; Yeckel, CW; Allen, K; Lopes, M; Savoye, M; Morrison, J; Sherwin, RS; Caprio, S			Obesity and the metabolic syndrome in children and adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; NATIONAL-HEALTH; GLUCOSE; ASSOCIATION; PREVALENCE; PREDICTS	Background: The prevalence and magnitude of childhood obesity are increasing dramatically. We examined the effect of varying degrees of obesity on the prevalence of the metabolic syndrome and its relation to insulin resistance and to C-reactive protein and adiponectin levels in a large, multiethnic, multiracial cohort of children and adolescents. Methods: We administered a standard glucose-tolerance test to 439 obese, 31 overweight, and 20 nonobese children and adolescents. Baseline measurements included blood pressure and plasma lipid, C-reactive protein, and adiponectin levels. Levels of triglycerides, high-density lipoprotein cholesterol, and blood pressure were adjusted for age and sex. Because the body-mass index varies according to age, we standardized the value for age and sex with the use of conversion to a z score. Results: The prevalence of the metabolic syndrome increased with the severity of obesity and reached 50 percent in severely obese youngsters. Each half-unit increase in the body-mass index, converted to a z score, was associated with an increase in the risk of the metabolic syndrome among overweight and obese subjects (odds ratio, 1.55; 95 percent confidence interval, 1.16 to 2.08), as was each unit of increase in insulin resistance as assessed with the homeostatic model (odds ratio, 1.12; 95 percent confidence interval, 1.07 to 1.18 for each additional unit of insulin resistance). The prevalence of the metabolic syndrome increased significantly with increasing insulin resistance (P for trend, <0.001) after adjustment for race or ethnic group and the degree of obesity. C-reactive protein levels increased and adiponectin levels decreased with increasing obesity. Conclusions: The prevalence of the metabolic syndrome is high among obese children and adolescents, and it increases with worsening obesity. Biomarkers of an increased risk of adverse cardiovascular outcomes are already present in these youngsters.	Yale Univ, Sch Med, Dept Pediat, POB 802064, New Haven, CT 06520 USA; Yale Univ, Sch Med, Childrens Gen Clin Res Ctr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Yale University; Yale University; Yale University; Cincinnati Children's Hospital Medical Center	Caprio, S (corresponding author), Yale Univ, Sch Med, Dept Pediat, POB 802064, New Haven, CT 06520 USA.	sonia.caprio@yale.edu			NCRR NIH HHS [M01-RR00125, M01-RR06022] Funding Source: Medline; NICHD NIH HHS [R01-HD28016, R01-HD40787, K24-HD01464] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040787, R01HD028016] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022, M01RR000125] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altman DG, 1991, PRACTICAL STAT MED R; [Anonymous], [No title captured]; Arslanian S, 2002, HORM RES, V57, P19, DOI 10.1159/000053308; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Caprio S, 2002, J PEDIATR ENDOCR MET, V15, P487; Cook S, 2003, OBES RES, V11, pA27; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; DAgostino R. B., 1983, FACTOR ANAL APPL APP; Falkner B, 1996, PEDIATRICS, V98, P649; Ford ES, 2003, CIRCULATION, V108, P1053, DOI 10.1161/01.CIR.0000080913.81393.B8; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goran MI, 1999, AM J HUM BIOL, V11, P201, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;201::AID-AJHB8&gt;3.0.CO;2-R; Goran MI, 1998, CORONARY ARTERY DIS, V9, P483, DOI 10.1097/00019501-199809080-00003; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; HOLM S, 1979, SCAND J STAT, V6, P65; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Levitt Naomi S, 2002, Cardiovasc J S Afr, V13, P179; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; *NAT CHOL ED PROGR, 2001, NIH PUBL; *NAT CHOL ED PROGR, 1991, NIH PUBL; NGHS Coordinating Center, 1998, NHLBI GROWTH HLTH ST; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Sinha R, 2002, NEW ENGL J MED, V346, P1756; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Tanner JM, 1962, GROWTH ADOLESCENCE G; Yanovski JA, 1996, AM J CLIN NUTR, V64, P833, DOI 10.1093/ajcn/64.6.833; Zietz B, 2003, FEBS LETT, V545, P103, DOI 10.1016/S0014-5793(03)00568-4	42	2282	2424	7	214	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2004	350	23					2362	2374		10.1056/NEJMoa031049	http://dx.doi.org/10.1056/NEJMoa031049			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825JY	15175438				2022-12-01	WOS:000221754200007
J	Donnan, PT; Wei, L; Steinke, DT; Phillips, G; Clarke, R; Noone, A; Sullivan, FM; MacDonald, TM; Davey, PG				Donnan, PT; Wei, L; Steinke, DT; Phillips, G; Clarke, R; Noone, A; Sullivan, FM; MacDonald, TM; Davey, PG			Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data	BRITISH MEDICAL JOURNAL			English	Article							URINARY-TRACT INFECTION; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; RISK-FACTORS; PERSISTENCE; CONSUMPTION; PROPHYLAXIS	Objective To look for evidence of a relation between antibiotic resistance and prescribing by general practitioners by analysis of prescribing at both practice and individual patient level. Design Repeated cross-sectional study in 1995 and 1996. Setting 28 general practices in the Ninewells Hospital laboratory catchment area, Tayside, Scotland. Subjects reviewed 8833 patients registered with the 28 practices who submitted urine samples for analysis. Main outcome measures Resistance to trimethoprim in bacteria isolated from urine samples at practice and individual level simultaneously in a multilevel model. Results Practices showed considerable variation in both the prevalence of trimethoprim resistance (26-50% of bacteria isolated) and trimethoprim prescribing (67-357 prescriptions per 100 practice patients). Although variation in prescribing showed no association with resistance at the practice level after adjustment for other factors (P = 0.101), in the multilevel model resistance to trimethoprim was significantly associated with age, sex, and individual-level exposure to trimethoprim (P < 0.001) or to other antibiotics (P = 0.002). The association with trimethoprim resistance was strongest for people recently exposed to trimethoprim, and there was no association for people with trimethoprim exposure more than six months before the date of the urine sample. Discussion Analysis of practice level data obscured important associations between antibiotic prescribing and resistance. The results support efforts to reduce unnecessary prescribing of antibiotics in the community and show the added value of individual patient data for research on the outcomes of prescribing.	Univ Dundee, Tayside Ctr Gen Practice Community Hlth Sci, Dundee DD2 4BF, Scotland; Univ Dundee, Med Monitoring Unit MEMO, Dundee DD2 4BF, Scotland; Informat & Stat Div, Primary Care Informat Unit, Edinburgh, Midlothian, Scotland; Ninewells Hosp, Dept Med Microbiol, Dundee DD1 9SY, Scotland; Scottish Ctr Infect & Environm Hlth, Glasgow, Lanark, Scotland	University of Dundee; University of Dundee; University of Dundee	Donnan, PT (corresponding author), Univ Dundee, Tayside Ctr Gen Practice Community Hlth Sci, Dundee DD2 4BF, Scotland.	p.t.donnan@dundee.ac.uk	Sullivan, Frank/L-8286-2019; Sullivan, Frank m/A-7767-2009	Sullivan, Frank/0000-0002-6623-4964; MacDonald, Thomas/0000-0001-5189-6669				Aarestrup FM, 2000, J CLIN MICROBIOL, V38, P2774, DOI 10.1128/JCM.38.7.2774-2777.2000; Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Austin DJ, 1997, P ROY SOC B-BIOL SCI, V264, P1629, DOI 10.1098/rspb.1997.0227; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; *BRIT MED ASS, 1996, 32 BMA RPS; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Chiew YF, 1998, J ANTIMICROB CHEMOTH, V41, P247, DOI 10.1093/jac/41.2.247; COHEN P S, 1985, Recombinant DNA Technical Bulletin, V8, P51; D'Agata EMC, 1999, CRIT CARE MED, V27, P1090, DOI 10.1097/00003246-199906000-00026; Department of Health and Social Care (DHSC), 2000, UK ANT RES STRAT ACT; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Evans J. M. M., 1995, Pharmaceutical Medicine (London), V9, P177; Hall AJ, 2001, LANCET, V358, P1197, DOI 10.1016/S0140-6736(01)06337-1; Harbarth S, 2001, CLIN INFECT DIS, V33, P1462, DOI 10.1086/322677; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; HARTLEY CL, 1975, BRIT MED J, V4, P71, DOI 10.1136/bmj.4.5988.71; Hillier SL, 2002, J ANTIMICROB CHEMOTH, V50, P241, DOI 10.1093/jac/dkf121; Holman CDJ, 2001, AUST NZ J PUBL HEAL, V25, P421, DOI 10.1111/j.1467-842X.2001.tb00285.x; Horsfield P, 2002, INFORM PRIM CARE, V10, P227; LANGLOIS BE, 1983, APPL ENVIRON MICROB, V46, P1433, DOI 10.1128/AEM.46.6.1433-1434.1983; Leibovici L, 2001, J ANTIMICROB CHEMOTH, V48, P535, DOI 10.1093/jac/48.4.535; Magee JT, 1999, BMJ-BRIT MED J, V319, P1239, DOI 10.1136/bmj.319.7219.1239; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; MCCLOONE P, 1991, CARSTAIRS CODES SCOT; MCLOONE P, 1991, CARSTAIRS CODES SCOT; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P816, DOI 10.1016/S0002-9378(99)70307-8; Pauker SG, 1999, BRIT MED J, V318, P1616; Powsner SM, 1998, LANCET, V352, P1617, DOI 10.1016/S0140-6736(98)08309-3; Priest P, 2001, BMJ-BRIT MED J, V323, P1037, DOI 10.1136/bmj.323.7320.1037; ROSDAHL VK, 1998, INV EU C MICR THREAT, P1; Standing Medical Advisory Committee: Sub-group on Antimicrobial Resistance, 1998, PATH LEAST RES; Steinke D, 2002, J ANTIMICROB CHEMOTH, V50, P1085, DOI 10.1093/jac/dkf223; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; Steinke DT, 2001, J ANTIMICROB CHEMOTH, V47, P781, DOI 10.1093/jac/47.6.781; Towers CV, 1998, AM J OBSTET GYNECOL, V179, P879, DOI 10.1016/S0002-9378(98)70182-6; Woods GM, 1997, J PEDIAT HEMATOL ONC, V19, P327, DOI 10.1097/00043426-199707000-00011; Young AF, 2001, AUST NZ J PUBL HEAL, V25, P417, DOI 10.1111/j.1467-842X.2001.tb00284.x	37	65	65	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 29	2004	328	7451					1297	1300		10.1136/bmj.328.7451.1297	http://dx.doi.org/10.1136/bmj.328.7451.1297			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826PN	15166067	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000221841100022
J	de Hoog, CL; Foster, LJ; Mann, M				de Hoog, CL; Foster, LJ; Mann, M			RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers	CELL			English	Article							ACTIN MESSENGER-RNA; QUANTITATIVE PROTEOMICS; KINASE-C; FOCAL ADHESIONS; BETA-SUBUNIT; AMINO-ACIDS; HNRNP-K; DYNAMICS; PHOSPHORYLATION; LOCALIZATION	Focal adhesions are specialized attachment and signaling centers that form at sites of cell-matrix contacts. We employed a quantitative mass spectrometry-based method called SILAC to identify and quantify proteins interacting in an attachment-dependent manner with focal adhesion proteins. Subsequent confocal microscopy revealed a previously undescribed structure, which we have termed a spreading initiation center (SIC), existing only in early stages of cell spreading. SICs contain focal adhesion markers, appear to be surrounded by an actin sheath, and, surprisingly, contain numerous RNA binding proteins, ribosomal RNA, and perhaps other RNAs. Interfering with the function of FUS/TLS, hnRNP K, and hnRNP E1 results in increased spreading. Spreading initiation centers are ribonucleoprotein complexes distinct from focal adhesions and demonstrate a role for RNA and RNA binding proteins in the initiation of cell spreading.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Mann, M (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	mann@bmb.sdu.dk	Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Meli Marc, 2001, International Microbiology, V4, P5; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pickford AS, 2003, CELL MOL LIFE SCI, V60, P871, DOI 10.1007/s00018-003-2245-2; Pruijn GJM, 1997, J AUTOIMMUN, V10, P127, DOI 10.1006/jaut.1996.0123; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Turner CE, 2000, J CELL SCI, V113, P4139; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Zamir E, 2001, J CELL SCI, V114, P3583	36	216	220	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					649	662		10.1016/S0092-8674(04)00456-8	http://dx.doi.org/10.1016/S0092-8674(04)00456-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163412	Bronze			2022-12-01	WOS:000221857900011
J	Youngman, EM; Brunelle, JL; Kochaniak, AB; Green, R				Youngman, EM; Brunelle, JL; Kochaniak, AB; Green, R			The active site of the ribosome is composed of two layers of conserved nucleotides with distinct roles in peptide bond formation and peptide release	CELL			English	Article							TRANSFER-RNA HYDROLYSIS; STOP CODON RECOGNITION; TRANSFERASE CENTER; FACTOR RF2; GGQ MOTIF; STRUCTURAL BASIS; MUTATIONS; COLI; CATALYSIS; PURIFICATION	Peptide bond formation and peptide release are catalyzed in the active site of the large subunit of the ribosome where universally conserved nucleotides surround the CCA ends of the peptidyl- and aminoacyl-tRNA substrates. Here, we describe the use of an affinity-tagging system for the purification of mutant ribosomes and analysis of four universally conserved nucleotides in the innermost layer of the active site: A2451, U2506, U2585, and A2602. While pre-steady-state kinetic analysis of the peptidyl transferase activity of the mutant ribosomes reveals substantially reduced rates of peptide bond formation using the minimal substrate puromycin, their rates of peptide bond formation are unaffected when the substrates are intact aminoacyl-tRNAs. These mutant ribosomes do, however, display substantial defects in peptide release. These results reveal a view of the catalytic center in which an inner shell of conserved nucleotides is pivotal for peptide release, while an outer shell is responsible for promoting peptide bond formation.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Youngman, Elaine/O-7449-2019; Youngman, Elaine/E-7072-2013	Loveland, Anna B./0000-0001-9172-7747				Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; Beringer M, 2003, RNA, V9, P919, DOI 10.1261/rna.5600503; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; COUTURE S, 1990, J MOL BIOL, V215, P345, DOI 10.1016/S0022-2836(05)80356-0; DAMMEL CS, 1993, GENE DEV, V7, P660, DOI 10.1101/gad.7.4.660; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Engelhardt MA, 2000, BIOCHEMISTRY-US, V39, P2639, DOI 10.1021/bi992313g; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Green R, 2002, CELL, V110, P665, DOI 10.1016/S0092-8674(02)00965-0; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Jencks W. P., 1969, CATALYSIS CHEM ENZYM; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; KUTUNIN VI, 2002, MOL CELL, V10, P1; LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035; Leonov AA, 2003, J BIOL CHEM, V278, P25664, DOI 10.1074/jbc.M302873200; LIEBERMAN KR, 1995, PROG NUCLEIC ACID RE, V50, P1, DOI 10.1016/S0079-6603(08)60809-0; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MISKIN R, 1968, BIOCHEM BIOPH RES CO, V33, P551, DOI 10.1016/0006-291X(68)90330-6; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Moore PB, 2003, RNA, V9, P155, DOI 10.1261/rna.2127103; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Muth GW, 2001, RNA, V7, P1403; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; O'Connor M, 2001, NUCLEIC ACIDS RES, V29, P710, DOI 10.1093/nar/29.3.710; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PAWLIK RT, 1981, BIOCHEM INT, V2, P421; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Peracchi A, 1998, BIOCHEMISTRY-US, V37, P14765, DOI 10.1021/bi980867y; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 2003, CURR OPIN STRUC BIOL, V13, P334, DOI 10.1016/S0959-440X(03)00065-4; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SIGMUND CD, 1988, METHOD ENZYMOL, V164, P673; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Spahn CMT, 1999, STRUCT FOLD DES, V7, P1567, DOI 10.1016/S0969-2126(00)88347-1; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; WEBER AL, 1979, J MOL EVOL, V13, P185, DOI 10.1007/BF01739478; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Xiong LQ, 2001, RNA, V7, P1365; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	57	276	281	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					589	599		10.1016/S0092-8674(04)00411-8	http://dx.doi.org/10.1016/S0092-8674(04)00411-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163407	Bronze			2022-12-01	WOS:000221857900006
J	Ohmoto, H; Watanabe, Y; Kumazawa, K				Ohmoto, H; Watanabe, Y; Kumazawa, K			Evidence from massive siderite beds for a CO2-rich atmosphere before, 1.8 billion years ago	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; IRON-FORMATION; STABLE-ISOTOPE; OXYGEN; ORIGIN; RICH; GEOCHEMISTRY; SUPERGROUP; PALEOSOLS; EVOLUTION	It is generally thought that, in order to compensate for lower solar flux and maintain liquid oceans on the early Earth, methane must have been an important greenhouse gas before similar to2.2 billion years (Gyr) ago(1-5). This is based upon a simple thermodynamic calculation that relates the absence of siderite (FeCO3) in some pre-2.2-Gyr palaeosols to atmospheric CO2 concentrations that would have been too low to have provided the necessary greenhouse effect(1). Using multi-dimensional thermodynamic analyses and geological evidence, we show here that the absence of siderite in palaeosols does not constrain atmospheric CO2 concentrations. Siderite is absent in many palaeosols (both pre- and post-2.2-Gyr in age) because the O-2 concentrations and pH conditions in well-aerated soils have favoured the formation of ferric (Fe3+)-rich minerals, such as goethite, rather than siderite. Siderite, however, has formed throughout geological history in subsurface environments, such as euxinic seas, where anaerobic organisms created H-2-rich conditions. The abundance of large, massive siderite-rich beds in pre-1.8-Gyr sedimentary sequences and their carbon isotope ratios indicate that the atmospheric CO2 concentration was more than 100 times greater than today, causing the rain and ocean waters to be more acidic than today. We therefore conclude that CO2 alone ( without a significant contribution from methane) could have provided the necessary greenhouse effect to maintain liquid oceans on the early Earth.	Penn State Univ, Astrobiol Res Ctr, NASA, Astrobiol Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Oyo Corp, Miyazaki Branch, Miyazaki 099561, Japan	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; OYO Corporation	Ohmoto, H (corresponding author), Penn State Univ, Astrobiol Res Ctr, NASA, Astrobiol Inst, University Pk, PA 16802 USA.	ohmoto@geosc.psu.edu		Ohmoto, Hiroshi/0000-0001-7605-0862				BAUR ME, 1985, ECON GEOL, V80, P270, DOI 10.2113/gsecongeo.80.2.270; BECKER RH, 1972, GEOCHIM COSMOCHIM AC, V36, P577, DOI 10.1016/0016-7037(72)90077-4; Beukes NJ, 2002, GEOLOGY, V30, P491, DOI 10.1130/0091-7613(2002)030<0491:TLLOLA>2.0.CO;2; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; CARRIGAN WJ, 1991, PRECAMBRIAN RES, V52, P347, DOI 10.1016/0301-9268(91)90088-R; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; GOODWIN AM, 1985, CAN J EARTH SCI, V22, P72, DOI 10.1139/e85-006; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Kimberley M.M., 1989, ORE GEOL REV, V5, P13, DOI [10.1016/0169-1368(89)90003-6, DOI 10.1016/0169-1368(89)90003-6]; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Langmuir D, 1997, AQUEOUS ENV, P600; Marmo J.S., 1992, EARLY ORGANIC EVOLUT, P41; MOORE SE, 1992, J SEDIMENT PETROL, V62, P357; MOZLEY PS, 1992, GEOLOGY, V20, P817, DOI 10.1130/0091-7613(1992)020<0817:ICOSAA>2.3.CO;2; Ohmoto H, 1999, GEOLOGY, V27, P1151, DOI 10.1130/0091-7613(1999)027<1151:RSOTAA>2.3.CO;2; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Ohmoto H., 1997, GEOCHEM NEWS, V93, P26; OHMOTO H, 1997, GEOCHEM NEWS, V93, P12; Panahi A, 2000, GEOCHIM COSMOCHIM AC, V64, P2199, DOI 10.1016/S0016-7037(99)00420-2; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Pavlov AA, 2001, GEOLOGY, V29, P1003, DOI 10.1130/0091-7613(2001)029<1003:OHIESE>2.0.CO;2; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; *ROCKWARE INC, 2002, GEOCH WORKB VERS 4; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schidlowski M., 1992, EARLY ORGANIC EVOLUT, P147; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P1022, DOI [DOI 10.5860/CHOICE.33-6312, 10.5860/choice.33-6312]; Watanabe Y, 2004, GEOCHIM COSMOCHIM AC, V68, P2129, DOI 10.1016/j.gca.2003.10.036; WINTER BL, 1992, PRECAMBRIAN RES, V59, P283, DOI 10.1016/0301-9268(92)90061-R	31	164	176	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					395	399		10.1038/nature02573	http://dx.doi.org/10.1038/nature02573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164058				2022-12-01	WOS:000221644600034
J	Prockop, DJ				Prockop, DJ			Targeting gene therapy for osteogenesis imperfecta	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA	Tulane University	Prockop, DJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA.							Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016	5	15	17	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2004	350	22					2302	2304		10.1056/NEJMcibr040806	http://dx.doi.org/10.1056/NEJMcibr040806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823VP	15163783				2022-12-01	WOS:000221641900015
J	Britton, A; Shipley, M; Marmot, M; Hemingway, H				Britton, A; Shipley, M; Marmot, M; Hemingway, H			Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; SOCIOECONOMIC-STATUS; REVASCULARIZATION RATES; HEALTH; ASIANS; ANGIOGRAPHY; MANAGEMENT; MORTALITY; ANGINA	Objective To determine whether access to cardiac procedures and drugs contributes to social and ethnic differences in coronary heart disease in a population settmg. Design Prospective study with follow up over 15 years. Civil service employment grade was used as a measure of individual socioeconomic position. Need for cardiac care was determined by the presence of angina, myocardial infarction, and coronary risk factors. Setting 20 civil service departments originally located in London. Participants 10 308 civil servants (3414 women; 560 South Asian) aged 35-55 years at baseline in 1985-8. Main outcome measures Use of exercise electrocardiography, coronary angiography, and coronary revascularisation procedures and secondary prevention drugs. Results Inverse social gradients existed in incident coronary morbidity and mortality. South Asian participants also had higher rates than white participants. After adjustment for clinical need, social position showed no association with the use of cardiac procedures or secondary prevention drugs. For example, men in the low versus high employment grade had an age adjusted odds ratio for angiography of 1.87 (95% confidence interval 1.32 to 2.64), which decreased to 1.27 (0.83 to 1.94) on adjustment for clinical need. South Asians tended to be more likely to have cardiac procedures and to be taking more secondary prevention drugs than white participants, even after adjustment for clinical need. Conclusion This population based study, which shows the widely observed social and ethnic patterning of coronary heart disease, found no evidence that low social position or South Asian ethnicity was associated with lower use of cardiac procedures or drugs, independently of clinical need. Differences in medical care are unlikely to contribute to social or ethnic differences in coronary heart disease in this cohort.	UCL, Sch Med, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London; UCL Medical School	Hemingway, H (corresponding author), UCL, Sch Med, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	h.hemingway@ucl.ac.uk	Marmot, M G/Y-3920-2019; Hemingway, Harry/C-1219-2009	Marmot, M G/0000-0002-2431-6419; Hemingway, Harry/0000-0003-2279-0624	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; AHRQ HHS [HS06516] Funding Source: Medline; Medical Research Council [G8802774, G0100222, G19/35] Funding Source: Medline; NHLBI NIH HHS [HL36310] Funding Source: Medline; NIA NIH HHS [AG13196] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acheson D., 1998, INEQUALITIES HLTH RE; Adams P, 2003, J ECONOMETRICS, V112, P3, DOI 10.1016/S0304-4076(02)00145-8; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Anderson Geoffrey, 1993, JAMA (Journal of the American Medical Association), V269, P1661, DOI 10.1001/jama.269.13.1661; BENSHLOMO Y, 1995, J EPIDEMIOL COMMUN H, V49, P200, DOI 10.1136/jech.49.2.200; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Chaturvedi N, 1997, LANCET, V350, P1578, DOI 10.1016/S0140-6736(97)06243-0; Coory M, 2002, J EPIDEMIOL COMMUN H, V56, P233, DOI 10.1136/jech.56.3.233; DHAWAN J, 1994, POSTGRAD MED J, V70, P625, DOI 10.1136/pgmj.70.827.625; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; FRISCELLA K, 2000, JAMA-J AM MED ASSOC, V283, P2579; GITTELSOHN AM, 1991, AM J PUBLIC HEALTH, V81, P1435, DOI 10.2105/AJPH.81.11.1435; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Goldsmith I, 1999, EUR HEART J, V20, P1094, DOI 10.1053/euhj.1998.1450; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Jones M, 2004, BRIT J GEN PRACT, V54, P423; KEE F, 1993, BRIT MED J, V307, P1305, DOI 10.1136/bmj.307.6915.1305; LEAR JT, 1994, J ROY SOC MED, V87, P661; LEAR JT, 1994, J ROY COLL PHYS LOND, V28, P143; LOWRY PJ, 1984, BRIT HEART J, V52, P610, DOI 10.1136/hrt.52.6.610; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; Manson-Siddle CJ, 1998, J EPIDEMIOL COMMUN H, V52, P507, DOI 10.1136/jech.52.8.507; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Morris RW, 1996, HEART, V75, P557, DOI 10.1136/hrt.75.6.557; MORRIS RW, IN PRESS HEART; MUKHTAR HT, 1995, BRIT HEART J, V73, P122; Nazroo James Y., 2001, Ethnicity and Disease, V11, P401; *NIH, 2000, STRAT RES PLAN RED U; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0; Raine R, 2000, J Health Serv Res Policy, V5, P237; SHANKAT N, 1993, BRIT MED J, V307, P717; Shaw M, 1999, WIDENING GAP HLTH IN; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Wilkinson P, 1996, BMJ-BRIT MED J, V312, P1330, DOI 10.1136/bmj.312.7042.1330	38	70	70	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					318	+		10.1136/bmj.38156.690150.AE	http://dx.doi.org/10.1136/bmj.38156.690150.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15237088	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000223300300015
J	Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M				Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M			Dysfunctional interaction of C/EBP alpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG FIBROBLASTS; RAT HEPATOMA-CELLS; NF-KAPPA-B; EPITHELIAL-CELLS; BETA ISOFORMS; IN-VIVO; PROLIFERATION; EXPRESSION; INHIBITION	BACKGROUND: Increased proliferation of bronchial smooth-muscle cells may lead to increased muscle mass in the airways of patients with asthma. The antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells in subjects without asthma is mediated by a complex of the glucocorticoid receptor and the CCAAT/enhancer binding protein (alpha) (C/EBP(alpha)). We examined the signaling pathway controlling the inhibitory effect of glucocorticoids on cell proliferation and interleukin-6 synthesis in bronchial smooth-muscle cells of subjects with asthma and those without asthma. METHODS: Lines of bronchial smooth-muscle cells were established from cells from 20 subjects with asthma, 8 subjects with emphysema, and 26 control subjects. Cell proliferation was determined by means of cell counts and [(sup 3)H]thymidine incorporation. Signal transduction was studied by means of an electrophoretic DNA mobility-shift assay, a supershift electrophoretic-mobility assay, immunoblotting, use of C/EBP(alpha) antisense oligonucleotides, and use of a human C/EBP(alpha) expression vector. Interleukin-6 release was determined by means of an enzyme-linked immunosorbent assay. RESULTS: Glucocorticoids activated the glucocorticoid receptor and inhibited serum-induced secretion of interleukin-6 in bronchial smooth-muscle cells from both subjects with asthma and those without asthma; however, glucocorticoids inhibited proliferation only in bronchial smooth-muscle cells from subjects without asthma. C/EBP(alpha) protein was detected by immunoblotting in all bronchial smooth-muscle cells from subjects without asthma but not in those with asthma, whereas the protein was expressed in lymphocytes from both groups of subjects. C/EBP(alpha) antisense oligonucleotides or the glucocorticoid-receptor inhibitor mifepristone reversed the antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells from subjects without asthma. When bronchial smooth-muscle cells from subjects with asthma were transiently transfected with an expression vector for human C/EBP(alpha), two forms of the protein were expressed, and subsequent administration of glucocorticoids inhibited cell proliferation. CONCLUSIONS: We hypothesize that a cell-type-specific absence of C/EBP(alpha) is responsible for the enhanced proliferation of bronchial smooth-muscle cells derived from subjects with asthma and that it explains the failure of glucocorticoids to inhibit proliferation in vitro.	Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Basel; University of Basel	Roth, M (corresponding author), Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia.		Ge, Qi/D-3988-2013; Burgess, Janette/M-7117-2019; Burgess, Janette K/A-3597-2010; Roth, Michael/H-8657-2019; Black, Judith L/C-6559-2008	Roth, Michael/0000-0002-8139-2821; Burgess, Janette/0000-0001-9868-9966; Hostettler, Katrin/0000-0001-8118-7441				Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Bellia V, 2003, CHEST, V123, P1066, DOI 10.1378/chest.123.4.1066; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1016, DOI 10.1164/ajrccm/144.5.1016; Cram EJ, 1998, J BIOL CHEM, V273, P2008, DOI 10.1074/jbc.273.4.2008; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; EATON EM, 2002, J CELL PHYSL, V190, P131; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; Gougat C, 2002, J MOL MED-JMM, V80, P309, DOI 10.1007/s00109-001-0302-6; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; JEFFERY PK, 1994, AM J RESP CRIT CARE, V150, pS6, DOI 10.1164/ajrccm/150.5_Pt_2.S6; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; LANE SJ, 1994, AM J RESP CELL MOL, V11, P42, DOI 10.1165/ajrcmb.11.1.8018337; O'Rourke JP, 1999, BIOCHEM BIOPH RES CO, V262, P696, DOI 10.1006/bbrc.1999.1256; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Parkin SE, 2002, J BIOL CHEM, V277, P23563, DOI 10.1074/jbc.M202184200; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ramos RA, 1999, FASEB J, V13, P169, DOI 10.1096/fasebj.13.1.169; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; Stewart AG, 1995, BRIT J PHARMACOL, V116, P3219, DOI 10.1111/j.1476-5381.1995.tb15127.x; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P819, DOI 10.1016/S0091-6749(03)02011-6; TIMICHENKO NA, 1996, GENE DEV, V10, P804; TIMICHENKO NA, 1997, MOL CELL BIOL, V17, P7353; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229, DOI 10.1080/09629359890910; Wilson SJ, 2001, AM J RESP CRIT CARE, V164, P1047, DOI 10.1164/ajrccm.164.6.2010045; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZITNIK RJ, 1994, AM J RESP CELL MOL, V10, P643, DOI 10.1165/ajrcmb.10.6.7516173	41	208	217	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					560	574		10.1056/NEJMoa021660	http://dx.doi.org/10.1056/NEJMoa021660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295049				2022-12-01	WOS:000223069900009
J	Kessler, A; Halitschke, R; Baldwin, IT				Kessler, A; Halitschke, R; Baldwin, IT			Silencing the jasmonate cascade: Induced plant defenses and insect populations	SCIENCE			English	Article							NICOTIANA-ATTENUATA; ARABIDOPSIS; RESPONSES; VOLATILES; BIOSYNTHESIS; EXPRESSION; RESISTANCE; EVOLUTION; GENES; COSTS	We transformed the native tobacco, Nicotiana attenuata, to silence its lipoxygenase, hydroperoxide lyase, and allene oxide synthase genes in order to inhibit oxylipin signaling, known to mediate the plant's direct and indirect defenses. When planted into native habitats, lipoxygenase-deficient plants were more vulnerable to N. attenuata's adapted herbivores but also attracted novel herbivore species, which fed and reproduced successfully. In addition to highlighting the value of genetically silencing plants to study ecological interactions in nature, these results show that lipoxygenase-dependent signaling determines host selection for opportunistic herbivores and that induced defenses influence herbivore community composition.	Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Hans Knoll Str 8, D-07745 Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Kessler, Andre/C-7810-2014; Halitschke, Rayko/AAY-2365-2020	Halitschke, Rayko/0000-0002-1109-8782; Kessler, Andre/0000-0002-1797-7518; Baldwin, Ian/0000-0001-5371-2974				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; HALITSCHKE R, IN PRESS PLANT J; HILDEBRAND DF, 1993, J CHEM ECOL, V19, P1875, DOI 10.1007/BF00983793; Karban R., 2007, INDUCED RESPONSES HE; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Kunert M, 2002, J SEP SCI, V25, P677, DOI 10.1002/1615-9314(20020701)25:10/11&lt;677::AID-; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Preston CA, 1999, ECOLOGY, V80, P481, DOI 10.1890/0012-9658(1999)080[0481:PANSRG]2.0.CO;2; Royo J, 1999, P NATL ACAD SCI USA, V96, P1146, DOI 10.1073/pnas.96.3.1146; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101	27	374	411	3	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					665	668		10.1126/science.1096931	http://dx.doi.org/10.1126/science.1096931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15232071				2022-12-01	WOS:000222992100047
J	Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW				Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW			Structural determinants for generating centromeric chromatin	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; CENP-A; PROTEIN; DNA; ORGANIZATION; NONDISJUNCTION; KINETOCHORES; CHROMOSOMES; ACTIVATION; DOMAIN	Mammalian centromeres are not defined by a consensus DNA sequence. In all eukaryotes a hallmark of functional centromeres - both normal ones and those formed aberrantly at atypical loci - is the accumulation of centromere protein A (CENP-A), a histone variant that replaces H3 in centromeric nucleosomes(1-7). Here we show using deuterium exchange/mass spectrometry coupled with hydrodynamic measures that CENP-A and histone H4 form sub-nucleosomal tetramers that are more compact and conformationally more rigid than the corresponding tetramers of histones H3 and H4. Substitution into histone H3 of the domain of CENP-A responsible for compaction is sufficient to direct it to centromeres. Thus, the centromere-targeting domain of CENP-A confers a unique structural rigidity to the nucleosomes into which it assembles, and is likely to have a role in maintaining centromere identity.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Colorado State University	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Cleveland, Don/0000-0002-1934-3682; Foltz, Daniel/0000-0001-7423-6188				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rudd MK, 2003, MOL CELL BIOL, V23, P7689, DOI 10.1128/MCB.23.21.7689-7697.2003; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002	30	322	340	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					578	582		10.1038/nature02766	http://dx.doi.org/10.1038/nature02766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282608				2022-12-01	WOS:000222946100052
J	Ho, HYH; Rohatgi, R; Lebensohn, AM; Ma, L; Li, JX; Gygi, SP; Kirschner, MW				Ho, HYH; Rohatgi, R; Lebensohn, AM; Ma, L; Li, JX; Gygi, SP; Kirschner, MW			Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex	CELL			English	Article							WISKOTT-ALDRICH-SYNDROME; BINDING PROTEIN CDC42; ARP2/3 COMPLEX; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; POLYMERIZATION; FAMILY; DOMAIN; CYTOSKELETON; VESICLES; RHOA	An important signaling pathway to the actin cytoskeleton links the Rho family GTPase Cdc42 to the actin-nucleating Arp2/3 complex through N-WASP. Nevertheless, these previously identified components are not sufficient to mediate Cdc42-induced actin polymerization in a physiological context. In this paper, we describe the biochemical purification of Toca-1 (transducer of Cdc42-dependent actin assembly) as an essential component of the Cdc42 pathway. Toca-1 binds both N-WASP and Cdc42 and is a member of the evolutionarily conserved PCH protein family. Toca-1 promotes actin nucleation by activating the N-WASP-WIP/CR16 complex, the predominant form of N-WASP in cells. Thus, the cooperative actions of two distinct Cdc42 effectors, the N-WASP-WIP complex and Toca-1, are required for Cdc42-induced actin assembly. These findings represent a significantly revised view of Cdc42-signaling and shed light on the pathogenesis of Wiskoft-Aldrich syndrome.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu	Ma, Le/A-3733-2013	Ma, Le/0000-0003-2769-9416	NHGRI NIH HHS [HG00041] Funding Source: Medline; NIGMS NIH HHS [GM026875-27] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026875, R01GM026875] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen PG, 2003, NAT CELL BIOL, V5, P972, DOI 10.1038/ncb1059; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Gygi SP, 1999, ELECTROPHORESIS, V20, P310, DOI 10.1002/(SICI)1522-2683(19990201)20:2<310::AID-ELPS310>3.0.CO;2-M; Harlow, 1999, USING ANTIBODIES LAB; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Huang M, 1999, CURR BIOL, V9, P979, DOI 10.1016/S0960-9822(99)80428-X; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Ma L, 1998, J CELL BIOL, V140, P1125; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Snapper SB, 2003, NEW ENGL J MED, V348, P350, DOI 10.1056/NEJMcibr001155; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	37	324	334	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					203	216		10.1016/j.cell.2004.06.027	http://dx.doi.org/10.1016/j.cell.2004.06.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260990	Bronze			2022-12-01	WOS:000222966000009
J	Qiao, F; Song, HY; Kim, CA; Sawaya, MR; Hunter, JB; Gingery, M; Rebay, I; Courey, AJ; Bowie, JU				Qiao, F; Song, HY; Kim, CA; Sawaya, MR; Hunter, JB; Gingery, M; Rebay, I; Courey, AJ; Bowie, JU			Derepression by depolymerization: Structural insights into the regulation of Yan by Mae	CELL			English	Article							ETS TRANSCRIPTION FACTORS; RECEPTOR SAM DOMAIN; KINASE PHOSPHORYLATION; NUCLEAR EXPORT; POINTED DOMAIN; DNA-BINDING; DROSOPHILA; PROTEIN; PATHWAY; FAMILY	Yan, an ETS family transcriptional repressor, is regulated by receptor tyrosine kinase signaling via the Ras/ MAPK pathway. Phosphorylation and downregulation of Yan is facilitated by a protein called Mae. Yan and Mae interact through their SAM domains. We find that repression by Yan requires the formation of a higher order structure mediated by Yan-SAM polymerization. Moreover, a crystal structure of the Yan-SAM/Mae-SAM complex shows that Mae-SAM specifically recognizes a surface on Yan-SAM that is also required for Yan-SAM polymerization. Mae-SAM binds to Yan-SAM with similar to1000-fold higher affinity than Yan-SAM binds to itself and can effectively depolymerize Yan-SAM. Mutations on Mae that specifically disrupt its SAM domain-dependent interactions with Yan disable the derepression function of Mae in vivo. Depolymerization of Yan by Mae represents a novel mechanism of transcriptional control that sensitizes Yan for regulation by receptor tyrosine kinases.	Univ Calif Los Angeles, DOE, Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; MIT, Dept Biol, Whitehead Inst, Cambridge, MA 02142 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Whitehead Institute	Bowie, JU (corresponding author), Univ Calif Los Angeles, DOE, Inst Genom & Proteom, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu		Hunter, Jacob/0000-0003-3479-1309; Sawaya, Michael/0000-0003-0874-9043	NATIONAL CANCER INSTITUTE [R01CA081000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044522] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA081000] Funding Source: Medline; NIGMS NIH HHS [R01 GM44522] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Baker DA, 2001, NATURE, V411, P330, DOI 10.1038/35077122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DITTMER J, 1998, BIOCHIM BIOPHYS ACTA, V1377, P1; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Gabay L, 1996, DEVELOPMENT, V122, P3355; Graves BJ, 1996, NATURE, V384, P322, DOI 10.1038/384322a0; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KLAMBT C, 1993, DEVELOPMENT, V117, P163; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Rogge R, 1995, DEVELOPMENT, V121, P3947; Roseman RR, 2001, GENETICS, V158, P291; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; Schultz J, 1997, PROTEIN SCI, V6, P249; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tootle TL, 2003, DEVELOPMENT, V130, P845, DOI 10.1242/dev.00312; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yamada T, 2003, DEVELOPMENT, V130, P4085, DOI 10.1242/dev.00624; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhao C, 2002, DEVELOPMENT, V129, P1669; Zhou HX, 2001, J AM CHEM SOC, V123, P6730, DOI 10.1021/ja015990i	39	83	83	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					163	173		10.1016/j.cell.2004.07.010	http://dx.doi.org/10.1016/j.cell.2004.07.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260987	Bronze			2022-12-01	WOS:000222966000006
J	Veronin, MA; Youan, BBC				Veronin, MA; Youan, BBC			Medicine - Magic bullet gone astray: Medications and the Internet	SCIENCE			English	Editorial Material									Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Veronin, MA (corresponding author), Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA.	michael.veronin@ttuhsc.edu						ABDOU H. M., 2000, REMINGTON SCI PRACTI, P654; Gee Michael, 2002, J Manag Care Pharm, V8, P453; Gibson Liza, 2004, BMJ, V328, P486, DOI 10.1136/bmj.328.7438.486-c; Mudur Ganapati, 2003, BMJ, V327, P414, DOI 10.1136/bmj.327.7412.414-b; WALKER J, 2002, E PHARM GUIDE INTERN, P192; Young D, 2003, AM J HEALTH-SYST PH, V60, P729, DOI 10.1093/ajhp/60.8.729	6	36	36	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					481	481		10.1126/science.1097355	http://dx.doi.org/10.1126/science.1097355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273381				2022-12-01	WOS:000222828900025
J	Clausen, J; Junge, W				Clausen, J; Junge, W			Detection of an intermediate of photosynthetic water oxidation	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; ELECTRON-TRANSFER; PROTON-TRANSFER; REDOX TRANSITIONS; CRYSTAL-STRUCTURE; SPLITTING ENZYME; MECHANISM; EVOLUTION; KINETICS	The oxygen that we breathe is produced by photosystem II of cyanobacteria and plants. The catalytic centre, a Mn4Ca cluster, accumulates four oxidizing equivalents before oxygen is formed, seemingly in a single reaction step1-8 2H(2)O(<--)(-->) O-2 = 4H(+) + 4e(-). The energy and cycling of this reaction derives solely from light. No intermediate oxidation product of water has been detected so far. Here, we shifted the equilibrium of the terminal reaction backward by increasing the oxygen pressure and monitoring ( by absorption transients in the near-ultraviolet spectrum) the electron transfer from bound water into the catalytic centre. A tenfold increase of ambient oxygen pressure (2.3 bar) half-suppressed the full progression to oxygen. The remaining electron transfer at saturating pressure ( 30 bar) was compatible with the formation of a stabilized intermediate. The abstraction of four electrons from water was probably split into at least two electron transfers: mildly endergonic from the centre's highest oxidation state to an intermediate, and exergonic from the intermediate to oxygen. There is little leeway for photosynthetic organisms to push the atmospheric oxygen concentration much above the present level.	Univ Osnabruck, Dept Biol Chem, Div Biophys, D-49069 Osnabruck, Germany	University Osnabruck	Junge, W (corresponding author), Univ Osnabruck, Dept Biol Chem, Div Biophys, D-49069 Osnabruck, Germany.	junge@uos.de						BABCOCK GT, 1976, FEBS LETT, V61, P286; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; BECK WF, 1985, BIOCHEMISTRY-US, V24, P3035, DOI 10.1021/bi00333a035; Clausen J, 2004, BBA-BIOENERGETICS, V1655, P184, DOI 10.1016/j.bbabio.2003.06.001; Clausen J, 2001, BBA-BIOENERGETICS, V1506, P224, DOI 10.1016/S0005-2728(01)00217-1; Dekker J. P., 1992, MANGANESE REDOX ENZY, P85; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P176, DOI 10.1016/0005-2728(84)90093-8; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Haumann M, 1997, PHOTOSYNTH RES, V51, P193, DOI 10.1023/A:1005861917596; Haumann M, 1996, BBA-BIOENERGETICS, V1273, P237, DOI 10.1016/0005-2728(95)00152-2; Hendry G, 2003, BIOCHEMISTRY-US, V42, P6209, DOI 10.1021/bi034279i; Hillier W, 1998, BIOCHEMISTRY-US, V37, P16908, DOI 10.1021/bi980756z; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; JAHNS P, 1991, BIOCHIM BIOPHYS ACTA, V1057, P313, DOI 10.1016/S0005-2728(05)80142-2; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Karge M, 1997, BIOCHEMISTRY-US, V36, P8904, DOI 10.1021/bi962342g; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; RENGER G, 1986, BIOCHIM BIOPHYS ACTA, V850, P184, DOI 10.1016/0005-2728(86)90173-8; Renger G., 1978, Metzner, H. : Photosynthetic oxygen evolution., P229; Renger G, 2001, BBA-BIOENERGETICS, V1503, P210, DOI 10.1016/S0005-2728(00)00227-9; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; SAYGIN O, 1987, BIOCHIM BIOPHYS ACTA, V893, P452, DOI 10.1016/0005-2728(87)90097-1; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	105	106	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					480	483		10.1038/nature02676	http://dx.doi.org/10.1038/nature02676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269775				2022-12-01	WOS:000222801400050
J	Lee, I; Yoganarasimha, D; Rao, G; Knierim, JJ				Lee, I; Yoganarasimha, D; Rao, G; Knierim, JJ			Comparison of population coherence of place cells in hippocampal subfields CA1 and CA3	NATURE			English	Article							SINGLE UNIT-ACTIVITY; PYRAMIDAL CELLS; NMDA RECEPTORS; MEMORY; RECALL; RAT; MODULATION; CIRCUITRY; STORAGE; SYSTEM	The hippocampus, a critical brain structure for navigation, context-dependent learning and episodic memory(1-3), is composed of anatomically heterogeneous subregions. These regions differ in their anatomical inputs as well as in their internal circuitry(4). A major feature of the CA3 region is its recurrent collateral circuitry, by which the CA3 pyramidal cells make excitatory synaptic contacts on each other(4,5). In contrast, pyramidal cells in the CA1 region are not extensively interconnected(4). Although these differences have inspired numerous theoretical models of differential processing capacities of these two regions(6-13), there have been few reports of robust differences in the firing properties of CA1 and CA3 neurons in behaving animals. The most extensively studied of these properties is the spatially selective firing of hippocampal 'place cells'(1,14). Here we report that in a dynamically changing environment, in which familiar landmarks on the behavioural track and along the wall are rotated relative to each other(15,16), the population representation of the environment is more coherent between the original and cue-altered environments in CA3 than in CA1. These results demonstrate a functional heterogeneity between the place cells of CA3 and CA1 at the level of neural population representations.	Univ Texas, Sch Med, Dept Neurobiol & Anat, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77225 USA	University of Texas System	Knierim, JJ (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	James.J.Knierim@uth.tmc.edu		Doreswamy, Yoganarasimha/0000-0001-7122-6953; Knierim, James/0000-0002-1796-2930				Amaral David G., 1995, P443; Anderson MI, 2003, J NEUROSCI, V23, P8827; [Anonymous], 1998, NEURAL NETWORKS BRAI; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Cressant A, 2002, EXP BRAIN RES, V143, P470, DOI 10.1007/s00221-002-1013-0; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kali S, 2000, J NEUROSCI, V20, P7463; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; LEUTGEB S, 2003, 915 SOC NEUR; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McNaughton B. L., 1990, NEUROSCIENCE CONNECT, P1; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VAZDARJANOVA A, IN PRESS J NEUROSCI; Zar JH., 1999, BIOSTAT ANAL	31	308	311	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					456	459		10.1038/nature02739	http://dx.doi.org/10.1038/nature02739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15229614				2022-12-01	WOS:000222801400044
J	Alexander, EK; Marqusee, E; Lawrence, J; Jarolim, P; Fischer, GA; Larsen, PR				Alexander, EK; Marqusee, E; Lawrence, J; Jarolim, P; Fischer, GA; Larsen, PR			Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	75th Annual Meeting of the American-Thyroid-Association	SEP, 2003	Palm Beach, FL	Amer Thyroid Assoc			THYROXINE-BINDING GLOBULIN; MATERNAL THYROID-DEFICIENCY; IODOTHYRONINE DEIODINASE; INCREASED NEED; DISORDERS; THERAPY; DISEASE; SERUM	BACKGROUND: Hypothyroidism during pregnancy has been associated with impaired cognitive development and increased fetal mortality. During pregnancy, maternal thyroid hormone requirements increase. Although it is known that women with hypothyroidism should increase their levothyroxine dose during pregnancy, biochemical hypothyroidism occurs in many. In this prospective study we attempted to identify precisely the timing and amount of levothyroxine adjustment required during pregnancy. METHODS: Women with hypothyroidism who were planning pregnancy were observed prospectively before and throughout their pregnancies. Thyroid function, human chorionic gonadotropin, and estradiol were measured before conception, approximately every two weeks during the first trimester, and monthly thereafter. The dose of levothyroxine was increased to maintain the thyrotropin concentration at preconception values throughout pregnancy. RESULTS: Twenty pregnancies occurred in 19 women and resulted in 17 full-term births. An increase in the levothyroxine dose was necessary during 17 pregnancies. The mean levothyroxine requirement increased 47 percent during the first half of pregnancy (median onset of increase, eight weeks of gestation) and plateaued by week 16. This increased dose was required until delivery. CONCLUSIONS: Levothyroxine requirements increase as early as the fifth week of gestation. Given the importance of maternal euthyroidism for normal fetal cognitive development, we propose that women with hypothyroidism increase their levothyroxine dose by approximately 30 percent as soon as pregnancy is confirmed. Thereafter, serum thyrotropin levels should be monitored and the levothyroxine dose adjusted accordingly.	Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Clin Labs, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Valdosta Specialty Clin, Valdosta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alexander, EK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Thyroid Sect, 221 Longwood Ave,2nd Fl, Boston, MA 02115 USA.	ekalexander@partners.org			NHLBI NIH HHS [HL-07609] Funding Source: Medline; NIDDK NIH HHS [DK-07529, DK-44128] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529, R01DK044128] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; AIN KB, 1987, J CLIN ENDOCR METAB, V65, P689, DOI 10.1210/jcem-65-4-689; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; [Anonymous], 2000, NATL VITAL STAT REPO; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Caixas A, 1999, J CLIN ENDOCR METAB, V84, P4000, DOI 10.1210/jc.84.11.4000; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Chopra IJ, 2003, METABOLISM, V52, P122, DOI 10.1053/meta.2003.50019; DELANGE F, 1994, THYROID, V4, P107, DOI 10.1089/thy.1994.4.107; GIRLING JC, 1992, BRIT J OBSTET GYNAEC, V99, P368, DOI 10.1111/j.1471-0528.1992.tb13750.x; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; GLINOER D, 1977, ENDOCRINOLOGY, V100, P807, DOI 10.1210/endo-100-3-807; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HARADA A, 1979, J CLIN ENDOCR METAB, V48, P793, DOI 10.1210/jcem-48-5-793; Huang SA, 2003, J CLIN ENDOCR METAB, V88, P1384, DOI 10.1210/jc.2002-021291; KAPLAN MM, 1992, THYROID, V2, P147, DOI 10.1089/thy.1992.2.147; Klein RZ, 2001, J MED SCREEN, V8, P18, DOI 10.1136/jms.8.1.18; LARSEN PR, 1987, J CLIN ENDOCR METAB, V64, P1089; MANDEL SJ, 1990, NEW ENGL J MED, V323, P91, DOI 10.1056/NEJM199007123230204; MCDOUGALL IR, 1995, J FAM PRACTICE, V41, P238; McDuffie RS, 1996, JAMA-J AM MED ASSOC, V275, P847, DOI 10.1001/jama.275.11.847; Muller AF, 2000, J CLIN ENDOCR METAB, V85, P545, DOI 10.1210/jc.85.2.545; PECK T M, 1979, Clinical Obstetrics and Gynecology, V22, P785, DOI 10.1097/00003081-197912000-00002; PEKONEN F, 1984, OBSTET GYNECOL, V63, P635; ROTI E, 1981, J CLIN ENDOCR METAB, V53, P498, DOI 10.1210/jcem-53-3-498; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VENTURA SJ, 2001, NATL VITAL STAT REPO, V49; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; Wasco EC, 2003, ENDOCRINOLOGY, V144, P4253, DOI 10.1210/en.2003-0490; Zigman JM, 2003, THYROID, V13, P1169, DOI 10.1089/10507250360731587	32	329	360	0	14	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					241	249		10.1056/NEJMoa040079	http://dx.doi.org/10.1056/NEJMoa040079			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254282	Bronze			2022-12-01	WOS:000222627200008
J	Zhang, SM; Adema, CM; Kepler, TB; Loker, ES				Zhang, SM; Adema, CM; Kepler, TB; Loker, ES			Diversification of Ig superfamily genes in an invertebrate	SCIENCE			English	Article							SNAIL BIOMPHALARIA-GLABRATA; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; FAMILY; CONVERSION; FREQUENCY; EVOLUTION; MEMBERS; DOMAINS; PCR	The freshwater snail Biomphalaria glabrata possesses a diverse family of fibrinogen-related proteins (FREPs), hemolymph polypeptides that consist of one or two amino-terminal immunoglobulin superfamily (IgSF) domains and a carboxylterminal fibrinogen domain. Here, we show that the IgSF1 domain of the FREP3 subfamily is diversified at the genomic level at higher rates than those recorded for control genes. All sequence variants are derived from a small set of nine source sequences by point mutation and recombinatorial processes. Diverse FREP3 transcripts are also produced. We hypothesize a mechanism present in snails that is capable of diversifying molecules involved in internal defense.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Duke Univ, Inst Genome Sci & Policy, Ctr Bioinformat & Computat Biol, Dept Biostat & Bioinformat, Durham, NC 27710 USA	University of New Mexico; Duke University	Loker, ES (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	esloker@unm.edu		Kepler, Thomas/0000-0002-1383-6865	NCRR NIH HHS [RR-1P20RR18754] Funding Source: Medline; NIAID NIH HHS [R01AI24340, R01AI52363] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052363, R01AI024340] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; ADEMA CM, 1997, PARASITE EFFECTS HOS, P77; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Agrawal AF, 2001, EVOLUTION, V55, P869, DOI 10.1554/0014-3820(2001)055[0869:PATEOS]2.0.CO;2; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Dewilde S, 1998, J BIOL CHEM, V273, P13583, DOI 10.1074/jbc.273.22.13583; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KAWANO T, 1992, MALACOLOGIA, V34, P25; Klein J, 1997, SCAND J IMMUNOL, V46, P558, DOI 10.1046/j.1365-3083.1997.d01-164.x; Laursen JR, 1997, J INVERTEBR PATHOL, V70, P226, DOI 10.1006/jipa.1997.4686; Leonard PM, 2001, GENE, V269, P155, DOI 10.1016/S0378-1119(01)00444-9; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Zhang S., UNPUB; Zhang SM, 2003, DEV COMP IMMUNOL, V27, P175, DOI 10.1016/S0145-305X(02)00091-5; Zhang SM, 2001, IMMUNOGENETICS, V53, P684, DOI 10.1007/s00251-001-0386-8	21	312	329	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					251	254		10.1126/science.1088069	http://dx.doi.org/10.1126/science.1088069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247481				2022-12-01	WOS:000222501000055
J	Yamamoto, M; Yamazaki, S; Uematsu, S; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Kuwata, H; Takeuchi, O; Takeshige, K; Saitoh, T; Yamaoka, S; Yamamoto, N; Yamamoto, S; Muta, T; Takeda, K; Akira, S				Yamamoto, M; Yamazaki, S; Uematsu, S; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Kuwata, H; Takeuchi, O; Takeshige, K; Saitoh, T; Yamaoka, S; Yamamoto, N; Yamamoto, S; Muta, T; Takeda, K; Akira, S			Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein I kappa B zeta	NATURE			English	Article							TOLL-LIKE RECEPTORS; ACTIVATION; MACROPHAGES; ADAPTER; FAMILY; MYD88; LIPOPOLYSACCHARIDE; INTERLEUKIN-6; TRANSCRIPTION; RECOGNITION	Toll-like receptors (TLRs) recognize microbial components and trigger the inflammatory and immune responses against pathogens. IkappaBzeta (also known as MAIL and INAP) is an ankyrin-repeat-containing nuclear protein that is highly homologous to the IkappaB family member Bcl-3 (refs 1-6). Transcription of IkappaBzeta is rapidly induced by stimulation with TLR ligands and interleukin-1 (IL-1). Here we show that IkappaBzeta is indispensable for the expression of a subset of genes activated in TLR/IL-1R signalling pathways. IkappaBzeta-deficient cells show severe impairment of IL-6 production in response to a variety of TLR ligands as well as IL-1, but not in response to tumour-necrosis factor-alpha. Endogenous IkappaBzeta specifically associates with the p50 subunit of NF-kappaB, and is recruited to the NF-kappaB binding site of the IL-6 promoter on stimulation. Moreover, NF-kappaB1/p50-deficient mice show responses to TLR/IL-1R ligands similar to those of IkappaBzeta-deficient mice. Endotoxin-induced expression of other genes such as Il12b and Csf2 is also abrogated in IkappaBzeta-deficient macrophages. Given that the lipopolysaccharide-induced transcription of IkappaBzeta occurs earlier than transcription of these genes, some TLR/IL-1R-mediated responses may be regulated in a gene expression process of at least two steps that requires inducible IkappaBzeta.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; Japan Sci & Technol Agcy, ERATO, Osaka 5650871, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biochem, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, PRESTO, Japan Sci & Technol Agcy, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Embryon & Genet Engn, Higashi Ku, Fukuoka 8128582, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan; Beppu Univ, Dept Food & Nutr, Oita 8740851, Japan	Osaka University; Japan Science & Technology Agency (JST); Kyushu University; Japan Science & Technology Agency (JST); Kyushu University; Kyushu University; RIKEN; Tokyo Medical & Dental University (TMDU)	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Hoshino, Katsuaki/AAE-2830-2022; Takeuchi, Osamu/AAG-9359-2019; Hoshino, Katsuaki/L-9162-2014; Takeda, Kiyoshi/C-9331-2009; Takeuchi, Osamu/D-6007-2011; Kuwata, Hiro/N-2023-2019; Saito, Takashi/C-9684-2009; Kaisho, Tsuneyasu/B-4130-2012; Akira, Shizuo/C-3134-2009	Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Hoshino, Katsuaki/0000-0003-0493-4815; Kuwata, Hiro/0000-0002-5023-1777; Saito, Takashi/0000-0001-9495-3547; Yamazaki, Soh/0000-0001-5038-1567; Sato, Shintaro/0000-0001-5156-3354				AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Douni E, 1996, J INFLAMM, V47, P27; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; HILL MR, 1992, INFECT IMMUN, V60, P4040, DOI 10.1128/IAI.60.10.4040-4050.1992; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jansen M, 2002, CANCER BIOL THER, V1, P293, DOI 10.4161/cbt.84; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	30	382	396	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					218	222		10.1038/nature02738	http://dx.doi.org/10.1038/nature02738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241416				2022-12-01	WOS:000222470600046
J	Loke, YK				Loke, YK			Assessing the benefit-harm balance at the bedside - We need pragmatic ways of using the best available information	BRITISH MEDICAL JOURNAL			English	Editorial Material							SAFETY		Hlth Policy & Practice Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Loke, YK (corresponding author), Hlth Policy & Practice Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England.	y.loke@uea.ac.uk						Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Berry DC, 2002, LANCET, V359, P853, DOI 10.1016/S0140-6736(02)07923-0; Bottiger LE, 2001, J INTERN MED, V250, P269, DOI 10.1046/j.1365-2796.2001.00884.x; Bracchi R, 1996, BRIT MED J, V312, P442; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; HILL K, 2002, DAILY TELEGRAPH 0619; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Loke YK, 2003, BRIT J CLIN PHARMACO, V55, P282, DOI 10.1046/j.1365-2125.2003.01774.x; Vandenbroucke JP, 2004, BRIT MED J, V329, P2, DOI 10.1136/bmj.329.7456.2	11	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 3	2004	329	7456					7	8		10.1136/bmj.329.7456.7	http://dx.doi.org/10.1136/bmj.329.7456.7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	836PP	15231591	Green Published			2022-12-01	WOS:000222568300006
J	Hipkin, CR; Simpson, DJ; Wainwright, SJ; Salem, MA				Hipkin, CR; Simpson, DJ; Wainwright, SJ; Salem, MA			Nitrification by plants that also fix nitrogen	NATURE			English	Article							AMERICAN ASTRAGALUS FABACEAE; 3-NITROPROPIONIC ACID; HIPPOCREPIS-COMOSA; MINERALIZATION; ECOSYSTEMS; LEGUMES; TOXINS; ENZYME	Nitrification is a key stage in the nitrogen cycle; it enables the transformation of nitrogen into an oxidized, inorganic state(1,2). The availability of nitrates produced by this process often limits primary productivity and is an important determinant in plant community ecology and biodiversity(3-6). Chemoautotrophic prokaryotes are recognized as the main facilitators of this process(7), although heterotrophic nitrification by fungi may be significant under certain conditions(8). However, there has been neither biochemical nor ecological evidence to support nitrification by photoautotrophic plants. Here we show how certain legumes that accumulate the toxin, 3-nitropropionic acid, generate oxidized inorganic nitrogen in their shoots, which is returned to the soil in their litter. In nitrogen-fixing populations this 'new' nitrate and nitrite can be derived from the assimilation of nitrogen gas. Normally, the transformation of elemental nitrogen from the atmosphere into a fixed oxidized form ( as nitrate) is represented in the nitrogen cycle as a multiphasic process involving several different organisms. We show how this can occur in a single photoautotrophic organism, representing a previously undescribed feature of this biogeochemical cycle.	Univ Wales Swansea, Inst Environm Sustainabil, Sch Biol Sci, Swansea SA2 8PP, W Glam, Wales	Swansea University	Hipkin, CR (corresponding author), Univ Wales Swansea, Inst Environm Sustainabil, Sch Biol Sci, Swansea SA2 8PP, W Glam, Wales.	c.r.hipkin@swansea.ac.uk	salem, mansour awiedat/AAU-1251-2021	salem, mansour awiedat/0000-0002-2990-9045				ALSTON TA, 1983, ACCOUNTS CHEM RES, V16, P418, DOI 10.1021/ar00095a005; [Anonymous], 1977, ADV MICROB ECOL, DOI [10.1007/978-1-4615-8219-9_4, DOI 10.1007/978-1-4615-8219-9_4]; Arnon DI, 1940, SOIL SCI, V50, P463; BAXTER RL, 1992, J CHEM SOC PERK T 1, P2495, DOI 10.1039/p19920002495; BERENDSE F, 1990, J ECOL, V78, P413, DOI 10.2307/2261121; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Dijkstra P, 2003, ISOT ENVIRON HEALT S, V39, P29, DOI 10.1080/1025601031000102189; EVEREST SA, 1984, J EXP MAR BIOL ECOL, V76, P263, DOI 10.1016/0022-0981(84)90192-8; GUSTINE DL, 1979, CROP SCI, V19, P197, DOI 10.2135/cropsci1979.0011183X001900020007x; Hipkin CR, 1999, BIOCHEM J, V340, P491, DOI 10.1042/0264-6021:3400491; Killham K., 1986, Special Publications of the Society for General Microbiology, V20, P117; Macdonald R.M., 1986, NITRIFICATION SOC GE, P1; MATSUMOTO H, 1961, ANAL CHEM, V33, P1442, DOI 10.1021/ac60178a054; MORECROFT MD, 1992, J ECOL, V80, P49, DOI 10.2307/2261062; Parsons TR, 1984, MANUAL CHEM BIOL MET; PASTOR J, 1987, OECOLOGIA, V71, P481, DOI 10.1007/BF00379285; REHDER H, 1978, OECOLOGIA, V34, P309, DOI 10.1007/BF00344909; SALEM MA, 1995, PHYTOCHEMISTRY, V40, P89, DOI 10.1016/0031-9422(95)00346-9; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; Simpson DJ, 1999, VET REC, V145, P169, DOI 10.1136/vr.145.6.169; Sprent J.I., 1987, ECOLOGY NITROGEN CYC; Verhoeven JTA, 1996, TRENDS ECOL EVOL, V11, P494, DOI 10.1016/S0169-5347(96)10055-0; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; WILLIAMS MC, 1981, AGRON J, V73, P434, DOI 10.2134/agronj1981.00021962007300030012x; WILLIAMS MC, 1977, BRITTONIA, V29, P327, DOI 10.2307/2806204; WILLIAMS MC, 1983, AGRON J, V75, P520, DOI 10.2134/agronj1983.00021962007500030024x; WILLIAMS MC, 1977, BRITTONIA, V29, P310, DOI 10.2307/2806203	27	30	34	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2004	430	6995					98	101		10.1038/nature02635	http://dx.doi.org/10.1038/nature02635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229604				2022-12-01	WOS:000222356800051
J	McDonald, SP; Craig, JC				McDonald, SP; Craig, JC		Australian New Zealand Paediat Nep	Long-term survival of children with end-stage renal disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; DIALYSIS; MORTALITY; INFANTS; TRANSPLANTATION; RECIPIENTS; FAILURE; COHORT	Background Although renal-replacement therapy for children with end-stage renal disease has been used for several decades, data on patients' long-term survival are sparse. Methods We examined the long-term survival of all children and adolescents who were under 20 years of age when renal-replacement therapy commenced (study period, April 1963 through March 2002), using data from the Australia and New Zealand Dialysis and Transplant Registry. Survival was analyzed with the use of Kaplan-Meier methods and age-standardized mortality rates. Risk factors for death were analyzed with the use of Cox regression analysis with time-dependent covariates. Results A total of 1634 children and adolescents were followed for a median of 9.7 years. The long-term survival rate among children requiring renal-replacement therapy was 79 percent at 10 years and 66 percent at 20 years. Mortality rates were 30 times as high as for children without end-stage renal disease. Risk factors for death were a young age at the time renal-replacement therapy was initiated (especially for children under 1 year of age, among whom the risk was four times as high as for children 15 to 19 years of age) and treatment with dialysis (which was associated with a risk more than four times as high as for renal transplantation). Overall, a trend toward improved survival was observed over the four decades of the study. Conclusions Despite improvement in long-term survival, mortality rates among children requiring renal-replacement therapy remain substantially higher than those among children without end-stage renal disease. Increasing the proportion of children treated with renal transplantation rather than with dialysis can improve survival further.	Queen Elizabeth Hosp, ANZDATA Registry, Adelaide, SA, Australia; Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia; Childrens Hosp Westmead, Natl Hlth & Med Res Council Ctr Clin Res Excellen, Sydney, NSW, Australia; Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	McDonald, SP (corresponding author), Queen Elizabeth Hosp, ANZDATA Registry, 28 Woodville Rd, Woodville S, SA 5011, Australia.	stephenm@anzdata.org.au	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035				[Anonymous], 2003, USRDS 2003 ANN DAT R; *AUSTR BUR STAT, 2001, 33020 ABS; Bakkaloglu SA, 2000, PERITON DIALYSIS INT, V20, P568; Coulthard MG, 2002, ARCH DIS CHILD, V87, P511, DOI 10.1136/adc.87.6.511; EHRICH JHH, 1992, NEPHROL DIAL TRANSPL, V7, P1171, DOI 10.1093/ndt/7.12.1171; Geary DF, 1998, J PEDIATR-US, V133, P154, DOI 10.1016/S0022-3476(98)70199-4; Groothoff JW, 2002, KIDNEY INT, V61, P621, DOI 10.1046/j.1523-1755.2002.00156.x; HELD PJ, 1992, CLIN TRANSPLANTS 199, P71; HENNING P, 1988, ARCH DIS CHILD, V63, P35, DOI 10.1136/adc.63.1.35; Ledermann SE, 2000, J PEDIATR-US, V136, P24, DOI 10.1016/S0022-3476(00)90044-1; Leonard MB, 2003, KIDNEY INT, V63, P744, DOI 10.1046/j.1523-1755.2003.00788.x; Li SQ, 2003, AUST NZ J PUBL HEAL, V27, P419, DOI 10.1111/j.1467-842X.2003.tb00420.x; McDonald SP, 2002, NEPHROL DIAL TRANSPL, V17, P2212, DOI 10.1093/ndt/17.12.2212; Mitsnefes MM, 2000, PEDIATR NEPHROL, V14, P898, DOI 10.1007/s004670000303; *NAPRTCS, 2003, 2003 ANN REP REN TRA; Parekh RS, 2002, J PEDIATR-US, V141, P191, DOI 10.1067/mpd.2002.125910; RUSS GR, 2002, AUSTR NZ DIALYSIS TR; Silverstein DM, 2000, PEDIATR NEPHROL, V14, P105, DOI 10.1007/s004670050022; Vats AN, 2000, TRANSPLANTATION, V69, P1414, DOI 10.1097/00007890-200004150-00035; WLAKER RG, 1999, 22 REPORT AUSTR NZ D, P90; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wood EG, 2001, AM J KIDNEY DIS, V37, P573, DOI 10.1053/ajkd.2001.22083	22	535	556	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2004	350	26					2654	2662		10.1056/NEJMoa031643	http://dx.doi.org/10.1056/NEJMoa031643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831MR	15215481				2022-12-01	WOS:000222199000006
J	Feinstein, P; Bozza, T; Rodriguez, I; Vassalli, A; Mombaerts, P				Feinstein, P; Bozza, T; Rodriguez, I; Vassalli, A; Mombaerts, P			Axon guidance of mouse olfactory sensory neurons by odorant receptors and the beta 2 adrenergic receptor	CELL			English	Article							EXPRESSION; GENES; VOMERONASAL; PROJECTIONS; SYSTEM; FAMILY; BULB; TRAFFICKING; MICE; MAP	Odorant receptors (ORs) provide the core determinant of identity for axons of olfactory sensory neurons (OSNs) to coalesce into glomeruli in the olfactory bulb. Here, using gene targeting in mice, we examine how the OR protein determines axonal identity. An OR::GFP fusion protein is present in axons, consistent with a direct function of ORs in axon guidance. When the OR coding region is deleted, we observe OSNs that coexpress other ORs that function in odorant reception and axonal identity. It remains unclear if such coexpression is normally prevented by negative feedback on OR gene choice. A drastic reduction in OR protein level produces axonal coalescence into novel, remote glomeruli. By contrast, chimeric ORs and ORs with minor mutations perturb axon outgrowth. Strikingly, the beta2 adrenergic receptor can substitute for an OR in glomerular formation when expressed from an OR locus. Thus, ORs have not evolved a unique function in axon guidance.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Feinstein, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	feinstp@rockefeller.edu; peter@rockefeller.edu	Vassalli, Anne/M-7866-2016	Vassalli, Anne/0000-0002-5314-5620; rodriguez, ivan/0000-0002-6468-0565				Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cho JY, 1996, J COMP NEUROL, V369, P264; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Ivic L, 2002, J NEUROBIOL, V50, P56, DOI 10.1002/neu.10016; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; RANDS E, 1990, J BIOL CHEM, V265, P10759; Reed RR, 2003, CURR OPIN NEUROBIOL, V13, P482, DOI 10.1016/S0959-4388(03)00104-1; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	35	229	231	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					833	846		10.1016/j.cell.2004.05.013	http://dx.doi.org/10.1016/j.cell.2004.05.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186782	Bronze			2022-12-01	WOS:000222048400014
J	Lal, R				Lal, R			Soil carbon sequestration impacts on global climate change and food security	SCIENCE			English	Article							ORGANIC-MATTER; AGRICULTURAL ECOSYSTEMS; ATMOSPHERIC CARBON; CROPLAND SOILS; TILLAGE; PRODUCTIVITY; MANAGEMENT; FERTILITY; EROSION; FERTILIZATION	The carbon sink capacity of the world's agricultural and degraded soils is 50 to 66% of the historic carbon loss of 42 to 78 gigatons of carbon. The rate of soil organic carbon sequestration with adoption of recommended technologies depends on soil texture and structure, rainfall, temperature, farming system, and soil management. Strategies to increase the soil carbon pool include soil restoration and woodland regeneration, no-till farming, cover crops, nutrient management, manuring and sludge application, improved grazing, water conservation and harvesting, efficient irrigation, agroforestry practices, and growing energy crops on spare lands. An increase of 1 ton of soil carbon pool of degraded cropland soils may increase crop yield by 20 to 40 kilograms per hectare (kg/ha) for wheat, 10 to 20 kg/ha for maize, and 0.5 to 1 kg/ha for cowpeas. As well as enhancing food security, carbon sequestration has the potential to offset fossil-fuel emissions by 0.4 to 1.2 gigatons of carbon per year, or 5 to 15% of the global fossil-fuel emissions.	Ohio State Univ, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lal, R (corresponding author), Ohio State Univ, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA.	lal.1@osu.edu	Lal, Rattan/D-2505-2013					Armstrong RD, 2003, AUST J EXP AGR, V43, P141, DOI 10.1071/EA01175; Aune JB, 1997, TROP AGR, V74, P96; BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Campbell CA, 2000, CAN J SOIL SCI, V80, P193, DOI 10.4141/S99-045; Diaz-Zorita M, 2002, SOIL TILL RES, V65, P1, DOI 10.1016/S0167-1987(01)00274-4; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Grace PR, 1995, AUST J EXP AGR, V35, P857, DOI 10.1071/EA9950857; Johnson E, 2004, ENVIRON INT, V30, P279, DOI 10.1016/j.envint.2003.09.001; JOHNSTON AE, 1986, SOIL USE MANAGE, V2, P97, DOI 10.1111/j.1475-2743.1986.tb00690.x; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Kapkiyai JJ, 1999, SOIL BIOL BIOCHEM, V31, P1773, DOI 10.1016/S0038-0717(99)00088-7; Lal R, 2003, SOIL SCI, V168, P827, DOI 10.1097/01.ss.0000106407.84926.6b; Lal R, 2004, SCIENCE, V304, P393, DOI 10.1126/science.1093079; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2001, ADV AGRON, V71, P145, DOI 10.1016/S0065-2113(01)71014-0; LAL R, 1981, GEODERMA, V25, P215, DOI 10.1016/0016-7061(81)90037-9; Levy R., 1984, CHEM IRRIGATED SOILS, P182; Manlay RJ, 2002, AGR ECOSYST ENVIRON, V88, P215, DOI 10.1016/S0167-8809(01)00218-3; PETCHAWEE S, 1995, ORGANIC MATTER MANAG, P21; PIERI C, 1986, AGRON TROP, V41, P1; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Sa JCD, 2001, SOIL SCI SOC AM J, V65, P1486, DOI 10.2136/sssaj2001.6551486x; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sauerbeck DR, 2001, NUTR CYCL AGROECOSYS, V60, P253, DOI 10.1023/A:1012617516477; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Smith P, 2001, NUTR CYCL AGROECOSYS, V60, P237, DOI 10.1023/A:1012617517839; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; West TO, 2002, ENVIRON POLLUT, V116, P439, DOI 10.1016/S0269-7491(01)00221-4; Wright DG, 2001, COMMUN SOIL SCI PLAN, V32, P1803, DOI 10.1081/CSS-120000251; Yamoah CF, 2002, FIELD CROP RES, V75, P53, DOI 10.1016/S0378-4290(02)00008-4; [No title captured]; [No title captured]	36	4001	4783	351	4357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2004	304	5677					1623	1627		10.1126/science.1097396	http://dx.doi.org/10.1126/science.1097396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192216				2022-12-01	WOS:000221934300036
J	Rosch, J; Caparon, M				Rosch, J; Caparon, M			A Microdomain for protein secretion in Gram-positive bacteria	SCIENCE			English	Article							STREPTOCOCCUS-PYOGENES; CELL-WALL; CYSTEINE PROTEINASE; BACILLUS-SUBTILIS; TRIGGER FACTOR; TRANSLOCATION; TRANSCRIPTION; GROWTH	Gram-positive bacteria face unique challenges in generating biologically active conformations for their exported proteins because they lack a dedicated compartment for folding secreted polypeptides. We have discovered that protein secretion by way of the general secretory ( Sec) pathway in the important human pathogen Streptococcus pyogenes proceeds through a single microdomain. Unlike other mechanisms for asymmetry involving the Sec pathway, proteins destined for secretion are targeted to a single locus distal to either cell pole that has specialized to contain the Sec translocons. This subcellular organization may represent a paradigm for secretion common to other Gram-positive pathogens with profound implications for pathogenesis.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Caparon, M (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Box 8230, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu	Rosch, Jason W/N-8106-2018	Rosch, Jason W/0000-0002-1798-1760	NIAID NIH HHS [AI46433] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046433] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; COLE RM, 1962, SCIENCE, V135, P722, DOI 10.1126/science.135.3505.722; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Gauthier A, 2003, J BIOL CHEM, V278, P25273, DOI 10.1074/jbc.R300012200; Kourtz L, 2000, MOL MICROBIOL, V37, P1342, DOI 10.1046/j.1365-2958.2000.02078.x; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Scott ME, 2001, P NATL ACAD SCI USA, V98, P13978, DOI 10.1073/pnas.241411198; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Snyder A, 2003, J BACTERIOL, V185, P5953, DOI 10.1128/JB.185.20.5953-5958.2003; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6	18	120	128	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1513	1515		10.1126/science.1097404	http://dx.doi.org/10.1126/science.1097404			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178803				2022-12-01	WOS:000221795800048
J	Verhelst, D; Rossert, J; Casadevall, N; Kruger, A; Eckardt, KU; Macdougall, LC				Verhelst, D; Rossert, J; Casadevall, N; Kruger, A; Eckardt, KU; Macdougall, LC		Pure Red Cell Aplasia Study Grp	Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study	LANCET			English	Article							ANTIERYTHROPOIETIN ANTIBODIES	Background Recombinant human erythropoietin is the standard treatment for anaemia related to chronic kidney disease, and its widespread use has been favoured by a very high therapeutic index. However, since 1998, more than 200 patients worldwide with chronic kidney disease treated in this way have developed neutralising antibodies to erythropoietin, causing pure red cell aplasia. We aimed to collate clinical and pathological features in patients unequivocally shown to have erythropoietin-induced pure red cell aplasia. Methods We retrospectively obtained data from the files of 47 patients with pure red cell aplasia. We assessed treatment and outcome of patients and defined recovery from pure red cell aplasia as an increase in reticulocyte counts to more than 20 000 per muL in patients who were no longer transfusion-dependent. Findings When patients developed pure red cell aplasia, all were receiving erythropoietin subcutaneously, and the product most typically prescribed was epoetin alfa (Eprex, Ortho Biotech). The median delay between start of erythropoietin treatment and occurrence of pure red cell aplasia was 11 months (IQR 7.5-14). Nine patients received no immunosuppressive treatment, and none of these recovered. Of 37 patients who received immunosuppressive therapy, 29 (78%) recovered. All six patients who received a kidney transplant recovered within 1 month, and recovery rates were between 56% and 88% in patients treated with corticosteroids, corticosteroids plus cyclophosphamide, or ciclosporin. No relapse of pure red cell aplasia happened after stopping immunosuppressive treatment, but no patient was rechallenged with erythropoietin. Interpretation Immunosuppressive treatment accelerates recovery from erythropoietin-induced pure red cell aplasia.	Assistance Publ Hop Paris, Tenon Hosp, Dept Nephrol, F-75020 Paris, France; Univ Paris 06, Paris, France; Assistance Publ Hop Paris, Hotel Dieu, Dept Haematol, Paris, France; INSERM, U362, Paris, France; Univ Erlangen Nurnberg, Div Nephrol & Hypertens, Nurnberg, Germany; Kings Coll Hosp London, Dept Renal Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Erlangen Nuremberg; King's College Hospital NHS Foundation Trust; King's College Hospital	Rossert, J (corresponding author), Assistance Publ Hop Paris, Tenon Hosp, Dept Nephrol, 4 Rue Chine, F-75020 Paris, France.	jerome.rossert@tnn.ap-hop-paris.fr						Bunn HF, 2002, NEW ENGL J MED, V346, P522, DOI 10.1056/NEJM200202143460711; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Casadevall N, 2002, NEPHROL DIAL TRANSPL, V17, P42, DOI 10.1093/ndt/17.suppl_5.42; Cavill I, 2002, LANCET, V360, P1606, DOI 10.1016/S0140-6736(02)11544-3; Chng WJ, 2003, AM J KIDNEY DIS, V41, P692, DOI 10.1053/ajkd.2003.50132; Eckardt KU, 2003, NEPHROL DIAL TRANSPL, V18, P865, DOI 10.1093/ndt/gfg182; Macdougall IC, 2004, CURR MED RES OPIN, V20, P576, DOI [10.1185/030079904125003520, 10.1185/030079903125002702]; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Tong EM, 2001, SEMIN NEPHROL, V21, P190, DOI 10.1053/snep.2001.20939	10	106	119	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 29	2004	363	9423					1768	1771		10.1016/S0140-6736(04)16302-2	http://dx.doi.org/10.1016/S0140-6736(04)16302-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824SD	15172775				2022-12-01	WOS:000221705800010
J	Cobb, BA; Wang, O; Tzianabos, AO; Kasper, DL				Cobb, BA; Wang, O; Tzianabos, AO; Kasper, DL			Polysaccharide processing and presentation by the MHCII pathway	CELL			English	Article							CHRONIC GRANULOMATOUS-DISEASE; HLA-DR MOLECULES; ABSCESS FORMATION; T-CELLS; ANTIGEN PRESENTATION; NITRIC-OXIDE; ZWITTERIONIC POLYSACCHARIDES; CAPSULAR POLYSACCHARIDE; BACTEROIDES-FRAGILIS; CATHEPSIN-S	The adaptive immune system functions through the combined action of antigen-presenting cells (APCs) and T cells. Specifically, class I major histocompatibility complex antigen presentation to CD8(+) T cells is limited to proteosome-generated peptides from intracellular pathogens while the class II (MHCII) endocytic pathway presents only proteolytic peptides from extracellular pathogens to CD4(+) T cells. Carbohydrates have been thought to stimulate immune responses independently of T cells; however, zwitterionic polysaccharides (ZPSs) from the capsules of some bacteria can activate CD4(+) T cells. Here we show that ZPSs are processed to low molecular weight carbohydrates by a nitric oxide-mediated mechanism and presented to T cells through the MHCII endocytic pathway. Furthermore, these carbohydrates bind to MHCII inside APCs for presentation to T cells. Our observations begin to elucidate the mechanisms by which some carbohydrates induce important immunologic responses through T cell activation, suggesting a fundamental shift in the MHCII presentation paradigm.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kasper, DL (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA.	dennis_kasper@hms.harvard.edu			NIAID NIH HHS [T32 AI007061, R01 AI039576-08, R01 AI052397, AI039576, AI52397, R01 AI039576, AI007061] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039576, R01AI052397, T32AI007061, R21AI039576] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBAS AK, 2000, CELLULAR MOL IMMUNOL; ACCOLLA RS, 1985, J IMMUNOL, V134, P3265; ADORINI L, 1990, NATURE, V346, P63, DOI 10.1038/346063a0; Bacci S, 1996, J INVEST DERMATOL, V107, P838, DOI 10.1111/1523-1747.ep12330994; Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574; Brubaker JO, 1999, J IMMUNOL, V162, P2235; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Choi YH, 2002, BIOCHEMISTRY-US, V41, P15144, DOI 10.1021/bi020491v; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DSOUZA MP, 1986, ARCH BIOCHEM BIOPHYS, V249, P522, DOI 10.1016/0003-9861(86)90030-5; Edmunds NJ, 2003, J VASC RES, V40, P68, DOI 10.1159/000068941; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; Kalka-Moll WM, 2000, J IMMUNOL, V164, P719, DOI 10.4049/jimmunol.164.2.719; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; Kaspar DL, 1996, J CLIN INVEST, V98, P2308, DOI 10.1172/JCI119042; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; PIER GB, 1984, J IMMUNOL, V133, P734; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; SHI GP, 1992, J BIOL CHEM, V267, P7258; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Svensson M, 1997, J IMMUNOL, V158, P4229; Tsuji S, 2002, NITRIC OXIDE-BIOL CH, V7, P283, DOI 10.1016/S1089-8603(02)00110-6; Tzianabos AO, 2000, J BIOL CHEM, V275, P6733, DOI 10.1074/jbc.275.10.6733; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Tzianabos AO, 1999, J IMMUNOL, V163, P893; Tzianabos AO, 2002, CURR OPIN MICROBIOL, V5, P92, DOI 10.1016/S1369-5274(02)00292-8; Tzianabos AO, 2001, P NATL ACAD SCI USA, V98, P9365, DOI 10.1073/pnas.161175598; Wang Y, 2000, P NATL ACAD SCI USA, V97, P13478, DOI 10.1073/pnas.97.25.13478; Watts C, 1999, Rev Immunogenet, V1, P60; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WIMAN K, 1982, BIOCHEMISTRY-US, V21, P5351, DOI 10.1021/bi00264a036	47	264	285	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					677	687		10.1016/j.cell.2004.05.001	http://dx.doi.org/10.1016/j.cell.2004.05.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163414	Green Accepted, Bronze			2022-12-01	WOS:000221857900013
J	Gardel, ML; Shin, JH; MacKintosh, FC; Mahadevan, L; Matsudaira, P; Weitz, DA				Gardel, ML; Shin, JH; MacKintosh, FC; Mahadevan, L; Matsudaira, P; Weitz, DA			Elastic Behavior of cross-linked and bundled actin networks	SCIENCE			English	Article							MECHANICAL-PROPERTIES; DYNAMICS; VISCOELASTICITY; FILAMENTS; POLYMERS; MODULUS; MOTION; GELS	Networks of cross-linked and bundled actin. laments are ubiquitous in the cellular cytoskeleton, but their elasticity remains poorly understood. We show that these networks exhibit exceptional elastic behavior that reflects the mechanical properties of individual. laments. There are two distinct regimes of elasticity, one reflecting bending of single. laments and a second reflecting stretching of entropic fluctuations of filament length. The mechanical stiffness can vary by several decades with small changes in cross-link concentration, and can increase markedly upon application of external stress. We parameterize the full range of behavior in a state diagram and elucidate its origin with a robust model.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; MIT, Whitehead Inst Biomed Res, Div Biol Engn, Cambridge, MA 02142 USA; Vrije Univ Amsterdam, Div Phys & Astron, Amsterdam, Netherlands	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Vrije Universiteit Amsterdam	Weitz, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	weitz@deas.harvard.edu	MacKintosh, Frederick/AAB-9332-2021; MacKintosh, Fred C/A-9450-2008; Gardel, Margaret/D-1703-2012; Shin, Jennifer H/C-1647-2011; Matsudaira, Paul/H-1475-2012	MacKintosh, Frederick/0000-0002-2607-9541; MacKintosh, Fred C/0000-0002-2607-9541; Shin, Jennifer H/0000-0001-8448-6236; Matsudaira, Paul/0000-0002-8399-3276	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052703] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52703] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Ferry J. D., 1980, VISCOELASTIC PROPERT; FIXMAN M, 1973, J CHEM PHYS, V58, P1564, DOI 10.1063/1.1679396; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Isambert H, 1996, MACROMOLECULES, V29, P1036, DOI 10.1021/ma946418x; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kreis T., 1999, CYTOSKELETAL MOTOR P; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lodish H., 1999, MOL CELL BIOL; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; RUDDIES R, 1993, EUR BIOPHYS J BIOPHY, V22, P309, DOI 10.1007/BF00213554; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; SEMENOV AN, 1986, J CHEM SOC FARAD T 2, V82, P317, DOI 10.1039/f29868200317; Sherman MB, 1999, J MOL BIOL, V294, P139, DOI 10.1006/jmbi.1999.3222; Shin J., UNPUB; Shin JH, 2004, J MOL BIOL, V337, P255, DOI 10.1016/j.jmb.2004.01.028; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; TILNEY LG, 1975, J CELL BIOL, V64, P289, DOI 10.1083/jcb.64.2.289; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Xu JY, 1998, BIOPHYS J, V74, P2731, DOI 10.1016/S0006-3495(98)77979-2; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570	28	924	943	9	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1301	1305		10.1126/science.1095087	http://dx.doi.org/10.1126/science.1095087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166374				2022-12-01	WOS:000221669600048
J	Toyoshima, C; Mizutani, T				Toyoshima, C; Mizutani, T			Crystal structure of the calcium pump with a bound ATP analogue	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; NUCLEOTIDE-BINDING DOMAIN; CA2+ TRANSPORT; ION-TRANSPORT; FUNCTIONAL CONSEQUENCES; SEGMENT; MECHANISM; CA-2+-ATPASE; DISSOCIATION; ORGANIZATION	P-type ATPases are ATP-powered ion pumps that establish ion concentration gradients across cell and organelle membranes. Here, we describe the crystal structure of the Ca2+ pump of skeletal muscle sarcoplasmic reticulum, a representative member of the P-type ATPase superfamily, with an ATPanalogue, a Mg2+ and two Ca2+ ions in the respective binding sites. In this state, the ATP analogue reorganizes the three cytoplasmic domains ( A, N and P), which are widely separated without nucleotide, by directly bridging the N and P domains. The structure of the P-domain itself is altered by the binding of the ATP analogue and Mg2+. As a result, the A-domain is tilted so that one of the transmembrane helices moves to lock the cytoplasmic gate of the transmembrane Ca2+-binding sites. This appears to be the mechanism for occluding the bound Ca2+ ions, before releasing them into the lumen of the sarcoplasmic reticulum.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019; Mizutani, Tatsuaki/AAA-5044-2021	Mizutani, Tatsuaki/0000-0002-4323-4347; Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cappello V, 2002, PROTEINS, V47, P106, DOI 10.1002/prot.10070; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; COLL RJ, 1984, J BIOL CHEM, V259, P4249; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.0.CO;2-S; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; INESI G, IN PRESS J BIOL CHEM; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Liu M, 2003, J BIOL CHEM, V278, P10112, DOI 10.1074/jbc.M212403200; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Mintz E, 1997, BBA-BIOENERGETICS, V1318, P52, DOI 10.1016/S0005-2728(96)00132-6; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POST RL, 1972, J BIOL CHEM, V247, P6530; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Toyoshima C, 2003, FEBS LETT, V555, P106, DOI 10.1016/S0014-5793(03)01086-X; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	45	364	378	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					529	535		10.1038/nature02680	http://dx.doi.org/10.1038/nature02680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15229613				2022-12-01	WOS:000222946100039
J	Sebat, J; Lakshmi, B; Troge, J; Alexander, J; Young, J; Lundin, P; Maner, S; Massa, H; Walker, M; Chi, MY; Navin, N; Lucito, R; Healy, J; Hicks, J; Ye, K; Reiner, A; Gilliam, TC; Trask, B; Patterson, N; Zetterberg, A; Wigler, M				Sebat, J; Lakshmi, B; Troge, J; Alexander, J; Young, J; Lundin, P; Maner, S; Massa, H; Walker, M; Chi, MY; Navin, N; Lucito, R; Healy, J; Hicks, J; Ye, K; Reiner, A; Gilliam, TC; Trask, B; Patterson, N; Zetterberg, A; Wigler, M			Large-scale copy number polymorphism in the human genome	SCIENCE			English	Article							SEGMENTAL DUPLICATIONS; MICROARRAY ANALYSIS; GENE; HYBRIDIZATION; DELETIONS; CLONING; DISEASE	The extent to which large duplications and deletions contribute to human genetic variation and diversity is unknown. Here, we show that large-scale copy number polymorphisms (CNPs) ( about 100 kilobases and greater) contribute substantially to genomic variation between normal humans. Representational oligonucleotide microarray analysis of 20 individuals revealed a total of 221 copy number differences representing 76 unique CNPs. On average, individuals differed by 11 CNPs, and the average length of a CNP interval was 465 kilobases. We observed copy number variation of 70 different genes within CNP intervals, including genes involved in neurological function, regulation of cell growth, regulation of metabolism, and several genes known to be associated with disease.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Karolinska Inst, SE-17176 Stockholm, Sweden; SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Broad Inst, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Fred Hutchinson Cancer Center; Karolinska Institutet; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Maestrini, Elena/K-7508-2012; Lucito, Robert/AID-7159-2022; Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022	Maestrini, Elena/0000-0001-5924-3179; Ye, Kenny/0000-0002-1466-855X; Sebat, Jonathan/0000-0002-9087-526X; Wigler, Michael/0000-0003-4396-1971	NCI NIH HHS [CA078544, CA81674, 5T32 CA069311] Funding Source: Medline; NHGRI NIH HHS [HG02606] Funding Source: Medline; NIDCD NIH HHS [DC004209] Funding Source: Medline; NIGMS NIH HHS [GM057070] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA081674, R01CA078544, R33CA081674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG002606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Gilles F, 2000, GENOMICS, V70, P364, DOI 10.1006/geno.2000.6388; Healy J, 2003, GENOME RES, V13, P2306, DOI 10.1101/gr.1350803; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Imai Y, 1998, BIOCHEM BIOPH RES CO, V252, P582, DOI 10.1006/bbrc.1998.9705; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Sainsbury A, 2002, GENE DEV, V16, P1077, DOI 10.1101/gad.979102; Shan JD, 2000, GENE, V257, P67, DOI 10.1016/S0378-1119(00)00395-4; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D	25	1799	1991	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					525	528		10.1126/science.1098918	http://dx.doi.org/10.1126/science.1098918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273396				2022-12-01	WOS:000222828900042
J	Leendertz, FH; Ellerbrok, H; Boesch, C; Couacy-Hymann, E; Matz-Rensing, K; Hakenbeck, R; Bergmann, C; Abaza, P; Junglen, S; Moebius, Y; Vigilant, L; Formenty, P; Pauli, G				Leendertz, FH; Ellerbrok, H; Boesch, C; Couacy-Hymann, E; Matz-Rensing, K; Hakenbeck, R; Bergmann, C; Abaza, P; Junglen, S; Moebius, Y; Vigilant, L; Formenty, P; Pauli, G			Anthrax kills wild chimpanzees in a tropical rainforest	NATURE			English	Article							BACILLUS-ANTHRACIS; NATIONAL-PARK; VIRUS; IDENTIFICATION; STRAINS; DECLINE; EBOLA; PCR	Infectious disease has joined habitat loss and hunting as threats to the survival of the remaining wild populations of great apes. Nevertheless, relatively little is known about the causative agents(1-3). We investigated an unusually high number of sudden deaths observed over nine months in three communities of wild chimpanzees (Pan troglodytes verus) in the Tai National Park, Ivory Coast. Here we report combined pathological, cytological and molecular investigations that identified Bacillus anthracis as the cause of death for at least six individuals. We show that anthrax can be found in wild non-human primates living in a tropical rainforest, a habitat not previously known to harbour B. anthracis. Anthrax is an acute disease that infects ruminants(4,5), but other mammals, including humans, can be infected through contacting or inhaling high doses of spores or by consuming meat from infected animals(6). Respiratory and gastrointestinal anthrax are characterized by rapid onset, fever, septicaemia and a high fatality rate without early antibiotic treatment(6,7). Our results suggest that epidemic diseases represent substantial threats to wild ape populations, and through bushmeat consumption also pose a hazard to human health.	Robert Koch Inst, Zentrum Biol Sicherheit, D-13353 Berlin, Germany; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Free Univ Berlin, Inst Parasitol & Int Anim Hlth, D-14163 Berlin, Germany; Lanada, Lcpa, Bingerville, Cote Ivoire; German Primate Ctr, D-37077 Gottingen, Germany; Univ Kaiserslautern, Dept Microbiol, D-67663 Kaiserslautern, Germany; WHO, Ebola Tai Forest Project, WHO Off, Abidjan, Cote Ivoire	Robert Koch Institute; Max Planck Society; Free University of Berlin; Deutsches Primatenzentrum (DPZ); University of Kaiserslautern; World Health Organization	Ellerbrok, H (corresponding author), Robert Koch Inst, Zentrum Biol Sicherheit, Nordufer 20, D-13353 Berlin, Germany.	ellerbrokh@rki.de	Leendertz, Fabian Hubertus/H-8902-2019; Junglen, Sandra/I-3033-2012	Junglen, Sandra/0000-0002-3799-6011				Andersen GL, 1996, J BACTERIOL, V178, P377, DOI 10.1128/jb.178.2.377-384.1996; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Boesch C., 2000, CHIMPANZEES TAI FORE; Boutin J P, 1985, Med Trop (Mars), V45, P79; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; Ferber D, 2000, SCIENCE, V289, P1277, DOI 10.1126/science.289.5483.1277; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Leendertz FH, 2004, J VIROL, V78, P4352, DOI 10.1128/JVI.78.8.4352-4356.2004; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Sirisanthana T, 2002, EMERG INFECT DIS, V8, P649, DOI 10.3201/eid0807.020062; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; TURNBULL PCB, 1992, EPIDEMIOL INFECT, V108, P299, DOI 10.1017/S0950268800049773; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	22	127	131	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					451	452		10.1038/nature02722	http://dx.doi.org/10.1038/nature02722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269768				2022-12-01	WOS:000222801400042
J	Sabine, CL; Feely, RA; Gruber, N; Key, RM; Lee, K; Bullister, JL; Wanninkhof, R; Wong, CS; Wallace, DWR; Tilbrook, B; Millero, FJ; Peng, TH; Kozyr, A; Ono, T; Rios, AF				Sabine, CL; Feely, RA; Gruber, N; Key, RM; Lee, K; Bullister, JL; Wanninkhof, R; Wong, CS; Wallace, DWR; Tilbrook, B; Millero, FJ; Peng, TH; Kozyr, A; Ono, T; Rios, AF			The oceanic sink for anthropogenic CO2	SCIENCE			English	Article							ATMOSPHERIC CO2; RED-SEA; INVENTORY; WATER	Using inorganic carbon measurements from an international survey effort in the 1990s and a tracer-based separation technique, we estimate a global oceanic anthropogenic carbon dioxide (CO2) sink for the period from 1800 to 1994 of 118 +/- 19 petagrams of carbon. The oceanic sink accounts for similar to48% of the total fossil-fuel and cement-manufacturing emissions, implying that the terrestrial biosphere was a net source of CO2 to the atmosphere of about 39 +/- 28 petagrams of carbon for this period. The current fraction of total anthropogenic CO2 emissions stored in the ocean appears to be about one-third of the long-term potential.	NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA; Pohang Univ Sci & Technol, Pohang 790784, South Korea; NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; Fisheries Oceans Canada Inst Ocean Sci, Climate Chem Lab, Sidney, BC V8L 4B2, Canada; Univ Kiel, Leibniz Inst Meereswissensch, Forsch Bereich Marine Biochem, IFM,GEOMAR, D-24105 Kiel, Germany; CSIRO, Marine Res & Antarctic Climate & Ecosyst Cooperat, Hobart, Tas 7001, Australia; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine & Atmospher Sci, Miami, FL 33149 USA; Oak Ridge Natl Lab, Carbon Dioxide Informat Anal Ctr, US Dept Energy, Oak Ridge, TN 37831 USA; Inst Global Change Res, Frontier Res Syst Global Change, Minato Ku, Hamamatsu, Shizuoka 1050013, Japan; CSIC, Inst Invest Marinas, Vigo 36208, Spain	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Pohang University of Science & Technology (POSTECH); National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); Fisheries & Oceans Canada; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Miami; United States Department of Energy (DOE); Oak Ridge National Laboratory; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Sabine, CL (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	chris.sabine@noaa.gov	Tilbrook, Bronte/W-4007-2019; Gruber, Nicolas/B-7013-2009; Lee, Kitack/G-7184-2015; Feely, Richard A./ABI-5740-2020; Tilbrook, Bronte/A-1522-2012	Tilbrook, Bronte/0000-0001-9385-3827; Gruber, Nicolas/0000-0002-2085-2310; Tilbrook, Bronte/0000-0001-9385-3827; Lee, Kitack/0000-0002-4226-2303				Archer D, 1998, GLOBAL BIOGEOCHEM CY, V12, P259, DOI 10.1029/98GB00744; Crutzen P, 2006, GLOBAL CHANGE NEWSLE, P13, DOI DOI 10.1007/3-540-26590-2_3; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gruber N, 2004, SCOPE SER, V62, P45; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Houghton RA, 2002, TRENDS COMPENDIUM DA; Keeling C. D., 2004, TRENDS COMPENDIUM DA; KEY RM, UNPUB; Lee K, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002067; Marland G., 2003, TRENDS COMPENDIUM DA; Mecking S, 1999, J GEOPHYS RES-OCEANS, V104, P11087, DOI 10.1029/1999JC900027; PAPAUD A, 1986, J MAR RES, V44, P385, DOI 10.1357/002224086788405347; POISSON A, 1987, DEEP-SEA RES, V34, P1255, DOI 10.1016/0198-0149(87)90075-6; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; REVELLE R, 1957, TELLUS, V9, P18, DOI 10.1111/j.2153-3490.1957.tb01849.x; Sabine CL, 2004, SCOPE SER, V62, P17; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001639; Sabine CL, 1999, GLOBAL BIOGEOCHEM CY, V13, P179, DOI 10.1029/1998GB900022; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; Wallace W.R., 2001, INT GEOPHYS, P489, DOI DOI 10.1016/S0074-6142(01)80136-4	23	2566	2728	59	1353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					367	371		10.1126/science.1097403	http://dx.doi.org/10.1126/science.1097403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256665	Green Accepted, Green Submitted, Green Published			2022-12-01	WOS:000222662400030
J	Subiaul, F; Cantlon, JF; Holloway, RL; Terrace, HS				Subiaul, F; Cantlon, JF; Holloway, RL; Terrace, HS			Cognitive imitation in rhesus macaques	SCIENCE			English	Article							CHIMPANZEES PAN-TROGLODYTES; CHILDREN HOMO-SAPIENS; OBJECTS	Experiments on imitation typically evaluate a student's ability to copy some feature of an expert's motor behavior. Here, we describe a type of observational learning in which a student copies a cognitive rule rather than a specific motor action. Two rhesus macaques were trained to respond, in a prescribed order, to different sets of photographs that were displayed on a touch-sensitive monitor. Because the position of the photographs varied randomly from trial to trial, sequences could not be learned by motor imitation. Both monkeys learned new sequences more rapidly after observing an expert execute those sequences than when they had to learn new sequences entirely by trial and error.	Columbia Univ, Dept Psychol, New York, NY 10027 USA; Columbia Univ, Dept Anthropol, New York, NY 10027 USA; Duke Univ, Dept Psychol & Brain Sci, Durham, NC 27708 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Duke University; New York State Psychiatry Institute	Subiaul, F (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	subiaul@aol.com; terrace@columbia.edu	cantlon, jessica/A-2699-2010	SUBIAUL, FRANCYS/0000-0002-5873-9524	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040462] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH40462] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BYRNE R, 2002, IMITATIVE MIND DEV E, P123; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; Galef B.G. Jr, 1988, P3; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Hauser M.D., 1988, P327; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; NAGELL K, 1993, J COMP PSYCHOL, V107, P174, DOI 10.1037/0735-7036.107.2.174; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; Terrace H.S., 1984, P7; Terrace HS, 2003, PSYCHOL SCI, V14, P66, DOI 10.1111/1467-9280.01420; TERRACE HS, 1984, QUANTITATIVE ANAL BE, P115; THORNDIKE EL, 1898, PSYCHOL REV MONOGR S, V2, P79; THORPE W, 1956, LEARNING INSTINCT AN, P122; Tomasello M., 1990, P274, DOI 10.1017/CBO9780511665486.012; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; Tomasello M., 1997, PRIMATE COGNITION; Visalberghi E., 1990, P247, DOI 10.1017/CBO9780511665486.011; Visalberghi E, 1998, BEHAV PROCESS, V42, P189, DOI 10.1016/S0376-6357(97)00076-4; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1998, J COMP PSYCHOL, V112, P270, DOI 10.1037/0735-7036.112.3.270; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; WHITEN A, 2002, IMITATIVE MIND DEV E, P98; ZAJONC RB, 1965, SCIENCE, V149, P106	26	111	113	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					407	410		10.1126/science.1099136	http://dx.doi.org/10.1126/science.1099136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256673				2022-12-01	WOS:000222662400042
J	McHugh, PR				McHugh, PR			Zygote and "clonote'' - The ethical use of embryonic stem cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Gearhart J, 2004, NEW ENGL J MED, V350, P1275, DOI 10.1056/NEJMp048045; *PUBL AFF, 2002, HUM CLON HUM DIGN RE	2	34	38	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					209	211		10.1056/NEJMp048147	http://dx.doi.org/10.1056/NEJMp048147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254278				2022-12-01	WOS:000222627200002
J	D'Amico, AV; Chen, MH; Roehl, KA; Catalona, WJ				D'Amico, AV; Chen, MH; Roehl, KA; Catalona, WJ			Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLING TIME	Background: We evaluated whether men at risk for death from prostate cancer after radical prostatectomy can be identified using information available at diagnosis. Methods: We studied 1095 men with localized prostate cancer to assess whether the rate of rise in the prostate-specific antigen (PSA) level-the PSA velocity-during the year before diagnosis, the PSA level at diagnosis, the Gleason score, and the clinical tumor stage could predict the time to death from prostate cancer and death from any cause after radical prostatectomy. Results: As compared with an annual PSA velocity of 2.0 ng per milliliter or less, an annual PSA velocity of more than 2.0 ng per milliliter was associated with a significantly shorter time to death from prostate cancer (P<0.001) and death from any cause (P=0.01). An increasing PSA level at diagnosis (P=0.01), a Gleason score of 8, 9, or 10 (P=0.02), and a clinical tumor stage of T2 (P<0.001) also predicted the time to death from prostate cancer. For men with an annual PSA velocity of more than 2.0 ng per milliliter, estimates of the risk of death from prostate cancer and death from any cause seven years after radical prostatectomy were also influenced by the PSA level, tumor stage, and Gleason score at diagnosis. Conclusions: Men whose PSA level increases by more than 2.0 ng per milliliter during the year before the diagnosis of prostate cancer may have a relatively high risk of death from prostate cancer despite undergoing radical prostatectomy.	Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Northwestern Feinberg Sch Med, Dept Urol, Chicago, IL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Connecticut; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine	D'Amico, AV (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, L-2 Level,75 Francis St, Boston, MA 02115 USA.	adamico@lroc.harvard.edu						BEAHRS OH, 1992, MANUAL STAGING CANC, P181; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; Egawa S, 2000, PROSTATE CANCER P D, V3, P269, DOI 10.1038/sj.pcan.4500424; Freedland SJ, 2001, UROLOGY, V57, P476, DOI 10.1016/S0090-4295(00)01016-5; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Goluboff ET, 1997, J UROLOGY, V158, P1876, DOI 10.1016/S0022-5347(01)64154-5; GREENE FL, 2002, MANUAL STAGING CANC, P309; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kessler B, 2003, UROL CLIN N AM, V30, P219, DOI 10.1016/S0094-0143(02)00182-9; Klein JP, 1997, SURVIVAL ANAL TECHNI, P96; Miller DC, 2003, CANCER-AM CANCER SOC, V98, P1169, DOI 10.1002/cncr.11635; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	15	567	587	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2004	351	2					125	135		10.1056/NEJMoa032975	http://dx.doi.org/10.1056/NEJMoa032975			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835GM	15247353	Bronze			2022-12-01	WOS:000222470700005
J	de Silva, HJ				de Silva, HJ			A middle-aged man	LANCET			English	Editorial Material									Univ Kelaniya, Fac Med, Dept Med, Ragama, Sri Lanka	University Kelaniya	de Silva, HJ (corresponding author), Univ Kelaniya, Fac Med, Dept Med, POB 6, Ragama, Sri Lanka.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	2004	364	9428					111	111		10.1016/S0140-6736(04)16600-2	http://dx.doi.org/10.1016/S0140-6736(04)16600-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234865				2022-12-01	WOS:000222392900042
J	Hogg, JC; Chu, F; Utokaparch, S; Woods, R; Elliott, WM; Buzatu, L; Cherniack, RM; Rogers, RM; Sciurba, FC; Coxson, HO; Pare, PD				Hogg, JC; Chu, F; Utokaparch, S; Woods, R; Elliott, WM; Buzatu, L; Cherniack, RM; Rogers, RM; Sciurba, FC; Coxson, HO; Pare, PD			The nature of small-airway obstruction in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC-BRONCHITIS; SMOKERS; INFLAMMATION; DIMENSIONS; FIBROSIS; SITE	Background Chronic obstructive pulmonary disease (COPD) is a major public health problem associated with long-term exposure to toxic gases and particles. We examined the evolution of the pathological effects of airway obstruction in patients with COPD. Methods The small airways were assessed in surgically resected lung tissue from 159 patients -39 with stage 0 (at risk), 39 with stage 1, 22 with stage 2, 16 with stage 3, and 43 with stage 4 (very severe) COPD, according to the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Results The progression of COPD was strongly associated with an increase in the volume of tissue in the wall (P<0.001) and the accumulation of inflammatory mucous exudates in the lumen (P<0.001) of the small airways. The percentage of the airways that contained polymorphonuclear neutrophils (P<0.001), macrophages (P<0.001), CD4 cells (P=0.02), CD8 cells (P=0.038), B cells (P<0.001), and lymphoid aggregates containing follicles (P=0.003) and the absolute volume of B cells (P=0.03) and CD8 cells (P=0.02) also increased as COPD progressed. Conclusions Progression of COPD is associated with the accumulation of inflammatory mucous exudates in the lumen and infiltration of the wall by innate and adaptive inflammatory immune cells that form lymphoid follicles. These changes are coupled to a repair or remodeling process that thickens the walls of these airways.	St Pauls Hosp, McDonald Res Wing, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Ctr Cardiovasc & Pulm Res, Vancouver, BC, Canada; Natl Jewish Med & Res Ctr, Denver, CO USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hogg, JC (corresponding author), St Pauls Hosp, McDonald Res Wing, Rm 166,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jhogg@mrl.ubc.ca	Sciurba, Frank/AAZ-9339-2021; Coxson, Harvey O/A-9861-2017; Pare, Peter D/C-7425-2011	Coxson, Harvey O/0000-0001-5750-9711; Woods, Ryan/0000-0002-9520-2128; sciurba, frank/0000-0001-7468-2225	NHLBI NIH HHS [R01 HL63117] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063117] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas A. K., 2000, CELLULAR MOL IMMUNOL, P270; Abbas AK, 2000, CELLULAR MOL IMMUNOL, P125; [Anonymous], 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3_10; BOSKEN CH, 1990, AM REV RESPIR DIS, V142, P563, DOI 10.1164/ajrccm/142.3.563; BOSKEN CH, 1992, AM REV RESPIR DIS, V145, P911, DOI 10.1164/ajrccm/145.4_Pt_1.911; Coxson HO, 1997, AM J RESP CRIT CARE, V155, P1649, DOI 10.1164/ajrccm.155.5.9154871; CRUZORIVE LM, 1981, J MICROSC-OXFORD, V122, P235, DOI 10.1111/j.1365-2818.1981.tb01265.x; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Dobson A.J., 2008, INTRO GEN LINEAR MOD; Espada R, 1999, CHEST, V116, P1750; FIHSER LD, 1993, BIOSTATISTICS METHOD; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fishman A, 2001, NEW ENGL J MED, V345, P1075; FLETCHER C, 1976, NATURAL HIST CHRONIC, P93; *GOLD, 2003, NIH PUBL, V2701; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; HOGG JC, 1994, THORAX, V49, P473, DOI 10.1136/thx.49.5.473; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136; JONES JG, 1980, LANCET, V1, P66; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KUWANO K, 1993, AM REV RESPIR DIS, V148, P1220, DOI 10.1164/ajrccm/148.5.1220; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; MATSUBA K, 1972, AM J PATHOL, V67, P265; MEAD J, 1967, J APPL PHYSIOL, V22, P95, DOI 10.1152/jappl.1967.22.1.95; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; MULLEN JBM, 1985, BMJ-BRIT MED J, V291, P1235, DOI 10.1136/bmj.291.6504.1235; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; SIMANI AS, 1974, LAB INVEST, V31, P75; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; VANBRABANDT H, 1983, J APPL PHYSIOL, V55, P1733, DOI 10.1152/jappl.1983.55.6.1733; Vestbo J, 2002, AM J RESP CRIT CARE, V166, P329, DOI 10.1164/rccm.2112048; WIGGS BR, 1990, J APPL PHYSIOL, V69, P849, DOI 10.1152/jappl.1990.69.3.849; WRIGHT JL, 1984, AM REV RESPIR DIS, V129, P989; YANAI M, 1992, J APPL PHYSIOL, V72, P1016, DOI 10.1152/jappl.1992.72.3.1016	40	2524	2645	4	236	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2004	350	26					2645	2653		10.1056/NEJMoa032158	http://dx.doi.org/10.1056/NEJMoa032158			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831MR	15215480				2022-12-01	WOS:000222199000005
J	Lu, T; Pan, Y; Kao, SY; Li, C; Kohane, I; Chan, J; Yankner, BA				Lu, T; Pan, Y; Kao, SY; Li, C; Kohane, I; Chan, J; Yankner, BA			Gene regulation and DNA damage in the ageing human brain	NATURE			English	Article							EXPRESSION; REPAIR; TRAFFICKING; MICROARRAYS; PROTEIN; PROFILE	The ageing of the human brain is a cause of cognitive decline in the elderly and the major risk factor for Alzheimer's disease1. The time in life when brain ageing begins is undefined(2-4). Here we show that transcriptional profiling of the human frontal cortex from individuals ranging from 26 to 106 years of age defines a set of genes with reduced expression after age 40. These genes play central roles in synaptic plasticity, vesicular transport and mitochondrial function. This is followed by induction of stress response, antioxidant and DNA repair genes. DNA damage is markedly increased in the promoters of genes with reduced expression in the aged cortex. Moreover, these gene promoters are selectively damaged by oxidative stress in cultured human neurons, and show reduced base-excision DNA repair. Thus, DNA damage may reduce the expression of selectively vulnerable genes involved in learning, memory and neuronal survival, initiating a programme of brain ageing that starts early in adult life.	Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Yankner, BA (corresponding author), Childrens Hosp, Dept Neurol, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.	Bruce.Yankner@childrens.harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Duarte, Graziela Biude Silva/Q-7728-2016	Kohane, Isaac Kohane/0000-0003-2192-5160; 				ATHAS WF, 1991, CANCER RES, V51, P5786; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bruner SD, 2000, COLD SPRING HARB SYM, V65, P103, DOI 10.1101/sqb.2000.65.103; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; TCHOU J, 1994, J BIOL CHEM, V269, P15318; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yankner BA, 2000, NATURE, V404, P125, DOI 10.1038/35004673	25	1320	1368	3	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					883	891		10.1038/nature02661	http://dx.doi.org/10.1038/nature02661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15190254				2022-12-01	WOS:000222213000044
J	Brownlee, DE; Horz, F; Newburn, RL; Zolensky, M; Duxbury, TC; Sandford, S; Sekanina, Z; Tsou, P; Hanner, MS; Clark, BC; Green, SF; Kissel, J				Brownlee, DE; Horz, F; Newburn, RL; Zolensky, M; Duxbury, TC; Sandford, S; Sekanina, Z; Tsou, P; Hanner, MS; Clark, BC; Green, SF; Kissel, J			Surface of young Jupiter family comet 81 P/Wild 2: View from the Stardust spacecraft	SCIENCE			English	Article							NUCLEUS; MORPHOLOGY; JETS	Images taken by the Stardust mission during its flyby of 81P/Wild 2 show the comet to be a 5-kilometer oblate body covered with remarkable topographic features, including unusual circular features that appear to be impact craters. The presence of high-angle slopes shows that the surface is cohesive and self-supporting. The comet does not appear to be a rubble pile, and its rounded shape is not directly consistent with the comet being a fragment of a larger body. The surface is active and yet it retains ancient terrain. Wild 2 appears to be in the early stages of its degradation phase as a small volatile-rich body in the inner solar system.	Univ Washington, Dept Astron, Seattle, WA 98195 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Massachusetts, Amherst, MA 01003 USA; Lockheed Martin Astronaut, Denver, CO 80201 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany	University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Massachusetts System; University of Massachusetts Amherst; Lockheed Martin; Open University - UK; Max Planck Society	Brownlee, DE (corresponding author), Univ Washington, Dept Astron, Seattle, WA 98195 USA.	brownlee@astro.washington.edu	Green, Simon F/C-7408-2009	Green, Simon F/0000-0002-9153-9786; Zolensky, Michael/0000-0002-3181-1303				Britt DT, 2004, ICARUS, V167, P45, DOI 10.1016/j.icarus.2003.09.004; Buratti BJ, 2004, ICARUS, V167, P16, DOI 10.1016/j.icarus.2003.05.002; DUXBURY TC, UNPUB; GRUN E, 1993, J GEOPHYS RES-PLANET, V98, P15091, DOI 10.1029/93JE01134; HORZ F, 1975, PLANET SPACE SCI, V23, P151, DOI 10.1016/0032-0633(75)90076-8; Housen KR, 2003, ICARUS, V163, P102, DOI 10.1016/S0019-1035(03)00024-1; HUGHES DW, 1975, Q J ROY ASTRON SOC, V16, P410; KELLER HU, 1990, COMET HALLEY INVESTI, V2, P133; KELLER HU, 2002, CENTURY SCI, P1323; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Newburn RL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002081; OBERBECK VR, 1968, ICARUS, V9, P446, DOI 10.1016/0019-1035(68)90039-0; Oberst J, 2004, ICARUS, V167, P70, DOI 10.1016/j.icarus.2003.05.001; Samarasinha NH, 2001, ICARUS, V154, P540, DOI 10.1006/icar.2001.6685; SEARS DWG, 1999, METEORIT PLANET SCI, V34, P105; Sekanina Z, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002093; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; SEKANINA Z, 1985, ASTRON J, V90, P2335, DOI 10.1086/113939; Soderblom LA, 2004, ICARUS, V167, P4, DOI 10.1016/j.icarus.2003.07.008; Yelle RV, 2004, ICARUS, V167, P30, DOI 10.1016/j.icarus.2003.08.020	20	251	254	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1764	1769		10.1126/science.1097899	http://dx.doi.org/10.1126/science.1097899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205524				2022-12-01	WOS:000222089500035
J	Hansen, H				Hansen, H			Faith-based treatment for addiction in Puerto Rico	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Yale Univ, Sch Med, New Haven, CT 06510 USA	Yale University	Hansen, H (corresponding author), Yale Univ, Sch Med, New Haven, CT 06510 USA.				NIGMS NIH HHS [GM07205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alegria M, 2001, INQUIRY-J HEALTH CAR, V38, P381, DOI 10.5034/inquiryjrnl_38.4.381; ALEGRIA M, 1998, DRUG ADDICTION RES H, P123; Brusco Elizabeth E., 1995, REFORMATION MACHISMO; *CENTR INT AG, WORLD FACTB 2003; Cleary Edward L., 1997, POWER POLITICS PENTE; *COL U CASA NAT CT, SHOV IMP SUBST AB ST; *COL U NAT CTR ADD, SO HELP ME GOD SUBST; COLON H, 1998, HOUSEHOLD STUDY NEED; De la Rosa MR, 2001, J PSYCHOACTIVE DRUGS, V33, P233, DOI 10.1080/02791072.2001.10400570; GOODNOUGH A, 2003, NY TIMES        1228, P20; HOFFMAN F, 1994, INT J ADDICT, V29, P445, DOI 10.3109/10826089409047392; Martin D., 2001, PENTECOSTALISM WORLD; Melendez I., 1998, PUERTO RICO SUBSTANC; *NAT DRUG INT CTR, 2003, PUERT RIC US VIRG IS	14	8	9	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2004	291	23					2882	2882		10.1001/jama.291.23.2882	http://dx.doi.org/10.1001/jama.291.23.2882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GT	15199043				2022-12-01	WOS:000221962500038
J	Peterson, S; Nsungwa-Sabiiti, J; Were, W; Nsabagasani, X; Magumba, G; Nambooze, J; Mukasa, G				Peterson, S; Nsungwa-Sabiiti, J; Were, W; Nsabagasani, X; Magumba, G; Nambooze, J; Mukasa, G			Coping with paediatric referral - Ugandan parents' experience	LANCET			English	Article							SEVERELY ILL CHILDREN; MANAGEMENT	Referral of severely ill children to hospital is key in the Integrated Management of Childhood Illness (IMCI). In rural Uganda, we documented the caretakers' ability to complete referral to hospital from 12 health facilities. Of 227 children, only 63 (28%) had completed referral after 2 weeks, at a median cost of US$8-85 (range 0.40-89.00). Failure to attend hospital resulted from lack of money (139 children, 90%), transport problems (39, 26%), and responsibilities at home (26, 17%). Children with incomplete referral continued treatment at referring health centres (87, 54%) or in the private sector (45, 28%). Our results show that cost of referral must decrease to make paediatric referral realistic. When referral is difficult, more specific IMCI referral criteria should be used and first-level health workers should be empowered to manage severely ill children.	Minist Hlth, Child Hlth Div, Kampala, Uganda; Rubaga Hosp, Kampala, Uganda; Makerere Univ, Makerere Inst Social Res, Kampala, Uganda; USAID, UPHOLD Program, Kampala, Uganda; Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda	Makerere University; United States Agency for International Development (USAID); Makerere University	Peterson, S (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, S-17176 Stockholm, Sweden.	stefan.peterson@phs.ki.se		Peterson, Stefan/0000-0001-7203-3096				Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P119; Kalter HD, 2003, ACTA PAEDIATR, V92, P103; Macintyre K, 1999, SOC SCI MED, V49, P1473, DOI 10.1016/S0277-9536(99)00201-4; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522	5	85	85	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2004	363	9425					1955	1956		10.1016/S0140-6736(04)16411-8	http://dx.doi.org/10.1016/S0140-6736(04)16411-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GW	15194257				2022-12-01	WOS:000221962800011
J	Kurdistani, SK; Tavazoie, S; Grunstein, M				Kurdistani, SK; Tavazoie, S; Grunstein, M			Mapping global histone acetylation patterns to gene expression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; H4; HETEROCHROMATIN; DEACETYLASE; CHROMATIN; H3; TRANSCRIPTION; BROMODOMAIN; DEPOSITION	Histone acetyltransferases and deacetylases with specificities for different sites of acetylation affect common chromatin regions. This could generate unique patterns of acetylation that may specify downstream biological processes. To search for existence of these patterns and their relationship to gene activity, we analyzed the genome-wide acetylation profiles for eleven lysines in the four core histones of Saccharomyces cerevisiae. We find that both hyper- and hypoacetylation of individual lysines are associated with transcription, generating distinct patterns of acetylation that define groups of biologically related genes. The genes within these groups are significantly coexpressed, mediate similar physiological processes, share unique cis-regulatory DNA motifs, and are enriched for binding of specific transcription factors. Our data also indicate that the in vivo binding of the transcription factor Bdf1 is associated with acetylation on most lysines but relative deacetylation on H4 lysine 16. Thus, certain acetylation patterns may be used as surfaces for specific protein-histone interactions, providing one mechanism for coordinate regulation of chromatin processes that are biologically related.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	Princeton University; Princeton University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tavazoie, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	mg@mbi.ucla.edu; tavazoie@molbio.princeton.edu		Kurdistani, Siavash/0000-0003-3295-3511				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Hartigan J.A., 1975, CLUSTERING ALGORITHM; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; WANG H, 1990, MOL CELL BIOL, V10, P17443; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	34	483	502	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					721	733		10.1016/j.cell.2004.05.023	http://dx.doi.org/10.1016/j.cell.2004.05.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186774	Bronze			2022-12-01	WOS:000222048400006
J	Bogaert, D; van Belkum, A; Sluijter, M; Luijendijk, A; de Groot, R; Rumke, HC; Verbrugh, HA; Hermans, PWM				Bogaert, D; van Belkum, A; Sluijter, M; Luijendijk, A; de Groot, R; Rumke, HC; Verbrugh, HA; Hermans, PWM			Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children	LANCET			English	Article							CONJUGATE VACCINE; DISEASE	A trial with a 7-valent pneumococcal-conjugate vaccine in children with recurrent acute otitis media showed a shift in pneumococcal colonisation towards non-vaccine serotypes and an increase in Staphylococcus aureus-related acute otitis media after vaccination. We investigated prevalence and determinants of nasopharyngeal carriage of Streptococcus pneumoniae and S aureus in 3198 healthy children aged 1-19 years. Nasopharyngeal carriage of S pneumoniae was detected in 598 (19%) children, and was affected by age (peak incidence at 3 years) and day-care attendance (odds ratio [OR] 2.14, 95% CI 1.44-3.18). S aureus carriage was affected by age (peak incidence at 10 years) and male sex (OR 1.46, 1.25-1.70). Serotyping showed 42% vaccine type pneumococci. We noted a negative correlation for co-colonisation of S aureus and vaccine-type pneumococci (OR 0.68, 0.48-0.94), but not for S aureus and non-vaccine serotypes. These findings suggest a natural competition between colonisation with vaccine-type pneumococci and S aureus, aureus, which might explain the increase in S aureus-related otitis media after vaccination.	Erasmus Med Ctr Sophia, Dept Paediat, Rotterdam, Netherlands; Erasmus Med Ctr Sophia, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; Vaxinostics, Rotterdam, Netherlands; Erasmus Univ, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Hermans, PWM (corresponding author), Erasmus Med Ctr Sophia, Dept Paediat, Rotterdam, Netherlands.	p.hermans@erasmusmc.nl	Hermans, Peter W.M./H-8042-2014; Hermans, Peter P.W.M./F-4655-2010	Bogaert, Debby/0000-0003-2651-7000				[Anonymous], MMWR RECOMM REP; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; de Greeff S C, 2003, Ned Tijdschr Geneeskd, V147, P1132; Ghaffar F, 1999, PEDIATR INFECT DIS J, V18, P638, DOI 10.1097/00006454-199907000-00016; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Leiberman A, 1999, INT J PEDIATR OTORHI, V49, pS151; LENETTE EH, 1985, MANUAL CLIN MICROBIO; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	9	425	444	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2004	363	9424					1871	1872		10.1016/S0140-6736(04)16357-5	http://dx.doi.org/10.1016/S0140-6736(04)16357-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15183627				2022-12-01	WOS:000221822300013
J	Bergmann, DC; Lukowitz, W; Somerville, CR				Bergmann, DC; Lukowitz, W; Somerville, CR			Stomatal development and pattern controlled by a MAPKK kinase	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; CASCADE; PLANTS; MOUTHS; LEAVES; CO2; TOO	Stomata are epidermal structures that modulate gas exchange between a plant and its environment. During development, stomata are specified and positioned nonrandomly by the integration of asymmetric cell divisions and intercellular signaling. The Arabidopsis mitogen-activated protein kinase kinase kinase gene, YODA, acts as part of a molecular switch controlling cell identities in the epidermis. Null mutations in YODA lead to excess stomata, whereas constitutive activation of YODA eliminated stomata. Transcriptome analysis of seedlings with altered YODA activity was used to identify potential stomatal regulatory genes. A putative transcription factor from this set was shown to regulate the developmental behavior of stomatal precursors.	Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Somerville, CR (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	crs@stanford.edu	Somerville, Christopher R/A-4048-2009	Somerville, Christopher R/0000-0003-4647-0094; Bergmann, Dominique/0000-0003-0873-3543	NIGMS NIH HHS [5 F32GM064273-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064273] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Berger D, 2000, GENE DEV, V14, P1119; BERGMANN DJ, UNPUB; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Innes RW, 2001, TRENDS PLANT SCI, V6, P392, DOI 10.1016/S1360-1385(01)02058-1; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2003, TRENDS PLANT SCI, V8, P294, DOI 10.1016/S1360-1385(03)00102-X; Nadeau JA, 2002, THE ARABIDOPSIS BOOK; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Rhee SY, 2003, PLANT PHYSIOL, V133, P1170, DOI 10.1104/pp.103.028266; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227; Zhao LM, 1999, AM J BOT, V86, P929, DOI 10.2307/2656609	25	386	426	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1494	1497		10.1126/science.1096014	http://dx.doi.org/10.1126/science.1096014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178800				2022-12-01	WOS:000221795800042
J	Howard, SC; Pedrosa, N; Lins, M; Pedrosa, A; Pui, CH; Ribeiro, RC; Pedrosa, F				Howard, SC; Pedrosa, N; Lins, M; Pedrosa, A; Pui, CH; Ribeiro, RC; Pedrosa, F			Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEVELOPING-COUNTRIES; EL SALVADOR; CHILDREN; CANCER; NICARAGUA; THERAPY; TRIALS	Context The cure rate for childhood acute lymphoblastic leukemia (ALL) differs markedly between developed and developing countries. Objective To assess the effect of a multidisciplinary team approach and protocol-based therapy on the event-free survival of children with ALL in an area with limited resources. Design, Population, and Setting A retrospective cohort study at a pediatric hospital in the resource-poor city of Recife, Brazil. We reviewed medical records of the outcomes of 375 children with ALL diagnosed between 1980 and 2002. Eighty-three children were diagnosed in the early period (1980-1989), in the absence of a dedicated pediatric oncology unit, protocol-based therapy, specially trained nurses, 24-hour-on-site physician coverage, and ready access to intensive care. Seventy-eight children were treated (all according to protocol) during the middle period (July 1994 to March 1997). During the recent period (April 1997 to December 2002), 214 children were treated with protocol in a dedicated pediatric oncology unit staffed 24 hours by pediatric oncologists and oncology nurses. Improvements were implemented gradually during the middle period and were completed during the recent period. Main Outcome Measure Event-free survival was estimated by the Kaplan-Meier method. Events included death from toxicity, disease progression or relapse, and abandonment of treatment. Results The 5-year event-free survival improved steadily: 32% (95% Cl, 21% 43%) in the early period, 47% (95% Cl, 36%-58%) in the middle period, and 63% (95% Cl, 55%-71%) in the recent period. The probability of cause-specific treatment failure in the early, middle, and late periods, respectively, within 1 year of diagnosis was 14% vs 3.8% vs 3.3% for relapse; 6.0% vs 12% vs 9.8% for death from infection; 2.4% vs 13% vs 4.2% for death from noninfectious toxicity; and 16% vs 1.3% vs 0.5% for abandonment of therapy. Conclusion Treatment of childhood ALL in a dedicated pediatric oncology unit using a comprehensive multidisciplinary team approach, protocol-based therapy, and local support and funding is associated with improved outcomes in a resource-poor area.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA; Inst Materno Infantil Pernambuco, Recife, PE, Brazil; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Howard, SC (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	scott.howard@stjude.org	Howard, Scott C/K-3401-2013; Pui, Ching-Hon/N-8076-2018	Howard, Scott C/0000-0003-2244-1686; Pui, Ching-Hon/0000-0003-0303-5658	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonilla M, 2000, J PEDIAT HEMATOL ONC, V22, P495, DOI 10.1097/00043426-200011000-00004; Campbell M, 1999, MED PEDIATR ONCOL, V33, P88, DOI 10.1002/(SICI)1096-911X(199908)33:2<88::AID-MPO5>3.0.CO;2-Z; Eden T, 2002, BRIT J HAEMATOL, V118, P945, DOI 10.1046/j.1365-2141.2002.03670.x; Laosombat V, 2002, MED PEDIATR ONCOL, V38, P266, DOI 10.1002/mpo.1321; Masera G, 1998, LANCET, V352, P1923, DOI 10.1016/S0140-6736(98)07077-9; MASERA G, 1993, ANN ONCOL, V4, P37, DOI 10.1093/oxfordjournals.annonc.a058354; Masera G, 1999, ANN ONCOL, V10, P137, DOI 10.1023/A:1008382631875; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Pedrosa F, 2000, J PEDIAT HEMATOL ONC, V22, P502, DOI 10.1097/00043426-200011000-00005; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2003, INT J HEMATOL, V78, P383, DOI 10.1007/BF02983810; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Ribeiro RC, 2000, LANCET, V356, pS7, DOI 10.1016/S0140-6736(00)91993-7; RiveraLuna R, 1997, ARCH MED RES, V28, P233; Sala A, 2004, CANCER-AM CANCER SOC, V100, P677, DOI 10.1002/cncr.11833; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Schrappe M, 2000, LEUKEMIA, V14, P2193, DOI 10.1038/sj.leu.2401977; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283; UNICEF. The States of the World's Children, 2017, STAT WORLDS CHILDR 2; von Stackelberg A, 1999, EUR J CANCER, V35, P1349, DOI 10.1016/S0959-8049(99)00112-4; Wagner HP, 1997, ANN NY ACAD SCI, V824, P193, DOI 10.1111/j.1749-6632.1997.tb46222.x; Wake DJ, 1998, TROP DOCT, V28, P4, DOI 10.1177/004947559802800104; Wehl G, 1999, MED PEDIATR ONCOL, V32, P336; *WHO, STAT INF; Wilimas JA, 2003, MED PEDIATR ONCOL, V41, P136, DOI 10.1002/mpo.10242; Wilimas JA, 2001, HEMATOL ONCOL CLIN N, V15, P775, DOI 10.1016/S0889-8588(05)70246-X; World Medical Association, DECL HELS	30	221	232	1	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2004	291	20					2471	2475		10.1001/jama.291.20.2471	http://dx.doi.org/10.1001/jama.291.20.2471			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823HB	15161898	Bronze			2022-12-01	WOS:000221599700030
J	Morley, M; Molony, CM; Weber, TM; Devlin, JL; Ewens, KG; Spielman, RS; Cheung, VG				Morley, M; Molony, CM; Weber, TM; Devlin, JL; Ewens, KG; Spielman, RS; Cheung, VG			Genetic analysis of genome-wide variation in human gene expression	NATURE			English	Article							QUANTITATIVE TRAIT; LINKAGE; DISSECTION; MAP	Natural variation in gene expression is extensive in humans and other organisms, and variation in the baseline expression level of many genes has a heritable component. To localize the genetic determinants of these quantitative traits ( expression phenotypes) in humans, we used microarrays to measure gene expression levels and performed genome-wide linkage analysis for expression levels of 3,554 genes in 14 large families. For approximately 1,000 expression phenotypes, there was significant evidence of linkage to specific chromosomal regions. Both cis- and trans-acting loci regulate variation in the expression levels of genes, although most act in trans. Many gene expression phenotypes are influenced by several genetic determinants. Furthermore, we found hotspots of transcriptional regulation where significant evidence of linkage for several expression phenotypes ( up to 31) coincides, and expression levels of many genes that share the same regulatory region are significantly correlated. The combination of microarray techniques for phenotyping and linkage analysis for quantitative traits allows the genetic mapping of determinants that contribute to variation in human gene expression.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Spielman, RS (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.	spielman@pobox.upenn.edu; vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020		NIGMS NIH HHS [R01 GM081930-08, R01 GM081930] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; *STAT SOL LTD, 2003, SAGE STAT AN GEN EP; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	22	906	956	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					743	747		10.1038/nature02797	http://dx.doi.org/10.1038/nature02797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15269782	Green Accepted			2022-12-01	WOS:000223233600032
J	Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A				Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A			Pancam multispectral imaging results from the Spirit Rover at Gusev crater	SCIENCE			English	Article							PATHFINDER LANDING SITE; MARS; REFLECTANCE; MINERALOGY; ROCKS; DUST; MOSSBAUER; ABUNDANCE; SOILS	Panoramic Camera images at Gusev crater reveal a rock-strewn surface interspersed with high-to moderate-albedo fine-grained deposits occurring in part as drifts or in small circular swales or hollows. Optically thick coatings of fine-grained ferric iron-rich dust dominate most bright soil and rock surfaces. Spectra of some darker rock surfaces and rock regions exposed by brushing or grinding show near-infrared spectral signatures consistent with the presence of mafic silicates such as pyroxene or olivine. Atmospheric observations show a steady decline in dust opacity during the mission, and astronomical observations captured solar transits by the martian moons, Phobos and Deimos, as well as a view of Earth from the martian surface.	Cornell Univ, Ithaca, NY 14853 USA; Washington Univ, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Search Extraterr Intelligence Inst, Moffett Field, CA 94035 USA; Univ Nevada, Reno, NV 89501 USA; Arizona State Univ, Tempe, AZ 85287 USA; Space Sci Inst, Boulder, CO 80301 USA; Univ Copenhagen, DK-2100 Copenhagen O, Denmark; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Aarhus Univ, DK-8000 Aarhus C, Denmark; Texas A&M Univ, College Stn, TX 77843 USA; Ohio State Univ, Columbus, OH 43210 USA; Malin Space Sci Syst Inc, San Diego, CA 92191 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Tennessee, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; University of Copenhagen; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Aarhus University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Bell, JF (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	jfb8@cornell.edu	Lemmon, Mark T/E-9983-2010; Lemmon, Mark/X-2333-2019; Johnson, Jeffrey R/F-3972-2015; Farmer, Jack D/B-9343-2019; Seelos, Frank/C-7875-2016; Moersch, Jeffrey E/F-7189-2010; Madsen, Morten Bo/D-2082-2011; Kinch, Kjartan Bergeron/C-5742-2015; Hayes, Alexander G/P-2024-2014	Lemmon, Mark T/0000-0002-4504-5136; Lemmon, Mark/0000-0002-4504-5136; Johnson, Jeffrey R/0000-0002-5586-4901; Seelos, Frank/0000-0001-9721-941X; Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Hayes, Alexander G/0000-0001-6397-2630; Wang, Aimei/0000-0002-6575-4028; Soderblom, Jason/0000-0003-3715-6407; McLennan, Scott/0000-0003-4259-7178				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BELL J, 2004, 8298 IAU; BELL JA, UNPUB; Bell JF, 1997, J GEOPHYS RES-PLANET, V102, P9109, DOI 10.1029/96JE03990; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Cabrol NA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002026; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hapke B., 1993, THEORY REFLECTANCE E; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Johnson JR, 2003, ICARUS, V163, P330, DOI 10.1016/S0019-1035(03)00084-8; Johnson JR, 1999, J GEOPHYS RES-PLANET, V104, P8809, DOI 10.1029/98JE02247; KLINGELHOFER G, 2004, LUNAR PLANET SCI, V35, P2184; LEMMON M, UNPUB; LEMMON MT, COMMUNICATION; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; MCCORD TB, 1982, J GEOPHYS RES, V87, P3021, DOI 10.1029/JB087iB04p03021; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; OckertBell ME, 1997, J GEOPHYS RES-PLANET, V102, P9039, DOI 10.1029/96JE03991; Selsis F, 2004, ASTRON ASTROPHYS, V416, P783, DOI 10.1051/0004-6361:20031724; Wolff MJ, 1999, J GEOPHYS RES-PLANET, V104, P9027, DOI 10.1029/98JE01967; WOLFF MJ, 2004, P LUN PLAN SCI 35	34	130	132	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					800	806		10.1126/science.1100175	http://dx.doi.org/10.1126/science.1100175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297658				2022-12-01	WOS:000223104900032
J	Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I				Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I			A plant vacuolar protease, VPE, mediates virus-induced hypersensitive cell death	SCIENCE			English	Article							PROCESSING ENZYME; PATHOGEN INTERACTIONS; STORAGE VACUOLES; LYTIC VACUOLES; APOPTOSIS; ENDOPEPTIDASE; PROTEINASE; PRECURSOR; CASPASES; REMOVAL	Programmed cell death (PCD) in animals depends on caspase protease activity. Plants also exhibit PCD, for example as a response to pathogens, although a plant caspase remains elusive. Here we show that vacuolar processing enzyme (VPE) is a protease essential for a virus-induced hypersensitive response that involves PCD. VPE deficiency prevented virus-induced hypersensitive cell death in tobacco plants. VPE is structurally unrelated to caspases, although VPE has a caspase-1 activity. Thus, plants have evolved a regulated cellular suicide strategy that, unlike PCD of animals, is mediated by VPE and the cellular vacuole.	Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Natl Agr Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Yamada, Kenji/C-4336-2018; Hatsugai, Noriyuki/O-9156-2015	Yamada, Kenji/0000-0003-4872-3729; Hatsugai, Noriyuki/0000-0002-5708-4263; Nishimura, Mikio/0000-0001-7960-9721; Kuroyanagi, Miwa/0000-0003-4362-8415				Angell SM, 1999, PLANT J, V20, P357, DOI 10.1046/j.1365-313X.1999.t01-1-00597.x; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Goodman R.N., 1994, HYPERSENSITIVE REACT; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; Hara-Nishimura I, 1998, HDB PROTEOLYTIC ENZY, P746; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; HARANISHIMURA I, 2000, VACUOLAR COMPARTMENT, P20; HATSUGAI N, UNPUB; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2002, PLANT CELL PHYSIOL, V43, P143, DOI 10.1093/pcp/pcf035; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mitsuhashi N, 2001, PLANT CELL, V13, P2361; Mittler R, 1997, J CELL SCI, V110, P1333; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	28	466	511	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					855	858		10.1126/science.1099859	http://dx.doi.org/10.1126/science.1099859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297671				2022-12-01	WOS:000223104900046
J	Gravett, MG; Novy, MJ; Rosenfeld, RG; Reddy, AP; Jacob, T; Turner, M; McCormack, A; Lapidus, JA; Hitti, J; Eschenbach, DA; Roberts, CT; Nagalla, SR				Gravett, MG; Novy, MJ; Rosenfeld, RG; Reddy, AP; Jacob, T; Turner, M; McCormack, A; Lapidus, JA; Hitti, J; Eschenbach, DA; Roberts, CT; Nagalla, SR			Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYMERASE-CHAIN-REACTION; AMNIOTIC-FLUID INFECTION; SELDI-TOF MS; INTRAUTERINE INFECTION; PRETERM DELIVERY; FETAL; CHORIOAMNIONITIS; ANTIBIOTICS; PROTEINS; INFANTS	Context Intra-amniotic infection (IAI) is commonly associated with preterm birth and adverse neonatal sequelae. Early diagnosis of IAI, however, has been hindered by insensitive or nonspecific tests. Objective To identify unique protein signatures in rhesus monkeys with experimental IAI, a proteomics-based analysis of amniotic fluid was used to develop diagnostic biomarkers for subclinical IN in amniotic fluid and blood of women with preterm labor. Design, Setting, and Participants Surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry, gel electrophoresis, and tandem mass spectrometry were used to characterize amniotic fluid peptides in 19 chronically instrumented pregnant rhesus monkeys before and after experimental IAI. Candidate biomarkers were determined by liquid chromatography-tandem mass spectrometry. Polyclonal antibodies were generated from synthetic peptides for validation of biomarkers of IAI Amniotic fluid peptide profiles identified in experimental IN were subsequently tested in a cohort of 33 women admitted to Seattle, Wash, hospitals between June 25, 1991, and June 30, 1997, with preterm delivery at 35 weeks or earlier associated with subclinical IAI (n=11), preterm delivery at 35 weeks or earlier without IN (n = 11), and preterm contractions with subsequent term delivery at later than 35 weeks (n=11). Main Outcome Measures Identification of peptide biomarkers for occult IAI. Results Protein expression profiles in amniotic fluid showed unique signatures of overexpression of polypeptides in the 3- to 5-kDa and 10- to 12-kDa molecular weight ranges in all animals after infection and in no animal prior to infection. In women, the 10- to 12-kDa signature was identified in all 11 patients with subclinical IAI, in 2 of 11 with preterm delivery without IAI, and in 0 of 11 with preterm labor and term delivery without infection (P<.001). Peptide fragment analysis of the diagnostic peak in amniotic fluid identified calgranulin B and a unique fragment of insulinlike growth factor binding protein 1, which were also expressed in maternal serum. Mapping of other amniotic fluid proteins differentially expressed in IAI identified several immunoregulators not previously described in amniotic fluid. Conclusions This proteomics-based characterization of the differential expression of amniotic fluid proteins in IAI identified a distinct proteomic profile in an experimental primate chorioamnionitis model that detected subclinical IN in a human cohort with preterm labor. These diagnostic protein expression signatures, complemented by immunodetection of specific biomarkers in amniotic fluid and in maternal serum, might have application in the early detection of IAI.	Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Prevent Med, Portland, OR 97201 USA; ProteoGenix Inc, Portland, OR USA; Lucile Packard Fdn Childrens Hlth, Palo Alto, CA USA; Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Gravett, MG (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	gravettm@oshu.edu	Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772	NCRR NIH HHS [RR00163] Funding Source: Medline; NIAID NIH HHS [AI42490] Funding Source: Medline; NICHD NIH HHS [HD06159] Funding Source: Medline; NIDDK NIH HHS [1U24DK5870] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD006159, R01HD006159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042490] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; BEJAR R, 1988, AM J OBSTET GYNECOL, V159, P357, DOI 10.1016/S0002-9378(88)80084-X; Courchesne PL, 1999, METH MOL B, V112, P487; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; Gibbs RS, 1997, AM J OBSTET GYNECOL, V177, P375, DOI 10.1016/S0002-9378(97)70201-1; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gravett M, 2003, AM J OBSTET GYNECOL, V189, pS56, DOI 10.1016/j.ajog.2003.10.002; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Gravett MG, 2000, AM J OBSTET GYNECOL, V182, P1404, DOI 10.1067/mob.2000.106180; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HILLIER SL, 1991, AM J OBSTET GYNECOL, V165, P955, DOI 10.1016/0002-9378(91)90447-Y; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hills FA, 1996, EARLY HUM DEV, V44, P71, DOI 10.1016/0378-3782(95)01694-5; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Issaq HJ, 2003, ANAL CHEM, V75, p148A, DOI 10.1021/ac031249c; MAILE L, 1999, IGF SYSTEM; Markenson GR, 1997, AM J OBSTET GYNECOL, V177, P1471, DOI 10.1016/S0002-9378(97)70093-0; Marvin L, 2000, RAPID COMMUN MASS SP, V14, P1287, DOI 10.1002/1097-0231(20000730)14:14<1287::AID-RCM27>3.0.CO;2-2; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; NEWTON ER, 1993, CLIN OBSTET GYNECOL, V36, P795, DOI 10.1097/00003081-199312000-00004; NOVY MJ, 1995, CLIN OBSTET GYNECOL, V38, P790, DOI 10.1097/00003081-199538040-00013; NOVY MJ, 2001, J SOC GYNECOL INVE S, V8, pA48; Page NM, 2002, REPRODUCTION, V123, P487, DOI 10.1530/reprod/123.4.487; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; ROMERO R, 1991, ANN NY ACAD SCI, V622, P355; SADOWSKY DW, 2002, J SOC GYNECOL INVEST, V9, pA206; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Yates Jr, 1999, METH MOL B, V112, P553; Yoon BH, 1998, AM J OBSTET GYNECOL, V179, P1254, DOI 10.1016/S0002-9378(98)70142-5	35	221	235	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					462	469		10.1001/jama.292.4.462	http://dx.doi.org/10.1001/jama.292.4.462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280344	Bronze			2022-12-01	WOS:000222900500023
J	Rogers, ME; Ilg, T; Nikolaev, AV; Ferguson, MAJ; Bates, PA				Rogers, ME; Ilg, T; Nikolaev, AV; Ferguson, MAJ; Bates, PA			Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG	NATURE			English	Article							ACID-PHOSPHATASE; INFECTIVE STAGE; MEXICANA; LIPOPHOSPHOGLYCAN; PHOSPHOGLYCAN; PROMASTIGOTES; VECTOR; PROTEOPHOSPHOGLYCANS; MACROPHAGES; SALIVA	Sand flies are the exclusive vectors of the protozoan parasite Leishmania(1), but the mechanism of transmission by fly bite has not been determined nor incorporated into experimental models of infection. In sand flies with mature Leishmania infections the anterior midgut is blocked by a gel of parasite origin, the promastigote secretory gel(2,3). Here we analyse the inocula from Leishmania mexicana-infected Lutzomyia longipalpis sand flies. Analysis revealed the size of the infectious dose, the underlying mechanism of parasite delivery by regurgitation, and the novel contribution made to infection by filamentous proteophosphoglycan (fPPG), a component of promastigote secretory gel found to accompany the parasites during transmission. Collectively these results have important implications for understanding the relationship between the parasite and its vector, the pathology of cutaneous leishmaniasis in humans and also the development of effective vaccines and drugs. These findings emphasize that to fully understand transmission of vector-borne diseases the interaction between the parasite, its vector and the mammalian host must be considered together.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Max Planck Inst Biol, Abt Membranbiochem, D-72076 Tubingen, Germany; Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland	Liverpool School of Tropical Medicine; University of Liverpool; Max Planck Society; University of Dundee	Bates, PA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	pbates@liv.ac.uk	Ferguson, Michael A. J./F-7829-2010	Ferguson, Michael A. J./0000-0003-1321-8714; Bates, Paul/0000-0001-6861-5421	Wellcome Trust [064945] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; BATES PA, 1990, MOL BIOCHEM PARASIT, V39, P247, DOI 10.1016/0166-6851(90)90063-R; BEACH R, 1985, AM J TROP MED HYG, V34, P278, DOI 10.4269/ajtmh.1985.34.278; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Castro-Sousa F, 2001, MEM I OSWALDO CRUZ, V96, P997, DOI 10.1590/S0074-02762001000700019; Gopfert U, 1999, BIOCHEM J, V344, P787, DOI 10.1042/0264-6021:3440787; HERTIG M, 1963, EXP PARASITOL, V14, P92, DOI 10.1016/0014-4894(63)90014-6; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; ILG T, 1993, EUR J BIOCHEM, V217, P603, DOI 10.1111/j.1432-1033.1993.tb18283.x; Ilg T, 1996, J BIOL CHEM, V271, P21583, DOI 10.1074/jbc.271.35.21583; Ilg T, 2001, J BIOL CHEM, V276, P4988, DOI 10.1074/jbc.M008030200; Ilg T, 2000, EMBO J, V19, P1953, DOI 10.1093/emboj/19.9.1953; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; NIKOLAEV AV, 1995, CARBOHYD RES, V272, P179, DOI 10.1016/0008-6215(95)00067-4; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; SARAIVA EMB, 1995, PARASITOLOGY, V111, P275, DOI 10.1017/S003118200008183X; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; Stierhof YD, 1999, EUR J CELL BIOL, V78, P675, DOI 10.1016/S0171-9335(99)80036-3; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; *UNDP WORLD BANK W, 2004, LEISHM; WARBURG A, 1986, AM J TROP MED HYG, V35, P926, DOI 10.4269/ajtmh.1986.35.926; WIESE M, 1995, EMBO J, V14, P1067, DOI 10.1002/j.1460-2075.1995.tb07089.x	28	189	199	2	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					463	467		10.1038/nature02675	http://dx.doi.org/10.1038/nature02675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269771	Green Accepted			2022-12-01	WOS:000222801400046
J	Vignal, C; Mathevon, N; Mottin, S				Vignal, C; Mathevon, N; Mottin, S			Audience drives male songbird response to partner's voice	NATURE			English	Article							TAENIOPYGIA-GUTTATA; SOCIAL-BEHAVIOR; RECOGNITION; CONTEXT; BUDGERIGARS; COURTSHIP; CHICKEN; CALLS; SEAL	According to the social intelligence hypothesis, social context represents an important force driving the selection of animal cognitive abilities such as the capacity to estimate the nature of the social relationships between other individuals(1-4). Despite this importance, the influence of this force has been assessed only in primates and never in other animals showing social interactions(5-7). In this way, avian communication generally takes place in a network of signallers and receivers, which represents an audience altering individual signalling behaviours(8,9). Indeed, vocal amplitude(10) and repertoire(11) are known to be socially regulated and the attitude towards the opposite sex may change depending on the audience(8,12,13). This 'audience effect'(8,14-16) provides support for the reality of social awareness in some bird species. However no evidence has yet been found to suggest that birds are able to estimate the characteristics of the social relationships between group-mates. Here we show that the male of a gregarious songbird species-the zebra finch (Taeniopygia guttata)-pays attention to the mating status of conspecific pairs, and uses this information to control its behaviour towards its female partner.	Univ Paris 11 Orsay, CNRS, UMR 8620, NAMC,Equipe Commun Acoust, F-42023 St Etienne 2, France; Univ St Etienne, CNRS, UMR 5516, TSI, F-42023 St Etienne 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet	Mathevon, N (corresponding author), Univ Paris 11 Orsay, CNRS, UMR 8620, NAMC,Equipe Commun Acoust, F-42023 St Etienne 2, France.	mathevon@univ-st-etienne.fr	MOTTIN, Stéphane/F-6850-2011	MOTTIN, Stéphane/0000-0002-7088-4353; Mathevon, Nicolas/0000-0003-0219-6601				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; AUBIN T, 1994, BIOACOUSTICS, V6, P80; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Barton RA, 1997, MACHIAVELLIAN INTELL, P240, DOI DOI 10.1017/CBO9780511525636.010; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Byrne R., 1988, MACHIAVELLIAN INTELL; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Cynx J, 2004, ANIM BEHAV, V67, P451, DOI 10.1016/j.anbehav.2003.04.008; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; MARLER P, 1986, ANIM BEHAV, V34, P194, DOI 10.1016/0003-3472(86)90023-0; McGregor Peter K., 2000, P329; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; Perry S, 2004, ANIM BEHAV, V67, P165, DOI 10.1016/j.anbehav.2003.04.005; ROBISSON P, 1993, ETHOLOGY, V94, P279; Sokal RR, 1995, BIOMETRY, P57; Striedter GF, 2003, ANIM BEHAV, V65, P875, DOI 10.1006/anbe.2003.2135; Tomasello M., 1997, PRIMATE COGNITION; [No title captured]	25	148	151	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					448	451		10.1038/nature02645	http://dx.doi.org/10.1038/nature02645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269767	Green Submitted			2022-12-01	WOS:000222801400041
J	Dobbelaere, J; Barral, Y				Dobbelaere, J; Barral, Y			Spatial coordination of cytokinetic events by compartmentalization of the cell cortex	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED SECRETION; YEAST CYTOKINESIS; SEPTIN DYNAMICS; FISSION YEAST; BUDDING YEAST; RING; MORPHOGENESIS; ACTOMYOSIN; SEC3P	During cytokinesis, furrow ingression and plasma membrane fission irreversibly separate daughter cells. How actomyosin ring assembly and contraction, vesicle fusion, and abscission are spatially coordinated was unknown. We found that during cytokinesis septin rings, located on both sides of the actomyosin ring, acted as barriers to compartmentalize the cortex around the cleavage site. Compartmentalization maintained diffusible cortical factors, such as the exocyst and the polarizome, to the site of cleavage. In turn, such factors were required for actomyosin ring function and membrane abscission. Thus, a specialized cortical compartment ensures the spatial coordination of cytokinetic events.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Barral, Y (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch		Barral, Yves/0000-0002-0989-3373; Dobbelaere, Jeroen/0000-0002-6727-532X				Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Berlin A, 2003, J CELL BIOL, V160, P1083, DOI 10.1083/jcb.200212016; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Finger FP, 1997, MOL BIOL CELL, V8, P647, DOI 10.1091/mbc.8.4.647; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2001, CELL STRUCT FUNCT, V26, P667, DOI 10.1247/csf.26.667; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Lippincott J, 2001, J CELL SCI, V114, P1379; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tolliday N, 2001, CURR OPIN MICROBIOL, V4, P690, DOI 10.1016/S1369-5274(01)00270-3; Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4	26	214	220	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					393	396		10.1126/science.1099892	http://dx.doi.org/10.1126/science.1099892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256669				2022-12-01	WOS:000222662400037
J	Giannakou, ME; Goss, M; Junger, MA; Hafen, E; Leevers, SJ; Partridge, L				Giannakou, ME; Goss, M; Junger, MA; Hafen, E; Leevers, SJ; Partridge, L			Long-lived Drosophila with overexpressed dFOXO in adult fat body	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; INSULIN-RECEPTOR; C-ELEGANS; LIFE-SPAN; DAF-16; LONGEVITY; TISSUE		UCL, Dept Biol, London WC1E 6BT, England; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; London Res Inst, Growth Regulat Lab, Canc Res UK, London WC2A 3PX, England	University of London; University College London; University of Zurich; Cancer Research UK	Partridge, L (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	L.Partridge@ucl.ac.uk	southall, Maria/ABA-4608-2021; Partridge, Linda/E-7342-2015; Jünger, Martin A./A-8010-2011; Partridge, Linda/A-5501-2010	southall, Maria/0000-0002-7935-6231; Partridge, Linda/0000-0001-9615-0094	Biotechnology and Biological Sciences Research Council [SF19106] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; GIANNAKOU M, UNPUB; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998	9	422	442	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2004	305	5682					361	361		10.1126/science.1098219	http://dx.doi.org/10.1126/science.1098219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15192154				2022-12-01	WOS:000222662400028
J	Smith, DJ; Lapedes, AS; de Jong, JC; Bestebroer, TM; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM				Smith, DJ; Lapedes, AS; de Jong, JC; Bestebroer, TM; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM			Mapping the antigenic and genetic evolution of influenza virus	SCIENCE			English	Article							T-LYMPHOCYTE ESCAPE; HEMAGGLUTININ; SELECTION; DYNAMICS	The antigenic evolution of influenza A (H3N2) virus was quantified and visualized from its introduction into humans in 1968 to 2003. Although there was remarkable correspondence between antigenic and genetic evolution, significant differences were observed: Antigenic evolution was more punctuated than genetic evolution, and genetic change sometimes had a disproportionately large antigenic effect. The method readily allows monitoring of antigenic differences among vaccine and circulating strains and thus estimation of the effects of vaccination. Further, this approach offers a route to predicting the relative success of emerging strains, which could be achieved by quantifying the combined effects of population level immune escape and viral fitness on strain evolution.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; United States Department of Energy (DOE); Los Alamos National Laboratory	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172				Alexander DJ, 1997, AVIAN PATHOL, V26, P399, DOI 10.1080/03079459708419222; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Daly JM, 1996, J GEN VIROL, V77, P661, DOI 10.1099/0022-1317-77-4-661; Dekker A, 1995, VET MICROBIOL, V47, P317, DOI 10.1016/0378-1135(95)00116-6; EDELSTEIN L, 1978, J THEOR BIOL, V73, P181, DOI 10.1016/0022-5193(78)90185-6; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Hampson AW, 2002, PERSP MED V, V7, P49; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lapedes A, 2001, J THEOR BIOL, V212, P57, DOI 10.1006/jtbi.2001.2347; LENNETTE DA, 1995, DIAGNOSTIC PROCEDURE; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; RENFELL BT, 2004, SCIENCE, V303, P327; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; SALK JE, 1949, AM J PUBLIC HEALTH, V39, P345, DOI 10.2105/AJPH.39.3.345; SHEPARD RN, 1963, HUM FACTORS, V5, P33, DOI 10.1177/001872086300500104; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Smith DJ, 1998, ARTIFICIAL IMMUNE SY, P105; SNEATH P. H. A., 1973, NUMERICAL TAXONOMY; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; UNDERWOOD PA, 1982, J GEN VIROL, V62, P153, DOI 10.1099/0022-1317-62-1-153; WEIJERS TF, 1985, J VIROL METHODS, V10, P241, DOI 10.1016/0166-0934(85)90064-3; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	34	1140	1194	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					371	376		10.1126/science.1097211	http://dx.doi.org/10.1126/science.1097211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15218094				2022-12-01	WOS:000222662400031
J	Dausmann, KH; Glos, J; Ganzhorn, JU; Heldmaier, G				Dausmann, KH; Glos, J; Ganzhorn, JU; Heldmaier, G			Physiology: Hibernation in a tropical primate - Even in the wound-down hibernating state, this lemur can warm up without waking up.	NATURE			English	Editorial Material							ENERGETIC CONSEQUENCES; MAMMALIAN HIBERNATION		Univ Marburg, Dept Anim Physiol, D-35043 Marburg, Germany; Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; Univ Hamburg, Dept Anim Ecol & Conservat, D-20146 Hamburg, Germany	Philipps University Marburg; University of Wurzburg; University of Hamburg	Heldmaier, G (corresponding author), Univ Marburg, Dept Anim Physiol, D-35043 Marburg, Germany.	dausmann@staff.uni-marburg.de	Dausmann, Kathrin/E-9270-2017; Ganzhorn, Joerg/AAO-6955-2020; Heldmaier, Gerhard/AAI-3286-2020	Ganzhorn, Joerg/0000-0003-1395-9758; 				ARNOLD W, 1991, J THERM BIOL, V16, P223, DOI 10.1016/0306-4565(91)90029-2; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Heldmaier Gerhard, 1993, P175; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Schmid J, 1998, INT J PRIMATOL, V19, P797, DOI 10.1023/A:1020389228665; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012	6	200	204	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2004	429	6994					825	826		10.1038/429825a	http://dx.doi.org/10.1038/429825a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215852				2022-12-01	WOS:000222213000029
J	Du, JL; Poo, MM				Du, JL; Poo, MM			Rapid BDNF-induced retrograde synaptic modification in a developing retinotectal system	NATURE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; RETINAL GANGLION-CELLS; VISUAL-SYSTEM; NEUROTROPHIC FACTOR; NEURAL-NETWORKS; RECEPTOR; SYNAPSES; CONDUCTANCE; PROPAGATION	In cultures of hippocampal neurons, induction of long-term synaptic potentiation or depression by repetitive synaptic activity is accompanied by a retrograde spread of potentiation or depression, respectively, from the site of induction at the axonal outputs to the input synapses on the dendrites of the presynaptic neuron(1,2). We report here that rapid retrograde synaptic modification also exists in an intact developing retinotectal system. Local application of brain-derived neurotrophic factor ( BDNF) to the Xenopus laevis optic tectum, which induced persistent potentiation of retinotectal synapses, led to a rapid modification of synaptic inputs at the dendrites of retinal ganglion cells (RGCs), as shown by a persistent enhancement of light-evoked excitatory synaptic currents and spiking activity of RGCs. This retrograde effect required TrkB receptor activation, phospholipase Cgamma activity and Ca2+ elevation in RGCs, and was accounted for by a selective increase in the number of postsynaptic AMPA-subtype glutamate receptors at RGC dendrites. Such retrograde information flow in the neuron allows rapid regulation of synaptic inputs at the dendrite in accordance to signals received at axon terminals, a process reminiscent of back-propagation algorithm for learning in neural networks(3).	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu						Balkowiec A, 2002, J NEUROSCI, V22, P10399; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; CHURCHLAND PS, 1992, COMPUTATIONAL BRAIN; Chytrova G, 2004, MOL CELL NEUROSCI, V25, P549, DOI 10.1016/j.mcn.2003.11.009; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lom B, 2002, J NEUROSCI, V22, P7639; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; PURVES D, 1976, NATURE, V260, P535, DOI 10.1038/260535a0; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; Watson FL, 1999, J NEUROSCI, V19, P7889; WINGATE RJT, 1994, J NEUROSCI, V14, P6621; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	30	88	92	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					878	883		10.1038/nature02618	http://dx.doi.org/10.1038/nature02618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215865				2022-12-01	WOS:000222213000043
J	Lane, D				Lane, D			Curing cancer with p53	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland	University of Dundee	Lane, D (corresponding author), Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland.		Lane, David P/C-4920-2008	Lane, David/0000-0003-0551-3545				HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996	4	23	24	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2004	350	26					2711	2712		10.1056/NEJMcibr041288	http://dx.doi.org/10.1056/NEJMcibr041288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831MR	15215489				2022-12-01	WOS:000222199000015
J	Day, C; Degenhardt, L; Gilmour, S; Hall, W				Day, C; Degenhardt, L; Gilmour, S; Hall, W			Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes	BRITISH MEDICAL JOURNAL			English	Article							AUSTRALIA		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Queensland, Off Publ Policy & Eth, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; University of Queensland	Day, C (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	carolyn.day@unsw.edu.au	Hall, Wayne D/A-3283-2008; Degenhardt, Louisa J/D-4515-2012	Hall, Wayne D/0000-0003-1984-0096; Degenhardt, Louisa J/0000-0002-8513-2218				Darke S, 2002, ADDICTION, V97, P179, DOI 10.1046/j.1360-0443.2002.00032.x; Degenhardt L., 2004, CAUSES COURSE CONSEQ; Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101; *NAT CTR HIV EP CL, 2003, HIV AIDS VIR HEP SEX; TOPP L, 2002, AUSTR DRUG TRENDS 20	5	30	30	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					428	429		10.1136/bmj.38201.410255.55	http://dx.doi.org/10.1136/bmj.38201.410255.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15292056	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000223520300016
J	Gong, Y; Mo, CH; Fraser, SE				Gong, Y; Mo, CH; Fraser, SE			Planar cell polarity signalling controls cell division orientation during zebrafish gastrulation	NATURE			English	Article							NEURAL PLATE; MITOTIC SPINDLE; NERVOUS-SYSTEM; XENOPUS-LAEVIS; WNT PATHWAY; MOVEMENTS; EMBRYOS; FATE; EXTENSION; NOTOCHORD	Oriented cell division is an integral part of pattern development in processes ranging from asymmetric segregation of cell-fate determinants to the shaping of tissues(1,2). Despite proposals that it has an important function in tissue elongation(3,4), the mechanisms regulating division orientation have been little studied outside of the invertebrates Caenorhabditis elegans and Drosophila melanogaster(1). Here, we have analysed mitotic divisions during zebrafish gastrulation using in vivo confocal imaging and found that cells in dorsal tissues preferentially divide along the animal - vegetal axis of the embryo. Establishment of this animal vegetal polarity requires the Wnt pathway components Silberblick/ Wnt11, Dishevelled and Strabismus. Our findings demonstrate an important role for non-canonical Wnt signalling in oriented cell division during zebrafish gastrulation, and indicate that oriented cell division is a driving force for axis elongation. Furthermore, we propose that non-canonical Wnt signalling has a conserved role in vertebrate axis elongation, orienting both cell intercalation and mitotic division.	CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Fraser, SE (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA.	sefraser@caltech.edu	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223				Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; BLACK SD, 1988, DEV BIOL, V128, P65, DOI 10.1016/0012-1606(88)90267-9; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Concha ML, 1998, DEVELOPMENT, V125, P983; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HERTWIG O, ARCH MIKROSK ANAT, V42, P662; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; MOON RT, 1993, DEVELOPMENT, V119, P97; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SAUSEDO RA, 1994, ANAT REC, V239, P103, DOI 10.1002/ar.1092390112; Sausedo RA, 1997, J COMP NEUROL, V381, P473; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; SCHOENWOLF GC, 1989, DEVELOPMENT, V106, P427; Tada M, 2000, DEVELOPMENT, V127, P2227; Tago K, 2000, GENE DEV, V14, P1741; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wei Y, 2000, DEVELOPMENT, V127, P87; WOO K, 1995, DEVELOPMENT, V121, P2595	30	314	318	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					689	693		10.1038/nature02796	http://dx.doi.org/10.1038/nature02796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15254551				2022-12-01	WOS:000223085400049
J	Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S				Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S			Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number	LANCET			English	Article							WESTERN BORDER; INCREASED SENSITIVITY; DRUG SUSCEPTIBILITY; ARTESUNATE; MALARIA; ANTIMALARIALS; POLYMORPHISMS; AMPLIFICATION; COMBINATION; POPULATION	Background The borders of Thailand harbour the world's most multidrug resistant Plasmodium falciparum parasites. In 1984 mefloquine was introduced as treatment for uncomplicated falciparum malaria, but substantial resistance developed within 6 years. A combination of artesunate with mefloquine now cures more than 95% of acute infections. For both treatment regimens, the underlying mechanisms of resistance are not known. Methods The relation between polymorphisms in the P falciparum multidrug resistant gene 1 (pfmdr1) and the in-vitro and in-vivo responses to mefloquine were assessed in 618 samples from patients with falciparum malaria studied prospectively over 12 years. pfmdr1 copy number was assessed by a robust real-time PCR assay. Single nucleotide polymorphisms of pfmdr1, P falciparum chloroquine resistance transporter gene (pfcrt) and P falciparum Ca2+ ATPase gene (pfATP6) were assessed by PCR-restriction fragment length polymorphism. Findings Increased copy number of pfmdr1 was the most important determinant of in-vitro and in-vivo resistance to mefloquine, and also to reduced artesunate sensitivity in vitro. In a Cox regression model with control for known confounders, increased pfmdr1 copy number was associated with an attributable hazard ratio (AHR) for treatment failure of 6.3 (95% CI 2.9-13.8, p<0.001) after mefloquine monotherapy and 5.4 (2.0-14.6, p=0.001) after artesunate-mefloquine therapy. Single nucleotide polymorphisms in pfmdr1 were associated with increased mefloquine susceptibility in vitro, but not in vivo. Interpretation Amplification in pfmdr1 is the main cause of resistance to mefloquine in falciparum malaria. Relevance to practice Multidrug resistant P falciparum malaria is common in southeast Asia, but difficult to identify and treat. Genes that encode parasite transport proteins maybe involved in export of drugs and so cause resistance. In this study we show that increase in copy number of pfmdr1, a gene encoding a parasite transport protein, is the best overall predictor of treatment failure with mefloquine. Increase in pfmdr1 copy number predicts failure even after chemotherapy with the highly effective combination of mefloquine and 3 days' artesunate. Monitoring of pfmdr1 copy number will be useful in epidemiological surveys of drug resistance in P falciparum, and potentially for predicting treatment failure in individual patients.	Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England; Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	St Georges University London; University of Oxford; Mahidol University; Charles Darwin University; Menzies School of Health Research; Mahidol University	Krishna, S (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England.	s.krishna@sghms.ac.uk	McGready, Rose/A-3290-2014; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019	McGready, Rose/0000-0003-1621-3257; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Laing, Ken/0000-0003-1883-3433; Price, Richard/0000-0003-2000-2874; Krishna, Sanjeev/0000-0003-0066-0634	Wellcome Trust [074637] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Basco LK, 1996, EXP PARASITOL, V82, P97, DOI 10.1006/expr.1996.0013; Basco LK, 1995, MOL BIOCHEM PARASIT, V74, P157, DOI 10.1016/0166-6851(95)02492-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1994, ACTA TROP, V56, P157, DOI 10.1016/0001-706X(94)90061-2; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Plowe CV, 2001, INFEC DIS S, P173; Price R, 1997, MOL BIOCHEM PARASIT, V85, P161, DOI 10.1016/S0166-6851(96)02822-8; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; terKuile FO, 1995, T ROY SOC TROP MED H, V89, P660, DOI 10.1016/0035-9203(95)90435-2; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Vaidya AB, 2001, INFEC DIS S, P203; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	30	607	619	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					438	447		10.1016/S0140-6736(04)16767-6	http://dx.doi.org/10.1016/S0140-6736(04)16767-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288742	Green Accepted			2022-12-01	WOS:000222998600034
J	Bakolitsa, C; Cohen, DM; Bankston, LA; Bobkov, AA; Cadwell, GW; Jennings, L; Critchley, DR; Craig, SW; Liddington, RC				Bakolitsa, C; Cohen, DM; Bankston, LA; Bobkov, AA; Cadwell, GW; Jennings, L; Critchley, DR; Craig, SW; Liddington, RC			Structural basis for vinculin activation at sites of cell adhesion	NATURE			English	Article							ALPHA-CATENIN; INTRAMOLECULAR ASSOCIATION; CRYSTAL-STRUCTURE; TALIN-BINDING; TAIL DOMAINS; ACTIN; PROTEINS; VASP; HEAD	Vinculin is a highly conserved intracellular protein with a crucial role in the maintenance and regulation of cell adhesion and migration(1-3). In the cytosol, vinculin adopts a default autoinhibited conformation(4,5). On recruitment to cell - cell and cell - matrix adherens-type junctions, vinculin becomes activated and mediates various protein - protein interactions that regulate the links between F-actin and the cadherin and integrin families of cell-adhesion molecules. Here we describe the crystal structure of the full-length vinculin molecule ( 1,066 amino acids), which shows a five-domain autoinhibited conformation in which the carboxyterminal tail domain is held pincer-like by the vinculin head, and ligand binding is regulated both sterically and allosterically. We show that conformational changes in the head, tail and proline-rich domains are linked structurally and thermodynamically, and propose a combinatorial pathway to activation that ensures that vinculin is activated only at sites of cell adhesion when two or more of its binding partners are brought into apposition.	Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University; University of Leicester	Liddington, RC (corresponding author), Burnham Inst, Program Cell Adhes, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@burnham.org	Ladoux, Benoit/A-9879-2013	Bakolitsa, Constantina/0000-0002-6980-9831; Cohen, Daniel/0000-0002-7963-668X				Adey NB, 1997, BIOCHEM J, V324, P523, DOI 10.1042/bj3240523; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JANSSEN MEW, UNPUB J CELL BIOL; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Liddington RC, 2000, EXP CELL RES, V261, P37, DOI 10.1006/excr.2000.5058; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; Miller GJ, 2001, J BIOL CHEM, V276, P28829, DOI 10.1074/jbc.M102561200; OHALLORAN T, 1986, METHOD ENZYMOL, V134, P69; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; PRICE GJ, 1989, BIOCHEM J, V259, P453, DOI 10.1042/bj2590453; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; VOLBERG T, 1995, J CELL SCI, V108, P2253; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200; Xu WM, 1998, DEVELOPMENT, V125, P327; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645	30	269	276	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					583	586		10.1038/nature02610	http://dx.doi.org/10.1038/nature02610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15195105				2022-12-01	WOS:000222946100053
J	Sayah, DM; Sokolskaja, E; Berthoux, L; Luban, J				Sayah, DM; Sokolskaja, E; Berthoux, L; Luban, J			Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; L1 RETROTRANSPOSITION; PROCESSED PSEUDOGENES; T-CELLS; EVOLUTION; PROTEIN; GENE; RESTRICTION; EXPRESSION; INFECTION	In Old World primates, TRIM5-alpha confers a potent block to human immunodeficiency virus type 1 ( HIV-1) infection that acts after virus entry into cells(1-5). Cyclophilin A ( CypA) binding to viral capsid protects HIV-1 from a similar activity in human cells(4,6-8). Among New World primates, only owl monkeys exhibit post-entry restriction of HIV-1 (ref. 1). Paradoxically, the barrier to HIV-1 in owl monkey cells is released by capsid mutants or drugs that disrupt capsid interaction with CypA(4). Here we show that knockdown of owl monkey CypA by RNA interference (RNAi) correlates with suppression of anti-HIV-1 activity. However, reintroduction of CypA protein to RNAi-treated cells did not restore antiviral activity. A search for additional RNAi targets unearthed TRIMCyp, an RNAi-responsive messenger RNA encoding a TRIM5 - CypA fusion protein. TRIMCyp accounts for post-entry restriction of HIV-1 in owl monkeys and blocks HIV-1 infection when transferred to otherwise infectable human or rat cells. It seems that TRIMCyp arose after the divergence of New and Old World primates when a LINE-1 retrotransposon catalysed the insertion of a CypA complementary DNA into the TRIM5 locus. This is the first vertebrate example of a chimaeric gene generated by this mechanism of exon shuffling.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Luban, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St,HHSC 1502, New York, NY 10032 USA.	jl45@columbia.edu	Liu, FL/D-1795-2009	Luban, Jeremy/0000-0001-5650-4054; Sayah, David/0000-0001-7021-8273				Asmal M, 2003, IMMUNITY, V19, P535, DOI 10.1016/S1074-7613(03)00268-1; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Damert A, 2004, MOL BIOL EVOL, V21, P647, DOI 10.1093/molbev/msh056; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Ejima Y, 2003, HUM MOL GENET, V12, P1321, DOI 10.1093/hmg/ddg138; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Fehr T, 1999, J ANTIBIOT, V52, P474, DOI 10.7164/antibiotics.52.474; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roy-Engel AM, 2002, J MOL BIOL, V316, P1033, DOI 10.1006/jmbi.2001.5380; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Xu LX, 2003, EXP CELL RES, V288, P84, DOI 10.1016/S0014-4827(03)00187-3; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	30	528	553	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					569	573		10.1038/nature02777	http://dx.doi.org/10.1038/nature02777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15243629				2022-12-01	WOS:000222946100050
J	Kaasik, K; Lee, CC				Kaasik, K; Lee, CC			Reciprocal regulation of haem biosynthesis and the circadian clock in mammals	NATURE			English	Article							SYNTHASE ACTIVITY; MELATONIN RHYTHM; NITRIC-OXIDE; IN-VIVO; VITAMIN-B-12; MPER1; TRANSCRIPTION; PROMOTERS; MECHANISM; PROTEINS	The circadian clock is the central timing system that controls numerous physiological processes. In mammals, one such process is haem biosynthesis, which the clock controls through regulation of the rate-limiting enzyme aminolevulinate synthase 1 (Alas1)(1,2). Several members of the core clock mechanism are PAS domain proteins, one of which, neuronal PAS 2 (NPAS2), has a haem-binding motif(3,4). Indeed, haem controls activity of the BMAL1-NPAS2 transcription complex in vitro by inhibiting DNA binding in response to carbon monoxide(3). Here we show that haem differentially modulates expression of the mammalian Period genes mPer1 and mPer2 in vivo by a mechanism involving NPAS2 and mPER2. Further experiments show that mPER2 positively stimulates activity of the BMAL1-NPAS2 transcription complex and, in turn, NPAS2 transcriptionally regulates Alas1. Vitamin B12 and haem compete for binding to NPAS2 and mPER2, but they have opposite effects on mPer2 and mPer1 expression in vivo. Our data show that the circadian clock and haem biosynthesis are reciprocally regulated and suggest that porphyrin-containing molecules are potential targets for therapy of circadian disorders.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-51010 Tartu, Estonia	Baylor College of Medicine; University of Tartu	Lee, CC (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	cheng.c.lee@uth.tmc.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; FREEDMAN ML, 1974, J BIOL CHEM, V249, P7290; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hashimoto S, 1996, NEUROSCI LETT, V220, P129, DOI 10.1016/S0304-3940(96)13247-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Levitman M Kh, 2002, Radiats Biol Radioecol, V42, P511; Lincoln DW, 2000, INT J CANCER, V88, P479, DOI 10.1002/1097-0215(20001101)88:3<479::AID-IJC23>3.0.CO;2-Z; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McLEan GR, 1997, CANCER RES, V57, P4015; Nakamura T, 1997, CHRONOBIOL INT, V14, P549, DOI 10.3109/07420529709001446; Norman P, 2001, Curr Opin Investig Drugs, V2, P1611; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rubio MF, 2003, NEUROSCI LETT, V353, P9, DOI 10.1016/j.neulet.2003.08.075; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Scagliotti GV, 2003, J CLIN ONCOL, V21, P1556, DOI 10.1200/JCO.2003.06.122; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; TSUTSUI K, 1982, ANAL BIOCHEM, V121, P244, DOI 10.1016/0003-2697(82)90475-4; Tunctan B, 2002, CHRONOBIOL INT, V19, P393, DOI 10.1081/CBI-120002915; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhu YH, 2002, DNA CELL BIOL, V21, P333, DOI 10.1089/104454902753759744	29	278	288	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					467	471		10.1038/nature02724	http://dx.doi.org/10.1038/nature02724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269772				2022-12-01	WOS:000222801400047
J	Lippman, Z; Gendrel, AV; Black, M; Vaughn, MW; Dedhia, N; McCombie, WR; Lavine, K; Mittal, V; May, B; Kasschau, KD; Carrington, JC; Doerge, RW; Colot, V; Martienssen, R				Lippman, Z; Gendrel, AV; Black, M; Vaughn, MW; Dedhia, N; McCombie, WR; Lavine, K; Mittal, V; May, B; Kasschau, KD; Carrington, JC; Doerge, RW; Colot, V; Martienssen, R			Role of transposable elements in heterochromatin and epigenetic control	NATURE			English	Article							DNA METHYLATION; TANDEM REPEATS; RNAI; GENE; ARABIDOPSIS; DROSOPHILA; PLANTS; MAINTENANCE; INHERITANCE; PHENOTYPE	Heterochromatin has been defined as deeply staining chromosomal material that remains condensed in interphase, whereas euchromatin undergoes de-condensation(1). Heterochromatin is found near centromeres and telomeres, but interstitial sites of heterochromatin ( knobs) are common in plant genomes and were first described in maize(2). These regions are repetitive and late-replicating(3). In Drosophila, heterochromatin influences gene expression, a heterochromatin phenomenon called position effect variegation(4). Similarities between position effect variegation in Drosophila and gene silencing in maize mediated by "controlling elements" ( that is, transposable elements) led in part to the proposal that heterochromatin is composed of transposable elements, and that such elements scattered throughout the genome might regulate development(2). Using microarray analysis, we show that heterochromatin in Arabidopsis is determined by transposable elements and related tandem repeats, under the control of the chromatin remodelling ATPase DDM1 (Decrease in DNA Methylation 1). Small interfering RNAs (siRNAs) correspond to these sequences, suggesting a role in guiding DDM1. We also show that transposable elements can regulate genes epigenetically, but only when inserted within or very close to them. This probably accounts for the regulation by DDM1 and the DNA methyltransferase MET1 of the euchromatic, imprinted gene FWA, as its promoter is provided by transposable-element-derived tandem repeats that are associated with siRNAs.	Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; UEVE, CNRS, INRA, Unite Rech Genom Vegetale, F-91057 Evry, France; Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97330 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University	Martienssen, R (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	colot@evry.inra.fr; martiens@cshl.edu	Black, Michael/F-1484-2010; Carrington, James C/A-4656-2012; Gendrel, Anne-Valerie/E-5584-2017	Carrington, James C/0000-0003-3572-129X; Gendrel, Anne-Valerie/0000-0003-4510-0024; Black, Michael/0000-0003-1174-6054; Vaughn, Matthew/0000-0002-1384-4283; McCombie, W. Richard/0000-0003-1899-0682; Lippman, Zachary/0000-0001-7668-9025				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Craig BA, 2003, J AGRIC BIOL ENVIR S, V8, P1, DOI 10.1198/1085711031256; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hennig W, 1999, CHROMOSOMA, V108, P1, DOI 10.1007/s004120050346; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Verbsky ML, 2001, CURR OPIN PLANT BIOL, V4, P494, DOI 10.1016/S1369-5266(00)00206-5; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	32	876	930	4	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					471	476		10.1038/nature02651	http://dx.doi.org/10.1038/nature02651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269773				2022-12-01	WOS:000222801400048
J	Siegel, AW				Siegel, AW			Temporal restrictions and the impasse on human embryonic stem-cell research	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA	Johns Hopkins University	Siegel, AW (corresponding author), Johns Hopkins Univ, Sch Med, Phoebe R Berman Bioeth Inst, 624 N Broadway,Room 352, Baltimore, MD 21205 USA.	asiegel@jhsph.edu						[Anonymous], 2001, FACT SHEET EMBR STEM; COOK G, 2004, BOSTON GLOBE    0523; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dawson L, 2003, FERTIL STERIL, V80, P1077, DOI 10.1016/S0015-0282(03)02218-0; DICKINSON T, 1999, COMMUNICATION   0112; Knowles LP, 2004, NAT BIOTECHNOL, V22, P157, DOI 10.1038/nbt0204-157; *MRC, STEM CELLS INT POL D; National Institute for Biological Standards and Control, UK STEM CELL BANK NI; *NIH, STEM CELL INF INF EL; Robertson John A, 1988, IRB, V10, P5, DOI 10.2307/3564200; *UK PAT OFF, 2003, INV INV HUM EMBR STE; 2001, US C CATH BISH BUSHS	12	5	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					215	218		10.1016/S0140-6736(04)16638-5	http://dx.doi.org/10.1016/S0140-6736(04)16638-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246738				2022-12-01	WOS:000222612200036
J	Gutierrez, JP; Johns, B; Adam, T; Bertozzi, SM; Edejer, TTT; Greener, R; Hankins, C; Evans, DB				Gutierrez, JP; Johns, B; Adam, T; Bertozzi, SM; Edejer, TTT; Greener, R; Hankins, C; Evans, DB			Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?	LANCET			English	Article								The "3 by 5" goal to have 3 million people in low and middle income countries on antiretroviral therapy (ART) by the end of 2005 is ambitious. Estimates of the necessary resources are needed to facilitate resource mobilisation and rapid channelling of funds to where they are required. We estimated the financial costs needed to implement treatment protocols, by use of country-specific estimates for 34 countries that account for 90% of the need for ART in resource-poor settings. We first estimated the number of people needing ART and supporting programmes for each country. We then estimated the cost per patient for each programme by country to derive total costs. We estimate that between US$5.1 billion and US$5.9 billion will be needed by the end of 2005 to provide ART, support programmes, and cover country-level administrative and logistic costs for 3 by 5.	WHO, Hlth Syst Financing Expenditure & Resource Alloca, CH-1211 Geneva 27, Switzerland; Natl Inst Publ Hlth, Div Hlth Econ & Policy, Cuernavaca, Morelos, Mexico; Ctr Res & Educ Econ CIDE, Mexico City, DF, Mexico; UNAIDS, Strateg Informat Social Mobilisat & Informat, Geneva, Switzerland	World Health Organization; Instituto Nacional de Salud Publica; Centro de Investigacion y Docencia Economicas A.C. (CIDE); UNAIDS	Johns, B (corresponding author), WHO, Hlth Syst Financing Expenditure & Resource Alloca, CH-1211 Geneva 27, Switzerland.	Johnsb@who.int	Gutierrez, Juan Pablo/A-4253-2010	Gutierrez, Juan Pablo/0000-0002-0557-5562; Bertozzi, Stefano M/0000-0002-1723-7085; Hankins, Catherine/0000-0002-1642-8592				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Grant AD, 2001, AM J TROP MED HYG, V65, P810, DOI 10.4269/ajtmh.2001.65.810; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; *UNAIDS WHO, 2003, EM SCAL UP ANT THER; *UNICEF UNAIDS WHO, 2003, SOURC PRIC SEL MED D; World Health Organization, 2002, SCAL ANT THER RES LT	7	36	36	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					63	64		10.1016/S0140-6736(04)16590-2	http://dx.doi.org/10.1016/S0140-6736(04)16590-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234857				2022-12-01	WOS:000222392900032
J	Kober, K; Van Damme, W				Kober, K; Van Damme, W			Scaling up access to antiretroviral treatment in southern Africa: who will do the job?	LANCET			English	Article							COST-EFFECTIVENESS; HEALTH-WORKERS; CRISIS; CARE; AIDS	Malawi, Mozambique, Swaziland, and South Africa have some of the highest HIV/AIDS burdens in the world. All four countries have ambitious plans for scaling-up antiretroviral treatment for the millions of HIV-positive people in the region. In January 2004, we visited these countries with the intention of directly observing the effect of AIDS, especially on health systems, to talk with policy makers and field workers about their concerns and perspectives regarding the epidemic, and to investigate the main issues related to scaling up antiretroviral treatment. We found that financial resources are not regarded as the main immediate constraint anymore, but that the lack of human resources for health is deplored as the single most serious obstacle for implementing the national treatment plans. Yet, none of the countries has developed an urgently required comprehensive human resource strategy. This may also need increased donor attention and resources.	Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Van Damme, W (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	wvdamme@itg.be	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				[Anonymous], TUB MAL; Boelaert M, 2002, TROP MED INT HEALTH, V7, P1001, DOI 10.1046/j.1365-3156.2002.00972.x; Campbell C., 2003, LETTING THEM DIE WHY; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; de Castella T, 2003, LANCET, V362, P46, DOI 10.1016/S0140-6736(03)13848-2; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; Department of Health, 2003, NAT HIV SYPH ANT SER; Huddart J., 2003, HLTH SECTOR HUMAN RE; KEMP J, 2003, EQUINET DISCUSSION P, V12; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; MATOMORA MKS, 1989, SOC SCI MED, V28, P1081, DOI 10.1016/0277-9536(89)90391-2; *MIL MIN HLTH POP, 2003, JOINT PROGR WORK 200; *MIN HLTH POP, 2004, TREATM AIDS 2 YEAR P; *MIN HLTH SOC WELF, 2003, HLTH SECT RESP HIV A; Nattrass N., 2004, MORAL EC AIDS S AFRI; Padarath A., 2003, EQUINET DISCUSSION P; PIOT P, 2003, PRESIDENTAL FELLOWS; *REP MOC, 2003, MIN SAUD PEN ITS HIV; SHEVEL A, HOSP OFFER INCENTIVE; *SO AFR DEV COMM H, STAT SADC HLTH MIN R; South Africa Department of Health, 2003, OP PLAN COMPR HIV AI; *TREATM ACT CAMP, 2004, TAC NEWSLETTER  0316; UNAIDS, 2003, AIDS EP UPD; Wendo C, 2004, LANCET, V363, P222; *WHO, 1998, EST HLTH PERS PHYS N; World Health Organization, COUNTR DAT; World Health Organization, 2003, TREAT 3 MILL 2005 WH	27	173	176	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					103	107		10.1016/S0140-6736(04)16597-5	http://dx.doi.org/10.1016/S0140-6736(04)16597-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234864				2022-12-01	WOS:000222392900039
J	Mihalcescu, I; Hsing, WH; Leibler, S				Mihalcescu, I; Hsing, WH; Leibler, S			Resilient circadian oscillator revealed in individual cyanobacteria	NATURE			English	Article							GENE-EXPRESSION; CELL-DIVISION; RHYTHMS; CLOCKS; NOISE; TIME	Circadian oscillators, which provide internal daily periodicity, are found in a variety of living organisms, including mammals, insects, plants, fungi and cyanobacteria(1). Remarkably, these biochemical oscillators are resilient to external and internal modifications, such as temperature and cell division cycles. They have to be 'fluctuation ( noise) resistant'(2) because relative fluctuations in the number of messenger RNA and protein molecules forming the intracellular oscillators are likely to be large. In multicellular organisms, the strong temporal stability of circadian clocks, despite molecular fluctuations, can easily be explained by intercellular interactions(3-5). Here we study circadian rhythms and their stability in unicellular cyanobacteria Synechoccocus elongatus. Low-light-level microscopy has allowed us to measure gene expression under circadian control in single bacteria, showing that the circadian clock is indeed a property of individual cells. Our measurements show that the oscillators have a strong temporal stability with a correlation time of several months. In contrast to many circadian clocks in multicellular organisms, this stability seems to be ensured by the intracellular biochemical network, because the interactions between oscillators seem to be negligible.	Univ Grenoble 1, Spectrometrie Phys Lab, F-38402 St Martin Dheres, France; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Princeton University; Rockefeller University; Rockefeller University	Mihalcescu, I (corresponding author), Univ Grenoble 1, Spectrometrie Phys Lab, BP87, F-38402 St Martin Dheres, France.	imihalce@spectro.ujf-grenoble.fr	Mihalcescu, Irina/AAT-7917-2020	Mihalcescu, Irina/0000-0002-8762-8241				Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gaspard P, 2002, J CHEM PHYS, V117, P8905, DOI 10.1063/1.1513461; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Pikovsky A., 2003, SYNCHRONIZATION UNIV; TSINOREMAS NF, 1994, J BIOL CHEM, V269, P16143; Winfree A.T., 1980, GEOMETRY BIOL TIME; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	19	187	196	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					81	85		10.1038/nature02533	http://dx.doi.org/10.1038/nature02533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229601				2022-12-01	WOS:000222356800047
J	Kanagawa, M; Saito, F; Kunz, S; Yoshida-Moriguchi, T; Barresi, R; Kobayashi, YM; Muschler, J; Dumanski, JP; Michele, DE; Oldstone, MBA; Campbell, KP				Kanagawa, M; Saito, F; Kunz, S; Yoshida-Moriguchi, T; Barresi, R; Kobayashi, YM; Muschler, J; Dumanski, JP; Michele, DE; Oldstone, MBA; Campbell, KP			Molecular recognition by LARGE is essential for expression of functional dystroglycan	CELL			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; HUMAN LARGE GENE; ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; SARCOGLYCAN COMPLEX; BETA-SARCOGLYCAN; LAMININ; DISRUPTION; DEFICIENCY; RECEPTOR	Reduced ligand binding activity of alpha-dystroglycan is associated with muscle and central nervous system pathogenesis in a growing number of muscular dystrophies. Posttranslational processing of alpha-dystroglycan is generally accepted to be critical for the expression of functional dystroglycan. Here we show that both the N-terminal domain and a portion of the mucin-like domain of alpha-dystroglycan are essential for high-affinity laminin-receptor function. Posttranslational modification of alpha-dystroglycan by glycosyltransferase, LARGE, occurs within the mucin-like domain, but the N-terminal domain interacts with LARGE, defining an intracellular enzyme-substrate recognition motif necessary to initiate functional glycosylation. Gene replacement in dystroglycan-deficient muscle demonstrates that the dystroglycan C-terminal domain is sufficient only for dystrophin-glycoprotein complex assembly, but to prevent muscle degeneration the expression of a functional dystroglycan through LARGE recognition and glycosylation is required. Therefore, molecular recognition of dystroglycan by LARGE is a key determinant in the biosynthetic pathway to produce mature and functional dystroglycan.	Univ Iowa, Royal J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Royal J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; Scripps Res Inst, Div Virol, Dept Neuropharmacol, La Jolla, CA 92037 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94115 USA; Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Scripps Research Institute; California Pacific Medical Center; California Pacific Medical Center Research Institute; Uppsala University	Campbell, KP (corresponding author), Univ Iowa, Royal J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Barresi, Rita/AAB-9569-2022; Kunz, Stefan/K-5840-2017	Barresi, Rita/0000-0001-7351-959X; Kanagawa, Motoi/0000-0003-0984-6398; Dumanski, Jan Piotr/0000-0002-1489-1452; Muschler, John/0000-0001-9916-5937; Campbell, Kevin/0000-0003-2066-5889; Kunz, Stefan/0000-0001-6030-9550	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45927] Funding Source: Medline; NIDDK NIH HHS [P30 DK54759] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRESI R, NAT MED; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Burton EA, 2002, CELL, V108, P5, DOI 10.1016/S0092-8674(01)00626-2; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Duclos F, 1998, NEUROMUSCULAR DISORD, V8, P30, DOI 10.1016/S0960-8966(97)00135-1; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 2001, J CELL SCI, V114, P1137; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Matsumura K, 2003, NEUROMUSCULAR DISORD, V13, P796, DOI 10.1016/S0960-8966(03)00139-1; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Noguchi S, 2000, EUR J BIOCHEM, V267, P640, DOI 10.1046/j.1432-1327.2000.00998.x; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Tome FMS, 1999, NEUROPEDIATRICS, V30, P55, DOI 10.1055/s-2007-973461; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yamada H, 1996, J NEUROCHEM, V66, P1518	46	204	208	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					953	964		10.1016/j.cell.2004.06.003	http://dx.doi.org/10.1016/j.cell.2004.06.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210115	Bronze			2022-12-01	WOS:000222300200012
J	Piot, P; Feachem, RGA; Jong-Wook, L; Wolfensohn, JD				Piot, P; Feachem, RGA; Jong-Wook, L; Wolfensohn, JD			A global response to AIDS: Lessons learned, next steps	SCIENCE			English	Editorial Material									World Hlth Org, Geneva, Switzerland; World Bank Grp, Washington, DC USA	World Health Organization; The World Bank		jon.liden@theglobalfund.org						*MIN HLTH BRAZ, 2002, NAT AIDS DRUG POL; *UNAIDS, 2004, MON EV TOOLK; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNAIDS, 2004, COMM PRINC CONC AIDS; World Health Organization, 2003, SCAL ANT THER RES LT	5	19	19	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1909	1910		10.1126/science.1101137	http://dx.doi.org/10.1126/science.1101137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218129				2022-12-01	WOS:000222241600024
J	Yang, J; Mani, SA; Donaher, JL; Ramaswamy, S; Itzykson, RA; Come, C; Savagner, P; Gitelman, I; Richardson, A; Weinberg, RA				Yang, J; Mani, SA; Donaher, JL; Ramaswamy, S; Itzykson, RA; Come, C; Savagner, P; Gitelman, I; Richardson, A; Weinberg, RA			Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DROSOPHILA MESODERM DEVELOPMENT; BREAST-CANCER METASTASIS; E-CADHERIN EXPRESSION; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; NEURAL-TUBE; CARCINOMA; SNAIL; CELLS	Metastasis is a multistep process during which cancer cells disseminate from the site of primary tumors and establish secondary tumors in distant organs. In a search for key regulators of metastasis in a murine breast tumor model, we have found that the transcription factor Twist, a master regulator of embryonic morphogenesis, plays an essential role in metastasis. Suppression of Twist expression in highly metastatic mammary carcinoma cells specifically inhibits their ability to metastasize from the mammary gland to the lung. Ectopic expression of Twist results in loss of E-cadherin-mediated cell-cell adhesion, activation of mesenchymal markers, and induction of cell motility, suggesting that Twist contributes to metastasis by promoting an epithelial-mesenchymal transition (EMT). In human breast cancers, high level of Twist expression is correlated with invasive lobular carcinoma, a highly infiltrating tumor type associated with loss of E-cadherin expression. These results establish a mechanistic link between Twist, EMT, and tumor metastasis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Broad Inst, Canc Genom Program, Cambridge, MA 02141 USA; MGH Ctr Canc Res, Charlestown, MA 02129 USA; Ecole Normale Super, F-75230 Paris 05, France; INSERM, EMI 0229, CRLC Val Aurelle Paul Lamarque, F-34298 Montpellier 5, France; Ben Gurion Univ Negev, Dept Mol Genet & Dev, IL-84105 Beer Sheva, Israel; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Ben Gurion University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Mani, Sendurai A./A-7244-2009; Côme, Christophe/E-8395-2016; Savagner, Pierre/AAD-9357-2020; Gitelman, Inna/F-1338-2012; Itzykson, Raphael/M-8517-2018	Mani, Sendurai A./0000-0002-5918-4276; Côme, Christophe/0000-0001-5229-4440; Savagner, Pierre/0000-0002-8287-2229; Itzykson, Raphael/0000-0003-2139-6262	NCI NIH HHS [R21-CA096689, P01-CA80111, 1 F32 CA101507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA101507, R21CA096689, P01CA080111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs G, 2001, AM J CLIN PATHOL, V115, P85; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Berx G, 1996, ONCOGENE, V13, P1919; BOYER B, 1993, APMIS, V101, P257, DOI 10.1111/j.1699-0463.1993.tb00109.x; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; GAMALLO C, 1993, AM J PATHOL, V142, P987; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Gohji K, 1997, AM J PATHOL, V151, P1655; Hajra KM, 2002, CANCER RES, V62, P1613; Hay ED, 1995, ACTA ANAT, V154, P8; Huiping C, 1999, BRIT J CANCER, V81, P1103, DOI 10.1038/sj.bjc.6690815; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; MILLER FR, 1993, CRIT REV ONCOGENESIS, V4, P293; MOLL R, 1993, AM J PATHOL, V143, P1731; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	36	2913	3138	4	356	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					927	939		10.1016/j.cell.2004.06.006	http://dx.doi.org/10.1016/j.cell.2004.06.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210113	Bronze			2022-12-01	WOS:000222300200010
J	Priola, SA; Vorberg, I				Priola, SA; Vorberg, I			Identification of possible animal origins of prion disease in human beings	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; SINGLE AMINO-ACID; SPONGIFORM ENCEPHALOPATHY; VARIANT CJD; INCUBATION-TIME; BSE AGENT; SCRAPIE; PROTEIN; MICE; PHENOTYPES		NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; Tech Univ Munich, Inst Virol, D-8000 Munich, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Technical University of Munich	Priola, SA (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	spriola@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000752, ZIAAI000752] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Belay ED, 2001, ARCH NEUROL-CHICAGO, V58, P1673, DOI 10.1001/archneur.58.10.1673; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Bruce Moira E., 1996, P223; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	17	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 19	2004	363	9426					2013	2014		10.1016/S0140-6736(04)16487-8	http://dx.doi.org/10.1016/S0140-6736(04)16487-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830YJ	15207949				2022-12-01	WOS:000222159800005
J	Valent, F; Little, D; Bertollini, R; Nemer, LE; Barbone, F; Tamburlini, G				Valent, F; Little, D; Bertollini, R; Nemer, LE; Barbone, F; Tamburlini, G			Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe	LANCET			English	Article							AIR-POLLUTION; LEAD-EXPOSURE; TIME-SERIES; SAO-PAULO; HEALTH; MORTALITY; BRAZIL; LEVEL; WATER	Background Environmental exposures contribute to the global burden of disease. We have estimated the burden of disease attributable to outdoor and indoor air pollution, inadequate water and sanitation, lead exposure, and injury among European children and adolescents. Methods Published studies and reports from international agencies were reviewed for calculation of risk-factor exposure in Europe. Disability-adjusted life years (DALYs) or deaths attributable to each factor, or both, were estimated by application of the potential impact fraction to the estimates of mortality and burden of disease from the WHO global database of burden of disease. Findings Among children aged 0-4 years, between 1.8% and 6.4% of deaths from all causes were attributable to outdoor air pollution; acute lower-respiratory-tract infections attributable to indoor air pollution accounted for 4.6% of all deaths and 3.1% of DALYs; and mild mental retardation resulting from lead exposure accounted for 4.4% of DALYs. In the age-group 0-14 years, diarrhoea attributable to inadequate water and sanitation accounted for 5.3% of deaths and 3.5% of DALYs. In the age-group 0-19 years, injuries were the cause of 22.6% of all deaths and 19.0% of DALYs. The burden of disease was much higher in European subregions B and C than subregion A. There was substantial uncertainty around some of the estimates, especially for outdoor air pollution. Interpretation Large proportions of deaths and DALYs in European children are attributable to outdoor and indoor air pollution, inadequate water and sanitation, lead exposure, and injuries. Interventions aimed at reducing children's exposure to environmental factors and injuries could result in substantial gains. The pronounced differences by subregion and age indicate the need for targeted action.	Univ Udine, Univ Hosp, DPMSC, Inst Hyg & Epidemiol, I-33100 Udine, Italy; WHO, Reg Off Europe, Div Hlth Determinants, DK-2100 Copenhagen, Denmark; WHO, European Ctr Environm & Hlth, Rome, Italy; Inst Child Hlth IRCCS Burlo Garofolo, Unit Hlth Serv Res & Int Hlth, Trieste, Italy	University of Udine; World Health Organization; World Health Organization; IRCCS Burlo Garofolo	Valent, F (corresponding author), Policlin Univ, Ist Igiene & Epidemiol, Via Colugna 40, I-33100 Udine, Italy.	francesca.valent@uniud.it	Valent, Francesca/J-4759-2016; Barbone, Fabio/K-1755-2014	Valent, Francesca/0000-0002-4071-0897; Barbone, Fabio/0000-0001-8795-9959; Barbone, Fabio/0000-0003-1337-5111				[Anonymous], 2002, CHILDRENS HLTH ENV R; Bonnefoy XR, 2003, AM J PUBLIC HEALTH, V93, P1559, DOI 10.2105/AJPH.93.9.1559; Bruckner JV, 2000, REGUL TOXICOL PHARM, V31, P280, DOI 10.1006/rtph.2000.1393; Conceicao GMS, 2001, ENVIRON HEALTH PERSP, V109, P347, DOI 10.2307/3434781; Desai MA, 2004, WHO ENV BURDEN DIS S, V4; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; *EUR ENV AG, AIR POLL EUR 1990 20; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Fewtrell L., 2003, WHO ENV BURDEN DIS S, V2; FISCHER AB, 2002, INT J HYG ENVIR HEAL, V205, P1; Gouveia N, 2000, OCCUP ENVIRON MED, V57, P477, DOI 10.1136/oem.57.7.477; HUTTLY SRA, 1997, B WORLD HEALTH ORGAN, V75, P165; KAY D, 2000, WHOSDRWSH007; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; LOVEI M, 1997, PHASING OUT LEAD GAS, P35; LYONS RA, 1982, INJURY PREV, V9, P33; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; Murray CJL, 1996, GLOBAL HLTH STAT; Murray CJL, 2002, SUMMARY MEASURES POP; OSTRO B, 2003, IN PRESS WHO ENV BUR, V5; OSTRO B, 1998, FINE PARTICLE STANDA, V2, P939; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Pruss-Ustun A, 2003, WHO ENV BURDEN DIS S, V1; SALDIVA PHN, 1995, AIR POLLUTION MORTAL, P1; SCHWARTZ J, 1994, ENVIRON RES, V65, P42, DOI 10.1006/enrs.1994.1020; SMITH K, IN PRESS INDOOR SMOK; Smith KR, 1999, EPIDEMIOLOGY, V10, P573, DOI 10.1097/00001648-199909000-00027; Stromberg U, 2003, OCCUP ENVIRON MED, V60, P370, DOI 10.1136/oem.60.5.370; Thomas VM, 1999, ENVIRON SCI TECHNOL, V33, P3942, DOI 10.1021/es990231+; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; *UNICEF, 2004, STAT WORLDS CHILDR; *US EPA, 2003, AM CHILDR ENV MEAS C; Von Schirnding Y, ADDRESSING IMPACT HO; WALSH M, DRAFT MEMO PHASEOUT; *WHO, 2003, BURD DIS PROJ 2001 M; *WHO, 1999, DECL 3 MIN C ENV HLT; *WHO CHOICE, LIST MEMB STAT WHO R; WHO/UNICEF, 2000, GLOB WAT SUPPL SAN A; *WORLD BANK, AIR POLL DAT REG COU; 1908, 4 MIN C ENV HLTH BUD	41	84	91	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2004	363	9426					2032	2039		10.1016/S0140-6736(04)16452-0	http://dx.doi.org/10.1016/S0140-6736(04)16452-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830YJ	15207953				2022-12-01	WOS:000222159800009
J	Cohen-Armon, M; Visochek, L; Katzoff, A; Levitan, D; Susswein, AJ; Klein, R; Valbrun, M; Schwartz, JH				Cohen-Armon, M; Visochek, L; Katzoff, A; Levitan, D; Susswein, AJ; Klein, R; Valbrun, M; Schwartz, JH			Long-term memory requires polyADP-ribosylation	SCIENCE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; ADP-RIBOSYLATION; FEEDING-BEHAVIOR; SENSORY NEURONS; APLYSIA; SENSITIZATION; CHROMATIN; PARP; FACILITATION; INHIBITION	PolyADP-ribose-polymerase 1 is activated in neurons that mediate several forms of long-term memory in Aplysia. Because polyADP-ribosylation of nuclear proteins is a response to DNA damage in virtually all eukaryotic cells, it is surprising that activation of the polymerase occurs during learning and is required for long-term memory. We suggest that fast and transient decondensation of chromatin structure by polyADP-ribosylation enables the transcription needed to form long-term memory without strand breaks in DNA.	Tel Aviv Univ, Sackler Sch Med, Neufeld Cardiac Res Inst, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; Bar Ilan Univ, Fac Life Sci, Gonda Goldschmied Med Diagnost Res Ctr, IL-52900 Ramat Gan, Israel; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Columbia University	Cohen-Armon, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Neufeld Cardiac Res Inst, Sheba Med Ctr, IL-69978 Tel Aviv, Israel.	marmon@post.tau.ac.3l; jhs6@columbia.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681; Susswein, Abraham J./0000-0001-6107-5901	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR010294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NCRR NIH HHS [RR10294] Funding Source: Medline; NIMH NIH HHS [MH48850] Funding Source: Medline; NINDS NIH HHS [NS29832] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnold J, 2002, BIOESSAYS, V24, P1060, DOI 10.1002/bies.10179; Botzer D, 1998, LEARN MEMORY, V5, P204; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; BOULIKAS T, 1990, J BIOL CHEM, V24, P46381; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Byrne JH, 1996, J NEUROSCI, V16, P425; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cleary LJ, 1998, J NEUROSCI, V18, P5988; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Guan ZH, 2003, J NEUROSCI, V23, P7317; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; JEANCHRISTOPHE A, 2000, DNA DAMAGE STRESS SI, P14; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katzoff A, 2002, J NEUROSCI, V22, P9581; KATZOFF A, 2001, SOC NEUR ABSTR, V27; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Mizzen C, 1998, COLD SPRING HARB SYM, V63, P469, DOI 10.1101/sqb.1998.63.469; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; RANKIN PW, 1989, J BIOL CHEM, V264, P4312; Richardson DS, 1999, ADV EXP MED BIOL, V457, P267; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; SATOH MS, 1994, BIOCHEMISTRY-US, V33, P7099, DOI 10.1021/bi00189a012; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; SUSSWEIN AJ, 1986, J NEUROSCI, V6, P1513; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; UDEA K, 1990, ADP RIBOSYLATING TOX, P530; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WALTERS ET, 1995, TRENDS NEUROSCI, V18, P137, DOI 10.1016/0166-2236(95)93891-Z; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	33	136	141	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1820	1822		10.1126/science.1096775	http://dx.doi.org/10.1126/science.1096775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205535				2022-12-01	WOS:000222089500050
J	Mitchell, SL; Kiely, DK; Hamel, MB; Park, PS; Morris, JN; Fries, BE				Mitchell, SL; Kiely, DK; Hamel, MB; Park, PS; Morris, JN; Fries, BE			Estimating prognosis for nursing home residents with advanced dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PREDICTION RULES; MINIMUM DATA SET; SURVIVAL; CARE; MORTALITY; CRITERIA	Context Survival varies for patients with advanced dementia, and accurate prognostic tools have not been developed. A small proportion of patients admitted to hospice have dementia, in part because of the difficulty in predicting survival. Objectives To identify factors associated with 6-month mortality in newly admitted nursing home residents with advanced dementia and to create a practical risk score to predict 6-month mortality in this population. Design, Setting, and Participants This was a retrospective cohort study of data from the Minimum Data Set (MDS). All Medicare or Medicaid licensed nursing homes in New York and Michigan were included. Participants had advanced dementia and were admitted to New York nursing homes between June 1, 1994, and December 30, 1998 (derivation cohort, n=6799), and to Michigan nursing homes from October 1, 1998, through July 30, 2000 (validation cohort, n=4631). Main Outcome Measures MDS factors associated with 6-month mortality were determined in the derivation group, and the resulting mortality risk score was evaluated in the validation cohort. Risk score performance was compared with the cut point of 7c on the Functional Assessment Staging (FAST) scale. Results Among residents with advanced dementia, 28.3% (n = 1922) died within 6 months of nursing home admission in the derivation cohort; 35.1% (n = 1626) died in the validation cohort. The 6-month mortality rate increased across risk scores (possible range, 0-19): 0 points, 8.9% mortality; 1 to 2, 10.8%; 3 to 5, 23.2%; 6 to 8, 40.4%; 9 to 11, 57.0%; and at least 12, 70.0% in the validation cohort. The, area under the receiver operating characteristic (AUROC) curve for predicting 6-month mortality was 0.74 and 0.70 in the derivation and validation cohorts, respectively. Our risk score demonstrated better discrimination to predict 6-month mortality (AUROC, 0.64 for a cutoff of greater than or equal to6 points vs 0.51 for FAST stage 7c). Conclusion A risk score based on 12 variables from the MDS estimates 6-month mortality for nursing home residents with advanced dementia with greater accuracy than existing prognostic guidelines.	Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Vet Adm Med Ctr, Ann Arbor, MI 48105 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mitchell, SL (corresponding author), Hebrew Rehabil Ctr Aged, Res & Training Inst, 1200 Ctr St, Boston, MA 02131 USA.	smitchell@mail.hrca.harvard.edu			NATIONAL INSTITUTE ON AGING [P01AG004390, P60AG008812, P30AG008812, K23AG020054] Funding Source: NIH RePORTER; NIA NIH HHS [AG04390, AG08812, K23AG20054] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguero-Torres H, 1998, J AM GERIATR SOC, V46, P444, DOI 10.1111/j.1532-5415.1998.tb02464.x; Berger A, 2001, J AM GERIATR SOC, V49, P1570, DOI 10.1046/j.1532-5415.2001.4911257.x; BILGRAD R, 2000, NATL DEATH INDEX USE; Carlson MC, 2001, J GERONTOL A-BIOL, V56, pM567, DOI 10.1093/gerona/56.9.M567; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; *COMM DIET HLTH FO, 1989, IMPL RED CHRON DIS R; FABISZEWSKI KJ, 1990, JAMA-J AM MED ASSOC, V263, P3168, DOI 10.1001/jama.263.23.3168; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Gambassi G, 1999, J NEUROL NEUROSUR PS, V67, P59, DOI 10.1136/jnnp.67.1.59; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HANRAHAN P, 1995, J AM GERIATR SOC, V43, P56, DOI 10.1111/j.1532-5415.1995.tb06243.x; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; Lynn J, 1996, NEW ENGL J MED, V335, P201, DOI 10.1056/NEJM199607183350311; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; MOR V, INTERRATER RELIABILI; Morris JN, 1997, J AM GERIATR SOC, V45, P1011, DOI 10.1111/j.1532-5415.1997.tb02974.x; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; National Hospice Organization, 1996, MED GUID DET PROGN S; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; VANDIJK PTM, 1991, J AM GERIATR SOC, V39, P603, DOI 10.1111/j.1532-5415.1991.tb03602.x; VOLICER BJ, 1993, J AM GERIATR SOC, V41, P535, DOI 10.1111/j.1532-5415.1993.tb01891.x; Volicer L, 1997, J AM GERIATR SOC, V45, P1147, DOI 10.1111/j.1532-5415.1997.tb05982.x; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501	33	167	167	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2004	291	22					2734	2740		10.1001/jama.291.22.2734	http://dx.doi.org/10.1001/jama.291.22.2734			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826XH	15187055				2022-12-01	WOS:000221862300028
J	Luscombe, CJ; Cooke, PW				Luscombe, CJ; Cooke, PW			Pain during prostate biopsy	LANCET			English	Editorial Material							ULTRASOUND-GUIDED BIOPSY; PERIPROSTATIC NERVE BLOCK; LOCAL-ANESTHESIA; TRIAL; LIDOCAINE; INJECTION		Royal Shrewsbury Hosp NHS Trust, Dept Urol, Shrewsbury SY3 8XQ, Shrops, England; New Cross Hosp, Dept Urol, Wolverhampton, W Midlands, England	New Cross Hospital	Luscombe, CJ (corresponding author), Royal Shrewsbury Hosp NHS Trust, Dept Urol, Shrewsbury SY3 8XQ, Shrops, England.	chrisluscombe@hotmail.com						ADAMAKIS I, 2003, WORLD J UROL; Crundwell MC, 1999, BJU INT, V83, P792; Davis M, 2002, J UROLOGY, V167, P566, DOI 10.1016/S0022-5347(01)69087-6; Jones JS, 2003, J UROLOGY, V170, P2316, DOI 10.1097/01.ju.0000095792.42718.83; Jones JS, 2003, PROSTATE CANCER P D, V6, P53, DOI 10.1038/sj.pcan.4500630; Lee-Elliott CE, 2004, J UROLOGY, V171, P247, DOI 10.1097/01.ju.0000098688.12631.a0; Lynn NNK, 2002, BJU INT, V90, P424, DOI 10.1046/j.1464-410X.2002.02902.x; Mallick S, 2004, J UROLOGY, V171, P730, DOI 10.1097/01.ju.0000108125.96072.ff; Manikandan R, 2003, J UROLOGY, V170, P1881, DOI 10.1097/01.ju.0000092501.40772.28; Ozden E, 2003, J UROLOGY, V170, P2319, DOI 10.1097/01.ju.0000095760.29931.f7; Schroder FH, 2003, BJU INT, V92, P1, DOI 10.1111/j.1464-410X.2003.04389.x	11	32	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 5	2004	363	9424					1840	1841		10.1016/S0140-6736(04)16392-7	http://dx.doi.org/10.1016/S0140-6736(04)16392-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15183618				2022-12-01	WOS:000221822300004
J	Ellwood, MDF; Foster, WA				Ellwood, MDF; Foster, WA			Doubling the estimate of invertebrate biomass in a rainforest canopy	NATURE			English	Article							ABUNDANCE; INSECTS; WEIGHT	Forest canopies represent the functional interface between 90% of the Earth's terrestrial biomass and the atmosphere(1) and include some of the most threatened of all terrestrial ecosystems(2). However, we lack even a basic understanding of how the biomass of plants and animals is distributed throughout forest canopies, even though this information is vital for estimating energy flow, carbon cycling, resource use and the transfer of materials within this ecosystem(3,4). Here we measure the biomass of invertebrates living in a common rainforest epiphyte, describe a striking relationship between fern size and the biomass of animals within the ferns, and reveal that one large epiphyte may contain an invertebrate biomass similar to that found in the whole of the rest of the tree crown on which it is growing. Using these data, we show that including the fauna of these epiphytes-a neglected component in rainforest ecosystems-can more than double our estimate of the total invertebrate biomass in an entire rainforest canopy.	Univ Cambridge, Dept Zool, Univ Museum Zool, Cambridge CB2 3EJ, England	University of Cambridge	Ellwood, MDF (corresponding author), Univ Cambridge, Dept Zool, Univ Museum Zool, Downing St, Cambridge CB2 3EJ, England.	mdfe2@cam.ac.uk						Adis Joachim, 1998, Ecotropica, V4, P93; Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; Benzing D.H., 1990, VASCULAR EPIPHYTES G; BESUCHET C, 1987, Coleopterists Bulletin, V41, P392; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; ELLWOOD M. D. F., 2002, GLOBAL CANOPY HDB TE, P115; Ellwood Martin D. F., 2001, Selbyana, V22, P97; Ellwood MDF, 2002, BIOTROPICA, V34, P575, DOI 10.1111/j.1744-7429.2002.tb00576.x; Guerrero JCH, 2003, ARTHROPODS OF TROPICAL FORESTS, P170; NADKARNI NM, 1990, BIOTROPICA, V22, P286, DOI 10.2307/2388539; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; PAGEL MD, 1991, AM NAT, V138, P836, DOI 10.1086/285255; Parris B. S., 1997, SANDAKANIA, V9, P77; POCS T, 1980, ACTA BOT HUNG, V26, P143; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Stork N.E., 1990, P173; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; STORK NE, 1991, J TROP ECOL, V7, P161, DOI 10.1017/S0266467400005319; Stork Nigel E., 1993, P115	21	165	180	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2004	429	6991					549	551		10.1038/nature02560	http://dx.doi.org/10.1038/nature02560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175749				2022-12-01	WOS:000221767700036
J	Munekaga, Y; Hashimoto, M; Miyaka, C; Tomizawa, KI; Endo, T; Tasaka, M; Shikanai, T				Munekaga, Y; Hashimoto, M; Miyaka, C; Tomizawa, KI; Endo, T; Tasaka, M; Shikanai, T			Cyclic electron flow around photosystem I is essential for photosynthesis	NATURE			English	Article							NAD(P)H DEHYDROGENASE; NADH DEHYDROGENASE; NDHB GENE; TRANSPORT; TOBACCO; CHLOROPLASTS; FERREDOXIN; PHOTOPHOSPHORYLATION; COMPONENTS; COMPLEX	Photosynthesis provides at least two routes through which light energy can be used to generate a proton gradient across the thylakoid membrane of chloroplasts, which is subsequently used to synthesize ATP. In the first route, electrons released from water in photosystem II (PSII) are eventually transferred to NADP(+) by way of photosystem I (PSI)(1). This linear electron flow is driven by two photochemical reactions that function in series. The cytochrome b(6)f complex mediates electron transport between the two photosystems and generates the proton gradient (DeltapH). In the second route, driven solely by PSI, electrons can be recycled from either reduced ferredoxin or NADPH to plastoquinone, and subsequently to the cytochrome b(6)f complex(2-5). Such cyclic flow generates DeltapH and thus ATP without the accumulation of reduced species. Whereas linear flow from water to NADP 1 is commonly used to explain the function of the light-dependent reactions of photosynthesis, the role of cyclic flow is less clear. In higher plants cyclic flow consists of two partially redundant pathways. Here we have constructed mutants in Arabidopsis thaliana in which both PSI cyclic pathways are impaired, and present evidence that cyclic flow is essential for efficient photosynthesis.	Res Inst Innovat Technol Earth, Plant Res Grp, Kyoto 6190225, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Research Institute of Innovative Technology for the Earth; Kyoto University; Nara Institute of Science & Technology	Shikanai, T (corresponding author), CEA Cadarache, Dept Plant Ecophysiol & Microbiol, F-13108 St Paul Les Durance, France.	shikanai@agr.kyushu-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020					Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; ARNON DI, 1967, NATURE, V214, P562, DOI 10.1038/214562a0; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Backhausen JE, 2000, PHOTOSYNTH RES, V64, P1, DOI 10.1023/A:1026523809147; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; Endo T, 1998, PLANT CELL PHYSIOL, V39, P1226, DOI 10.1093/oxfordjournals.pcp.a029324; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; Heber U, 2002, PHOTOSYNTH RES, V73, P223, DOI 10.1023/A:1020459416987; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567	30	648	690	10	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					579	582		10.1038/nature02598	http://dx.doi.org/10.1038/nature02598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175756				2022-12-01	WOS:000221767700044
J	Duggan, C; Fontaine, O; Pierce, NF; Glass, RI; Mahalanabis, D; Alam, NH; Bhan, MK; Santosham, M				Duggan, C; Fontaine, O; Pierce, NF; Glass, RI; Mahalanabis, D; Alam, NH; Bhan, MK; Santosham, M			Scientific rationale for a change in the composition of oral rehydration solution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE DIARRHEA; REDUCED OSMOLARITY; DOUBLE-BLIND; CLINICAL-TRIAL; SALT-SOLUTION; THERAPY; CHILDREN; GLUCOSE; CHOLERA; DISEASE		Childrens Hosp Boston, Div Gastroenterol & Nutr, Boston, MA 02115 USA; WHO, Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Soc Appl Studies, Kolkata, India; ICDDR B, Div Clin Sci, Ctr Hlth & Populat Res B, Dhaka, Bangladesh; All India Inst Med Sci, Dept Pediat, New Delhi, India	Harvard University; Boston Children's Hospital; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; International Centre for Diarrhoeal Disease Research (ICDDR); All India Institute of Medical Sciences (AIIMS) New Delhi	Duggan, C (corresponding author), Childrens Hosp Boston, Div Gastroenterol & Nutr, 300 Longwood Ave, Boston, MA 02115 USA.	christopher.duggan@childrens.harvard.edu						Alam NH, 1999, LANCET, V354, P296, DOI 10.1016/S0140-6736(98)09332-5; Alam NH, 2001, PEDIATRICS, V107, P613, DOI 10.1542/peds.107.4.613; Alam S, 2000, Indian Pediatr, V37, P952; [Anonymous], 1978, LANCET, V2, P300; AVERY ME, 1990, NEW ENGL J MED, V323, P891, DOI 10.1056/NEJM199009273231307; BHAN MK, 1994, B WORLD HEALTH ORGAN, V72, P945; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BROWN KH, 1988, J PEDIATR-US, V112, P191, DOI 10.1016/S0022-3476(88)80055-6; Cash R, 1999, LANCET, V354, P1733, DOI 10.1016/S0140-6736(05)76725-8; Duggan C, 1997, J PEDIATR-US, V131, P801, DOI 10.1016/S0022-3476(97)70024-6; Dutta D, 2000, ACTA PAEDIATR, V89, P787, DOI 10.1080/080352500750043657; Dutta P, 2001, ARCH DIS CHILD, V84, P237, DOI 10.1136/adc.84.3.237; ELMOUGI M, 1994, J PEDIATR GASTR NUTR, V19, P83, DOI 10.1097/00005176-199407000-00013; Farthing M J, 1989, Acta Paediatr Scand Suppl, V364, P23; FAYAD IM, 1992, LANCET, V339, P389, DOI 10.1016/0140-6736(92)90079-I; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fontaine O, 2000, COCHRANE DB SYST REV; Hahn S, 2001, BMJ-BRIT MED J, V323, P81, DOI 10.1136/bmj.323.7304.81; HIRSCHHORN N, 1968, NEW ENGL J MED, V279, P176, DOI 10.1056/NEJM196807252790402; Hirschhorn N, 2002, PEDIATRICS, V109, P713, DOI 10.1542/peds.109.4.713-a; Hirschhorn N, 2002, LANCET, V360, P340, DOI 10.1016/S0140-6736(02)09528-4; HIRSCHHORN N, 1980, AM J CLIN NUTR, V33, P637, DOI 10.1093/ajcn/33.3.637; HIRSCHHORN N, 1972, Lancet, V2, P15; HIRSCHHORN N, 1991, SCI AM, V264, P50, DOI 10.1038/scientificamerican0591-50; HUNT JB, 1994, GUT, V35, P211, DOI 10.1136/gut.35.2.211; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; MOLLA AM, 1989, LANCET, V2, P429; MOLLA AM, 1981, J PEDIATR-US, V98, P835, DOI 10.1016/S0022-3476(81)80863-3; NALIN DR, 1970, GUT, V11, P768, DOI 10.1136/gut.11.9.768; Nazarian LF, 1996, PEDIATRICS, V97, P424; NICHOLS BL, 1977, AM J CLIN NUTR, V30, P1457, DOI 10.1093/ajcn/30.9.1457; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Penny M. E., 2003, Nutrition in pediatrics: basic science and clinical applications, P174; PIERCE NF, 1968, GASTROENTEROLOGY, V55, P333; RIBEIRO H, 1994, J AM COLL NUTR, V13, P251, DOI 10.1080/07315724.1994.10718405; SANTOSHAM M, 1986, J PEDIATR-US, V109, P795, DOI 10.1016/S0022-3476(86)80696-5; SANTOSHAM M, 1982, NEW ENGL J MED, V306, P1070, DOI 10.1056/NEJM198205063061802; SANTOSHAM M, 1985, PEDIATRICS, V76, P292; Santosham M, 1996, J PEDIATR-US, V128, P45, DOI 10.1016/S0022-3476(96)70426-2; Sarker SA, 2001, J PEDIATR-US, V138, P532, DOI 10.1067/mpd.2001.112161; SNYDER JD, 1982, B WORLD HEALTH ORGAN, V60, P605; Thillainayagam AV, 1998, GASTROENTEROLOGY, V114, P197, DOI 10.1016/S0016-5085(98)70647-X; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; *WHO, 2001, WHOFCHCAH0122 UNICEF	46	40	48	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2004	291	21					2628	2631		10.1001/jama.291.21.2628	http://dx.doi.org/10.1001/jama.291.21.2628			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825EM	15173155				2022-12-01	WOS:000221738800027
J	Ianora, A; Miralto, A; Poulet, SA; Carotenuto, Y; Buttino, I; Romano, G; Casotti, R; Pohnert, G; Wichard, T; Colucci-D'Amato, L; Terrazzano, G; Smetacek, V				Ianora, A; Miralto, A; Poulet, SA; Carotenuto, Y; Buttino, I; Romano, G; Casotti, R; Pohnert, G; Wichard, T; Colucci-D'Amato, L; Terrazzano, G; Smetacek, V			Aldehyde suppression of copepod recruitment in blooms of a ubiquitous planktonic diatom	NATURE			English	Article							CHEMICAL DEFENSE; CALANUS-HELGOLANDICUS; HATCHING SUCCESS; FERTILIZATION; REPRODUCTION; INHIBITION; ECOSYSTEMS; ABUNDANCE; EXTRACTS; CYCLES	The growth cycle in nutrient-rich, aquatic environments starts with a diatom bloom that ends in mass sinking of ungrazed cells and phytodetritus(1). The low grazing pressure on these blooms has been attributed to the inability of overwintering copepod populations to track them temporally(2). We tested an alternative explanation: that dominant diatom species impair the reproductive success of their grazers. We compared larval development of a common overwintering copepod fed on a ubiquitous, early-blooming diatom species with its development when fed on a typical post-bloom dinoflagellate. Development was arrested in all larvae in which both mothers and their larvae were fed the diatom diet. Mortality remained high even if larvae were switched to the dinoflagellate diet. Aldehydes, cleaved from a fatty acid precursor by enzymes activated within seconds after crushing of the cell(3), elicit the teratogenic effect(4). This insidious mechanism, which does not deter the herbivore from feeding but impairs its recruitment, will restrain the cohort size of the next generation of early-rising overwinterers. Such a transgenerational plant-herbivore interaction could explain the recurringly inefficient use of a predictable, potentially valuable food resource-the spring diatom bloom-by marine zooplankton.	Stn Zool A Dohrn, Ecophysiol Lab, I-80121 Naples, Italy; CNRS, Stn Biol Roscoff, F-29682 Roscoff, France; Max Planck Inst Chem Ecol, D-07745 Jena, Germany; CNR, Inst Endocrinol & Expt Oncol, I-80131 Naples, Italy; Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ianora, A (corresponding author), Stn Zool A Dohrn, Ecophysiol Lab, Villa Comunale, I-80121 Naples, Italy.	ianora@szn.it	Ianora, Adrianna/O-3408-2019; Wichard, Thomas/L-9861-2019; Carotenuto, Ylenia/ABG-4872-2021; Buttino, Isabella/AAI-3264-2020; Romano, Giovanna/F-4561-2015; Pohnert, Georg/D-3721-2013; Casotti, Raffaella/I-9833-2019; Wichard, Thomas/C-2794-2009; Carotenuto, Ylenia/B-5708-2013; Casotti, Raffaella/H-1697-2016	Wichard, Thomas/0000-0003-0061-4160; Carotenuto, Ylenia/0000-0002-7188-9279; Romano, Giovanna/0000-0002-4898-7153; Pohnert, Georg/0000-0003-2351-6336; Casotti, Raffaella/0000-0002-9876-4601; Wichard, Thomas/0000-0003-0061-4160; Carotenuto, Ylenia/0000-0002-7188-9279; Casotti, Raffaella/0000-0002-9876-4601; TERRAZZANO, Giuseppe/0000-0003-3556-6891				Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Caldwell GS, 2003, TOXICON, V42, P301, DOI 10.1016/S0041-0101(03)00147-8; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; CALDWELL GS, 2004, THESIS U NEWCASTLE U; COLEBROOK JM, 1982, J PLANKTON RES, V4, P435, DOI 10.1093/plankt/4.3.435; CUSHING DH, 1975, MASRINE ECOLOGY FISH; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6133, DOI 10.1016/S0040-4039(02)01285-6; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; LUO XP, 1995, ANAL BIOCHEM, V228, P294, DOI 10.1006/abio.1995.1353; Mauchline, 1998, BIOL CALANOID COPEPO; Miralto A, 2003, MAR ECOL PROG SER, V254, P253, DOI 10.3354/meps254253; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Poulet SA, 1995, MAR ECOL PROG SER, V129, P85, DOI 10.3354/meps129085; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Smetacek V, 2002, NATURE, V419, P565, DOI 10.1038/419565a; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; TAKAI M, 1992, ACS S SER, V489, P38; Tester P.A., 1991, B PLANKTON SOC JPN, P603; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Turner JT, 2001, MAR ECOL PROG SER, V220, P187, DOI 10.3354/meps220187; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Weikert H, 2001, J MARINE SYST, V30, P221, DOI 10.1016/S0924-7963(01)00060-4; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	31	327	339	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					403	407		10.1038/nature02526	http://dx.doi.org/10.1038/nature02526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164060				2022-12-01	WOS:000221644600036
J	McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J				McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J			Basaltic rocks analyzed by the Spirit rover in Gusev Crater	SCIENCE			English	Article							CHEMICAL CLASSIFICATION; PATHFINDER SITE; VOLCANIC-ROCKS; SOILS; MARS	The Spirit landing site in Gusev Crater on Mars contains dark, fine-grained, vesicular rocks interpreted as lavas. Pancam and Mini-Thermal Emission Spectrometer (Mini-TES) spectra suggest that all of these rocks are similar but have variable coatings and dust mantles. Magnified images of brushed and abraded rock surfaces show alteration rinds and veins. Rock interiors contain less than or equal to25% megacrysts. Chemical analyses of rocks by the Alpha Particle X-ray Spectrometer are consistent with picritic basalts, containing normative olivine, pyroxenes, plagioclase, and accessory FeTi oxides. Mossbauer, Pancam, and Mini-TES spectra confirm the presence of olivine, magnetite, and probably pyroxene. These basalts extend the known range of rock compositions composing the martian crust.	Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Max Planck Inst Chem, D-55099 Mainz, Germany; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Mainz, Inst Anorgan & Analyt Chem, D-6500 Mainz, Germany; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Co Vale Rio Doce, BR-29090900 Vitoria, ES, Brazil	University of Tennessee System; University of Tennessee Knoxville; Washington University (WUSTL); Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Arizona State University; Arizona State University-Tempe; Lockheed Martin; Max Planck Society; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	McSween, HY (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu	Crisp, Joy/H-8287-2016; de Souza, Paulo A/B-8961-2008; de Souza, Paulo/P-7294-2019; Johnson, Jeffrey R/F-3972-2015; de Souza, Paulo/W-2993-2019; Farmer, Jack D/B-9343-2019; Moersch, Jeffrey E/F-7189-2010	Crisp, Joy/0000-0002-3202-4416; de Souza, Paulo A/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo/0000-0002-0091-8925; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; McSween H.Y., 1998, PLANETARY MAT, V36; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	16	225	225	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					842	845		10.1126/science.1099851	http://dx.doi.org/10.1126/science.1099851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297668				2022-12-01	WOS:000223104900041
J	Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE				Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE			Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLIZING ENZYMES; IN-VIVO; CHILDHOOD; SENSITIVITY; PHARMACOGENOMICS; CLASSIFICATION; ASPARAGINASE; PREDICTION; PROFILES; PROTEINS	BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy in approximately 80 percent of patients. However, the cause of treatment failure in the remaining 20 percent of patients is largely unknown. METHODS: We tested leukemia cells from 173 children for sensitivity in vitro to prednisolone, vincristine, asparaginase, and daunorubicin. The cells were then subjected to an assessment of gene expression with the use of 14,500 probe sets to identify differentially expressed genes in drug-sensitive and drug-resistant ALL. Gene-expression patterns that differed according to sensitivity or resistance to the four drugs were compared with treatment outcome in the original 173 patients and an independent cohort of 98 children treated with the same drugs at another institution. RESULTS: We identified sets of differentially expressed genes in B-lineage ALL that were sensitive or resistant to prednisolone (33 genes), vincristine (40 genes), asparaginase (35 genes), or daunorubicin (20 genes). A combined gene-expression score of resistance to the four drugs, as compared with sensitivity to the four, was significantly and independently related to treatment outcome in a multivariate analysis (hazard ratio for relapse, 3.0; P=0.027). Results were confirmed in an independent population of patients treated with the same medications (hazard ratio for relapse, 11.85; P=0.019). Of the 124 genes identified, 121 have not previously been associated with resistance to the four drugs we tested. CONCLUSIONS: Differential expression of a relatively small number of genes is associated with drug resistance and treatment outcome in childhood ALL.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Div Pediat Hematol Oncol, Rotterdam, Netherlands; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; Pharmacogenet Res Network, Pharmacogenet Anticanc Agents Res Grp, Memphis, TN USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Free Univ Amsterdam, Med Ctr, Dept Pediat Hematol Oncol, Amsterdam, Netherlands; Childrens Univ Hosp, German Cooperat Study Grp Childhood Acute Lymphob, Dept Hematol Oncol, Hamburg, Germany	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Veerman, Anjo/AAT-2443-2020; Cheok, Meyling/AFS-4025-2022; Evans, William E./C-2069-2012; Cheok, Meyling h/C-3822-2014; Relling, Mary/N-5032-2018; Cheng, Cheng/N-8075-2018; Pui, Ching-Hon/N-8076-2018	Cheok, Meyling/0000-0002-7820-8026; Evans, William E./0000-0002-9333-5322; Cheok, Meyling h/0000-0002-7820-8026; Pui, Ching-Hon/0000-0003-0303-5658; den Boer, Monique/0000-0002-5795-2921; Veerman, Anjo JP/0000-0002-9309-301X; de Haar-Holleman, Amy/0000-0003-4929-2860	NATIONAL CANCER INSTITUTE [R01CA078224, R37CA036401, R01CA051001, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061394, U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA51001, R37 CA36401, R01 CA78224, P30 CA21765] Funding Source: Medline; NIGMS NIH HHS [U01 GM61393, U01 GM61394] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Cheok MH, 2003, NAT GENET, V34, P231, DOI 10.1038/ng0603-231b; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; DUI JP, 2003, ZHONGHUA ZHONG LIU Z, V25, P21; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hongo T, 2002, INT J HEMATOL, V76, P251, DOI 10.1007/BF02982795; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; Kearns PR, 2001, BLOOD, V97, P393, DOI 10.1182/blood.V97.2.393; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Martell RL, 1997, BRIT J CANCER, V75, P161, DOI 10.1038/bjc.1997.27; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pieters R, 2003, INT J HEMATOL, V78, P402, DOI 10.1007/BF02983812; Prokop A, 2000, LEUKEMIA, V14, P1606, DOI 10.1038/sj.leu.2401866; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Ramakers-van Woerden NL, 2001, BRIT J HAEMATOL, V112, P680, DOI 10.1046/j.1365-2141.2001.02586.x; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VAN AL, 1997, GENE DEV, V11, P2295; van den Heuvel-Eibrink MM, 2000, INT J CLIN PHARM TH, V38, P94; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zembutsu H, 2002, CANCER RES, V62, P518	34	452	473	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					533	542		10.1056/NEJMoa033513	http://dx.doi.org/10.1056/NEJMoa033513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295046				2022-12-01	WOS:000223069900006
J	Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA				Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA			Rates of hyperkalemia after publication of the randomized aldactone evaluation study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-THREATENING HYPERKALEMIA; CONGESTIVE-HEART-FAILURE; TIME-SERIES; SPIRONOLACTONE; GUIDELINES; PREVALENCE; INHIBITORS; MORBIDITY	BACKGROUND: The Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting-enzyme (ACE) inhibitors is also indicated in these patients. However, life-threatening hyperkalemia can occur when these drugs are used together. METHODS: We conducted a population-based time-series analysis to examine trends in the rate of spironolactone prescriptions and the rate of hospitalization for hyperkalemia in ambulatory patients before and after the publication of RALES. We linked prescription-claims data and hospital-admission records for more than 1.3 million adults 66 years of age or older in Ontario, Canada, for the period from 1994 through 2001. RESULTS: Among patients treated with ACE inhibitors who had recently been hospitalized for heart failure, the spironolactone-prescription rate was 34 per 1000 patients in 1994, and it increased immediately after the publication of RALES, to 149 per 1000 patients by late 2001 (P<0.001). The rate of hospitalization for hyperkalemia rose from 2.4 per 1000 patients in 1994 to 11.0 per 1000 patients in 2001 (P<0.001), and the associated mortality rose from 0.3 per 1000 to 2.0 per 1000 patients (P<0.001). As compared with expected numbers of events, there were 560 (95 percent confidence interval, 285 to 754) additional hyperkalemia-related hospitalizations and 73 (95 percent confidence interval, 27 to 120) additional hospital deaths during 2001 among older patients with heart failure who were treated with ACE inhibitors in Ontario. Publication of RALES was not associated with significant decreases in the rates of readmission for heart failure or death from all causes. CONCLUSIONS: The publication of RALES was associated with abrupt increases in the rate of prescriptions for spironolactone and in hyperkalemia-associated morbidity and mortality. Closer laboratory monitoring and more judicious use of spironolactone may reduce the occurrence of this complication.	Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Pharm, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, G Wing 106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Antrobus J H, 1993, J Cardiothorac Vasc Anesth, V7, P76, DOI 10.1016/1053-0770(93)90124-4; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ghali WA, 2000, LANCET, V355, P579, DOI 10.1016/S0140-6736(05)73234-7; Hamad A, 2001, AM J NEPHROL, V21, P241, DOI 10.1159/000046255; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jarman PR, 2003, BRIT MED J, V327, P812, DOI 10.1136/bmj.327.7418.812; JARMAN PR, 1995, POSTGRAD MED J, V71, P551, DOI 10.1136/pgmj.71.839.551; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rubinfeld DL., 2013, MICROECONOMICS; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141; van Walraven C, 1998, JAMA-J AM MED ASSOC, V280, P2028, DOI 10.1001/jama.280.23.2028; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853; vanWalraven C, 2000, JAMA-J AM MED ASSOC, V283, P481; Wrenger E, 2003, BRIT MED J, V327, P147, DOI 10.1136/bmj.327.7407.147	29	1206	1231	0	24	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					543	551		10.1056/NEJMoa040135	http://dx.doi.org/10.1056/NEJMoa040135			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295047				2022-12-01	WOS:000223069900007
J	Wingerchuk, D				Wingerchuk, D			Cannabis for medical purposes: cultivating science, weeding out the fiction	LANCET			English	Editorial Material							MULTIPLE-SCLEROSIS; MARIJUANA USE; PREVALENCE; EPILEPSY		Mayo Clin, Dept Neurol, Multiple Sclerosis Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Wingerchuk, D (corresponding author), Mayo Clin, Dept Neurol, Multiple Sclerosis Ctr, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu						Baker D, 2003, LANCET NEUROL, V2, P291, DOI 10.1016/S1474-4422(03)00381-8; Clark AJ, 2004, NEUROLOGY, V62, P2098, DOI 10.1212/01.WNL.0000127707.07621.72; Compton WM, 2004, JAMA-J AM MED ASSOC, V291, P2114, DOI 10.1001/jama.291.17.2114; Fox P, 2004, NEUROLOGY, V62, P1105, DOI 10.1212/01.WNL.0000118203.67138.3E; GREENBERG HS, 1994, CLIN PHARMACOL THER, V55, P324, DOI 10.1038/clpt.1994.33; Gross DW, 2004, NEUROLOGY, V62, P2095, DOI 10.1212/01.WNL.0000127623.03766.75; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Ogborne AC, 2000, SUBST USE MISUSE, V35, P301, DOI 10.3109/10826080009147698; Page SA, 2003, CAN J NEUROL SCI, V30, P201, DOI 10.1017/S0317167100002584; Sirven JI, 2004, NEUROLOGY, V62, P1924, DOI 10.1212/01.WNL.0000129703.59857.D6; Webb E, 1996, LANCET, V348, P922, DOI 10.1016/S0140-6736(96)03410-1; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	14	15	32	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					315	316		10.1016/S0140-6736(04)16741-X	http://dx.doi.org/10.1016/S0140-6736(04)16741-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276375				2022-12-01	WOS:000222853300010
J	Payne, JL; Lehrmann, DJ; Wei, JY; Orchard, MJ; Schrag, DP; Knoll, AH				Payne, JL; Lehrmann, DJ; Wei, JY; Orchard, MJ; Schrag, DP; Knoll, AH			Large perturbations of the carbon cycle during recovery from the end-Permian extinction	SCIENCE			English	Article							TRIASSIC BOUNDARY; MASS EXTINCTION; SOUTH CHINA; ISOTOPE; EVOLUTION; CALIBRATION; HYPOTHESES; HISTORY; CORALS; REGION	High-resolution carbon isotope measurements of multiple stratigraphic sections in south China demonstrate that the pronounced carbon isotopic excursion at the Permian-Triassic boundary was not an isolated event but the first in a series of large fluctuations that continued throughout the Early Triassic before ending abruptly early in the Middle Triassic. The unusual behavior of the carbon cycle coincides with the delayed recovery from end-Permian extinction recorded by fossils, suggesting a direct relationship between Earth system function and biological rediversification in the aftermath of Earth's most devastating mass extinction.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; Guizhou Bur Geol & Mineral Resources, Guiyang 550011, Peoples R China; Geol Survey Canada, Vancouver, BC V6B 5J3, Canada	Harvard University; University of Wisconsin System; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Payne, JL (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jpayne@fas.harvard.edu	Payne, Jonathan L/A-1240-2007; Payne, Jonathan/B-8088-2012	Payne, Jonathan L/0000-0002-9601-3310; 				Atudorei V., 1997, ALBERTIANA, V20, P45; Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Baud A, 1996, GEODIN ACTA, V9, P57, DOI 10.1080/09853111.1996.11105278; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brasier MD, 1996, GEOL MAG, V133, P445, DOI 10.1017/S0016756800007603; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; de Wit MJ, 2002, J GEOL, V110, P227, DOI 10.1086/338411; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Erwin D.H., 1993, CRITICAL MOMENTS PAL; Erwin Douglas H., 1996, P398; FLUGEL E, 1994, GEOL S AM S, P247; Flugel E., 1985, PALEOALGOLOGY CONT R, P344; Flugel E., 2002, PHANEROZOIC REEF PAT, P391; Hallam A., 1991, Historical Biology, V5, P257; HORACEK M, 2001, 3 VIENN WORKSH STABL; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kamo SL, 2003, EARTH PLANET SC LETT, V214, P75, DOI 10.1016/S0012-821X(03)00347-9; Kaufman AJ, 1996, GEOL MAG, V133, P509, DOI 10.1017/S0016756800007810; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Lehrmann DJ, 1998, J SEDIMENT RES, V68, P311, DOI 10.2110/jsr.68.311; MAGARITZ M, 1988, NATURE, V331, P337, DOI 10.1038/331337a0; Martin B, 2001, OPT LASER TECHNOL, V33, P201, DOI 10.1016/S0030-3992(01)00014-7; Mundil R, 1996, EARTH PLANET SC LETT, V141, P137, DOI 10.1016/0012-821X(96)00057-X; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Ott E., 1972, NEUES JB F R GEOLOGI, V141, P81; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Riedel P., 1991, P465; Romano SL, 2000, B MAR SCI, V67, P1043; Schrag D. P., 2002, GEOCHEM GEOPHYS GEOS, V3; SCHUBERT JK, 1995, PALAEOGEOGR PALAEOCL, V116, P1, DOI 10.1016/0031-0182(94)00093-N; Senowbari-Daryan Baba, 1993, Facies, V28, P181, DOI 10.1007/BF02539736; Sepkoski, 2002, B AM PALEONTOL, V363, P1; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Tong J, 2003, SCI CHINA SER D, V46, P1182, DOI 10.1360/03yd0295; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; [No title captured]	43	617	695	13	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					506	509		10.1126/science.1097023	http://dx.doi.org/10.1126/science.1097023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273391				2022-12-01	WOS:000222828900036
J	Rakoff-Nahoum, S; Paglino, J; Eslami-Varzaneh, F; Edberg, S; Medzhitov, R				Rakoff-Nahoum, S; Paglino, J; Eslami-Varzaneh, F; Edberg, S; Medzhitov, R			Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis	CELL			English	Article							DEXTRAN SULFATE SODIUM; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; HUMAN GINGIVAL FIBROBLASTS; HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION; IMMUNODEFICIENT MICE; INDUCED COLITIS; CROHNS-DISEASE; LIPOPOLYSACCHARIDE	Toll-like receptors (TLRs) play a crucial role in host defense against microbial infection. The microbial ligands recognized by TLRs are not unique to pathogens, however, and are produced by both pathogenic and commensal microorganisms. It is thought that an inflammatory response to commensal bacteria is avoided due to sequestration of microflora by surface epithelia. Here, we show that commensal bacteria are recognized by TLRs under normal steady-state conditions, and this interaction plays a crucial role in the maintenance of intestinal epithelial homeostasis. Furthermore, we find that activation of TLRs by commensal microflora is critical for the protection against gut injury and associated mortality. These findings reveal a novel function of TLRs-control of intestinal epithelial homeostasis and protection from injury-and provide a new perspective on the evolution of host-microbial interactions.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			NIAID NIH HHS [AI46688] Funding Source: Medline; NIGMS NIH HHS [GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Basile JR, 2003, MOL CANCER RES, V1, P262; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; CHO CH, 2002, GASTROINTESTINAL MUC; Clark RAF, 2003, J INVEST DERMATOL, V120, pIX, DOI 10.1046/j.1523-1747.2003.12264.x; de Groot PG, 2002, SEMIN THROMB HEMOST, V28, P133, DOI 10.1055/s-2002-27815; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; INAN MS, 2000, LIVER PHYSL, V279, pG1282; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kojima K, 2003, GASTROENTEROLOGY, V124, P1395, DOI 10.1016/S0016-5085(03)00215-4; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MIDVEDT T, 1999, PROBIOTICS OTHER NUT, P79; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Neta, 1996, Semin Radiat Oncol, V6, P306, DOI 10.1016/S1053-4296(96)80026-9; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Putnins EE, 2002, INFECT IMMUN, V70, P6541, DOI 10.1128/IAI.70.12.6541-6548.2002; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Sansonetti P, 2002, GUT, V50, P2; Sartor R, 2000, INFLAMM BOWEL DIS, P153; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Siegel V, 2001, DEV CELL, V1, P1, DOI 10.1016/S1534-5807(01)00021-1; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sugiyama A, 1996, INFECT IMMUN, V64, P1426, DOI 10.1128/IAI.64.4.1426-1431.1996; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tamai H, 2002, ALCOHOL CLIN EXP RES, V26, p75S, DOI 10.1097/01.ALC.0000026981.32386.FD; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; UELAND JM, 2003, AM J PHYSIOL-RENAL, V3, pF581; van Tol EAF, 1999, AM J PHYSIOL-GASTR L, V277, pG245, DOI 10.1152/ajpgi.1999.277.1.G245; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; YOO J, 2002, GASTROINTESTINAL MUC, P14; Yoshioka T, 2001, J INT MED RES, V29, P409, DOI 10.1177/147323000102900505; Zheng M, 2002, P NATL ACAD SCI USA, V99, P8944, DOI 10.1073/pnas.132605599	60	3056	3269	10	405	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					229	241		10.1016/j.cell.2004.07.002	http://dx.doi.org/10.1016/j.cell.2004.07.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260992	Bronze			2022-12-01	WOS:000222966000011
J	Tansey, WP				Tansey, WP			Death, destruction, and the proteasome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							APOPTOSIS; CELLS		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tansey, WP (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.							Hideshima T, 2001, CANCER RES, V61, P3071; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	5	13	15	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					393	394		10.1056/NEJMcibr041505	http://dx.doi.org/10.1056/NEJMcibr041505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269322				2022-12-01	WOS:000222801200017
J	Stoessl, AJ; de la Fuente-Fernandez, R				Stoessl, AJ; de la Fuente-Fernandez, R			Willing oneself better on placebo-effective in its own right	LANCET			English	Editorial Material							PARKINSONS-DISEASE; DOPAMINE RELEASE; EXPECTATION; TRANSPLANTATION; MECHANISM; ANALGESIA; NEURONS; SURGERY; MOTOR; TRIAL		Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada; Hosp Arquitecto Marcide, Div Neurol, Ferrol, Spain	University of British Columbia; Complejo Hospitalario Universitario de Ferrol	Stoessl, AJ (corresponding author), Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada.	jstoessl@interchange.ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246				Benedetti F, 2004, NAT NEUROSCI, V7, P587, DOI 10.1038/nn1250; Benedetti F, 2003, J NEUROSCI, V23, P4315; Clark PA, 2002, J LAW MED ETHICS, V30, P58, DOI 10.1111/j.1748-720X.2002.tb00720.x; de la Fuente-Fernandez R, 2004, PARKINSONISM RELAT D, V10, P125, DOI 10.1016/j.parkreldis.2003.10.003; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Goetz CG, 2002, MOVEMENT DISORD, V17, P283, DOI 10.1002/mds.10024; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Kirsch I, 2004, PSYCHOL BULL, V130, P341, DOI 10.1037/0033-2909.130.2.341; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; McRae C, 2004, ARCH GEN PSYCHIAT, V61, P412, DOI 10.1001/archpsyc.61.4.412; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Watts RL, 2001, PARKINSONISM RELAT D, V7, pS87; Weijer C, 2002, J LAW MED ETHICS, V30, P69, DOI 10.1111/j.1748-720X.2002.tb00721.x	18	18	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 17	2004	364	9430					227	228		10.1016/S0140-6736(04)16689-0	http://dx.doi.org/10.1016/S0140-6736(04)16689-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15262083				2022-12-01	WOS:000222784900006
J	Feely, RA; Sabine, CL; Lee, K; Berelson, W; Kleypas, J; Fabry, VJ; Millero, FJ				Feely, RA; Sabine, CL; Lee, K; Berelson, W; Kleypas, J; Fabry, VJ; Millero, FJ			Impact of anthropogenic CO2 on the CaCO3 system in the oceans	SCIENCE			English	Article							CALCIUM-CARBONATE; INORGANIC CARBON; ATLANTIC-OCEAN; PACIFIC-OCEAN; CALCIFICATION; FLUXES; DISSOLUTION; DIOXIDE; PARTICLES; CHEMISTRY	Rising atmospheric carbon dioxide (CO2) concentrations over the past two centuries have led to greater CO2 uptake by the oceans. This acidification process has changed the saturation state of the oceans with respect to calcium carbonate (CaCO3) particles. Here we estimate the in situ CaCO3 dissolution rates for the global oceans from total alkalinity and chlorofluorocarbon data, and we also discuss the future impacts of anthropogenic CO2 on CaCO3 shell forming species. CaCO3 dissolution rates, ranging from 0.003 to 1.2 micromoles per kilogram per year, are observed beginning near the aragonite saturation horizon. The total water column CaCO3 dissolution rate for the global oceans is approximately 0.5 +/- 0.2 petagrams of CaCO3-C per year, which is approximately 45 to 65% of the export production of CaCO3.	NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Natl Ctr Atmospher Res, Environm & Soc Impacts Grp, Boulder, CO 80307 USA; Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Pohang University of Science & Technology (POSTECH); University of Southern California; National Center Atmospheric Research (NCAR) - USA; California State University System; California State University San Marcos; University of Miami	Feely, RA (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	richard.a.feely@noaa.gov	Feely, Richard A./ABI-5740-2020; Lee, Kitack/G-7184-2015	Lee, Kitack/0000-0002-4226-2303				ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; BETZER PR, 1984, SCIENCE, V226, P1074, DOI 10.1126/science.226.4678.1074; Brewer PG, 1997, GEOPHYS RES LETT, V24, P1367, DOI 10.1029/97GL01179; Broecker W., 1982, TRACERS SEA; BROECKER WS, 1979, SCIENCE, V206, P409, DOI 10.1126/science.206.4417.409; BROECKER WS, 1977, FATE FOSSIL CO2 OCEA, P207; BROECKER WS, 2003, TREATISE GEOCHEMISTR, V6, P1; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Catubig NR, 1998, PALEOCEANOGRAPHY, V13, P298, DOI 10.1029/98PA00609; Chung SN, 2004, LIMNOL OCEANOGR, V49, P315, DOI 10.4319/lo.2004.49.2.0315; Chung SN, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002001; FABRY VJ, 1991, DEEP-SEA RES, V38, P713, DOI 10.1016/0198-0149(91)90008-4; Feely RA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001866; Gruber N, 2004, SCOPE SER, V62, P45; HONJO S, 1995, DEEP-SEA RES PT II, V42, P831, DOI 10.1016/0967-0645(95)00034-N; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; KANAMORI S, 1982, Journal of the Oceanographical Society of Japan, V38, P57, DOI 10.1007/BF02110291; Kawahata H, 2000, DEEP-SEA RES PT I, V47, P2061, DOI 10.1016/S0967-0637(00)00025-X; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Lowenstam H.A., 1989, BIOMINERALISATION; Marubini F, 1999, LIMNOL OCEANOGR, V44, P716, DOI 10.4319/lo.1999.44.3.0716; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Milliman JD, 1999, DEEP-SEA RES PT I, V46, P1653, DOI 10.1016/S0967-0637(99)00034-5; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/BF02369004; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; NORIKI S, 1999, J OCEANOGR, V55, P693; PESTANA H, 1985, J SEDIMENT PETROL, V55, P184; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ridgwell AJ, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000512; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rodier M, 1997, DEEP-SEA RES PT II, V44, P2085, DOI 10.1016/S0967-0645(97)00092-1; Sabine CL, 2004, SCOPE SER, V62, P17; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001869; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Sciandra A, 2003, MAR ECOL PROG SER, V261, P111, DOI 10.3354/meps261111; SEIBEL BA, 2003, CLIMATE CHANGE BIODI, P59; Simkiss K., 1989, BIOMINERALIZATION; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; SPINDLER M, 1980, NEUES JB GEOL PAL, V9, P659; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; TSUNOGAI S, 1991, TELLUS B, V43, P256, DOI 10.1034/j.1600-0889.1991.00018.x; Wong CS, 1999, DEEP-SEA RES PT II, V46, P2735, DOI 10.1016/S0967-0645(99)00082-X; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	51	1527	1614	24	1181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					362	366		10.1126/science.1097329	http://dx.doi.org/10.1126/science.1097329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256664				2022-12-01	WOS:000222662400029
J	Carcedo, CH; Bonazzi, M; Spano, S; Turacchio, G; Colanzi, A; Luini, A; Corda, D				Carcedo, CH; Bonazzi, M; Spano, S; Turacchio, G; Colanzi, A; Luini, A; Corda, D			Mitotic Golgi partitioning is driven by the membrane-fissioning protein CtBP3/BARS	SCIENCE			English	Article							APPARATUS IN-VIVO; ENDOPLASMIC-RETICULUM; BREFELDIN-A; MAMMALIAN-CELLS; MITOSIS; FRAGMENTATION; KINASE; REDISTRIBUTION; ASSOCIATION; CTBP/BARS	Organelle inheritance is an essential feature of all eukaryotic cells. As with other organelles, the Golgi complex partitions between daughter cells through the fission of its membranes into numerous tubulovesicular fragments. We found that the protein CtBP3/BARS ( BARS) was responsible for driving the fission of Golgi membranes during mitosis in vivo. Moreover, by in vitro analysis, we identified two stages of this Golgi fragmentation process: disassembly of the Golgi stacks into a tubular network, and BARS-dependent fission of these tubules. Finally, this BARS-induced fission of Golgi membranes controlled the G(2)-to-prophase transition of the cell cycle, and hence cell division.	Consorzio Mario Negri Sud, Lab Cell Regulat, I-66030 Santa Maria Imbaro, Chieti, Italy; Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Lab Membrane Traff, I-66030 Santa Maria Imbaro, Chieti, Italy	Consorzio Mario Negri Sud; Consorzio Mario Negri Sud	Luini, A (corresponding author), Consorzio Mario Negri Sud, Lab Cell Regulat, Via Nazl, I-66030 Santa Maria Imbaro, Chieti, Italy.	luini@dcbo.negrisud.it; corda@negrisud.it	Luini, Alberto/L-1372-2013; Spanò, Stefania/F-4951-2011; Corda, Daniela/K-6385-2016; Bonazzi, Matteo/G-1623-2011; Colanzi, Antonino/D-6821-2012; Bonazzi, Matteo/AAT-2653-2020; hidalgo carcedo, cristina/M-6908-2015; Hidalgo-Carcedo, Cristina/K-8876-2017	Luini, Alberto/0000-0002-8729-2549; Spanò, Stefania/0000-0001-9154-7463; Corda, Daniela/0000-0002-3614-751X; Bonazzi, Matteo/0000-0001-5499-8759; Colanzi, Antonino/0000-0002-5643-0216; Bonazzi, Matteo/0000-0001-5499-8759; hidalgo carcedo, cristina/0000-0003-3571-2449; Hidalgo-Carcedo, Cristina/0000-0003-3571-2449	Telethon [E.0982] Funding Source: Medline; Fondazione Telethon Funding Source: Custom	Telethon(Fondazione Telethon); Fondazione Telethon(Fondazione Telethon)		Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; BONAZZI M, UNPUB; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; CARCEDO C, UNPUB; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; MISTELI T, 1995, J CELL SCI, V108, P2715; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Pecot MY, 2004, CELL, V116, P99, DOI 10.1016/S0092-8674(03)01068-7; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; THYBERG J, 1992, J SUBMICR CYTOL PATH, V24, P495; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Weigert R, 1997, J BIOL CHEM, V272, P14200, DOI 10.1074/jbc.272.22.14200; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	25	99	102	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					93	96		10.1126/science.1097775	http://dx.doi.org/10.1126/science.1097775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232108				2022-12-01	WOS:000222386000043
J	Mangold, N; Quantin, C; Ansan, V; Delacourt, C; Allemand, P				Mangold, N; Quantin, C; Ansan, V; Delacourt, C; Allemand, P			Evidence for precipitation on Mars from dendritic valleys in the valles marineris area	SCIENCE			English	Article							MARTIAN VALLEYS; EVOLUTION; NETWORKS; ORIGIN; PLATEAU	Dendritic valleys on the plateau and canyons of the Valles Marineris region were identified from Thermal Emission Imaging System (THEMIS) images taken by Mars Odyssey. The geomorphic characteristics of these valleys, especially their high degree of branching, favor formation by atmospheric precipitation. The presence of inner channels and the maturity of the branched networks indicate sustained fluid flows over geologically long periods of time. These fluvial landforms occur within the Late Hesperian units ( about 2.9 to 3.4 billion years old), when Mars was thought to have been cold. Our results suggest a period of warmer conditions conducive to hydrological activity.	CNRS, UMR, Lab IDES, F-91405 Orsay, France; Univ Paris 11, F-91405 Orsay, France; Univ Lyon 1, CNRS, UMR, Lab Sci Terre, F-69622 Villeurbanne, France; ENS Lyon, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Mangold, N (corresponding author), CNRS, UMR, Lab IDES, Orsay Campus, F-91405 Orsay, France.	mangold@geol.u-psud.fr	Quantin, Cathy/H-1516-2014; allemand, pascal/B-3148-2008; delacourt, christophe/A-8240-2008	allemand, pascal/0000-0003-1269-6298; Delacourt, Christophe/0000-0003-2484-1464				BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Carr M.H, 1996, WATER MARS; Carr MH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018575; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; CLOW GD, 1987, ICARUS, V72, P95, DOI 10.1016/0019-1035(87)90123-0; Craddock RA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001505; Dohm JM, 1999, PLANET SPACE SCI, V47, P411, DOI 10.1016/S0032-0633(98)00141-X; Goldspiel JM, 2000, ICARUS, V148, P176, DOI 10.1006/icar.2000.6465; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; KOCHEL RC, 1986, J GEOPHYS RES, V91, P175; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; Lucchitta B.K., 1992, CANYON SYSTEM MARS, P453; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Malin MC, 1999, NATURE, V397, P589, DOI 10.1038/17551; MASURSKY H, 1973, J GEOPHYS RES, V78, P4009, DOI 10.1029/JB078i020p04009; MENZIES J, 1996, GLACIAL ENV, V2, P15; Miller J., 1992, FLUVIAL PROCESSES GE; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PHILLIPS LF, 1987, GEOLOGY, V15, P813, DOI 10.1130/0091-7613(1987)15<813:EORSOD>2.0.CO;2; PIERI DC, 1980, SCIENCE, V210, P895, DOI 10.1126/science.210.4472.895; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; Tanaka K. L., 1992, MARS, P345; Weitz CM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002022; [No title captured]	29	217	219	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					78	81		10.1126/science.1097549	http://dx.doi.org/10.1126/science.1097549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232103				2022-12-01	WOS:000222386000038
J	Islam, FS; Gault, AG; Boothman, C; Polya, DA; Charnock, JM; Chatterjee, D; Lloyd, JR				Islam, FS; Gault, AG; Boothman, C; Polya, DA; Charnock, JM; Chatterjee, D; Lloyd, JR			Role of metal-reducing bacteria in arsenic release from Bengal delta sediments	NATURE			English	Article							DISSIMILATORY REDUCTION; GANGES DELTA; WEST-BENGAL; GROUNDWATER; BANGLADESH; IRON; MOBILIZATION; EXTRACTION; MOBILITY	The contamination of ground waters, abstracted for drinking and irrigation, by sediment-derived arsenic threatens the health of tens of millions of people worldwide, most notably in Bangladesh and West Bengal(1-3). Despite the calamitous effects on human health arising from the extensive use of arsenic-enriched ground waters in these regions, the mechanisms of arsenic release from sediments remain poorly characterized and are topics of intense international debate(4-8). We use a microscosm-based approach to investigate these mechanisms: techniques of microbiology and molecular ecology are used in combination with aqueous and solid phase speciation analysis of arsenic. Here we show that anaerobic metal-reducing bacteria can play a key role in the mobilization of arsenic in sediments collected from a contaminated aquifer in West Bengal. We also show that, for the sediments in this study, arsenic release took place after Fe(III) reduction, rather than occurring simultaneously. Identification of the critical factors controlling the biogeochemical cycling of arsenic is one important contribution to fully informing the development of effective strategies to manage these and other similar arsenic-rich ground waters worldwide.	Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England; Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England; Univ Kalyani, Dept Chem, Santini Ketan 731235, W Bengal, India	University of Manchester; University of Manchester; STFC Daresbury Laboratory; Kalyani University	Lloyd, JR (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.	jon.lloyd@man.ac.uk	Boothman, Chris/E-7208-2013	Polya, David/0000-0002-7484-6696; Boothman, Christopher/0000-0002-4321-1719; Lloyd, Jonathan/0000-0002-0719-0498	Engineering and Physical Sciences Research Council [GR/S30207/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Acharyya SK, 1999, NATURE, V401, P545, DOI 10.1038/44052; Appelo CAJ, 2002, ENVIRON SCI TECHNOL, V36, P3096, DOI 10.1021/es010130n; Bard A.J., 1985, STANDARD POTENTIALS; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Chatterjee D, 2003, J PHYS IV, V107, P293, DOI 10.1051/jp4:20030299; Chowdhury TR, 1999, NATURE, V401, P545, DOI 10.1038/44056; Das D, 1996, ENVIRON GEOCHEM HLTH, V18, P5, DOI 10.1007/BF01757214; Dixit S, 2003, ENVIRON SCI TECHNOL, V37, P4182, DOI 10.1021/es030309t; Gault AG, 2003, MINERAL MAG, V67, P1183, DOI 10.1180/0026461036760157; Gault AG, 2003, PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, P112, DOI 10.1039/9781847551689-00112; Gault AG, 2001, ROY SOC CH, P387, DOI 10.1039/9781847551696-00387; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Kuai L, 2001, APPL ENVIRON MICROB, V67, P3168, DOI 10.1128/AEM.67.7.3168-3173.2001; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; McArthur JM, 2001, WATER RESOUR RES, V37, P109, DOI 10.1029/2000WR900270; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Nickson RT, 2000, APPL GEOCHEM, V15, P403, DOI 10.1016/S0883-2927(99)00086-4; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; TESKE A, 1994, J BACTERIOL, V176, P6623, DOI 10.1128/JB.176.21.6623-6630.1994; VANDERPEER Y, 2001, COMPUT APPL BIOSCI, V100, P569; Welham NJ, 2000, MINER ENG, V13, P911, DOI 10.1016/S0892-6875(00)00078-9; Wenzel WW, 2001, ANAL CHIM ACTA, V436, P309, DOI 10.1016/S0003-2670(01)00924-2; Zobrist J, 2000, ENVIRON SCI TECHNOL, V34, P4747, DOI 10.1021/es001068h	30	941	1009	22	557	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					68	71		10.1038/nature02638	http://dx.doi.org/10.1038/nature02638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229598				2022-12-01	WOS:000222356800043
J	Jones, LM; Depireux, DA; Simons, DJ; Keller, A				Jones, LM; Depireux, DA; Simons, DJ; Keller, A			Robust temporal coding in the trigeminal system	SCIENCE			English	Article							VISUAL-CORTEX; RAT; NEURONS; BARREL; POTENTIALS; DEFLECTION; SYNCHRONY; SURFACES	The ability of rats to use their whiskers for. ne tactile discrimination rivals that of humans using their fingertips. Rats perform discriminations rapidly and accurately while palpating the environment with their whiskers. This suggests that whisker deflections produce a robust and reliable neural code. Whisker primary afferents respond with highly reproducible temporal spike patterns to transient stimuli. Here we show that, with the use of a linear kernel, any of these reproducible response trains recorded from an individual neuron can reliably predict complex whisker deflections. These predictions are significantly improved by integrating responses from neurons with opposite angular preferences.	Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Keller, A (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	akeller@umaryland.edu		Keller, Asaf/0000-0001-8727-663X; Jones-Lush, Lauren/0000-0002-5388-3770	NIDCD NIH HHS [R01 DC-05937-01, R01 DC005937] Funding Source: Medline; NINDS NIH HHS [R01 NS31078, NS19950, F31 NS046100, F31 NS46100-01, R01 NS031078, R01 NS019950] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031078, F31NS046100, R01NS019950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005937] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Dayan P., 2001, THEORETICAL NEUROSCI, P460; GIBSON JM, 1983, SOMATOSENS RES, V1, P51, DOI 10.3109/07367228309144540; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Ito M, 2002, J PHYSIOL-LONDON, V539, P511, DOI 10.1113/jphysiol.2001.013004; JONES LM, J NEUROPHYSIOL; LEHKY SR, 1990, PROC R SOC SER B-BIO, V240, P251, DOI 10.1098/rspb.1990.0037; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Rieke F, 1997, SPIKES EXPLORING NEU, P395; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Theunissen FE, 2003, TRENDS NEUROSCI, V26, P61, DOI 10.1016/S0166-2236(02)00016-4; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	20	128	128	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1986	1989		10.1126/science.1097779	http://dx.doi.org/10.1126/science.1097779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218153	Green Accepted			2022-12-01	WOS:000222241600051
J	Goldacre, MJ; Roberts, SE				Goldacre, MJ; Roberts, SE			Hospital admission for acute pancreatitis in an English population, 1963-98: database study of incidence and mortality	BRITISH MEDICAL JOURNAL			English	Article							ETIOLOGY; ENGLAND; COUNTY; EPIDEMIOLOGY; PATTERNS; DISEASES; SCOTLAND; AUDIT	Objectives To investigate trends in the incidence of acute pancreatitis resulting in admission to hospital, and mortality after admission, from 1963 to 1998. Design Analysis of hospital inpatient statistics for acute pancreatitis, linked to data from death certificates. Setting Southern England. Subjects 5312 people admitted to hospital with acute pancreatitis. Main outcome measures Incidence rates for admission to hospital, case fatality rates at 0-29 and 30-364 days after admission, and standardised mortality ratios at monthly intervals up to one year after admission. Results The incidence of acute pancreatitis with admission to hospital increased from 1963-98: age standardised incidence rates were 4.9 per 100 000 population in 1963-74,7.7 in 1975-86, and 9.8 in 1987-98. Age standardised case fatality rates within 30 days of admission were 14.2% in 1963-74,7.6% in 1975-86, and 6.7% in 1987-98. From 1975-98, standardised mortality ratios at 30 days were 30 in men and 31 in women (compared with the general population of equivalent age in the same period = 1), and they remained significantly increased until month 5 for men and month 6 for women. Conclusions Incidence rates for acute pancreatitis with admission to hospital rose in both men and women from 1963 to 1998, particularly among younger age groups. This probably reflects, at least in part, an increase in alcoholic pancreatitis. Mortality after admission has not declined since the 1970s. This presumably reflects the fact that no major innovations in the treatment of acute pancreatitis have been introduced. Pancreatitis remains a disease with a poor prognosis during the acute phase.	Univ Oxford, Unit Hlth Care Epidemiol, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Unit Hlth Care Epidemiol, Dept Publ Hlth, Old Rd, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk						Appelros S, 1999, BRIT J SURG, V86, P465, DOI 10.1046/j.1365-2168.1999.01049.x; BOURKE JB, 1975, LANCET, V2, P967; CORFIELD AP, 1985, GUT, V26, P724, DOI 10.1136/gut.26.7.724; Eland IA, 2000, SCAND J GASTROENTERO, V35, P1110; Floyd A, 2002, SCAND J GASTROENTERO, V37, P1461, DOI 10.1080/003655202762671369; Go Vay Liang W., 1994, P235; Gronroos JM, 1999, HEPATO-GASTROENTEROL, V46, P2572; Halvorsen FA, 1996, SCAND J GASTROENTERO, V31, P411, DOI 10.3109/00365529609006419; JOHNSON CD, 1991, GUT, V32, P1401, DOI 10.1136/gut.32.11.1401; LANKISCH PG, 1989, DIGESTION, V44, P20, DOI 10.1159/000199888; Lankisch PG, 2002, PANCREATOLOGY, V2, P469, DOI 10.1159/000064713; MANN DV, 1994, BRIT J SURG, V81, P890, DOI 10.1002/bjs.1800810632; McKay CJ, 1999, BRIT J SURG, V86, P1302, DOI 10.1046/j.1365-2168.1999.01246.x; MERO M, 1982, ANN CHIR GYNAECOL FE, V71, P126; *NAT STAT, 2001, LIV BRIT RES 2000 GE, P159; OSULLIVAN JN, 1972, GASTROENTEROLOGY, V62, P373; Secknus R, 2000, CHIRURG, V71, P249; THOMSON SR, 1987, BRIT J SURG, V74, P398, DOI 10.1002/bjs.1800740526; Tinto A, 2002, ALIMENT PHARM THER, V16, P2097, DOI 10.1046/j.1365-2036.2002.01367.x; Toh SKC, 2000, GUT, V46, P239, DOI 10.1136/gut.46.2.239; Tran D. D., 1994, Digestion, V55, P342; TRAPNELL JE, 1975, BRIT MED J, V2, P179, DOI 10.1136/bmj.2.5964.179; WILSON C, 1990, BRIT J SURG, V77, P731, DOI 10.1002/bjs.1800770705; [No title captured]	24	157	162	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 19	2004	328	7454					1466	1469		10.1136/bmj.328.7454.1466	http://dx.doi.org/10.1136/bmj.328.7454.1466			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CK	15205290	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000222244600015
J	Kraus, M; Alimzhanov, MB; Rajewsky, N; Rajewsky, K				Kraus, M; Alimzhanov, MB; Rajewsky, N; Rajewsky, K			Survival of resting mature B lymphocytes depends on BCR signaling via the Ig alpha/beta heterodimer	CELL			English	Article							CELL ANTIGEN RECEPTOR; NF-KAPPA-B; CLONAL SELECTION; ACTIVATION MOTIF; IN-VIVO; MICE; BETA; IMMUNOGLOBULIN; IMMATURE; MATURATION	We previously showed that type I interferon-induced, Cre-mediated ablation of surface BCR expression in mature B cells through Ig-heavy chain deletion results in apoptosis of these cells. This led to the hypothesis that survival signals from the BCR are vital for mature B cells. Here, we test two critical assumptions of this model. First, we demonstrate loss of mature B cells upon induced mutation of a signaling module of the BCR, not precluding BCR surface expression. Second, we show that the cells are also lost upon BCR inactivation in the absence of an exogenous inducer like interferon, excluding that cell death depends on previous cellular activation by the latter. Kinetic data demonstrate that BCR-less mature B cells have a severely reduced lifespan, with a half-life of 3-6 days. Together these results establish that BCR signaling is required to keep resting mature B cells alive in vivo.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; NYU, Dept Biol, New York, NY 10003 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Cologne; New York University	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu		Rajewsky, Nikolaus/0000-0002-4785-4332; Rajewsky, Klaus/0000-0002-6633-6370	PHS HHS [R01-A1054636-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLISON J, 1991, P NATL ACAD SCI USA, V88, P2070, DOI 10.1073/pnas.88.6.2070; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kraus M, 1999, IMMUNITY, V11, P537, DOI 10.1016/S1074-7613(00)80129-6; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Meffre E, 2002, P NATL ACAD SCI USA, V99, P11334, DOI 10.1073/pnas.172369999; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Reth M, 2000, IMMUNOL REV, V176, P10; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Takahashi K, 1997, J IMMUNOL, V159, P1557; Torres RM, 1999, IMMUNITY, V11, P527, DOI 10.1016/S1074-7613(00)80128-4; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Wang Y, 2002, AM J MED GENET, V108, P333, DOI 10.1002/ajmg.10296; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963	52	419	441	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					787	800		10.1016/j.cell.2004.05.014	http://dx.doi.org/10.1016/j.cell.2004.05.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186779	Bronze			2022-12-01	WOS:000222048400011
J	Sorensen, TLM; Moller, JV; Nissen, P				Sorensen, TLM; Moller, JV; Nissen, P			Phosphoryl transfer and calcium ion occlusion in the calcium pump	SCIENCE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASE; CA2+ OCCLUSION; TRANSPORT; DOMAIN; SITES; DISSOCIATION; INTERMEDIATE; RESOLUTION; PROGRAM	A tight coupling between adenosine triphosphate (ATP) hydrolysis and vectorial ion transport has to be maintained by ATP-consuming ion pumps. We report two crystal structures of Ca2+-bound sarco(endo) plasmic reticulum Ca2+- adenosine triphosphatase (SERCA) at 2.6 and 2.9 angstrom resolution in complex with (i) a nonhydrolyzable ATP analog [adenosine (beta-gamma methylene) triphosphate] and (ii) adenosine diphosphate plus aluminum fluoride. SERCA reacts with ATP by an associative mechanism mediated by two Mg2+ ions to form an aspartyl-phosphorylated intermediate state (Ca-2- E1 similar to P). The conformational changes that accompany the reaction with ATP pull the transmembrane helices 1 and 2 and close a cytosolic entrance for Ca2+, thereby preventing backflow before Ca2+ is released on the other side of the membrane.	Aarhus Univ, Dept Biophys, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moller, JV (corresponding author), Aarhus Univ, Dept Biophys, Ole Worms Alle 185, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; nissen@imsb.au.dk	Sørensen, Thomas Lykke-Møller/AAA-7052-2020; Nissen, Poul/D-5774-2014	Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Nissen, Poul/0000-0003-0948-6628				Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; COAN C, 1994, BIOCHEMISTRY-US, V33, P3722, DOI 10.1021/bi00178a032; DUPONT Y, 1980, EUR J BIOCHEM, V109, P231, DOI 10.1111/j.1432-1033.1980.tb04788.x; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LAUGER P, 1991, ELECTROGENIC PUMPS; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; Sorensen T. J., UNPUB; SUMIDA M, 1974, J BIOCHEM-TOKYO, V75, P283, DOI 10.1093/oxfordjournals.jbchem.a130396; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; VERJOVSKIALMEIDA S, 1978, BIOCHEMISTRY-US, V17, P5006, DOI 10.1021/bi00616a023; VILSEN B, 1992, J BIOL CHEM, V267, P25739; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	25	366	374	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1672	1675		10.1126/science.1099366	http://dx.doi.org/10.1126/science.1099366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192230				2022-12-01	WOS:000221934300051
J	Gross, E; Kastner, DB; Kaiser, CA; Fass, D				Gross, E; Kastner, DB; Kaiser, CA; Fass, D			Structure of Ero1p, source of disulfide bonds for oxidative protein folding in the cell	CELL			English	Article							WHITE SULFHYDRYL OXIDASE; MECHANISM; PATHWAY; YEAST; MOTIF; GENE; DSBB; THIOREDOXIN; STABILITY; CYSTEINES	The flavoenzyme Ero1p produces disulficle bonds for oxidative protein folding in the endoplasmic reticulum. Disulfides generated de novo within Ero1p are transferred to protein disulfide isomerase and then to substrate proteins by dithiol-disulfide exchange reactions. Despite this key role of Ero1p, little is known about the mechanism by which this enzyme catalyzes thiol oxidation. Here, we present the X-ray crystallographic structure of Ero1p, which reveals the molecular details of the catalytic center, the role of a CXXCXXC motif, and the spatial relationship between functionally significant cysteines and the bound cofactor. Remarkably, the Ero1p active site closely resembles that of the versatile thiol oxidase module of Erv2p, a protein with no sequence homology to Ero1p. Furthermore, both Ero1p and Erv2p display essential dicysteine motifs on mobile polypeptide segments, suggesting that shuttling electrons to a rigid active site using a flexible strand is a fundamental feature of disulfide-generating flavoenzymes.	Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il	Gross, Einav/AAS-7417-2021					Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816; Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung YS, 2000, J BIOL CHEM, V275, P36974, DOI 10.1074/jbc.M004947200; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; Niimura Y, 2000, J BACTERIOL, V182, P5046, DOI 10.1128/JB.182.18.5046-5051.2000; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1988, J BIOL CHEM, V263, P11820; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Raje S, 2002, ANAL BIOCHEM, V307, P266, DOI 10.1016/S0003-2697(02)00050-7; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; SALAMOV AA, 1995, J MOL BIOL, V247, P11, DOI 10.1006/jmbi.1994.0116; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	48	194	199	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					601	610		10.1016/S0092-8674(04)00418-0	http://dx.doi.org/10.1016/S0092-8674(04)00418-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163408	Bronze			2022-12-01	WOS:000221857900007
J	Newsome, TP; Scaplehorn, N; Way, M				Newsome, TP; Scaplehorn, N; Way, M			Src mediates a switch from microtubule- to actin-based motility of vaccinia virus	SCIENCE			English	Article							INTRACELLULAR ENVELOPED VIRIONS; FUNCTIONAL-ANALYSIS; N-WASP; MOVEMENT; PROTEIN; TRANSPORT; DOMAINS; A33R	The cascade of events that leads to vaccinia-induced actin polymerization requires Src-dependent tyrosine phosphorylation of the viral membrane protein A36R. We found that a localized outside-in signaling cascade induced by the viral membrane protein B5R is required to potently activate Src and induce A36R phosphorylation at the plasma membrane. In addition, Src-mediated phosphorylation of A36R regulated the ability of virus particles to recruit and release conventional kinesin. Thus, Src activity regulates the transition between cytoplasmic microtubule transport and actin-based motility at the plasma membrane.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, Room 529,44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Way, Michael/0000-0001-7207-2722; Scaplehorn, Niki/0000-0001-9451-8748				Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Katz E, 2003, J VIROL, V77, P12266, DOI 10.1128/JVI.77.22.12266-12275.2003; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; Ward BM, 2003, J VIROL, V77, P4113, DOI 10.1128/JVI.77.7.4113-4126.2003; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	124	131	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					124	129		10.1126/science.1101509	http://dx.doi.org/10.1126/science.1101509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15297625				2022-12-01	WOS:000224304000052
J	Devenny, A; Wassall, H; Ninan, T; Omran, M; Khan, SD; Russell, G				Devenny, A; Wassall, H; Ninan, T; Omran, M; Khan, SD; Russell, G			Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCHOOLCHILDREN; INCREASE; ASTHMA		Royal Aberdeen Childrens Hosp, Dept Med Paediat, Aberdeen AB25 2ZG, Scotland; Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England; Doncaster Royal Infirm, Dept Child Hlth, Doncaster DN2 5LT, England	University of Aberdeen; Heart of England NHS Foundation Trust; University of Birmingham	Russell, G (corresponding author), Royal Aberdeen Childrens Hosp, Dept Med Paediat, Aberdeen AB25 2ZG, Scotland.	libra@ifb.co.uk						Chang AB, 1998, ARCH DIS CHILD, V79, P6, DOI 10.1136/adc.79.1.6; HILL R, 1989, BRIT MED J, V299, P898, DOI 10.1136/bmj.299.6704.898; NINAN TK, 1992, BRIT MED J, V304, P873, DOI 10.1136/bmj.304.6831.873; Omran M, 1996, BRIT MED J, V312, P34, DOI 10.1136/bmj.312.7022.34; Ronchetti R, 2001, EUR RESPIR J, V17, P881, DOI 10.1183/09031936.01.17508810	5	102	106	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					489	490		10.1136/bmj.38139.666447.F7	http://dx.doi.org/10.1136/bmj.38139.666447.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15217840	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000223684600015
J	Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R				Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R			Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans	CELL			English	Article							E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; QUALITY-CONTROL; DOMAIN PROTEIN; HEAVY-CHAIN; CHIP; GENE; IDENTIFICATION; FAMILY	The organization of the motor protein myosin into motile cellular structures requires precise temporal and spatial control. Caenorhabditis elegans UNC-45 facilitates this by functioning both as a chaperone and as a Hsp90 cochaperone for myosin during thick filament assembly. Consequently, mutations in C. elegans unc45 result in paralyzed animals with severe myofibril disorganization in striated body wall muscles. Here, we report a new E3/E4 complex, formed by CHN-1, the C. elegans ortholog of CHIP (carboxyl terminus of Hsc70-interacting protein), and UFD-2, an enzyme known to have ubiquitin conjugating E4 activity in yeast, as necessary and sufficient to multiubiquitylate UNC-45 in vitro. The phenotype of unc-45 temperature-sensitive animals is partially suppressed by chn-1 loss of function, while UNC-45 overexpression in worms deficient for chn-1 results in severely disorganized muscle cells. These results identify CHN-1 and UFD-2 as a functional E3/E4 complex and UNC-45 as its physiologically relevant substrate.	Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, D-80336 Munich, Germany; Univ Freiburg, Dept Bioinformat & Mol Genet, D-79104 Freiburg, Germany; Univ Hamburg, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Munich; University of Freiburg; University of Hamburg; Baylor College of Medicine; Baylor College of Medicine	Baumeister, R (corresponding author), Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, Schillerstr 44, D-80336 Munich, Germany.	baumeister@celegans.de	Hutagalung, Alex/AAH-5795-2021; Hoppe, Thorsten/AAC-7880-2020	Hoppe, Thorsten/0000-0002-4734-9352; Springer, Wolfdieter/0000-0002-1178-3149				Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; BRENNER S, 1974, GENETICS, V77, P71; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; Etheridge L, 2002, DEV DYNAM, V224, P457, DOI 10.1002/dvdy.10123; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jones D, 2002, GENOME BIOL, V3; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Waterston R., 1988, NEMATODE CAENORHABDI, P281; Wong KCY, 2000, J CELL SCI, V113, P2421; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	35	113	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					337	349		10.1016/j.cell.2004.07.014	http://dx.doi.org/10.1016/j.cell.2004.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294159	Bronze			2022-12-01	WOS:000223353100010
J	Spiegel, PB; Salama, P; Maloney, S; van der Veen, A				Spiegel, PB; Salama, P; Maloney, S; van der Veen, A			Quality of malnutrition assessment surveys conducted during famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITIONAL-STATUS; DISPLACED PERSONS; PUBLIC-HEALTH; MORTALITY; MORBIDITY; REFUGEE; CAMPS	Context During 1999 and 2000, approximately 10 million people were affected by famine in Ethiopia. Results of nutrition assessments and surveys conducted by humanitarian organizations were used by donors and government agencies to determine needs for food aid and to make other decisions on geographic allocation of limited resources; however, accurate results might have been hampered by methodological errors. Objectives To identify common methodological errors in nutrition assessments and surveys and to provide practical recommendations for improvement. Design and Setting Nutrition assessments and surveys (n=125) conducted by 14 nongovernmental organizations (NGOs) in 54 woredas (districts) in Ethiopia from May 1, 1999, through July 31, 2000. Surveys were ranked as valid and precise according to 5 criteria: use of population proportional to size sampling, sample size, number of clusters, number of children per cluster, and use of weight-for-height index. Main Outcome Measures Number and proportion of surveys that used standard, internationally accepted methods and reported valid and precise results. Results Fifty-eight of the 125 surveys (46%) were not intended to be standard 30 X 30 cluster surveys. Of the remaining 67 surveys, 6 (9%) met predetermined criteria for validity and precision. All 67 used the anthropometric index of weight-for-height, with 58 (87%) reporting z scores. Fifty-four (81%) used nonrandom sampling without consideration of population size and 6 (9%) had sample sizes of fewer than 500 persons. Conclusions Major methodological errors were identified among 30 X 30 cluster surveys designed to measure acute malnutrition prevalence in Ethiopia during the famine of 1999-2000. Donor agencies and NGOs should be educated about the need for improved quality of nutrition assessments and their essential role in directing allocation of scarce food resources.	Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Emergency & Environm Hlth Serv, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; WHO, Off Reg Humanitarian Emergency Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Spiegel, PB (corresponding author), UNHCR, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1997, REF HLTH APPR EM SIT; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BINKIN N, 1992, DISASTERS, V16, P97, DOI 10.1111/j.1467-7717.1992.tb00383.x; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Cochran W.G., 1963, SAMPLING TECHNIQUES; DEGOYET CD, 1979, MANAGEMENT NUTR EMER; *EV BAS WORK GROUP, CLIN EP GLOSS; Garfield R, 2000, NUTR REV, V58, P269, DOI 10.1111/j.1753-4887.2000.tb01880.x; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; KATZ J, 1995, AM J CLIN NUTR, V61, P155, DOI 10.1093/ajcn/61.1.155; LEMESHOW S, 1985, INT J EPIDEMIOL, V14, P473, DOI 10.1093/ije/14.3.473; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; *MSF, 1995, NUTR GUID; MURRAY MJ, 1976, LANCET, V1, P1283; *OG WELF SOC, 1999, WORLD FOOD PROGR SUM; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SEAMAN J, 1978, INT J EPIDEMIOL, V7, P31, DOI 10.1093/ije/7.1.31; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; SULLIVAN K, 1995, ANN M SOC EP RES JUN; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; TOOLE MJ, 1995, INFECT DIS CLIN N AM, V9, P353; *TRANS GOV ETH REL, 1995, GUID NUTR STAT DAT F; *UNICEF, 2000, SIT REP ETH; *USAID, 2000, US AG INT DEV COMB T; World Health Organization, 2000, MAN NUTR MAJ EM	30	44	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					613	618		10.1001/jama.292.5.613	http://dx.doi.org/10.1001/jama.292.5.613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292087	Bronze			2022-12-01	WOS:000223045500019
J	Urbakh, M; Klafter, J; Gourdon, D; Israelachvili, J				Urbakh, M; Klafter, J; Gourdon, D; Israelachvili, J			The nonlinear nature of friction	NATURE			English	Article							STICK-SLIP MOTION; DYNAMIC FORCE SPECTROSCOPY; CONFINED LIQUIDS; STATIC FRICTION; SHEAR; LUBRICATION; ORIGIN; FILMS; FLUCTUATIONS; TRANSITIONS	Tribology Is the study of adhesion, friction, lubrication and wear of surfaces in relative motion. It remains as important today as it was in ancient times, arising in the fields of physics, chemistry, geology, biology and engineering. The more we learn about tribology the more complex it appears. Nevertheless, recent experiments coupled to theoretical modelling have made great advances in unifying apparently diverse phenomena and revealed many subtle and often non-intuitive aspects of matter in motion, which stem from the nonlinear nature of the problem.	Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Tel Aviv University; University of California System; University of California Santa Barbara	Urbakh, M (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel.		Urbakh, Michael/AAU-4993-2021; Hoelscher, Hendrik/G-5165-2013	Hoelscher, Hendrik/0000-0002-1033-1669				Aranson IS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125402; Barrat JL, 1999, FARADAY DISCUSS, V112, P119, DOI 10.1039/a809733j; Bhushan B, 1997, NATO ADV SCI I E-APP, V330, P1; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braiman Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.094301; Carlson JM, 1996, PHYS REV E, V53, P4153, DOI 10.1103/PhysRevE.53.4153; Chang KC, 2000, BIOPHYS J, V79, P1891, DOI 10.1016/S0006-3495(00)76439-3; Cochard A, 2003, J APPL MECH-T ASME, V70, P220, DOI 10.1115/1.1546241; Demirel AL, 1996, PHYS REV LETT, V77, P4330, DOI 10.1103/PhysRevLett.77.4330; Drummond C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011705; Drummond C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066110; Drummond C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041506; Drummond C, 2000, MACROMOLECULES, V33, P4910, DOI 10.1021/ma9919918; Dudko OK, 2002, CHEM PHYS LETT, V352, P499, DOI 10.1016/S0009-2614(01)01469-5; Dudko OK, 2003, P NATL ACAD SCI USA, V100, P11378, DOI 10.1073/pnas.1534554100; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Filippov AE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.275506; Filippov AE, 2002, J CHEM PHYS, V116, P6871, DOI 10.1063/1.1471242; Gao JP, 1998, J PHYS CHEM B, V102, P5033, DOI 10.1021/jp982150q; Gao JP, 1997, PHYS REV LETT, V79, P705, DOI 10.1103/PhysRevLett.79.705; Gao JP, 2004, J PHYS CHEM B, V108, P3410, DOI 10.1021/jp036362l; GOETZ DJ, 1994, BIOPHYS J, V66, P2202, DOI 10.1016/S0006-3495(94)81016-1; Gourdon D, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021602; He G, 1999, SCIENCE, V284, P1650, DOI 10.1126/science.284.5420.1650; Heuberger M, 1998, J PHYS CHEM B, V102, P5038, DOI 10.1021/jp9823143; HU HW, 1991, PHYS REV LETT, V66, P2758, DOI 10.1103/PhysRevLett.66.2758; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1986, J COLLOID INTERF SCI, V110, P263, DOI 10.1016/0021-9797(86)90376-0; KLEIN J, 1995, SCIENCE, V269, P816, DOI 10.1126/science.269.5225.816; LANDMAN U, 1992, NATO ADV SCI I E-APP, V220, P463; Lemaitre A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195503; LEMAITRE A, IN PRESS PHYS REV E; Muser MH, 2003, ADV CHEM PHYS, V126, P187, DOI 10.1002/0471428019.ch5; Muser MH, 2001, PHYS REV LETT, V86, P1295, DOI 10.1103/PhysRevLett.86.1295; Persson B.N.J., 2000, SLIDING FRICTION PHY; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Riedo E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.084502; ROBBINS MO, 2001, TRIBOLOGY HDB, P717; Rozman MG, 1996, PHYS REV E, V54, P6485, DOI 10.1103/PhysRevE.54.6485; Rozman MG, 1998, J PHYS CHEM B, V102, P7924, DOI 10.1021/jp981332h; Rozman MG, 1996, PHYS REV LETT, V77, P683, DOI 10.1103/PhysRevLett.77.683; Rozman MG, 1998, PHYS REV E, V57, P7340, DOI 10.1103/PhysRevE.57.7340; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sang Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.174301; Stills S., 2003, PHYS REV LETT, V91; THOMPSON PA, 1995, ISR J CHEM, V35, P93; THOMPSON PA, 1990, SCIENCE, V250, P792, DOI 10.1126/science.250.4982.792; URBAKH M, 1995, PHYS REV E, V51, P2137, DOI 10.1103/PhysRevE.51.2137; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033; Zaloj V, 1999, PHYS REV LETT, V82, P4823, DOI 10.1103/PhysRevLett.82.4823	50	520	534	17	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					525	528		10.1038/nature02750	http://dx.doi.org/10.1038/nature02750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282597				2022-12-01	WOS:000222946100038
J	Laporte, R; Pernes, P; Pronni, P; Gottrand, F; Vincent, P				Laporte, R; Pernes, P; Pronni, P; Gottrand, F; Vincent, P			Acquisition of Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey in institutionalised young people	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ISCHEMIC-HEART-DISEASE; PASSIVE SMOKING; COTININE; MORTALITY; EXPOSURE; RISK; POPULATION; NONSMOKERS		Univ Lille II JE 2225, INSERM E9919, Lille, France; Ctr Antoine Saint Exupery, Vendin Le Vieil, France; Hop Jeanne Flandre, Pediat Clin, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Vincent, P (corresponding author), Ctr Hosp Reg & Univ Lille, Hop Calmette, Lab Bacteriol Hyg, 1 Blvd J, F-59037 Lille, France.	p-vincent@chru-lille.fr	gottrand, frederic F/G-7370-2015	gottrand, frederic F/0000-0002-5290-0436; Laporte, Remi/0000-0003-4097-462X				Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; BUTLER TL, 1988, THESIS U CALIFORNIA; Enstrom JE, 2003, BMJ-BRIT MED J, V326, P1057, DOI 10.1136/bmj.326.7398.1057; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; GARLAND C, 1985, AM J EPIDEMIOL, V121, P645, DOI 10.1093/aje/121.5.645; Gisbert JP, 2001, AM J GASTROENTEROL, V96, P2829, DOI 10.1111/j.1572-0241.2001.04235.x; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HIRAYAMA T, 1990, NEW ZEAL MED J, V103, P54; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; HUMBLE C, 1990, AM J PUBLIC HEALTH, V80, P599, DOI 10.2105/AJPH.80.5.599; JARVIS M, 1984, J EPIDEMIOL COMMUN H, V38, P335, DOI 10.1136/jech.38.4.335; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; JARVIS MJ, 1992, BRIT J ADDICT, V87, P111; Jarvis MJ, 2001, TOB CONTROL, V10, P368, DOI 10.1136/tc.10.4.368; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Leung WK, 1999, AM J GASTROENTEROL, V94, P2881, DOI 10.1111/j.1572-0241.1999.01431.x; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; SHAPER AG, 1988, J HUM HYPERTENS, V2, P71; SHAPER AG, 1991, BRIT HEART J, V66, P384; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; SVENDSEN KH, 1987, AM J EPIDEMIOL, V126, P783, DOI 10.1093/oxfordjournals.aje.a114715; THOMAS JE, 1992, LANCET, V340, P1194, DOI 10.1016/0140-6736(92)92894-L; TUNSTALLPEDOE H, 1995, J EPIDEMIOL COMMUN H, V49, P139, DOI 10.1136/jech.49.2.139; Walker A, 2002, LIVING BRITAIN RESUL; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479	31	16	17	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2004	329	7459					204	205		10.1136/bmj.329.7459.204	http://dx.doi.org/10.1136/bmj.329.7459.204			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271830	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000222866900017
J	Tagle, R; Claeys, P				Tagle, R; Claeys, P			Comet or asteroid shower in the late Eocene?	SCIENCE			English	Article									Free Univ Brussels, Dept Geol, B-1050 Brussels, Belgium; Museum Naturkunde, Inst Mineral, D-10099 Berlin, Germany	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Claeys, P (corresponding author), Free Univ Brussels, Dept Geol, Pleinlaan 2, B-1050 Brussels, Belgium.	phclaeys@vub.ac.be	(VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008	(VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687				Farley KA, 1998, SCIENCE, V280, P1250, DOI 10.1126/science.280.5367.1250; FRENCH BM, 1998, CONTRIBUTION LUNEAR, V954; Montanari A, 2000, LECT NOTES EARTH SCI, V93; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Schmitz B, 2003, SCIENCE, V300, P961, DOI 10.1126/science.1082182; Weissman PR, 1997, ASTROPHYS J, V488, pL133, DOI 10.1086/310940	6	37	38	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					492	492		10.1126/science.1098481	http://dx.doi.org/10.1126/science.1098481			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273387	Green Submitted			2022-12-01	WOS:000222828900031
J	Jick, H; Kaye, JA; Jick, SS				Jick, H; Kaye, JA; Jick, SS			Antidepressants and the risk of suicidal behaviors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLUOXETINE; DEPRESSION	Context The relation between use of antidepressants, especially selective serotonin reuptake inhibitors (SSRls), and suicidal ideation and behaviors has received considerable public attention recently. The use of such drugs among teenagers has been of particular concern. Objective To estimate the relative risks (RRs) of nonfatal suicidal behavior in patients starting treatment with 1 of 3 antidepressant drugs compared with patients starting treatment with dothiepin. Design and Setting Matched case-control study of patients treated in UK general practices using the UK General Practice Research Database for 1993-1999. Participants The base population included 159810 users of the 4 antidepressant drugs. Participants could have used only 1 of these antidepressants and had to have received at least 1 prescription for the study antidepressant within 90 days before their index date (the date of suicidal behavior or ideation for cases and the same date for matched controls). Main Outcome Measures Frequency of first-time exposure to amitriptyline, fluoxetine, paroxetine, and dothiepin of patients with a recorded diagnosis of first-time nonfatal suicidal behavior or suicide compared with comparable patients who did not exhibit suicidal behavior. Results After controlling forage, sex, calendar time, and time from first antidepressant prescription to the onset of suicidal behavior, the relative risks for newly diagnosed nonfatal suicidal behavior in 555 cases and 2062 controls were 0.83 (95% confidence interval, [Cl]0.61-1.13) for amitriptyline, 1.16 (95% Cl, 0.90-1.50) for fluoxetine, and 1.29 (95% Cl, 0.97-1.70) for paroxetine compared with those using dothiepin. The RR for suicidal behavior among patients first prescribed an antidepressant within 1 to 9 days before their index date was 4.07 (95% Cl, 2.89-5.74) compared with patients who were first prescribed an antidepressant 90 days or more before their index date. Time since first antidepressant prescription was not, however, a confounder of the relation between specific antidepressants and suicidal behavior since its relation to suicidal behavior was not materially different among users of the 4 study drugs. Similarly for fatal suicide, the RR among patients who were first prescribed an antidepressant within 1 to 9 days before their index date was 38.0 (95% Cl, 6.2-231) compared with those who were first prescribed an antidepressant 90 days or more before their index date. There were no significant associations between the use of a particular study antidepressant and the risk of suicide. Conclusions The risk of suicidal behavior after starting antidepressant treatment is similar among users of amitriptyline, fluoxetine, and paroxetine compared with the risk among users of dothiepin. The risk of suicidal behavior is increased in the first month after starting antidepressants, especially during the first 1 to 9 days. A possible small increase in risk (bordering statistical significance) among those starting the newest antidepressant, paroxetine, is of a magnitude that could readily be due to uncontrolled confounding by severity of depression. Based on limited information, we also conclude that there is no substantial difference in effect of the 4 drugs on people aged 10 to 19 years.	Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Jick, H (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA.	hjick@bu.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Jick, Susan/0000-0002-2215-1067; Kaye, James A./0000-0002-9357-4227; Jick, Hershel/0000-0003-4270-5992				BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; *COMM SAF MED EXP, INT REP COMM SAF MED; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Editorial, 2004, LANCET, V363, P1335; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; *US FDA, 1991, PSYCH DRUGS ADV COMM; *US FDA, SUBJ WORS DEPR SUIC; *US FDA, FDA TALK PAP FDA ISS	11	415	434	7	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2004	292	3					338	343		10.1001/jama.292.3.338	http://dx.doi.org/10.1001/jama.292.3.338			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838DL	15265848				2022-12-01	WOS:000222693500018
J	Degenholtz, HB; Rhee, Y; Arnold, RM				Degenholtz, HB; Rhee, Y; Arnold, RM			Brief communication: The relationship between having a living will and dying in place	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	54th Annual Scientific Meeting of the Gerontological-Society-of-America	NOV 14-18, 2001	Chicago, IL	Gerontol Soc Amer			SELF-DETERMINATION ACT; LIFE-SUSTAINING TREATMENT; NURSING-HOME POPULATION; ADVANCE DIRECTIVES; DEATH; CARE; END; DECISIONS; SAVINGS; PEOPLE	Background: Living wills, a type of advance directive, are promoted as a way for patients to document preferences for life-sustaining treatments should they become incompetent. Previous research, however, has found that these documents do not guide decision making in the hospital. Objective: To test the hypothesis that people with living wills are less likely to die in a hospital than in their residence before death. Design: secondary analysis of data from a nationally representative longitudinal study. Setting: Publicly available data from the Asset and Health Dynamics Among the Oldest Old (AHEAD) study. Patients: People older than 70 years of age living in the community in 1993 who died between 1993 and 1995. Measurements: Self-report and proxy informant interviews conducted in 1993 and 1995. Results: Having a living will was associated with lower probability of dying in a hospital for nursing home residents and people living in the community. For people living in the community, the probability of in-hospital death decreased from 0.65 (95% CI, 0.58 to 0.71) to 0.52 (CI, 0.42 to 0.62). For people living in nursing homes, the probability of in-hospital death decreased from 0.35 (CI, 0.23 to 0.49) to 0.13 (CI, 0.07 to 0.22). Limitations: Retrospective survey data do not contain detailed clinical information on whether the living will was consulted. Conclusion: Living wills are associated with dying in place rather than in a hospital. This implies that previous research examining only people who died in a hospital suffers from selection bias. During advance care planning, physicians should discuss patients' preferences for location of death.	Univ Pittsburgh, Ctr Bioeth & Hlth Law, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Degenholtz, HB (corresponding author), Univ Pittsburgh, Ctr Bioeth & Hlth Law, 3708 5th Ave,Suite 300, Pittsburgh, PA 15213 USA.	degen@pitt.edu		Degenholtz, Howard/0000-0003-1986-7360	NIA NIH HHS [1R0 3AG18811-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R03AG018811] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; CHAMBERS CV, 1994, ARCH INTERN MED, V154, P541, DOI 10.1001/archinte.154.5.541; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; GORDON GH, 1992, HOSP PRACT, V27, P39; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; HOLTZMAN J, 1994, J AM GERIATR SOC, V42, P275, DOI 10.1111/j.1532-5415.1994.tb01751.x; Jacobson JA, 1996, ARCH INTERN MED, V156, P1862, DOI 10.1001/archinte.156.16.1862; KELLOGG FR, 1995, J AM GERIATR SOC, V43, P113, DOI 10.1111/j.1532-5415.1995.tb06375.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; Miles SH, 1996, ARCH INTERN MED, V156, P1062, DOI 10.1001/archinte.156.10.1062; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; *NAT CTR HLTH STAT, 1998, NAT MORT FOLL SURV P; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; Soldo BJ, 1997, J GERONTOL B-PSYCHOL, V52, P1, DOI 10.1093/geronb/52B.Special_Issue.1; STELTER KL, 1992, ARCH INTERN MED, V152, P954, DOI 10.1001/archinte.152.5.954; Teno J, 1997, J AM GERIATR SOC, V45, P513, DOI 10.1111/j.1532-5415.1997.tb05180.x; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Teno JM, 1997, J AM GERIATR SOC, V45, P939, DOI 10.1111/j.1532-5415.1997.tb02963.x; TENO JM, 1994, J CLIN ETHIC, V5, P23; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015; *U MI I SOC RES, 1999, ASS HLTH DYN OLD OLD; WEEKS WB, 1994, ARCH INTERN MED, V154, P2077, DOI 10.1001/archinte.154.18.2077	30	84	87	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2004	141	2					113	117		10.7326/0003-4819-141-2-200407200-00009	http://dx.doi.org/10.7326/0003-4819-141-2-200407200-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	839BL	15262666				2022-12-01	WOS:000222758200004
J	Kremsner, PG; Krishna, S				Kremsner, PG; Krishna, S			Antimalarial combinations	LANCET			English	Review							UNCOMPLICATED FALCIPARUM-MALARIA; RANDOMIZED CONTROLLED-TRIAL; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; DRUG-RESISTANCE; ARTEMETHER-LUMEFANTRINE; ARTESUNATE-MEFLOQUINE; AFRICAN CHILDREN; DOUBLE-BLIND; DIHYDROARTEMISININ-PIPERAQUINE	Multidrug resistance has rendered monotherapy for malaria useless in most parts of the world, and has also compromised the usefulness of many of the available combination chemotherapies. New antimalarial regimens are, therefore, urgently needed. We review the various antimalarial combinations that can be used to treat otherwise drug-resistant disease, and discuss what defines an ideal antimalarial combination regimen.	Univ Tubingen, Inst Trop Med, Dept Parasitol, D-72074 Tubingen, Germany; Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med, London SW17 0RE, England	Eberhard Karls University of Tubingen; St Georges University London	Kremsner, PG (corresponding author), Univ Tubingen, Inst Trop Med, Dept Parasitol, Wilhelmstr 27, D-72074 Tubingen, Germany.	peter.kremsner@uni-tuebingen.de		Krishna, Sanjeev/0000-0003-0066-0634				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; AMIES CR, 1930, B I MED RES FEDERATE, V2, P1; Angus BJ, 1997, BLOOD, V90, P2037, DOI 10.1182/blood.V90.5.2037; Athan E, 2001, S AFR MED J, V91, P592; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Bakshi R, 2000, T ROY SOC TROP MED H, V94, P419, DOI 10.1016/S0035-9203(00)90126-3; BASHAM D, 1998, NATURE, V393, P537; Bojang KA, 1998, T ROY SOC TROP MED H, V92, P73, DOI 10.1016/S0035-9203(98)90962-2; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Brandts CH, 1997, LANCET, V350, P704, DOI 10.1016/S0140-6736(97)02255-1; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P534; CANFIELD CJ, 1995, EXP PARASITOL, V80, P373, DOI 10.1006/expr.1995.1049; CLYDE D. F., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P505, DOI 10.1016/0035-9203(57)90039-1; COLLIGNON P, 1991, J INFECT DIS, V164, P222, DOI 10.1093/infdis/164.1.222; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; DIVO AA, 1985, ANTIMICROB AGENTS CH, V27, P21, DOI 10.1128/AAC.27.1.21; Dorsey G, 2003, J INFECT DIS, V188, P1231, DOI 10.1086/378523; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Edstein M. D., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P216; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; FICHERA ME, 1995, ANTIMICROB AGENTS CH, V39, P1530, DOI 10.1128/AAC.39.7.1530; Fleck SL, 1996, T ROY SOC TROP MED H, V90, P309, DOI 10.1016/S0035-9203(96)90266-7; FUNGLADDA W, 1998, B WHO S, V76, P57; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasasira AF, 2003, AM J TROP MED HYG, V68, P127, DOI 10.4269/ajtmh.2003.68.127; Giao PT, 2001, AM J TROP MED HYG, V65, P690, DOI 10.4269/ajtmh.2001.65.690; Giao PT, 2001, CLIN PHARMACOKINET, V40, P343, DOI 10.2165/00003088-200140050-00003; HATTON CSR, 1986, LANCET, V1, P411; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; HIEN TT, 1993, LANCET, V341, P603; Honigsbaum Mark, 2001, FEVER TRAIL; Honrado ER, 1999, B WORLD HEALTH ORGAN, V77, P235; Hussein Z, 1997, CLIN PHARMACOL THER, V61, P518, DOI 10.1016/S0009-9236(97)90132-6; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; KREMSNER PG, 1995, ANTIMICROB AGENTS CH, V39, P1603, DOI 10.1128/AAC.39.7.1603; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; KREMSNER PG, 1994, J INFECT DIS, V169, P467, DOI 10.1093/infdis/169.2.467; Kremsner PG, 2002, LANCET, V360, P1998, DOI 10.1016/S0140-6736(02)12032-0; KREMSNER PG, 1993, AM J TROP MED HYG, V49, P650, DOI 10.4269/ajtmh.1993.49.650; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Kun JFJ, 1998, LANCET, V351, P265, DOI 10.1016/S0140-6736(05)78273-8; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; Laveran C.L.A., 1880, B MEM SOC MED HOP P, V17, P158; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Lell B, 1998, AM J TROP MED HYG, V58, P619, DOI 10.4269/ajtmh.1998.58.619; Lell B, 2003, ANTIMICROB AGENTS CH, V47, P735, DOI 10.1128/AAC.47.2.735-738.2003; Lell B, 2002, ANTIMICROB AGENTS CH, V46, P2315, DOI 10.1128/AAC.46.8.2315-2320.2002; Lell B, 1998, LANCET, V351, P709, DOI 10.1016/S0140-6736(97)09222-2; Lell B, 2001, CLIN INFECT DIS, V32, P838, DOI 10.1086/319217; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; LUZZI GA, 1993, DRUG SAFETY, V8, P295, DOI 10.2165/00002018-199308040-00004; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Marquino W, 2003, AM J TROP MED HYG, V68, P608, DOI 10.4269/ajtmh.2003.68.608; Massougbodji A, 2002, T ROY SOC TROP MED H, V96, P655, DOI 10.1016/S0035-9203(02)90344-5; McGready R, 2001, T ROY SOC TROP MED H, V95, P651, DOI 10.1016/S0035-9203(01)90106-3; McIntosh HM, 1998, ANN TROP MED PARASIT, V92, P265, DOI 10.1080/00034989859825; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; METZGER W, 1995, ANTIMICROB AGENTS CH, V39, P245, DOI 10.1128/AAC.39.1.245; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Mordmuller B, 1998, WIEN KLIN WOCHENSCHR, V110, P321; Nakazawa S, 2002, ANTIMICROB AGENTS CH, V46, P958, DOI 10.1128/AAC.46.4.958-965.2002; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; OLLIARO P, 2003, COCHRANE LIB; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Parola P, 2001, ANTIMICROB AGENTS CH, V45, P932, DOI 10.1128/AAC.45.3.932-935.2001; PETERS W, 1982, BRIT MED BULL, V38, P187, DOI 10.1093/oxfordjournals.bmb.a071757; Peters W, 1999, ANN TROP MED PARASIT, V93, P569, DOI 10.1080/00034989958087; Peters W, 1987, CHEMOTHERAPY DRUG RE; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Plowe CV, 2001, INFEC DIS S, P173; Price RN, 2001, DRUG RESIST UPDATE, V4, P187, DOI 10.1054/drup.2001.0195; PUKRITTAYAKAMEE S, 1994, T ROY SOC TROP MED H, V88, P324, DOI 10.1016/0035-9203(94)90102-3; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Rahman MR, 2001, T ROY SOC TROP MED H, V95, P661, DOI 10.1016/S0035-9203(01)90108-7; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schurmann D, 2001, J INFECTION, V42, P8, DOI 10.1053/jinf.2000.0772; Schwobel B, 2003, TROP MED INT HEALTH, V8, P19, DOI 10.1046/j.1365-3156.2003.00977.x; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Stepniewska K, 2001, T ROY SOC TROP MED H, V95, P637, DOI 10.1016/S0035-9203(01)90104-X; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; Toovey S, 2004, T ROY SOC TROP MED H, V98, P261, DOI 10.1016/j.trstmh.2003.11.001; Udomsangpetch R, 1996, J INFECT DIS, V173, P691, DOI 10.1093/infdis/173.3.691; Vaidya AB, 2001, INFEC DIS S, P203; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; vonSeidlein L, 1997, J INFECT DIS, V176, P1113, DOI 10.1086/516524; VONSEIDLEIN L, 2003, T R SOC TROP MED HYG, V97, P129; Warhurst DC, 2001, NEW ENGL J MED, V344, P299, DOI 10.1056/NEJM200101253440411; WATKINS WM, 1993, AM J TROP MED HYG, V49, P106, DOI 10.4269/ajtmh.1993.49.106; WERNSDORFER WH, 1994, ACTA TROP, V56, P143, DOI 10.1016/0001-706X(94)90060-4; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHITE NJ, 1989, T ROY SOC TROP MED H, V83, P767, DOI 10.1016/0035-9203(89)90322-2; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 1998, ANN TROP MED PARASIT, V92, P449, DOI 10.1080/00034989859429; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; Wilairatana P, 1997, ANN TROP MED PARASIT, V91, P125, DOI 10.1080/00034989761454; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	113	206	208	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2004	364	9430					285	294		10.1016/S0140-6736(04)16680-4	http://dx.doi.org/10.1016/S0140-6736(04)16680-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15262108				2022-12-01	WOS:000222784900033
J	Jones, JC; Myerscough, MR; Graham, S; Oldroyd, BP				Jones, JC; Myerscough, MR; Graham, S; Oldroyd, BP			Honey bee nest thermoregulation: Diversity promotes stability	SCIENCE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; SELF-ORGANIZATION; EVOLUTION; VARIABILITY; MODELS	A honey bee colony is characterized by high genetic diversity among its workers, generated by high levels of multiple mating by its queen. Few clear benefits of this genetic diversity are known. Here we show that brood nest temperatures in genetically diverse colonies (i.e., those sired by several males) tend to be more stable than in genetically uniform ones (i.e., those sired by one male). One reason this increased stability arises is because genetically determined diversity in workers' temperature response thresholds modulates the hive-ventilating behavior of individual workers, preventing excessive colony-level responses to temperature fluctuations.	Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Jones, JC (corresponding author), Univ Sydney, Sch Biol Sci, Macleay Bldg A12, Sydney, NSW 2006, Australia.	jjones@bio.usyd.edu.au	Graham, Sonia/B-1544-2008; Jones, Julia/P-2339-2016; Graham, Sonia/G-4399-2012; Oldroyd, Benjamin/A-4800-2008	Jones, Julia/0000-0002-3557-1941; Graham, Sonia/0000-0003-4195-4559; Oldroyd, Benjamin/0000-0001-6831-3677; Myerscough, Mary/0000-0002-4993-765X				Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; CALDERONE NW, 1988, BEHAV ECOL SOCIOBIOL, V22, P17, DOI 10.1007/BF00395694; CALDERONE NW, 1991, AM NAT, V138, P69, DOI 10.1086/285205; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; ESTOUP A, 1995, GENETICS, V140, P679; Fewell JH, 1999, EVOL ECOL RES, V1, P537; Fewell JH, 2000, BEHAV ECOL SOCIOBIOL, V48, P173, DOI 10.1007/s002650000183; FEWELL JH, 1993, EXPERIENTIA, V49, P1106, DOI 10.1007/BF01929923; Fisher R., 2005, TEACHING CHILDREN TH; Franck P, 1999, INSECT MOL BIOL, V8, P419, DOI 10.1046/j.1365-2583.1999.83131.x; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Harbo J.R., 1986, P361; Hartl D.L., 1997, PRINCIPLES POPULATIO; Jassim O, 2000, J INSECT PHYSIOL, V46, P243, DOI 10.1016/S0022-1910(99)00176-6; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; Laidlaw HH., 1997, QUEEN REARING BEE BR; Lindauer M., 1967, COMMUNICATION SOCIAL; Myerscough MR, 2004, INSECT SOC, V51, P146, DOI 10.1007/s00040-003-0713-1; PAGE RE, 1989, WESTV STUD, P15; PAGE RE, 1980, GENETICS, V96, P263; Page RE, 1998, APIDOLOGIE, V29, P171, DOI 10.1051/apido:19980110; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Reeve HK, 1999, MG BEH ECOL, P3; ROBINSON GE, 1989, WESTV STUD, P61; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 1998, APIDOLOGIE, V29, P159, DOI 10.1051/apido:19980109; Seeley T., 1981, P159; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Sokal RR, 2012, BIOMETRY, V4th; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020	36	284	297	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					402	404		10.1126/science.1096340	http://dx.doi.org/10.1126/science.1096340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15218093				2022-12-01	WOS:000222662400040
J	Ohlenschlaeger, T; Garred, P; Madsen, HO; Jacobsen, S				Ohlenschlaeger, T; Garred, P; Madsen, HO; Jacobsen, S			Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-CARDIOLIPIN ANTIBODIES; ACCELERATED ATHEROSCLEROSIS; CHLAMYDIA-PNEUMONIAE; DISEASE; ASSOCIATION; GENE; POLYMORPHISMS; PROTEIN; SUSCEPTIBILITY; INFECTIONS	BACKGROUND: Cardiovascular disease is an important complication in patients with systemic lupus erythematosus (SLE). Variant alleles of the mannose-binding lectin gene are associated with SLE as well as with severe atherosclerosis. We determined whether mannose-binding lectin variant alleles were associated with an increased risk of arterial thrombosis among patients with SLE. METHODS: Mannose-binding lectin alleles were genotyped by means of a polymerase-chain-reaction assay in 91 Danish patients with SLE. Arterial and venous thromboses occurring after the diagnosis of SLE were assessed in a prospective study. Arterial and venous thromboses were confirmed by appropriate diagnostic methods. RESULTS: Fifty-four patients had no mannose-binding lectin variant alleles (A/A genotype), 30 were heterozygous (A/O genotype), and 7 were homozygous (O/O genotype). During a median follow-up of 9.1 years, arterial thromboses (cerebral or myocardial infarction or leg embolus) developed in 6 of the 7 patients with the O/O genotype, as compared with 18 of the 84 patients with the other two genotypes (hazard ratio, 5.8; 95 percent confidence interval, 2.2 to 15.2; overall incidence, 26 percent). After correction for other known risk factors, the hazard ratio was 7.0 (95 percent confidence interval, 1.9 to 25.4). Venous thromboses, which occurred in 14 patients, were statistically unrelated to the mannose-binding lectin genotype. CONCLUSIONS: Among patients with SLE, homozygosity for mannose-binding lectin variant alleles is associated with an increased risk of arterial thrombosis. The risk of venous thrombosis is not increased, indicating that mannose-binding lectin has a specific role in providing protection against arterial thrombosis.	Univ Copenhagen, Rigshosp, Dept Clin Immunol, Tissue Typing Lab, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Dept Rheumatol, DK-2100 Copenhagen, Denmark; Hvidovre Univ Hosp, Dept Rheumatol, Copenhagen, Denmark; Bispebjerg Hosp, Dept Rheumatol, DK-2400 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Jacobsen, S (corresponding author), Rigshosp, Dept Rheumatol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	sj@dadlnet.dk	Jacobsen, Søren/T-2491-2019; Madsen, Hans O/Q-2035-2015	Jacobsen, Søren/0000-0002-5654-4993; Madsen, Hans O/0000-0001-5551-4787; Garred, Peter/0000-0002-2876-8586				Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Danesh J, 2002, EUR HEART J, V23, P371, DOI 10.1053/euhj.2001.2801; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Garred P, 2001, GENES IMMUN, V2, P442, DOI 10.1038/sj.gene.6363804; Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Garred P, 1996, COLLECTINS INNATE IM, P139; Hegele RA, 2000, J INVEST MED, V48, P198; Jacobsen S, 2002, J RHEUMATOL, V29, P2148; Jacobsen S, 2001, J RHEUMATOL, V28, P935; Jacobsen S, 1998, CLIN RHEUMATOL, V17, P478, DOI 10.1007/BF01451283; Kao AH, 2003, CURR OPIN RHEUMATOL, V15, P519, DOI 10.1097/00002281-200309000-00001; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; LIPSCOMBE RJ, 1993, HUM MOL GENET, V2, P342, DOI 10.1093/hmg/2.3.342; LOIZOU S, 1985, CLIN EXP IMMUNOL, V62, P738; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9; Manger K, 2003, ANN RHEUM DIS, V62, P846, DOI 10.1136/ard.62.9.846; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOURITSEN S, 1989, CLIN EXP IMMUNOL, V76, P178; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Rugonfalvi-Kiss S, 2002, CIRCULATION, V106, P1071, DOI 10.1161/01.CIR.0000027137.96791.6A; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Svenungsson E, 2003, ARTHRITIS RHEUM-US, V48, P2533, DOI 10.1002/art.11264; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thorburn CM, 2003, ARTHRITIS RHEUM, V48, P2519, DOI 10.1002/art.11241; Turner M W, 2000, Rev Immunogenet, V2, P305; Vlachoyiannopoulos PG, 2003, RHEUMATOLOGY, V42, P645, DOI 10.1093/rheumatology/keg182; Voss A, 2001, LUPUS, V10, P533, DOI 10.1191/096120301701549651; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U	38	172	175	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					260	267		10.1056/NEJMoa033122	http://dx.doi.org/10.1056/NEJMoa033122			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254284				2022-12-01	WOS:000222627200010
J	Le, CT				Le, CT			Baby Mo - A letter from Vietnam	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												Chinhlego2@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2004	292	2					153	154		10.1001/jama.292.2.153	http://dx.doi.org/10.1001/jama.292.2.153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	836TS	15249554				2022-12-01	WOS:000222579300001
J	Joannides, A; Gaughwin, P; Schwiening, C; Majed, H; Sterling, J; Compston, A; Chandran, S				Joannides, A; Gaughwin, P; Schwiening, C; Majed, H; Sterling, J; Compston, A; Chandran, S			Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells	LANCET			English	Article							PROGENITOR CELLS; NEURONS; MARROW; DIFFERENTIATE; HIPPOCAMPUS; PHENOTYPE; INDUCTION; LINEAGES; SYSTEM; FUSION	Background Neural stem cells are a potential source of cells for drug screening or cell-based treatments for neurodegenerative diseases. However, ethical and practical considerations limit the availability of neural stem cells derived from human embryonic tissue. An alternative source of human neural stem cells is needed; a source that is readily accessible, easily expanded, and reliably induced to a neural fate. Methods Dermis isolated from biopsy samples of adult human skin was cultured and expanded in the presence of the mitogens epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF 2), and then by serum. We used immunocytochemical techniques, clonal analysis, and physiological characterisation to assess neural differentiation after the treatment of expanded cells with novel induction media. Findings initial characterisation of skin samples confirmed the absence of nestin, a neural precursor marker. Sequential culture in EGF and FGF 2 followed by adherent expansion in serum, and re-exposure to mitogens in substrate-free conditions resulted in large numbers of nestin-positive/musashi-positive neural precursors. Subsequent exposure of these precursors to hippocampal-astrocyte-derived signals resulted in cells of neuronal morphology that had stable expression of markers of neuronal differentiation (neurofilament, P tubulin). We also show the presence of voltage-dependent calcium transients, and demonstrate monoclonal neural potential. Interpretation We describe the isolation and characterisation of cells derived from adult human dermis that can be expanded for extended periods of time in vitro, while retaining inducible neural potential. The generation of almost limitless numbers of neural precursors from a readily accessible autologous adult human source provides a platform for further experimental studies and has potential therapeutic implications.	Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CP2 2PY, England; Univ Cambridge, Dept Physiol, Cambridge CP2 2PY, England; Univ Cambridge, Dept Med, Cambridge CP2 2PY, England; Addenbrookes Hosp, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chandran, S (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Forvie Site,Robinson Way, Cambridge CP2 2PY, England.	sc222@cam.ac.uk						CHANDRAN S, IN PRESS GLIA; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joannides A, 2003, J HEMATOTH STEM CELL, V12, P681, DOI 10.1089/15258160360732704; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Lako M, 2002, J CELL SCI, V115, P3967, DOI 10.1242/jcs.00060; Liang LC, 2002, STEM CELLS, V20, P21, DOI 10.1634/stemcells.20-1-21; Martin-Rendon E, 2003, BRIT J HAEMATOL, V122, P877, DOI 10.1046/j.1365-2141.2003.04576.x; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	23	155	174	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2004	364	9429					172	178		10.1016/S0140-6736(04)16630-0	http://dx.doi.org/10.1016/S0140-6736(04)16630-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246730				2022-12-01	WOS:000222612200028
J	Tauer, CA				Tauer, CA			International policy failures: cloning and stem-cell research	LANCET			English	Article								In late 2003, two international bodies were unable to resolve disagreements that involved bioethical issues. First, the United Nations General Assembly failed to pass a treaty on reproductive cloning because of insistence by some countries that the treaty include a ban on cloning for research. In view of the importance of enacting prohibition of reproductive cloning, the two issues should be separated and each argued on its own merits. Relevant objections to separation of the two issues can be refuted. Second, the European Union (EU) failed to agree on conditions for funding stem-cell research because of the diversity of views and policies of the countries of the EU. Because a stalemate was reached, funding decisions in the next programme cycle will be made on an ad hoc basis. Scientists will not have information they need to plan research programmes, suggesting that clear guidelines, even if restrictive, are preferable to vague unpublicised criteria.	Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Tauer, CA (corresponding author), Univ Minnesota, Ctr Bioeth, Suite N504 Boynton,410 Church St SE, Minneapolis, MN 55455 USA.	tauer007@umn.edu						Abbott A, 2003, NATURE, V426, P595, DOI 10.1038/426595b; BERKOWITZ P, JUS PC BIOETHICS MON; CHILDRESS J, 1994, CONCEPT MORAL CONSEN, P163; Council of Europe, CONV PROT HUM RIGHTS; *EUR GROUP ETH SCI, ETH ASP RES INV US H; *ISR AC SCI HUM BI, REC EMBR STEM CELL R; KITCHER P, 2000, HUMAN CLONING SCI ET, P53; Knowles LP, 2004, NAT BIOTECHNOL, V22, P157, DOI 10.1038/nbt0204-157; MURRAY J, 1960, WE HOLD THESE TRUTHS; *NIH, 1994, REP HUM EMBR RES PAN, V1; PONNURU R, 2004, KASS COUNCILS EXFRIE; RUSSO E, SCIENTIST; SCOTT A, SCIENTIST; *US PC BIOETH, 2004, REPR RESP REG NEW BI; Vogel G, 2003, SCIENCE, V302, P1872; Wakayama T, 2004, NAT BIOTECHNOL, V22, P399, DOI 10.1038/nbt0404-399; *WHO INT DIG HLTH, ISR PROH GEN INT HUM	17	14	16	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					209	214		10.1016/S0140-6736(04)16637-3	http://dx.doi.org/10.1016/S0140-6736(04)16637-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246737				2022-12-01	WOS:000222612200035
J	Adams, PL; Stahley, MR; Kosek, AB; Wang, JM; Strobel, SA				Adams, PL; Stahley, MR; Kosek, AB; Wang, JM; Strobel, SA			Crystal structure of a self-splicing group I intron with both exons	NATURE			English	Article							METAL-ION INTERACTION; TETRAHYMENA RIBOZYME; ACTIVE-SITE; RNA; BINDING; GUANOSINE; IDENTIFICATION; MECHANISM; CATALYSIS; CLEAVAGE	The discovery of the RNA self-splicing group I intron provided the first demonstration that not all enzymes are proteins. Here we report the X-ray crystal structure (3.1-Angstrom resolution) of a complete group I bacterial intron in complex with both the 50'-and the 3'-exons. This complex corresponds to the splicing intermediate before the exon ligation step. It reveals how the intron uses structurally unprecedented RNA motifs to select the 5'-and 3'-splice sites. The 5'-exon's 3'-OH is positioned for inline nucleophilic attack on the conformationally constrained scissile phosphate at the intron-3'-exon junction. Six phosphates from three disparate RNA strands converge to coordinate two metal ions that are asymmetrically positioned on opposing sides of the reactive phosphate. This structure represents the first splicing complex to include a complete intron, both exons and an organized active site occupied with metal ions.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Wang, JM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	wang@csb.yale.edu; strobel@csb.yale.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BASS BL, 1986, BIOCHEMISTRY-US, V25, P4473, DOI 10.1021/bi00364a001; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Cech TR, 1999, RNA WORLD, P321; DAMBERGER SH, 1994, NUCLEIC ACIDS RES, V22, P3508, DOI 10.1093/nar/22.17.3508; Duarte CM, 2003, NUCLEIC ACIDS RES, V31, P4755, DOI 10.1093/nar/gkg682; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; GROSSHANS CA, 1989, BIOCHEMISTRY-US, V28, P6888, DOI 10.1021/bi00443a017; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knitt DS, 1996, BIOCHEMISTRY-US, V35, P1560, DOI 10.1021/bi9521147; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; MCSWIGGEN JA, 1989, SCIENCE, V244, P679, DOI 10.1126/science.2470150; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MORAN S, 1993, BIOCHEMISTRY-US, V32, P5247, DOI 10.1021/bi00070a037; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; ROULD MA, 1992, ACTA CRYSTALLOGR A, V48, P751, DOI 10.1107/S0108767392003404; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; Shan SO, 1999, BIOCHEMISTRY-US, V38, P10958, DOI 10.1021/bi990388e; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Sjogren AS, 1997, NUCLEIC ACIDS RES, V25, P648, DOI 10.1093/nar/25.3.648; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Soukup JK, 2002, BIOCHEMISTRY-US, V41, P10426, DOI 10.1021/bi020265l; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Strobel SA, 1998, NAT STRUCT BIOL, V5, P60, DOI 10.1038/nsb0198-60; Strobel SA, 1999, CHEM BIOL, V6, P153, DOI 10.1016/S1074-5521(99)89007-3; STROBEL SA, 1995, SCIENCE, V267, P675, DOI 10.1126/science.7839142; Szewczak AA, 2002, BIOCHEMISTRY-US, V41, P2516, DOI 10.1021/bi011973u; Tanner MA, 1996, RNA, V2, P74; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318	50	350	371	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					45	50		10.1038/nature02642	http://dx.doi.org/10.1038/nature02642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15175762				2022-12-01	WOS:000222356800037
J	Wang, Q; Zhao, JL; Brady, AE; Feng, J; Allen, PB; Lefkowitz, RJ; Greengard, P; Limbird, LE				Wang, Q; Zhao, JL; Brady, AE; Feng, J; Allen, PB; Lefkowitz, RJ; Greengard, P; Limbird, LE			Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors	SCIENCE			English	Article							3RD INTRACELLULAR LOOP; ALPHA(2)-ADRENERGIC RECEPTORS; ADRENERGIC-RECEPTOR; BETA-ARRESTIN; DENDRITIC SPINES; BINDING-PROTEIN; KINASE; ENDOCYTOSIS; DESENSITIZATION; MORPHINE	Arrestin regulates almost all G protein-coupled receptor (GPCR)-mediated signaling and trafficking. We report that the multidomain protein, spinophilin, antagonizes these multiple arrestin functions. Through blocking G protein receptor kinase 2 (GRK2) association with receptor-Gbetagamma complexes, spinophilin reduces arrestin-stabilized receptor phosphorylation, receptor endocytosis, and the acceleration of mitogen-activated protein kinase ( MAPK) activity following endocytosis. Spinophilin knockout mice were more sensitive than wild-type mice to sedation elicited by stimulation of alpha(2) adrenergic receptors, whereas arrestin 3 knockout mice were more resistant, indicating that the signal-promoting, rather than the signal-terminating, roles of arrestin are more important for certain response pathways. The reciprocal interactions of GPCRs with spinophilin and arrest in represent a regulatory mechanism for fine-tuning complex receptor-orchestrated cell signaling and responses.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Duke Univ, Med Ctr, Dept Med & Biochem, Howard Hughes Med Inst, Durham, NC 27708 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Duke University; Howard Hughes Medical Institute; Rockefeller University	Limbird, LE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 464 Robinson Res Bldg, Nashville, TN 37232 USA.	lee.limbird@mcmail.vanderbilt.edu	Lefkowitz, Robert/AAW-2649-2021	Wang, Qin/0000-0002-1079-5914	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037, HL42671] Funding Source: Medline; NIDA NIH HHS [DA10044] Funding Source: Medline; NIDDK NIH HHS [DK43879] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Conner DA, 1997, CIRC RES, V81, P1021; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; FAURE M, 1994, J BIOL CHEM, V269, P7851; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Krueger KM, 1997, J BIOL CHEM, V272, P5; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; PFISTER C, 1985, SCIENCE, V228, P891, DOI 10.1126/science.2988124; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang Q., UNPUB; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	32	116	120	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1940	1944		10.1126/science.1098274	http://dx.doi.org/10.1126/science.1098274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218143				2022-12-01	WOS:000222241600038
J	Wang, ZR; Singhvi, A; Kong, P; Scott, K				Wang, ZR; Singhvi, A; Kong, P; Scott, K			Taste representations in the Drosophila brain	CELL			English	Article							ODORANT RECEPTOR EXPRESSION; OLFACTORY SENSORY MAP; C-ELEGANS; CHEMOSENSORY NEURONS; MAMMALIAN SWEET; GENE-EXPRESSION; ANTENNAL LOBE; BITTER TASTE; FLY BRAIN; MELANOGASTER	Drosophila taste compounds with gustatory neurons on many parts of the body, suggesting that a fly detects both the location and quality of a food source. For example, activation of taste neurons on the legs causes proboscis extension or retraction, whereas activation of proboscis taste neurons causes food ingestion or rejection. We examined whether the features of taste location and taste quality are mapped in the fly brain using molecular, genetic, and behavioral approaches. We find that projections are segregated by the category of tastes that they recognize: neurons that recognize sugars project to a region different from those recognizing noxious substances. Transgenic axon labeling experiments also demonstrate that gustatory projections are segregated based on their location in the periphery. These studies reveal the gustatory map in the first relay of the fly brain and demonstrate that taste quality and position are represented in anatomical projection patterns.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIDCD NIH HHS [R01 DC006252, 1R01DC006252-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Glover JC, 2000, PHYSIOL REV, V80, P615, DOI 10.1152/physrev.2000.80.2.615; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; Han DD, 2000, DEVELOPMENT, V127, P573; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Laissue PP, 1999, J COMP NEUROL, V405, P543; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RICE MJ, 1977, NATURE, V268, P747, DOI 10.1038/268747a0; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RUBIN GM, 1985, TRENDS NEUROSCI, V8, P231, DOI 10.1016/0166-2236(85)90094-3; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TRUMAN JW, 1993, FORMATION ADULT NERV, V2, P1245; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	56	323	333	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					981	991		10.1016/j.cell.2004.06.011	http://dx.doi.org/10.1016/j.cell.2004.06.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210117	Bronze			2022-12-01	WOS:000222300200014
J	Nee, S				Nee, S			More than meets the eye - Earth's real biodiversity is invisible, whether we like it or not	NATURE			English	Editorial Material									Univ Edinburgh, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Nee, S (corresponding author), Univ Edinburgh, Ashworth Labs, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	sean.nee@ed.ac.uk						Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Surridge AK, 1999, NATURE, V400, P726, DOI 10.1038/23393	5	44	48	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2004	429	6994					804	805		10.1038/429804a	http://dx.doi.org/10.1038/429804a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215837				2022-12-01	WOS:000222213000017
J	Guthrie, RD				Guthrie, RD			Radiocarbon evidence of mid-Holocene mammoths stranded on an Alaskan Bering Sea island	NATURE			English	Article							EXTINCTION	Island colonization and subsequent dwarfing of Pleistocene proboscideans is one of the more dramatic evolutionary and ecological occurrences(1-3), especially in situations where island populations survived end-Pleistocene extinctions whereas those on the nearby mainland did not(4). For example, Holocene mammoths have been dated from Wrangel Island in northern Russia(4). In most of these cases, few details are available about the dynamics of how island colonization and extinction occurred. As part of a large radiocarbon dating project of Alaskan mammoth fossils, I addressed this question by including mammoth specimens from Bering Sea islands known to have formed during the end-Pleistocene sea transgression(5). One date of 7,908 +/- 6 100 yr BP (radiocarbon years before present) established the presence of Holocene mammoths on St Paul Island, a first Holocene island record for the Americas. Four lines of evidence 265 accelerator mass spectrometer (AMS) radiocarbon dates from Alaskan mainland mammoths(6), 13 new dates from Alaskan island mammoths, recent reconstructions of bathymetric plots(5) and sea transgression rates from the Bering Sea(5)-made it possible to reconstruct how mammoths became stranded in the Pribilofs and why this apparently did not happen on other Alaskan Bering Sea islands.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Guthrie, RD (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	ffrdg@uaf.edu						Agenbroad Larry D., 2003, Deinsea, V9, P1; AGENBROAD LD, 2002, AM QUAT ASS 17 AMQUA; AGER TA, 2003, QUATERNARY RES, V60, P17; COLINVAUX P, 1981, QUATERNARY RES, V16, P18, DOI 10.1016/0033-5894(81)90125-3; CROSSEN KJ, 2003, ANN GEOL SOC AM C NW, P424; Falconer D. S., 1989, Introduction to quantitative genetics.; FITZHUGH WW, 1997, ANTHR NEWS NATL MUS, V9, P1; FLADMARK KR, 1977, AM ANTIQUITY, V4, P55; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; GERASIMOV D, 2002, NEW MAT INTERPRETATI, P379; Guthrie R.D., 1984, P259; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; HOPKINS DM, 1966, SCIENCE, V152, P343, DOI 10.1126/science.152.3720.343; Johnstone, 1975, ELEPHANTS THEIR HABI; LISTER AM, 1999, ANN NAT HIST MUS ROT, V6, P79; MANLEY WF, INSTAAR2002; Martin P. S., 1984, QUATERNARY EXTINCTIO, P345; Palombo MR, 2001, WORLD ELEPHANTS, P486; Scheffer VB, 1951, SCI MON, V73, P356; Sondaar PY., 1977, MAJOR PATTERNS VERTE, P671, DOI DOI 10.1007/978-1-4684-8851-7; Sulerzhitsky LD, 1999, AMBIO, V28, P251; VARTANYAN SL, 1993, NATURE, V362, P336, DOI DOI 10.1038/362337A0	23	101	109	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					746	749		10.1038/nature02612	http://dx.doi.org/10.1038/nature02612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201907				2022-12-01	WOS:000222059900035
J	Falini, B; Tiacci, E; Liso, A; Basso, K; Sabattini, E; Pacini, R; Foa, R; Pulsoni, A; Dalla Favera, R; Pileri, S				Falini, B; Tiacci, E; Liso, A; Basso, K; Sabattini, E; Pacini, R; Foa, R; Pulsoni, A; Dalla Favera, R; Pileri, S			Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)	LANCET			English	Article								A marker capable of distinguishing with certainty between hairy cell leukaemia and other B-cell malignant disease would be of great diagnostic value. Through gene expression profiling, annexin A1 (ANXA1) has been identified as a gene that is upregulated in hairy cell leukaemia. We did immunostaining of 500 B-cell tumours with a specific anti-ANXA1 monoclonal antibody and showed that ANXA1 protein expression is specific to hairy cell leukaemia. Immunocytochemical detection of ANXA1 represents a simple, inexpensive, highly sensitive and specific (100%) assay for diagnosis of hairy cell leukaemia. This assay will be especially useful in distinguishing hairy cell leukaemia from splenic lymphoma with villous lymphocytes and variant hairy cell leukaemia, both of which usually respond poorly to treatments that are effective in hairy cell leukaemia.	Univ Perugia, Monteluce Policlin, Inst Haematol, I-06100 Perugia, Italy; Univ Foggia, Inst Haematol, Foggia, Italy; Columbia Univ, Inst Canc Genet, New York, NY USA; Columbia Univ, Dept Pathol, New York, NY USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Roma La Sapienza, Inst Haematol, Rome, Italy; Univ Bologna, Inst Haematol, I-40126 Bologna, Italy	University of Perugia; University of Foggia; Columbia University; Columbia University; Columbia University; Sapienza University Rome; University of Bologna	Falini, B (corresponding author), Univ Perugia, Monteluce Policlin, Inst Haematol, I-06100 Perugia, Italy.	faliniem@unipg.it		Liso, Arcangelo/0000-0001-5638-227X; FALINI, Brunangelo/0000-0002-7198-5965				Basso K, 2004, J EXP MED, V199, P59, DOI 10.1084/jem.20031175; FOUCAR K, 2001, WHO CLASSIFICATION T, P138; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; MATUTES E, 1994, LEUKEMIA LYMPHOMA, V14, P57; TALLMAN MS, 2000, HEMATOLOGY BASIC PRI, P1363	5	165	176	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2004	363	9424					1869	1871		10.1016/S0140-6736(04)16356-3	http://dx.doi.org/10.1016/S0140-6736(04)16356-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15183626				2022-12-01	WOS:000221822300012
J	Xie, HF; Ye, M; Feng, R; Graf, T				Xie, HF; Ye, M; Feng, R; Graf, T			Stepwise reprogramming of B cells into macrophages	CELL			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; BINDING PROTEIN ALPHA; LINEAGE COMMITMENT; C/EBP-BETA; TRANSCRIPTION FACTORS; DEFICIENT MICE; SINGLE CELLS; PROGENITORS; EXPRESSION	Starting with multipotent progenitors, hematopoietic lineages are specified by lineage-restricted transcription factors. The transcription factors that determine the decision between lymphoid and myeloid cell fates, and the underlying mechanisms, remain largely unknown. Here, we report that enforced expression of C/EBPalpha. and C/EBPbeta in differentiated B cells leads to their rapid and efficient reprogramming into macrophages. C/EBPs induce these changes by inhibiting the B cell commitment transcription factor Pax5, leading to the downregulation of its target CD19, and synergizing with endogenous PU.1, an ETS family factor, leading to the upregulation of its target Mac-1 and other myeloid markers. The two processes can be uncoupled, since, in PU.1-deficient pre-B cells, C/EBPs induce CD19 downregulation but not Mac-1 activation. Our observations indicate that C/EBPalpha and beta remodel the transcription network of B cells into that of macrophages through a series of parallel and sequential changes that require endogenous PU.1.	Albert Einstein Coll Med, Ctr Canc Res, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Graf, T (corresponding author), Albert Einstein Coll Med, Ctr Canc Res, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	graf@aecom.yu.edu	Wilson, Matthew H/K-3193-2013; Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117	NCI NIH HHS [T01 CA89590-01] Funding Source: Medline; NINDS NIH HHS [R01 NS43881-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043881] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen XN, 1997, BLOOD, V90, P156; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; COOPER CL, 1994, J IMMUNOL, V153, P5049; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kee BL, 2001, CURR OPIN IMMUNOL, V13, P180, DOI 10.1016/S0952-7915(00)00202-8; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; MIRRO J, 1986, BLOOD, V68, P597; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	46	699	744	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					663	676		10.1016/S0092-8674(04)00419-2	http://dx.doi.org/10.1016/S0092-8674(04)00419-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163413	Bronze			2022-12-01	WOS:000221857900012
J	Saikawa, Y; Hashimoto, K; Nakata, M; Yoshihara, M; Nagai, K; Ida, M; Komiya, T				Saikawa, Y; Hashimoto, K; Nakata, M; Yoshihara, M; Nagai, K; Ida, M; Komiya, T			Pigment chemistry: The red sweat of the hippopotamus	NATURE			English	Editorial Material									Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Keio University	Saikawa, Y (corresponding author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.	kimikoh@mb.kyoto-phu.ac.jp	Nakata, Masaya/C-4916-2014					Eltringham S. K, 1999, HIPPAS, P8	1	57	58	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					363	363		10.1038/429363a	http://dx.doi.org/10.1038/429363a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	823WN	15164051	Bronze			2022-12-01	WOS:000221644600027
J	Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M				Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M			Cell cycle regulation of central spindle assembly	NATURE			English	Article							CYTOKINESIS; PROTEIN; KINESIN; COMPLEX; MITOSIS; INCENP; MCAK; PHOSPHORYLATION; LOCALIZATION; PHOSPHATASE	The bipolar mitotic spindle is responsible for segregating sister chromatids at anaphase. Microtubule motor proteins generate spindle bipolarity and enable the spindle to perform mechanical work(1). A major change in spindle architecture occurs at anaphase onset when central spindle assembly begins. This structure regulates the initiation of cytokinesis and is essential for its completion(2). Central spindle assembly requires the central-spindlin complex composed of the Caenorhabditis elegans ZEN-4 (mammalian orthologue MKLP1) kinesin-like protein and the Rho family GAP CYK-4 (MgcRacGAP). Here we describe a regulatory mechanism that controls the timing of central spindle assembly. The mitotic kinase Cdk1/cyclin B phosphorylates the motor domain of ZEN-4 on a conserved site within a basic amino-terminal extension characteristic of the MKLP1 subfamily. Phosphorylation by Cdk1 diminishes the motor activity of ZEN-4 by reducing its affinity for microtubules. Preventing Cdk1 phosphorylation of ZEN-4/MKLP1 causes enhanced metaphase spindle localization and defects in chromosome segregation. Thus, phosphoregulation of the motor domain of MKLP1 kinesin ensures that central spindle assembly occurs at the appropriate time in the cell cycle and maintains genomic stability.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society	Glotzer, M (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	mglotzer@imp.univie.ac.at	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Mishima, Masanori/0000-0002-8908-7485; nigg, erich/0000-0003-4835-5719; Glotzer, Michael/0000-0002-8723-7232				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	30	209	214	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					908	913		10.1038/nature02767	http://dx.doi.org/10.1038/nature02767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15282614				2022-12-01	WOS:000223369800046
J	Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J				Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J			Localization and physical properties experiments conducted by Spirit at Gusev crater	SCIENCE			English	Article							PATHFINDER	The precise location and relative elevation of Spirit during its traverses from the Columbia Memorial station to Bonneville crater were determined with bundle-adjusted retrievals from rover wheel turns, suspension and tilt angles, and overlapping images. Physical properties experiments show a decrease of 0.2% per Mars solar day in solar cell output resulting from deposition of airborne dust, cohesive soil-like deposits in plains and hollows, bright and dark rock coatings, and relatively weak volcanic rocks of basaltic composition. Volcanic, impact, aeolian, and water-related processes produced the encountered landforms and materials.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Luft & Raumfahrt Inst Raumsimulat, D-51170 Cologne, Germany	Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.		Haldemann, Albert F C/I-9224-2012; Seelos, Frank/C-7875-2016	Haldemann, Albert F C/0000-0003-3741-8841; Seelos, Frank/0000-0001-9721-941X				Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Moore HJ, 1999, J GEOPHYS RES-PLANET, V104, P8729, DOI 10.1029/1998JE900005; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	10	143	154	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					821	824		10.1126/science.1099922	http://dx.doi.org/10.1126/science.1099922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297662				2022-12-01	WOS:000223104900035
J	Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J				Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J			Chemistry of rocks and soils in Gusev crater from the alpha particle x-ray spectrometer	SCIENCE			English	Article							CHEMICAL-COMPOSITION; PATHFINDER SITE; MARS; ROVER	The alpha particle x-ray spectrometer on the Spirit rover determined major and minor elements of soils and rocks in Gusev crater in order to unravel the crustal evolution of planet Mars. The composition of soils is similar to those at previous landing sites, as a result of global mixing and distribution by dust storms. Rocks ( fresh surfaces exposed by the rock abrasion tool) resemble volcanic rocks of primitive basaltic composition with low intrinsic potassium contents. High abundance of bromine ( up to 170 parts per million) in rocks may indicate the alteration of surfaces formed during a past period of aqueous activity in Gusev crater.	Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ Chicago, Enrico Fermi Inst, Lab Atmospher & Space Res, Chicago, IL 60637 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Lockheed Martin; University of Chicago; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University	Gellert, R (corresponding author), Max Planck Inst Chem, JJ Becher Weg 27, D-55128 Mainz, Germany.	gellert@mpch-mainz.mpg.de						Banin A., 1992, MARS, P594; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; CLARK BC, 1979, GEOPHYS RES LETT, V6, P811, DOI 10.1029/GL006i010p00811; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; DREIBUS G, UNPUB; Dreibus G., 2003, INT S EV SOL SYST MA, P19; Foley CN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002019; GOREVAN SP, 2003, J GEOPHYS RES-PLANET, V108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Newsom HE, 1997, J GEOPHYS RES-PLANET, V102, P19345, DOI 10.1029/97JE01687; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; SUTTON SR, 2002, LUNAR PLANET SCI, V33, P1278; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	17	243	246	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					829	832		10.1126/science.1099913	http://dx.doi.org/10.1126/science.1099913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297665				2022-12-01	WOS:000223104900038
J	Pitts, S; Kellermann, AL				Pitts, S; Kellermann, AL			Hyperventilation during cardiac arrest	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION		Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Kellermann, AL (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.	akell01@emory.edu						ANDERSEN MN, 1966, ANN SURG, V163, P161, DOI 10.1097/00000658-196602000-00001; [Anonymous], 2000, CIRCULATION S, V102, P186; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Maheshwari A, 2002, EMERG MED CLIN N AM, V20, P759, DOI 10.1016/S0733-8627(02)00026-3; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Sigurdsson Gardar, 2003, Curr Opin Crit Care, V9, P183, DOI 10.1097/00075198-200306000-00002	8	32	37	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					313	315		10.1016/S0140-6736(04)16740-8	http://dx.doi.org/10.1016/S0140-6736(04)16740-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276374				2022-12-01	WOS:000222853300009
J	Dwyer, G; Dushoff, J; Yee, SH				Dwyer, G; Dushoff, J; Yee, SH			The combined effects of pathogens and predators on insect outbreaks	NATURE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GYPSY-MOTH LEPIDOPTERA; FIR TUSSOCK MOTH; NATURAL ENEMIES; POPULATION-CYCLES; LYMANTRIIDAE; SYNCHRONY; FOREST; DYNAMICS; CATERPILLAR	The economic damage caused by episodic outbreaks of forest-defoliating insects has spurred much research(1), yet why such outbreaks occur remains unclear(2). Theoretical biologists argue that outbreaks are driven by specialist pathogens or parasitoids, because host-pathogen and host-parasitoid models show large-amplitude, long-period cycles resembling time series of outbreaks(3,4). Field biologists counter that outbreaks occur when generalist predators fail, because predation in low-density defoliator populations is usually high enough to prevent outbreaks(5-8). Neither explanation is sufficient, however, because the time between outbreaks in the data is far more variable than in host-pathogen and host-parasitoid models(1,2), and far shorter than in generalist-predator models(9-11). Here we show that insect outbreaks can be explained by a model that includes both a generalist predator and a specialist pathogen. In this host pathogen-predator model, stochasticity causes defoliator densities to fluctuate erratically between an equilibrium maintained by the predator, and cycles driven by the pathogen(12,13). Outbreaks in this model occur at long but irregular intervals, matching the data. Our results suggest that explanations of insect outbreaks must go beyond classical models to consider interactions among multiple species.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Chicago; Princeton University	Dwyer, G (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	gdwyer@uchicago.edu	Dwyer, Greg/L-1134-2015	Dwyer, Greg/0000-0002-7387-2075				ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Bjornstad ON, 2000, J ANIM ECOL, V69, P869, DOI 10.1046/j.1365-2656.2000.00444.x; Cory JS, 1997, BACULOVIRUSES, P301, DOI DOI 10.1007/978-1-4899-1834-5_12; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Dwyer G, 2000, AM NAT, V156, P105, DOI 10.1086/303379; Elkinton JS, 1996, ECOLOGY, V77, P2332, DOI 10.2307/2265735; GOULD JR, 1990, J ANIM ECOL, V59, P213, DOI 10.2307/5169; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hunter Alison F., 1995, P41, DOI 10.1016/B978-012159270-7/50004-X; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Klemola T, 2002, OIKOS, V99, P83, DOI 10.1034/j.1600-0706.2002.990109.x; Liebhold A, 1996, RES POPUL ECOL, V38, P87, DOI 10.1007/BF02514974; Liebhold A, 2000, POPUL ECOL, V42, P205, DOI 10.1007/PL00011999; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; MASON RR, 1983, ENVIRON ENTOMOL, V12, P587, DOI 10.1093/ee/12.2.587; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MURRAY KD, 1989, J INVERTEBR PATHOL, V53, P324, DOI 10.1016/0022-2011(89)90096-7; MYERS JH, 1988, ADV ECOL RES, V18, P179; Parry D, 1997, ECOL ENTOMOL, V22, P97, DOI 10.1046/j.1365-2311.1997.00022.x; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Ruohomaki K, 2000, POPUL ECOL, V42, P211, DOI 10.1007/PL00012000; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schwerdtfeger F., 1941, Zeitschrift fuer Angewandte Entomologie, V28, P254; SHEPHERD RF, 1988, MEM ENTOMOL SOC CAN, P107, DOI 10.4039/entm120146107-1; SOUTHWOOD TRE, 1976, J ANIM ECOL, V45, P949, DOI 10.2307/3591; VARLEY GC, 1973, INSECT POPULATION EC, P135; WILLIAMS DW, 1991, J ECON ENTOMOL, V84, P1508, DOI 10.1093/jee/84.5.1508; WILLIAMS DW, 1995, ENVIRON ENTOMOL, V24, P987, DOI 10.1093/ee/24.5.987; WOODS SA, 1987, J INVERTEBR PATHOL, V50, P151, DOI 10.1016/0022-2011(87)90115-7	30	181	190	6	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					341	345		10.1038/nature02569	http://dx.doi.org/10.1038/nature02569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254536				2022-12-01	WOS:000222631200039
J	Zhang, XD; Beaulieu, JM; Sotnikova, TD; Gainetdinov, RR; Caron, MG				Zhang, XD; Beaulieu, JM; Sotnikova, TD; Gainetdinov, RR; Caron, MG			Tryptophan hydroxylase-2 controls brain serotonin synthesis	SCIENCE			English	Article							MICE; DISORDERS; MODELS		Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst Lab, Durham, NC 27710 USA; Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Models Human Dis, Durham, NC 27710 USA	Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst Lab, Box 3287, Durham, NC 27710 USA.	caron002@mc.duke.edu	Gainetdinov, Raul R/G-5875-2011; Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017	Gainetdinov, Raul R/0000-0003-2951-6038; Beaulieu, Jean-Martin/0000-0002-0446-7447; 	NIMH NIH HHS [MH60451] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Murphy DL, 2003, GENES BRAIN BEHAV, V2, P350, DOI 10.1046/j.1601-1848.2003.00049.x; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; ZHANG X, UNPUB	9	515	548	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					217	217		10.1126/science.1097540	http://dx.doi.org/10.1126/science.1097540			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247473				2022-12-01	WOS:000222501000044
J	Ramachandran, N; Hainsworth, E; Bhullar, B; Eisenstein, S; Rosen, B; Lau, AY; Walter, JC; LaBaer, J				Ramachandran, N; Hainsworth, E; Bhullar, B; Eisenstein, S; Rosen, B; Lau, AY; Walter, JC; LaBaer, J			Self-assembling protein microarrays	SCIENCE			English	Article							DNA-REPLICATION; S-PHASE; EXPRESSION; COMPLEX; ORIGINS; IDENTIFICATION; BINDING; CLONING; ARRAYS	Protein microarrays provide a powerful tool for the study of protein function. However, they are not widely used, in part because of the challenges in producing proteins to spot on the arrays. We generated protein microarrays by printing complementary DNAs onto glass slides and then translating target proteins with mammalian reticulocyte lysate. Epitope tags fused to the proteins allowed them to be immobilized in situ. This obviated the need to purify proteins, avoided protein stability problems during storage, and captured sufficient protein for functional studies. We used the technology to map pairwise interactions among 29 human DNA replication initiation proteins, recapitulate the regulation of Cdt1 binding to select replication proteins, and map its geminin-binding domain.	Harvard Univ, Sch Med, Harvard Inst Proteom, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02141 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Technol & Engn Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LaBaer, J (corresponding author), Harvard Univ, Sch Med, Harvard Inst Proteom, Dept Biol Chem & Mol Pharmacol, 320 Charles St, Cambridge, MA 02141 USA.	josh@hms.harvard.edu		Lau, Albert/0000-0002-0967-7558; Walter, Johannes/0000-0002-4186-7570	NATIONAL CANCER INSTITUTE [R21CA099191] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA99191-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Brizuela L, 2001, MOL BIOCHEM PARASIT, V118, P155, DOI 10.1016/S0166-6851(01)00366-8; Cahill DJ, 2003, ADV BIOCHEM ENG BIOT, V83, P177; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-15; Haab BB, 2001, GENOME BIOL, V2; He MY, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e73; Jona G, 2003, CURR OPIN MOL THER, V5, P271; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Labaer J, 2004, PROTEOME ANALYSIS: INTERPRETING THE GENOME, P287, DOI 10.1016/B978-044451024-2/50028-X; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; MacBeath G, 2000, SCIENCE, V289, P1760; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; RAMACHANDRAN N, UNPUB; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	28	444	497	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					86	90		10.1126/science.1097639	http://dx.doi.org/10.1126/science.1097639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232106				2022-12-01	WOS:000222386000041
J	Wittkopp, PJ; Haerum, BK; Clark, AG				Wittkopp, PJ; Haerum, BK; Clark, AG			Evolutionary changes in cis and trans gene regulation	NATURE			English	Article							DROSOPHILA-MELANOGASTER; TRANSCRIPTIONAL REGULATION; EXPRESSION; RESCUE; SIMULANS; HYBRIDS; CROSSES; MOUSE	Differences in gene expression are central to evolution. Such differences can arise from cis-regulatory changes that affect transcription initiation, transcription rate and/or transcript stability in an allele-specific manner, or from trans-regulatory changes that modify the activity or expression of factors that interact with cis-regulatory sequences(1,2). Both cis- and trans-regulatory changes contribute to divergent gene expression, but their respective contributions remain largely unknown(3). Here we examine the distribution of cis- and trans-regulatory changes underlying expression differences between closely related Drosophila species, D. melanogaster and D. simulans, and show functional cis- regulatory differences by comparing the relative abundance of species-specific transcripts in F-1 hybrids(4,5). Differences in trans-regulatory activity were inferred by comparing the ratio of allelic expression in hybrids with the ratio of gene expression between species. Of 29 genes with interspecific expression differences, 28 had differences in cis- regulation, and these changes were sufficient to explain expression divergence for about half of the genes. Trans-regulatory differences affected 55% (16 of 29) of genes, and were always accompanied by cis-regulatory changes. These data indicate that interspecific expression differences are not caused by select trans-regulatory changes with widespread effects, but rather by many cis- acting changes spread throughout the genome.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Wittkopp, PJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	pw72@cornell.edu		Clark, Andrew/0000-0001-7159-8511				Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbash DA, 2000, GENETICS, V154, P1747; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; DAVIDSON EH, P NATL ACAD SCI US, V100, P1475; Davidson EH, 2001, GENOMIC REGULATORY S; Davis AW, 1996, NATURE, V380, P157, DOI 10.1038/380157a0; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Hollocher H, 2000, J EXP ZOOL, V288, P205, DOI 10.1002/1097-010X(20001015)288:3&lt;205::AID-JEZ2&gt;3.0.CO;2-S; Montooth KL, 2003, GENETICS, V165, P623; Neve B, 2002, BIOTECHNIQUES, V32, P1138, DOI 10.2144/02325dd03; Otto P, 1998, PROMEGA NOTES, V69, P19; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Powell J.R., 1997, PROGR PROSPECTS EVOL; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; SAWAMURA K, 1993, GENETICS, V133, P307; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Weatherbee, 2001, DNA DIVERSITY MOL GE; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	23	560	576	6	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					85	88		10.1038/nature02698	http://dx.doi.org/10.1038/nature02698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229602				2022-12-01	WOS:000222356800048
J	Wu, LJ; Errington, J				Wu, LJ; Errington, J			Coordination of cell division and chromosome segregation by a nucleoid occlusion protein in Bacillus subtillis	CELL			English	Article							ESCHERICHIA-COLI; DNA-REPLICATION; PROPER PLACEMENT; SITE SELECTION; MINICELL LOCUS; RING FORMATION; MINE RING; FTSZ; GENE; LOCALIZATION	A range of genetical and physiological experiments have established that diverse bacterial cells possess a function called nucleoid occlusion, which acts to prevent cell division in the vicinity of the nucleoid. We have identified a specific effector of nucleoid occlusion in Bacillus subtilis, Noc (YyaA), as an inhibitor of division that is also a nonspecific DNA binding protein. Under various conditions in which the cell cycle is perturbed, Noc prevents the division machinery from assembling in the vicinity of the nucleoid. Unexpectedly, cells lacking both Noc and the Min system (which prevents division close to the cell poles) are blocked for division, apparently because they establish multiple nonproductive accumulations of division proteins. The results help to explain how B. subtilis specifies the division site under a range of conditions and how it avoids catastrophic breakage of the chromosome by division through the nucleoid.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Wu, LJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.	jeff.errington@path.ox.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Wu, Ling Juan/0000-0003-2432-8820				BROWN NC, 1971, J MOL BIOL, V59, P1, DOI 10.1016/0022-2836(71)90409-8; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Cook WR, 1999, J BACTERIOL, V181, P1900, DOI 10.1128/JB.181.6.1900-1905.1999; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; FOLEY M, 1989, MOL MICROBIOL, V3, P1329, DOI 10.1111/j.1365-2958.1989.tb00114.x; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Harry EJ, 1999, MOL MICROBIOL, V33, P33, DOI 10.1046/j.1365-2958.1999.01439.x; Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; MULDER E, 1989, J BACTERIOL, V171, P4303, DOI 10.1128/JB.171.8.4303-4314.1989; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Quisel JD, 2001, J BACTERIOL, V183, P6573, DOI 10.1128/JB.183.22.6573-6578.2001; Rajagopalan S, 2003, TRENDS GENET, V19, P403, DOI 10.1016/S0168-9525(03)00149-5; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Regamey A, 2000, MOL MICROBIOL, V38, P423, DOI 10.1046/j.1365-2958.2000.02130.x; Rowland SL, 1997, MOL MICROBIOL, V23, P295, DOI 10.1046/j.1365-2958.1997.2141580.x; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Sievers J, 2002, J BACTERIOL, V184, P1102, DOI 10.1128/jb.184.4.1102-1111.2002; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Yu XC, 2000, J BACTERIOL, V182, P6203, DOI 10.1128/JB.182.21.6203-6213.2000; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	43	302	309	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					915	925		10.1016/j.cell.2004.06.002	http://dx.doi.org/10.1016/j.cell.2004.06.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210112	Bronze			2022-12-01	WOS:000222300200009
J	Reddy, KS				Reddy, KS			Cardiovascular disease in non-Western countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									All India Inst Med Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Reddy, KS (corresponding author), All India Inst Med Sci, New Delhi, India.							[Anonymous], 2002, WORLD HLTH REP 2002; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298	3	279	289	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2004	350	24					2438	2440		10.1056/NEJMp048024	http://dx.doi.org/10.1056/NEJMp048024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	827GH	15190135				2022-12-01	WOS:000221887200002
J	Lewis, CL; Coffroth, MA				Lewis, CL; Coffroth, MA			The acquisition of exogenous algal symbionts by an octocoral after bleaching	SCIENCE			English	Article							ZOOXANTHELLAE; DIVERSITY; ECOLOGY; CORALS; SYMBIODINIUM; SPECIFICITY; EVOLUTION	Episodes of coral bleaching (loss of the symbiotic dinoflagellates) and coral mortality have occurred with increasing frequency over the past two decades. Although some corals recover from bleaching events, the source of the repopulating symbionts is unknown. Here we show that after bleaching, the adult octocoral Briareum sp. acquire dinoflagellate symbionts (Symbiodinium sp.) from the environment. Uptake of exogenous symbionts provides a mechanism for response to changes in the environment and resilience in the symbiosis.	SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Coffroth, MA (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	coffroth@buffalo.edu						Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2004, CORAL HEALTH AND DISEASE, P177; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BILLINGHURST Z, 1997, P 8 INT COR REEF S, V2, P1291; Buddemeier RW, 2004, CORAL HEALTH AND DISEASE, P427; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Davy SK, 1997, BIOL BULL, V192, P208, DOI 10.2307/1542715; Diekmann OE, 2002, MAR ECOL PROG SER, V227, P221, DOI 10.3354/meps227221; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Muller-Parker Gisele, 1997, LIFE DEATH CORAL REE, p97 100; Muscatine L., 1990, P75; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Savage AM, 2002, MAR ECOL PROG SER, V244, P27, DOI 10.3354/meps244027; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; [No title captured]	23	99	105	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1490	1492		10.1126/science.1097323	http://dx.doi.org/10.1126/science.1097323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178798				2022-12-01	WOS:000221795800040
J	Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC				Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC			Structural basis of mitochondrial tethering by mitofusin complexes	SCIENCE			English	Article							MEMBRANE-FUSION; MAMMALIAN-CELLS; MORPHOLOGY; DYNAMICS; MECHANISMS; DIVISION; DESIGN	Vesicle fusion involves vesicle tethering, docking, and membrane merger. We show that mitofusin, an integral mitochondrial membrane protein, is required on adjacent mitochondria to mediate fusion, which indicates that mitofusin complexes act in trans ( that is, between adjacent mitochondria). A heptad repeat region (HR2) mediates mitofusin oligomerization by assembling a dimeric, antiparallel coiled coil. The transmembrane segments are located at opposite ends of the 95 angstrom coiled coil and provide a mechanism for organelle tethering. Consistent with this proposal, truncated mitofusin, in an HR2-dependent manner, causes mitochondria to become apposed with a uniform gap. Our results suggest that HR2 functions as a mitochondrial tether before fusion.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem, Pasadena, CA 91125 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043	NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM62967] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330; MEEUSEN S, UNPUB; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whyte JRC, 2002, J CELL SCI, V115, P2627; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	22	630	661	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					858	862		10.1126/science.1099793	http://dx.doi.org/10.1126/science.1099793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297672				2022-12-01	WOS:000223104900047
J	Wurmser, AE; Nakashima, K; Summers, RG; Toni, N; D'Amour, KA; Lie, DC; Gage, FH				Wurmser, AE; Nakashima, K; Summers, RG; Toni, N; D'Amour, KA; Lie, DC; Gage, FH			Cell fusion-independent differentiation of neural stem cells to the endothelial lineage	NATURE			English	Article							BONE-MARROW; PROGRESSION; PROGENITOR; MECHANISMS; INVITRO; PROTEIN; SYSTEM; MUSCLE; BLOOD; VIVO	Somatic stem cells have been claimed to possess an unexpectedly broad differentiation potential ( referred to here as plasticity) that could be induced by exposing stem cells to the extracellular developmental signals of other lineages in mixed-cell cultures(1-6). Recently, this and other experimental evidence supporting the existence of stem-cell plasticity have been refuted because stem cells have been shown to adopt the functional features of other lineages by means of cell-fusion-mediated acquisition of lineage-specific determinants (chromosomal DNA) rather than by signal-mediated differentiation(1,2,5,7,8). In this study we co-cultured mouse neural stem cells (NSCs), which are committed to become neurons and glial cells(9,10), with human endothelial cells, which form the lining of blood vessels(11). We show that in the presence of endothelial cells six per cent of the NSC population converted to cells that did not express neuronal or glial markers, but instead showed the stable expression of multiple endothelial markers and the capacity to form capillary networks. This was surprising because NSCs and endothelial cells are believed to develop from the ectoderm and mesoderm, respectively. Experiments in which endothelial cells were killed by fixation before co-culture with live NSCs (to prevent cell fusion) and karyotyping analyses, revealed that NSCs had differentiated into endothelial-like cells independently of cell fusion. We conclude that stem-cell plasticity is a true characteristic of NSCs and that the conversion of NSCs to unanticipated cell types can be accomplished without cell fusion.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Modulat, Kumamoto 8600811, Japan	Salk Institute; Kumamoto University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Lie, Dieter Chichung/S-7914-2017; Lie, Dieter Chichung/AAS-8604-2020; Toni, Nicolas/M-2057-2014	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; Toni, Nicolas/0000-0001-5585-268X				Alexanian AR, 2003, NEUROSCIENCE, V118, P1, DOI 10.1016/S0306-4522(02)00994-6; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; CHEN TR, 1979, CYTOGENET CELL GENET, V23, P221, DOI 10.1159/000131332; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GRANT DS, 1991, IN VITRO CELL DEV B, V27, P327; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; NEWMAN PJ, 1992, NOUV REV FR HEMATOL, V34, P9; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHALL D, 1978, SOMAT CELL GENET, V4, P661, DOI 10.1007/BF01543157; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; St Croix B, 2000, SCIENCE, V289, P1197; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VACQUIER VD, 1979, DEV GROWTH DIFFER, V21, P61; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	30	277	297	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					350	356		10.1038/nature02604	http://dx.doi.org/10.1038/nature02604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254537				2022-12-01	WOS:000222631200041
J	O'Donoghue, K; Chan, J; de la Fuente, J; Kennea, N; Sandison, A; Anderson, JR; Roberts, IAG; Fisk, NM				O'Donoghue, K; Chan, J; de la Fuente, J; Kennea, N; Sandison, A; Anderson, JR; Roberts, IAG; Fisk, NM			Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy	LANCET			English	Article							MATERNAL BLOOD	Fetal cells enter maternal blood during pregnancy and persist in women with autoimmune disease. The frequency of subsequent fetomaternal microchimerism in healthy women and its cell type is unknown. To test the hypothesis that fetal mesenchymal stem cells persist in maternal organs, we studied female bone marrow and ribs. Male cells were identified by XY fluorescence in-situ hybridisation in marrow-derived mesenchymal stem cells and in rib sections from all women with male pregnancies, but not in controls (9/9 vs 0/5, p=0.0005). We conclude that fetal stem cells transfer-red into maternal blood engraft in marrow, where they remain throughout life. This finding has implications for normal pregnancy, for obstetric complications that increase fetomaternal trafficking, and for graft survival after transplantation.	Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Div Paediat Obstet & Gynaecol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Div Invest Sci, London W12 0NN, England; Charing Cross Hosp, Dept Histopathol, London W6 8RF, England; Hammersmith Hosp, Dept Cardiothorac Surg, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	O'Donoghue, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Div Paediat Obstet & Gynaecol, Hammersmith Campus, London W12 0NN, England.	k.odonoghue@imperial.ac.uk	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975; de la Fuente, Josu/0000-0002-0974-1249; O'Donoghue, Keelin/0000-0002-4616-2887				Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Khosrotehrani K, 2003, CURR OPIN OBSTET GYN, V15, P195, DOI 10.1097/00001703-200304000-00014; Nelson JL, 2002, ARTHRITIS RHEUM-US, V46, P291, DOI 10.1002/art.501; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4	5	177	187	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					179	182		10.1016/S0140-6736(04)16631-2	http://dx.doi.org/10.1016/S0140-6736(04)16631-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246731				2022-12-01	WOS:000222612200029
J	Gauthier, LR; Charrin, BC; Borrell-Pages, M; Dompierre, JP; Rangone, H; Cordelieres, FP; De Mey, J; MacDonald, ME; Lessmann, V; Humbert, S; Saudou, F				Gauthier, LR; Charrin, BC; Borrell-Pages, M; Dompierre, JP; Rangone, H; Cordelieres, FP; De Mey, J; MacDonald, ME; Lessmann, V; Humbert, S; Saudou, F			Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules	CELL			English	Article							AXONAL-TRANSPORT; PROTEIN-1 HAP1; DISEASE; BRAIN; DYNACTIN; LOCALIZATION; DISRUPTION; APOPTOSIS; MOVEMENT; SUBUNIT	Polyglutamine expansion (polyQ) in the protein huntingtin is pathogenic and responsible for the neuronal toxicity associated with Huntington's disease (HD). Although wild-type huntingtin possesses antiapoptotic properties, the relationship between the neuroprotective functions of huntingtin and pathogenesis of HD remains unclear. Here, we show that huntingtin specifically enhances vesicular transport of brain-derived neurotrophic factor (BDNF) along microtubules. Huntingtin-mediated transport involves huntingtin-associated protein-1 (HAP1) and the p150(Glued) subunit of dynactin, an essential component of molecular motors. BDNF transport is attenuated both in the disease context and by reducing the levels of wild-type huntingtin. The alteration of the huntingtin/HAP1/p150(Glued) complex correlates with reduced association of motor proteins with microtubules. Finally, we find that the polyQ-huntingtin-induced transport deficit results in the loss of neurotrophic support and neuronal toxicity. Our findings indicate that a key role of huntingtin is to promote BDNF transport and suggest that loss of this function might contribute to pathogenesis.	Ctr Univ, Inst Curie, CNRS, Unite Mixte Rech 146, F-91405 Orsay, France; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Harvard University; Massachusetts General Hospital; Johannes Gutenberg University of Mainz	Saudou, F (corresponding author), Ctr Univ, Inst Curie, CNRS, Unite Mixte Rech 146, Bldg 110, F-91405 Orsay, France.	sandrine.humbert@curie.u-psud.fr; frederic.saudou@curie.u-psud.fr	SAUDOU, Frédéric/L-3454-2014; Gauthier, Laurent/ABC-7614-2021; Humbert, Sandrine/S-2981-2016; Cordelières, Fabrice P/G-3574-2017; Leßmann, Volkmar/E-8125-2013; Borrell-Pages, Maria/Q-6307-2019	SAUDOU, Frédéric/0000-0001-6107-1046; Gauthier, Laurent/0000-0003-4644-7660; Cordelières, Fabrice P/0000-0002-5383-5816; Leßmann, Volkmar/0000-0002-6863-323X; Borrell-Pages, Maria/0000-0002-1759-9756; Humbert, Sandrine/0000-0002-9501-2658; Charrin, Benedicte/0000-0003-3843-4157	NIMH NIH HHS [MH/NS 31862] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH031862] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Bertaux F, 1998, FEBS LETT, V426, P229, DOI 10.1016/S0014-5793(98)00352-4; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DiFiglia M, 2002, MOL CELL, V10, P224, DOI 10.1016/S1097-2765(02)00609-3; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hoffner G, 2002, J CELL SCI, V115, P941; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lione LA, 1999, J NEUROSCI, V19, P10428; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Schroer TA, 1996, SEMIN CELL DEV BIOL, V7, P321, DOI 10.1006/scdb.1996.0041; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tukamoto T, 1997, MOL BRAIN RES, V51, P8, DOI 10.1016/S0169-328X(97)00205-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	45	817	861	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2004	118	1					127	138		10.1016/j.cell.2004.06.018	http://dx.doi.org/10.1016/j.cell.2004.06.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242649	Bronze			2022-12-01	WOS:000222626800013
J	Deechongkit, S; Nguyen, H; Powers, ET; Dawson, PE; Gruebele, M; Kelly, JW				Deechongkit, S; Nguyen, H; Powers, ET; Dawson, PE; Gruebele, M; Kelly, JW			Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics	NATURE			English	Article							WW DOMAIN; STAPHYLOCOCCAL NUCLEASE; THERMODYNAMIC STABILITY; AMINO-ACIDS; PROTEIN; STATE; DEPSIPEPTIDES; TEMPERATURE; LANDSCAPE; PEPTIDES	Backbone hydrogen bonds (H-bonds) are prominent features of protein structures; however, their role in protein folding remains controversial because they cannot be selectively perturbed by traditional methods of protein mutagenesis(1-3). Here we have assessed the contribution of backbone H-bonds to the folding kinetics and thermodynamics of the PIN WW domain, a small beta-sheet protein(4), by individually replacing its backbone amides with esters. Amide-to-ester mutations site-specifically perturb backbone H-bonds in two ways: a H-bond donor is eliminated by replacing an amide NH with an ester oxygen, and a H-bond acceptor is weakened by replacing an amide carbonyl with an ester carbonyl(5-13). We perturbed the 11 backbone H-bonds of the PIN WW domain by synthesizing 19 amide-to-ester mutants. Thermodynamic studies on these variants show that the protein is most destabilized when H-bonds that are enveloped by a hydrophobic cluster are perturbed. Kinetic studies indicate that native-like secondary structure forms in one of the protein's loops in the folding transition state, but the backbone is less ordered elsewhere in the sequence. Collectively, our results provide an unusually detailed picture of the folding of a beta-sheet protein.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem Phys, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10440 N Torrey Pines Rd,BCC 506, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Powers, Evan/0000-0001-8185-8487	NIGMS NIH HHS [R01 GM051105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Beligere GS, 2000, J AM CHEM SOC, V122, P12079, DOI 10.1021/ja001648e; Blankenship JW, 2002, BIOCHEMISTRY-US, V41, P15676, DOI 10.1021/bi026862p; BRAMSON HN, 1985, J BIOL CHEM, V260, P5452; Chapman E, 1997, J AM CHEM SOC, V119, P7151, DOI 10.1021/ja970826+; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Crane JC, 2000, J MOL BIOL, V298, P283, DOI 10.1006/jmbi.2000.3665; Deechongkit S, 2004, ORG LETT, V6, P497, DOI 10.1021/ol036102m; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Gruebele M, 1998, ACCOUNTS CHEM RES, V31, P699, DOI 10.1021/ar970083x; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; HONIG B, 1995, ADV PROTEIN CHEM, V46, P27, DOI 10.1016/S0065-3233(08)60331-9; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; Kaul R, 2002, J AM CHEM SOC, V124, P11900, DOI 10.1021/ja020675x; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; Kowalski JA, 2002, BIOPOLYMERS, V63, P111, DOI 10.1002/bip.10020; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Nguyen H, 2003, P NATL ACAD SCI USA, V100, P3948, DOI 10.1073/pnas.0538054100; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Shin IJ, 1997, J AM CHEM SOC, V119, P12667, DOI 10.1021/ja972820q; Silinski P, 2003, BIOCHEMISTRY-US, V42, P6620, DOI 10.1021/bi020700b; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; THORSON JS, 1995, J AM CHEM SOC, V117, P9361, DOI 10.1021/ja00141a032; Wales TE, 2001, J AM CHEM SOC, V123, P7709, DOI 10.1021/ja010775n	30	230	230	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					101	105		10.1038/nature02611	http://dx.doi.org/10.1038/nature02611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229605				2022-12-01	WOS:000222356800052
J	Yusa, K; Horie, K; Kondoh, G; Kouno, M; Maeda, Y; Kinoshita, T; Takeda, J				Yusa, K; Horie, K; Kondoh, G; Kouno, M; Maeda, Y; Kinoshita, T; Takeda, J			Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION CLONING; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; HUMAN BLASTOCYSTS; MICE; SCREEN; LINES; LOCUS; FATE	The chief limitation of phenotype-based genetic screening in mammalian systems is the diploid nature of the genome. Cells deficient in the Bloom's syndrome gene (Blm) show an increased rate of loss of heterozygosity(1-3). Here we have used a tetracycline-regulated Blm allele (Blm(tet)) to introduce bi-allelic mutations across the genome in mouse embryonic stem (ES) cells. Transient loss of Blm expression induces homologous recombination not only between sister chromatids but also between homologous chromosomes. We considered that the phenotype of ES cells bearing bi-allelic mutations would be maintained after withdrawal of the tetracycline analogue doxycycline. Indeed, a combination of N-ethyl-N-nitrosourea mutagenesis and transient loss of Blm expression enabled us to generate an ES cell library with genome-wide bi-allelic mutations. The library was evaluated by screening for mutants of glycosylphosphatidylinositol-anchor biosynthesis, which involves at least 23 genes distributed throughout the genome. Mutants derived from 12 different genes were obtained and two unknown mutants were simultaneously isolated. Our results indicate that phenotype-based genetic screening with Blm(tet) is very efficient and raises possibilities for identifying gene functions in ES cells.	Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Osaka Univ, Collaborat Res Ctr Adv Sci & Technol, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Takeda, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takeda@mr-envi.med.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009	Horie, Kyoji/0000-0001-9036-8180				Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; GUPTA RS, 1978, CELL, V14, P1007, DOI 10.1016/0092-8674(78)90354-9; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; KAWAGOE K, 1994, GENOMICS, V23, P566, DOI 10.1006/geno.1994.1544; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koike H, 2002, EMBO REP, V3, P433, DOI 10.1093/embo-reports/kvf097; Kondoh G, 1999, FEBS LETT, V458, P299, DOI 10.1016/S0014-5793(99)01172-2; Kyba M, 2003, EXP HEMATOL, V31, P994, DOI 10.1016/j.exphem.2003.08.002; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luria SE, 1943, GENETICS, V28, P491; Munroe RJ, 2000, NAT GENET, V24, P318, DOI 10.1038/73563; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	26	63	66	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					896	899		10.1038/nature02646	http://dx.doi.org/10.1038/nature02646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215867				2022-12-01	WOS:000222213000046
J	Steinbrook, R				Steinbrook, R			Waiting for plan B - The FDA and nonprescription use of emergency contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Raymond EG, 2004, CONTRACEPTION, V69, P367, DOI 10.1016/j.contraception.2004.02.003; Trussell J, 2004, AM J OBSTET GYNECOL, V190, pS30, DOI 10.1016/j.ajog.2004.01.063	5	25	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2004	350	23					2327	2329		10.1056/NEJMp048135	http://dx.doi.org/10.1056/NEJMp048135			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825JY	15175432				2022-12-01	WOS:000221754200001
J	Pengo, V; Lensing, AWA; Prins, MH; Marchiori, A; Davidson, BL; Tiozzo, F; Albanese, P; Biasiolo, A; Pegoraro, C; Iliceto, S; Prandoni, P; Razzolini, R; Ramondo, A; Bellotto, F; Noventa, F; Villanova, C; Barbero, F; Casara, D; Nante, G; Tormene, D; Gerosa, G; Testolin, L; Bottio, T; Piovella, F; Vigano, M; D'Armini, A				Pengo, V; Lensing, AWA; Prins, MH; Marchiori, A; Davidson, BL; Tiozzo, F; Albanese, P; Biasiolo, A; Pegoraro, C; Iliceto, S; Prandoni, P; Razzolini, R; Ramondo, A; Bellotto, F; Noventa, F; Villanova, C; Barbero, F; Casara, D; Nante, G; Tormene, D; Gerosa, G; Testolin, L; Bottio, T; Piovella, F; Vigano, M; D'Armini, A		Thromboembolic Pulmonary Hypertens	Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOSIS; CLINICAL COURSE; ANTICOAGULANT; ANGIOGRAPHY; OBSTRUCTION	BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented. METHODS: We conducted a prospective, long-term, follow-up study to assess the incidence of symptomatic CTPH in consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism. Patients with unexplained persistent dyspnea during follow-up underwent transthoracic echocardiography and, if supportive findings were present, ventilation-perfusion lung scanning and pulmonary angiography. CTPH was considered to be present if systolic and mean pulmonary-artery pressures exceeded 40 mm Hg and 25 mm Hg, respectively; pulmonary-capillary wedge pressure was normal; and there was angiographic evidence of disease. RESULTS: The cumulative incidence of symptomatic CTPH was 1.0 percent (95 percent confidence interval, 0.0 to 2.4) at six months, 3.1 percent (95 percent confidence interval, 0.7 to 5.5) at one year, and 3.8 percent (95 percent confidence interval, 1.1 to 6.5) at two years. No cases occurred after two years among the patients with more than two years of follow-up data. The following increased the risk of CTPH: a previous pulmonary embolism (odds ratio, 19.0), younger age (odds ratio, 1.79 per decade), a larger perfusion defect (odds ratio, 2.22 per decile decrement in perfusion), and idiopathic pulmonary embolism at presentation (odds ratio, 5.70). CONCLUSIONS: CTPH is a relatively common, serious complication of pulmonary embolism. Diagnostic and therapeutic strategies for the early identification and prevention of CTPH are needed.	Univ Amsterdam, Acad Med Ctr F4 211, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Hosp Padua, Dept Clin & Expt Med, Div Clin Cardiol, Padua, Italy; Univ Hosp Padua, Dept Med & Surg Sci, Med Clin 2, Padua, Italy; Univ Hosp Padua, Div Geriatr Med, Padua, Italy; Univ Maastricht, Acad Hosp, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; Swedish Med Ctr, Seattle, WA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; Maastricht University; Maastricht University Medical Centre (MUMC); University of Washington; University of Washington Seattle; Swedish Medical Center	Lensing, AWA (corresponding author), Univ Amsterdam, Acad Med Ctr F4 211, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	awalensing@planet.nl	Bottio, Tomaso/AAC-4207-2021; Piovella, Franco/AAM-8305-2020; Bottio, Tomaso/AAQ-9040-2020; Pengo, Vittorio/AAV-9491-2020; Gerosa, Gino/M-8106-2014; Pengo, Vittorio/GSE-5972-2022; Noventa, Franco/C-1202-2008	Bottio, Tomaso/0000-0001-7299-2983; Pengo, Vittorio/0000-0003-2064-6071; Gerosa, Gino/0000-0002-6261-699X; Pengo, Vittorio/0000-0003-2064-6071; Noventa, Franco/0000-0003-4622-5523				AUGER WR, 1995, AM J MED, V99, P392, DOI 10.1016/S0002-9343(99)80187-9; AUGER WR, 1992, RADIOLOGY, V182, P393, DOI 10.1148/radiology.182.2.1732955; Badorff C, 2000, CIRCULATION, V102, P2276; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Egermayer P, 2000, EUR RESPIR J, V15, P440, DOI 10.1034/j.1399-3003.2000.15.03.x; Fedullo PF, 2001, NEW ENGL J MED, V345, P1465, DOI 10.1056/NEJMra010902; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Koopman MMW, 1997, NEW ENGL J MED, V337, P1251; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; MEYER G, 1990, EUR J NUCL MED, V17, P315, DOI 10.1007/BF01268022; MILLER GAH, 1971, BRIT MED J, V2, P681, DOI 10.1136/bmj.2.5763.681; Otto CM, 2000, TXB CLIN ECHOCARDIOG, P123; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Torbicki A, 2000, EUR HEART J, V21, P1301; vanBeek EJR, 1997, ARCH INTERN MED, V157, P2593, DOI 10.1001/archinte.157.22.2593; Wolf M, 2000, EUR RESPIR J, V15, P395, DOI 10.1034/j.1399-3003.2000.15b28.x	20	1215	1281	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2004	350	22					2257	2264		10.1056/NEJMoa032274	http://dx.doi.org/10.1056/NEJMoa032274			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823VP	15163775				2022-12-01	WOS:000221641900006
J	Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ				Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ			Argonaute2 is the catalytic engine of mammalian RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; INTERFERING RNA; C-ELEGANS; DROSOPHILA; GENE; CLEAVAGE; MICRORNA; PIWI	Gene silencing through RNA interference (RNAi) is carried out by RISC, the RNA-induced silencing complex. RISC contains two signature components, small interfering RNAs (siRNAs) and Argonaute family proteins. Here, we show that the multiple Argonaute proteins present in mammals are both biologically and biochemically distinct, with a single mammalian family member, Argonaute2, being responsible for messenger RNA cleavage activity. This protein is essential for mouse development, and cells tacking Argonaute2 are unable to mount an experimental response to siRNAs. Mutations within a cryptic ribonuclease H domain within Argonaute2, as identified by comparison with the structure of an archeal. Argonaute protein, inactivate RISC. Thus, our evidence supports a model in which Argonaute contributes "Slicer" activity to RISC, providing the catalytic engine for RNAi.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Song, Ji-Joon/C-1721-2011; Hannon, Gregory/AAB-3568-2019	Joshua-Tor, Leemor/0000-0001-8185-8049				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	43	1916	2068	7	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1437	1441		10.1126/science.1102513	http://dx.doi.org/10.1126/science.1102513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284456	Bronze			2022-12-01	WOS:000223761900040
J	Manoli, DS; Baker, BS				Manoli, DS; Baker, BS			Median bundle neurons coordinate behaviours during Drosophila male courtship	NATURE			English	Article							DETERMINATION GENE FRUITLESS; MALE SEXUAL-BEHAVIOR; EXPRESSION PATTERNS; MELANOGASTER; PROTEIN; MUTANT; ORIENTATION; ENCODES; DOMAIN; ROLES	Throughout the animal kingdom the innate nature of basic behaviour routines suggests that the underlying neuronal substrates necessary for their execution are genetically determined and developmentally programmed(1-2). Complex innate behaviours require proper timing and ordering of individual component behaviours. In Drosophila melanogaster, analyses of combinations of mutations of the fruitless (fru) gene have shown that male-specific isoforms (Fru(M)) of the Fru transcription factor are necessary for proper execution of all steps of the innate courtship ritual(3-9). Here, we eliminate Fru(M) expression in one group of about 60 neurons in the Drosophila central nervous system and observe severely contracted courtship behaviour, including rapid courtship initiation, absence of orienting and tapping, and the simultaneous occurrence of wing vibration, licking and attempted copulation. Our results identify a small group of median bundle neurons, that in wild-type Drosophila appropriately trigger the sequential execution of the component behaviours that constitute the Drosophila courtship ritual.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@cmgm.stanford.edu		Manoli, Devanand/0000-0002-7238-2330				ALONSOPIMENTEL H, 1994, CELL TISSUE RES, V275, P467, DOI 10.1007/BF00318816; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Gaines P, 2000, GENETICS, V154, P1627; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; MANNING AUBREY, 1959, BEHAVIOUR, V15, P123; Melnattur K, 2002, GENESIS, V34, P29, DOI 10.1002/gene.10151; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; SPIETH HERMAN T., 1940, JOUR NEW YORK ENT SOC, V48, P379; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STONE GN, 1995, ECOL ENTOMOL, V20, P169, DOI 10.1111/j.1365-2311.1995.tb00443.x; Villella A, 1997, GENETICS, V147, P1107; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	25	62	64	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					564	569		10.1038/nature02713	http://dx.doi.org/10.1038/nature02713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282607				2022-12-01	WOS:000222946100049
J	Kuruvilla, R; Zweifel, LS; Glebova, NO; Lonze, BE; Valdez, G; Ye, HH; Ginty, DD				Kuruvilla, R; Zweifel, LS; Glebova, NO; Lonze, BE; Valdez, G; Ye, HH; Ginty, DD			A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling	CELL			English	Article							NERVE GROWTH-FACTOR; IN-VIVO; TARGET INNERVATION; RECEPTOR COMPLEX; SENSORY NEURONS; AXON GUIDANCE; NGF; SURVIVAL; P75; EXPRESSION	A fundamental question in developmental biology is how a limited number of growth factors and their cognate receptors coordinate the formation of tissues and organs endowed with enormous morphological complexity. We report that the related neurotrophins NGF and NT-3, acting through a common receptor, TrkA, are required for sequential stages of sympathetic axon growth and, thus, innervation of target fields. Yet, while NGF supports TrkA internalization and retrograde signaling from distal axons to cell bodies to promote neuronal survival, NT-3 cannot. Interestingly, final target-derived NGF promotes expression of the p75 neurotrophin receptor, in turn causing a reduction in the sensitivity of axons to intermediate target-derived NT-3. We propose that a hierarchical neurotrophin signaling cascade coordinates sequential stages of sympathetic axon growth, innervation of targets, and survival in a manner dependent on the differential control of TrkA internalization, trafficking, and retrograde axonal signaling.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Johns Hopkins University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Ye, Haihong/0000-0001-7282-6280; Lonze, Bonnie/0000-0002-0973-1657; Kuruvilla, Rejji/0000-0002-2851-675X	NINDS NIH HHS [NS18218, NS34814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS018218, R01NS034814, R37NS034814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fagan AM, 1996, J NEUROSCI, V16, P6208; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lein PJ, 2002, J NEUROSCI, V22, P10377; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liebl DJ, 1997, J NEUROSCI, V17, P9113; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Ryden M, 1996, J BIOL CHEM, V271, P5623, DOI 10.1074/jbc.271.10.5623; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zhou XF, 1996, J COMP NEUROL, V372, P37, DOI 10.1002/(SICI)1096-9861(19960812)372:1<37::AID-CNE4>3.0.CO;2-N	45	271	287	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					243	255		10.1016/j.cell.2004.06.021	http://dx.doi.org/10.1016/j.cell.2004.06.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260993	Bronze			2022-12-01	WOS:000222966000012
J	Miyashita, M; Sasaki, M; Hattori, I; Sakai, M; Tanino, K				Miyashita, M; Sasaki, M; Hattori, I; Sakai, M; Tanino, K			Total synthesis of norzoanthamine	SCIENCE			English	Article							HETEROCYCLIC AMINAL CORE; ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; MIZOROKI-HECK REACTION; DIELS-ALDER REACTION; ABC RING-SYSTEM; ZOANTHAMINE ALKALOIDS; MARINE ZOANTHID; STEREOSELECTIVE-SYNTHESIS; ZOANTHAMINE/NORZOANTHAMINE ALKALOIDS; CDEFG RING	Norzoanthamine, an alkaloid isolated from Zoanthus sp., can suppress the loss of bone weight and strength in ovariectomized mice. Norzoanthamine derivatives can also strongly inhibit the growth of P-388 murine leukemia cell lines and human platelet aggregation. However, norzoanthamine's densely functionalized complex stereostructure and scarce availability from natural sources have proved a synthetic challenge. We report the stereoselective total synthesis of norzoanthamine in 41 steps, with an overall yield of 3.5% ( an average of 92% yield each step).	Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Miyashita, M (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan.	miyasita@sci.hokudai.ac.jp	Tanino, Keiji/M-3564-2019; Tanino, Keiji/D-8399-2012	Tanino, Keiji/0000-0002-0580-0125; Tanino, Keiji/0000-0002-0580-0125				CLIVE DLJ, 1994, J AM CHEM SOC, V116, P11275, DOI 10.1021/ja00104a009; CLIVE DLJ, 1993, TETRAHEDRON, V49, P7917, DOI 10.1016/S0040-4020(01)88016-9; Daranas AH, 1999, TETRAHEDRON, V55, P5539, DOI 10.1016/S0040-4020(99)00198-2; Daranas AH, 1998, TETRAHEDRON, V54, P7891, DOI 10.1016/S0040-4020(98)00423-2; Fukuzawa S., 1995, HETEROCYCL COMMUN, V1, P207; Ghosh S, 2004, ORG LETT, V6, P941, DOI 10.1021/ol036492c; Hikage N, 2000, CHEM PHARM BULL, V48, P1370; Hikage N, 1998, TETRAHEDRON LETT, V39, P6241, DOI 10.1016/S0040-4039(98)01285-4; Hikage N, 1998, TETRAHEDRON LETT, V39, P6237, DOI 10.1016/S0040-4039(98)01284-2; Hirai G, 2002, ORG LETT, V4, P1627, DOI 10.1021/ol025852d; Hirai G, 2001, TETRAHEDRON LETT, V42, P5783, DOI 10.1016/S0040-4039(01)01110-8; Hirai G, 1999, CHEM LETT, P141, DOI 10.1246/cl.1999.141; ITO Y, 1978, J ORG CHEM, V43, P1011, DOI 10.1021/jo00399a052; KATSUMURA S, 1985, TETRAHEDRON LETT, V26, P4625, DOI 10.1016/S0040-4039(00)98769-0; Kuramoto M, 1998, B CHEM SOC JPN, V71, P771, DOI 10.1246/bcsj.71.771; Kuramoto M, 1997, TETRAHEDRON LETT, V38, P5683, DOI 10.1016/S0040-4039(97)01238-0; Lebel H, 1999, TETRAHEDRON LETT, V40, P7303, DOI 10.1016/S0040-4039(99)01502-6; Moharram SM, 2000, TETRAHEDRON LETT, V41, P6669, DOI 10.1016/S0040-4039(00)01116-3; Mutti S, 1996, TETRAHEDRON LETT, V37, P3125, DOI 10.1016/0040-4039(96)00519-9; NAKAMURA E, 1986, TETRAHEDRON LETT, V27, P4029, DOI 10.1016/S0040-4039(00)84902-3; Nakamura H, 1998, B CHEM SOC JPN, V71, P781, DOI 10.1246/bcsj.71.781; Nielsen TE, 2002, J ORG CHEM, V67, P6366, DOI 10.1021/jo025902s; OJIMA I, 1982, ORGANOMETALLICS, V1, P1390, DOI 10.1021/om00070a024; Ooi T, 2001, HETEROCYCLES, V54, P593; RAHMAN AU, 1989, TETRAHEDRON LETT, V30, P6825; RAO CB, 1989, HETEROCYCLES, V28, P103; RAO CB, 1984, J AM CHEM SOC, V106, P7983, DOI 10.1021/ja00337a062; RAO CB, 1985, J ORG CHEM, V50, P3757, DOI 10.1021/jo00220a016; Sakai M, 2002, TETRAHEDRON LETT, V43, P1705, DOI 10.1016/S0040-4039(02)00079-5; TANNER D, 1994, TETRAHEDRON, V50, P9135, DOI 10.1016/S0040-4020(01)85379-5; Tanner D, 1997, ACTA CHEM SCAND, V51, P1217, DOI 10.3891/acta.chem.scand.51-1217; TROST BM, 1984, TETRAHEDRON LETT, V25, P173, DOI 10.1016/S0040-4039(00)99832-0; Vedejs E, 2002, J AM CHEM SOC, V124, P748, DOI 10.1021/ja0120835; Venkateswarlu Y, 1998, HETEROCYCL COMMUN, V4, P575; Villar RM, 2003, BIOORGAN MED CHEM, V11, P2301, DOI 10.1016/S0968-0896(03)00107-X; Williams DR, 1998, TETRAHEDRON LETT, V39, P2675, DOI 10.1016/S0040-4039(98)00369-4; Williams DR, 2000, ORG LETT, V2, P1023, DOI 10.1021/ol9904085; Yamaguchi K, 1999, BIOL PHARM BULL, V22, P920	38	168	172	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					495	499		10.1126/science.1098851	http://dx.doi.org/10.1126/science.1098851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	840AH	15205476				2022-12-01	WOS:000222828900033
J	Habu, D; Shiomi, S; Tamori, A; Takeda, T; Tanaka, T; Kubo, S; Nishiguchi, S				Habu, D; Shiomi, S; Tamori, A; Takeda, T; Tanaka, T; Kubo, S; Nishiguchi, S			Role of vitamin K-2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYELODYSPLASTIC SYNDROME; HEPATITIS-C; MENATETRENONE; APOPTOSIS; THERAPY; CELLS; RISK; BONE	Context Previous findings indicate that vitamin K-2 (menaquinone) may play a role in controlling cell growth. Objective To determine whether vitamin K-2 has preventive effects on the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. Design, Setting, and Participants Forty women diagnosed as having viral liver cirrhosis were admitted to a university hospital between 1996 and 1998 and were randomly assigned to the treatment or control group. The original goal of the trial was to assess the long-term effects of vitamin K-2 on bone loss in women with viral liver cirrhosis. However, study participants also satisfied criteria required for examination of the effects of such treatment on the development of hepatocellular carcinoma. Interventions The treatment group received 45 mg/d of vitamin K-2 (n=21). Participants in the treatment and control groups received symptomatic therapy to treat ascites, if necessary, and dietary advice. Main Outcome Measure Cumulative proportion of patients with hepatocellular carcinoma. Results Hepatocellular carcinoma was detected in 2 of the 21 women given vitamin K-2 and 9 of the 19 women in the control group. The cumulative proportion of patients with hepatocellular carcinoma was smaller in the treatment group (log-rank test, P=.02). On univariate analysis, the risk ratio for the development of hepatocellular carcinoma in the treatment group compared with the control group was 0.20 (95% confidence interval [Cl], 0.04-0.91; P=.04). On multivariate analysis with adjustment for age, alanine aminotransferase activity, serum albumin, total bilirubin, platelet count, alpha-fetoprotein, and history of treatment with interferon alfa, the risk ratio for the development of hepatocellular carcinoma in patients given vitamin K-2 was 0.13 (95% Cl, 0.02-0.99; P=.05). Conclusion There is a possible role for vitamin K-2 in the prevention of hepatocellular carcinoma in women with viral cirrhosis.	Osaka City Univ, Sch Med, Grad Sch Med, Dept Nucl Med,Abeno Ku, Osaka 5458585, Japan; Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; Osaka City Univ, Grad Sch Med, Dept Publ Hlth, Osaka 5458585, Japan; Osaka City Univ, Grad Sch Med, Dept Surg, Osaka 5458585, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Shiomi, S (corresponding author), Osaka City Univ, Sch Med, Grad Sch Med, Dept Nucl Med,Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	shiomis@med.osaka-cu.ac.jp						CARR BI, 1995, P AACR, V36, P266; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1002/hep.1840180109; International Union Against Cancer (UICC), 1997, J CLIN PATHOL; JEROME G, 2000, J HEPATOL, V32, P447; Kar S, 2000, J CELL PHYSIOL, V185, P386, DOI 10.1002/1097-4652(200012)185:3<386::AID-JCP8>3.0.CO;2-X; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Nishimaki J, 1999, LEUKEMIA, V13, P1399, DOI 10.1038/sj.leu.2401491; OHIZUMI H, 1995, J BIOCHEM-TOKYO, V117, P11, DOI 10.1093/oxfordjournals.jbchem.a124695; Orimo H, 1998, J BONE MINER METAB, V16, P106, DOI 10.1007/s007740050034; PERE G, 1987, HEPATOLOGY, V7, P122; SASAKI I, 1994, BIOCHEM BIOPH RES CO, V205, P1305; Shiomi S, 2002, AM J GASTROENTEROL, V97, P978, DOI 10.1111/j.1572-0241.2002.05618.x; Takami A, 1999, INT J HEMATOL, V69, P24; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; ZOLI M, 1991, AM J GASTROENTEROL, V86, P1508	17	118	123	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2004	292	3					358	361		10.1001/jama.292.3.358	http://dx.doi.org/10.1001/jama.292.3.358			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838DL	15265851	Bronze			2022-12-01	WOS:000222693500021
J	Singel, DJ; Stamler, JS				Singel, DJ; Stamler, JS			Blood traffic control	NATURE			English	Editorial Material									Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Montana State University System; Montana State University Bozeman; Duke University; Howard Hughes Medical Institute	Singel, DJ (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.			Stamler, Jonathan/0000-0002-6866-1572				Datta B, 2004, CIRCULATION, V109, P1339, DOI 10.1161/01.CIR.0000124450.07016.1D; DULING BR, 1975, CIRC RES, V37, P325, DOI 10.1161/01.RES.37.3.325; Gonzalez-Alonso J, 2001, J PHYSIOL-LONDON, V530, P331, DOI 10.1111/j.1469-7793.2001.0331l.x; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; SINGEL DJ, IN PRESS ANN REV PHY, V67	5	42	44	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2004	430	6997					297	297		10.1038/430297a	http://dx.doi.org/10.1038/430297a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254518	Bronze			2022-12-01	WOS:000222631200020
J	Suchyna, TM; Tape, SE; Koeppe, RE; Andersen, OS; Sachs, F; Gottlieb, PA				Suchyna, TM; Tape, SE; Koeppe, RE; Andersen, OS; Sachs, F; Gottlieb, PA			Bilayer-dependent inhibition of mechanosensitive channels by neuroactive peptide enantiomers	NATURE			English	Article							GRAMICIDIN-A; LIPID BILAYERS; SPIDER VENOM; K+ CHANNELS; MEMBRANES; TENSION; INACTIVATION; ACTIVATION; LIFETIME; KINETICS	The peptide GsMTx4, isolated from the venom of the tarantula Grammostola spatulata, is a selective inhibitor of stretch-activated cation channels (SACs)(1). The mechanism of inhibition remains unknown; but both GsMTx4 and its enantiomer, enGsMTx4, modify the gating of SACs, thus violating a trademark of the traditional lock-and-key model of ligand-protein interactions. Suspecting a bilayer-dependent mechanism, we examined the effect of GsMTx4 and enGsMTx4 on gramicidin A (gA) channel gating(2). Both peptides are active, and the effect increases with the degree of hydrophobic mismatch between bilayer thickness and channel length, meaning that GsMTx4 decreases the energy required to deform the boundary lipids adjacent to the channel. GsMTx4 decreases inward SAC single-channel currents but has no effect on outward currents, suggesting it is located within a Debye length of the outer vestibule of the SACs, but significantly farther from the inner vestibule. Likewise, GsMTx4 decreases gA single-channel currents. Our results suggest that modulation of membrane proteins by amphipathic peptides-mechanopharmacology-involves not only the protein itself but also the surrounding lipids. The surprising efficacy of the D form of GsMTx4 peptide has important therapeutic implications, because D peptides are not hydrolysed by endogenous proteases and may be administered orally.	Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Arkansas System; University of Arkansas Fayetteville	Andersen, OS (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	sparre@med.cornell.edu; philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885; Koeppe, Roger/0000-0003-0676-6413	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM021342] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen O S, 1999, Methods Enzymol, V294, P208; ANDERSEN OS, 1983, BIOPHYS J, V41, P119, DOI 10.1016/S0006-3495(83)84414-2; Bett GCL, 2000, J MEMBRANE BIOL, V173, P237, DOI 10.1007/s002320001023; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Greathouse D V, 1999, Methods Enzymol, V294, P525; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; KOEPPE RE, 1992, PROTEINS, V12, P49, DOI 10.1002/prot.340120107; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Laitko U, 2004, J GEN PHYSIOL, V123, P135, DOI 10.1085/jgp.200308965; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; MARKIN VS, IN PRESS PHYS BIOL; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Suchyna TM, 2004, PHYS BIOL, V1, P1, DOI 10.1088/1478-3967/1/1/001; TRUDELLE Y, 1987, INT J PEPT PROT RES, V30, P163; White SH, 1998, METHOD ENZYMOL, V295, P62	29	241	254	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					235	240		10.1038/nature02743	http://dx.doi.org/10.1038/nature02743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241420				2022-12-01	WOS:000222470600050
J	Auerbach, JD				Auerbach, JD			No "access for all" to US Government HIV/AIDS research	LANCET			English	Editorial Material									Amer Fdn AIDS Res, New York, NY 10005 USA		Auerbach, JD (corresponding author), Amer Fdn AIDS Res, 120 Wall St,13th Floor, New York, NY 10005 USA.	judy.auerbach@amfar.org						Couzin J, 2004, SCIENCE, V304, P499; GARRETT L, 2004, LOS ANGELES TIM 0530, P5	2	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	2004	364	9428					109	110		10.1016/S0140-6736(04)16599-9	http://dx.doi.org/10.1016/S0140-6736(04)16599-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	834DX	15239174				2022-12-01	WOS:000222392900041
J	Power, L				Power, L			HIV and sexual health in the UK: politics and public health	LANCET			English	Editorial Material									Terrence Higgins Trust, Policy & Publ Affairs, London W11 1QT, England		Power, L (corresponding author), Terrence Higgins Trust, Policy & Publ Affairs, London W11 1QT, England.	lisa.power@tht.org.uk						Coker R, 2003, MIGRATION PUBLIC HLT; *HLTH PROT AG, AIDS HIV STII DAT; KINGHORN GR, HIV TREATM INF OTH N; *T HIGG TRUST, 2003, REC MIGR US HIV SERV; WEATHERBURN P, PROJECT NASAH INVEST	5	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	2004	364	9428					108	109		10.1016/S0140-6736(04)16598-7	http://dx.doi.org/10.1016/S0140-6736(04)16598-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	834DX	15239173				2022-12-01	WOS:000222392900040
J	Stach, S; Benard, J; Giurfa, M				Stach, S; Benard, J; Giurfa, M			Local-feature assembling in visual pattern recognition and generalization in honeybees	NATURE			English	Article							EQUAL ORTHOGONAL BARS; APIS-MELLIFERA; SPECTRAL PROPERTIES; VISION; DISCRIMINATION; ORIENTATION; PERCEPTION; BEES; MEDULLA; INSECT	Generalization is a cognitive ability that allows similar stimuli along a given dimension to be treated as equivalents(1-3). Insects exhibit high levels of visual generalization(4-6). Honeybees trained to recognize complex visual stimuli on the basis of a single feature generalize their choice to novel stimuli sharing that common feature with the trained stimuli(7). The demonstration of this kind of performance has been limited to the use of a single visual feature, and the possibility that bees link different features in learning a visual pattern has been denied(8,9). Here we show that honeybees trained with a series of complex patterns sharing a common layout comprising four edge orientations remember these orientations simultaneously in their appropriate positions, and generalize their response to novel stimuli that preserve the trained layout. Honeybees also generalize their response to patterns with fewer correct orientations, depending on their match with the trained layout. Stimulation of the achromatic L-photoreceptor input is necessary for this task. The mini-brain of the honeybee can thus extract regularities in its environment and establish correspondences among correlated features. It can thus generate a large set of object descriptions from a finite set of elements.	Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, F-31062 Toulouse 4, France; Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Free University of Berlin	Giurfa, M (corresponding author), Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, 118 Route Narbonne, F-31062 Toulouse 4, France.	giurfa@cict.fr	Giurfa, Martin/AAS-4945-2020; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/H-5140-2016	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X				BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; Ghirlanda S, 2003, ANIM BEHAV, V66, P15, DOI 10.1006/anbe.2003.2174; Giger AD, 1996, J COMP PHYSIOL A, V178, P763; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; HORRIDGE GA, 1995, J INSECT PHYSIOL, V41, P681, DOI 10.1016/0022-1910(95)00021-L; Horridge GA, 1997, J INSECT PHYSIOL, V43, P741, DOI 10.1016/S0022-1910(97)00041-3; Horridge GA, 2003, J COMP PHYSIOL A, V189, P703, DOI 10.1007/s00359-003-0446-7; Horridge GA, 1996, J INSECT PHYSIOL, V42, P131, DOI 10.1016/0022-1910(95)00088-7; Horridge GA, 1997, J COMP PHYSIOL A, V181, P267, DOI 10.1007/s003590050113; James AC, 1996, J COMP PHYSIOL A, V178, P183, DOI 10.1007/BF00188161; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Menzel Randolf, 1991, P262; OSORIO D, 1987, J COMP PHYSIOL A, V161, P441, DOI 10.1007/BF00603969; RONACHER B, 1992, VISION RES, V32, P1837, DOI 10.1016/0042-6989(92)90045-K; Ronacher B, 1998, BIOL CYBERN, V79, P477, DOI 10.1007/s004220050497; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; SRINIVASAN MV, 1994, J INSECT PHYSIOL, V40, P183, DOI 10.1016/0022-1910(94)90041-8; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Werner C. W., 1999, ANIM COGN, V2, P27	28	97	97	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					758	761		10.1038/nature02594	http://dx.doi.org/10.1038/nature02594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201910				2022-12-01	WOS:000222059900038
J	English, M; Esamai, F; Wasunna, A; Were, F; Ogutu, B; Wamae, A; Snow, RW; Peshu, N				English, M; Esamai, F; Wasunna, A; Were, F; Ogutu, B; Wamae, A; Snow, RW; Peshu, N			Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya	LANCET			English	Article							BLOOD-TRANSFUSION; CHILDREN; SURVIVAL	Background The district hospital is considered essential for delivering basic, cost-effective health care to children in resource poor countries. We aimed to investigate the performance of these facilities in Kenya. Methods Government hospitals providing first referral level care were prospectively sampled from 13 Kenyan districts. Workload statistics and data documenting the management and care of admitted children were obtained by specially trained health workers. Findings Data from 14 hospitals were surveyed with routine statistics showing considerable variation in inpatient paediatric mortality (range 4-15%) and specific case fatality rates (eg, anaemia 3-46%). The value of these routine data is seriously undermined by missing data, apparent avoidance of a diagnosis of HIV/AIDS, and absence of standard definitions. Case management practices are often not in line with national or international guidelines. For malaria, signs defining severity such as the level of consciousness and degree of respiratory distress are often not documented (range per hospital 0-100% and 9-77%, respectively), loading doses of quinine are rarely given (3% of cases) and dose errors are not uncommon. Resource constraints such as a lack of nutritional supplements for malnourished children also restrict the provision of basic, effective care. Interpretation Even crude performance measures suggest there is a great need to improve care and data quality, and to identify and tackle key health system constraints at the first referral level in Kenya. Appropriate intervention might. lead to more effective use of health workers' efforts in such hospitals.	KEMRI Ctr Geog Med Res, Kilifi, Kenya; Univ Oxford, Dept Paediat, Oxford, England; John Radcliffe Hosp, Oxford OX3 9DU, England; Moi Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Eldoret, Kenya; Moi Teaching & Referral Hosp, Eldoret, Kenya; Univ Nairobi, Dept Paediat & Child Hlth, Kenyatta Natl Hosp, Nairobi, Kenya; KEMRI Ctr Clin Res, Kisumu, Kenya; Minist Hlth, Dept Prevent & Promot Hlth Serv, Div Child Hlth, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; KEMRI Wellcome Trust Collaborat Programme, Nairobi, Kenya	University of Oxford; University of Oxford; Moi University; Kenyatta National Hospital; University of Nairobi; University of Oxford	English, M (corresponding author), KEMRI Wellcome Trust Collaborat Programme, POB 43640,00100 GPO, Nairobi, Kenya.	menglish@wtnairobi.mimcom.net	ESAMAI, FABIAN/AAI-3268-2020; Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; English, Michael/0000-0002-7427-0826				BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; DULEY L, 1995, LANCET, V345, P1455; DULEY L, 2002, COCHRANE LIB; English M, 2003, B WORLD HEALTH ORGAN, V81, P166; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; Fisman DN, 2000, INFECT DIS CLIN N AM, V14, P475, DOI 10.1016/S0891-5520(05)70259-2; Global Forum for Health Research, 1999, 10 90 REP HLTH RES 1; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Lee JW, 2003, LANCET, V362, P262, DOI 10.1016/S0140-6736(03)14006-8; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; *MIN HLTH NAT AIDS, 2001, AIDS KEN; *MIN HLTH REP KEN, 1994, CLIN GUID; *MIN HLTH REP KEN, 2001, HLTH MAN INF SYST RE; Moore A, 2001, LANCET, V358, P657, DOI 10.1016/S0140-6736(01)05783-X; *NAT MAL CONTR PRO, 1998, NAT GUID DIAGN TREAT; National Center for Health Statistics, 2000, 2000 CDC GROWTH CHAR; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Ross LM, 2000, ARCH DIS CHILD, V83, P492, DOI 10.1136/adc.83.6.492; United Nations Development Programme, MILL DEV GOALS; WHO, 2000, WORLD HLTH REP HLTH; WHO, 1994, MOTH BAB PACK IMPL S; *WHO, 2002, IMPR QUAL PAED CAR A; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, INT MAN CHILDH ILLN; World Health Organization, 1990, AC RESP INF CHILDR C; World Health Organization, 1999, MAN SEV MALN MAN PHY	28	199	203	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2004	363	9425					1948	1953		10.1016/S0140-6736(04)16408-8	http://dx.doi.org/10.1016/S0140-6736(04)16408-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GW	15194254				2022-12-01	WOS:000221962800009
J	Laland, KN; Odling-Smee, J; Feldman, MW				Laland, KN; Odling-Smee, J; Feldman, MW			Causing a commotion	NATURE			English	Editorial Material									Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland; Univ Oxford, Inst Biol Anthropol, Oxford OX1 2JD, England; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of St Andrews; University of Oxford; Stanford University	Laland, KN (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland.		Laland, Kevin N/C-9482-2011					Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Keller L, 2003, NATURE, V425, P769, DOI 10.1038/425769a; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Odling-Smee J., 2003, MONOGRAPHS POPULATIO, V37; Vandermeer J, 2004, SCIENCE, V303, P472, DOI 10.1126/science.1091922	5	31	33	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					609	609		10.1038/429609a	http://dx.doi.org/10.1038/429609a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190333	Bronze			2022-12-01	WOS:000221912600021
J	Murthy, VH; Krumholz, HM; Gross, CP				Murthy, VH; Krumholz, HM; Gross, CP			Participation in cancer clinical trials - Race-, sex-, and age-based disparities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AFRICAN-AMERICANS; OLDER; WOMEN; RECRUITMENT; PREVENTION; ATTITUDES; PROSTATE; REPRESENTATION; ENROLLMENT; INSTITUTE	Context Despite the importance of diversity of cancer trial participants with regard to race, ethnicity, age, and sex, there is little recent information about the representation of these groups in clinical trials. Objective To characterize the representation of racial and ethnic minorities, the elderly, and women in cancer trials sponsored by the National Cancer Institute. Design, Setting, and Patients Cross-sectional population-based analysis of all participants in therapeutic nonsurgical National Cancer Institute Clinical Trial Cooperative Group breast, colorectal, lung, and prostate cancer clinical trials in 2000 through 2002. In a separate analysis, the ethnic distribution of patients enrolled in 2000 through 2002 was compared with those enrolled in 1 996 through 1998, using logistic regression models to estimate the relative risk ratio of enrollment for racial and ethnic minorities to that of white patients during these time periods. Main Outcome Measure Enrollment fraction, defined as the number of trial enrollees divided by the estimated US cancer cases in each race and age subgroup. Results Cancer research participation varied significantly across racial/ethnic and age groups. Compared with a 1.8% enrollment fraction among white patients, lower enrollment fractions were noted in Hispanic (1.3 %; odds ratio [OR] vs whites, 0.72; 95% confidence interval [CI], 0.68-0.77; P<.001) and black (1.3%; OR, 0.71; 95% Cl, 0.68-0.74; P<001) patients. There was a strong relationship between age and enrollment fraction, with trial participants 30 to 64 years of age representing 3.0% of incident cancer patients in that age group, in comparison to 1.3% of 65- to 74-year-old patients and 0.5% of patients 75 years of age and older. This inverse relationship between age and trial enrollment fraction was consistent across racial and ethnic groups. Although the total number of trial participants increased during our study period, the representation of racial and ethnic minorities decreased. in comparison to whites, after adjusting for age, cancer type, and sex, patients enrolled in 2000 through 2002 were 24% less likely to be black (adjusted relative risk ratio, 0.76; 95% Cl, 0.65-0.89; P<.001). Men were more likely than women to enroll in colorectal cancer trials (enrollment fractions: 2.1 % vs 1.6%, respectively; OR, 1.30; 95% Cl, 1.24-1,35; P<.001) and lung cancer trials (enrollment fractions: 0.9% vs 0.7%, respectively; OR, 1.23; 95% Cl, 1.16-1.31; P<001). Conclusions Enrollment in cancer trials is low for all patient groups. Racial and ethnic minorities, women, and the elderly were less likely to enroll in cooperative group cancer trials than were whites, men, and younger patients, respectively. The proportion of trial participants who are black has declined in recent years.	Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale New Haven Hosp, Ctr Outcomes Res & Evaluat,Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	, Harlan/AAI-2875-2020		NCI NIH HHS [1K07CA-90402] Funding Source: Medline; NIA NIH HHS [P30AG21342] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA090402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Cancer Society, 1999, CANC FACTS FIG 1999; Bach PB, 2002, MED CARE, V40, P19; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Chang SM, 2002, CANCER-AM CANCER SOC, V94, P2681, DOI 10.1002/cncr.10536; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; CRIVELLARI D, ADJUVANT TREATMENT E; Dignam JJ, 2003, J CLIN ONCOL, V21, P413, DOI 10.1200/JCO.2003.02.004; Farkas Andrew, 2000, Ethnicity and Disease, V10, P69; Ford ME, 2003, GERONTOLOGIST, V43, P27, DOI 10.1093/geront/43.1.27; Fowler JE, 1999, CANCER, V86, P836, DOI 10.1002/(SICI)1097-0142(19990901)86:5<836::AID-CNCR20>3.3.CO;2-G; FRELICK RW, 1994, J CLIN ONCOL, V12, P1718, DOI 10.1200/JCO.1994.12.8.1718; Gross CP, 2000, JAMA-J AM MED ASSOC, V284, P2886, DOI 10.1001/jama.284.22.2886; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Harris Y, 1996, J NATL MED ASSOC, V88, P630; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; INGRAM D, 2003, US CENSUS 2000 POP 2; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Lyman GH, 1997, ANN SURG ONCOL, V4, P80, DOI 10.1007/BF02316814; Meinert CL, 2000, NEW ENGL J MED, V343, P1972; Mouton CP, 1997, J NATL MED ASSOC, V89, P721; *NAT CANC I, AR HLTH REL EXCL KEE; *NAT I AG NAT CANC, 2001, EXPL ROL CANC CTR IN; Paskett ED, 1996, PREV MED, V25, P547, DOI 10.1006/pmed.1996.0088; Ramasubbu K, 2001, J WOMEN HEALTH GEN-B, V10, P757, DOI 10.1089/15246090152636514; Rathore SS, 2003, BRIT MED J, V327, P763, DOI 10.1136/bmj.327.7418.763; Robinson SB, 1996, J COMMUN HEALTH, V21, P77, DOI 10.1007/BF01682300; Sateren WB, 2002, J CLIN ONCOL, V20, P2109, DOI 10.1200/JCO.2002.08.056; SEER Program, SEER STAT DAT INC SE; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Shavers-Hornaday V L, 1997, Ethn Health, V2, P31; SHIAO YH, 1995, CANCER RES, V55, P1485; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; *STATACORP, 2004, STAT REF MAN REL 8, V4; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; Tejeda HA, 1996, J NATL CANCER I, V88, P812, DOI 10.1093/jnci/88.12.812; TRIMBLE EL, 1994, CANCER, V74, P2208, DOI 10.1002/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-#; U.S. Office of Management and Budget (OMB), 1997, FED REG         1030; Unson CG, 2001, J NATL MED ASSOC, V93, P392; *US GEN ACC OFF, 1999, NIH CLIN TRIALS VAR; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Zhu KM, 2000, J NATL MED ASSOC, V92, P169	41	1408	1415	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2004	291	22					2720	2726		10.1001/jama.291.22.2720	http://dx.doi.org/10.1001/jama.291.22.2720			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826XH	15187053	Bronze			2022-12-01	WOS:000221862300026
J	Roy, D; Liston, DR; Idone, VJ; Di, A; Nelson, DJ; Pujol, C; Bliska, JB; Chakrabarti, S; Andrews, NW				Roy, D; Liston, DR; Idone, VJ; Di, A; Nelson, DJ; Pujol, C; Bliska, JB; Chakrabarti, S; Andrews, NW			A process for controlling intracellular bacterial infections induced by membrane injury	SCIENCE			English	Article							PHAGOSOME-LYSOSOME FUSION; PORE FORMATION; SALMONELLA-TYPHIMURIUM; EPITHELIAL-CELLS; SYNAPTOTAGMIN; PHAGOCYTOSIS; MACROPHAGES; INHIBITION; EXOCYTOSIS	Strategies for inhibiting phagolysosome fusion are essential for the intracellular survival and replication of many pathogens. We found that the lysosomal synaptotagmin Syt VII is required for a mechanism that promotes phagolysosomal fusion and limits the intracellular growth of pathogenic bacteria. Syt VII was required for a form of Ca2+-dependent phagolysosome fusion that is analogous to Ca2+-regulated exocytosis of lysosomes, which can be triggered by membrane injury. Bacterial type III secretion systems, which permeabilize membranes and cause Ca2+ influx in mammalian cells, promote lysosomal exocytosis and inhibit intracellular survival in Syt VII +/+ but not -/- cells. Thus, the lysosomal repair response can also protect cells against pathogens that trigger membrane permeabilization.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Univ Chicago, Dept Physiol & Pharmacol, Chicago, IL 60637 USA; SUNY Stony Brook, Sch Med, Ctr Infect Dis, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Yale University; Yale University; University of Chicago; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Andrews, NW (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06510 USA.			Andrews, Norma/0000-0002-0611-2412; Idone, Vincent/0000-0002-5622-2011	NIAID NIH HHS [AI43389, AI48507, AI34867] Funding Source: Medline; NIGMS NIH HHS [R01 GM064625, GM64625] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048507, R01AI043389, R01AI034867, R56AI043389, R37AI034867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064625] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Oh YK, 1996, INFECT IMMUN, V64, P3877, DOI 10.1128/IAI.64.9.3877-3883.1996; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; TILNEY LG, 1990, J CELL BIOL, V111, P2979, DOI 10.1083/jcb.111.6.2979; Viboud GI, 2002, METHOD ENZYMOL, V358, P345; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x	22	122	125	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1515	1518		10.1126/science.1098371	http://dx.doi.org/10.1126/science.1098371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178804				2022-12-01	WOS:000221795800049
J	Humphray, SJ; Oliver, K; Hunt, AR; Plumb, RW; Loveland, JE; Howe, KL; Andrews, TD; Searle, S; Hunt, SE; Scott, CE; Jones, MC; Ainscough, R; Almeida, JP; Ambrose, KD; Ashwell, RIS; Babbage, AK; Babbage, S; Bagguley, CL; Bailey, J; Banerjee, R; Barker, DJ; Barlow, KF; Bates, K; Beasley, H; Beasley, O; Bird, CP; Bray-Allen, S; Brown, AJ; Brown, JY; Burford, D; Burrill, W; Burton, J; Carder, C; Carter, NP; Chapman, JC; Chen, Y; Clarke, G; Clark, SY; Clee, CM; Clegg, S; Collier, RE; Corby, N; Crosier, M; Cummings, AT; Davies, J; Dhami, P; Dunn, M; Dutta, I; Dyer, LW; Earthrowl, ME; Faulkner, L; Fleming, CJ; Frankish, A; Frankland, JA; French, L; Fricker, DG; Garner, P; Garnett, J; Ghori, J; Gilbert, JGR; Glison, C; Grafham, DV; Gribble, S; Griffiths, C; Jones, SG; Grocock, R; Guy, J; Hall, RE; Hammond, S; Harley, JL; Harrison, ESI; Hart, EA; Heath, PD; Henderson, CD; Hopkins, BL; Howard, PJ; Howden, PJ; Huckle, E; Johnson, C; Johnson, D; Joy, AA; Kay, M; Keenan, S; Kershaw, JK; Kimberley, AM; King, A; Knights, A; Laird, GK; Langford, C; Lawlor, S; Leongamornlert, DA; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, J; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; McLaren, S; McLay, KE; McMurray, A; Milne, S; Nickerson, T; Nisbett, J; Nordsiek, G; Pearce, AV; Peck, AI; Porter, KM; Pandian, R; Pelan, S; Phillimore, B; Povey, S; Ramsey, Y; Rand, V; Scharfe, M; Sehra, HK; Shownkeen, R; Sims, SK; Skuce, CD; Smith, M; Steward, CA; Swarbreck, D; Sycamore, N; Tester, J; Thorpe, A; Tracey, A; Tromans, A; Thomas, DW; Wall, M; Wallis, JM; West, AP; Whitehead, SL; Willey, DL; Williams, SA; Wilming, L; Wray, PW; Young, L; Ashurst, JL; Coulson, A; Blocker, H; Durbin, R; Sulston, JE; Hubbard, T; Jackson, MJ; Bentley, DR; Beck, S; Rogers, J; Dunham, I				Humphray, SJ; Oliver, K; Hunt, AR; Plumb, RW; Loveland, JE; Howe, KL; Andrews, TD; Searle, S; Hunt, SE; Scott, CE; Jones, MC; Ainscough, R; Almeida, JP; Ambrose, KD; Ashwell, RIS; Babbage, AK; Babbage, S; Bagguley, CL; Bailey, J; Banerjee, R; Barker, DJ; Barlow, KF; Bates, K; Beasley, H; Beasley, O; Bird, CP; Bray-Allen, S; Brown, AJ; Brown, JY; Burford, D; Burrill, W; Burton, J; Carder, C; Carter, NP; Chapman, JC; Chen, Y; Clarke, G; Clark, SY; Clee, CM; Clegg, S; Collier, RE; Corby, N; Crosier, M; Cummings, AT; Davies, J; Dhami, P; Dunn, M; Dutta, I; Dyer, LW; Earthrowl, ME; Faulkner, L; Fleming, CJ; Frankish, A; Frankland, JA; French, L; Fricker, DG; Garner, P; Garnett, J; Ghori, J; Gilbert, JGR; Glison, C; Grafham, DV; Gribble, S; Griffiths, C; Jones, SG; Grocock, R; Guy, J; Hall, RE; Hammond, S; Harley, JL; Harrison, ESI; Hart, EA; Heath, PD; Henderson, CD; Hopkins, BL; Howard, PJ; Howden, PJ; Huckle, E; Johnson, C; Johnson, D; Joy, AA; Kay, M; Keenan, S; Kershaw, JK; Kimberley, AM; King, A; Knights, A; Laird, GK; Langford, C; Lawlor, S; Leongamornlert, DA; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, J; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; McLaren, S; McLay, KE; McMurray, A; Milne, S; Nickerson, T; Nisbett, J; Nordsiek, G; Pearce, AV; Peck, AI; Porter, KM; Pandian, R; Pelan, S; Phillimore, B; Povey, S; Ramsey, Y; Rand, V; Scharfe, M; Sehra, HK; Shownkeen, R; Sims, SK; Skuce, CD; Smith, M; Steward, CA; Swarbreck, D; Sycamore, N; Tester, J; Thorpe, A; Tracey, A; Tromans, A; Thomas, DW; Wall, M; Wallis, JM; West, AP; Whitehead, SL; Willey, DL; Williams, SA; Wilming, L; Wray, PW; Young, L; Ashurst, JL; Coulson, A; Blocker, H; Durbin, R; Sulston, JE; Hubbard, T; Jackson, MJ; Bentley, DR; Beck, S; Rogers, J; Dunham, I			DNA sequence and analysis of human chromosome 9	NATURE			English	Article							HUMAN GENOME SEQUENCE; BCR-ABL; SEGMENTAL DUPLICATIONS; GENE; EVOLUTION; REGION; MAP; CONSERVATION; BOUNDARY; RECEPTOR	Chromosome 9 is highly structurally polymorphic. It contains the largest autosomal block of heterochromatin, which is heteromorphic in 6-8% of humans, whereas pericentric inversions occur in more than 1% of the population. The finished euchromatic sequence of chromosome 9 comprises 109,044,351 base pairs and represents >99.6% of the region. Analysis of the sequence reveals many intra- and interchromosomal duplications, including segmental duplications adjacent to both the centromere and the large heterochromatic block. We have annotated 1,149 genes, including genes implicated in male-to-female sex reversal, cancer and neurodegenerative disease, and 426 pseudogenes. The chromosome contains the largest interferon gene cluster in the human genome. There is also a region of exceptionally high gene and G + C content including genes paralogous to those in the major histocompatibility complex. We have also detected recently duplicated genes that exhibit different rates of sequence divergence, presumably reflecting natural selection.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; European Bioinformat Inst, Cambridge CB10 1SD, England; Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; German Res Ctr Biotechnol GBF, Dept Genome Anal, D-38124 Braunschweig, Germany; UCL, Dept Biol, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Newcastle University - UK; Helmholtz Association; Helmholtz-Center for Infection Research; University of London; University College London	Humphray, SJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	sjh@sanger.ac.uk	Andrews, Dan/ABG-4815-2020; Durbin, Richard/AAE-7178-2019; Hubbard, Tim J/C-2567-2008; Johnson, David/A-3907-2011; Frankish, Adam/G-6545-2011; Hubbard, Tim J.P./AAT-4571-2020; Barker, David JP/A-5671-2013; Griffiths-Jones, Sam/H-2998-2014	Durbin, Richard/0000-0002-9130-1006; Hubbard, Tim J/0000-0002-1767-9318; Johnson, David/0000-0003-0887-3343; Hubbard, Tim J.P./0000-0002-1767-9318; Wass, Elizabeth/0000-0002-8605-9921; Jackson, Michael/0000-0001-7179-1354; Swarbreck, David/0000-0002-5453-1013; Steward, Charles/0000-0001-8829-5349; Dunham, Ian/0000-0003-2525-5598; Hunt, Adrienne/0000-0002-1227-0310; Davidson, Claire/0000-0002-4910-8202; Wilming, Laurens/0000-0002-4154-7358; Griffiths-Jones, Sam/0000-0001-6043-807X; Martin, Sancha/0000-0001-6213-5259; Leongamornlert, Daniel/0000-0002-3486-3168; Gilbert, James/0000-0001-8079-3159; Frankish, Adam/0000-0002-4333-628X; Keenan, Stephen/0000-0002-9141-7690; Rand, Vikki/0000-0002-2198-8949; Fosker, Christine/0000-0002-3799-9474; Andrews, Dan/0000-0003-3922-6376; Loveland, Jane/0000-0002-7669-2934; Kay, Mike/0000-0002-3282-0834; Hunt, Sarah/0000-0002-8350-1235; Howe, Kevin/0000-0002-1751-9226				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bathgate RAD, 2003, TRENDS ENDOCRIN MET, V14, P207, DOI 10.1016/S1043-2760(03)00081-X; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brun ME, 2003, GENE, V312, P41, DOI 10.1016/S0378-1119(03)00530-4; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; CRAWFORD RJ, 1989, J MOL ENDOCRINOL, V3, P169, DOI 10.1677/jme.0.0030169; Della Torre G, 2001, BRIT J CANCER, V85, P836; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Fan YX, 2002, GENOME RES, V12, P1663, DOI 10.1101/gr.338402; Felsenfeld A, 1999, GENOME RES, V9, P1; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; Humphray SJ, 2001, METH MOL B, V175, P69; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MADAN K, 1974, ANN GENET-PARIS, V17, P81; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Park JP, 1998, CYTOGENET CELL GENET, V82, P192, DOI 10.1159/000015097; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shan ZH, 2000, EUR J HUM GENET, V8, P167, DOI 10.1038/sj.ejhg.5200431; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Warder DE, 2003, J BIOMED SCI, V10, P406, DOI 10.1159/000071160; Wong S, 2003, P NATL ACAD SCI USA, V100, P11630, DOI 10.1073/pnas.2035020100; Yang ZH, 2000, GENETICS, V155, P431; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	50	88	872	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					369	374		10.1038/nature02465	http://dx.doi.org/10.1038/nature02465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164053	Green Accepted, Bronze			2022-12-01	WOS:000221644600029
J	Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R				Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R			Magnetic Properties Experiments on the Mars exploration Rover Spirit at Gusev crater	SCIENCE			English	Article							IRON-OXIDES; MOSSBAUER; SPECTROMETER; SOILS; ROCKS	The magnetic properties experiments are designed to help identify the magnetic minerals in the dust and rocks on Mars-and to determine whether liquid water was involved in the formation and alteration of these magnetic minerals. Almost all of the dust particles suspended in the martian atmosphere must contain ferrimagnetic minerals (such as maghemite or magnetite) in an amount of similar to2% by weight. The most magnetic fraction of the dust appears darker than the average dust. Magnetite was detected in the first two rocks ground by Spirit.	Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-2100 Copenhagen, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus, Denmark; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Aarhus, Dept Earth Sci, DK-8000 Aarhus, Denmark; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Honeybee Robot Ltd, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany; Max Planck Inst Chem, D-55020 Mainz, Germany	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Aarhus University; Max Planck Society; Aarhus University; Cornell University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johannes Gutenberg University of Mainz; Max Planck Society	Bertelsen, P (corresponding author), Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark.	preben@fys.ku.dk	merrison, jonathan p/L-6524-2018; Nornberg, Per/A-6228-2012; Madsen, Morten Bo/D-2082-2011; Kinch, Kjartan Bergeron/C-5742-2015; Gunnlaugsson, Haraldur/L-6535-2016	merrison, jonathan p/0000-0003-4362-6356; Madsen, Morten Bo/0000-0001-8909-5111; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Gunnlaugsson, Haraldur/0000-0002-8958-0245				ASHWAL LD, 1977, J GEOPHYS RES, V82, P1315, DOI 10.1029/JB082i008p01315; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; BELL JF, 1990, J GEOPHYS RES-SOLID, V95, P14447, DOI 10.1029/JB095iB09p14447; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Madsen MB, 1999, J GEOPHYS RES-PLANET, V104, P8761, DOI 10.1029/1998JE900006; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MORRIS RV, 1993, GEOCHIM COSMOCHIM AC, V57, P4597, DOI 10.1016/0016-7037(93)90185-Y; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Smith PH, 1997, J GEOPHYS RES-PLANET, V102, P4003, DOI 10.1029/96JE03568; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	13	69	72	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					827	829		10.1126/science.1100112	http://dx.doi.org/10.1126/science.1100112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297664				2022-12-01	WOS:000223104900037
J	Acinas, SG; Klepac-Ceraj, V; Hunt, DE; Pharino, C; Ceraj, I; Distel, DL; Polz, MF				Acinas, SG; Klepac-Ceraj, V; Hunt, DE; Pharino, C; Ceraj, I; Distel, DL; Polz, MF			Fine-scale phylogenetic architecture of a complex bacterial community	NATURE			English	Article							GENOMIC ANALYSIS; DIVERSITY; SEQUENCE; POPULATION; DIVERGENCE	Although molecular data have revealed the vast scope of microbial diversity(1), two fundamental questions remain unanswered even for well-defined natural microbial communities: how many bacterial types co-exist, and are such types naturally organized into phylogenetically discrete units of potential ecological significance? It has been argued that without such information, the environmental function, population biology and biogeography of microorganisms cannot be rigorously explored(2). Here we address these questions by comprehensive sampling of two large 16S ribosomal RNA clone libraries from a coastal bacterioplankton community. We show that compensation for artefacts generated by common library construction techniques reveals fine-scale patterns of community composition. At least 516 ribotypes ( unique rRNA sequences) were detected in the sample and, by statistical extrapolation, at least 1,633 co-existing ribotypes in the sampled population. More than 50% of the ribotypes fall into discrete clusters containing less than 1% sequence divergence. This pattern cannot be accounted for by interoperon variation, indicating a large predominance of closely related taxa in this community. We propose that such microdiverse clusters arise by selective sweeps and persist because competitive mechanisms are too weak to purge diversity from within them.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Bugaco, Somerville, MA 02144 USA; Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA	Massachusetts Institute of Technology (MIT); University of Maine System; University of Maine Orono	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Hunt, Dana/A-2051-2012; Polz, Martin/ABE-7199-2020; Distel, Daniel/A-8047-2017; chen, qi/C-8585-2011; Acinas, Silvia/F-7462-2016	Hunt, Dana/0000-0002-8801-9624; Distel, Daniel/0000-0002-3860-194X; Acinas, Silvia/0000-0002-3439-0428; Polz, Martin/0000-0002-4975-2946; /0000-0001-9296-3733; Klepac-Ceraj, Vanja/0000-0001-5387-5706				Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1111/j.1574-6976.2001.tb00571.x; Schleper C, 1998, J BACTERIOL, V180, P5003, DOI 10.1128/JB.180.19.5003-5009.1998; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	29	397	406	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					551	554		10.1038/nature02649	http://dx.doi.org/10.1038/nature02649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282603				2022-12-01	WOS:000222946100045
J	Bateson, P; Barker, D; Clutton-Brock, T; Deb, D; D'Udine, B; Foley, RA; Gluckman, P; Godfrey, K; Kirkwood, T; Lahr, MM; McNamara, J; Metcalfe, NB; Monaghan, P; Spencer, HG; Sultan, SE				Bateson, P; Barker, D; Clutton-Brock, T; Deb, D; D'Udine, B; Foley, RA; Gluckman, P; Godfrey, K; Kirkwood, T; Lahr, MM; McNamara, J; Metcalfe, NB; Monaghan, P; Spencer, HG; Sultan, SE			Developmental plasticity and human health	NATURE			English	Article							CATCH-UP GROWTH; HYPOTHESIS; ORIGINS; DISEASE; OBESITY; NUMBER; BIRTH	Many plants and animals are capable of developing In a variety of ways, forming characteristics that are well adapted to the environments In which they are likely to live. In adverse circumstances, for example, small size and slow metabolism can facilitate survival, whereas larger size and more rapid metabolism have advantages for reproductive success when resources are more abundant Often these characteristics are induced In early life or are even set by cues to which their parents or grandparents were exposed. Individuals developmentally adapted to one environment may, however, he at risk when exposed to another when they are older, The biological evidence may be relevant to the understanding of human development and susceptibility to disease. As the nutritional state of many human mothers has improved around the world, the characteristics of their offspring-such as body size and metabolism-have also changed, Responsiveness to their mothers' condition before birth may generally prepare individuals so that they are best suited to the environment forecast by cues available in early life. Paradoxically, however, rapid improvements in nutrition and other environmental Conditions may have damaging effects on the health of those people whose parents and grandparents lived In impoverished conditions. A fuller understanding of patterns of human plasticity in response to early nutrition and other environmental factors will have implications for the administration of public health.	Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Ctr Interdisciplinary Studies, Kolkata 700123, India; Univ Udine, Dept Pisiol Vegetale, I-33100 Udine, Italy; Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England; Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; Univ Newcastle, Sch Clin Med Sci Gerontol, Henry Wellcome Lab Biogerontol Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Otago, Dept Zool, Dunedin, New Zealand; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	University of Cambridge; University of Southampton; University of Cambridge; University of Udine; University of Cambridge; University of Auckland; University of Auckland; Newcastle University - UK; University of Bristol; University of Glasgow; University of Otago; Wesleyan University	Bateson, P (corresponding author), Univ Cambridge, Subdept Anim Behav, High St, Cambridge CB3 8AA, England.	ppgb@cam.ac.uk	Metcalfe, Neil B./C-5997-2009; Barker, David JP/A-5671-2013; Spencer, Hamish G/B-9637-2008; Monaghan, Pat/A-4271-2008; Monaghan, Pat/E-6810-2015	Metcalfe, Neil B./0000-0002-1970-9349; Spencer, Hamish G/0000-0001-7531-597X; Mirazon Lahr, Marta/0000-0001-5752-5770; Godfrey, Keith/0000-0002-4643-0618; Deb, Debal/0000-0002-7230-659X	Biotechnology and Biological Sciences Research Council [BEP17042] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Barker D.J.P., 1998, MOTHERS BABIES HLTH; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bateson P, 2001, J BIOSCIENCES, V26, P561, DOI 10.1007/BF02704754; Bateson P, 1999, DESIGN LIFE BEHAV DE; Chali D, 1998, ETHIOPIAN MED J, V36, P227; Chapman C, 2000, J NUTR, V130, P146, DOI 10.1093/jn/130.2.146; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Gilbert SF, 2001, DEV BIOL, V233, P1, DOI 10.1006/dbio.2001.0210; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Godfrey KM, 1997, BRIT J OBSTET GYNAEC, V104, P663, DOI 10.1111/j.1471-0528.1997.tb11975.x; Hales CN, 1997, DIABETIC MED, V14, P189; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; HUCK UW, 1987, BIOL REPROD, V37, P612, DOI 10.1095/biolreprod37.3.612; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MACKENZIE HS, 1995, AM J KIDNEY DIS, V26, P91, DOI 10.1016/0272-6386(95)90161-2; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; PIGLIUCCI M, 2001, SYN ECO EVO, pR13; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Schmitt J, 1995, AM NAT, V146, P937, DOI 10.1086/285832; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2003, J EXP ZOOL PART B, V296B, P1, DOI 10.1002/jez.b.00010; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; Tufto J, 2000, AM NAT, V156, P121, DOI 10.1086/303381; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vitzthum VJ, 2003, HUM BIOL, V75, P539, DOI 10.1353/hub.2003.0064; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; West-Eberhard Mary Jane, 2003, pi; WIDDOWSON EM, 1972, ARCH DIS CHILD, V47, P652, DOI 10.1136/adc.47.254.652	40	1137	1175	3	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					419	421		10.1038/nature02725	http://dx.doi.org/10.1038/nature02725			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269759				2022-12-01	WOS:000222801400033
J	Barratt, CLR; St John, JC; Afnan, M				Barratt, CLR; St John, JC; Afnan, M			Clinical challenges in providing embryos for stem-cell initiatives	LANCET			English	Editorial Material							GENE-EXPRESSION; LINES; DONATION		Birmingham Womens Hosp, Assisted Concept Unit, Birmingham B15 2TG, W Midlands, England; Univ Birmingham, Sch Med, Div Med Sci, Mitochondrial & Reprod Biol Grp, Birmingham, W Midlands, England	Birmingham Women's Hospital; University of Birmingham	Barratt, CLR (corresponding author), Birmingham Womens Hosp, Assisted Concept Unit, Birmingham B15 2TG, W Midlands, England.	c.l.barratt@bham.ac.uk	St. John, Justin C/A-2942-2010	Barratt, christopher/0000-0003-0062-9979; St. John, Jus/0000-0002-3993-1449				Abe Y, 2003, J NEUROSCI, V23, P8513; Bjuresten K, 2003, HUM REPROD, V18, P1353, DOI 10.1093/humrep/deg265; *CDC, 2001, ASS REPR TECHN SUCC; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DEAN WL, 2002, METH MOL B, V181, P1; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Elford K, 2004, FERTIL STERIL, V81, P1154, DOI 10.1016/j.fertnstert.2003.08.048; Gardner DK, 2003, CLIN OBSTET GYNECOL, V46, P231, DOI 10.1097/00003081-200306000-00005; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; *HUM FERT EMBR AUT, PAT GUID IN VITR FER; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; McMahon CA, 2003, HUM REPROD, V18, P871, DOI 10.1093/humrep/deg167; *NAT I CLIN EXC, FERT ASS TREATM PEOP; Neuber E, 2003, HUM REPROD, V18, P1307, DOI 10.1093/humrep/deg269; Park SP, 2004, HUM REPROD, V19, P676, DOI 10.1093/humrep/deh102; Pickering Susan J, 2003, Reprod Biomed Online, V7, P353; Reik W, 2003, NATURE, V423, P390, DOI 10.1038/423390a; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564	24	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2004	364	9429					115	118		10.1016/S0140-6736(04)16649-X	http://dx.doi.org/10.1016/S0140-6736(04)16649-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246710				2022-12-01	WOS:000222612200003
J	Gibot, S; Kolopp-Sarda, MN; Bene, MC; Cravoisy, A; Levy, B; Faure, GC; Bollaert, PE				Gibot, S; Kolopp-Sarda, MN; Bene, MC; Cravoisy, A; Levy, B; Faure, GC; Bollaert, PE			Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis	ANNALS OF INTERNAL MEDICINE			English	Article							PROCALCITONIN CONCENTRATIONS; ORGAN FAILURE; TREM-1; BACTEREMIA; MARKER; SCORE; SIRS	Background: Previous experimental studies have suggested that the triggering receptor expressed on myeloid cells-1 (TREM-1) is specifically upregulated in the presence of microbial products. Objective: To evaluate the diagnostic value of plasma levels of the soluble form of TREM-1 in patients admitted with clinical suspicion of infection. Design: Prospective, noninterventional study conducted between July and September 2003. Setting: Medical adult intensive care unit at a university hospital in France. Participants: 76 consecutive newly admitted patients who presented with clinically suspected infection and fulfilled at least 2 criteria of the systemic inflammatory response syndrome. Measurements: Sensitivity and specificity of plasma soluble TREM-1 levels at admission for the diagnosis of infection. Two independent intensivists blinded to the results of soluble TREM-1 assays retrospectively classified patients as having the systemic inflammatory response syndrome, sepsis, severe sepsis, or septic shock. Results: The systemic inflammatory response syndrome was diagnosed in 29 patients (38%), and sepsis, severe sepsis, or septic shock was diagnosed in the remaining 47 (62%). A plasma soluble TREM-1 level higher than 60 ng/mL was more accurate than any other clinical or laboratory finding for indicating infection (sensitivity, 96% [95% Cl, 92% to 100%]; specificity, 89% [Cl, 82% to 95%]; positive likelihood ratio, 8.6 [Cl, 3.8 to 21.5]; negative likelihood ratio, 0.04 [Cl, 0.01 to 0.2]). Limitations: The study did not enroll patients with mild infections not requiring intensive care unit hospitalization, patients older than 80 years of age, or patients who were immunocompromised. Conclusion: in newly admitted critically ill patients, measurement of plasma levels of soluble TREM-1 could help to rapidly identify those with infection.	Hop Cent, Serv Reanimat Med, F-54035 Nancy, France; Fac Med Vandoeuvre Nancy, F-54505 Vandoeuvre Les Nancy, France	CHU de Nancy; Universite de Lorraine	Gibot, S (corresponding author), Hop Cent, Serv Reanimat Med, 29 Ave Marechal de Lattre de Tassigny, F-54035 Nancy, France.							ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; Birmingham MC, 1997, PHARMACOECONOMICS, V12, P637, DOI 10.2165/00019053-199712060-00004; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boucher BA, 1999, CRIT CARE MED, V27, P1390, DOI 10.1097/00003246-199907000-00041; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728; Cohen J, 2001, LANCET, V358, P776, DOI 10.1016/S0140-6736(01)06007-X; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Lapillonne A, 1998, LANCET, V351, P1211, DOI 10.1016/S0140-6736(05)79165-0; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reinhart K, 2001, ADV SEPSIS, V1, P42; Ruokonen E, 1999, EUR J CLIN MICROBIOL, V18, P283, DOI 10.1007/s100960050277; Ugarte H, 1999, CRIT CARE MED, V27, P498, DOI 10.1097/00003246-199903000-00024; Vincent JL, 2000, CRIT CARE MED, V28, P1226, DOI 10.1097/00003246-200004000-00057; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	25	271	329	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2004	141	1					9	15		10.7326/0003-4819-141-1-200407060-00009	http://dx.doi.org/10.7326/0003-4819-141-1-200407060-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834RF	15238365				2022-12-01	WOS:000222427600002
J	Romano, A; Gueant-Rodriguez, RM; Viola, M; Pettinato, R; Gueant, JL				Romano, A; Gueant-Rodriguez, RM; Viola, M; Pettinato, R; Gueant, JL			Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins	ANNALS OF INTERNAL MEDICINE			English	Article							BETA-LACTAM ANTIBIOTICS; ALLERGIC REACTIONS; SERUM IGE; SKIN; HISTORY; CEFTRIAXONE; AMOXICILLIN; EXPERIENCE; CHALLENGE; DIAGNOSIS	Background: In patients with documented IgE-mediated hypersensitivity to penicillins, data on sensitization to cephalosporins vary. Administering cephalosporins to such patients is often deferred because of the risk for cross-reactivity. Objective: To assess the cross-reactivity with cephalosporins and its potential determinants in patients with documented penicillin allergy. Design: Prospective study in patients without clinical indications for cephalosporin treatment. Setting: Italy. Patients: 128 consecutive patients who sustained anaphylactic shock (n = 81) or urticaria (n = 47) and had positive results on skin tests for at least 1 of the penicillin reagents tested. Measurements: All patients were skin tested with cephalothin, cefamandole, cefuroxime, ceftazidime, ceftriaxone, and cefotaxime. Patients with negative results for the last 4 cephalosporins were challenged with cefuroxime axetil and ceftriaxone. Results: 14 patients (10.9% [95% Cl, 6.1% 17.7%]) had positive results on skin tests for cephalosporins, mostly for cephalothin or cefamandole. Skin test results for the minor determinant mixture were positive in 10 of 14 patients (71.4%) with cross-reactivity and 44 of 114 patients (38.6%) without cross-reactivity (odds ratio, 3.90 [Cl, 1.17 to 13.40]; P = 0.0189). All 101 patients with negative results on skin tests for cefuroxime, ceftazidime, ceftriaxone, and cefotaxime tolerated cefuroxime axetil and ceftriaxone (tolerability rate, 100% [Cl, 96.4% to 100%]). Limitations: Challenges were not followed by full therapeutic courses. Twenty-two patients declined challenges; positive responses in those patients would have decreased the tolerability rate to 82.1% (Cl, 74.2% to 88.4%). Conclusions: These data confirm the advisability of avoiding cephalosporin treatment in patients with positive results on skin tests for penicillin. In patients who especially require cephalosporin treatment, we recommend skin tests with cephalosporins before assessing the tolerability of the cephalosporin with a graded challenge.	Univ Cattolica Sacro Cuore, Unita Allergol, I-00168 Rome, Italy; Ist Ricovero & Cura Carattere Sci, Troina, Italy; INSERM, Lab Pathol Cellulaire & Mol Nutr, F-54511 Vandoeuvre Les Nancy, France; CHU Nancy Brabois, Vandoeuvre Les Nancy, France	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy	Romano, A (corresponding author), Univ Cattolica Sacro Cuore, Unita Allergol, Complesso Integrato Columbus,Via G Moscati,31, I-00168 Rome, Italy.	columbus.romano@linet.it	Pettinato, Rosa/D-3358-2017; Romano, Antonino/D-3102-2017	Pettinato, Rosa/0000-0002-2120-3152; Romano, Antonino/0000-0001-9742-9898				ADKINSON NF, 1971, NEW ENGL J MED, V285, P22, DOI 10.1056/NEJM197107012850104; ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167; ASSEM ESK, 1974, IMMUNOLOGY, V27, P255; AUDICANA M, 1994, ALLERGY, V49, P108, DOI 10.1111/j.1398-9995.1994.tb00809.x; Baldo BA, 1999, CLIN EXP ALLERGY, V29, P744; Bernstein IL, 1999, ANN ALLERG ASTHMA IM, V83, pVIII; BLANCA M, 1989, J ALLERGY CLIN IMMUN, V83, P381, DOI 10.1016/0091-6749(89)90122-X; BLANCA M, 1994, CLIN EXP ALLERGY, V24, P407, DOI 10.1111/j.1365-2222.1994.tb00928.x; Blanca M, 2002, CLIN EXP ALLERGY, V32, P192, DOI 10.1046/j.1365-2222.2002.01299.x; BRAVO CM, 1995, ALLERGY, V50, P359, DOI 10.1111/j.1398-9995.1995.tb01160.x; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Demoly P, 2000, ALLERGY, V55, P418, DOI 10.1034/j.1398-9995.2000.00605.x; Gaig P, 1999, ALLERGY, V54, P901, DOI 10.1034/j.1398-9995.1999.00261.x; Gilbert D, 2003, SANFORD GUIDE ANTIMI; GRIECO MH, 1967, ARCH INTERN MED, V119, P141, DOI 10.1001/archinte.119.2.141; Gruchalla Rebecca S., 2003, Journal of Allergy and Clinical Immunology, V111, pS548; GUEANT JL, 1995, MOL IMMUNOL, V32, P259, DOI 10.1016/0161-5890(94)00152-Q; Harris AD, 1999, AM J MED, V107, P166, DOI 10.1016/S0002-9343(99)00190-4; Kelkar PS, 2001, NEW ENGL J MED, V345, P804, DOI 10.1056/NEJMra993637; KISHIYAMA JL, 1994, DRUG SAFETY, V10, P318, DOI 10.2165/00002018-199410040-00006; LEVINE BB, 1966, NEW ENGL J MED, V275, P1115, DOI 10.1056/NEJM196611172752009; Li JTC, 2000, MAYO CLIN PROC, V75, P902, DOI 10.4065/75.9.902; Macy E, 1998, J ALLERGY CLIN IMMUN, V102, P281, DOI 10.1016/S0091-6749(98)70097-1; Macy E, 2003, J ALLERGY CLIN IMMUN, V111, P1111, DOI 10.1067/mai.2003.1385; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; Mendelson LM, 1998, IMMUNOL ALLERGY CLIN, V18, P745, DOI 10.1016/S0889-8561(05)70036-9; Novalbos A, 2001, CLIN EXP ALLERGY, V31, P438, DOI 10.1046/j.1365-2222.2001.00992.x; ONG R, 1988, J ALLERGY CLIN IMMUN, V81, P222, DOI 10.1016/0091-6749(88)90452-6; Pichichero ME, 1998, J PEDIATR-US, V132, P137, DOI 10.1016/S0022-3476(98)70499-8; Puchner TC, 2002, ANN ALLERG ASTHMA IM, V88, P24, DOI 10.1016/S1081-1206(10)63589-2; Pumphrey RSH, 1999, LANCET, V353, P1157, DOI 10.1016/S0140-6736(99)00449-3; Romano A, 1999, J ALLERGY CLIN IMMUN, V104, P1113, DOI 10.1016/S0091-6749(99)70100-4; Romano A, 2000, J ALLERGY CLIN IMMUN, V106, P1177; ROMANO A, 1995, INT J IMMUNOPATHO S2, V10, P187; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SHEPHERD GM, 1993, J ALLERGY CLIN IMMUN, V91, P262; SHEPHERD GM, 1991, IMMUNOL ALLERGY CLIN, V11, P611; Solensky R, 2000, ANN ALLERG ASTHMA IM, V84, P329, DOI 10.1016/S1081-1206(10)62782-2; SOLLEY GO, 1982, J ALLERGY CLIN IMMUN, V69, P238, DOI 10.1016/0091-6749(82)90105-1; Strom BL, 2003, NEW ENGL J MED, V349, P1628, DOI 10.1056/NEJMoa022963; Torres MJ, 2002, CLIN EXP ALLERGY, V32, P270, DOI 10.1046/j.1365-2222.2002.01296.x; Torres MJ, 2001, ALLERGY, V56, P850, DOI 10.1034/j.1398-9995.2001.00089.x; WARRINGTON RJ, 1978, CAN MED ASSOC J, V118, P787; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; WICKERN GM, 1994, J ALLERGY CLIN IMMUN, V94, P725, DOI 10.1016/0091-6749(94)90180-5; Zar JH., 1999, BIOSTAT ANAL	47	157	164	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2004	141	1					16	22		10.7326/0003-4819-141-1-200407060-00010	http://dx.doi.org/10.7326/0003-4819-141-1-200407060-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834RF	15238366				2022-12-01	WOS:000222427600003
J	Maviel, T; Durkin, TP; Menzaghi, F; Bontempi, B				Maviel, T; Durkin, TP; Menzaghi, F; Bontempi, B			Sites of neocortical reorganization critical for remote spatial memory	SCIENCE			English	Article							LONG-TERM-MEMORY; TIME-DEPENDENT REORGANIZATION; ANTERIOR CINGULATE CORTEX; CONNECTIONIST MODELS; FEAR MEMORY; CONSOLIDATION; HIPPOCAMPUS; PLASTICITY; MICE; DISSOCIATION	The hippocampus is crucial for spatial memory formation, yet it does not store long-lasting memories. By combining functional brain imaging and region-specific neuronal inactivation in mice, we identified prefrontal and anterior cingulate cortex as critical for storage and retrieval of remote spatial memories. Imaging of activity-dependent genes also revealed an involvement of parietal and retrosplenial cortices during consolidation of remote memory. Long-term memory storage within some of these neocortical regions was accompanied by structural changes including synaptogenesis and laminar reorganization, concomitant with a functional disengagement of the hippocampus and posterior cingulate cortices. Thus, consolidation of spatial memory requires a time-dependent hippocampal-cortical dialogue, ultimately enabling widespread cortical networks to mediate effortful recall and use of cortically stored remote memories independently.	Univ Bordeaux 1, CNRS, UMR 5106, Lab Neurosci Cognit, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Bontempi, B (corresponding author), Univ Bordeaux 1, CNRS, UMR 5106, Lab Neurosci Cognit, Ave Fac, F-33405 Talence, France.	b.bontempi@lnc.u-bordeaux1.fr						Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Durkin TP, 2000, BEHAV BRAIN RES, V116, P39, DOI 10.1016/S0166-4328(00)00248-5; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KESNER RP, 1989, BEHAV NEUROSCI, V103, P956, DOI 10.1037/0735-7044.103.5.956; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller R, 1996, BIOL CYBERN, V75, P253, DOI 10.1007/s004220050292; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Murre JMJ, 2001, BRAIN, V124, P647, DOI 10.1093/brain/124.4.647; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Save E, 2000, HIPPOCAMPUS, V10, P491, DOI 10.1002/1098-1063(2000)10:4<491::AID-HIPO16>3.3.CO;2-S; SIF J, 1989, NEUROSCI LETT, V101, P223, DOI 10.1016/0304-3940(89)90535-1; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takahashi N, 1997, NEUROLOGY, V49, P464, DOI 10.1212/WNL.49.2.464; Takehara K, 2003, J NEUROSCI, V23, P9897; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	29	475	483	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					96	99		10.1126/science.1098180	http://dx.doi.org/10.1126/science.1098180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232109				2022-12-01	WOS:000222386000044
J	Zakany, J; Kmita, M; Duboule, D				Zakany, J; Kmita, M; Duboule, D			A dual role for Hox genes in limb anterior-posterior asymmetry	SCIENCE			English	Article							SONIC-HEDGEHOG; POLARIZING ACTIVITY; VERTEBRATE LIMB; SHORT-RANGE; EXPRESSION; BUD; GLI3; ESTABLISHMENT; REGION; TRANSCRIPTION	Anterior-to-posterior patterning, the process whereby our digits are differently shaped, is a key aspect of limb development. It depends on the localized expression in posterior limb bud of Sonic hedgehog (Shh) and the morphogenetic potential of its diffusing product. By using an inversion of and a large deficiency in the mouse HoxD cluster, we found that a perturbation in the early collinear expression of Hoxd11, Hoxd12, and Hoxd13 in limb buds led to a loss of asymmetry. Ectopic Hox gene expression triggered abnormal Shh transcription, which in turn induced symmetrical expression of Hox genes in digits, thereby generating double posterior limbs. We conclude that early posterior restriction of Hox gene products sets up an anterior-posterior prepattern, which determines the localized activation of Shh. This signal is subsequently translated into digit morphological asymmetry by promoting the late expression of Hoxd genes, two collinear processes relying on opposite genomic topographies, upstream and downstream Shh signaling.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Program Frontiers Genet, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	Denis.Duboule@zoo.unige.ch		duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478				Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Charite J, 2000, DEVELOPMENT, V127, P2461; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Grieshammer U, 1996, DEVELOPMENT, V122, P3851; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mackem S, 1999, CELL TISSUE RES, V296, P27, DOI 10.1007/s004410051263; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Sharpe J, 1999, CURR BIOL, V9, P97, DOI 10.1016/S0960-9822(99)80022-0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tickle C, 2002, INT J DEV BIOL, V46, P847; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zuniga A, 1999, DEVELOPMENT, V126, P13	32	223	228	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1669	1672		10.1126/science.1096049	http://dx.doi.org/10.1126/science.1096049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192229				2022-12-01	WOS:000221934300050
J	Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C				Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C			Surficial deposits at Gusev crater along Spirit Rover traverses	SCIENCE			English	Article							SIZE-FREQUENCY DISTRIBUTIONS; MAADIM-VALLIS; LANDING SITES; MARS; ROCKS; EROSION	The Mars Exploration Rover Spirit has traversed a fairly flat, rock-strewn terrain whose surface is shaped primarily by impact events, although some of the landscape has been altered by eolian processes. Impacts ejected basaltic rocks that probably were part of locally formed lava flows from at least 10 meters depth. Some rocks have been textured and/or partially buried by windblown sediments less than 2 millimeters in diameter that concentrate within shallow, partially filled, circular impact depressions referred to as hollows. The terrain traversed during the 90-sol (martian solar day) nominal mission shows no evidence for an ancient lake in Gusev crater.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, SETI Inst, Div Space Sci, Moffett Field, CA 94035 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR, Inst Space Simulat, D-51170 Cologne, Germany; NASA Headquarters, Washington, DC 20560 USA	Smithsonian Institution; Washington University (WUSTL); Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Grant, JA (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	grantj@nasm.si.edu	Farmer, Jack D/B-9343-2019; Moersch, Jeffrey E/F-7189-2010	Moersch, Jeffrey E/0000-0003-3433-9419				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Folk R.L., 1980, PETROLOGY SEDIMENTAR; Golombek M, 1997, J GEOPHYS RES-PLANET, V102, P4117, DOI 10.1029/96JE03319; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI; Grant JA, 2004, PLANET SPACE SCI, V52, P11, DOI 10.1016/j.pss.2003.08.011; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P15033, DOI 10.1029/93JE01580; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; Hartmann WK, 2001, ICARUS, V149, P37, DOI 10.1006/icar.2000.6532; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HURST M, 2004, LUNAR PLANET SCI; Irwin RP, 2002, SCIENCE, V296, P2209, DOI 10.1126/science.1071143; IRWIN RP, 2004, LUNAR PLANET SCI; Komatsu G, 1997, J GEOPHYS RES-PLANET, V102, P4151, DOI 10.1029/96JE02564; Leeder M.R, 1982, SEDIMENTOLOGY PROCES; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; RICE JW, 2003, LUNAR PLANET SCI; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	30	66	66	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					807	810		10.1126/science.1099849	http://dx.doi.org/10.1126/science.1099849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297659				2022-12-01	WOS:000223104900033
J	Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E				Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E			PI3K gamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects	CELL			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; HEART-FAILURE; TRANSGENIC MICE; HYPERTROPHY; RECEPTOR; PROTEIN; ACTIVATION; PATHWAY; PHOSPHORYLATION	The G protein-coupled, receptor-activated phosphoinositide 3-kinase gamma (PI3Kgamma) mediates inflammatory responses and negatively controls cardiac contractility by reducing cAMP concentration. Here, we report that mice carrying a targeted mutation in the PI3Kgamma gene causing loss of kinase activity (PI3K-gamma(KD/KD)) display reduced inflammatory reactions but no alterations in cardiac contractility. We show that, in PI3K-gamma(KD/KD) hearts, cAMP levels are normal and that PI3Kgamma-deficient mice but not PI3Kgamma(KD/KD) mice develop dramatic myocardial damage after chronic pressure overload induced by transverse aortic constriction (TAC). Finally, our data indicate that PI3Kgamma is an essential component of a complex controlling PDE3B phosphodiesterase-mediated cAMP destruction. Thus, cardiac PI3Kgamma participates in two distinct signaling pathways: a kinase-dependent activity that controls PKB/Akt as well as MAPK phosphorylation and contributes to TAC-induced cardiac remodeling, and a kinase-independent activity that relies on protein interactions to regulate PDE3B activity and negatively modulates cardiac contractility.	San Giovanni Battista Hosp, Dept Genet Biol & Biochem, I-10126 Turin, Italy; San Giovanni Battista Hosp, Expt Med Res Ctr, I-10126 Turin, Italy; Neuromed Inst, Dept Neurocardiol, I-86077 Pozzilli, Isernia, Italy; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Hosp Jena, Res Unit Mol Cell Biol, D-07747 Jena, Germany; Univ Basel, Dept Clin & Biol Sci, CH-4301 Basel, Switzerland; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Neuromed; University of Washington; University of Washington Seattle; Friedrich Schiller University of Jena; University of Basel; Sapienza University Rome	Lembo, G (corresponding author), San Giovanni Battista Hosp, Dept Genet Biol & Biochem, Via Santena 5Bis, I-10126 Turin, Italy.	lernbo@neuromed.it; hirsch@unito.it	Selvetella, Giulio/J-4342-2012; Wymann, Matthias P/C-3227-2008; Lembo, Giuseppe/AAE-8096-2020; Wetzker, Reinhard/AAD-8713-2019; maffei, angelo/AAC-2219-2020; Hirsch, Emilio/F-4848-2013	Wymann, Matthias P/0000-0003-3349-4281; Lembo, Giuseppe/0000-0002-3510-223X; Hirsch, Emilio/0000-0002-9073-6024; Patrucco, Enrico/0000-0001-8060-5058; maffei, angelo/0000-0002-7491-0344	NIDDK NIH HHS [DK 21723] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alloatti G, 2003, CARDIOVASC RES, V60, P242, DOI 10.1016/j.cardiores.2003.08.008; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MOVSESIAN MA, 2002, BASIC RES CARDIOL S1, V97, P183; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Rapacciuolo A, 2001, J AM COLL CARDIOL, V38, P876, DOI 10.1016/S0735-1097(01)01433-4; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P590; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	36	378	407	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					375	387		10.1016/j.cell.2004.07.017	http://dx.doi.org/10.1016/j.cell.2004.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294162	Bronze			2022-12-01	WOS:000223353100013
J	Takeuchi, Y; Yoshizaki, G; Takeuchi, T				Takeuchi, Y; Yoshizaki, G; Takeuchi, T			Surrogate broodstock produces salmonids	NATURE			English	Editorial Material							PRIMORDIAL GERM-CELLS		Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo University of Marine Science & Technology; Japan Science & Technology Agency (JST)	Takeuchi, Y (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan.	goro@s.kaiyodai.ac.jp	Wei, Qiwei/B-6928-2014; YOSHIZAKI, Goro/O-1937-2014	Wei, Qiwei/0000-0002-6366-1020; Takeuchi, Yutaka/0000-0001-5450-4632				Bella DA, 2002, SCIENCE, V295, P1236; Kobayashi T, 2003, FISH PHYSIOL BIOCHEM, V28, P479, DOI 10.1023/B:FISH.0000030634.37486.fa; LAWRENCE PA, 1993, GENETICS, V134, P1145; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; Ono T, 1996, EXP ANIM TOKYO, V45, P347, DOI 10.1538/expanim.45.347; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7	8	130	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					629	630		10.1038/430629a	http://dx.doi.org/10.1038/430629a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295587				2022-12-01	WOS:000223085400032
J	Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O				Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O			Structural basis for template-independent RNA polymerization	NATURE			English	Article							CCA-ADDING ENZYME; DNA-POLYMERASE-BETA; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; NUCLEOTIDYLTRANSFERASE; COMPLEXES; SUBSTRATE; INSIGHTS; PRIMER; ATP	The 3'-terminal CCA nucleotide sequence ( positions 74 - 76) of transfer RNA is essential for amino acid attachment(1) and interaction with the ribosome(2-4) during protein synthesis. The CCA sequence is synthesized de novo and/or repaired by a template-independent RNA polymerase, 'CCA-adding enzyme', using CTP and ATP as substrates(5). Despite structural and biochemical studies(5-8), the mechanism by which the CCA-adding enzyme synthesizes the defined sequence without a nucleic acid template remains elusive. Here we present the crystal structure of Aquifex aeolicus CCA-adding enzyme, bound to a primer tRNA lacking the terminal adenosine and an incoming ATP analogue, at 2.8 Angstrom resolution. The enzyme enfolds the acceptor T helix of the tRNA molecule. In the catalytic pocket, C75 is adjacent to ATP, and their base moieties are stacked. The complementary pocket for recognizing C74-C75 of tRNA forms a 'protein template' for the penultimate two nucleotides, mimicking the nucleotide template used by template-dependent polymerases. These results are supported by systematic analyses of mutants. Our structure represents the 'pre-insertion' stage of selecting the incoming nucleotide and provides the structural basis for the mechanism underlying template-independent RNA polymerization.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058666, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; SPring 8, RIKEN Harima Inst, Cellular Signaling Lab, Mikazuki, Hyogo 6795148, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	onureki@bio.titech.ac.jp	Ueda, Takuya/K-5217-2014; Vassylyev, Dmitry/A-9005-2008; Tomita, Kozo/J-5746-2013; Fukai, Shuya/X-4838-2018; Tomita, Kozo/E-9390-2017	Ueda, Takuya/0000-0002-7760-8271; Fukai, Shuya/0000-0002-1241-1443; Tomita, Kozo/0000-0002-7374-3898				Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HEGG LA, 1990, NUCLEIC ACIDS RES, V18, P5975, DOI 10.1093/nar/18.20.5975; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomita K, 2002, J BIOL CHEM, V277, P48192, DOI 10.1074/jbc.M207527200; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	30	82	85	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					700	704		10.1038/nature02712	http://dx.doi.org/10.1038/nature02712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295603				2022-12-01	WOS:000223085400051
J	Grace, RJ				Grace, RJ			Klinefelter's syndrome: a late diagnosis	LANCET			English	Editorial Material												editorial@lancet.com							0	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2004	364	9430					284	284		10.1016/S0140-6736(04)16679-8	http://dx.doi.org/10.1016/S0140-6736(04)16679-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15262107				2022-12-01	WOS:000222784900032
J	Gougoux, F; Lepore, F; Lassonde, M; Voss, P; Zatorre, RJ; Belin, P				Gougoux, F; Lepore, F; Lassonde, M; Voss, P; Zatorre, RJ; Belin, P			Pitch discrimination in the early blind	NATURE			English	Editorial Material							SIGHTED SUBJECTS		Univ Montreal, Ctr Rech Neuropsychol & Cognit, Dept Psychol, Montreal, PQ H3C 3J7, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; McGill University	Gougoux, F (corresponding author), Univ Montreal, Ctr Rech Neuropsychol & Cognit, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	pascal.belin@umontreal.ca	voss, patrice/I-7026-2019; Belin, Pascal/C-6247-2009	voss, patrice/0000-0001-8698-7130; Belin, Pascal/0000-0002-7578-6365				Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Juurmaa J., 1967, AM FDN BLIND RES B, V14, P109; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; MUCHNIK C, 1991, SCAND AUDIOL, V20, P19, DOI 10.3109/01050399109070785; PITMAN DJ, 1965, AM FDN BLIND RES B, V11, P63; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; SAKURABAYASHI IL, 1956, J PSYCHOL BLIND, V1, P3; Stankov L., 1978, APPLIED PSYCHOL MEAS, V2, P491, DOI 10.1177/014662167800200403; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	9	268	272	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					309	309		10.1038/430309a	http://dx.doi.org/10.1038/430309a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254527	Bronze			2022-12-01	WOS:000222631200027
J	Ito, T; Wellmer, F; Yu, H; Das, P; Ito, N; Alves-Ferreira, M; Riechmann, JL; Meyerowitz, EM				Ito, T; Wellmer, F; Yu, H; Das, P; Ito, N; Alves-Ferreira, M; Riechmann, JL; Meyerowitz, EM			The homeotic protein AGAMOUS controls microsporogenesis by regulation of SPOROCYTELESS	NATURE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; OVULE DEVELOPMENT; PATTERN-FORMATION; EXPRESSION; TRANSCRIPTION; SPOROGENESIS; VERSATILE	The Arabidopsis homeotic gene AGAMOUS (AG) is necessary for the specification of reproductive organs ( stamens and carpels) during the early steps of flower development(1-3). AG encodes a transcription factor of the MADS-box family that is expressed in stamen and carpel primordia. At later stages of development, AG is expressed in distinct regions of the reproductive organs(2-5). This suggests that AG might function during the maturation of stamens and carpels, as well as in their early development. However, the developmental processes that AG might control during organogenesis and the genes that are regulated by this factor are largely unknown. Here we show that microsporogenesis, the process leading to pollen formation, is induced by AG through activation of the SPOROCYTELESS gene (SPL, also known as NOZZLE, NZZ), a regulator of sporogenesis(6,7). Furthermore, we demonstrate that SPL can induce microsporogenesis in the absence of AG function, suggesting that AG controls a specific process during organogenesis by activating another regulator that performs a subset of its functions.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; Univ Fed Rio de Janeiro, Dept Genet, BR-21941590 Rio De Janeiro, Brazil	California Institute of Technology; National University of Singapore; Universidade Federal do Rio de Janeiro	Meyerowitz, EM (corresponding author), CALTECH, Div Biol 156 29, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	meyerow@its.caltech.edu	Meyerowitz, Elliot M/A-7118-2009; Riechmann, José Luis/M-7005-2018; Alves-Ferreira, Marcio/C-5849-2009; Yu, Hao/A-3867-2010	Riechmann, José Luis/0000-0003-1108-1945; Alves-Ferreira, Marcio/0000-0002-6107-3700; Yu, Hao/0000-0002-9778-8855; Ito, Toshiro/0000-0002-8206-2787; Wellmer, Frank/0000-0002-2095-0981				Balasubramanian S, 2002, DEVELOPMENT, V129, P4291; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HUANG H, 1993, NUCLEIC ACIDS RES, V21, P4769, DOI 10.1093/nar/21.20.4769; Ito T, 2003, CURR BIOL, V13, P1524, DOI 10.1016/S0960-9822(03)00612-2; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Long JA, 1998, DEVELOPMENT, V125, P3027; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; SHIRAISHI H, 1993, PLANT J, V4, P385, DOI 10.1046/j.1365-313X.1993.04020385.x; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Wagner D, 2004, PLANT J, V39, P273, DOI 10.1111/j.1365-313X.2004.02127.x; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	30	227	255	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					356	360		10.1038/nature02733	http://dx.doi.org/10.1038/nature02733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254538				2022-12-01	WOS:000222631200042
J	Liao, EH; Hung, W; Abrams, B; Zhen, M				Liao, EH; Hung, W; Abrams, B; Zhen, M			An SCF-like ubiquitin ligase complex that controls presynaptic differentiation	NATURE			English	Article							RECEPTOR TYROSINE KINASE; C-ELEGANS; SYNAPTIC GROWTH; CAENORHABDITIS-ELEGANS; PROTEIN; DROSOPHILA; ALK; SYNAPTOGENESIS; DEGRADATION; GENE	During synapse formation, specialized subcellular structures develop at synaptic junctions in a tightly regulated fashion. Cross-signalling initiated by ephrins, Wnts and transforming growth factor-beta family members between presynaptic and postsynaptic termini are proposed to govern synapse formation(1-3). It is not well understood how multiple signals are integrated and regulated by developing synaptic termini to control synaptic differentiation. Here we report the identification of FSN-1, a novel F-box protein that is required in presynaptic neurons for the restriction and/or maturation of synapses in Caenorhabditis elegans. Many F-box proteins are target recognition subunits of SCF (Skp, Cullin, F-box) ubiquitin-ligase complexes(4-7). fsn-1 functions in the same pathway as rpm-1, a gene encoding a large protein with RING finger domains(8,9). FSN-1 physically associates with RPM-1 and the C. elegans homologues of SKP1 and Cullin to form a new type of SCF complex at presynaptic periactive zones. We provide evidence that T10H9.2, which encodes the C. elegans receptor tyrosine kinase ALK ( anaplastic lymphoma kinase(10)), may be a target or a downstream effector through which FSN-1 stabilizes synapse formation. This neuron-specific, SCF-like complex therefore provides a localized signal to attenuate presynaptic differentiation.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California Santa Cruz	Zhen, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	zhen@mshri.on.ca	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Liao, Edward/0000-0002-4955-6881; Abrams, Benjamin/0000-0002-8164-2675				Broadie KS, 2002, CURR OPIN NEUROBIOL, V12, P491, DOI 10.1016/S0959-4388(02)00359-8; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jin YS, 2002, CURR OPIN NEUROBIOL, V12, P71, DOI 10.1016/S0959-4388(02)00292-1; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Nayak S, 2002, CURR BIOL, V12, P277, DOI 10.1016/S0960-9822(02)00682-6; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Sone M, 2000, DEVELOPMENT, V127, P4157; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	30	172	190	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2004	430	6997					345	350		10.1038/nature02647	http://dx.doi.org/10.1038/nature02647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15208641				2022-12-01	WOS:000222631200040
J	Seo, BM; Miura, M; Gronthos, S; Bartold, PM; Batouli, S; Brahim, J; Young, M; Robey, PG; Wang, CY; Shi, ST				Seo, BM; Miura, M; Gronthos, S; Bartold, PM; Batouli, S; Brahim, J; Young, M; Robey, PG; Wang, CY; Shi, ST			Investigation of multipotent postnatal stem cells from human periodontal ligament	LANCET			English	Article							ENAMEL MATRIX PROTEINS; IN-VITRO; DENTAL-PULP; ATTACHMENT PROTEIN; REGENERATION; BONE; CEMENTUM; VIVO; FIBROBLASTS; TISSUE	Background Periodontal diseases that lead to the destruction of periodontal tissues-including periodontal ligament (PDL), cementum, and bone-are a major cause of tooth loss in adults and are a substantial public-health burden worldwide. PDL is a specialised connective tissue that connects cementum and alveolar bone to maintain and support teeth in situ and preserve tissue homoeostasis. We investigated the notion that human PDL contains stem cells that could be used to regenerate periodontal tissue. 19 Methods PDL tissue was obtained from 25 surgically extracted human third molars and used to isolate PDL stem cells (PDLSCs) by single-colony selection and magnetic activated cell sorting. Immunohistochemical staining, RT-PCR, and northern and western blot analyses were used to identify putative stem-cell markers. Human PDLSCs were transplanted into immunocompromised mice (n=12) and rats (n=6) to assess capacity for tissue regeneration and periodontal repair. Findings PDLSCs expressed the mesenchymal stem-cell markers STRO-1 and CD146/MUC18. Under defined culture conditions, PDLSCs differentiated into cementoblast-like cells, adipocytes, and collagen-forming cells. When transplanted into immunocompromised rodents, PDLSCs showed the capacity to generate a cementum/PDL-like structure and contribute to periodontal tissue repair. Interpretation Our findings suggest that PDL contains stem cells that have the potential to generate cementum/PDL-like tissue in vivo. Transplantation of these cells, which can be obtained from an easily accessible tissue resource and expanded ex vivo, might hold promise as a therapeutic approach for reconstruction of tissues destroyed by periodontal diseases.	Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, US Dept HHS, Bethesda, MD 20892 USA; Univ Adelaide, Mesenchymal Stem Cell Grp, Div Haematol, Inst Med & Vet Sci, Adelaide, SA 5005, Australia; Univ Adelaide, Sch Dent, Adelaide, SA 5005, Australia; Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Ann Arbor, MI 48109 USA; Univ Michigan, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Seoul Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seoul National University (SNU)	Shi, ST (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, US Dept HHS, Bldg 30,Room 222,30 Convent Dr MSC-4320, Bethesda, MD 20892 USA.	sshi@dir.nidcr.nih.gov	Bartold, Mark/H-8122-2019; Robey, Pamela Gehron/H-1429-2011; Gronthos, Stan/Y-4419-2019	Robey, Pamela Gehron/0000-0002-5316-5576; Gronthos, Stan/0000-0002-6225-3084; Seo, Byoung-Moo/0000-0002-3798-1987; Bartold, Peter/0000-0002-5695-3877; Young, Marian F/0000-0003-0929-8854	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380, ZIADE000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000705, Z01DE000379, Z01DE000380] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; BOYKO GA, 1981, J PERIODONTAL RES, V16, P73, DOI 10.1111/j.1600-0765.1981.tb00951.x; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Cochran DL, 1999, PERIODONTOL 2000, V19, P40, DOI 10.1111/j.1600-0757.1999.tb00146.x; Cochran DL, 2003, J PERIODONTOL, V74, P1043, DOI 10.1902/jop.2003.74.7.1043; Cochran DL, 2003, J PERIODONTOL, V74, P1269, DOI 10.1902/jop.2003.74.9.1269; Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22; Elter JR, 2003, J DENT RES, V82, P998, DOI 10.1177/154405910308201212; GOULD TRL, 1977, ANAT REC, V188, P133, DOI 10.1002/ar.1091880202; GOULD TRL, 1980, J PERIODONTAL RES, V15, P20, DOI 10.1111/j.1600-0765.1980.tb00258.x; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Grzesik WJ, 1998, J BONE MINER RES, V13, P1547, DOI 10.1359/jbmr.1998.13.10.1547; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605; Han X, 2003, J DENT RES, V82, P454, DOI 10.1177/154405910308200610; Handa K, 2002, CONNECT TISSUE RES, V43, P406, DOI 10.1080/03008200290001023; Isaka J, 2001, J PERIODONTOL, V72, P314, DOI 10.1902/jop.2001.72.3.314; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Lekic P, 2001, J PERIODONTAL RES, V36, P71, DOI 10.1034/j.1600-0765.2001.360202.x; Liu HW, 1997, J BONE MINER RES, V12, P1691, DOI 10.1359/jbmr.1997.12.10.1691; MacNeil RL, 1999, PERIODONTOL 2000, V19, P8, DOI 10.1111/j.1600-0757.1999.tb00144.x; Marcopoulou C E, 2003, J Int Acad Periodontol, V5, P63; MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x; MCCULLOCH CAG, 1985, ANAT REC, V211, P258, DOI 10.1002/ar.1092110305; MCCULLOCH CAG, 1983, AM J ANAT, V167, P43, DOI 10.1002/aja.1001670105; MELCHER A H, 1970, Archives of Oral Biology, V15, P1183, DOI 10.1016/0003-9969(70)90010-5; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282; Ohno S, 2002, J DENT RES, V81, P822, DOI 10.1177/154405910208101205; Ouyang HJ, 2000, ARCH ORAL BIOL, V45, P293, DOI 10.1016/S0003-9969(99)00142-9; Pitaru S, 2002, CONNECT TISSUE RES, V43, P257, DOI 10.1080/03008200290001276; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; Zhao M, 2003, J DENT RES, V82, P23, DOI 10.1177/154405910308200106; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441	37	2255	2492	21	333	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2004	364	9429					149	155		10.1016/S0140-6736(04)16627-0	http://dx.doi.org/10.1016/S0140-6736(04)16627-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246727				2022-12-01	WOS:000222612200025
J	Mnaimneh, S; Davierwala, AP; Haynes, J; Moffat, J; Peng, WT; Zhang, W; Yang, XQ; Pootoolal, J; Chua, G; Lopez, A; Trochesset, M; Morse, D; Krogan, NJ; Hiley, SL; Li, ZJ; Morris, Q; Grigull, J; Mitsakakis, N; Roberts, CJ; Greenblatt, JF; Boone, C; Kaiser, CA; Andrews, BJ; Hughes, TR				Mnaimneh, S; Davierwala, AP; Haynes, J; Moffat, J; Peng, WT; Zhang, W; Yang, XQ; Pootoolal, J; Chua, G; Lopez, A; Trochesset, M; Morse, D; Krogan, NJ; Hiley, SL; Li, ZJ; Morris, Q; Grigull, J; Mitsakakis, N; Roberts, CJ; Greenblatt, JF; Boone, C; Kaiser, CA; Andrews, BJ; Hughes, TR			Exploration of essential gene functions via titratable promoter alleles	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SYSTEMATIC IDENTIFICATION; GLOBAL ANALYSIS; TRANSFER-RNA; YEAST; EXPRESSION; PROTEINS; PATHWAYS; CYCLE; GOLGI	Nearly 20% of yeast genes are required for viability, hindering genetic analysis with knockouts. We created promoter-shutoff strains for over two-thirds of all essential yeast genes and subjected them to morphological analysis, size profiling, drug sensitivity screening, and microarray expression profiling. We then used this compendium of data to ask which phenotypic features characterized different functional classes and used these to infer potential functions for uncharacterized genes. We identified genes involved in ribosome biogenesis (HAS1, URB1, and URB2), protein secretion (SEC39), mitochondrial import (MIM1), and tRNA charging (GSN1). In addition, apparent negative feedback transcriptional regulation of both ribosome biogenesis and the proteasome was observed. We furthermore show that these strains are compatible with automated genetic analysis. This study underscores the importance of analyzing mutant phenotypes and provides a resource to complement the yeast knockout collection.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT)	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	t.hughes@utoronto.ca	Moffat, Jason/AAC-1110-2020; Haynes, Jennifer/P-8565-2019; Morris, Quaid/ABE-8343-2020	Moffat, Jason/0000-0002-5663-8586; Morris, Quaid/0000-0002-2760-6999				Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BARNES G, 1984, MOL CELL BIOL, V4, P2381, DOI 10.1128/MCB.4.11.2381; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Bishop CM, 1995, NEURAL NETWORKS PATT; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chun KT, 1997, MOL GEN GENET, V256, P365, DOI 10.1007/s004380050580; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Davis S., 2000, J SEX EDUC THER, V25, P25, DOI DOI 10.1007/S10508-012-9946-2; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P7920; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gasch AP, 2002, GENOME BIOL, V3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLAEVER G, 1999, NAT GENET, V21, P278; GLAEVER G, 2004, P NATL ACAD SCI USA, V101, P793; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kressler D, 1999, MOL CELL BIOL, V19, P8633; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SACHS L, 1982, APPL STAT; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xing F, 2004, J BIOL CHEM, V279, P17850, DOI 10.1074/jbc.M401221200; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	62	443	486	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2004	118	1					31	44		10.1016/j.cell.2004.06.013	http://dx.doi.org/10.1016/j.cell.2004.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242642	Bronze			2022-12-01	WOS:000222626800006
J	Meinhart, A; Cramer, P				Meinhart, A; Cramer, P			Recognition of RNA polymerase II carboxy-terminal domain by 3 '-RNA-processing factors	NATURE			English	Article							STRUCTURAL BASIS; PROCESSING FACTORS; DIFFRACTION DATA; LARGEST SUBUNIT; TRANSCRIPTION; CTD; PHOSPHORYLATION; INTERACTS; PROTEINS; SIGNAL	During transcription, RNA polymerase (Pol) II synthesizes eukaryotic messenger RNA. Transcription is coupled to RNA processing by the carboxy-terminal domain (CTD) of Pol II, which consists of up to 52 repeats of the sequence Tyr1-Ser 2-Pro 3-Thr 4-Ser 5-Pro 6-Ser 7 (refs 1, 2). After phosphorylation, the CTD binds tightly to a conserved CTD-interacting domain ( CID) present in the proteins Pcf11 and Nrd1, which are essential and evolutionarily conserved factors for polyadenylation-dependent and -independent 3'-RNA processing, respectively. Here we describe the structure of a Ser 2-phosphorylated CTD peptide bound to the CID domain of Pcf11. The CTD motif Ser 2-Pro 3-Thr 4-Ser 5 forms a beta-turn that binds to a conserved groove in the CID domain. The Ser 2 phosphate group does not make direct contact with the CID domain, but may be recognized indirectly because it stabilizes the beta-turn with an additional hydrogen bond. Iteration of the peptide structure results in a compact beta-spiral model of the CTD. The model suggests that, during the mRNA transcription-processing cycle, compact spiral regions in the CTD are unravelled and regenerated in a phosphorylation-dependent manner.	Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich	Cramer, P (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de	Meinhart, Anton/M-9647-2014					Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CAGAS PM, 1995, PROTEINS, V21, P149, DOI 10.1002/prot.340210209; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Hirose Y, 2000, GENE DEV, V14, P1415; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kumaki Y, 2001, BBA-PROTEIN STRUCT M, V1548, P81, DOI 10.1016/S0167-4838(01)00216-3; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Meredith GD, 1996, J MOL BIOL, V258, P413, DOI 10.1006/jmbi.1996.0258; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WEST ML, 1995, GENETICS, V140, P1223; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZHANG J, 1991, J BIOL CHEM, V266, P2297	30	224	226	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					223	226		10.1038/nature02679	http://dx.doi.org/10.1038/nature02679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241417	Green Submitted			2022-12-01	WOS:000222470600047
J	Deayton, JR; Sabin, CA; Johnson, MA; Emery, VC; Wilson, P; Griffiths, PD				Deayton, JR; Sabin, CA; Johnson, MA; Emery, VC; Wilson, P; Griffiths, PD			Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; CMV DNA LOAD; AIDS PATIENTS; HEMOPHILIA; RETINITIS; SURVIVAL; SEROCONVERSION; COHORT	Background Before highly active antiretroviral therapy (HAART) became available, cytomegalovirus was a major cause of opportunistic infection in HIV-infected patients and was associated with accelerated progression to AIDS and death. We have investigated whether cytomegalovirus viraemia remains a significant risk factor for progression of HIV disease and death in the era of HAART. Methods 374 patients whose CD4-cell count had ever been below 100 per muL were enrolled in a prospective study. Serial blood samples were tested for cytomegalovirus by PCR. Rates of new cytomegalovirus disease, new AIDS-defining disorders, and death were calculated over a median follow-up of 37 months after stratification according to baseline and most recent cytomegalovirus PCR status at any point during follow-up. Findings Of 2969 PCR assays, 375 (12.6%) were positive for cytomegalovirus DNA. 259 (69.3%) patients were persistently negative for cytomegalovirus by PCR; 15 were persistently positive; and 100 were intermittently positive and negative. In multivariate models, cytomegalovirus PCR-positive status as a time-updated covariate was significantly associated with increased relative rates of progression to a new AIDS-defining disorder (2.22 [95% Cl 1.27-3.88] p=0.005) and death (4.14 [1.97-8.70] p=0.0002). Interpretation Detection of cytomegalovirus in blood by PCR continues to identify patients with a poor prognosis, even in the era of HAART. Randomised controlled clinical trials of drugs active against cytomegalovirus are needed to investigate whether this virus is a marker or a determinant of HIV disease progression.	UCL, Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL, Royal Free & Univ Coll Med Sch, Dept HIV AIDS, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London	Griffiths, PD (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Virol, Royal Free Campus, London NW3 2PF, England.	pgriffiths@rfc.ucl.ac.uk	Sabin, Caroline/C-2464-2008; Emery, Vincent/G-8928-2013	Sabin, Caroline/0000-0001-5173-2760; Emery, Vincent/0000-0001-5893-9756	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041687] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01 AI41687] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECHERER PR, 1990, AM J HEMATOL, V34, P204, DOI 10.1002/ajh.2830340310; Bowen EF, 1997, AIDS, V11, P889, DOI 10.1097/00002030-199707000-00008; Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009; Deayton J, 1999, AIDS, V13, P1203, DOI 10.1097/00002030-199907090-00008; Deayton JR, 2000, AIDS, V14, P1163, DOI 10.1097/00002030-200006160-00013; DETELS R, 1994, J INFECT DIS, V169, P766, DOI 10.1093/infdis/169.4.766; Dodt KK, 1997, AIDS, V11, pF21, DOI 10.1097/00002030-199703110-00001; Griffiths PD, 1998, J GEN VIROL, V79, P213, DOI 10.1099/0022-1317-79-2-213; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Kempen JH, 2003, CLIN INFECT DIS, V37, P1365, DOI 10.1086/379077; KIDD IM, 1993, TRANSPLANTATION, V56, P867, DOI 10.1097/00007890-199310000-00018; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; MONFORTE AD, 1992, AIDS, V6, P1159, DOI 10.1097/00002030-199210000-00015; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PILLAY D, 1993, AIDS, V7, P969, DOI 10.1097/00002030-199307000-00010; RABKIN CS, 1993, J INFECT DIS, V168, P1260, DOI 10.1093/infdis/168.5.1260; Razonable RR, 2002, TRANSPLANTATION, V73, P968, DOI 10.1097/00007890-200203270-00025; Robain M, 2000, EPIDEMIOL INFECT, V125, P415, DOI 10.1017/S0950268899004549; SABIN CA, 1995, EPIDEMIOL INFECT, V114, P361, DOI 10.1017/S095026880005799X; Sabin CA, 2000, J INFECT DIS, V181, P1800, DOI 10.1086/315476; Shinkai M, 1997, J INFECT DIS, V175, P302, DOI 10.1093/infdis/175.2.302; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Touloumi G, 1998, J ACQ IMMUN DEF SYND, V19, P89, DOI 10.1097/00042560-199809010-00014; WEBSTER A, 1989, LANCET, V2, P63; WEBSTER A, 1992, CLIN EXP IMMUNOL, V88, P6; WILKES MS, 1988, LANCET, V2, P85	27	153	165	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2004	363	9427					2116	2121		10.1016/S0140-6736(04)16500-8	http://dx.doi.org/10.1016/S0140-6736(04)16500-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832LF	15220032				2022-12-01	WOS:000222268300007
J	de Bruin, RAM; McDonald, WH; Kalashnikova, TI; Yates, J; Wittenberg, C				de Bruin, RAM; McDonald, WH; Kalashnikova, TI; Yates, J; Wittenberg, C			Cln3 activates G1-specific transcription via phosphorylation of the SBF transcription bound repressor Whi5	CELL			English	Article							G(1) CYCLIN CLN3; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; SYSTEMATIC IDENTIFICATION; YEAST; GENE; SWI4; SIZE; G1	G1-specific transcriptional activation by Cln3/CDK initiates the budding yeast cell cycle. To identify targets of Cln3/CDK, we analyzed the SBF and MBF transcription factor complexes by multidimensional protein interaction technology [MudPIT). Whi5 was identified as a stably bound component of SBF but not MBF. Inactivation of Whi5 leads to premature expression of G1-specific genes and budding, whereas overexpression retards those processes. Whi5 inactivation bypasses the requirement for Cln3 both for transcriptional activation and cell cycle initiation. Whi5 associates with G1-specific promoters via SBF during early G1 phase, then dissociates coincident with transcriptional activation. Dissociation of Whi5 is promoted by Cln3 in vivo. Cln/CDK phosphorylation of Whi5 in vitro promotes its dissociation from SBF complexes. Mutation of putative CDK phosphorylation sites, at least five of which are phosphorylated in vivo, strongly reduces SBF-dependent transcription and delays cell cycle initiation. Like mammalian Rb, Whi5 is a G1-specific transcriptional repressor antagonized by CDK.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wittenberg, C (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	curtw@scripps.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NIGMS NIH HHS [GM59941] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; CROSS FR, 1994, MOL CELL BIOL, V14, P4779, DOI 10.1128/MCB.14.7.4779; DESHAIES RJ, 1995, P NATL ACAD SCI USA, V92, P1182, DOI 10.1073/pnas.92.4.1182; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EPSTEIN CB, 1994, MOL CELL BIOL, V14, P2041, DOI 10.1128/MCB.14.3.2041; Flick K, 1998, MOL CELL BIOL, V18, P2492, DOI 10.1128/MCB.18.5.2492; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Harrington LA, 1996, NUCLEIC ACIDS RES, V24, P558, DOI 10.1093/nar/24.4.558; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kesti T, 2004, J BIOL CHEM, V279, P14245, DOI 10.1074/jbc.M313289200; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; MARINI NJ, 1992, GENE DEV, V6, P557, DOI 10.1101/gad.6.4.557; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Partridge JF, 1997, J BIOL CHEM, V272, P9071; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Reid RJD, 2002, YEAST, V19, P319, DOI 10.1002/yea.817; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Wijnen H, 1999, GENETICS, V153, P1131; Wittenberg C, 2003, MOL B INT U, P14; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	54	289	293	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					887	898		10.1016/j.cell.2004.05.025	http://dx.doi.org/10.1016/j.cell.2004.05.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210110	Bronze			2022-12-01	WOS:000222300200007
J	Sirovich, BE; Welch, HG				Sirovich, BE; Welch, HG			Cervical cancer screening among women without a cervix	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAPANICOLAOU SMEARS; UNITED-STATES; PAP-SMEAR; HYSTERECTOMY; ACCURACY; DISEASE; POPULATION	Context Most US women who have undergone hysterectomy are not at risk of cervical cancer-they underwent the procedure for benign disease and they no longer have a cervix. In 1996, the US Preventive Services Task Force recommended that routine Papanicolaou (Pap) smear screening is unnecessary for these women. Objective To determine whether Pap smear screening among women who have undergone hysterectomy has decreased following the recommendation. Design We used data from the Behavioral Risk Factor Surveillance System (1992-2002), an annual, population-based telephone survey of US adults conducted by the Centers for Disease Control and Prevention. Data about timing, type, and indication for hysterectomies were obtained from the Nationwide Inpatient Sample and other sources. Study Participants in each year of the survey, a representative sample of US women 18 years and older who had undergone hysterectomy (combined n=188390) was studied. Main Outcome Measure The main outcome was the proportion of women with a history of hysterectomy who reported a current Pap smear (within 3 years). Overall proportions are age adjusted to the 2002 US female population. Results Twenty-two million US women 18 years and older have undergone hysterectomy, representing 21% of the population. The proportion of these women who reported a current Pap smear did not change during the 10-year study period. In 1992 (before the US Preventive Services Task Force recommendations), 68.5% of women who had undergone hysterectomy reported having had a Pap smear in the past 3 years; in 2002 (6 years after the recommendation), 69.1% had had a Pap smear during the same period (P value for the comparison=.22). After accounting for Pap smears that may have preceded a recent hysterectomy and hysterectomies that spared the cervix or were performed for cervical neoplasia, we estimate that almost 10 million women, or half of all women who have undergone hysterectomy, are being screened unnecessarily. Conclusions Many US women are undergoing Pap smear screening even though they are not at risk of cervical cancer. The US Preventive Services Task Force recommendations either have not been heard or have been ignored.	Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA	VA Outcomes Group; Dartmouth College	Sirovich, BE (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.	brenda.sirovich@dartmouth.edu						ACOG committee opinion, 1995, INT J GYNECOL OBSTET, V49, P210; *AG HEALTHC RES QU, 2003, NAT INP SAMPL NIS HE; Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; Agency for Healthcare Research and Quality, 2003, AHRQ PUBL; *AM CANC SOC, 1988, SUMM CURR GUID CANC; [Anonymous], BEH RISK FACT SURV S; Bowman JA, 1997, SOC SCI MED, V44, P969, DOI 10.1016/S0277-9536(96)00222-5; Eaker ED, 1998, OBSTET GYNECOL, V91, P551, DOI 10.1016/S0029-7844(98)00020-9; Fetters MD, 1996, JAMA-J AM MED ASSOC, V275, P940, DOI 10.1001/jama.275.12.940; Gimbel H, 2001, ACTA OBSTET GYN SCAN, V80, P267, DOI 10.1034/j.1600-0412.2001.080003267.x; HCUP Cost to Charge Ratio Files (CCR), 2000, HEALTHC COST UT PROJ; Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1; McGovern PG, 1998, AM J PREV MED, V14, P201, DOI 10.1016/S0749-3797(97)00076-7; National Center for Health Statistics, 2000, DAT FIL DOC NAT HLTH; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; Pearce KF, 1996, NEW ENGL J MED, V335, P1559, DOI 10.1056/NEJM199611213352103; Saraiya M, 2001, OBSTET GYNECOL, V98, P269, DOI 10.1016/S0029-7844(01)01447-8; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; *US DEP HHS, 2003, 2002 BEH RISK FACT S; *US DEP HHS, 2001, 2000 BEH RISK FACT S; *US DEP HHS, 1999, 1998 BEH RISK FACT S; *US DEP HHS, 1995, 1994 BEH RISK FACT S; *US DEP HHS, 2000, 1999 BEH RISK FACT S; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P105; *US PREV SERV TASK, 1989, GUID CLIN PREV SERV, P57	26	62	64	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2004	291	24					2990	2993		10.1001/jama.291.24.2990	http://dx.doi.org/10.1001/jama.291.24.2990			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831HD	15213211	Bronze			2022-12-01	WOS:000222184600029
J	Lee, H; Habas, R; Abate-Shen, C				Lee, H; Habas, R; Abate-Shen, C			Msx1 cooperates with histone H1b for inhibition of transcription and myogenesis	SCIENCE			English	Article							IN-VIVO; DLX HOMEOPROTEINS; LINKER HISTONES; GENE; EXPRESSION; MYOD; DIFFERENTIATION; ORGANIZATION; INVOLVEMENT; HOMEODOMAIN	During embryogenesis, differentiation of skeletal muscle is regulated by transcription factors that include members of the Msx homeoprotein family. By investigating Msx1 function in repression of myogenic gene expression, we identified a physical interaction between Msx1 and H1b, a specific isoform of mouse histone H1. We found that Msx1 and H1b bind to a key regulatory element of MyoD, a central regulator of skeletal muscle differentiation, where they induce repressed chromatin. Moreover, Msx1 and H1b cooperate to inhibit muscle differentiation in cell culture and in Xenopus animal caps. Our findings define a previously unknown function for "linker" histones in gene-specific transcriptional regulation.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Abate-Shen, C (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	abate@cabm.rutgers.edu	Abate-Shen, Cory/O-2520-2014	Abate-Shen, Cory/0000-0002-5021-0570	NICHD NIH HHS [HD29446] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029446] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bendall AJ, 1999, DEVELOPMENT, V126, P4965; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; CATRON KM, 1995, MOL CELL BIOL, V15, P861; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Houzelstein D, 1999, DEVELOPMENT, V126, P2689; Hu GZ, 2001, DEVELOPMENT, V128, P2373; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kucharczuk KL, 1999, DEVELOPMENT, V126, P1957; LEE HM, UNPUB; LENNOX RW, 1988, BIOCHEM CELL BIOL, V66, P636, DOI 10.1139/o88-073; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Wang ZF, 1997, J MOL BIOL, V271, P124, DOI 10.1006/jmbi.1997.1166; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; ZLATANOVA J, 1992, J CELL SCI, V103, P889	25	188	205	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2004	304	5677					1675	1678		10.1126/science.1098096	http://dx.doi.org/10.1126/science.1098096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192231				2022-12-01	WOS:000221934300052
J	Rak, A; Pylypenko, O; Niculae, A; Pyatkov, K; Goody, RS; Alexandrov, K				Rak, A; Pylypenko, O; Niculae, A; Pyatkov, K; Goody, RS; Alexandrov, K			Structure of the Rab7 : REP-1 complex: Insights into the mechanism of rab prenylation and choroideremia disease	CELL			English	Article							GERANYLGERANYLTRANSFERASE TYPE-II; GDP-DISSOCIATION INHIBITOR; ESCORT PROTEIN; SMALL GTPASES; IN-VITRO; BINDING; SUPERFAMILY; TRANSFERASE; EXPRESSION; FAMILY	Members of the RabGDI/REP family serve as multifunctional regulators of the Rab family of GTP binding proteins. Mutations in members of this family, such as REP-1, lead to abnormalities, including progressive retinal degradation (choroideremia) in humans. The crystal structures of the REP-1 protein in complex with monoprenylated or C-terminally truncated Rab7 proteins revealed that Rab7 interacts with the Rab binding platform of REP-1 via an extended interface involving the Switch 1 and 2 regions. The C terminus of the REP-1 molecule functions as a mobile lid covering a conserved hydrophobic patch on the surface of REP-1 that in the complex coordinates the C terminus of Rab proteins. Using semisynthetic fluorescent Rab27A, we demonstrate that although Rab27A can be prenylated by REP-2, this reaction can be effectively inhibited by other Rab proteins, providing a possible explanation for the accumulation of unprenylated Rab27A in choroideremia.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA	Max Planck Society; California Institute of Technology	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	kirill.alexandrov@mpi-dortmund.mpg.de	Goody, Roger S/J-8845-2014; Alexandrov, Kirill/A-5830-2013	Goody, Roger S/0000-0002-0772-0444; Pylypenko, Olena/0000-0001-7073-5238; Alexandrov, Kirill/0000-0002-0957-6511				Alexandrov K, 1999, EUR J BIOCHEM, V265, P160, DOI 10.1046/j.1432-1327.1999.00699.x; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; Alory C, 2001, TRAFFIC, V2, P532, DOI 10.1034/j.1600-0854.2001.20803.x; Alory C, 2000, J CELL BIOL, V150, P89, DOI 10.1083/jcb.150.1.89; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Day GJ, 1998, MOL CELL BIOL, V18, P7444, DOI 10.1128/MCB.18.12.7444; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Iakovenko A, 2000, FEBS LETT, V468, P155, DOI 10.1016/S0014-5793(00)01143-1; JOHN J, 1993, J BIOL CHEM, V268, P923; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; Miaczynska M, 1997, J BIOL CHEM, V272, P16972, DOI 10.1074/jbc.272.27.16972; Overmeyer JH, 1998, MOL BIOL CELL, V9, P223, DOI 10.1091/mbc.9.1.223; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rak A, 2003, J STRUCT BIOL, V141, P93, DOI 10.1016/S1047-8477(02)00634-2; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seabra MC, 1996, OPHTHALMIC GENET, V17, P43, DOI 10.3109/13816819609057869; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Sidorovitch V, 2002, PROTEIN EXPRES PURIF, V26, P50, DOI 10.1016/S1046-5928(02)00506-5; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; Thoma NH, 2001, BIOCHEMISTRY-US, V40, P268, DOI 10.1021/bi002034p; WILSON AL, 1993, J BIOL CHEM, V268, P14561; Wu SK, 1998, J BIOL CHEM, V273, P26931, DOI 10.1074/jbc.273.41.26931	33	125	135	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					749	760		10.1016/j.cell.2004.05.017	http://dx.doi.org/10.1016/j.cell.2004.05.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186776	Bronze			2022-12-01	WOS:000222048400008
J	Barnea, G; O'Donnell, S; Mancia, F; Sun, X; Nemes, A; Mendelsohn, M; Axel, R				Barnea, G; O'Donnell, S; Mancia, F; Sun, X; Nemes, A; Mendelsohn, M; Axel, R			Odorant receptors on axon termini in the brain	SCIENCE			English	Article							ORGANIZATION; GENE; MAP		Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	ra27@columbia.edu		Mancia, Filippo/0000-0003-3293-2200; Axel, Richard/0000-0002-3141-4076				BARNEA G, UNPUB; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9	7	140	145	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1468	1468		10.1126/science.1096146	http://dx.doi.org/10.1126/science.1096146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178793				2022-12-01	WOS:000221795800033
J	Palmer, M; Bernhardt, E; Chornesky, E; Collins, S; Dobson, A; Duke, C; Gold, B; Jacobson, R; Kingsland, S; Kranz, R; Mappin, M; Martinez, ML; Micheli, F; Morse, J; Pace, M; Pascual, M; Palumbi, S; Reichman, OJ; Simons, A; Townsend, A; Turner, M				Palmer, M; Bernhardt, E; Chornesky, E; Collins, S; Dobson, A; Duke, C; Gold, B; Jacobson, R; Kingsland, S; Kranz, R; Mappin, M; Martinez, ML; Micheli, F; Morse, J; Pace, M; Pascual, M; Palumbi, S; Reichman, OJ; Simons, A; Townsend, A; Turner, M			Ecology for a crowded planet	SCIENCE			English	Editorial Material									Univ Maryland, College Pk, MD 20742 USA; Duke Univ, Durham, NC USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Princeton Univ, Princeton, NJ 08544 USA; Ecol Soc Amer, Washington, DC USA; David & Lucile Packard Fdn, Los Altos, CA USA; US Geol Survey, Columbia, MD USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calgary, Calgary, AB T2N 1N4, Canada; Inst Ecol, Xalapa, Veracruz, Mexico; Stanford Univ, Pacific Grove, CA USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; COMPASS, Washington, DC USA; Univ Colorado, Boulder, CO 80309 USA; Univ Wisconsin, Madison, WI USA	University System of Maryland; University of Maryland College Park; Duke University; University of California System; University of California Santa Cruz; University of New Mexico; Princeton University; United States Department of the Interior; United States Geological Survey; Johns Hopkins University; University of Calgary; Instituto de Ecologia - Mexico; Stanford University; Cary Institute of Ecosystem Studies; University of Michigan System; University of Michigan; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison	Palmer, M (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	mpalmer@umd.edu	Townsend, Alan/AAE-9602-2019; Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010; Collins, Scott L/P-7742-2014; Martinez, M. Luisa/R-4631-2017; Palmer, Margaret A/F-9648-2013	Bernhardt, Emily S/0000-0003-3031-621X; Collins, Scott L/0000-0002-0193-2892; Martinez, M. Luisa/0000-0002-4469-5284; Palmer, Margaret A/0000-0003-1468-7993; Morse, Jennifer/0000-0001-8872-4940; Pace, Michael/0000-0001-5945-6131; Micheli, Fiorenza/0000-0002-6865-1438				Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; [Anonymous], 1997, NATURES SERVICES; Font WF, 2003, BIOSCIENCE, V53, P1061, DOI 10.1641/0006-3568(2003)053[1061:TGSOPW]2.0.CO;2; Gleick PH, 2000, WORLDS WATER BIENNIA; Graham DW, 2004, FRONT ECOL ENVIRON, V2, P199, DOI 10.1890/1540-9295(2004)002[0199:DESAOE]2.0.CO;2; Gunderson L., 2002, RESILIENCE BEHAV LAR; LUBCHENCO J, 1991, ECOLOGY, V72, P371, DOI 10.2307/2937183; MARTINEZ ML, 2004, ECOLOGICAL STUDIES S, V171; McMichael AJ, 2003, SCIENCE, V302, P1919; Millennium Ecosystem Assessment, 2003, EC HUM WELL BEING; Palmer MA, 2004, ECOLOGICAL SCI SUSTA; Palumbi SR, 2003, P NATL ACAD SCI USA, V100, P11927, DOI 10.1073/pnas.2335832100; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	13	318	368	6	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1251	1252		10.1126/science.1095780	http://dx.doi.org/10.1126/science.1095780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166349				2022-12-01	WOS:000221669600023
J	Sobering, AK; Watanabe, R; Romeo, MJ; Yan, BC; Specht, CA; Orlean, P; Riezman, H; Levin, DE				Sobering, AK; Watanabe, R; Romeo, MJ; Yan, BC; Specht, CA; Orlean, P; Riezman, H; Levin, DE			Yeast Ras regulates the complex that catalyzes the first step in GPI-anchor biosynthesis at the ER	CELL			English	Article							PHOSPHATE-MANNOSE SYNTHASE; SACCHAROMYCES-CEREVISIAE; CHITIN SYNTHESIS; ENDOPLASMIC-RETICULUM; CELL-WALL; PROTEINS; GENE; PATHWAYS; CLONING; KINASE	The yeast ERI1 gene encodes a small ER-localized protein that associates in vivo with GTP bound Ras2 in an effector loop-dependent manner. We showed previously that loss of Eri1 function results in hyperactive Ras phenotypes. Here, we demonstrate that Eri1 is a component of the GPl-GlcNAc transferase (GPl-GnT) complex in the ER, which catalyzes transfer of GlcNAc from UDP-GlcNAc to an acceptor phosphatidylinositol, the first step in the production of GPl-anchors for cell surface proteins. We also show that GTP bound Ras2 associates with the GPl-GnT complex in vivo and inhibits its activity, indicating that yeast Ras uses the ER as a signaling platform from which to negatively regulate the GPl-GnT. We propose that diminished GPl-anchor protein production contributes to hyperactive Ras phenotypes.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; Univ Geneva, Dept Biochem Sci 2, CH-1211 Geneva, Switzerland; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign; Boston University	Levin, DE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	levin@jhmi.edu		Romeo, Martin/0000-0001-7941-1862; Levin, David/0000-0003-0696-2860; Riezman, Howard/0000-0003-4680-9422; Watanabe, Reika/0000-0002-7427-7702	NCI NIH HHS [5T32CA09110] Funding Source: Medline; NIGMS NIH HHS [GM46220, GM48533, R01 GM067698, GM67698] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067698, R01GM048533, R01GM046220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; BULAWA CE, 1992, MOL CELL BIOL, V12, P1764, DOI 10.1128/MCB.12.4.1764; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; CABIB E, 1987, ADV ENZYMOL RAMB, V59, P59; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; DEFEOJONES D, 1985, SCIENCE, V228, P179, DOI 10.1126/science.3883495; Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; GIBBS JB, 1989, MICROBIOL REV, V53, P171, DOI 10.1128/MMBR.53.2.171-185.1989; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629; JOENS EW, 1997, MOL CELLULAR BIOL YE, P363; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Kostova Z, 2000, BIOCHEM J, V350, P815, DOI 10.1042/0264-6021:3500815; LEIDICH SD, 1995, J BIOL CHEM, V270, P13029, DOI 10.1074/jbc.270.22.13029; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; NUOFFER C, 1993, J BIOL CHEM, V268, P10558; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; Orlean P., 1997, MOL CELLULAR BIOL YE, P229; Osmond BC, 1999, P NATL ACAD SCI USA, V96, P11206, DOI 10.1073/pnas.96.20.11206; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Romeo MJ, 2002, MOL CELL BIOL, V22, P8165, DOI 10.1128/MCB.22.23.8165-8174.2002; SCHONBACHLER M, 1995, EMBO J, V14, P1637, DOI 10.1002/j.1460-2075.1995.tb07152.x; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Sobering AK, 2003, MOL CELL BIOL, V23, P4983, DOI 10.1128/MCB.23.14.4983-4990.2003; Sobering AK, 2002, EUKARYOT CELL, V1, P56, DOI 10.1128/EC.1.1.56-65.2002; Sutterlin C, 1997, J CELL SCI, V110, P2703; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Valdivieso MH, 2000, J BACTERIOL, V182, P4752, DOI 10.1128/JB.182.17.4752-4757.2000; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; WATZELE G, 1989, J BIOL CHEM, V264, P8753; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Yan BC, 2001, YEAST, V18, P1383, DOI 10.1002/yea.783	44	52	56	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					637	648		10.1016/j.cell.2004.05.003	http://dx.doi.org/10.1016/j.cell.2004.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163411	Bronze			2022-12-01	WOS:000221857900010
J	Flematti, GR; Ghisalberti, EL; Dixon, KW; Trengove, RD				Flematti, GR; Ghisalberti, EL; Dixon, KW; Trengove, RD			A compound from smoke that promotes seed germination	SCIENCE			English	Article									Univ Western Australia, Sch Biomed & Chem Sci, Crawley, WA 6009, Australia; Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; Kings Pk & Bot Gardens, Perth, WA 6005, Australia; Murdoch Univ, Sch Engn Sci, Rockingham, WA 6168, Australia	University of Western Australia; University of Western Australia; Murdoch University	Flematti, GR (corresponding author), Univ Western Australia, Sch Biomed & Chem Sci, Crawley, WA 6009, Australia.	gflematt@chem.uwa.edu.au	Dixon, Kingsley W/A-8133-2016; Flematti, Gavin R/J-2018-2012; Dixon, Kingsley W/B-1042-2011	Dixon, Kingsley W/0000-0001-5989-2929; Flematti, Gavin/0000-0003-2545-6939; Trengove, Robert/0000-0003-2454-0477				Brown NAC, 1997, PLANT GROWTH REGUL, V22, P115, DOI 10.1023/A:1005852018644; DREWES FE, 1995, PLANT GROWTH REGUL, V16, P205, DOI 10.1007/BF00029542; Roche S, 1997, AUST J BOT, V45, P783, DOI 10.1071/BT96099; Wigchert SCM, 1999, J AGR FOOD CHEM, V47, P1320, DOI 10.1021/jf980926e	4	486	522	13	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					977	977		10.1126/science.1099944	http://dx.doi.org/10.1126/science.1099944			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	845ND	15247439				2022-12-01	WOS:000223250700038
J	Proft, M; Struhl, K				Proft, M; Struhl, K			MAP kinase-mediated stress relief that precedes and regulates the timing of transcriptional induction	CELL			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; SIGNAL-TRANSDUCTION; BUDDING YEAST; ENVIRONMENTAL-CHANGES; SALT STRESS; IN-VIVO; POL-II; HOG1	In yeast, hyperosmotic stress causes an immediate dissociation of most proteins from chromatin, presumably because cells are unprepared for, and initially unresponsive to, increased ion concentrations in the nucleus. Osmotic stress activates Hog1 MAP kinase which phosphorylates at least two proteins located at the plasma membrane, the Nha1 Na+/H+ antiporter and the Tok1 potassium channel. Hog1 phosphorylation stimulates Nha1 activity, and this is crucial for the rapid reassociation of proteins with their target sites in chromatin. This initial response to hyperosmolarity precedes and temporally regulates the activation of stress-response genes that depends on Hog1 phosphorylation of transcription factors in the nucleus. Thus, a single MAP kinase coordinates temporally, spatially, and mechanistically distinct responses to stress, thereby providing very rapid stress relief that facilitates subsequent changes in gene expression that permit long-term adaptation to harsh environmental conditions.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830	NIGMS NIH HHS [GM30186] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x	36	162	168	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					351	361		10.1016/j.cell.2004.07.016	http://dx.doi.org/10.1016/j.cell.2004.07.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294160	Bronze			2022-12-01	WOS:000223353100011
J	Giron, D; Dunn, DW; Hardy, ICW; Strand, MR				Giron, D; Dunn, DW; Hardy, ICW; Strand, MR			Aggression by polyembryonic wasp soldiers correlates with kinship but not resource competition	NATURE			English	Article							COPIDOSOMA-FLORIDANUM; VISCOUS POPULATIONS; INCLUSIVE FITNESS; EVOLUTION; ALTRUISM; INVERTEBRATES; RELATEDNESS; ENVIRONMENT; ALLOCATION; RELATIVES	Kin selection theory predicts that individuals will show less aggression and more altruism towards relatives(1,2). However, recent theoretical developments suggest that with limited dispersal, competition between relatives can override the effects of relatedness(3-9). The predicted and opposing influences of relatedness and competition are difficult to approach experimentally because conditions that increase average relatedness among individuals also tend to increase competition. Polyembryonic wasps in the family Encyrtidae are parasites whose eggs undergo clonal division to produce large broods(10). These insects have also evolved a caste system: some embryos in a clone develop into reproductive larvae that mature into adults, whereas others develop into sterile soldier larvae that defend siblings from competitors(11-14). In a brood from a single egg, reproductive altruism by soldiers reflects clone-level allocation to defence at the cost of reproduction, with no conflict between individuals. When multiple eggs are laid into a host, inter-clone conflicts of interest arise. Here we report that soldier aggression in Copidosoma floridanum is inversely related to the genetic relatedness of competitors but shows no correlation with the level of resource competition.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University System of Georgia; University of Georgia; University of Nottingham	Strand, MR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrstrand@bugs.ent.uga.edu	Giron, David/B-9108-2013	Giron, David/0000-0001-8356-0983				Abbot P, 2001, P NATL ACAD SCI USA, V98, P12068, DOI 10.1073/pnas.201212698; Buss L. W., 1987, EVOLUTION INDIVIDUAL; CROZIER RH, 1986, EVOLUTION, V40, P1100, DOI 10.1111/j.1558-5646.1986.tb00578.x; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; DONNELL D, IN PRESS P NATL ACAD; GIRON D, 2004, P R SOC LOND S; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, P62; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1996, DEVELOPMENT, V122, P795; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Harvey JA, 2000, NATURE, V406, P183, DOI 10.1038/35018074; Ode PJ, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P218, DOI 10.1017/CBO9780511542053.011; ODE PJ, 1995, J ANIM ECOL, V64, P213, DOI 10.2307/5756; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; STRAND MR, 1989, ENTOMOL EXP APPL, V50, P37, DOI 10.1007/BF00190127; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Strand MR, 2003, ENCY INSECTS, P928; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	27	90	94	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					676	679		10.1038/nature02721	http://dx.doi.org/10.1038/nature02721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295600				2022-12-01	WOS:000223085400045
J	Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N				Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N			KIF1A alternately uses two loops to bind microtubules	SCIENCE			English	Article							KINESIN MOTOR; MECHANISM; PROCESSIVITY; ATPASE; MYOSIN; MODEL; DYNAMICS; ACTIN	The motor protein kinesin moves along microtubules, driven by adenosine triphosphate (ATP) hydrolysis. However, it remains unclear how kinesin converts the chemical energy into mechanical movement. We report crystal structures of monomeric kinesin KIF1A with three transition-state analogs: adenylyl imidodiphosphate (AMP-PNP), adenosine diphosphate (ADP)-vanadate, and ADP-AlFx (aluminofluoride complexes). These structures, together with known structures of the ADP-bound state and the adenylyl-(beta, gamma-methylene) diphosphate (AMP-PCP)-bound state, show that kinesin uses two microtubule-binding loops in an alternating manner to change its interaction with microtubules during the ATP hydrolysis cycle; loop L11 is extended in the AMP-PNP structure, whereas loop L12 is extended in the ADP structure. ADP-vanadate displays an intermediate structure in which a conformational change in two switch regions causes both loops to be raised from the microtubule, thus actively detaching kinesin.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Tokyo; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Nitta, Ryo/C-3727-2017; Okada, Yasushi/N-5067-2015; Kikkawa, Masahide/I-7958-2015	Nitta, Ryo/0000-0002-6537-9272; Okada, Yasushi/0000-0003-2601-3689; Kikkawa, Masahide/0000-0001-7656-8194				Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; GEEVES MA, 1991, BIOCHEM J, V274, P1; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KORETZ JF, 1975, J BIOL CHEM, V250, P6344; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; MIDELFORT CF, 1981, P NATL ACAD SCI-BIOL, V78, P2067, DOI 10.1073/pnas.78.4.2067; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; YOUNT RG, 1995, BIOPHYS J, V68, pS44; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	30	143	152	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					678	683		10.1126/science.1096621	http://dx.doi.org/10.1126/science.1096621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286375				2022-12-01	WOS:000222992100052
J	Williams, PA; Cosme, J; Vinkovic, DM; Ward, A; Angove, HC; Day, PJ; Vonrhein, C; Tickle, IJ; Jhoti, H				Williams, PA; Cosme, J; Vinkovic, DM; Ward, A; Angove, HC; Day, PJ; Vonrhein, C; Tickle, IJ; Jhoti, H			Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone	SCIENCE			English	Article							SUBSTRATE RECOGNITION SITE; ACTIVE-SITE; ALPHA-NAPHTHOFLAVONE; SCANNING MUTAGENESIS; MEMBRANE-BINDING; DRUG-METABOLISM; CYP3A4; ACTIVATION; RESIDUES; KINETICS	Cytochromes P450 (P450s) metabolize a wide range of endogenous compounds and xenobiotics, such as pollutants, environmental compounds, and drug molecules. The microsomal, membrane-associated, P450 isoforms CYP3A4, CYP2D6, CYP2C9, CYP2C19, CYP2E1, and CYP1A2 are responsible for the oxidative metabolism of more than 90% of marketed drugs. Cytochrome P450 3A4 ( CYP3A4) metabolizes more drug molecules than all other isoforms combined. Here we report three crystal structures of CYP3A4: unliganded, bound to the inhibitor metyrapone, and bound to the substrate progesterone. The structures revealed a surprisingly small active site, with little conformational change associated with the binding of either compound. An unexpected peripheral binding site is identified, located above a phenylalanine cluster, which may be involved in the initial recognition of substrates or allosteric effectors.	Astex Technol, Cambridge CB4 0QA, England; Global Phasing Ltd, Cambridge CB3 0AX, England	Global Phasing Limited	Jhoti, H (corresponding author), Astex Technol, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England.	h.jhoti@astex-technology.com		Williams, Pamela/0000-0002-1257-2351; Tickle, Ian/0000-0003-2977-0650				Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; GRAHAMLORENCE SE, 1995, PHYSL FUNCTIONS CYTO, P57; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011; HENDLICH M, 1997, J MOL GRAPH MODEL, V15, P355; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Kenworthy KE, 1999, BRIT J CLIN PHARMACO, V48, P716; Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Kim KH, 2003, BIOCHEMISTRY-US, V42, P15377, DOI 10.1021/bi035280k; KOLEY AP, 1995, J BIOL CHEM, V270, P5014, DOI 10.1074/jbc.270.10.5014; Koley AP, 1997, J BIOL CHEM, V272, P3149, DOI 10.1074/jbc.272.6.3149; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Lewis DFV, 1996, XENOBIOTICA, V26, P1067; Lu P, 2001, DRUG METAB DISPOS, V29, P1473; NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Stevens JC, 1999, J PHARMACOL EXP THER, V290, P594; Szklarz GD, 1997, J COMPUT AID MOL DES, V11, P265, DOI 10.1023/A:1007956612081; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862	34	667	690	6	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					683	686		10.1126/science.1099736	http://dx.doi.org/10.1126/science.1099736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15256616				2022-12-01	WOS:000222992100053
J	Biant, LC; Teare, EL; Williams, WW; Tuite, JD				Biant, LC; Teare, EL; Williams, WW; Tuite, JD			Eradication of methicillin resistant Staphylococcus aureus by "ring fencing" of elective orthopedic beds	BRITISH MEDICAL JOURNAL			English	Article								Problem Deep infection after joint arthroplasty can be catastrophic, leading to further surgery, loss of the prosthesis, disability, and risk of mortality. Twenty nine new cases of methicillin resistant Staphylococcus aureus occurred in the first year after elective orthopaedic surgery was centralised to a district general hospital in Essex. Design Prospective trial to establish whether ring fencing of elective orthopaedic beds and introduction of simple infection control measures has an effect on the rates of postoperative infections and number of patients treated. Participants and setting All patients undergoing primary hip or knee replacement in a district general hospital in Essex, England, between July 1999 and July 2001. Main measures for improvement Number of patients having joint replacement; number of all postoperative infections in the participant group; Dumber of cases of methicillin resistant Staphylococcus aureus. Strategies for change Ring fencing of the elective orthopaedic ward and introduction of simple infection control measures; Effects of change The incidence of all postoperative infections decreased from 43/417 to 15/488 (P < 0.0001), with no new cases of methicillin resistant Staphylococcus aureus. Lessons learnt The introduction of a ring fenced elective orthopaedic ward and simple infection control measures allowed 17% more patients to be treated and significantly reduced the incidence of all postoperative infections.	Broomfield Hosp, Chelmsford, Essex, England	Mid Essex Hospital Services NHS Trust; Broomfield Hospital	Biant, LC (corresponding author), Broomfield Hosp, Chelmsford, Essex, England.	lcbiant@yahoo.com		Biant, Leela/0000-0002-5291-8898				AMSTUTZ HC, 1974, INSTR COURSE LECT, V23, P248; *BRIT ORTH ASS, 1999, REC STER PROC OP THE; Plowman R., 2000, SOCIO EC BURDEN HOSP; SETO WH, 1990, J HOSP INFECT, V90, P157	4	46	46	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 17	2004	329	7458					149	151						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840BP	15258070				2022-12-01	WOS:000222832300024
J	Olson, MV; Varki, A				Olson, MV; Varki, A			The chimpanzee genome - A bittersweet celebration	SCIENCE			English	Editorial Material							EVOLUTION; HUMANS		Univ Washington, Genome Ctr, Dept Med, Seattle, WA 98195 USA; Univ Washington, Genome Ctr, Dept Genome Sci, Seattle, WA 98195 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego	Olson, MV (corresponding author), Univ Washington, Genome Ctr, Dept Med, Seattle, WA 98195 USA.	mvo@u.washington.edu; a1varki@ucsd.edu						Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; *G HAR LY MATH CHA, 2004, SEQ CHIMP GEN WHAT H; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Varki A, 1998, SCIENCE, V282, P239; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; WILSON R., UNPUB	9	12	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2004	305	5681					191	192		10.1126/science.1100975	http://dx.doi.org/10.1126/science.1100975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247465				2022-12-01	WOS:000222501000036
J	Silvarolla, MB; Mazzafera, P; Fazuoli, LC				Silvarolla, MB; Mazzafera, P; Fazuoli, LC			Plant biochemistry - A naturally decaffeinated arabica coffee	NATURE			English	Editorial Material							CAFFEINE		IAC APTA, Ctr Anal & Pesquisa Tecnol Agronegocio Cafe Alcid, BR-13001970 Campinas, SP, Brazil; Univ Estadual Campinas, Inst Biol, Dept Fisiol Vegetal, BR-13083862 Campinas, Brazil	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas	Silvarolla, MB (corresponding author), IAC APTA, Ctr Anal & Pesquisa Tecnol Agronegocio Cafe Alcid, CP 28, BR-13001970 Campinas, SP, Brazil.	pmazza@unicamp.br	Mazzafera, Paulo/D-4766-2012; Silvarolla, Maria Bernadete/AAD-8237-2020	Mazzafera, Paulo/0000-0001-9073-4056; 				Ashihara H, 2004, FRONT BIOSCI-LANDMRK, V9, P1864, DOI 10.2741/1367; Charrier A, 1978, STRUCTURE GENETIQUE; Evans W.C., 1996, TREASE EVANS PHARMAC; *FAO, 1968, FAO REP COFF MISS ET; JAMES JE, 1991, CAFFEINE HLTH; Kato M, 2004, FRONT BIOSCI-LANDMRK, V9, P1833, DOI 10.2741/1364; MAZZAFERA P, 1994, J AGR FOOD CHEM, V42, P1423, DOI 10.1021/jf00043a007; Mazzafera P., 1992, Euphytica, V59, P55; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Silvarolla MB, 2000, GENET MOL BIOL, V23, P213, DOI 10.1590/S1415-47572000000100036; Vossen H. A. M. van der, 1985, Coffee: botany, biochemistry and production of beans and beverage., P48	11	78	88	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					826	826		10.1038/429826a	http://dx.doi.org/10.1038/429826a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215853	Bronze			2022-12-01	WOS:000222213000030
J	Beja-Pereira, A; England, PR; Ferrand, N; Jordan, S; Bakhiet, AO; Abdalla, MA; Mashkour, M; Jordana, J; Taberlet, P; Luikart, G				Beja-Pereira, A; England, PR; Ferrand, N; Jordan, S; Bakhiet, AO; Abdalla, MA; Mashkour, M; Jordana, J; Taberlet, P; Luikart, G			African origins of the domestic donkey	SCIENCE			English	Article									CNRS, Lab Ecol Alpine, UMR UJF 5553, F-38041 Grenoble, France; Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, P-44485 Vairao, Portugal; Univ Porto, SAECA, Fac Ciencias, P-44485 Vairao, Portugal; Fac Ciencias, P-4099 Oporto, Portugal; Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; Sudan Univ Sci & Technol, Coll Vet Med, Khartoum, Sudan; Museum Natl Hist Nat, CNRS, UMR 5197, F-75005 Paris, France; UAB, Dept Ciencia Anim Aliments, Fac Vet, Bellaterra 8193, Spain	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universidade do Porto; Universidade do Porto; Universidade do Porto; Bucknell University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Barcelona	Beja-Pereira, A (corresponding author), CNRS, Lab Ecol Alpine, UMR UJF 5553, F-38041 Grenoble, France.	albano.beja-pereira@ujf-grenoble.fr	Ferrand, Nuno/E-6085-2014; abdalla, mohamed/AAB-6069-2020; Jordana, Jordi/T-6986-2017; Bakhiet, Amel O/P-6642-2014; Taberlet, Pierre/D-1178-2010; Beja-Pereira, Albano/B-3681-2008; Mashkour, Marjan/B-5724-2018	Ferrand, Nuno/0000-0002-2408-4195; Jordana, Jordi/0000-0002-7789-2989; Bakhiet, Amel O/0000-0003-2386-2458; Taberlet, Pierre/0000-0002-3554-5954; Beja-Pereira, Albano/0000-0002-1607-7382; Mashkour, Marjan/0000-0003-3630-9459; Luikart, Gordon/0000-0001-8697-0582				Clutton-Brock J., 1999, NATURAL HIST DOMESTI, V2nd ed.; Marshall F., 2000, ORIGINS DEV AFRICAN, P191; Peters J., 1986, THESIS RIJKSUNIVERSI	3	153	168	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1781	1781		10.1126/science.1096008	http://dx.doi.org/10.1126/science.1096008			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205528				2022-12-01	WOS:000222089500039
J	Hernandez, LD; Hueffer, K; Wenk, MR; Galan, JE				Hernandez, LD; Hueffer, K; Wenk, MR; Galan, JE			Salmonella modulates vesicular traffic by altering phosphoinositide metabolism	SCIENCE			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; TYPHIMURIUM-CONTAINING VACUOLES; III SECRETION SYSTEM; EPITHELIAL-CELLS; HOST-CELL; FILAMENTOUS STRUCTURES; ACTIN CYTOSKELETON; INVASION; PHOSPHATASE; PROTEIN	Salmonella enterica, the cause of food poisoning and typhoid fever, induces actin cytoskeleton rearrangements and membrane ruffling to gain access into nonphagocytic cells, where it can replicate and avoid innate immune defenses. Here, we found that SopB, a phosphoinositide phosphatase that is delivered into host cells by a type III secretion system, was essential for the establishment of Salmonella's intracellular replicative niche. SopB mediated the formation of spacious phagosomes following bacterial entry and was responsible for maintaining high levels of phosphatidylinositol-three-phosphate [PtdIns(3)P] in the membrane of the bacteria-containing vacuoles. Absence of SopB caused a significant defect in the maturation of the Salmonella-containing vacuole and impaired bacterial intracellular growth.	Yale Univ, Sch Microbial Pathogenesis, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Microbial Pathogenesis, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Wenk, Markus Rene/D-1441-2014	Hueffer, Karsten/0000-0001-7154-9066	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055472] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055472] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galyov E. E., 1997, MOL MICROBIOL, V25, P1903; GARCIADELPORTILLO F, 1993, INFECT AGENT DIS, V2, P227; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641, DOI 10.1128/IAI.62.10.4641-4645.1994; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gorvel JP, 2001, MICROBES INFECT, V3, P1299, DOI 10.1016/S1286-4579(01)01490-3; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hernandez L., UNPUB; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pattni K, 2001, CURR BIOL, V11, P1636, DOI 10.1016/S0960-9822(01)00486-9; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	37	237	244	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1805	1807		10.1126/science.1098188	http://dx.doi.org/10.1126/science.1098188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205533				2022-12-01	WOS:000222089500046
J	Matsuzaki, M; Honkura, N; Ellis-Davies, GCR; Kasai, H				Matsuzaki, M; Honkura, N; Ellis-Davies, GCR; Kasai, H			Structural basis of long-term potentiation in single dendritic spines	NATURE			English	Article							SYNAPTIC PLASTICITY; SILENT SYNAPSES; AMPA RECEPTORS; ADULT CORTEX; LTP; CA1; EXPRESSION; CAMKII; TRANSMISSION; STIMULATION	Dendritic spines of pyramidal neurons in the cerebral cortex undergo activity-dependent structural remodelling(1-5) that has been proposed to be a cellular basis of learning and memory(6). How structural remodelling supports synaptic plasticity(4),5, such as long-term potentiation(7), and whether such plasticity is input-specific at the level of the individual spine has remained unknown. We investigated the structural basis of long-term potentiation using two-photon photolysis of caged glutamate at single spines of hippocampal CA1 pyramidal neurons(8). Here we show that repetitive quantum-like photorelease (uncaging) of glutamate induces a rapid and selective enlargement of stimulated spines that is transient in large mushroom spines but persistent in small spines. Spine enlargement is associated with an increase in AMPA-receptor-mediated currents at the stimulated synapse and is dependent on NMDA receptors, calmodulin and actin polymerization. Long-lasting spine enlargement also requires Ca2+/calmodulin-dependent protein kinase II. Our results thus indicate that spines individually follow Hebb's postulate for learning. They further suggest that small spines are preferential sites for long-term potentiation induction, whereas large spines might represent physical traces of long-term memory.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies Sokendai, Okazaki, Aichi, Japan; Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Drexel University	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan.	hkasai@nips.ac.jp	Honkura, Naoki/N-5521-2017	Honkura, Naoki/0000-0002-6018-867X; Matsuzaki, Masanori/0000-0003-3872-4322; Kasai, Haruo/0000-0003-2327-9027	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053395-08, R01 GM053395] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; GUSTAFSSON B, 1990, PROG BRAIN RES, V83, P223; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 2002, CLIN PSYCHOL; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	30	1674	1710	6	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					761	766		10.1038/nature02617	http://dx.doi.org/10.1038/nature02617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15190253	Green Accepted			2022-12-01	WOS:000222059900039
J	Rothwell, PM; Coull, AJ; Giles, MF; Howard, SC; Silver, LE; Bull, LM; Gutnikov, SA; Edwards, P; Mant, D; Sackley, CM; Farmer, A; Sandercock, PAG; Dennis, MS; Warlow, CP; Bamford, JM; Anslow, P				Rothwell, PM; Coull, AJ; Giles, MF; Howard, SC; Silver, LE; Bull, LM; Gutnikov, SA; Edwards, P; Mant, D; Sackley, CM; Farmer, A; Sandercock, PAG; Dennis, MS; Warlow, CP; Bamford, JM; Anslow, P		Oxford Vascular Study	Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACKS; SECULAR TRENDS; CARDIOVASCULAR-DISEASE; CAPTURE-RECAPTURE; NORTHERN SWEDEN; BLOOD-PRESSURE; EPIDEMIOLOGY; POPULATION; RATES; CHOLESTEROL	Background The incidence of stroke is predicted to rise because of the rapidly ageing population. However, over the past two decades, findings of randomised trials have identified several interventions that are effective in prevention of stroke. Reliable data on time-trends in stroke incidence, major risk factors, and use of preventive treatments in an ageing population are required to ascertain whether implementation of preventive strategies can offset the predicted rise in stroke incidence. We aimed to obtain these data. Methods We ascertained changes in incidence of transient ischaemic attack and stroke, risk factors, and premorbid use of preventive treatments from 1981-84 (Oxford Community Stroke Project; OCSP) to 2002-04 (Oxford Vascular Study; OXVASC). Findings Of 476 patients with transient ischaemic attacks or strokes in OXVASC, 262 strokes and 93 transient ischaemic attacks were incident events. Despite more complete case-ascertainment than in OCSP, age-adjusted and sex-adjusted incidence of first-ever stroke fell by 29% (relative incidence 0.71, 95% Cl 0.61-0.83, p=0.0002). Incidence declined by more than 50% for primary intracerebral haemorrhage (0.47, 0.27-0.83, p=0.01) but was unchanged for subarachnoid haemorrhage (0.83, 0.44-1.57, p=0.57). Thus, although 28% more incident strokes (366 vs 286) were expected in OXVASC due to demographic change alone (33% increase in those aged 75 or older), the observed number fell (262 vs 286). Major reductions were recorded in mortality rates for incident stroke (0.63, 0.44-0.90, p=0.02) and in incidence of disabling or fatal stroke (0.60, 0.50-0.73, p<0.0001), but no change was seen in case-fatality due to incident stroke (17.2% vs 17.8%; age and sex adjusted relative risk 0.85, 95% Cl 0.57-1.28, p=0-45). Comparison of premorbid risk factors revealed substantial reductions in the proportion of smokers, mean total cholesterol, and mean systolic and diastolic blood pressures and major increases in premorbid treatment with antiplatelet, lipid-lowering, and blood pressure lowering drugs (all p<0.0001). Interpretation The age-specific incidence of major stroke in Oxfordshire has fallen by 40% over the past 20 years in association with increased use of preventive treatments and major reductions in premorbid risk factors.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Care, Oxford, England; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; St James Hosp, Dept Neurol, Leeds LS9 7TF, W Yorkshire, England; Radcliffe Infirm, Dept Neuroradiol, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; University of Edinburgh; Saint James's University Hospital; Radcliffe Infirmary	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Woodstock Rd, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Bamford, John/ABE-6218-2021; Mant, David CA/C-7763-2009; Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; sackley, catherine/0000-0002-8580-6622; Edwards, Phil/0000-0003-4431-8822	Medical Research Council [G0500987] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acheson E.D., 1967, MED RECORD LINKAGE; [Anonymous], 2001, 2001 CENSUS AREA STA; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BONITA R, 1990, STROKE, V21, P989, DOI 10.1161/01.STR.21.7.989; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Broderick J P, 1993, Ann Epidemiol, V3, P476; Brown RD, 1996, STROKE, V27, P373; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; DENNIS MS, 1989, STROKE, V20, P333, DOI 10.1161/01.STR.20.3.333; Department of the Environment, 2000, IND DEPR; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; FEIGIN VL, 1995, STROKE, V26, P924, DOI 10.1161/01.STR.26.6.924; Gillum RF, 1997, STROKE, V28, P1527, DOI 10.1161/01.STR.28.8.1527; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Jamrozik K, 1999, STROKE, V30, P2105, DOI 10.1161/01.STR.30.10.2105; Johansson B, 2000, STROKE, V31, P481, DOI 10.1161/01.STR.31.2.481; JORGENSEN HS, 1992, STROKE, V23, P1701, DOI 10.1161/01.STR.23.12.1701; Kodama K, 1993, Ann Epidemiol, V3, P524; Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; Lemesle M, 1999, STROKE, V30, P371, DOI 10.1161/01.STR.30.2.371; MCGOVERN PG, 1992, JAMA-J AM MED ASSOC, V268, P753; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Morris RW, 2003, STROKE, V34, P2604, DOI 10.1161/01.STR.0000092489.98235.1D; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Neal B, 2000, LANCET, V356, P1955; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Rastenyte D, 1996, CEREBROVASC DIS, V6, P13, DOI 10.1159/000107986; Reitsma JB, 1998, NEUROEPIDEMIOLOGY, V17, P121, DOI 10.1159/000026163; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SCHOUTEN LJ, 1994, INT J EPIDEMIOL, V23, P1111, DOI 10.1093/ije/23.6.1111; STEGMAYR B, 1994, STROKE, V25, P1738, DOI 10.1161/01.STR.25.9.1738; Stegmayr B, 1996, J INTERN MED, V240, P143, DOI 10.1046/j.1365-2796.1996.519857000.x; Terent A, 2003, STROKE, V34, P1353, DOI 10.1161/01.STR.0000074038.71700.1C; TERENT A, 1988, STROKE, V19, P598, DOI 10.1161/01.STR.19.5.598; Thom T J, 1993, Ann Epidemiol, V3, P509; Tuomilehto J, 1993, Ann Epidemiol, V3, P519; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	47	783	797	2	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2004	363	9425					1925	1933		10.1016/S0140-6736(04)16405-2	http://dx.doi.org/10.1016/S0140-6736(04)16405-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GW	15194251				2022-12-01	WOS:000221962800006
J	Ricci, JE; Munoz-Pinedo, C; Fitzgerald, P; Bailly-Maitre, B; Perkins, GA; Yadava, N; Scheffler, IE; Ellisman, MH; Green, DR				Ricci, JE; Munoz-Pinedo, C; Fitzgerald, P; Bailly-Maitre, B; Perkins, GA; Yadava, N; Scheffler, IE; Ellisman, MH; Green, DR			Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain	CELL			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; BOVINE HEART-MITOCHONDRIA; PROGRAMMED CELL-DEATH; PHOSPHATIDYLSERINE EXPOSURE; DEPENDENT FORMATION; HL-60 CELLS; MEMBRANE; GENERATION; ACTIVATION	Mitochondrial outer membrane permeabilization and cytochrome c release promote caspase activation and execution of apoptosis through cleavage of specific caspase substrates in the cell. Among the first targets of activated caspases are the permeabilized mitochondria themselves, leading to disruption of electron transport, loss of mitochondrial transmembrane potential (Deltapsim), decline in ATP levels, production of reactive oxygen species (ROS), and loss of mitochondrial structural integrity. Here, we identify NDUFS1, the 75 kDa subunit of respiratory complex 1, as a critical caspase substrate in the mitochondria. Cells expressing a noncleavable mutant of p75 sustain Deltapsim and ATP levels during apoptosis, and ROS production in response to apoptotic stimuli is dampened. While cytochrome c release and DNA fragmentation are unaffected by the noncleavable p75 mutant, mitochondrial morphology of dying cells is maintained, and loss of plasma membrane integrity is delayed. Therefore, caspase cleavage of NDUFS1 is required for several mitochondrial changes associated with apoptosis.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Burnham Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org	RICCI, Jean Ehrland/AAS-4379-2020; Ricci, Jean Ehrland/I-7117-2016; Green, Douglas R/N-8083-2018; Munoz-Pinedo, Cristina/B-6118-2008	RICCI, Jean Ehrland/0000-0003-1585-8117; Ricci, Jean Ehrland/0000-0003-1585-8117; Green, Douglas R/0000-0002-7332-1417; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Bailly-Maitre, Beatrice/0000-0002-8389-8498; Perkins, Guy/0000-0002-1834-6646	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI047891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014718] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NCRR NIH HHS [P41 RR04050] Funding Source: Medline; NIAID NIH HHS [AI47891, AI40646] Funding Source: Medline; NIGMS NIH HHS [GM52735] Funding Source: Medline; NINDS NIH HHS [R01 NS14718] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Dinsdale D, 1999, AM J PATHOL, V155, P607, DOI 10.1016/S0002-9440(10)65156-5; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gleiss B, 2002, FEBS LETT, V519, P153, DOI 10.1016/S0014-5793(02)02743-6; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Matsura T, 2002, FEBS LETT, V524, P25, DOI 10.1016/S0014-5793(02)02990-3; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; OHNISHI T, 1985, J BIOL CHEM, V260, P2782; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Rudel T, 1998, J IMMUNOL, V160, P7; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SMITH S, 1980, BIOCHEM J, V185, P315, DOI 10.1042/bj1850315; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Uthaisang W, 2003, FEBS LETT, V545, P110, DOI 10.1016/S0014-5793(03)00508-8; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhuang JG, 1998, CELL DEATH DIFFER, V5, P953, DOI 10.1038/sj.cdd.4400440; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; [No title captured]	50	449	463	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					773	786		10.1016/j.cell.2004.05.008	http://dx.doi.org/10.1016/j.cell.2004.05.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186778	Bronze			2022-12-01	WOS:000222048400010
J	Huxman, TE; Smith, MD; Fay, PA; Knapp, AK; Shaw, MR; Loik, ME; Smith, SD; Tissue, DT; Zak, JC; Weltzin, JF; Pockman, WT; Sala, OE; Haddad, BM; Harte, J; Koch, GW; Schwinning, S; Small, EE; Williams, DG				Huxman, TE; Smith, MD; Fay, PA; Knapp, AK; Shaw, MR; Loik, ME; Smith, SD; Tissue, DT; Zak, JC; Weltzin, JF; Pockman, WT; Sala, OE; Haddad, BM; Harte, J; Koch, GW; Schwinning, S; Small, EE; Williams, DG			Convergence across biomes to a common rain-use efficiency	NATURE			English	Article							UNITED-STATES; ELEVATED CO2; ECOSYSTEMS; PRODUCTIVITY; DYNAMICS; GRADIENT; SHRUBS; STEPPE	Water availability limits plant growth and production in almost all terrestrial ecosystems(1-5). However, biomes differ substantially in sensitivity of aboveground net primary production ( ANPP) to between-year variation in precipitation(6-8). Average rain-use efficiency ( RUE; ANPP/precipitation) also varies between biomes, supposedly because of differences in vegetation structure and/or biogeochemical constraints(8). Here we show that RUE decreases across biomes as mean annual precipitation increases. However, during the driest years at each site, there is convergence to a common maximum RUE (RUEmax) that is typical of arid ecosystems. RUEmax was also identified by experimentally altering the degree of limitation by water and other resources. Thus, in years when water is most limiting, deserts, grasslands and forests all exhibit the same rate of biomass production per unit rainfall, despite differences in physiognomy and site-level RUE. Global climate models(9,10) predict increased between-year variability in precipitation, more frequent extreme drought events, and changes in temperature. Forecasts of future ecosystem behaviour should take into account this convergent feature of terrestrial biomes.	Univ Arizona, Tucson, AZ 85721 USA; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06511 USA; Nat Resources Res Inst, Duluth, MN 55811 USA; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA; Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; Univ Tennessee, Knoxville, TN 37919 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Buenos Aires, Fac Agron, Dept Ecol, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; Columbia Univ, Biosphere Ctr 2, Oracle, AZ 85623 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Wyoming, Laramie, WY 82071 USA	University of Arizona; National Center for Ecological Analysis & Synthesis; Yale University; Colorado State University; Carnegie Institution for Science; University of California System; University of California Santa Cruz; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Texas Tech University System; Texas Tech University; University of Tennessee System; University of Tennessee Knoxville; University of New Mexico; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California Berkeley; Northern Arizona University; Columbia University; University of Colorado System; University of Colorado Boulder; University of Wyoming	Huxman, TE (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	huxman@email.arizona.edu; melinda.smith@yale.edu	small, eric/B-4939-2011; Schwinning, Susanne/G-6412-2015; Knapp, Alan K/A-2931-2008; Pockman, William T/D-4086-2014; Small, eric/K-6007-2015; Williams, David G/A-6407-2014; Tissue, David T/N-1710-2019; Smith, Melinda D/J-8987-2014; Tissue, David T/H-6596-2015; Fay, Philip A./I-1853-2012; Tissue, David/AAA-8829-2019	Schwinning, Susanne/0000-0002-9740-0291; Pockman, William T/0000-0002-3286-0457; Williams, David G/0000-0003-3627-5260; Tissue, David T/0000-0002-8497-2047; Fay, Philip A./0000-0002-8291-6316; Tissue, David/0000-0002-8497-2047; Small, ERIC/0000-0002-5010-4954; Sala, Osvaldo/0000-0003-0142-9450				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2001, CLIMATE CHANGE 2001; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Chapin III F. S., 2011, PRINCIPLES TERRESTRI; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ehleringer JR, 2001, TERRESTRIAL GLOBAL P, P345, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50016-8]; Ehleringer JR, 1983, ENCY PLANT PHYSL D, V12D, P205; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Jobbagy EG, 2000, ECOL APPL, V10, P541, DOI 10.1890/1051-0761(2000)010[0541:COGASA]2.0.CO;2; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; LEHOUEROU HN, 1998, J ARID ENVIRON, V15, P1; Lieth H., 2012, PRIMARY PRODUCTIVITY, V14, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12, 10.1007/978-3-642-80913-2, DOI 10.1007/978-3-642-80913-2]; NOYMEIR I, 1973, ANNU REV ECOL SYST, V4, P51; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SEASTEDT TR, 1993, AM NAT, V141, P421; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Smith S.D., 1997, PHYSIOLOGICAL ECOLOG; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; TURNER FB, 1989, J ARID ENVIRON, V17, P23, DOI 10.1016/S0140-1963(18)30921-2; Veron SR, 2002, ECOSYSTEMS, V5, P625, DOI 10.1007/s10021-002-0145-1; WALTER HEINRICH, 1939, JAHRB WISS BOT, V87, P750; WEBB WL, 1983, ECOLOGY, V64, P134, DOI 10.2307/1937336	30	810	881	25	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					651	654		10.1038/nature02561	http://dx.doi.org/10.1038/nature02561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190350				2022-12-01	WOS:000221912600038
J	Gostin, LO				Gostin, LO			International Infectious Disease Law - Revision of the World Health Organization's International Health Regulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The International Health Regulations (IHR), the only global regulations for infectious disease control, have not been significantly changed since they were first issued in 1951. The World Health Organization (WHO) is currently engaged in a process to modernize the IHR. This article reviews WHO's draft revised IHR and recommends new reforms to improve global health; which include (1) a robust mission, emphasizing the WHO's core public health purposes, functions, and essential services; (2) broad scope, flexibly covering diverse health threats; (3) global surveillance, developing informational networks of official and unofficial data sources; (4) national public health systems, setting performance criteria, measuring outcomes, and holding states accountable; (5) human rights protection; setting science-based standards and fair procedures; and (6) good governance, adopting the principles of fairness, objectivity, and transparency. The WHO should ensure state compliance with health norms and generous economic and technical assistance to poorer countries. An important issue for the international community is how sovereign countries can join together to make global health work for everyone, the poor and the wealthy alike.	Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						[Anonymous], 1996, NEBR LAW REV, V75, P181; Arai-Takahashi Y, 2001, LAW PUBLIC DIMENSION, P113; Ashraf H, 1999, LANCET, V354, P2062, DOI 10.1016/S0140-6736(05)76812-4; Fidler D. P, 1999, INT LAW INFECT DIS; Fidler DP, 2003, J LAW MED ETHICS, V31, P485, DOI 10.1111/j.1748-720X.2003.tb00117.x; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Gostin LO, 2000, PUBLIC HLTH LAW POWE; GOSTIN LO, 2003, FLORIDA LAW REV, V52, P1; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; HEYMANN D, 2002, OXFORD TXB PUBLIC HL, P171; *I MED, 2003, MICR TRHEATS HLTH EM; *INT WORK GROUP RE, 2003, 12 IGWGIHR WHO; Klempner MS, 2004, NEW ENGL J MED, V350, P1171, DOI 10.1056/NEJMp048039; Koh H. H., 1997, YALE L J, V106, P2599, DOI DOI 10.2307/797228; Slaughter Anne-Marie., 2004, NEW WORLD ORDER; TAYLOR AL, 2002, OXFORD TXB PUBLIC HL, P359; *URB MORG I, 1985, HUM RIGHTS Q, V7, P3; WHO, 1997, MID IMP US ANT FOOD; WHO, 2002, WHOCDSCSRGAR20024, P6; *WHO, 1995, PUBL WHO; *WHO, 1999, WKLY EPIDEMIOL REC, V74, P193; *WHO, 2000, GLOB DAT BLOOD SAF 1; *WHO, 2003, PUBL WHO; *WHO, 2003, WHO BAS DOC; *WHO SECR, 2004, PUBL WHO; *WHO SECR, 2003, PUBL WHO; *WHO SECR, 2002, PUBL WHO	27	54	54	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2004	291	21					2623	2627		10.1001/jama.291.21.2623	http://dx.doi.org/10.1001/jama.291.21.2623			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825EM	15173154				2022-12-01	WOS:000221738800026
J	Yach, D; Hawkes, C; Gould, CL; Hofman, KJ				Yach, D; Hawkes, C; Gould, CL; Hofman, KJ			The global burden of chronic diseases - Overcoming impediments to prevention and control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH; CHALLENGES; DEATHS	Chronic diseases are the largest cause of death in the world. In 2002, the leading chronic diseases-cardiovascular disease, cancer, chronic respiratory disease, and diabetes-caused 29 million deaths worldwide. Despite growing evidence of epidemiological and economic impact, the global response to the problem remains inadequate. Stakeholders include governments, the World Health Organization and other United Nations bodies, academic and research groups, nongovernmental organizations, and the private sector. Lack of financial support retards capacity development for prevention, treatment, and research in most developing countries. Reasons for this include that up-to-date evidence related to the nature of the burden of chronic diseases is not in the hands of decision makers and strong beliefs persist that chronic diseases afflict only the affluent and the elderly, that they arise solely from freely acquired risks, and that their control is ineffective and too expensive and should wait until infectious diseases are addressed. The influence of global economic factors on chronic disease risks impedes progress, as does the orientation of health systems toward acute care. We identify 3 policy levers to address these impediments: elevating chronic diseases on the health agenda of key policymakers, providing them with better evidence about risk factor control, and persuading them of the need for health systems change. A more concerted, strategic, and multisectoral policy approach, underpinned by solid research, is essential to help reverse the negative trends in the global incidence of chronic disease.	WHO, CH-1211 Geneva 27, Switzerland; US Natl Inst Hlth, Fogarty Int Ctr, Washington, DC USA	World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Yach, D (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	yachd@who.int	Stockwell, Tim/B-6662-2012	HOFMAN, KAREN/0000-0001-9512-7220				ALANO BP, 2003, GLOB FOR HLTH RES FO; [Anonymous], 2001, ASSESSMENT NATL CAPA; [Anonymous], 2003, WHO FRAM CONV TOB CO; [Anonymous], 2003, TOBACCO CONTROL POLI; [Anonymous], 2002, WORLD HLTH REP 2002; *AS DEV BANK, 1999, POL HLTH SECT; *B M GAT FDN, 2004, GLOB HLTH PROGR FACT; Babor T., 2003, ALCOHOL NO ORDINARY; Basnyat B, 2004, BMJ-BRIT MED J, V328, P781, DOI 10.1136/bmj.328.7443.781; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Bettcher DW, 2000, B WORLD HEALTH ORGAN, V78, P521; Brownell K. D., 2004, FOOD FIGHT INSIDE ST; BUMGARNER R, IN PRESS SOC PREV ME; Dodd R, 2002, POVERTY REDUCTION ST; FLECK R, 2004, BRIT MED J, V328, P730; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; *GLOB FOR HLTH RES, 2002, 10 99 REP HLTH RES 2, P89; *GLOB FOR HLTH RES, 2002, MONT FIN FLOWS HLTH; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Hawkes C., 2002, GLOBALIZATION DIETS; *IND COUNC MED RES, NONC DIS WEB PAG; Jha P, 2000, TOBACCO CONTROL DEV; Jha P, 1999, CURBING EPIDEMIC GOV; Leeder S, 2004, RACE TIME CHALLENGE; Mann J, 2004, LANCET, V363, P1068, DOI 10.1016/S0140-6736(04)15844-3; Marmot MG, 2004, BRIT MED J, V328, P906, DOI 10.1136/bmj.328.7445.906; McKeown T., 1988, ORIGINS HUMAN DIS; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; Nchinda TC, 2002, SOC SCI MED, V54, P1699, DOI 10.1016/S0277-9536(01)00338-0; Organization WH, 2003, INT PREV NONC DIS DR; PENA M, 2000, PAN AM HLTH ORG SCI, V576, P3; Popkin BM, 1998, NUTR REV, V56, P106; RAMESH A, 1999, EC ANAL HLTH SECTOR, P8; *ROCK FDN, 2000, ROCK FDN LAUNCH NEW; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sklar P, 2003, NEW ENGL J MED, V349, P2065, DOI 10.1056/NEJMe038158; Stewart B, 2003, WORLD CANC REPORT; STEYN K, 2003, DETERMINANTS TREATME; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Tsalikian E, 2004, DIABETES CARE, V27, P722; *UN GLOB COMP, 2001, GUID GLOB COMP PRACT; *UN POP FUND, SUMM ICPD PROGR ACT; UNCTAD, 2003, WORLD INVESTMENT REP, P114; *UNDP, IMPL MILL DECL GOAL; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Wakefield M, 2003, ADDICTION, V98, P79, DOI 10.1046/j.1360-0443.98.s1.6.x; Wanless, 2002, SECURING OUR FUTURE; *WHO, 2000, TOB CO STRAT UND TOB, V46, P116; *WHO, 1956, 9 WORLD HLTH ASS GEN; *WHO, 2000, 53 WORLD HLTH ASS MA; *WHO, 1999, UN FDN PROJ BUILD AL; *WHO, 2003, FIN MAN REP EXP IMPL; *WHO DEP GOV PRIV, 2003, BIL AID GUID; WHO/UNAIDS, 2003, TREAT 3 MILL 2005 MA; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilkinson RG, 2003, SOCIAL DETERMINANTS; World Bank, 1997, HLTH NUTR POP SECT S; World Health Organization, 2003, INTRO DRUG UTILIZATI; World Health Organization, 2002, WHO STRAT PREV CONTR; World Health Organization (WHO), 2002, INN CAR CHRON COND B; YACH D, 1990, INT J EPIDEMIOL, V19, P1122, DOI 10.1093/ije/19.4.1122; Yach D, 2003, J PUBLIC HEALTH POL, V24, P274, DOI 10.2307/3343374; YACH D, IN PRESS SOCIAL JUST; 2000, LANCET, V355, P1923; 2000, G8 COMMUNIQUE; 2004, MANDAG MORGEN   0209	68	853	895	1	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2004	291	21					2616	2622		10.1001/jama.291.21.2616	http://dx.doi.org/10.1001/jama.291.21.2616			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825EM	15173153				2022-12-01	WOS:000221738800025
J	George, S; Rochford, JJ; Wolfrum, C; Gray, SL; Schinner, S; Wilson, JC; Soos, MA; Murgatroyd, PR; Williams, RM; Acerini, CL; Dunger, DB; Barford, D; Umpleby, AM; Wareham, NJ; Davies, HA; Schafer, AJ; Stoffel, M; O'Rahilly, S; Barroso, I				George, S; Rochford, JJ; Wolfrum, C; Gray, SL; Schinner, S; Wilson, JC; Soos, MA; Murgatroyd, PR; Williams, RM; Acerini, CL; Dunger, DB; Barford, D; Umpleby, AM; Wareham, NJ; Davies, HA; Schafer, AJ; Stoffel, M; O'Rahilly, S; Barroso, I			A family with severe insulin resistance and diabetes due to a mutation in AKT2	SCIENCE			English	Article							STRUCTURAL BASIS; MICE LACKING; KINASE; HYPERTENSION; GENETICS; MELLITUS; BETA; PKB	Inherited defects in signaling pathways downstream of the insulin receptor have long been suggested to contribute to human type 2 diabetes mellitus. Here we describe a mutation in the gene encoding the protein kinase AKT2/PKBbeta in a family that shows autosomal dominant inheritance of severe insulin resistance and diabetes mellitus. Expression of the mutant kinase in cultured cells disrupted insulin signaling to metabolic end points and inhibited the function of coexpressed, wild-type AKT. These findings demonstrate the central importance of AKT signaling to insulin sensitivity in humans.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Guys Kings & St Thomas Sch Med, Dept Diabet Endocrinol & Internal Med, London, England; MRC, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England; Darent Valley Hosp, Dartford DA2 8DA, Kent, England; Incyte, Palo Alto, CA 94304 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Rockefeller University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; Incyte; Wellcome Trust Sanger Institute	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Hills Rd, Cambridge CB2 2QQ, England.	sorahill@hgmp.mrc.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Dunger, Professor David/0000-0002-2566-9304; Barroso, Ines/0000-0001-5800-4520; Rochford, Justin/0000-0002-5020-4939; Stoffel, Markus/0000-0003-1304-5817; Acerini, Carlo/0000-0003-2121-5871; Wolfrum, Christian/0000-0002-3862-6805	Wellcome Trust [078986] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Baynes KCR, 1997, QJM-MON J ASSOC PHYS, V90, P557, DOI 10.1093/qjmed/90.9.557; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gloyn AL, 2001, BEST PRACT RES CL EN, V15, P293, DOI 10.1053/beem.2001.0147; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; McCarthy M I, 2001, Expert Rev Mol Diagn, V1, P403, DOI 10.1586/14737159.1.4.403; Pedersen O, 1999, EXP CLIN ENDOCR DIAB, V107, P113, DOI 10.1055/s-0029-1212085; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vihinen M, 2000, CLIN IMMUNOL, V96, P108, DOI 10.1006/clim.2000.4880; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870	18	399	423	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1325	1328		10.1126/science.1096706	http://dx.doi.org/10.1126/science.1096706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166380	Green Accepted			2022-12-01	WOS:000221669600055
J	Finke, DL; Denno, RF				Finke, DL; Denno, RF			Predator diversity dampens trophic cascades	NATURE			English	Article							INTRAGUILD PREDATION; SPECIES RICHNESS; FOOD WEBS; ECOSYSTEM PROCESSES; BIODIVERSITY; PRODUCTIVITY; SUPPRESSION; VEGETATION; ECOLOGY	Food web complexity is thought to weaken the strength of terrestrial trophic cascades(1-3) in which strong impacts of natural enemies on herbivores cascade to influence primary production indirectly(4). Predator diversity can enhance food web complexity because predators may feed on each other and on shared prey(5-7). In such cases, theory suggests that the impact of predation on herbivores relaxes and cascading effects on basal resources are dampened(8,9). Despite this view, no empirical studies have explicitly investigated the role of predator diversity in mediating primary productivity in a natural terrestrial system(10,11). Here we compare, in a coastal marsh community, impacts of arthropod predators on herbivores and plant productivity between a simple food web with a single predator species and a complex food web with a diverse predator assemblage. We show that enhancing predator diversity dampens enemy effects on herbivores and weakens trophic cascades. Consequently, changes in diversity at higher trophic levels can significantly alter ecosystem function in natural systems.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Finke, DL (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	dfinke@umd.edu						Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DENNO RF, IN PRESS ECOL ENTOMO; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Fraser LH, 1998, OECOLOGIA, V113, P239, DOI 10.1007/s004420050374; Gutierrez JR, 1997, OECOLOGIA, V109, P398, DOI 10.1007/s004420050099; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; Hart DR, 2002, J THEOR BIOL, V218, P111, DOI 10.1006/jtbi.2002.3053; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; LANGELLOTTO G. A., 2002, THESIS U MARYLAND; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MORIN PJ, 1995, ANNU REV ECOL SYST, V26, P505, DOI 10.1146/annurev.es.26.110195.002445; Mulder CPH, 1999, ECOL LETT, V2, P237; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Norberg J, 2000, OECOLOGIA, V122, P264, DOI 10.1007/PL00008855; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391	30	408	426	5	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2004	429	6990					407	410		10.1038/nature02554	http://dx.doi.org/10.1038/nature02554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164061				2022-12-01	WOS:000221644600037
J	Tamkins, T				Tamkins, T			South Koreans create human stem cell line using nuclear transfer	LANCET			English	News Item																			0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 21	2004	363	9409					623	623		10.1016/S0140-6736(04)15628-6	http://dx.doi.org/10.1016/S0140-6736(04)15628-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	776EZ	15202474				2022-12-01	WOS:000189104900014
J	Davis, CC; Wurdack, KJ				Davis, CC; Wurdack, KJ			Host-to-parasite gene transfer in flowering plants: Phylogenetic evidence from malpighiales	SCIENCE			English	Article							MITOCHONDRIAL; RAFFLESIA	Horizontal gene transfer (HGT) between sexually unrelated species has recently been documented for higher plants, but mechanistic explanations for HGTs have remained speculative. We show that a parasitic relationship may facilitate HGT between flowering plants. The endophytic parasites Rafflesiaceae are placed in the diverse order Malpighiales. Our multigene phylogenetic analyses of Malpighiales show that mitochrodrial ( matR) and nuclear loci (18S ribosomal DNA and PHYC) place Rafflesiaceae in Malpighiales, perhaps near Ochnaceae/Clusiaceae. Mitochondrial nad1B-C, however, groups them within Vitaceae, near their obligate host Tetrastigma. These discordant phylogenetic hypotheses strongly suggest that part of the mitochondrial genome in Rafflesiaceae was acquired via HGT from their hosts.	Univ Michigan Herbarium, Ann Arbor, MI 48108 USA; Smithsonian Inst, Dept Bot, Suitland, MD 20746 USA; Smithsonian Inst, Labs Analyt Biol, Suitland, MD 20746 USA	University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian Institution	Davis, CC (corresponding author), Univ Michigan Herbarium, 3600 Vars Dr, Ann Arbor, MI 48108 USA.	chdavis@umich.edu						Barkman TJ, 2004, P NATL ACAD SCI USA, V101, P787, DOI 10.1073/pnas.0305562101; BEAMAN RS, 1988, AM J BOT, V75, P1148, DOI 10.2307/2444098; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Cronquist A., 1981, INTEGRATED SYSTEM CL; Davis CC, 2004, AM J BOT, V91, P262, DOI 10.3732/ajb.91.2.262; Ingrouille MJ, 2002, BOT J LINN SOC, V138, P421, DOI 10.1046/j.1095-8339.2002.00028.x; KUIJT J., 1969, The biology of parasitic flowering plants. University of California Press, Berkeley.; NICKRENT DL, 1994, J MOL EVOL, V39, P62; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Stevens P.F., 2001, ANGIOSPERM PHYLOGENY; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Won H, 2003, P NATL ACAD SCI USA, V100, P10824, DOI 10.1073/pnas.1833775100	12	179	196	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					676	678		10.1126/science.1100671	http://dx.doi.org/10.1126/science.1100671			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15256617	Green Submitted			2022-12-01	WOS:000222992100051
J	Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG				Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG			Social parasitism by male-producing reproductive workers in a eusocial insect	NATURE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; BUMBLE BEES; MALE PARENTAGE; QUEEN CONFLICT; SEX-RATIOS; APIDAE; MICROSATELLITES; HYPNORUM; COLONIES; HONEYBEE	The evolution of extreme cooperation, as found in eusocial insects ( those with a worker caste), is potentially undermined by selfish reproduction among group members(1-3). In some eusocial Hymenoptera ( ants, bees and wasps), workers can produce male offspring from unfertilized eggs(4). Kin selection theory predicts levels of worker reproduction as a function of the relatedness structure of the workers' natal colony and the colony-level costs of worker reproduction(5,6). However, the theory has been only partially successful in explaining levels of worker reproduction(7-9). Here we show that workers of a eusocial bumble bee (Bombus terrestris) enter unrelated, conspecific colonies in which they then produce adult male offspring, and that such socially parasitic workers reproduce earlier and are significantly more reproductive and aggressive than resident workers that reproduce within their own colonies. Explaining levels of worker reproduction, and hence the potential of worker selfishness to undermine the evolution of cooperation, will therefore require more than simply a consideration of the kin-selected interests of resident workers. It will also require knowledge of the full set of reproductive options available to workers, including intraspecific social parasitism.	Zool Soc London, Inst Zool, London NW1 4RY, England	Zoological Society of London	Lopez-Vaamonde, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	carlos.lopez.vaamonde@ioz.ac.uk; andrew.bourke@ioz.ac.uk	Vaamonde, Carlos Lopez/A-5548-2009; Bourke, Andrew F. G./E-5271-2011	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Koning, Will/0000-0002-9895-1140				AKRE R D, 1976, Journal of the Kansas Entomological Society, V49, P63; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 1997, PHILOS T ROY SOC B, V352, P1921, DOI 10.1098/rstb.1997.0179; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; Brown MJF, 2003, MOL ECOL, V12, P1599, DOI 10.1046/j.1365-294X.2003.01840.x; BULMER MG, 1981, J THEOR BIOL, V93, P239, DOI 10.1016/0022-5193(81)90068-0; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Duchateau MJ, 1996, P 20 INT C ENT FIR, P404; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Foster KR, 2000, NATURE, V407, P692, DOI 10.1038/35037665; Goulson D., 2003, BUMBLEBEES THEIR BEH; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammond RL, 2003, J EVOLUTION BIOL, V16, P446, DOI 10.1046/j.1420-9101.2003.00544.x; HARDER LD, 1986, HOLARCTIC ECOL, V9, P99; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Keller L, 1999, LEVELS SELECTION EVO; Lopez-Vaamonde C, 2003, ANIM BEHAV, V66, P577, DOI 10.1006/anbe.2003.2205; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Moritz RFA, 2004, ANIM BEHAV, V67, P681, DOI 10.1016/j.anbehav.2003.08.004; OWEN RE, 1982, BEHAV ECOL SOCIOBIOL, V11, P91, DOI 10.1007/BF00300097; Paxton RJ, 2001, MOL ECOL, V10, P2489, DOI 10.1046/j.0962-1083 .2001.01377.x; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; Toth E, 2004, INSECT SOC, V51, P1, DOI 10.1007/s00040-003-0707-z; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847	30	124	127	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					557	560		10.1038/nature02769	http://dx.doi.org/10.1038/nature02769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282605				2022-12-01	WOS:000222946100047
J	Shah, NP; Tran, C; Lee, FY; Chen, P; Norris, D; Sawyers, CL				Shah, NP; Tran, C; Lee, FY; Chen, P; Norris, D; Sawyers, CL			Overriding imatinib resistance with a novel ABL kinase inhibitor	SCIENCE			English	Article							CHRONIC MYELOID-LEUKEMIA; BCR-ABL; TYROSINE KINASE; CLINICAL RESISTANCE; CHRONIC-PHASE; MUTATIONS; STI-571; STI571; CELLS; GENE	Resistance to the ABL kinase inhibitor imatinib (STI571 or Gleevec) in chronic myeloid leukemia (CML) occurs through selection for tumor cells harboring BCR-ABL kinase domain point mutations that interfere with drug binding. Crystallographic studies predict that most imatinib-resistant mutants should remain sensitive to inhibitors that bind ABL with less stringent conformational requirements. BMS-354825 is an orally bioavailable ABL kinase inhibitor with two-log increased potency relative to imatinib that retains activity against 14 of 15 imatinib-resistant BCR-ABL mutants. BMS-354825 prolongs survival of mice with BCR-ABL-driven disease and inhibits proliferation of BCR-ABL-positive bone marrow progenitor cells from patients with imatinib-sensitive and imatinib-resistant CML. These data illustrate how molecular insight into kinase inhibitor resistance can guide the design of second-generation targeted therapies.	Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Bristol Myers Squibb Oncol, Princeton, NJ USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Bristol-Myers Squibb	Sawyers, CL (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA.	csawyers@mednet.ucla.edu	Sawyers, Charles/G-5327-2016; Tran, Canh-Dung/D-4442-2011	Tran, Canh-Dung/0000-0002-1011-4226				Al-Ali HK, 2004, HEMATOL J, V5, P55, DOI 10.1038/sj.thj.6200319; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Deng M, 2001, BLOOD, V97, P3491, DOI 10.1182/blood.V97.11.3491; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Huron DR, 2003, CLIN CANCER RES, V9, P1267; La Rosee P, 2002, CANCER RES, V62, P7149; LOMBARDO LJ, UNPUB; Nagar B, 2002, CANCER RES, V62, P4236; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; ODA T, 1994, J BIOL CHEM, V269, P22925; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shah N. A. A., UNPUB; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288	22	1409	1502	5	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					399	401		10.1126/science.1099480	http://dx.doi.org/10.1126/science.1099480			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	837TE	15256671				2022-12-01	WOS:000222662400039
J	Lin, Z; Owen, AB; Altman, RB				Lin, Z; Owen, AB; Altman, RB			Genomic research and human subject privacy	SCIENCE			English	Editorial Material							DATABASE		Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Moffett Field, CA 94035 USA	Stanford University; Stanford University	Altman, RB (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	russ.altman@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; NIGMS NIH HHS [U01-GM61374] Funding Source: Medline; NLM NIH HHS [LM007033] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Anderlik MR, 2001, ANNU REV GENOM HUM G, V2, P401, DOI 10.1146/annurev.genom.2.1.401; [Anonymous], 2002, FED REGISTER, V67, P53181; Austin MA, 2003, GENET MED, V5, P451, DOI 10.1097/01.GIM.0000093976.08649.1B; Barbour V, 2003, LANCET, V361, P1734, DOI 10.1016/S0140-6736(03)13377-6; Carey L, 2002, ELECTROPHORESIS, V23, P1386, DOI 10.1002/1522-2683(200205)23:10<1386::AID-ELPS1386>3.0.CO;2-M; CASH HD, 2003, PAC S BIOCOMPUT, V8, P638; Chadwick R, 1999, BRIT MED J, V319, P441, DOI 10.1136/bmj.319.7207.441; Frank L, 2000, SCIENCE, V290, P31, DOI 10.1126/science.290.5489.31; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; LI WH, 1991, GENETICS, V129, P513; National Commission on the Future of DNA Evidence, 2000, FUT FOR DNA TEST PRE; Sankar P, 2003, ANNU REV MED, V54, P393, DOI 10.1146/annurev.med.54.101601.152131; Willenborg L., 2001, ELEMENTS STAT DISCLO	13	217	222	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					183	183		10.1126/science.1095019	http://dx.doi.org/10.1126/science.1095019			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247459				2022-12-01	WOS:000222501000030
J	Waldmann, H; Cobbold, S				Waldmann, H; Cobbold, S			Exploiting tolerance processes in transplantation	SCIENCE			English	Article							REGULATORY T-CELLS; DONOR BONE-MARROW; STAGE RENAL-DISEASE; ALLOGRAFT TOLERANCE; MONOCLONAL-ANTIBODY; LYMPHOHEMATOPOIETIC CHIMERISM; MULTIPLE-MYELOMA; CUTTING EDGE; INDUCTION; ANTIGEN	The full potential of organ transplantation has not yet been realized because of the hazards associated with the long-term use of immunosuppressive drugs. Modern research into mechanisms of immune tolerance offers the promise of reprogramming the immune system, so as to harness the body's natural tolerance mechanisms in the service of graft acceptance. This would allow the minimization of immunosuppressive treatment and offers the prospect of eventually weaning transplant recipients off their drugs.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Waldmann, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	herman.waldmann@path.ox.ac.uk	waldmann, herman/W-8051-2019; waldmann, herman/F-7412-2011	Waldmann, Herman/0000-0001-7519-6720; Cobbold, Stephen/0000-0003-1206-4880				Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Bemelman F, 1998, J IMMUNOL, V160, P2645; BENJAMIN RJ, 1986, NATURE, V320, P449, DOI 10.1038/320449a0; Billingham RE, 2003, TRANSPLANTATION, V76, P1409, DOI 10.1097/01.TP.0000102675.72061.88; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Calne R, 1998, LANCET, V351, P1701, DOI 10.1016/S0140-6736(05)77739-4; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0; Davies JD, 1996, J IMMUNOL, V156, P3602; Durham MM, 2000, J IMMUNOL, V165, P1, DOI 10.4049/jimmunol.165.1.1; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hale G, 1994, J Hematother, V3, P15, DOI 10.1089/scd.1.1994.3.15; Honey K, 1999, J IMMUNOL, V163, P4805; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; PEARSON TC, 1992, TRANSPLANTATION, V54, P475, DOI 10.1097/00007890-199209000-00018; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; Suciu-Foca N, 2003, TRANSPL IMMUNOL, V11, P235, DOI 10.1016/S0966-3274(03)00052-2; THOMAS FT, 1983, ANN SURG, V198, P370, DOI 10.1097/00000658-198309000-00013; Thomas JM, 1997, TRANSPLANTATION, V64, P124, DOI 10.1097/00007890-199707150-00022; Wekerle T, 1998, J EXP MED, V187, P2037, DOI 10.1084/jem.187.12.2037; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0	35	60	68	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					209	212		10.1126/science.1099538	http://dx.doi.org/10.1126/science.1099538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247471				2022-12-01	WOS:000222501000042
J	Ostrowski, SG; Van Bell, CT; Winograd, N; Ewing, AG				Ostrowski, SG; Van Bell, CT; Winograd, N; Ewing, AG			Mass spectrometric imaging of highly curved membranes during Tetrahymena mating	SCIENCE			English	Article							NONBILAYER LIPIDS; CELL-MEMBRANES; FUSION; SIMS; IDENTIFICATION; CONJUGATION; MICROSCOPY; PYRIFORMIS; CULTURES; SYSTEM	Biological membrane fusion is crucial to numerous cellular events, including sexual reproduction and exocytosis. Here, mass spectrometry images demonstrate that the low-curvature lipid phosphatidylcholine is diminished in the membrane regions between fusing Tetrahymena, where a multitude of highly curved fusion pores exist. Additionally, mass spectra and principal component analysis indicate that the fusion region contains elevated amounts of 2-aminoethylphosphonolipid, a high-curvature lipid. This evidence suggests that biological fusion involves and might in fact be driven by a heterogeneous redistribution of lipids at the fusion site.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Edinboro Univ, Dept Biol & Hlth Serv, Edinboro, PA 16444 USA; Penn State Univ, Dept Neural & Behav Sci, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania State System of Higher Education (PASSHE); Edinboro University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ostrowski, SG (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.		Ewing, Andrew G/A-3650-2009	Winograd, Nicholas/0000-0002-2690-7714	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002016] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB002016, R01 EB002016-11] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ANSELL GB, 1973, FORM FUNCTION PHOSPH, V3; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Cannon DM, 2000, J AM CHEM SOC, V122, P603, DOI 10.1021/ja992078p; Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i; CHANDRA S, 1992, BIOL CELL, V74, P31, DOI 10.1016/0248-4900(92)90006-M; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748; D'Onofrio TG, 2003, LANGMUIR, V19, P1618, DOI 10.1021/la026133a; Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; FRISCH A, 1978, BIOCHIM BIOPHYS ACTA, V506, P18, DOI 10.1016/0005-2736(78)90431-5; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Jackson J.E, 2003, USERS GUIDE PRINCIPA; McMahon JM, 1996, RAPID COMMUN MASS SP, V10, P335, DOI 10.1002/(SICI)1097-0231(199602)10:3<335::AID-RCM516>3.0.CO;2-W; OSTROWSKI S, UNPUB; Pacholski ML, 1998, RAPID COMMUN MASS SP, V12, P1232, DOI 10.1002/(SICI)1097-0231(19980930)12:18<1232::AID-RCM319>3.0.CO;2-G; PSCHEID P, 1981, J MICROSC-OXFORD, V121, P149, DOI 10.1111/j.1365-2818.1981.tb01208.x; Roddy TP, 2003, ANAL CHEM, V75, P4087, DOI 10.1021/ac026353t; Roddy TP, 2002, ANAL CHEM, V74, P4020, DOI 10.1021/ac025574w; Roddy TP, 2002, ANAL CHEM, V74, P4011, DOI 10.1021/ac0255734; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; THOMPSON GA, 1977, BIOCHIM BIOPHYS ACTA, V472, P55, DOI 10.1016/0304-4157(77)90014-4; THOMPSON GA, 1972, J PROTOZOOL, V19, P231, DOI 10.1111/j.1550-7408.1972.tb03442.x; WOLFE J, 1985, J CELL SCI, V73, P69; WOLFE J, 1982, J MORPHOL, V172, P159, DOI 10.1002/jmor.1051720204; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	27	270	273	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2004	305	5680					71	73		10.1126/science.1099791	http://dx.doi.org/10.1126/science.1099791			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232100	Green Accepted			2022-12-01	WOS:000222386000035
J	Huber, R; Ghilardi, MF; Massimini, M; Tononi, G				Huber, R; Ghilardi, MF; Massimini, M; Tononi, G			Local sleep and learning	NATURE			English	Article							MEMORY; EEG; CONSOLIDATION; STIMULATION; TOPOGRAPHY; RESONANCE; STATES; SKILL; FORMS	Human sleep is a global state whose functions remain unclear. During much of sleep, cortical neurons undergo slow oscillations in membrane potential, which appear in electroencephalograms as slow wave activity (SWA) of < 4 Hz(1). The amount of SWA is homeostatically regulated, increasing after wakefulness and returning to baseline during sleep(2). It has been suggested that SWA homeostasis may reflect synaptic changes underlying a cellular need for sleep(3). If this were so, inducing local synaptic changes should induce local SWA changes, and these should benefit neural function. Here we show that sleep homeostasis indeed has a local component, which can be triggered by a learning task involving specific brain regions. Furthermore, we show that the local increase in SWA after learning correlates with improved performance of the task after sleep. Thus, sleep homeostasis can be induced on a local level and can benefit performance.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu	Massimini, Marcello/T-8115-2017	Massimini, Marcello/0000-0003-2271-957X				Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Hoffman KL, 2002, TRENDS NEUROSCI, V25, P1, DOI 10.1016/S0166-2236(00)02005-1; Huber R, 2000, J NEUROPHYSIOL, V84, P1888, DOI 10.1152/jn.2000.84.4.1888; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; WALKER M, IN PRESS BEHAV BRAIN; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	30	1213	1228	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					78	81		10.1038/nature02663	http://dx.doi.org/10.1038/nature02663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15184907				2022-12-01	WOS:000222356800046
J	Emini, EA; Koff, WC				Emini, EA; Koff, WC			Developing an AIDS vaccine: Need, uncertainty, hope	SCIENCE			English	Editorial Material							VIRUS; HIV; TRANSMISSION; INFECTION; REVERSION; REGION; DESIGN; GP41		Int AIDS Vaccine Initiat, New York, NY 10038 USA	International AIDS Vaccine Initiative	Emini, EA (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10038 USA.							Blattner WA, 2004, J INFECT DIS, V189, P1793, DOI 10.1086/386306; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; UNAIDS, 2003, AIDS EP UPD 2003; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	12	36	37	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2004	304	5679					1913	1914		10.1126/science.1100368	http://dx.doi.org/10.1126/science.1100368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218131				2022-12-01	WOS:000222241600026
J	Freitag, M; Lee, DW; Kothe, GO; Pratt, RJ; Aramayo, R; Selker, EU				Freitag, M; Lee, DW; Kothe, GO; Pratt, RJ; Aramayo, R; Selker, EU			DNA methylation is independent of RNA interference in neurospora	SCIENCE			English	Article							GENOME; CRASSA; HP1		Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Texas A&M Univ, Coll Sci, Dept Biol, College Stn, TX 77843 USA	University of Oregon; Texas A&M University System; Texas A&M University College Station	Selker, EU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	selker@molbio.uoregon.edu		Aramayo, Rodolfo/0000-0001-9702-6204	NIGMS NIH HHS [GM58770, R01 GM058770, GM35690] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035690, R01GM035690, R01GM058770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; FREITAG M, UNPUB; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Matzke M, 2003, SCIENCE, V301, P1060, DOI 10.1126/science.1089047; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564	8	97	101	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1939	1939		10.1126/science.1099709	http://dx.doi.org/10.1126/science.1099709			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218142				2022-12-01	WOS:000222241600037
J	Sui, GC; El Bachir, A; Shi, YJ; Brignone, C; Wall, NR; Yin, P; Donohoe, M; Luke, MP; Calvo, D; Grossman, SR; Shi, Y				Sui, GC; El Bachir, A; Shi, YJ; Brignone, C; Wall, NR; Yin, P; Donohoe, M; Luke, MP; Calvo, D; Grossman, SR; Shi, Y			Yin Yang 1 is a negative regulator of p53	CELL			English	Article							TUMOR-SUPPRESSOR P53; TRANSCRIPTIONAL REPRESSION; ADENOVIRUS E1A; MDM2-DEFICIENT MICE; EMBRYONIC LETHALITY; TARGETED DISRUPTION; MAMMALIAN-CELLS; GENE-EXPRESSION; MDM2; YY1	Yin Yang 1 (YY1) is a transcription factor that plays an essential role in development. However, the full spectrum of YY1's functions and mechanism of action remains unclear. We find that YY1 ablation results in p53 accumulation due to a reduction of p53 ubiquitination in vivo. Conversely, YY1 overexpression stimulates p53 ubiquitination and degradation. Significantly, recombinant YY1 is sufficient to induce Hdm2-mediated p53 polyubiquitination in vitro, suggesting that this function of YY1 is independent of its transcriptional activity. We identify direct physical interactions of YY1 with Hdm2 and p53 and show that the basis for YY1-regulating p53 ubiquitination is its ability to facilitate Hdm2-p53 interaction. Importantly, the tumor suppressor p14(ARF) compromises the Hdm2-YY1 interaction, which is important for YY1 regulation of p53. Taken together, these findings identify YY1 as a potential cofactor for Hdm2 in the regulation of p53 homeostasis and suggest a possible role for YY1 in tumorigenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386; Sui, Guangchao/0000-0002-8164-5585	NATIONAL CANCER INSTITUTE [T32CA009031, R01CA107532, T32CA072320, F32CA097802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053874] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107532, F32CA097802, T32CA09031, T32CA72320, R01 CA107532-01] Funding Source: Medline; NIGMS NIH HHS [GM53874] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Cummins JM, 2004, NATURE, V416, P648; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; FIRE A, 1988, NATURE, V39, P806; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gurtu V, 1997, ANAL BIOCHEM, V251, P98, DOI 10.1006/abio.1997.2220; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUNA RMD, 1995, NATURE, V378, P203; MIYASHITA T, 1995, CELL, V80, P293; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	46	334	358	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					859	872		10.1016/j.cell.2004.06.004	http://dx.doi.org/10.1016/j.cell.2004.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210108	Bronze			2022-12-01	WOS:000222300200005
J	Ebbeling, CB; Sinclair, KB; Pereira, MA; Garcia-Lago, E; Feldman, HA; Ludwig, DS				Ebbeling, CB; Sinclair, KB; Pereira, MA; Garcia-Lago, E; Feldman, HA; Ludwig, DS			Compensation for energy intake from fast food among overweight and lean adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; RESTAURANT USE; PORTION SIZE; OBESE; DIETARY; CONSUMPTION; TRENDS; MEN	Context Fast food consumption has increased greatly among children in recent years, in tandem with the obesity epidemic. Fast food tends to promote a positive energy balance and, for this reason, may result in weight gain. However, if fast food and obesity are causally related, the question arises of why some children who frequently eat fast food do not become overweight. Objective To test the hypothesis that overweight adolescents are more susceptible to the adverse effects of fast food than lean adolescents. Design and Setting In study 1, we fed participants an "extra large" fast food meal in a naturalistic setting (a food court). The participants were instructed to eat as much or little as desired during this 1-hour meal. In study 2, we assessed energy intake under free-living conditions for 2 days when fast food was consumed and 2 days when it was not consumed. Data were collected in Boston, Mass, between July 2002 and March 2003. Participants Overweight (n=26) and lean (n=28) adolescents aged 13 to 17 years. Overweight was defined as a body mass index exceeding sex- and age-specific 85th percentiles based on the 2000 Centers for Disease Control and Prevention growth charts. Main Outcome Measures Energy intake determined by direct observation in study 1 and by unannounced 24-hour dietary recalls, administered by telephone, in study 2. Results In study 1, mean (SEM) energy intake from the fast food meal among all participants was extremely large (1652 [87] kcal), accounting for 61.6% (2.2%) of estimated daily energy requirements. Overweight participants ate more than lean participants whether energy was expressed in absolute terms (1860 [129] vs 1458 [107] kcal, P=.02) or relative to estimated daily energy requirements (66.5% [3.1%] vs 57.0% [2.9%], P=.03). In study 2, overweight participants consumed significantly more total energy on fast food days than non-fast food days (2703 [226] vs 2295 [162] kcal/d; +409 [142] kcal/d; P=.02), an effect that was not observed among lean participants (2575 [157] vs 2622 [191] kcal/d; -47 [173] kcal/d; P=.76). Conclusions In this study, adolescents overconsumed fast food regardless of body weight, although this phenomenon was especially pronounced in overweight participants. Moreover, overweight adolescents were less likely to compensate for the energy in fast food, by adjusting energy intake throughout the day, than their lean counterparts.	Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA	Harvard University; Boston Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Feldman, Henry/M-2302-2013	Pereira, Mark/0000-0002-6704-5276; Ludwig, David/0000-0003-3307-8544	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240, K01DK062237] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR02172] Funding Source: Medline; NIDDK NIH HHS [K01 DK62237, R01 DK59240] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], [No title captured]; BANDINI LG, 1990, AM J CLIN NUTR, V52, P421, DOI 10.1093/ajcn/52.3.421; Bandini LG, 1999, OBES RES, V7, P438, DOI 10.1002/j.1550-8528.1999.tb00431.x; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Brownell K. D., 2004, FOOD FIGHT INSIDE ST; DIETZ WH, 1991, J PEDIATR-US, V118, P146, DOI 10.1016/S0022-3476(05)81870-0; Diliberti N, 2004, OBES RES, V12, P562, DOI 10.1038/oby.2004.64; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; EDELMAN B, 1986, APPETITE, V7, P71, DOI 10.1016/S0195-6663(86)80043-5; Fisher JO, 2003, AM J CLIN NUTR, V77, P1164, DOI 10.1093/ajcn/77.5.1164; Freeland-Graves J, 2002, J AM DIET ASSOC, V102, P100, DOI 10.1016/S0002-8223(02)90030-1; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; GAZZANIGA JM, 1993, AM J CLIN NUTR, V58, P21, DOI 10.1093/ajcn/58.1.21; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; HEITMANN BL, 1995, BRIT MED J, V311, P986; Jeffery RW, 1998, AM J PUBLIC HEALTH, V88, P277, DOI 10.2105/AJPH.88.2.277; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Krebs-Smith SM, 2000, EUR J CLIN NUTR, V54, P281, DOI 10.1038/sj.ejcn.1600936; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; McCrory MA, 2002, J NUTR, V132, p3830S, DOI 10.1093/jn/132.12.3830S; McNutt SW, 1997, J ADOLESCENT HEALTH, V20, P27, DOI 10.1016/S1054-139X(96)00176-0; Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pate RR, 2003, PEDIATR EXERC SCI, V15, P257, DOI 10.1123/pes.15.3.257; Pereira MA, 2003, CIRCULATION, V107, pE7008; Pereira MA, 2001, PEDIATR CLIN N AM, V48, P969, DOI 10.1016/S0031-3955(05)70351-5; Rolls BJ, 1999, AM J CLIN NUTR, V69, P863; Rolls BJ, 2004, APPETITE, V42, P63, DOI 10.1016/S0195-6663(03)00117-X; St-Onge MP, 2003, AM J CLIN NUTR, V78, P1068, DOI 10.1093/ajcn/78.6.1068; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; 1989, N ENGL J MED, V321, P752	35	140	146	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2004	291	23					2828	2833		10.1001/jama.291.23.2828	http://dx.doi.org/10.1001/jama.291.23.2828			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GT	15199032	Bronze			2022-12-01	WOS:000221962500027
J	Chen, YH; Li, MH; Zhang, Y; He, LL; Yamada, Y; Fitzmaurice, A; Shen, Y; Zhang, HL; Tong, L; Yang, J				Chen, YH; Li, MH; Zhang, Y; He, LL; Yamada, Y; Fitzmaurice, A; Shen, Y; Zhang, HL; Tong, L; Yang, J			Structural basis of the alpha(1)-beta subunit interaction of voltage-gated Ca2+ channels	NATURE			English	Article							GUANYLATE KINASE; CALCIUM-CHANNELS; PROTEINS; IDENTIFICATION; ASSOCIATION; DIFFRACTION; DOMAINS; PROGRAM; PSD-95; MODELS	High-voltage-activated Ca2+ channels are essential for diverse biological processes. They are composed of four or five subunits, including alpha(1), alpha(2)-delta, beta and gamma ( ref. 1). Their expression and function are critically dependent on the beta-subunit, which transports alpha(1) to the surfacemembrane and regulates diverse channel properties(2-4). It is believed(3-6) that the beta-subunit interacts with alpha(1) primarily through the beta-interaction domain (BID), which binds directly to the alpha-interaction domain (AID) of alpha(1)(7); however, the molecular mechanism of the alpha(1)-beta interaction is largely unclear. Here we report the crystal structures of the conserved core region of b 3, alone and in complex with AID, and of b 4 alone. The structures show that the beta-subunit core contains two interacting domains: a Src homology 3 (SH3) domain and a guanylate kinase (GK) domain. The AID binds to a hydrophobic groove in the GK domain through extensive interactions, conferring extremely high affinity between alpha(1) and beta-subunits(4,8). The BID is essential both for the structural integrity of and for bridging the SH3 and GK domains, but it does not participate directly in binding alpha(1). The presence of multiple protein-interactingmodules in the beta-subunit opens a new dimension to its function as a multi-functional protein.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jy160@columbia.edu	Tuluc, Petronel/C-2527-2011	Tong, Liang/0000-0002-0563-6468				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DOLPHIN AC, 2003, J BIOENERG BIOMEMBR, V55, P607; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	30	239	249	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					675	680		10.1038/nature02641	http://dx.doi.org/10.1038/nature02641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15170217				2022-12-01	WOS:000221912600045
J	Lipton, SA				Lipton, SA			Erythropoietin for neurologic protection and diabetic neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRAIN		Salk Inst Biol Studies, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Salk Institute; Scripps Research Institute; University of California System; University of California San Diego	Lipton, SA (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Lipton, Stuart/0000-0002-3490-1259				Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; DIGICAYLIOGLU M, IN PRESS P NATL ACAD; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029	6	45	52	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2004	350	24					2516	2517		10.1056/NEJMcibr041121	http://dx.doi.org/10.1056/NEJMcibr041121			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	827GH	15190146				2022-12-01	WOS:000221887200014
J	Roca, AL; Bar-Gal, GK; Eizirik, E; Helgen, KM; Maria, R; Springer, MS; O'Brien, SJ; Murphy, WJ				Roca, AL; Bar-Gal, GK; Eizirik, E; Helgen, KM; Maria, R; Springer, MS; O'Brien, SJ; Murphy, WJ			Mesozoic origin for West Indian insectivores	NATURE			English	Article							MOLECULAR EVIDENCE; BIOGEOGRAPHY; EVOLUTION; MAMMALS; VERTEBRATES; PHYLOGENY; ORDER	The highly endangered solenodons, endemic to Cuba ( Solenodon cubanus) and Hispaniola ( S. paradoxus), comprise the only two surviving species of West Indian insectivores(1,2). Combined gene sequences (13.9 kilobases) from S. paradoxus established that solenodons diverged from other eulipotyphlan insectivores 76 million years ago in the Cretaceous period, which is consistent with vicariance, though also compatible with dispersal. A sequence of 1.6 kilobases of mitochondrial DNA from S. cubanus indicated a deep divergence of 25 million years versus the congeneric S. paradoxus, which is consistent with vicariant origins as tectonic forces separated Cuba and Hispaniola(3,4). Efforts to prevent extinction of the two surviving solenodon species would conserve an entire lineage as old or older than many mammalian orders.	SAIC Frederick, Lab Genom Divers, Basic Res Program, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Pontificia Univ Catolica Rio Grande do Sul, Ctr Biol Genom & Mol, Porto Alegre, RS, Brazil; Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; ZOODOM, Parque Zool Nacl, Santo Domingo, Dominican Rep; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pontificia Universidade Catolica Do Rio Grande Do Sul; University of Adelaide; University of California System; University of California Riverside	Roca, AL (corresponding author), SAIC Frederick, Lab Genom Divers, Basic Res Program, Frederick, MD 21702 USA.	roca@ncifcrf.gov; obrien@ncifcrf.gov; murphywi@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Eizirik, Eduardo/K-8034-2012; Helgen, Kristofer M./AAB-8348-2019	Eizirik, Eduardo/0000-0002-9658-0999; Helgen, Kristofer M./0000-0002-8776-4040; OBRIEN, STEPHEN/0000-0001-7857-0757; Roca, Alfred/0000-0001-9217-5593				ACTON GD, 2000, P OCEAN DRILLING PRO, V165, P149; Asher RJ, 1999, CLADISTICS, V15, P231, DOI 10.1111/j.1096-0031.1999.tb00266.x; Asher RJ, 2002, B AM MUS NAT HIST, P1; BUTLER PM, 1988, PHYLOGENY CLASSIFICA, V2, P117; Cabrera A., 1925, GENERA MAMMALIUM INS; Donnelly Thomas W., 1992, P1; Eisenberg J.F., 1985, ACTA ZOOL FENN, V173, P275; Emerson GL, 1999, CLADISTICS, V15, P221, DOI 10.1111/j.1096-0031.1999.tb00265.x; HEDGES SB, 1992, P NATL ACAD SCI USA, V89, P1909, DOI 10.1073/pnas.89.5.1909; Hedges SB, 1996, ANNU REV ECOL SYST, V27, P163, DOI 10.1146/annurev.ecolsys.27.1.163; HEDGES SB, 1993, MOL PHYLOGENET EVOL, V2, P76, DOI 10.1006/mpev.1993.1008; Hershkovitz P., 1972, EVOLUTION MAMMALS SO, P311; *INT UN CONS NAT, 2003 IUCN RED LIST T; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LILLEGRAVEN J A, 1981, University of Wyoming Publications, V45, P1; MACFADDEN BJ, 1980, J BIOGEOGR, V7, P11, DOI 10.2307/2844544; MacPhee R.D.E., 1999, American Museum Novitates, V3261, P1; MACPHEE RDE, 1993, MAMMAL PHYLOGENY : PLACENTALS, P13; MCDOWELL SAMUEL BOOKER, 1958, BULL AMER MUS NAT HIST, V115, P113; McKenna MC, 1997, CLASSIFICATION MAMMA; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; OTTENWALDER JA, 1985, THESIS U FLORIDA GAI, P1; Ottenwalder Jose A., 2001, P253; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Whidden Howard P., 2001, P237	30	105	109	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					649	651		10.1038/nature02597	http://dx.doi.org/10.1038/nature02597			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190349				2022-12-01	WOS:000221912600037
J	Wang, XL; Zhou, ZH				Wang, XL; Zhou, ZH			Palaeontology: Pterosaur embryo from the Early Cretaceous	NATURE			English	Editorial Material							CHINA		Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, XL (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xlinwang@263.net						BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Ji SA, 1999, NATURE, V398, P573, DOI 10.1038/19221; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Wang X., 2003, JEHOL BIOTA, P19; Wang XL, 2001, CHINESE SCI BULL, V46, P1112; Wellnhofer P., 1991, P1	11	49	61	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					621	621		10.1038/429621a	http://dx.doi.org/10.1038/429621a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190343	Bronze			2022-12-01	WOS:000221912600029
J	Ferraroli, S; Georges, JY; Gaspar, P; Le Maho, Y				Ferraroli, S; Georges, JY; Gaspar, P; Le Maho, Y			Endangered species - Where leatherback turtles meet fisheries	NATURE			English	Editorial Material									Univ Strasbourg 1, F-67070 Strasbourg, France; Diren Guyane, Direct Reg Environm, F-97300 Cayenne, Guyane Francais, French Guiana; CLS, Direct Oceanog Spatiale, F-31526 Ramonville St Agne, France; CNRS, UPR 9010, CEPE, F-67087 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ferraroli, S (corresponding author), WWF France, F-97300 Cayenne, Guyane Francais, French Guiana.	jean-yves.georges@c-strasbourg.fr		GEORGES, Jean Yves/0000-0003-1161-2275				[Anonymous], [No title captured]; BLEAKNEY J. SHERMAN, 1965, CAN FIELD NATUR, V79, P120; FERRAROLI S, 2003, C R ACAD SCI PARIS R, V17, P319; Gueguen F, 2000, CR ACAD SCI III-VIE, V323, P775, DOI 10.1016/S0764-4469(00)01222-1; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; LAURS RM, 1984, DEEP-SEA RES, V31, P1085, DOI 10.1016/0198-0149(84)90014-1; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Morrisey J. K., 1996, Exotic Pet Practice, V1, P1; PODESTA GP, 1993, CONT SHELF RES, V13, P253, DOI 10.1016/0278-4343(93)90109-B; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209	10	118	131	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					521	522		10.1038/429521a	http://dx.doi.org/10.1038/429521a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175741	Green Submitted			2022-12-01	WOS:000221767700028
J	Svoboda, T; Henry, B; Shulman, L; Kennedy, E; Rea, E; Ng, W; Wallington, T; Yaffe, B; Gournis, E; Vicencio, E; Basrur, S; Glazier, RH				Svoboda, T; Henry, B; Shulman, L; Kennedy, E; Rea, E; Ng, W; Wallington, T; Yaffe, B; Gournis, E; Vicencio, E; Basrur, S; Glazier, RH			Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARS	Background: Toronto was the site of North America's largest outbreak of the severe acute respiratory syndrome (SARS). An understanding of the patterns of transmission and the effects on public health in relation to control measures that were taken will help health officials prepare for any future outbreaks. Methods: We analyzed SARS case, quarantine, and hotline records in relation to control measures. The two phases of the outbreak were compared. Results: Toronto Public Health investigated 2132 potential cases of SARS, identified 23,103 contacts of SARS patients as requiring quarantine, and logged 316,615 calls on its SARS hotline. In Toronto, 225 residents met the case definition of SARS, and all but 3 travel-related cases were linked to the index patient, from Hong Kong. SARS spread to 11 (58 percent) of Toronto's acute care hospitals. Unrecognized SARS among in-patients with underlying illness caused a resurgence, or a second phase, of the outbreak, which was finally controlled through active surveillance of hospitalized patients. In response to the control measures of Toronto Public Health, the number of persons who were exposed to SARS in nonhospital and nonhousehold settings dropped from 20 (13 percent) before the control measures were instituted (phase 1) to 0 afterward (phase 2). The number of patients who were exposed while in a hospital ward rose from 25 (17 percent) in phase 1 to 68 (88 percent) in phase 2, and the number exposed while in the intensive care unit dropped from 13 (9 percent) in phase 1 to 0 in phase 2. Community spread (the length of the chains of transmission outside of hospital settings) was significantly reduced in phase 2 of the outbreak (P<0.001). Conclusions: The transmission of SARS in Toronto was limited primarily to hospitals and to households that had had contact with patients. For every case of SARS, health authorities should expect to quarantine up to 100 contacts of the patients and to investigate 8 possible cases. During an outbreak, active in-hospital surveillance for SARS-like illnesses and heightened infection-control measures are essential.	Univ Toronto, Inner City Hlth Res Unit, Toronto Publ Hlth, Toronto, ON M5C 1N8, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5C 1N8, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5C 1N8, Canada; St Michaels Hosp, Inner City Hlth Res Unit, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Svoboda, T (corresponding author), Univ Toronto, Inner City Hlth Res Unit, Toronto Publ Hlth, 70 Richmond St E,4th Fl, Toronto, ON M5C 1N8, Canada.	tomislav.svoboda@utoronto.ca	Glazier, Richard H/E-5255-2012					[Anonymous], MAN SEV AC RESP SYND; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; Dyer O, 2003, BRIT MED J, V326, P999, DOI 10.1136/bmj.326.7397.999; *GREAT TOR AIRP AU, 2002, 6 YEARS ACC ANN REP; *HLTH CAN, 2003, OUTBR PER NAT CAS DE; Hoey J, 2003, CAN MED ASSOC J, V168, P1013; *KPMG CAN, 2003, TOR TOUR REV LOSS EX; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; National Instruments, 2003, LEARN SARS REN PUBL; Oyranoski D, 2003, NATURE, V423, P4, DOI 10.1038/423004a; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; *TOR BOARD TRAD, 2003, IMP SARS TOR BUS COM; Varia M, 2003, CAN MED ASSOC J, V169, P285; *WHO, 2003, SEV AC RESP SYNDR VI; WHO, CUM NUMB REP PROB CA; 2003, JAMA, V289, P2788; 2003, MMWR MORB MORTAL WKL, V52, P547	21	159	164	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2004	350	23					2352	2361		10.1056/NEJMoa032111	http://dx.doi.org/10.1056/NEJMoa032111			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825JY	15175437	Bronze			2022-12-01	WOS:000221754200006
J	Wolkers, MC; Brouwenstijn, N; Bakker, AH; Toebes, M; Schumacher, TNM				Wolkers, MC; Brouwenstijn, N; Bakker, AH; Toebes, M; Schumacher, TNM			Antigen bias in T cell cross-priming	SCIENCE			English	Article							DENDRITIC CELLS; LYMPHOCYTE EPITOPE; CD8(+); INDUCTION; SEQUENCES; MOUSE	Activated CD8(+) T cells detect virally infected cells and tumor cells by recognition of major histocompatibility complex class I-bound peptides derived from degraded, endogenously produced proteins. In contrast, CD8(+) T cell activation often occurs through interaction with specialized antigen-presenting cells displaying peptides acquired from an exogenous cellular source, a process termed cross-priming. Here, we observed a marked inefficiency in exogenous presentation of epitopes derived from signal sequences in mouse models. These data indicate that certain virus- and tumor-associated antigens may not be detected by CD8(+) T cells because of impaired cross-priming. Such differences in the ability to cross-present antigens should form important considerations in vaccine design.	Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Bakker, Arne/0000-0003-1944-6515; Wolkers, Monika/0000-0003-3242-1363				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BACIK I, 1994, J IMMUNOL, V152, P381; Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Chen W, 1996, J VIROL, V70, P7773, DOI 10.1128/JVI.70.11.7773-7782.1996; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Haanen JBAG, 1999, EUR J IMMUNOL, V29, P1168, DOI 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.3.CO;2-A; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCCOY JL, 1967, CANCER RES, V27, P1743; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; WOLFEL T, 1994, EUR J IMMUNOL, V24, P759, DOI 10.1002/eji.1830240340; Wolkers MC, 2001, J IMMUNOL, V167, P3577, DOI 10.4049/jimmunol.167.7.3577; WOLKERS MC, UNPUB; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	27	153	160	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1314	1317		10.1126/science.1096268	http://dx.doi.org/10.1126/science.1096268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166378				2022-12-01	WOS:000221669600052
J	Trifunovic, A; Wredenberg, A; Falkenberg, M; Spelbrink, JN; Rovio, AT; Bruder, CE; Bohlooly-Y, M; Gidlof, S; Oldfors, A; Wibom, R; Tornell, J; Jacobs, HT; Larsson, NG				Trifunovic, A; Wredenberg, A; Falkenberg, M; Spelbrink, JN; Rovio, AT; Bruder, CE; Bohlooly-Y, M; Gidlof, S; Oldfors, A; Wibom, R; Tornell, J; Jacobs, HT; Larsson, NG			Premature ageing in mice expressing defective mitochondrial DNA polymerase	NATURE			English	Article							POINT MUTATIONS; AGE; DELETIONS; MUSCLE; MOUSE; CELLS	Point mutations and deletions of mitochondrial DNA (mtDNA) accumulate in a variety of tissues during ageing in humans(1), monkeys(2) and rodents(3). These mutations are unevenly distributed and can accumulate clonally in certain cells, causing a mosaic pattern of respiratory chain deficiency in tissues such as heart(4), skeletal muscle(5) and brain(6). In terms of the ageing process, their possible causative effects have been intensely debated because of their low abundance and purely correlative connection with ageing(7,8). We have now addressed this question experimentally by creating homozygous knock-in mice that express a proof-reading-deficient version of PolgA, the nucleus-encoded catalytic subunit of mtDNA polymerase. Here we show that the knock-in mice develop an mtDNA mutator phenotype with a threefold to fivefold increase in the levels of point mutations, as well as increased amounts of deleted mtDNA. This increase in somatic mtDNA mutations is associated with reduced lifespan and premature onset of ageing-related phenotypes such as weight loss, reduced subcutaneous fat, alopecia ( hair loss), kyphosis (curvature of the spine), osteoporosis, anaemia, reduced fertility and heart enlargement. Our results thus provide a causative link between mtDNA mutations and ageing phenotypes in mammals.	Karolinska Inst, Novum, Karolinska Univ Hosp, Dept Med Nutr, S-14186 Huddinge, Sweden; Karolinska Inst, Novum, Karolinska Univ Hosp, Dept Biosci, S-14186 Huddinge, Sweden; Tampere Univ, Tampere Univ Hosp, FIN-33014 Tampere, Finland; Astra Zeneca R&D, S-43183 Molndal, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Tampere University; Tampere University Hospital; AstraZeneca; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska University Hospital	Larsson, NG (corresponding author), Karolinska Inst, Novum, Karolinska Univ Hosp, Dept Med Nutr, S-14186 Huddinge, Sweden.	nils-goran.larsson@mednut.ki.se	Larsson, Nils-Göran/GVS-5578-2022; Jacobs, Howard T/G-2434-2011; Gidlöf, Sebastian/L-5039-2013; Spelbrink, Johannes N/L-4661-2015	Larsson, Nils-Göran/0000-0001-5100-996X; Spelbrink, Johannes N/0000-0002-9756-2602; Oldfors, Anders/0000-0002-5758-7397; Gidlof, Sebastian/0000-0002-1432-8344; Wredenberg, Anna/0000-0002-2500-6121; Jacobs, Howard/0000-0003-1895-6003				ARKING R, 1998, BIOL AGING; Balducci L, 2003, J AM GERIATR SOC, V51, pS2; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Braunwald E., 1997, HEART DIS TXB CARDIO, V5th; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009; Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; KALU DN, 1995, HDB PHYSL 11; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; MUELLER-HOECKER J, 1989, American Journal of Pathology, V134, P1167; Pal L, 2003, ENDOCRIN METAB CLIN, V32, P669, DOI 10.1016/S0889-8529(03)00046-X; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; TANEMURA K, 1993, J VET MED SCI, V55, P703, DOI 10.1292/jvms.55.703; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; WEISS A, 1991, BONE, V12, P165, DOI 10.1016/8756-3282(91)90039-L; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	30	1846	1922	4	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					417	423		10.1038/nature02517	http://dx.doi.org/10.1038/nature02517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164064				2022-12-01	WOS:000221644600040
J	Naylor, CD; Chantler, C; Griffiths, S				Naylor, CD; Chantler, C; Griffiths, S			Learning from SARS in Hong Kong and Toronto	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; INFECTION		Univ Toronto, Fac Med, Toronto, ON M5S 1A8, Canada; Kings Fund, London, England; Univ Oxford, Dept Publ Hlth, Oxford, England	University of Toronto; University of Oxford	Naylor, CD (corresponding author), Univ Toronto, Fac Med, MSB2109,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	david.naylor@utoronto.ca						Detsky AS, 2003, NEW ENGL J MED, V349, P804, DOI 10.1056/NEJMhpr035304; *HL SEL COMM SCI T, 2003, FIGHT INF; LANARD J, SARS COMMUNICATION W; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; *NAT ADV COMM SARS, LEARN SARS REN PUBL; *ONT EXP PAN SARS, 2004, PUBL HLTH PLAN ACT; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; *SARS EXP COMM, SARS HONG KONG EXP A; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; World Health Organization, SUMM PROB SARS CAS O; Zoutman DE, 2003, AM J INFECT CONTROL, V31, P266, DOI 10.1067/mic.2003.88	11	34	34	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2004	291	20					2483	2487		10.1001/jama.291.20.2483	http://dx.doi.org/10.1001/jama.291.20.2483			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823HB	15161900				2022-12-01	WOS:000221599700032
J	Meeusen, S; McCaffery, JM; Nunnari, J				Meeusen, S; McCaffery, JM; Nunnari, J			Mitochondrial fusion intermediates revealed in vitro	SCIENCE			English	Article							DYNAMIN-RELATED GTPASE; DOMINANT OPTIC ATROPHY; OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; PROTEIN; FISSION; MGM1P; APOPTOSIS; FZO1P; YEAST	The events that occur during the fusion of double-membraned mitochondria are unknown. As an essential step toward determining the mechanism of mitochondria) fusion, we have captured this event in vitro. Mitochondrial outer and inner membrane fusion events were separable and mechanistically distinct, but both required guanosine 5'-triphosphate hydrolysis. Homotypic trans interactions of the ancient outer transmembrane guanosine triphosphatase, Fzo1, were required to promote the fusion of mitochondrial outer membranes, whereas electrical potential was also required for fusion of inner membranes. Our conclusions provide fundamental insights into the molecular events driving mitochondrial fusion and advance our understanding of the evolution of mitochondria) fusion in eukaryotic cells.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD 21218 USA	University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins University	Nunnari, J (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01-GM62942A] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.e02-12-0788; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SIMON VR, 1995, J CELL BIOL, V130, P345, DOI 10.1083/jcb.130.2.345; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	23	328	350	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1747	1752		10.1126/science.1100612	http://dx.doi.org/10.1126/science.1100612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15297626	Bronze			2022-12-01	WOS:000224039500033
J	Chaudhuri, J; Khuong, C; Alt, FW				Chaudhuri, J; Khuong, C; Alt, FW			Replication protein A interacts with AID to promote deamination of somatic hypermutation targets	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; B-CELLS; IMMUNOGLOBULIN GENES; IN-VITRO; TRANSCRIPTION; SEQUENCES; MECHANISM; REGION	Activation-induced cytidine deaminase ( AID) is a single-stranded ( ss) DNA deaminase required for somatic hypermutation (SHM) and class switch recombination of immunoglobulin genes. Class switch recombination involves transcription through switch regions, which generates ssDNA within R loops. However, although transcription through immunoglobulin variable region exons is required for SHM, it does not generate stable ssDNA, which leaves the mechanism of AID targeting unresolved. Here we characterize the mechanism of AID targeting to in-vitro-transcribed substrates harbouring SHM motifs. We show that the targeting activity of AID is due to replication protein A (RPA), a ssDNA-binding protein involved in replication, recombination and repair. The 32-kDa subunit of RPA interacts specifically with AID from activated B cells in a manner that seems to be dependent on post-translational AID modification. Thus, our study implicates RPA as a novel factor involved in immunoglobulin diversification. We propose that B-cell-specific AID-RPA complexes preferentially bind to ssDNA of small transcription bubbles at SHM 'hotspots', leading to AID-mediated deamination and RPA-mediated recruitment of DNA repair proteins.	Childrens Hosp, Ctr Blood Res, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Childrens Hosp, Ctr Blood Res, Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu						Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Storb U, 1998, IMMUNOL REV, V162, P153; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	50	298	308	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					992	998		10.1038/nature02821	http://dx.doi.org/10.1038/nature02821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15273694				2022-12-01	WOS:000223514900034
J	Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ				Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ			Structural basis for inhibition of the replication licensing factor Cdt1 by geminin	NATURE			English	Article							DNA-REPLICATION; BACILLUS-SUBTILIS; PROTEIN; RECOGNITION; BINDING; CDC6	To maintain chromosome stability in eukaryotic cells, replication origins must be licensed by loading mini-chromosome maintenance (MCM2-7) complexes once and only once per cell cycle(1-9). This licensing control is achieved through the activities of geminin(10-12) and cyclin-dependent kinases(9,13,14). Geminin binds tightly to Cdt1, an essential component of the replication licensing system(6,15-18), and prevents the inappropriate reinitiation of replication on an already fired origin. The inhibitory effect of geminin is thought to prevent the interaction between Cdt1 and the MCM helicase(19,20). Here we describe the crystal structure of the mouse geminin-Cdt1 complex using tGeminin (residues 79-157, truncated geminin) and tCdt1 (residues 172-368, truncated Cdt1). The amino-terminal region of a coiled-coil dimer of tGeminin interacts with both N-terminal and carboxy-terminal parts of tCdt1. The primary interface relies on the steric complementarity between the tGeminin dimer and the hydrophobic face of the two short N-terminal helices of tCdt1 and, in particular, Pro 181, Ala 182, Tyr 183, Phe 186 and Leu 189. The crystal structure, in conjunction with our biochemical data, indicates that the N-terminal region of tGeminin might be required to anchor tCdt1, and the C-terminal region of tGeminin prevents access of the MCM complex to tCdt1 through steric hindrance.	Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Pohang, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbook, South Korea; Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Mitsubishi Kagaku Inst Life Sci, Biomol & Technol Dept, Tokyo 1948511, Japan; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); United States Department of Energy (DOE); Argonne National Laboratory	Cho, YJ (corresponding author), Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Hyoja Dong,San 31, Pohang, Kyungbook, South Korea.	yunje@postech.ac.kr	Lee, Changwook/D-6010-2011	Kim, Youngchang/0000-0002-1610-4889; Choi, Jung Min/0000-0003-2450-3916				Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSSIERE DE, 1995, CELL, V80, P651; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Gautam A, 2001, J BIOL CHEM, V276, P23471, DOI 10.1074/jbc.M009537200; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shreeram S, 2003, Prog Cell Cycle Res, V5, P287; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamaguchi R, 2003, CELL, V113, P115, DOI 10.1016/S0092-8674(03)00200-9; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 1999, MOL CELL BIOL, V19, P8003	29	114	119	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					913	917		10.1038/nature02813	http://dx.doi.org/10.1038/nature02813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15286659				2022-12-01	WOS:000223369800047
J	Vaccari, NE; Edgecombe, GD; Escudero, C				Vaccari, NE; Edgecombe, GD; Escudero, C			Cambrian origins and affinities of an enigmatic fossil group of arthropods	NATURE			English	Article							SCUTIGERA-COLEOPTRATA; HOUSE CENTIPEDE; EVOLUTION; SEQUENCES; PHYLOGENY; ARGENTINA	Euthycarcinoids are one of the most enigmatic arthropod groups, having been assigned to nearly all major clades of Arthropoda. Recent work has endorsed closest relationships with crustaceans(1) or a myriapod - hexapod assemblage(2), a basal position in the Euarthropoda(3), or a placement in the Hexapoda(4) or hexapod stem group(5). Euthycarcinoids are known from 13 species ranging in age from Late Ordovician or Early Silurian to Middle Triassic, all in freshwater or brackish water environments(6). Here we describe a euthycarcinoid from marine strata in Argentina dating from the latest Cambrian period, extending the group's record back as much as 50 million years. Despite its antiquity and marine occurrence, the Cambrian species demonstrates that morphological details were conserved in the transition to fresh water. Trackways in the same unit as the euthycarcinoid strengthen arguments that similar traces of subaerial origin from Cambro-Ordovician rocks were made by euthycarcinoids(7,8). Large mandibles in euthycarcinoids(6,9) are confirmed by the Cambrian species. A morphology-based phylogeny resolves euthycarcinoids as stem-group Mandibulata, sister to the Myriapoda and Crustacea plus Hexapoda.	Univ Nacl Jujuy, Inst Geol & Mineria, RA-4600 San Salvador De Jujuy, Argentina; Australian Museum, Sydney, NSW 2010, Australia; OHiggins & Zarate, RA-4612 San Salvador De Jujuy, Argentina	Australian Museum	Vaccari, NE (corresponding author), Univ Nacl Jujuy, Inst Geol & Mineria, Ave Bolivia 1661, RA-4600 San Salvador De Jujuy, Argentina.	evac@idgym.unju.edu.ar		Edgecombe, Gregory/0000-0002-9591-8011				Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; Bergstrom J., 1980, Abhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V23, P7; Bitsch J, 2001, ANN SOC ENTOMOL FR, V37, P305; Buatois LA, 2003, J S AM EARTH SCI, V16, P343, DOI 10.1016/S0895-9811(03)00097-X; Edgecombe GD, 1999, ALCHERINGA, V23, P193, DOI 10.1080/03115519908619516; Edgecombe Gregory D., 2003, African Invertebrates, V44, P115; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Gall J. C., 1964, Annales de Paleontologie Invertebres, V50, P1; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Kusche K, 2003, EUR J BIOCHEM, V270, P2860, DOI 10.1046/j.1432-1033.2003.03664.x; MacNaughton RB, 2002, GEOLOGY, V30, P391, DOI 10.1130/0091-7613(2002)030<0391:FSOLAT>2.0.CO;2; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; MCNAMARA KJ, 1993, PALAEONTOLOGY, V36, P319; Muller CHG, 2003, ZOOMORPHOLOGY, V122, P191, DOI 10.1007/s00435-003-0085-0; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; SCHRAM F R, 1991, Memoirs of the Queensland Museum, V31, P1; SCHRAM FR, 1982, J PALEONTOL, V56, P1434; SCHULTKA S, 1991, Palaeontologische Zeitschrift, V65, P319; Tortello MF, 2003, AMEGHINIANA, V40, P323; TREWIN NH, 1994, PALAEONTOLOGY, V37, P811; TREWIN NH, 1995, T ROY SOC EDINBURGH, V85, P117; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Wilson HM, 2001, PALAEONTOLOGY, V44, P143, DOI 10.1111/1475-4983.00174	24	30	32	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					554	557		10.1038/nature02705	http://dx.doi.org/10.1038/nature02705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282604				2022-12-01	WOS:000222946100046
J	Molyneux, DH				Molyneux, DH			"Neglected" diseases but unrecognised successes - challenges and opportunities for infectious disease control	LANCET			English	Editorial Material							LYMPHATIC FILARIASIS ELIMINATION; ONCHOCERCIASIS CONTROL; MALARIA; PROGRAMS; TARGETS; HEALTH		Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	fahy@liv.ac.uk						Akhavan D., 2000, ANALISE CUSTO EFETIV; [Anonymous], TUB MAL; Aylward RB, 2003, LANCET, V362, P909, DOI 10.1016/S0140-6736(03)14337-1; Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034989859537; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Hagmann R, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-15; Hopkins DR, 2002, AM J TROP MED HYG, V67, P415, DOI 10.4269/ajtmh.2002.67.415; Hopkins DR, 2002, AM J TROP MED HYG, V67, P266; Kim A, 1997, 1835 AFR HUM DEV DEP; Molyneux DH, 2004, BMJ-BRIT MED J, V328, P1129, DOI 10.1136/bmj.328.7448.1129; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Najera J. A., 2001, Parassitologia (Rome), V43, P1; Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; TAYLOR LE, 1998, ERADICATION INFECT D, P145; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Utzinger J, 2002, TROP MED INT HEALTH, V7, P657, DOI 10.1046/j.1365-3156.2002.00916.x; *WHO, WHOCDS200315; *WHO, 2003, LEPR EL PROJ STAT RE; *WHO, 2002, WHOCDSSTB200116; Widdus R, 2001, B WORLD HEALTH ORGAN, V79, P713	25	112	115	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					380	383		10.1016/S0140-6736(04)16728-7	http://dx.doi.org/10.1016/S0140-6736(04)16728-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276399				2022-12-01	WOS:000222853300038
J	Bok, H; Schill, KE; Faden, RR				Bok, H; Schill, KE; Faden, RR			Justice, ethnicity, and stem-cell banks	LANCET			English	Editorial Material									Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA		Schill, KE (corresponding author), Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA.	kschill@jhsph.edu						European Commission, 2003, HLTH STAT EUR UN NAR; Faden RR, 2003, HASTINGS CENT REP, V33, P13, DOI 10.2307/3527822	2	16	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2004	364	9429					118	121		10.1016/S0140-6736(04)16650-6	http://dx.doi.org/10.1016/S0140-6736(04)16650-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246711				2022-12-01	WOS:000222612200004
J	Moles, A; Kieffer, BL; D'Amato, FR				Moles, A; Kieffer, BL; D'Amato, FR			Deficit in attachment behavior in mice lacking the mu-opioid receptor gene	SCIENCE			English	Article							MORPHINE-INDUCED ANALGESIA; SEPARATION DISTRESS; RAT PUPS; RESPONSES; MEDIATION; KNOCKOUT; EXPOSURE; NALOXONE; OPIATES; AUTISM	Endogenous opioid binding to mu receptors is hypothesized to mediate natural rewards and has been proposed to be the basis of infant attachment behavior. Here, we report that mu-opioid receptor knockout mouse pups emit fewer ultrasonic vocalizations when removed from their mothers but not when exposed to cold or male mice odors. Moreover these knockout pups do not show a preference toward their mothers' cues and do not show ultrasonic calls potentiation after brief maternal exposure. Results from this study may indicate a molecular mechanism for diseases characterized by deficits in attachment behavior, such as autism or reactive attachment disorder.	CNR, Inst Neurosci Psychobiol & Psychopharmacol, I-00137 Rome, Italy; Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Consiglio Nazionale delle Ricerche (CNR); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	D'Amato, FR (corresponding author), CNR, Inst Neurosci Psychobiol & Psychopharmacol, Viale Marx 43, I-00137 Rome, Italy.	f.damato@ipsifar.rm.cnr.it		D'Amato, Francesca/0000-0002-4577-4574; Moles, Anna/0000-0002-5805-5763				Agmo A, 1997, DEV NEUROSCI-BASEL, V19, P505, DOI 10.1159/000111248; BENTON D, 1988, PSYCHOPHARMACOLOGY A, P115; Bowlby J., 1980, ATTACHMENT, V1; CARDEN SE, 1991, DEV BRAIN RES, V62, P17, DOI 10.1016/0165-3806(91)90185-L; CHAMBERLAIN RS, 1990, BIOL PSYCHIAT, V28, P773, DOI 10.1016/0006-3223(90)90513-2; DAMATO FR, 1987, BEHAV NEURAL BIOL, V48, P197, DOI 10.1016/S0163-1047(87)90738-2; Dichter GS, 1996, PHYSIOL BEHAV, V60, P299, DOI 10.1016/0031-9384(95)02222-8; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; HERMAN BH, 1978, PHARMACOL BIOCHEM BE, V9, P213, DOI 10.1016/0091-3057(78)90167-3; HOFER MA, 1994, DEV PSYCHOBIOL, V27, P503, DOI 10.1002/dev.420270804; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; KALIN NH, 1988, BRAIN RES, V440, P285, DOI 10.1016/0006-8993(88)90997-3; KEHOE P, 1986, DEV PSYCHOBIOL, V19, P385, DOI 10.1002/dev.420190410; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Mandillo S, 1999, PSYCHOPHARMACOLOGY, V146, P297, DOI 10.1007/s002130051120; Martin M, 2003, EUR J NEUROSCI, V17, P701, DOI 10.1046/j.1460-9568.2003.02482.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; PANKSEPP J, 1979, TRENDS NEUROSCI, V2, P174, DOI 10.1016/0166-2236(79)90071-7; PANKSEPP J, 1978, BIOL PSYCHIAT, V13, P607; PANKSEPP J, 1994, ACTA PAEDIATR, V83, P40, DOI 10.1111/j.1651-2227.1994.tb13264.x; Panksepp J, 1985, PSYCHOBIOLOGY ATTACH, P3, DOI DOI 10.1016/B978-0-12-586780-1.50006-9; ROBINSON DJ, 1985, BEHAV PROCESS, V11, P253, DOI 10.1016/0376-6357(85)90020-8; Roth TL, 2003, PHYSIOL BEHAV, V78, P135, DOI 10.1016/S0031-9384(02)00961-7; SCOTT JP, 1974, P 9 C NEUR PHARM CIN, P735; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; WINSLOW JT, 1991, BEHAV NEUROSCI, V105, P253, DOI 10.1037/0735-7044.105.2.253	27	333	337	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1983	1986		10.1126/science.1095943	http://dx.doi.org/10.1126/science.1095943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218152				2022-12-01	WOS:000222241600050
J	Imhoff, ML; Bounoua, L; Ricketts, T; Loucks, C; Harriss, R; Lawrence, WT				Imhoff, ML; Bounoua, L; Ricketts, T; Loucks, C; Harriss, R; Lawrence, WT			Global patterns in human consumption of net primary production	NATURE			English	Article							HUMAN APPROPRIATION; MODEL	The human population and its consumption profoundly affect the Earth's ecosystems(1,2). A particularly compelling measure of humanity's cumulative impact is the fraction of the planet's net primary production that we appropriate for our own use(3,4). Net primary production-the net amount of solar energy converted to plant organic matter through photosynthesis-can be measured in units of elemental carbon and represents the primary food energy source for the world's ecosystems. Human appropriation of net primary production, apart from leaving less for other species to use, alters the composition of the atmosphere(5), levels of biodiversity(6), energy flows within food webs(7) and the provision of important ecosystem services(8). Here we present a global map showing the amount of net primary production required by humans and compare it to the total amount generated on the landscape. We then derive a spatial balance sheet of net primary production 'supply' and 'demand' for the world. We show that human appropriation of net primary production varies spatially from almost zero to many times the local primary production. These analyses reveal the uneven footprint of human consumption and related environmental impacts, indicate the degree to which human populations depend on net primary production 'imports' and suggest policy options for slowing future growth of human appropriation of net primary production.	NASA, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; World Wildlife Fund, Washington, DC 20037 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Natl Ctr Atmospher Res, Foothills Lab, Environm & Societal Impacts Grp, Boulder, CO 80307 USA; Bowie State Univ, Dept Nat Sci, Bowie, MD 20715 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; World Wildlife Fund; Stanford University; National Center Atmospheric Research (NCAR) - USA; University System of Maryland; Bowie State University	Imhoff, ML (corresponding author), NASA, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA.	Marc.L.Imhoff@nasa.gov	Noojipady, Praveen/B-2511-2010; Imhoff, Michael/B-5119-2015	Imhoff, Michael/0000-0001-6037-6446				*COUNC AGR SCI TEC, 1999, R135 COUNC AGR SCI T; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; *CTR INT EARTH SCI, 2000, GRIDD POP WORLD GPW; Daily GC., 1997, ISSUES ECOL, V2, P1; DEPADUA DB, 1978, ACCELERATING AGR DEV, P135; Field CB, 2001, SCIENCE, V294, P2490, DOI 10.1126/science.1066317; Haberl H, 2002, SCIENCE, V296, P1968, DOI 10.1126/science.296.5575.1968; Haberl H, 1997, AMBIO, V26, P143; HOLDREN JP, 1974, AM SCI, V62, P282; INCE PJ, 2000, FPLRN0272 USDA FOR S; LIETH H, 1975, PRIMARY PRODUCTIVITY, P119; Luck MA, 2001, ECOSYSTEMS, V4, P782, DOI 10.1007/s10021-001-0046-8; O'Neill RV, 2000, BIOSCIENCE, V50, P333, DOI 10.1641/0006-3568(2000)050[0333:HEAAKS]2.3.CO;2; OLTJEN JW, 1992, COMPUTERS IN AGRICULTURAL EXTENSION PROGRAMS, P59; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PULKKI RE, 1997, GFSSWP06 UNFAO FOR P; Rojstaczer S, 2001, SCIENCE, V294, P2549, DOI 10.1126/science.1064375; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Sere C, 1996, 127 FAO; SKOG KE, 1998, P N AM FOR COMM; Slayback DA, 2003, GLOBAL CHANGE BIOL, V9, P1, DOI 10.1046/j.1365-2486.2003.00507.x; Smil V., 1983, BIOMASS ENERGIES RES, P1, DOI [10.1007/978-1-4613-3691-4, DOI 10.1007/978-1-4613-3691-4]; *UN FAO, 2001, FAOSTAT 2001 DAT; *UN POP DIV, 2003, WORLD POP PROSP 2000; van den Bergh JCJM, 1999, ECOL ECON, V29, P61, DOI 10.1016/S0921-8009(99)00032-4; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; [No title captured]	29	435	466	15	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					870	873		10.1038/nature02619	http://dx.doi.org/10.1038/nature02619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215863	Green Published			2022-12-01	WOS:000222213000041
J	Terrak, M; Kerff, F; Langsetmo, K; Tao, T; Dominguez, R				Terrak, M; Kerff, F; Langsetmo, K; Tao, T; Dominguez, R			Structural basis of protein phosphatase 1 regulation	NATURE			English	Article							MUSCLE MYOSIN PHOSPHATASE; LIGHT-CHAIN-PHOSPHATASE; CATALYTIC SUBUNIT; SMOOTH-MUSCLE; CRYSTAL-STRUCTURE; PHOSPHORYLATION; COMPLEX; P53; INHIBITION; ANKYRIN	The coordinated and reciprocal action of serine/threonine (Ser/Thr) protein kinases and phosphatases produces transient phosphorylation, a fundamental regulatory mechanism for many biological processes. The human genome encodes a far greater number of Ser/Thr protein kinases than of phosphatases. Protein phosphatase 1 (PP1), in particular, is ubiquitously distributed and regulates a broad range of cellular functions, including glycogen metabolism, cell-cycle progression and muscle relaxation(1,2). PP1 has evolved effective catalytic machinery but lacks substrate specificity. Substrate specificity is conferred upon PP1 through interactions with a large number of regulatory subunits. The regulatory subunits are generally unrelated, but most possess the RVxF motif, a canonical PP1-binding sequence. Here we reveal the crystal structure at 2.7 Angstrom resolution of the complex between PP1 and a 34-kDa N-terminal domain of the myosin phosphatase targeting subunit MYPT1. MYPT1 is the protein that regulates PP1 function in smooth muscle relaxation(3). Structural elements amino- and carboxy-terminal to the RVxF motif of MYPT1 are positioned in a way that leads to a pronounced reshaping of the catalytic cleft of PP1, contributing to the increased myosin specificity of this complex. The structure has general implications for the control of PP1 activity by other regulatory subunits.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Dominguez, R (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	dominguez@bbri.org			NIAMS NIH HHS [R01 AR046524, P01 AR041637] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046524, P01AR041637] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen PTW, 2002, J CELL SCI, V115, P241; Connor JH, 1999, J BIOL CHEM, V274, P22366, DOI 10.1074/jbc.274.32.22366; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Gailly P, 1996, EUR J BIOCHEM, V239, P326, DOI 10.1111/j.1432-1033.1996.0326u.x; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; Hirano K, 1997, J BIOL CHEM, V272, P3683, DOI 10.1074/jbc.272.6.3683; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; Johnson K P, 1996, Mult Scler, V1, P325; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Long X, 2002, APOPTOSIS, V7, P31, DOI 10.1023/A:1013508811252; Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Tanaka J, 1998, BIOCHEMISTRY-US, V37, P16697, DOI 10.1021/bi980782x; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; Toth A, 2000, EUR J BIOCHEM, V267, P1687, DOI 10.1046/j.1432-1327.2000.01158.x; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7	30	283	297	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					780	784		10.1038/nature02582	http://dx.doi.org/10.1038/nature02582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15164081	Bronze			2022-12-01	WOS:000222059900043
J	Hummel, M; Bonifacio, E; Schmid, S; Walter, M; Knopff, A; Ziegler, AG				Hummel, M; Bonifacio, E; Schmid, S; Walter, M; Knopff, A; Ziegler, AG			Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents	ANNALS OF INTERNAL MEDICINE			English	Article							BETA-CELL AUTOIMMUNITY; YOUNG DAISY; RISK; MELLITUS; CHILDREN; DISEASE; PATHOGENESIS; ASSOCIATION; EXPOSURE; BABYDIAB	Background: The development of type 1 diabetes mellitus is preceded by autoimmunity against islet beta cells. Objective: To determine the risk for islet autoimmunity and childhood diabetes in offspring of affected parents. Design: Prospective cohort study. Setting: German BABYDIAB study. Participants: 1610 offspring of parents with type 1 diabetes. Measurements: Autoantibodies to islet autoantigens were measured at 9 months, 2 years, 5 years, and 8 years of age. Results: By 5 years of age, the frequency of islet autoantibodies was 5.9% (95% Cl, 4.6% to 7.2%), the frequency of multiple islet autoantibodies was 3.5% (Cl, 2.5% to 4.5%), and the frequency of diabetes was 1.5% (Cl, 0.9% to 2.1%). The risk for diabetes was highest in offspring with multiple autoantibodies (40% within 5 years vs. 3% in offspring with single autoantibodies; P = 0.005). Progression to multiple islet autoantibodies was fastest in children who were autoantibody positive by age 2 years (P < 0.001), and progression to diabetes was inversely related to the age of positivity for multiple autoantibodies (P = 0.02). Limitations: The findings are limited to childhood diabetes in affected families. Conclusions: Childhood autoimmune diabetes is associated with autoimmunity that starts before 2 years of age.	Diabet Res Inst, D-80804 Munich, Germany; Ist Sci San Raffaele, Milan, Italy; Acad Hosp Schwabing, Munich, Germany	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ziegler, AG (corresponding author), Diabet Res Inst, Kolner Pl 1, D-80804 Munich, Germany.	anziegler@lrz.uni-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Hummel, Sandra/Q-3538-2016; Bonifacio, Ezio/E-7700-2010	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713				ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Green A, 2000, LANCET, V355, P873; Greener M, 2000, MOL MED TODAY, V6, P3, DOI 10.1016/S1357-4310(99)01625-1; Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; Knip M, 2003, DIABETES, V52, pA7; Naserke HE, 1999, J CLIN ENDOCR METAB, V84, P1239, DOI 10.1210/jc.84.4.1239; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721; ZIEGLER AG, 1993, DIABETOLOGIA, V36, P402, DOI 10.1007/BF00402275; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	19	117	119	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2004	140	11					882	886		10.7326/0003-4819-140-11-200406010-00009	http://dx.doi.org/10.7326/0003-4819-140-11-200406010-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824IS	15172902				2022-12-01	WOS:000221680600004
J	Nesic, D; Hsu, Y; Stebbins, CE				Nesic, D; Hsu, Y; Stebbins, CE			Assembly and function of a bacterial genotoxin	NATURE			English	Article							CYTOLETHAL DISTENDING TOXIN; CELL-CYCLE ARREST; DNA-DAMAGE; HELA-CELLS; CDTB; COMPLEX; CHECKPOINT; INVOLVEMENT; ACTIVATION; RESIDUES	The tripartite cytolethal distending toxin (CDT) induces cell cycle arrest and apoptosis in eukaryotic cells(1,2). The subunits CdtA and CdtC associate with the nuclease CdtB to form a holotoxin that translocates CdtB into the host cell, where it acts as a genotoxin by creating DNA lesions(3-7). Here we show that the crystal structure of the holotoxin from Haemophilus ducreyi reveals that CDT consists of an enzyme of the DNase-I family, bound to two ricin-like lectin domains. CdtA, CdtB and CdtC form a ternary complex with three interdependent molecular interfaces, characterized by globular, as well as extensive non-globular, interactions. The lectin subunits form a deeply grooved, highly aromatic surface that we show to be critical for toxicity. The holotoxin possesses a steric block of the CdtB active site by means of a non-globular extension of the CdtC subunit, and we identify putative DNA binding residues in CdtB that are essential for toxin activity.	Rockefeller Univ, Lab Stuct Microbiol, New York, NY 10021 USA	Rockefeller University	Stebbins, CE (corresponding author), Rockefeller Univ, Lab Stuct Microbiol, 1230 York Ave, New York, NY 10021 USA.	stebbins@rockefeller.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308				Alby F, 2001, FEBS LETT, V491, P261, DOI 10.1016/S0014-5793(01)02205-0; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 2001, TOXICON, V39, P1729, DOI 10.1016/S0041-0101(01)00159-3; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Deng KP, 2003, INFECT IMMUN, V71, P6633, DOI 10.1128/IAI.71.11.6633-6640.2003; Deng KP, 2001, BIOCHEM BIOPH RES CO, V285, P609, DOI 10.1006/bbrc.2001.5223; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Escalas N, 2000, EXP CELL RES, V257, P206, DOI 10.1006/excr.2000.4878; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Frisan T, 2002, INT J MED MICROBIOL, V291, P495; Hassane DC, 2001, INFECT IMMUN, V69, P5752, DOI 10.1128/IAI.69.9.5752-5759.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Lewis DA, 2001, INFECT IMMUN, V69, P5626, DOI 10.1128/IAI.69.9.5626-5634.2001; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V	30	227	238	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					429	433		10.1038/nature02532	http://dx.doi.org/10.1038/nature02532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164065				2022-12-01	WOS:000221644600042
J	HATSOPOULOS, N; GABBIANI, F; LAURENT, G				HATSOPOULOS, N; GABBIANI, F; LAURENT, G			ELEMENTARY COMPUTATION OF OBJECT APPROACH BY A WIDE-FIELD VISUAL NEURON	SCIENCE			English	Article							MOVEMENT DETECTOR SYSTEM; ORTHOPTERAN DCMD NEURON; SENSORY ANALYZER; MOVING-OBJECTS; FLOW-FIELD; REEVALUATION; COLLISION; RESPONSES; VISION; MOTION	An essential function of the brain is to detect threats, such as those posed by objects or predators on a collision course. A wide-field, movement-sensitive visual neuron in the brain of the locust was studied by presenting simulated approaching, receding, and translating objects. The neuron's responses could be described simply by multiplying the velocity of the image edge (d theta/dt) with an exponential function of the size of the object's image on the retina (e(-alpha theta)). Because this product peaks before the image reaches its maximum size during approach, this neuron can anticipate collision. The neuron's activity peaks approximately when the approaching object reaches a certain angular size. Because this neuron receives distinct inputs about image size and velocity, the dendritic tree of a single neuron may function as a biophysical device that can carry out a multiplication of two independent input signals.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology			Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Gibson J.J., 1979, ECOLOGICAL APPROACH; GIBSON JJ, 1957, PSYCHOL REV, V64, P288, DOI 10.1037/h0044277; HOLMQVIST MH, 1991, J COMP PHYSIOL A, V169, P451, DOI 10.1007/BF00197657; KOCH C, 1987, SYNAPTIC FUNCTION, P637; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1992, J COMP PHYSIOL A, V171, P563, DOI 10.1007/BF00194105; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Mead C., 1989, ANALOG VLSI IMPLEMEN; OSHEA M, 1976, J EXP BIOL, V65, P289; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; PALKA J, 1967, J INSECT PHYSIOL, V13, P235, DOI 10.1016/0022-1910(67)90151-5; RIND FC, 1984, J EXP BIOL, V110, P143; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; RIND FC, 1987, J COMP PHYSIOL A, V161, P477, DOI 10.1007/BF00603973; ROWELL CHF, 1977, J EXP BIOL, V68, P157; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0	21	197	199	0	22	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					1000	1003		10.1126/science.270.5238.1000	http://dx.doi.org/10.1126/science.270.5238.1000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	15290817				2022-12-01	WOS:A1995TD87800053
J	Harper, NS; McAlpine, D				Harper, NS; McAlpine, D			Optimal neural population coding of an auditory spatial cue	NATURE			English	Article							INTERAURAL TIME DIFFERENCE; INFERIOR COLLICULUS; SOUND LOCALIZATION; FISHER INFORMATION; CENTRAL NUCLEUS; BARN OWL; NEURONS; DELAY; DISCRIMINATION; CAT	A sound, depending on the position of its source, can take more time to reach one ear than the other. This interaural ( between the ears) time difference (ITD) provides a major cue for determining the source location(1,2). Many auditory neurons are sensitive to ITDs(3,4), but the means by which such neurons represent ITD is a contentious issue. Recent studies question whether the classical general model ( the Jeffress model(5)) applies across species(6,7). Here we show that ITD coding strategies of different species can be explained by a unifying principle: that the ITDs an animal naturally encounters should be coded with maximal accuracy. Using statistical techniques and a stochastic neural model, we demonstrate that the optimal coding strategy for ITD depends critically on head size and sound frequency. For small head sizes and/or low-frequency sounds, the optimal coding strategy tends towards two distinct sub-populations tuned to ITDs outside the range created by the head. This is consistent with recent observations in small mammals(6,7). For large head sizes and/or high frequencies, the optimal strategy is a homogeneous distribution of ITD tunings within the range created by the head. This is consistent with observations in the barn owl(8-10). For humans, the optimal strategy to code ITDs from an acoustically measured distribution depends on frequency; above 400 Hz a homogeneous distribution is optimal, and below 400 Hz distinct sub-populations are optimal.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, UCL Ear Inst, London WC1E 6BT, England; UCL, CoMPLEX, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	McAlpine, D (corresponding author), UCL, Dept Physiol, Mortimer St, London WC1E 6BT, England.	d.mcalpine@ucl.ac.uk		McAlpine, David/0000-0001-5467-6725; Harper, Nicol/0000-0002-7851-4840				Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; BERNSTEIN LR, 1985, J ACOUST SOC AM, V78, P514, DOI 10.1121/1.392473; Bethge M, 2002, NEURAL COMPUT, V14, P2317, DOI 10.1162/08997660260293247; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Culling JF, 1998, J ACOUST SOC AM, V103, P3540, DOI 10.1121/1.423061; Dayan P., 2001, THEORETICAL NEUROSCI; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; HENNING GB, 1974, J ACOUST SOC AM, V55, P84, DOI 10.1121/1.1928135; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; KUWADA S, 1983, J NEUROPHYSIOL, V50, P981, DOI 10.1152/jn.1983.50.4.981; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [10.1080/14786440709463595, DOI 10.1080/14786440709463595]; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; Wagner H, 2002, EUR J NEUROSCI, V15, P1343, DOI 10.1046/j.1460-9568.2002.01970.x; WAGNER H, 1987, J NEUROSCI, V7, P3105; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	24	210	211	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					682	686		10.1038/nature02768	http://dx.doi.org/10.1038/nature02768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295602				2022-12-01	WOS:000223085400047
J	Newman, LS; Feinberg, MW; LeWine, HE				Newman, LS; Feinberg, MW; LeWine, HE			A bitter tale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOXGLOVE EXTRACT		Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates	Newman, LS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	lnewman1@partners.org						ANTMAN EM, 1990, CIRCULATION, V81, P1744, DOI 10.1161/01.CIR.81.6.1744; Gowda R M, 2003, Heart, V89, pe14, DOI 10.1136/heart.89.4.e14; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; HOFFMAN B F, 1990, P814; KELLY RA, 1992, AM J CARDIOL, V69, pG108, DOI 10.1016/0002-9149(92)91259-7; KWAN T, 1992, CHEST, V102, P949, DOI 10.1378/chest.102.3.949; RICH SA, 1993, ANN EMERG MED, V22, P1904, DOI 10.1016/S0196-0644(05)80420-2; SMITH TW, 1973, NEW ENGL J MED, V289, P1125, DOI 10.1056/NEJM197311222892106; Thierry S, 2000, INTENS CARE MED, V26, P1586, DOI 10.1007/s001340000636; Watson WA, 2003, AM J EMERG MED, V21, P353, DOI 10.1016/S0735-6757(03)00088-3	10	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					594	599		10.1056/NEJMcps040238	http://dx.doi.org/10.1056/NEJMcps040238			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295053				2022-12-01	WOS:000223069900014
J	Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E				Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E			Photo-onycholysis associated with the use of doxycycline	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Netherlands Pharmacovigilance Ctr Lareb, NL-5327 MH Shertogenbosch, Netherlands		Passier, A (corresponding author), Netherlands Pharmacovigilance Ctr Lareb, Goudsbloemvallei 7, NL-5327 MH Shertogenbosch, Netherlands.	A.Passier@Lareb.nl	van Puijenbroek, Eugene/AAI-3240-2020	Passier, Anneke/0000-0001-5594-6360; van Puijenbroek, Eugene/0000-0002-2236-1398				BRUINSMA W, 2000, GUIDE DRUG ERUPTIONS, P26; CAVENS TR, 1981, CUTIS, V27, P53; FRANK SB, 1971, ARCH DERMATOL, V103, P520, DOI 10.1001/archderm.103.5.520; SHEA CR, 1993, J INVEST DERMATOL, V101, P329, DOI 10.1111/1523-1747.ep12365484; Yong CKK, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.1.e13	5	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					265	265		10.1136/bmj.329.7460.265	http://dx.doi.org/10.1136/bmj.329.7460.265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284149	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000223133300017
J	Wilson, DR; Hare, JF				Wilson, DR; Hare, JF			Ground squirrel uses ultrasonic alarms	NATURE			English	Article									Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Wilson, DR (corresponding author), Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada.	harejf@cc.umanitoba.ca	Wilson, David R/E-2869-2010	Wilson, David R/0000-0002-6558-6415				Hare JF, 1998, ANIM BEHAV, V55, P451, DOI 10.1006/anbe.1997.0613; KOEPPL JW, 1978, J MAMMAL, V59, P677, DOI 10.2307/1380133; Sales GD, 1974, ULTRASONIC COMMUNICA; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; SMITH WJ, 1979, AM ZOOL, V19, P531; WITKIN SR, 1977, CONDOR, V79, P490, DOI 10.2307/1367730	8	56	57	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					523	523		10.1038/430523a	http://dx.doi.org/10.1038/430523a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282596	Green Accepted			2022-12-01	WOS:000222946100035
J	Arai, F; Hirao, A; Ohmura, M; Sato, H; Matsuoka, S; Takubo, K; Ito, K; Koh, GY; Suda, T				Arai, F; Hirao, A; Ohmura, M; Sato, H; Matsuoka, S; Takubo, K; Ito, K; Koh, GY; Suda, T			Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche	CELL			English	Article							RECEPTOR TYROSINE KINASE; TIE2 RECEPTOR; ANGIOPOIETIN-1; IDENTIFICATION; GROWTH; TEK; BETA-1-INTEGRINS; EXPRESSION; SURVIVAL; ADHESION	The quiescent state is thought to be an indispensable property for the maintenance of hematopoietic stem cells (HSCs). Interaction of HSCs with their particular microenvironments, known as the stem cell niches, is critical for adult hematopoiesis in the bone marrow (BM). Here, we demonstrate that HSCs expressing the receptor tyrosine kinase Tie2 are quiescent and antiapoptotic, and comprise a side-population (SP) of HSCs, which adhere to osteoblasts (OBs) in the BM niche. The interaction of Tie2 with its ligand Angiopoietin-1 (Ang-1) induced cobblestone formation of HSCs in vitro and maintained in vivo long-term repopulating activity of HSCs. Furthermore, Ang-1 enhanced the ability of HSCs to become quiescent and induced adhesion to bone, resulting in protection of the HSC compartment from myelosuppressive stress. These data suggest that the Tie2/Ang-1 signaling pathway plays a critical role in the maintenance of HSCs in a quiescent state in the BM niche.	Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan; Kyowa Hakko Kogyo Corp Ltd, Tokyo 1948533, Japan; Korea Adv Inst Sci & Technol, Ctr Biomed Res, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Keio University; Kyowa Kirin Ltd; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Suda, T (corresponding author), Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sudato@sc.itc.keio.ac.jp	Arai, Fumio/J-5241-2013; Takubo, Keiyo/AAX-5546-2020; Koh, Gou Young/C-1615-2011; Suda, Toshio/H-6761-2013	Arai, Fumio/0000-0003-1936-4907; Takubo, Keiyo/0000-0002-1736-7592; Suda, Toshio/0000-0001-7540-1771				ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Arai F, 2002, J EXP MED, V195, P1549, DOI 10.1084/jem.20011700; Arboleda MJ, 2003, CANCER RES, V63, P196; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; FUNK PE, 1994, BLOOD, V83, P361; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; HALL PA, 1989, DEVELOPMENT, V106, P619; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Li YH, 2002, J INFRARED MILLIM W, V21, P1; Lin HF, 1997, ANNU REV GENET, V31, P455, DOI 10.1146/annurev.genet.31.1.455; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Partanen J, 1996, DEVELOPMENT, V122, P3013; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodewald HR, 1996, ONCOGENE, V12, P397; Sato A, 1998, INT IMMUNOL, V10, P1217, DOI 10.1093/intimm/10.8.1217; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Termine John D., 1996, P24; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	46	1432	1520	2	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					149	161		10.1016/j.cell.2004.07.004	http://dx.doi.org/10.1016/j.cell.2004.07.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260986	Bronze			2022-12-01	WOS:000222966000005
J	Azzam, R; Chen, SL; Shou, WY; Mah, AS; Alexandru, G; Nasmyth, K; Annan, RS; Carr, SA; Deshaies, RJ				Azzam, R; Chen, SL; Shou, WY; Mah, AS; Alexandru, G; Nasmyth, K; Annan, RS; Carr, SA; Deshaies, RJ			Phosphorylation by cyclin B-Cdk underlies release of mitotic exit activator Cdc14 from the nucleolus	SCIENCE			English	Article							CHROMOSOME SEGREGATION; ANAPHASE TRANSITION; PHOSPHATASE CDC14; BUDDING YEAST; RENT COMPLEX; KINASE CDC5; POLO KINASE; SEPARASE; LOCALIZATION; METAPHASE	Budding yeast protein phosphatase Cdc14 is sequestered in the nucleolus in an inactive state during interphase by the anchor protein Net1. Upon entry into anaphase, the Cdc14 early anaphase release ( FEAR) network initiates dispersal of active Cdc14 throughout the cell. We report that the FEAR network promotes phosphorylation of Net1 by cyclin-dependent kinase (Cdk) complexed with cyclin B1 or cyclin B2. These phosphorylations appear to be required for FEAR and sustain the proper timing of late mitotic events. Thus, a regulatory circuit exists to ensure that the arbiter of the mitotic state, Cdk, sets in motion events that culminate in exit from mitosis.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; GlaxoSmithKline, Dept Computat Analyt & Struct Sci, King Of Prussia, PA 19406 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; GlaxoSmithKline; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Deshaies, RJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014; Carr, Steven A./AAH-8366-2019	Deshaies, Raymond/0000-0002-3671-9354; Shou, Wenying/0000-0001-5693-381X; Alexandru, Gabriela/0000-0002-7058-5644; Nasmyth, Kim/0000-0001-7030-4403	NIGMS NIH HHS [GM59940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZZAM R, UNPUB; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Johnston LH, 1997, METHOD ENZYMOL, V283, P342; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, METHOD ENZYMOL, V351, P279; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Walker Graeme M., 1999, Methods in Cell Science, V21, P87, DOI 10.1023/A:1009824520278; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676	22	143	146	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					516	519		10.1126/science.1099402	http://dx.doi.org/10.1126/science.1099402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273393				2022-12-01	WOS:000222828900039
J	Bernard, C; Anderson, A; Becker, A; Poolos, NP; Beck, H; Johnston, D				Bernard, C; Anderson, A; Becker, A; Poolos, NP; Beck, H; Johnston, D			Acquired dendritic channelopathy in temporal lobe epilepsy	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; CA1 PYRAMIDAL NEURONS; STATUS EPILEPTICUS; GABAERGIC INHIBITION; HIPPOCAMPAL-NEURONS; POTASSIUM CHANNELS; UP-REGULATION; K+ CHANNELS; FIRING MODE; H-CHANNELS	Inherited channelopathies are at the origin of many neurological disorders. Here we report a form of channelopathy that is acquired in experimental temporal lobe epilepsy (TLE), the most common form of epilepsy in adults. The excitability of CA1 pyramidal neuron dendrites was increased in TLE because of decreased availability of A-type potassium ion channels due to transcriptional ( loss of channels) and posttranslational ( increased channel phosphorylation by extracellular signal-regulated kinase) mechanisms. Kinase inhibition partly reversed dendritic excitability to control levels. Such acquired channelopathy is likely to amplify neuronal activity and may contribute to the initiation and/or propagation of seizures in TLE.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; INSERM, U29, F-13273 Marseille 09, France; Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; Univ Bonn, Med Ctr, Dept Epileptol, Lab Expt Epileptol, D-53105 Bonn, Germany; Univ Washington, Dept Neurol, Seattle, WA 98104 USA; Univ Washington, Reg Epilepsy Ctr, Seattle, WA 98104 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn; University of Bonn; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bernard, C (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	cbernard@inmed.univ-mrs.fr	Becker, Albert J/F-6248-2012; bernard, christophe/S-5937-2016; bernard, christophe/A-4929-2012	bernard, christophe/0000-0003-3014-1966; bernard, christophe/0000-0003-3014-1966	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039943, P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [MH44754, MH48432] Funding Source: Medline; NINDS NIH HHS [NS39943, NS37444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Bernard C, 2000, EPILEPSIA, V41, pS90, DOI 10.1111/j.1528-1157.2000.tb01564.x; Brisman JL, 2002, BRAIN RES, V933, P50, DOI 10.1016/S0006-8993(02)02304-1; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Garrido YCS, 1998, BRAIN RES BULL, V47, P223, DOI 10.1016/S0361-9230(98)00075-6; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller Y, 2002, J NEUROPHYSIOL, V88, P2954, DOI 10.1152/jn.00525.2001; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Su H, 2002, J NEUROSCI, V22, P3645; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; Wheal HV, 1998, TRENDS NEUROSCI, V21, P167, DOI 10.1016/S0166-2236(97)01182-X; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	28	337	356	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					532	535		10.1126/science.1097065	http://dx.doi.org/10.1126/science.1097065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273397				2022-12-01	WOS:000222828900044
J	Aggarwal, BD; Calvi, BR				Aggarwal, BD; Calvi, BR			Chromatin regulates origin activity in Drosophila follicle cells	NATURE			English	Article							CHORION GENE AMPLIFICATION; HISTONE ACETYLTRANSFERASE HBO1; DNA-REPLICATION; TRANSCRIPTIONAL REPRESSION; PROTEIN; LOCALIZATION; DEACETYLASE; MELANOGASTER; ORGANIZATION; MECHANISMS	It is widely believed that DNA replication in multicellular animals (metazoa) begins at specific origins to which a prereplicative complex (pre-RC) binds(1). Nevertheless, a consensus sequence for origins has yet to be identified in metazoa. Origin identity can change during development, suggesting that there are epigenetic influences. A notable example of developmental specificity occurs in Drosophila, where somatic follicle cells of the ovary transition from genomic replication to exclusive rereplication at origins that control amplification of the eggshell ( chorion) protein genes(2). Here we show that chromatin acetylation is critical for this developmental transition in origin specificity. We find that histones at the active origins are hyper-acetylated, coincident with binding of the origin recognition complex (ORC). Mutation of the histone deacetylase ( HDAC) Rpd3 induced genome-wide hyperacetylation, genomic replication and a redistribution of the origin-binding protein ORC2 in amplification-stage cells, independent of effects on transcription. Tethering Rpd3 or Polycomb proteins to the origin decreased its activity, whereas tethering the Chameau acetyltransferase increased origin activity. These results suggest that nucleosome acetylation and other epigenetic changes are important modulators of origin activity in metazoa.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Calvi, BR (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	Calvi@mail.med.upenn.edu	Aggarwal, Bhagwan D/I-7949-2019	Aggarwal, Bhagwan D/0000-0002-1128-8578				Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bandura JL, 2002, CANCER BIOL THER, V1, P8, DOI 10.4161/cbt.1.1.31; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Calvi BR, 2001, CHROMOSOMA, V110, P159, DOI 10.1007/s004120100131; Cayirlioglu P, 2003, MOL CELL BIOL, V23, P2123, DOI 10.1128/MCB.23.6.2123-2134.2003; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; DECICCO DV, 1984, CELL, V38, P45, DOI 10.1016/0092-8674(84)90525-7; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mottus R, 2000, GENETICS, V154, P657; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; SPRADLING AC, 1980, P NATL ACAD SCI-BIOL, V77, P1096, DOI 10.1073/pnas.77.2.1096; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Whittaker AJ, 2000, GENE DEV, V14, P1765	29	218	221	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					372	376		10.1038/nature02694	http://dx.doi.org/10.1038/nature02694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254542				2022-12-01	WOS:000222631200046
J	Bertet, C; Sulak, L; Lecuit, T				Bertet, C; Sulak, L; Lecuit, T			Myosin-dependent junction remodelling controls planar cell intercalation and axis elongation	NATURE			English	Article							POLARIZED MEMBRANE GROWTH; HEAVY-CHAIN FUNCTION; NONMUSCLE MYOSIN; EPITHELIAL-CELLS; LIGHT CHAIN; DROSOPHILA; MORPHOGENESIS; CYTOKINESIS; OOGENESIS; MIGRATION	Shaping a developing organ or embryo relies on the spatial regulation of cell division and shape. However, morphogenesis also occurs through changes in cell-neighbourhood relationships produced by intercalation(1,2). Intercalation poses a special problem in epithelia because of the adherens junctions, which maintain the integrity of the tissue. Here we address the mechanism by which an ordered process of cell intercalation directs polarized epithelial morphogenesis during germ-band elongation, the developmental elongation of the Drosophila embryo. Intercalation progresses because junctions are spatially reorganized in the plane of the epithelium following an ordered pattern of disassembly and reassembly. The planar remodelling of junctions is not driven by external forces at the tissue boundaries but depends on local forces at cell boundaries. Myosin II is specifically enriched in disassembling junctions, and its planar polarized localization and activity are required for planar junction remodelling and cell intercalation. This simple cellular mechanism provides a general model for polarized morphogenesis in epithelial organs.	Univ Mediterranee, Lab Genet & Physiol Dev, Inst Biol Dev Marseille, CNRS,INSERM, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Mediterranee, Lab Genet & Physiol Dev, Inst Biol Dev Marseille, CNRS,INSERM, Campus Luminy,Case 907, F-13288 Marseille 9, France.	lecuit@ibdm.univ-mrs.fr	Ladoux, Benoit/A-9879-2013					Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Johansen KA, 2003, DEVELOPMENT, V130, P135, DOI 10.1242/dev.00202; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIEHART DP, 1990, CELL, V60, P347, DOI 10.1016/0092-8674(90)90583-Z; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Oda H, 2001, J CELL SCI, V114, P493; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Stein JA, 2002, DEVELOPMENT, V129, P3925; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wolf WA, 1999, CELL MOL LIFE SCI, V55, P108, DOI 10.1007/s000180050274; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	29	644	654	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					667	671		10.1038/nature02590	http://dx.doi.org/10.1038/nature02590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190355				2022-12-01	WOS:000221912600043
J	Johansson, JE; Andren, O; Andersson, SO; Dickman, PW; Holmberg, L; Magnuson, A; Adami, HO				Johansson, JE; Andren, O; Andersson, SO; Dickman, PW; Holmberg, L; Magnuson, A; Adami, HO			Natural history of early, localized prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SURVIVAL; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; FOLLOW-UP; POPULATION; MEN; METASTASIS; MANAGEMENT; CARCINOMA; TUMORS	Context Among men with early prostate cancer, the natural history without initial therapy determines the potential for survival benefit following radical local treatment. However, little is known about disease progression and mortality beyond 10 to 15 years of watchful waiting. Objective To examine the long-term natural history of untreated, early stage prostatic cancer. Design Population-based, cohort study with a mean observation period of 21 years. Setting Regionally well-defined catchment area in central Sweden (recruitment March 1977 through February 1984). Patients A consecutive sample of 223 patients (98% of all eligible) with early-stage (T0-T2 NX MO classification), initially untreated prostatic cancer. Patients with tumor progression were hormonally treated (either by orchiectomy or estrogens) if they had symptoms. Main Outcome Measures Progression-free, cause-specific, and overall survival. Results After complete follow-up, 39 (17%) of all patients experienced generalized disease. Most cancers had an indolent course during the first 10 to 15 years. However, further follow-up from 15 (when 49 patients were still alive) to 20 years, revealed a substantial decrease in cumulative progression-free survival (from 45.0% to 36.0%), survival without metastases (from 76.9% to 51.2%), and prostate cancer-specific survival (from 78.7% to 54.4%). The prostate cancer mortality rate increased from 15 per 1000 person-years (95% confidence interval, 10-21) during the first 15 years to 44 per 1000 person-years (95% confidence interval, 22-88) beyond 15 years of follow-up (P=.01). Conclusion Although most prostate cancers diagnosed at an early stage have an indolent course, local tumor progression and aggressive metastatic disease may develop in the long term. These findings would support early radical treatment, notably among patients with an estimated life expectancy exceeding 15 years.	Orebro Univ Hosp, Dept Urol, SE-70185 Orebro, Sweden; Orebro Univ Hosp, Dept Clin Med, SE-70185 Orebro, Sweden; Orebro Univ Hosp, Clin Res Ctr, Stat Unit, SE-70185 Orebro, Sweden; Ctr Assessment Med Technol, Orebro, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Orebro University; Orebro University; Orebro University; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Johansson, JE (corresponding author), Orebro Univ Hosp, Dept Urol, SE-70185 Orebro, Sweden.	jan-erik.johansson@orebroll.se	Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380				Adolfsson J, 2000, PROSTATE CANCER P D, V3, P37, DOI 10.1038/sj.pcan.4500395; Adolfsson J, 1997, UROLOGY, V50, P722, DOI 10.1016/S0090-4295(97)00320-8; ALBERTSEN PC, 1995, JAMA-J AM MED ASSOC, V274, P626, DOI 10.1001/jama.274.8.626; AUS G, 1995, J UROLOGY, V154, P460, DOI 10.1016/S0022-5347(01)67074-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bishoff JT, 1998, J UROLOGY, V160, P454, DOI 10.1016/S0022-5347(01)62924-0; Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7; Borre M, 1997, CANCER, V80, P917; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Clayton D., 1993, STAT MODELS EPIDEMIO; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615; HAKULINEN T, 1977, J CHRON DIS, V30, P431, DOI 10.1016/0021-9681(77)90036-4; HAKULINEN T, 1985, COMPUT PROG BIOMED, V19, P197, DOI 10.1016/0010-468X(85)90011-X; Hanks GE, 2000, INT J RADIAT ONCOL, V46, P823, DOI 10.1016/S0360-3016(99)00498-8; Helgesen F, 1996, JNCI-J NATL CANCER I, V88, P1216, DOI 10.1093/jnci/88.17.1216; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; *INT UN CANC, 1978, TNM CLASS MAL TUM; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Oliver SE, 2003, BJU INT, V91, P331, DOI 10.1046/j.1464-410X.2003.04083.x; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WALSH PC, 1987, CANCER, V60, P526, DOI 10.1002/1097-0142(19870801)60:3+<526::AID-CNCR2820601515>3.0.CO;2-9; *WHO, 1980, INT HIST CLASS TUM, V22	26	491	519	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2004	291	22					2713	2719		10.1001/jama.291.22.2713	http://dx.doi.org/10.1001/jama.291.22.2713			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826XH	15187052	Bronze			2022-12-01	WOS:000221862300025
J	de Gruchy, J; Fish, J				de Gruchy, J; Fish, J			Doctors' involvement in human rights abuses of men who have sex with men in Egypt	LANCET			English	Editorial Material									Nottingham City Primary Care Trust, Hlth Equal Directorate, Nottingham NG1 6GN, England; De Montfort Univ, Sch Life & Hlth Sci, Leicester LE1 9BH, Leics, England	De Montfort University	de Gruchy, J (corresponding author), Nottingham City Primary Care Trust, Hlth Equal Directorate, Stand Court,Pk Row, Nottingham NG1 6GN, England.	jeanelle.degruchy@ntlworld.com						Human Rights Watch, 2004, TIM TORT ASS JUST EG; International Dual Loyalty Working Group, 2002, DUAL LOYALT HUM RIGH; Lewin S, 2001, LANCET, V358, P1899, DOI 10.1016/S0140-6736(01)06894-5; Miller AM, 2001, AM J PUBLIC HEALTH, V91, P861, DOI 10.2105/AJPH.91.6.861	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 5	2004	363	9424					1903	1903		10.1016/S0140-6736(04)16362-9	http://dx.doi.org/10.1016/S0140-6736(04)16362-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15185707				2022-12-01	WOS:000221822300026
J	Pancer, Z; Amemiya, CT; Ehrhardt, GRA; Ceitlin, J; Gartland, GL; Cooper, MD				Pancer, Z; Amemiya, CT; Ehrhardt, GRA; Ceitlin, J; Gartland, GL; Cooper, MD			Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey	NATURE			English	Article							IMMUNE-RESPONSE; PETROMYZON-MARINUS; ANTIGENIC VARIATION; INNATE IMMUNITY; EVOLUTION; GENE; IMMUNOGLOBULIN; CELLS; IDENTIFICATION; EXPRESSION	Although jawless vertebrates are apparently capable of adaptive immune responses, they have not been found to possess the recombinatorial antigen receptors shared by all jawed vertebrates. Our search for the phylogenetic roots of adaptive immunity in the lamprey has instead identified a new type of variable lymphocyte receptors (VLRs) composed of highly diverse leucine-rich repeats (LRR) sandwiched between amino- and carboxy-terminal LRRs. An invariant stalk region tethers the VLRs to the cell surface by means of a glycosyl-phosphatidyl-inositol anchor. To generate rearranged VLR genes of the diversity necessary for an anticipatory immune system, the single lamprey VLR locus contains a large bank of diverse LRR cassettes, available for insertion into an incomplete germline VLR gene. Individual lymphocytes express a uniquely rearranged VLR gene in monoallelic fashion. Different evolutionary strategies were thus used to generate highly diverse lymphocyte receptors through rearrangement of LRR modules in agnathans ( jawless fish) and of immunoglobulin gene segments in gnathostomes ( jawed vertebrates).	Univ Alabama, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Benaroya Res Inst Virginia Mason, Mol Genet Program, Seattle, WA 98101 USA; Univ Michigan, Ann Arbor, MI 48109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Benaroya Research Institute; Virginia Mason Medical Center; University of Michigan System; University of Michigan	Cooper, MD (corresponding author), Univ Alabama, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	max.cooper@ccc.uab.edu						Amemiya Chris T., 1996, P223, DOI 10.1016/B978-012101285-4/50009-6; Anderson MK, 2001, P NATL ACAD SCI USA, V98, P553, DOI 10.1073/pnas.021478998; ARDAVIN CF, 1987, DEV COMP IMMUNOL, V11, P79, DOI 10.1016/0145-305X(87)90010-3; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bryan MB, 2003, CONSERV GENET, V4, P113, DOI 10.1023/A:1021808909811; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; COOPER AJ, 1971, AMMOCOETE LYMPHOID C, P137; Duffy MF, 2003, TRENDS PARASITOL, V19, P121, DOI 10.1016/S1471-4922(03)00003-5; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; FUJII T, 1982, J MORPHOL, V173, P87, DOI 10.1002/jmor.1051730108; GOOD RA, 1972, BIOL LAMPREYS, V2, P405; HAGEN M, 1985, COMP BIOCHEM PHYS A, V82, P207, DOI 10.1016/0300-9629(85)90727-3; Haire RN, 2000, J IMMUNOL, V165, P306, DOI 10.4049/jimmunol.165.1.306; Hamrick TS, 2001, MICROBIOL-UK, V147, P839, DOI 10.1099/00221287-147-4-839; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Kaufman J, 2002, NAT IMMUNOL, V3, P1124, DOI 10.1038/ni1202-1124; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Landmann R, 2000, MICROBES INFECT, V2, P295, DOI 10.1016/S1286-4579(00)00298-7; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; LITMAN GW, 1970, J IMMUNOL, V105, P1278; MARCHALONIS JJ, 1968, J EXP MED, V127, P891, DOI 10.1084/jem.127.5.891; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Mayer WE, 2002, SCAND J IMMUNOL, V55, P162, DOI 10.1046/j.1365-3083.2002.01026.x; Nash TE, 2002, MOL MICROBIOL, V45, P585, DOI 10.1046/j.1365-2958.2002.03029.x; PEREY DYE, 1968, LAB INVEST, V19, P591; PIAVIS GW, 1971, COPEIA, P722; POLLARA B, 1970, J IMMUNOL, V105, P738; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Schluter SF, 1999, DEV COMP IMMUNOL, V23, P107; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Shintani S, 2000, P NATL ACAD SCI USA, V97, P7417, DOI 10.1073/pnas.110505597; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; Uinuk-ool T, 2002, P NATL ACAD SCI USA, V99, P14356, DOI 10.1073/pnas.212527699; Uinuk-ool TS, 2003, IMMUNOGENETICS, V55, P38, DOI 10.1007/s00251-003-0548-y; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x	42	490	535	11	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					174	180		10.1038/nature02740	http://dx.doi.org/10.1038/nature02740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241406	Green Published			2022-12-01	WOS:000222470600035
J	Kasischke, KA; Vishwasrao, HD; Fisher, PJ; Zipfel, WR; Webb, WW				Kasischke, KA; Vishwasrao, HD; Fisher, PJ; Zipfel, WR; Webb, WW			Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis	SCIENCE			English	Article							RESPIRATORY ENZYMES; GLUCOSE-METABOLISM; CEREBRAL-CORTEX; RAT-BRAIN; FLUORESCENCE; PHOSPHORYLATION; ELECTROPHORUS; SPECTROSCOPY; OXYGENATION; STIMULATION	We have found that two-photon fluorescence imaging of nicotinamide adenine dinucleotide ( NADH) provides the sensitivity and spatial three-dimensional resolution to resolve metabolic signatures in processes of astrocytes and neurons deep in highly scattering brain tissue slices. This functional imaging reveals spatiotemporal partitioning of glycolytic and oxidative metabolism between astrocytes and neurons during focal neural activity that establishes a unifying hypothesis for neurometabolic coupling in which early oxidative metabolism in neurons is eventually sustained by late activation of the astrocyte-neuron lactate shuttle. Our model integrates existing views of brain energy metabolism and is in accord with known macroscopic physiological changes in vivo.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Webb, WW (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	www2@cornell.edu	Webb, Watt W./B-5905-2011; Zipfel, Warren/B-4059-2016	Kasischke, Karl/0000-0003-0582-4319; Zipfel, Warren/0000-0003-2640-329X	NIBIB NIH HHS [P41-EB001976-16] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001976] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AUBERT X, 1964, PROC R SOC SER B-BIO, V160, P211, DOI 10.1098/rspb.1964.0037; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Brandes R, 1996, BIOPHYS J, V71, P1024, DOI 10.1016/S0006-3495(96)79303-7; CHANCE B, 1958, J BIOL CHEM, V233, P736; CHANCE B, 1955, J BIOL CHEM, V217, P409; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 1996, P NATL ACAD SCI USA, V93, P7612, DOI 10.1073/pnas.93.15.7612; JOBSIS FF, 1971, J NEUROPHYSIOL, V34, P735, DOI 10.1152/jn.1971.34.5.735; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; LIPTON P, 1973, BIOCHEM J, V136, P999, DOI 10.1042/bj1360999; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mangia S, 2003, NEUROSCIENCE, V118, P7, DOI 10.1016/S0306-4522(02)00792-3; MERILL DK, 1981, BRAIN RES, V221, P307; MERILL DK, 1976, J NEUROCHEM, V27, P459; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; WILLIAMS.JR, 1967, J BIOL CHEM, V242, P5119; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3	30	545	561	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					99	103		10.1126/science.1096485	http://dx.doi.org/10.1126/science.1096485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232110				2022-12-01	WOS:000222386000045
J	Vasan, RS; Evans, JC; Larson, MG; Wilson, PWF; Meigs, JB; Rifai, N; Benjamin, EJ; Levy, D				Vasan, RS; Evans, JC; Larson, MG; Wilson, PWF; Meigs, JB; Rifai, N; Benjamin, EJ; Levy, D			Serum aldosterone and the incidence of hypertension in nonhypertensive persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA-RENIN ACTIVITY; BLOOD-PRESSURE; VASCULAR ALDOSTERONE; ANGIOTENSIN-II; SODIUM-INTAKE; HEART; FRAMINGHAM; SALT; POTASSIUM; SYSTEM	Background: Primary hyperaldosteronism is a well-recognized cause of secondary hypertension. It is unknown whether serum aldosterone levels within the physiologic range influence the risk of hypertension. Methods: We investigated the relation of baseline serum aldosterone levels to increases in blood pressure and the incidence of hypertension after four years in 1688 nonhypertensive participants in the Framingham Offspring Study (mean age, 55 years), 58 percent of whom were women. We defined an increase in blood pressure as an increment of at least one blood-pressure category (as defined by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) and defined hypertension as a systolic blood pressure of 140 mm Hg or higher, a diastolic blood pressure of 90 mm Hg or higher, or the use of antihypertensive medications. Results: At follow-up, the blood-pressure category had increased in 33.6 percent of the participants, and hypertension had developed in 14.8 percent. In multivariable models, a 16 percent increase in the risk of an elevation in blood pressure (P=0.002) and a 17 percent increase in the risk of hypertension (P=0.03) were observed per quartile increment in the serum aldosterone level. The highest serum aldosterone quartile, relative to the lowest, was associated with a 1.60-fold risk of an elevation in blood pressure (95 percent confidence interval, 1.19 to 2.14) and a 1.61-fold risk of hypertension (95 percent confidence interval, 1.05 to 2.46). The associations between the serum aldosterone level and blood-pressure outcomes were not significantly affected by adjustment for urinary sodium excretion or left ventricular thickness or internal dimensions. Conclusions: In our community-based sample, increased aldosterone levels within the physiologic range predisposed persons to the development of hypertension.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Med Univ S Carolina, Dept Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Medical University of South Carolina; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019; Meigs, James/P-3927-2019; Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Meigs, James/0000-0002-2439-2657; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL04334, N01-HC-25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdelhamid S, 2003, AM J HYPERTENS, V16, P522, DOI 10.1016/S0895-7061(03)00858-6; Blacher J, 1997, AM J HYPERTENS, V10, P1326, DOI 10.1016/S0895-7061(97)00301-4; Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; COLLINS RD, 1970, J CLIN INVEST, V49, P1415, DOI 10.1172/JCI106359; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Funder JW, 2002, AM HEART J, V144, pS8, DOI 10.1067/mhj.2002.129971; Ganguly A, 1998, NEW ENGL J MED, V339, P1828, DOI 10.1056/NEJM199812173392507; Ganguly A, 2001, J CLIN ENDOCR METAB, V86, P4002, DOI 10.1210/jcem.86.8.9995; GENEST J, 1975, CAN MED ASSOC J, V113, P421; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; GORDON T, 1976, INT J EPIDEMIOL, V5, P327, DOI 10.1093/ije/5.4.327; HARRAP SB, 1988, AM J PHYSIOL, V254, pF697, DOI 10.1152/ajprenal.1988.254.5.F697; HARRIS P, 1983, CARDIOVASC RES, V17, P437, DOI 10.1093/cvr/17.8.437; HATAKEYAMA H, 1994, J BIOL CHEM, V269, P24316; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; ITO T, 1972, J CLIN ENDOCR METAB, V34, P106, DOI 10.1210/jcem-34-1-106; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION NAT; Kaplan NM, 2001, LANCET, V357, P953, DOI 10.1016/S0140-6736(00)04223-9; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lim PO, 2000, QJM-INT J MED, V93, P703, DOI 10.1093/qjmed/93.11.703; Lim PO, 2000, J HUM HYPERTENS, V14, P311, DOI 10.1038/sj.jhh.1001013; Lim PO, 2002, J HYPERTENS, V20, P11, DOI 10.1097/00004872-200201000-00003; LJUNGMAN S, 1982, ACTA MED SCAND, V211, P351; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; POST WS, 1994, CIRCULATION, V90, P179, DOI 10.1161/01.CIR.90.1.179; Rocha R, 2002, ANN NY ACAD SCI, V970, P89, DOI 10.1111/j.1749-6632.2002.tb04415.x; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAS Institute, 1996, SAS STAT SOFTW CHANG; Schunkert H, 1997, HEART, V77, P24, DOI 10.1136/hrt.77.1.24; Schwartz GL, 2002, CLIN CHEM, V48, P1919; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Takeda Y, 2000, HYPERTENSION, V36, P495, DOI 10.1161/01.HYP.36.4.495; Takeda Y, 1997, HYPERTENSION, V29, P45, DOI 10.1161/01.HYP.29.1.45; TOLAGEN K, 1978, SCAND J CLIN LAB INV, V38, P487, DOI 10.3109/00365517809108455; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; WALKER WG, 1979, HYPERTENSION, V1, P287, DOI 10.1161/01.HYP.1.3.287; Walsh CR, 2002, AM J HYPERTENS, V15, P130, DOI 10.1016/S0895-7061(01)02293-2; WISENBAUGH PE, 1972, AM J MED, V52, P175, DOI 10.1016/0002-9343(72)90067-8; Young MJ, 1996, STEROIDS, V61, P233, DOI 10.1016/0039-128X(96)00020-7	43	431	448	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2004	351	1					33	41		10.1056/NEJMoa033263	http://dx.doi.org/10.1056/NEJMoa033263			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833QC	15229305				2022-12-01	WOS:000222352200007
J	Sigala, JLD; Bottero, V; Young, DB; Shevchenko, A; Mercurio, F; Verma, IM				Sigala, JLD; Bottero, V; Young, DB; Shevchenko, A; Mercurio, F; Verma, IM			Activation of transcription factor NF-kappa B requires ELKS, an I kappa B kinase regulatory subunit	SCIENCE			English	Article							PAPILLARY THYROID-CARCINOMA; IKK COMPLEX; INDUCED APOPTOSIS; MAMMALIAN-CELLS; ALPHA; BETA; GENE; RNAS; OLIGOMERIZATION; PHOSPHORYLATION	The nuclear factor-kappa B (NF-kappaB) family of transcription factors plays a seminal role in inflammation, apoptosis, development, and cancer. Modulation of NF-kappaB-mediated gene expression in response to diverse signals is coordinated by the IkappaB kinase (IKK) complex. We identified ELKS, an essential regulatory subunit of the IKK complex. Silencing ELKS expression by RNA interference blocked induced expression of NF-kappaB target genes, including the NF-kappaB inhibitor IkappaBalpha and proinflammatory genes such as cyclo-oxygenase 2 and interleukin 8. These cells were also not protected from apoptosis in response to cytokines. ELKS likely functions by recruiting IkappaBalpha to the IKK complex and thus serves a regulatory function for IKK activation.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Celgene, San Diego, CA 92121 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Salk Institute; Bristol-Myers Squibb; Celgene Corporation; Max Planck Society	Verma, IM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu						Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Nakata T, 2002, GENE CHROMOSOME CANC, V35, P30, DOI 10.1002/gcc.10095; Nakata T, 1999, GENE CHROMOSOME CANC, V25, P97, DOI 10.1002/(SICI)1098-2264(199906)25:2<97::AID-GCC4>3.0.CO;2-L; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIGALA JLD, UNPUB; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; VAN AD, 1996, SCIENCE, V274, P787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yokota T, 2000, J HUM GENET, V45, P6, DOI 10.1007/s100380050002; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	31	177	188	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1963	1967		10.1126/science.1098387	http://dx.doi.org/10.1126/science.1098387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218148				2022-12-01	WOS:000222241600045
J	Guo, G; Wang, W; Bradley, A				Guo, G; Wang, W; Bradley, A			Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells	NATURE			English	Article							MUTATIONS; RECOMBINATION; DISRUPTION; EXPRESSION; BINDING; TUMORS; LEADS; GTBP; MSH2	Phenotype-driven recessive genetic screens in diploid organisms require a strategy to render the mutation homozygous. Although homozygous mutant mice can be generated by breeding, a reliable method to make homozygous mutations in cultured cells has not been available, limiting recessive screens in culture. Cultured embryonic stem (ES) cells(1) provide access to all of the genes required to elaborate the fundamental components and physiological systems of a mammalian cell. Here we have exploited the high rate of mitotic recombination in Bloom's syndrome protein (Blm)-deficient ES2 cells to generate a genome-wide library of homozygous mutant cells from heterozygous mutations induced with a revertible gene trap(3) retrovirus. We have screened this library for cells with defects in DNA mismatch repair (MMR), a system that detects and repairs base-base mismatches(4). We demonstrate the recovery of cells with homozygous mutations in known and novel MMR genes. We identified Dnmt1(ref. 5) as a novel MMR gene and confirmed that Dnmt1-deficient ES cells exhibit micro-satellite instability(6), providing a mechanistic explanation for the role of Dnmt1 in cancer. The combination of insertional mutagenesis in Blm-deficient ES cells establishes a new approach for phenotype-based recessive genetic screens in ES cells.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk		Bradley, Allan/0000-0002-2349-8839				Abuin A, 2000, MOL CELL BIOL, V20, P149, DOI 10.1128/MCB.20.1.149-157.2000; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; HOOPER ML, 1977, DEV BIOL, V55, P271, DOI 10.1016/0012-1606(77)90172-5; Ishida Y, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e35; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luria SE, 1943, GENETICS, V28, P491; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; STRAND M, 1994, NATURE, V368, P569, DOI 10.1038/368569a0; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	29	119	128	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					891	895		10.1038/nature02653	http://dx.doi.org/10.1038/nature02653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215866				2022-12-01	WOS:000222213000045
J	Kaneda, M; Okano, M; Hata, K; Sado, T; Tsujimoto, N; Li, E; Sasaki, H				Kaneda, M; Okano, M; Hata, K; Sado, T; Tsujimoto, N; Li, E; Sasaki, H			Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting	NATURE			English	Article							COMPLETE HYDATIDIFORM MOLES; OOCYTE GROWTH; METHYLATION; GENE; MOUSE; ESTABLISHMENT; LOCUS; MICE	Imprinted genes are epigenetically marked during gametogenesis so that they are exclusively expressed from either the paternal or the maternal allele in offspring(1). Imprinting prevents parthenogenesis in mammals and is often disrupted in congenital malformation syndromes, tumours and cloned animals(1). Although de novo DNA methyltransferases of the Dnmt3 family are implicated in maternal imprinting(2), the lethality of Dnmt3a and Dnmt3b knockout mice(3) has precluded further studies. We here report the disruption of Dnmt3a and Dnmt3b in germ cells, with their preservation in somatic cells, by conditional knockout technology(4). Offspring from Dnmt3a conditional mutant females die in utero and lack methylation and allele-specific expression at all maternally imprinted loci examined. Dnmt3a conditional mutant males show impaired spermatogenesis and lack methylation at two of three paternally imprinted loci examined in spermatogonia. By contrast, Dnmt3b conditional mutants and their offspring show no apparent phenotype. The phenotype of Dnmt3a conditional mutants is indistinguishable from that of Dnmt3L knockout mice2,5, except for the discrepancy in methylation at one locus. These results indicate that both Dnmt3a and Dnmt3L are required for methylation of most imprinted loci in germ cells, but also suggest the involvement of other factors.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Grad Univ Adv Studies Sokendai, Sch Adv Sci, Dept Biosyst Sci, Hayama 2400193, Japan; JST, PRESTO, Kawaguchi 3320012, Japan; Natl Inst Genet, Res Org Informat & Syst, Dept Integrat Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; RIKEN, Ctr Dev Biol, Lab Mammalian Epigenet Studies, Kobe, Hyogo 6500047, Japan	Harvard University; Massachusetts General Hospital; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; RIKEN	Sasaki, H (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	hisasaki@lab.nig.ac.jp	Sado, Takashi/AAI-1689-2019; Kaneda, Masahiro/E-3117-2010	Kaneda, Masahiro/0000-0003-0660-7156; Sado, Takashi/0000-0002-1232-0250				Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cerrato F, 2003, HUM MOL GENET, V12, P3123, DOI 10.1093/hmg/ddg338; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DAVID B V, 1985, Pesticides (Bombay), V19, P9; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; HASHIMOTO N, 1990, J EXP ZOOL, V253, P61, DOI 10.1002/jez.1402530109; Hata K, 2002, DEVELOPMENT, V129, P1983; Hayward BE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-2; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sado T, 2004, DEVELOPMENT, V131, P975, DOI 10.1242/dev.00995; Torres RM, 1997, LAB PROTOCOLS CONDIT; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025	24	967	1011	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					900	903		10.1038/nature02633	http://dx.doi.org/10.1038/nature02633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215868				2022-12-01	WOS:000222213000047
J	Weaver, HA				Weaver, HA			Not a rubble pile?	SCIENCE			English	Editorial Material							CAMERA		Johns Hopkins Univ, Appl Phys Lab, Dept Space, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Weaver, HA (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Dept Space, Johns Hopkins Rd, Laurel, MD 20723 USA.	hal.weaver@jhuapl.edu	Weaver, Harold A/D-9188-2016	Weaver, Harold A/0000-0003-0951-7762				Britt D.T., 2002, ASTEROIDS, P485; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; Levasseur-Regourd AC, 2004, SCIENCE, V304, P1762, DOI 10.1126/science.1100601; Newburn RL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002081; Richardson D.C., 2002, ASTEROIDS, P501; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; Tuzzolino AJ, 2004, SCIENCE, V304, P1776, DOI 10.1126/science.1098759; WEISSMAN PR, IN PRESS COMETS, V2; Yelle RV, 2004, ICARUS, V167, P30, DOI 10.1016/j.icarus.2003.08.020	12	18	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1760	1762						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205522				2022-12-01	WOS:000222089500033
J	Xue, LL; Gollapalli, DR; Maiti, P; Jahng, WJ; Rando, RR				Xue, LL; Gollapalli, DR; Maiti, P; Jahng, WJ; Rando, RR			A palmitoylation switch mechanism in the regulation of the visual cycle	CELL			English	Article							LECITHIN RETINOL ACYLTRANSFERASE; PIGMENT-EPITHELIUM; VITAMIN-A; PROTEIN PALMITOYLATION; BINDING-PROTEIN; ENERGY-SOURCE; RPE65; 11-CIS-RETINOL; PURIFICATION; ISOMERIZATION	RPE65 is essential for the biosynthesis of 11-cis-retinal, the chromophore of rhodopsin. Here, we show that the membrane-associated form (mRPE65) is triply palmitoylated and is a chaperone for all-trans-retinyl esters, allowing their entry into the visual cycle for processing into 11-cis-retinal. The soluble form of RPE65 (sRPE65) is not palmitoylated and is a chaperone for vitamin A, rather than all-trans-retinyl esters. Thus, the palmitoylation of RPE65 controls its ligand binding selectivity. The two chaperones are interconverted by lecithin retinol acyl transferase (LRAT) acting as a molecular switch. Here mRPE65 is a palmitoyl donor, revealing a new acyl carrier protein role for palmitoylated proteins. When chromophore synthesis is not required, mRPE65 is converted into sRPE65 by LRAT, and further chromophore synthesis is blocked. The studies reveal new roles for palmitoylated proteins as molecular switches and LRAT as a palmitoyl transferase whose role is to catalyze the mRPE65 to sRPE65 conversion.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rando, RR (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 45 Shattuck St, Boston, MA 02115 USA.	robert_rando@hms.harvard.edu	Jahng, Wan Jin/C-1236-2018	Jahng, Wan Jin/0000-0001-8241-7739	NATIONAL EYE INSTITUTE [R01EY004096, R37EY004096] Funding Source: NIH RePORTER; NEI NIH HHS [EY-04096] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BARRY RJ, 1989, J BIOL CHEM, V264, P9231; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BRIDGES CDB, 1976, EXP EYE RES, V22, P435, DOI 10.1016/0014-4835(76)90182-2; CANADA FJ, 1990, BIOCHEMISTRY-US, V29, P9690, DOI 10.1021/bi00493a026; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Gollapalli DR, 2004, BIOCHEMISTRY-US, V43, P7226, DOI 10.1021/bi040028d; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hanna-Rose W, 2002, DEV BIOL, V241, P247, DOI 10.1006/dbio.2001.0514; HOUSLAY MD, 1996, CELL SIGNAL, V8, P403; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P6159, DOI 10.1021/bi034002i; Kammer B, 2003, MOL CELL NEUROSCI, V23, P333, DOI 10.1016/S1044-7431(03)00064-2; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Morello JP, 1996, BIOCHEM CELL BIOL, V74, P449, DOI 10.1139/o96-049; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Patterson SI, 2002, BIOL RES, V35, P139, DOI 10.4067/S0716-97602002000200005; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; RANDO RR, 1990, ANGEW CHEM INT EDIT, V29, P461, DOI 10.1002/anie.199004611; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SEGAL I, 1993, ENZYME KINETICS; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P3077, DOI 10.1021/bi00063a019; STACIE RL, 1997, J NEUROCHEM, V69, P1864; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; WALD G, 1953, ANNU REV BIOCHEM, V22, P497, DOI 10.1146/annurev.bi.22.070153.002433; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d	46	114	115	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					761	771		10.1016/j.cell.2004.05.016	http://dx.doi.org/10.1016/j.cell.2004.05.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186777	Bronze			2022-12-01	WOS:000222048400009
J	Siemers, BM; Schnitzler, HU				Siemers, BM; Schnitzler, HU			Echolocation signals reflect niche differentiation in five sympatric congeneric bat species	NATURE			English	Article							NOTCH-EARED BAT; FORAGING BEHAVIOR; MYOTIS-EMARGINATUS; FLIGHT PERFORMANCE; RHINOLOPHOID BATS; GENUS MYOTIS; EATING BATS; VESPERTILIONIDAE; PREY; CHIROPTERA	Echolocating bats can be divided into guilds according to their preferred habitat and foraging behaviour(1-4), which coincide with distinct adaptations in wing morphology(5) and structure of echolocation signals(6). Although coarse structuring of niche space between different guilds is generally accepted, it is not clear how niches differ within guilds(7-10), or whether there is fine-grained niche differentiation reflected in echolocation signal structure(11,12). Using a standardized performance test, here we show clutter-dependent differences in prey-capture success for bats from five species of European Myotis. These species are morphologically similar, sympatric(13), and all belong to the guild labelled "edge space aerial/trawling foragers"(4). We further demonstrate a strong correlation between the prey-detection ability of the species and the respective search-call bandwidth. Our findings indicate that differences in echolocation signals contribute to within-guild niche differentiation. This is the first study relating sensory abilities of a set of potentially competing animal species to a direct measure of their respective foraging performance, suggesting an important role of sensory ecology in the structuring of animal communities.	Univ Tubingen, Inst Zool, D-72706 Tubingen, Germany	Eberhard Karls University of Tubingen	Siemers, BM (corresponding author), Univ Tubingen, Inst Zool, Morgenstelle 28, D-72706 Tubingen, Germany.	bjoern.siemers@uni-tuebingen.de						ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Britton ARC, 1997, J ZOOL, V241, P503, DOI 10.1111/j.1469-7998.1997.tb04842.x; CROME FHJ, 1988, ECOLOGY, V69, P1960, DOI 10.2307/1941173; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; FINDLEY JS, 1976, AM NAT, V110, P129, DOI 10.1086/283053; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; JONES G, 1988, J ZOOL, V215, P113, DOI 10.1111/j.1469-7998.1988.tb04888.x; Kingston T, 1999, J ZOOL, V249, P359, DOI 10.1111/j.1469-7998.1999.tb00771.x; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; MCKENZIE NL, 1986, J ANIM ECOL, V55, P401, DOI 10.2307/4727; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Schmidt S, 2000, J COMP PHYSIOL A, V186, P975, DOI 10.1007/s003590000151; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHUMM A, 1991, BEHAV ECOL SOCIOBIOL, V28, P255; Siemers BM, 2001, J EXP BIOL, V204, P3843; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Sleep DJH, 2003, J MAMMAL, V84, P216, DOI 10.1644/1545-1542(2003)084<0216:AETOCT>2.0.CO;2; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; [No title captured]; [No title captured]	29	261	283	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					657	661		10.1038/nature02547	http://dx.doi.org/10.1038/nature02547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190352				2022-12-01	WOS:000221912600040
J	Busza, A; Emery-Le, M; Rosbash, M; Emery, P				Busza, A; Emery-Le, M; Rosbash, M; Emery, P			Roles of the two Drosophila CRYPTOCHROME structural domains in circadian photoreception	SCIENCE			English	Article							LIGHT RESPONSE; S-PHASE; CLOCK; TIMELESS; ENTRAINMENT; PROTEIN; CRY; MECHANISM; SUGGESTS	CRYPTOCHROME ( CRY) is the primary circadian photoreceptor in Drosophila. We show that CRY binding to TIMELESS ( TIM) is light-dependent in flies and irreversibly commits TIM to proteasomal degradation. In contrast, CRY degradation is dependent on continuous light exposure, indicating that the CRY-TIM interaction is transient. A novel cry mutation (cry(m)) reveals that CRY's photolyase homology domain is sufficient for light detection and phototransduction, whereas the carboxyl-terminal domain regulates CRY stability, CRY-TIM interaction, and circadian photosensitivity. This contrasts with the function of Arabidopsis CRY domains and demonstrates that insect and plant cryptochromes use different mechanisms.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	University of Massachusetts System; University of Massachusetts Worcester; Brandeis University; Howard Hughes Medical Institute	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu		Busza, Ania/0000-0002-1761-088X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205, R01GM066777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007366, P01NS044232] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM33205, GM66777-01] Funding Source: Medline; NINDS NIH HHS [P01 NS44232, 5 T32 NS07366-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Foss EJ, 2001, GENETICS, V157, P567; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.3.CO;2-I; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	29	222	233	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1503	1506		10.1126/science.1096973	http://dx.doi.org/10.1126/science.1096973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178801				2022-12-01	WOS:000221795800045
J	Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M				Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M			IKK beta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer	CELL			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; ACTIVATION; APOPTOSIS; INHIBITION; EXPRESSION; KINASE; PREVENTION	A link between inflammation and cancer has long been suspected, but its molecular nature remained ill defined. A key player in inflammation is transcription factor NF-kappaB whose activity is triggered in response to infectious agents and proinflammatory cytokines via the IkappaB kinase (IKK) complex. Using a colitis-associated cancer model, we show that although deletion of IKKbeta in intestinal epithelial cells does not decrease inflammation, it leads to a dramatic decrease in tumor incidence without affecting tumor size. This is linked to increased epithelial apoptosis during tumor promotion. Deleting IKKbeta in myeloid cells, however, results in a significant decrease in tumor size. This deletion diminishes expression of proinflammatory cytokines that may serve as tumor growth factors, without affecting apoptosis. Thus, specific inactivation of the IKK/NF-kappaB pathway in two different cell types can attenuate formation of inflammation-associated tumors. In addition to suppressing apoptosis in advanced tumors, IKKbeta may link inflammation to cancer.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30655 Hannover, Germany; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hannover Medical School; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020; Greten, Tim F/B-3127-2015	Greten, Florian R/0000-0002-3928-6080; Greten, Tim F/0000-0002-0806-2535	NIAID NIH HHS [AI43477, AI56075] Funding Source: Medline; NIDDK NIH HHS [DK35108] Funding Source: Medline; NIEHS NIH HHS [ES10337] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amit S, 2003, SEMIN CANCER BIOL, V13, P15, DOI 10.1016/S1044-579X(02)00096-2; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ekbom A, 1998, J Gastrointest Surg, V2, P312, DOI 10.1016/S1091-255X(98)80067-X; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hacker H, 2002, CANCER CELL, V2, P431, DOI 10.1016/S1535-6108(02)00213-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Iwamoto M, 1996, J PATHOL, V180, P152; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SELTZ CS, 1998, P NATL ACAD SCI USA, V95, P2307; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; van Hogerlinden M, 1999, CANCER RES, V59, P3299; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	65	1950	2072	8	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					285	296		10.1016/j.cell.2004.07.013	http://dx.doi.org/10.1016/j.cell.2004.07.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294155	Bronze			2022-12-01	WOS:000223353100006
J	Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N				Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N			Calmodulin and Munc13 form a Ca2+ sensor/effector complex that controls short-term synaptic plasticity	CELL			English	Article							CORTICOTROPIN-RELEASING FACTOR; READILY RELEASABLE POOL; TRANSMITTER RELEASE; BINDING-PROTEIN; DEPRESSION; VESICLES; CALCIUM; UNC-13; TRANSMISSION; FACILITATION	The efficacy of synaptic transmission between neurons can be altered transiently during neuronal network activity. This phenomenon of short-term plasticity is a key determinant of network properties; is involved in many physiological processes such as motor control, sound localization, or sensory adaptation; and is critically dependent on cytosolic [Call]. However, the underlying molecular mechanisms and the identity of the Ca2+ sensor/effector complexes involved are unclear. We now identify a conserved calmodulin binding site in UNC-13/Munc13s, which are essential regulators of synaptic vesicle priming and synaptic efficacy. Ca2+ sensor/effector complexes consisting of calmodulin and Munc13s regulate synaptic vesicle priming and synaptic efficacy in response to a residual [Ca2+] signal and thus shape short-term plasticity characteristics during periods of sustained synaptic activity.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	Max Planck Society; Max Planck Society; Max Planck Society; University of Texas System	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Varoqueaux, Frederique/AAC-1834-2021; Jahn, Olaf/AAD-8212-2020	Rosenmund, Christian/0000-0002-3905-2444; Varoqueaux, Frederique/0000-0002-3614-3121; Jahn, Olaf/0000-0002-3397-8924; Waxham, M. Neal/0000-0003-4801-1190; JUNGE, HARALD/0000-0003-2458-6010				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Eccles JC, 1941, J NEUROPHYSIOL, V4, P362, DOI 10.1152/jn.1941.4.5.362; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; FENG TP, 1941, CHIN J PHYSL, V13, P79; Jahn O, 2002, P NATL ACAD SCI USA, V99, P12055, DOI 10.1073/pnas.192449299; Jahn O, 2001, PEPTIDES, V22, P47, DOI 10.1016/S0196-9781(00)00356-9; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 2000, CURR OPIN NEUROBIOL, V10, P683, DOI 10.1016/S0959-4388(00)00159-8; ONEIL KT, 1989, PROTEINS, V6, P284, DOI 10.1002/prot.340060311; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	175	180	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					389	401		10.1016/j.cell.2004.06.029	http://dx.doi.org/10.1016/j.cell.2004.06.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294163	Bronze			2022-12-01	WOS:000223353100014
J	Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C				Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C		China Tuberculosis Control Collabo	The effect of tuberculosis control in China	LANCET			English	Article							IMPACT	Background China has 1 . 4 million new cases of tuberculosis every year, more than any country except India. A new tuberculosis control project based on short-course chemotherapy was introduced in half the country in 1991, after a national survey of tuberculosis prevalence in 1990. Another survey was done in 2000 to re-evaluate the national tuberculosis burden, providing the opportunity to assess the effect of the control project. Methods The survey in 2000 identified 375 599 eligible individuals at 257 investigation points chosen from all 31 mainland provinces by stratified random sampling. Children (aged 0-14 years) were suspected of having tuberculosis if they had an induration of 10 mm or greater after a tuberculin skin test, and an abnormal fluorograph. Adults were suspected if they had a persistent cough, abnormal fluorograph, or both. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture. Findings 365 097 people were examined (97% of those eligible). Prevalences of pulmonary, culture-positive, and smear-positive tuberculosis in 2000 were 367 (95% CI 340-397), 160 (144-177), and 122 (110-137) per 100 000 population, respectively. Between 1990 and 2000, prevalences of these three forms of the disease had fallen, respectively, by 32% (5-68), 37% (7-66), and 32% (9-51) more in areas in which the project was implemented than in non-project areas. For culture-positive disease, a 30% (9-48) reduction was directly attributable to the project. Interpretation Between 1991 and 2000, prevalence of tuberculosis was reduced significantly in areas of China by use of short-course chemotherapy following WHO guidelines. We estimate that in 2000, in a population of more than half a billion, there were 382 000 fewer prevalent culture-positive cases and 280 000 fewer prevalent smear-positive cases than there would otherwise have been.	WHO, CH-1211 Geneva 27, Switzerland; Minist Hlth, Dept Dis Control, Beijing, Peoples R China; Korean Inst TB, Seoul, South Korea	World Health Organization	Chen, XY (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Dye, Christopher/AIC-4659-2022					Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davison A.C., 1997, BOOTSTRAP METHODS TH; Dye C, 2002, B WORLD HEALTH ORGAN, V80, P437; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; *MIN HLTH PEOPL RE, 2000, REP NAT RAND SURV EP; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Styblo K, 1985, B INT UNION TUBERC L, V60, P117; *UN STAT DIV, MILL IND DAT; *WHO, WHOCDSTB2002, V297, P1; World Health Organization, 2002, PREV CONTR SCHIST SO; Zhang LX, 2000, INT J TUBERC LUNG D, V4, P904; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	14	148	151	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					417	422						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288739				2022-12-01	WOS:000222998600031
J	Serebrov, V; Pyle, AM				Serebrov, V; Pyle, AM			Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase	NATURE			English	Article							STEP-SIZE; NONSTRUCTURAL PROTEINS; CRYSTAL-STRUCTURE; RECBCD HELICASE; DNA HELICASE; NPH-II; TRANSLOCATION; MECHANISM; ENZYME; MODULATION	The NS3 helicase is essential for cytoplasmic RNA replication by the hepatitis C virus(1-4), and it is a representative member of helicase superfamily 2 (SF2). NS3 is an important model system for understanding unwinding activities of DExH/D proteins(5-7), and it has been the subject of extensive structural and mutational analyses(8-11). Despite intense interest in NS3, the molecular and kinetic mechanisms for RNA unwinding by this helicase have remained obscure. We have developed a combinatorial, time-resolved approach for monitoring the microscopic behaviour of a helicase at each nucleotide of a duplex substrate. By applying this analysis to NS3, we have independently established the 'physical' and 'kinetic' step size for unwinding of RNA (18 base pairs, in each case), which we relate to the stoichiometry of the functional, translocating species. Having obtained microscopic unwinding rate constants at each position along the duplex, we demonstrate that NS3 unwinds RNA through a highly coordinated cycle of fast ripping and local pausing that occurs with regular spacing along the duplex substrate, much like the stepping behaviour of cytoskeletal motor proteins(12).	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103				Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; ESSINGES MN, 2004, P NATL ACAD SCI USA, V101, P6439; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Paolini C, 2000, J GEN VIROL, V81, P1335, DOI 10.1099/0022-1317-81-5-1335; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	30	109	112	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					476	480		10.1038/nature02704	http://dx.doi.org/10.1038/nature02704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269774				2022-12-01	WOS:000222801400049
J	Pilote, L; Abrahamowicz, M; Rodrigues, E; Eisenberg, MJ; Rahme, E				Pilote, L; Abrahamowicz, M; Rodrigues, E; Eisenberg, MJ; Rahme, E			Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: A class effect?	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; ACE-INHIBITOR; CAPTOPRIL; TRIAL; QUINAPRIL; RAMIPRIL; SURVIVAL; LISINOPRIL; ENALAPRIL; OUTCOMES	Background: several randomized, controlled trials show that angiotensin-converting enzyme (ACE) inhibitors improve survival in patients who have had an acute myocardial infarction. However, existing data from trials do not address whether all ACE inhibitors benefit patients similarly. Objective: To evaluate whether all ACE inhibitors are associated with similar mortality in patients 65 years of age or older who have had an acute myocardial infarction. Design: Retrospective cohort study that used linked hospital discharge and prescription databases containing information on 18453 patients 65 years of age or older who were admitted for an acute myocardial infarction between 1 April 1996 and 31 March 2000. Setting: 109 hospitals in Quebec, Canada. Patients: 7512 patients who filled a prescription for an ACE inhibitor within 30 days of discharge and who continued to receive the same drug for at least 1 year. Measurements: The association between the specific drugs and clinical outcomes was measured by using Cox proportional hazards models, with adjustment for demographic, clinical, physician, and hospital variables and dosage categories, represented by time-dependent variables. Results: Enalapril, fosinopril, captopril, quinapril, and lisinopril were associated with higher mortality than was ramipril; the adjusted hazard ratios and 95% CIs were 1.47 (95% CI, 1.14 to 1.89), 1.71 (CI, 1.29 to 2.25), 1.56 (CI, 1.13 to 2.15), 1.58 (CI, 1.10 to 2.82), and 1.28 (CI, 0.98 to 1.67), respectively. The adjusted hazard ratio associated with perindopril was 0.98 (CI, 0.60 to 1.60). Limitations: The administrative databases did not contain detailed clinical information, and unmeasured factors associated with a patient's risk for death may have influenced physicians' prescription choices. Conclusion: Survival benefits in the first year after acute myocardial infarction in patients 65 years of age or older seem to differ according to the specific ACE inhibitor prescribed. Ramipril was associated with lower mortality than most other ACE inhibitors.	Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada; McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University	Pilote, L (corresponding author), Montreal Gen Hosp, Div Clin Epidemiol, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	louise.pilote@mcgill.ca		Pilote, Louise/0000-0002-6159-0628; Abrahamowicz, Michal/0000-0002-3172-3952				Abrahamowicz M, 1996, J AM STAT ASSOC, V91, P1432, DOI 10.2307/2291569; ABRAMS J, 1995, ARCH INTERN MED, V155, P357, DOI 10.1001/archinte.155.4.357; BACH R, 1992, AM J CARDIOL, V70, pC70; BALL SG, 1993, LANCET, V342, P821; Battaglia A, 2000, CARDIOVASC DRUG THER, V14, P671; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; BYAR DP, 1991, STAT MED, V10, P663, DOI 10.1002/sim.4780100417; Collett, 2014, MODELLING SURVIVAL D; COLLINS R, 1995, LANCET, V345, P669; COX DR, 1972, J R STAT SOC B, V34, P187; DEVITA C, 1994, LANCET, V343, P1115; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; FOY SG, 1994, AM J CARDIOL, V73, P1180, DOI 10.1016/0002-9149(94)90178-3; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; FUFBERG CD, 2000, CLIN CARDIOL, V23, P15; Furberg CD, 1999, LANCET, V354, P1202, DOI 10.1016/S0140-6736(99)03190-6; GAVAZZI A, 1994, J HYPERTENS, V12, pS89; GILES TD, 1989, J AM COLL CARDIOL, V13, P1240, DOI 10.1016/0735-1097(89)90294-5; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Kakinoki S, 2001, AM J HYPERTENS, V14, P66, DOI 10.1016/S0895-7061(00)00300-9; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Khalil ME, 2001, J AM COLL CARDIOL, V37, P1757, DOI 10.1016/S0735-1097(01)01229-3; Kizer JR, 2001, ARCH INTERN MED, V161, P1145, DOI 10.1001/archinte.161.9.1145; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; LEONETTI G, 1995, DRUGS, V49, P516, DOI 10.2165/00003495-199549040-00003; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LIU LS, 1995, LANCET, V345, P686; Michalewicz L, 1997, AM J CARDIOL, V79, P39, DOI 10.1016/S0002-9149(97)00271-3; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Oosterga M, 2001, AM J CARDIOL, V87, P542, DOI 10.1016/S0002-9149(00)01428-4; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Piepho RW, 2000, AM J HEALTH-SYST PH, V57, pS3, DOI 10.1093/ajhp/57.suppl_1.S3; Pilote L, 2003, CAN MED ASSOC J, V168, P1647; Pilote L, 2003, CAN MED ASSOC J, V168, P568; Pilote L, 2000, CAN MED ASSOC J, V163, P31; Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8; REID N, 1985, BIOMETRIKA, V72, P1; Rodrigues EJ, 2003, AM J MED, V115, P473, DOI 10.1016/S0002-9343(03)00435-2; Sica DA, 2000, AM J MANAG CARE, V6, pS85; Simpson E, 2003, AM HEART J, V145, P438, DOI 10.1067/mhj.2003.143; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Tamblyn R, 1998, ENCY BIOSTATISTICS, P1235; THERNEAU TM, 2000, MODELING SURVIVAL EX; Tu K, 2003, CAN MED ASSOC J, V168, P553; Voors A A, 1995, J Cardiovasc Risk, V2, P413; Wooltorton E, 2001, CAN MED ASSOC J, V165, P632; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 1997, ARCH INTERN MED, V157, P2413	49	91	95	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2004	141	2					102	112		10.7326/0003-4819-141-2-200407200-00008	http://dx.doi.org/10.7326/0003-4819-141-2-200407200-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839BL	15262665				2022-12-01	WOS:000222758200003
J	Ananworanich, J; Cheunyam, T; Teeratakulpisam, S; Boyd, MA; Ruxrungtham, K; Lange, J; Cooper, D; Phanuphak, P				Ananworanich, J; Cheunyam, T; Teeratakulpisam, S; Boyd, MA; Ruxrungtham, K; Lange, J; Cooper, D; Phanuphak, P			Creation of a drug fund for post-clinical trial access to antiretrovirals	LANCET			English	Editorial Material							VACCINE; AIDS		HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand		Ananworanich, J (corresponding author), HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.	jintanat.a@chula.ac.th	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Boyd, Mark/0000-0002-6848-3307				Angell M, 2000, NEW ENGL J MED, V342, P967, DOI 10.1056/NEJM200003303421309; Berkley S, 2003, LANCET, V362, P992, DOI 10.1016/S0140-6736(03)14371-1; Fitzgerald DW, 2003, LANCET, V362, P993, DOI 10.1016/S0140-6736(03)14372-3; Frankish H, 2003, LANCET, V361, P1963, DOI 10.1016/S0140-6736(03)13607-0; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kunanusont Chaiyos, 1999, Journal of the Medical Association of Thailand, V82, P425; Lo B, 2003, BMJ-BRIT MED J, V327, P337, DOI 10.1136/bmj.327.7410.337; Tucker T, 2003, LANCET, V362, P995, DOI 10.1016/S0140-6736(03)14374-7; Vermund SH, 2003, CLIN INFECT DIS, V37, pS4, DOI 10.1086/375367	9	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					101	102		10.1016/S0140-6736(04)16596-3	http://dx.doi.org/10.1016/S0140-6736(04)16596-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234863				2022-12-01	WOS:000222392900038
J	Potts, R; Behrensmeyer, AK; Deino, A; Ditchfield, P; Clark, J				Potts, R; Behrensmeyer, AK; Deino, A; Ditchfield, P; Clark, J			Small mid-Pleistocene hominin associated with east African Acheulean technology	SCIENCE			English	Article							OLD HOMO CRANIUM; OLORGESAILIE FORMATION; MIDDLE PLEISTOCENE; AFAR DEPRESSION; REMAINS; ERECTUS; CEPRANENSIS; EVOLUTION; MATUYAMA; ETHIOPIA	Hominin fossils from the African mid-Pleistocene are rare despite abundant Acheulean tools in Africa and apparently African-derived hominins in Eurasia between 1.0 and 0.5 million years ago (Ma). Here we describe an African fossil cranium constrained by 40Ar/39Ar analyses, magnetostratigraphy, and sedimentary features to 0.97 to 0.90 Ma, and stratigraphically associated with Acheulean handaxes. Although the cranium represents possibly the smallest adult or near-adult known between 1.7 and 0.5 Ma, it retains features observed in larger Homo erectus individuals, yet shows a distinct suite of traits indicative of wide population variation in the hominins of this period.	Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Natl Museums Kenya, Div Paleontol, Nairobi, Kenya; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Oxford, Res Lab Archaeol, Oxford OX1 3QJ, England	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Berkeley Geochronolgy Center; University of Oxford	Potts, R (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA.	potts.rick@nmnh.si.edu						Abbate E, 1998, NATURE, V393, P458, DOI 10.1038/30954; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 2004, J HUM EVOL, V46, P337, DOI 10.1016/j.jhevol.2003.12.005; Anton SC, 1997, AM J PHYS ANTHROPOL, V102, P497, DOI 10.1002/(SICI)1096-8644(199704)102:4<497::AID-AJPA6>3.0.CO;2-P; Arsuaga JL, 1999, J HUM EVOL, V37, P431, DOI 10.1006/jhev.1999.0309; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; CONROY GC, 1978, NATURE, V276, P67, DOI 10.1038/276067a0; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gilbert WH, 2003, J HUM EVOL, V45, P255, DOI 10.1016/j.jhevol.2003.08.007; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Isaac GL, 1977, OLORGESAILIE ARCHAEO; Mallegni F, 2003, C R PALEVOL, V2, P153, DOI 10.1016/S1631-0683(03)00015-0; Manzi G, 2003, J HUM EVOL, V44, P731, DOI 10.1016/S0047-2484(03)00061-7; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; Rightmire GP, 1996, J HUM EVOL, V31, P21; RIGHTMIRE GP, 1983, AM J PHYS ANTHROPOL, V61, P245, DOI 10.1002/ajpa.1330610214; Sarna-Wojcicki AM, 2000, J GEOPHYS RES-SOL EA, V105, P21431, DOI 10.1029/2000JB900901; TAMRAT E, 1995, PALAEOGEOGR PALAEOCL, V114, P273, DOI 10.1016/0031-0182(94)00080-R; TATTERSALL I, 1986, J HUM EVOL, V15, P165, DOI 10.1016/S0047-2484(86)80043-4; TAUXE L, 1992, EARTH PLANET SC LETT, V109, P561, DOI 10.1016/0012-821X(92)90114-B; White T. D., 2000, ENCY HUMAN EVOLUTION, P486; Wolpoff Milford H., 1994, Courier Forschungsinstitut Senckenberg, V171, P341	26	91	94	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					75	78		10.1126/science.1097661	http://dx.doi.org/10.1126/science.1097661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232102				2022-12-01	WOS:000222386000037
J	Sun, S; Ting, CT; Wu, CI				Sun, S; Ting, CT; Wu, CI			The normal function of a speciation gene, Odysseus, and its hybrid sterility effect	SCIENCE			English	Article							POSTMATING REPRODUCTIVE ISOLATION; DROSOPHILA-MELANOGASTER; HOMOLOGOUS RECOMBINATION; HALDANES RULE; EVOLUTION; SIMULANS; SPERMATOGENESIS; INTROGRESSION; MUTAGENESIS; MAURITIANA	To understand how postmating isolation is connected to the normal process of species divergence and why hybrid male sterility is often the first sign of speciation, we analyzed the Odysseus ( OdsH) gene of hybrid male sterility in Drosophila. We carried out expression analysis, transgenic study, and gene knockout. The combined evidence suggests that the sterility phenotype represents a novel manifestation of the gene function rather than the reduction or loss of the normal one. The gene knockout experiment identified the normal function of OdsH as a modest enhancement of sperm production in young males. The implication of a weak effect of OdsH on the normal phenotype but a strong influence on hybrid male sterility is discussed in light of Haldane's rule of postmating isolation.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	University of Chicago; National Tsing Hua University	Wu, CI (corresponding author), Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA.	ciwu@uchicago.edu		Ting, Chau-Ti/0000-0003-1802-8864				CASTRILLON DH, 1993, GENETICS, V135, P489; Civetta A, 1995, J MOL EVOL, V41, P1085, DOI 10.1007/BF00173190; Fuller Margaret T., 1993, P71; Hollocher H, 1996, GENETICS, V143, P1243; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; OLIVIERI G, 1965, MUTAT RES, V2, P366, DOI 10.1016/0027-5107(65)90072-2; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; Palumbi SR, 1998, ENDLESS FORMS, P271; PEREZ DE, 1995, GENETICS, V140, P201; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952; Raff EC, 1997, SCIENCE, V275, P70, DOI 10.1126/science.275.5296.70; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; SUN S, 2003, THESIS U CHICAGO; Tao Y, 2003, GENETICS, V164, P1383; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TING CY, UNPUB; True JR, 1996, GENETICS, V142, P819; Tsaur SC, 1997, MOL BIOL EVOL, V14, P544, DOI 10.1093/oxfordjournals.molbev.a025791; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	27	94	99	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					81	83		10.1126/science.1093904	http://dx.doi.org/10.1126/science.1093904			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232104	Green Submitted			2022-12-01	WOS:000222386000039
J	Benatar, SR				Benatar, SR			Health care reform and the crisis of HIV and AIDS in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV/AIDS; TRANSMISSION; PREVENTION; ETHICS; POLICY; EPIDEMIC; PROGRAM; SYSTEM		Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Benatar, SR (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa.	sbenatar@uctgsh1.uct.ac.za						Barr S, 2001, CFO-MAG SR FINANC EX, V17, P48; BARRON P, 2003, MAIL GUARDIAN   0819, P19; Bateman C, 2004, SAMJ S AFR MED J, V94, P144; Bateman C, 2003, SAMJ S AFR MED J, V93, P734; Benatar SR, 1997, NEW ENGL J MED, V336, P891, DOI 10.1056/NEJM199703203361224; Benatar SR, 2000, S AFR MED J, V90, P790; Benatar SR, 2001, INT J-TORONTO, V56, P611, DOI 10.2307/40203607; Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; Benatar SR, 2003, INT AFF, V79, P107, DOI 10.1111/1468-2346.00298; BENATAR SR, 1990, S AFR MED J, V77, P441; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; Benatar SR, 2002, J MED PHILOS, V27, P163, DOI 10.1076/jmep.27.2.163.2992; Benatar SR, 2001, INT AFF, V77, P347, DOI 10.1111/1468-2346.00196; BENATAR SR, 2002, SUNDAY INDEPEND 0407, P7; BENATAR SR, 2003, MANSONS TROPICAL DIS, P85; Berkley S, 2003, LANCET, V362, P992, DOI 10.1016/S0140-6736(03)14371-1; Blecher M, 2002, SAMJ S AFR MED J, V92, P449; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Clinton WJ, 2003, NEW ENGL J MED, V348, P1800, DOI 10.1056/NEJMsb023052; Day C, 2001, S AFRICAN HLTH REV 2, P283; Dedicoat M, 2003, SAMJ S AFR MED J, V93, P777; *DEP HLTH, HIV AIDS STD STRAT P; Doherty J, 2002, S AFRICAN HLTH REV 2, P13; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; Floyd K, 1999, JAMA-J AM MED ASSOC, V282, P1087, DOI 10.1001/jama.282.11.1087; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Gandy M., 2003, RETURN WHITE PLAGUE; Goemaere E, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09343-1; GOUDGE J, 2001, S AFRICAN HLTH REV 2, P69; GREEN J, 1903, STORY AUSTR BUSHMEN, P1; Hilderbrand K, 2003, SAMJ S AFR MED J, V93, P779; Karim SA, 2002, LANCET, V359, P992, DOI 10.1016/S0140-6736(02)08063-7; Karim SSA, 2004, LANCET, V363, P1395, DOI 10.1016/S0140-6736(04)16056-X; Kassalow Jordan S., 2001, WHY HLTH IS IMPORTAN; Katz Alison, 2002, Afr J AIDS Res, V1, P125, DOI 10.2989/16085906.2002.9626552; Kawachi I., 2002, HLTH NATIONS WHY INE; KENYON C, 2001, S AFRICAN HLTH REV, P161; Makgoba MW, 2002, VACCINE, V20, P1899, DOI 10.1016/S0264-410X(02)00063-4; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; MARTINSON N, 2002, S AFRICAN HLTH REV 2, P235; MBTASHA S, 2001, S AFRICAN HLTH REV 2, P49; MCINTYRE D, GEOGRAPHIC PATTERNS; Moorman J, 2001, S AFRICAN HLTH REV 2, P83; *NAT TREAS REP S A, 2003, INT FISC REV 2003, P75; NAYLOR CD, 1987, S AFR MED J, V72, P673; PILLAY Y, 2002, S AFRICAN HLTH REV 2, P3; POWER S, 2003, NEW YORKER      0519, P54; PRETORIUS E, IN PRESS HLTH HLTH C; *ROYAL DAN MIN FOR, 2000, BUILD GLOB COMM GLOB; *S AFR MED RES COU, IN PRESS GUID ETH ME; SAIT L, 2001, S AFRICAN HLTH REV 2, P1; Schneider H, 2003, SAMJ S AFR MED J, V93, P772; Schwab Peter, 2001, AFRICA CONTINENT SEL; Shaw M, 2002, AFR AFFAIRS, V101, P291, DOI 10.1093/afraf/101.404.291; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Sparks Colin., 2003, MIRACLE INSIDE NEW S; Terreblanche S., 2002, HIST INEQUALITY S AF; TERREBLANCHE SJ, 2002, HIST INEQUALITY S AF, P477; *UN DEV PROGR, 2002, HUM DEV REP 2002 DEE; VANRENSBURG HCJ, 1999, ACTA ACAD, V31, P1; VANRENSBURG HCJ, 1993, S AFRICAN J SOCIOLOG, V24, P99; VANRENSBURG HJC, IN PRESS HLTH HLTH C; Wilkinson RG., 1996, UNHEALTHY SOC AFFLIC; World Health Organization, 2003, ANT THER PRIM HLTH C; [No title captured]; 2001, S AFRICA GLANCE	69	113	116	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2004	351	1					81	92		10.1056/NEJMhpr033471	http://dx.doi.org/10.1056/NEJMhpr033471			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	833QC	15229313				2022-12-01	WOS:000222352200014
J	Ye, YH; Shibata, Y; Yun, C; Ron, D; Rapoport, TA				Ye, YH; Shibata, Y; Yun, C; Ron, D; Rapoport, TA			A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol	NATURE			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; I HEAVY-CHAINS; AAA-ATPASE; DISULFIDE-ISOMERASE; MISFOLDED GLYCOPROTEINS; CAENORHABDITIS-ELEGANS; QUALITY-CONTROL; RETROTRANSLOCATION; DISLOCATION; RECOGNITION	Elimination of misfolded proteins from the endoplasmic reticulum (ER) by retro-translocation is an important physiological adaptation to ER stress. This process requires recognition of a substrate in the ER lumen and its subsequent movement through the membrane by the cytosolic p97 ATPase. Here we identify a p97-interacting membrane protein complex in the mammalian ER that links these two events. The central component of the complex, Derlin-1, is a homologue of Der1, a yeast protein whose inactivation prevents the elimination of misfolded luminal ER proteins. Derlin-1 associates with different substrates as they move through the membrane, and inactivation of Derlin-1 in C. elegans causes ER stress. Derlin-1 interacts with US11, a virally encoded ER protein that specifically targets MHC class I heavy chains for export from the ER, as well as with VIMP, a novel membrane protein that recruits the p97 ATPase and its cofactor.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; New York University	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Ron, David/0000-0002-3014-5636	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008, Z01DK033008] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; FRANKS CM, 1970, BEHAV THER, V1, P1, DOI 10.1016/S0005-7894(70)80053-3; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; LILLEY BN, NATURE; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Plemper RK, 1999, J CELL SCI, V112, P4123; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang QQ, 2003, EMBO J, V22, P3792, DOI 10.1093/emboj/cdg378; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	40	753	780	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					841	847		10.1038/nature02656	http://dx.doi.org/10.1038/nature02656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215856				2022-12-01	WOS:000222213000033
J	Xiang, JH; George, SL; Wunschmann, S; Chang, Q; Klinzman, D; Stapleton, JT				Xiang, JH; George, SL; Wunschmann, S; Chang, Q; Klinzman, D; Stapleton, JT			Inhibition of HIV-1 veplication by GB virus C infection through increases in RANTES, MIP-1 alpha, MIP-1 beta, and SDF-1	LANCET			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G VIRUS; CHEMOKINE RECEPTORS; INCUBATION PERIOD; T-LYMPHOCYTES; SUPPRESSION; CELLS; IDENTIFICATION; REPLICATION; PROGRESSION	Background People coinfected with HIV and GB virus C (GBV-C) have lower mortality than HIV-positive individuals without GBV-C infection. HIV uses either of the chemokine receptors CCR5 and CXCR4 for entry into CD4-positive cells. Longer survival in HIV-positive individuals is associated with high serum concentrations of ligands for CCR5 (RANTES [regulated on activation, normal T-cell expressed and secreted] and macrophage inflammatory proteins [MIP] 1alpha and 1beta) and CXCR4 (stromal-derived factor [SDF-1]), and with decreased expression of CCR5 on lymphocytes. Methods Peripheral-blood mononuclear cells were coinfected with GBV-C and HIV, and HIV replication was monitored by measuring infectivity and HIV p24 antigen production. Chemokine secretion was measured by ELISA, chemokine-receptor expression by flow cytometry, and cellular chemokine mRNA expression by differential hybridisation. Findings GBV-C infection of peripheral-blood mononuclear cells resulted in decreased replication of both clinical and laboratory HIV strains that use either CCR5 or CXCR4 as their coreceptor. Inhibition was related to the dose and timing of the GBV-C infection. Expression of mRNA for RANTES, MIP-1alpha, MIP-1beta, and SDF-1 and secretion of the chemokines into culture supernatants were higher in GBV-C-infected cells than in mock-infected cells. The inhibitory effect of GBV-C on HIV replication was blocked by incubation with neutralising antibodies against the relevant chemokines, and surface expression of CCR5 was significantly lower in GBV-C-infected cells than in mock-infected cells. Interpretation GBV-C induces HIV-inhibitory chemokines and reduces expression of the HIV coreceptor CCR5 in vitro. This study provides insight into the epidemiological association between GBV-C infection and longer survival in HIV-infected individuals.	Iowa City VA Med Ctr, Res Serv, Iowa City, IA USA; Iowa City VA Med Ctr, Dept Internal Med, Iowa City, IA USA; Univ Iowa, Iowa City, IA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Stapleton, JT (corresponding author), UIHC Iowa City, Dept Internal Med, SW34-P,GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	jack-stapleton@uiowa.edu		Stapleton, Jack/0000-0002-2302-9055; George, Sarah/0000-0002-9699-1042	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI050478, U01AI027661, R01AI058740] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27661, AI058740, AI50478] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cook RT, 1997, J INVEST MED, V45, P265; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Fogeda M, 2000, J VIROL, V74, P7936, DOI 10.1128/JVI.74.17.7936-7942.2000; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; George SL, 2003, VIROLOGY, V316, P191, DOI 10.1016/S0042-6822(03)00585-3; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Kalinkovich A, 1999, IMMUNOL LETT, V68, P281, DOI 10.1016/S0165-2478(99)00059-0; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; LUI KJ, 1988, SCIENCE, V240, P1333, DOI 10.1126/science.3163848; Pinto LA, 2000, J VIROL, V74, P4505, DOI 10.1128/JVI.74.10.4505-4511.2000; Rowland-Jones S, 1999, J INFECTION, V38, P67, DOI 10.1016/S0163-4453(99)90070-1; Rowland-Jones S, 1999, SEX TRANSM INFECT, V75, P148, DOI 10.1136/sti.75.3.148; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Tacke M, 1997, HEPATOLOGY, V26, P1626, DOI 10.1002/hep.510260635; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000	30	162	171	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2004	363	9426					2040	2046		10.1016/S0140-6736(04)16453-2	http://dx.doi.org/10.1016/S0140-6736(04)16453-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830YJ	15207954				2022-12-01	WOS:000222159800010
J	Green, MT; Dawson, JH; Gray, HB				Green, MT; Dawson, JH; Gray, HB			Oxoiron(IV) in chloroperoxidase compound II is basic: Implications for P450 chemistry	SCIENCE			English	Article							CYTOCHROME-C PEROXIDASE; NITRIC-OXIDE SYNTHASE; X-RAY-ABSORPTION; RESONANCE RAMAN-SPECTRA; HORSERADISH-PEROXIDASE; MICE LACKING; BIOINORGANIC CHEMISTRY; HIGH-RESOLUTION; AXIAL LIGAND; SPECTROSCOPY	With the use of x-ray absorption spectroscopy, we have found that the Fe-O bond in chloroperoxidase compound II (CPO-II) is much longer than expected for an oxoiron(IV) (ferryl) unit; notably, the experimentally determined bond length of 1.82(1)Angstrom accords closely with density functional calculations on a protonated ferryl (Fe-IV- OH, 1.81 Angstrom). The basicity of the CPO-II ferryl [pK(a) > 8.2 (where K-a is the acid dissociation constant)] is attributable to strong electron donation by the axial thiolate. We suggest that the CPO-II protonated ferryl is a good model for the rebound intermediate in the P450 oxygenation cycle; with elevated pK(a) values after one-electron reduction, thiolate-ligated ferryl radicals are competent to oxygenate saturated hydrocarbons at potentials that can be tolerated by folded polypeptide hosts.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; California Institute of Technology	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu	Dawson, John/HDM-6702-2022	Dawson, John H/0000-0002-4902-4295	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026730] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19038] Funding Source: Medline; NIGMS NIH HHS [GM26730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; [Anonymous], 1999, HEME PEROXIDASES; Antony J, 1997, J PHYS CHEM A, V101, P2692, DOI 10.1021/jp9632955; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bonagura CA, 2003, BIOCHEMISTRY-US, V42, P5600, DOI 10.1021/bi034058c; BORDWELL FG, 1991, J AM CHEM SOC, V113, P9790, DOI 10.1021/ja00026a012; CHANCE B, 1984, ARCH BIOCHEM BIOPHYS, V235, P596, DOI 10.1016/0003-9861(84)90234-0; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Egawa T, 2001, J BIOL INORG CHEM, V6, P46, DOI 10.1007/s007750000181; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Green MT, 1999, J AM CHEM SOC, V121, P7939, DOI 10.1021/ja991541v; Green MT, 2001, J AM CHEM SOC, V123, P9218, DOI 10.1021/ja010105h; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; HAYASHI Y, 1979, J BIOL CHEM, V254, P9101; Hersleth HP, 2002, J BIOL INORG CHEM, V7, P299, DOI 10.1007/s007750100296; Hoffman BM, 2003, P NATL ACAD SCI USA, V100, P3575, DOI 10.1073/pnas.0636464100; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kincaid JR, 1996, J BIOL CHEM, V271, P28805, DOI 10.1074/jbc.271.46.28805; LAMBEIR AM, 1987, EUR J BIOCHEM, V163, P123, DOI 10.1111/j.1432-1033.1987.tb10744.x; LIBBY RD, 1982, J BIOL CHEM, V257, P5030; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; PALCIC MM, 1980, BIOCHEM BIOPH RES CO, V94, P1123, DOI 10.1016/0006-291X(80)90535-5; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; RECZEK CM, 1989, J MOL STRUCT, V214, P27, DOI 10.1016/0022-2860(89)80004-3; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Schoneboom JC, 2002, J AM CHEM SOC, V124, P8142, DOI 10.1021/ja026279w; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; van Rantwijk F, 2000, CURR OPIN BIOTECH, V11, P554, DOI 10.1016/S0958-1669(00)00143-9; vanDeurzen MPJ, 1997, TETRAHEDRON, V53, P13183, DOI 10.1016/S0040-4020(97)00477-8; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Wolter T, 2000, J INORG BIOCHEM, V78, P117, DOI 10.1016/S0162-0134(99)00217-2	33	413	419	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2004	304	5677					1653	1656		10.1126/science.1096897	http://dx.doi.org/10.1126/science.1096897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827WL	15192224				2022-12-01	WOS:000221934300045
J	Santelli, E; Bankston, LA; Leppla, SH; Liddington, RC				Santelli, E; Bankston, LA; Leppla, SH; Liddington, RC			Crystal structure of a complex between anthrax toxin and its host cell receptor	NATURE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; PROTECTIVE ANTIGEN; A-DOMAIN; I-DOMAIN; BINDING; IDENTIFICATION; MUTATIONS; PATHWAY; REVEAL	Anthrax toxin consists of the proteins protective antigen (PA), lethal factor (LF) and oedema factor (EF)(1). The first step of toxin entry into host cells is the recognition by PA of a receptor on the surface of the target cell. Subsequent cleavage of receptor-bound PA enables EF and LF to bind and form a heptameric PA(63) prepore, which triggers endocytosis. Upon acidification of the endosome, PA(63) forms a pore that inserts into the membrane and translocates EF and LF into the cytosol(2). Two closely related host cell receptors, TEM8 and CMG2, have been identified. Both bind to PA with high affinity and are capable of mediating toxicity(3,4). Here, we report the crystal structure of the PA-CMG2 complex at 2.5 Angstrom resolution. The structure reveals an extensive receptor-pathogen interaction surface mimicking the nonpathogenic recognition of the extracellular matrix by integrins(5). The binding surface is closely conserved in the two receptors and across species, but is quite different in the integrin domains, explaining the specificity of the interaction. CMG2 engages two domains of PA, and modelling of the receptor-bound PA(63) heptamer(6-8) suggests that the receptor acts as a pH-sensitive brace to ensure accurate and timely membrane insertion. The structure provides new leads for the discovery of anthrax antitoxins, and should aid the design of cancer therapeutics(9).	Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA; NIAID, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Liddington, RC (corresponding author), Burnham Inst, Program Cell Adhes, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@burnham.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929, Z01AI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Frankel AE, 2003, CURR PHARM DESIGN, V9, P2060, DOI 10.2174/1381612033454162; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PETOSA C, 1995, THESIS HARVARD U; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200	29	195	204	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					905	908		10.1038/nature02763	http://dx.doi.org/10.1038/nature02763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15243628				2022-12-01	WOS:000223369800045
J	Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A				Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A			Textures of the soils and rocks at Gusev crater from Spirit's Microscopic Imager	SCIENCE			English	Article							ROVER	The Microscopic Imager on the Spirit rover analyzed the textures of the soil and rocks at Gusev crater on Mars at a resolution of 100 micrometers. Weakly bound agglomerates of dust are present in the soil near the Columbia Memorial Station. Some of the brushed or abraded rock surfaces show igneous textures and evidence for alteration rinds, coatings, and veins consistent with secondary mineralization. The rock textures are consistent with a volcanic origin and subsequent alteration and/or weathering by impact events, wind, and possibly water.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-1168 Copenhagen, Denmark; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Aarhus Univ, Inst Phys & Astron, Aarhus, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA	United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Max Planck Society; Aarhus University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; Washington University (WUSTL); Washington University (WUSTL)	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Hayes, Alexander G/P-2024-2014; Sullivan, Robert/AAR-8193-2020; Madsen, Morten Bo/D-2082-2011; Kinch, Kjartan Bergeron/C-5742-2015; Johnson, Jeffrey R/F-3972-2015	Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Johnson, Jeffrey R/0000-0002-5586-4901; Wang, Aimei/0000-0002-6575-4028; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Butler JB, 2001, J HYDRAUL RES, V39, P1, DOI DOI 10.1080/00221686.2001.9628276; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; LANDIS G, 2004, LUNAR PLANETARY SCI, V35; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rubin DM, 2004, J SEDIMENT RES, V74, P160, DOI 10.1306/052203740160; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; WAGNER JA, UNPUB; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	19	110	112	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					824	826		10.1126/science.3050824	http://dx.doi.org/10.1126/science.3050824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297663				2022-12-01	WOS:000223104900036
J	Baron, JM; Abuzahra, F				Baron, JM; Abuzahra, F			Evidence-based staging system for malignant melanoma: is new necessarily better?	LANCET			English	Editorial Material									Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Baron, JM (corresponding author), Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany.	jensmalte.baron@post.rwth-aachen.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946				Abuzahra F, 2004, LANCET ONCOL, V5, P250, DOI 10.1016/S1470-2045(04)01429-9; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Baron J. M., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P393, DOI 10.2174/1568011033482224; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; KAUFMANN R, 1998, HAUTARZT, V48, P530; Kim Christina J, 2002, Cancer Control, V9, P9; Nambiar S, 2004, EXPERT REV MOL DIAGN, V4, P549, DOI 10.1586/14737159.4.4.549; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					395	396		10.1016/S0140-6736(04)16780-9	http://dx.doi.org/10.1016/S0140-6736(04)16780-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288720				2022-12-01	WOS:000222998600006
J	Hazuda, DJ; Young, SD; Guare, JP; Anthony, NJ; Gomez, RP; Wai, JS; Vacca, JP; Handt, L; Motzel, SL; Klein, HJ; Dornadula, G; Danovich, RM; Witmer, MV; Wilson, KAA; Tussey, L; Schleif, WA; Gabryelski, LS; Jin, LX; Miller, MD; Casimiro, DR; Emini, EA; Shiver, JW				Hazuda, DJ; Young, SD; Guare, JP; Anthony, NJ; Gomez, RP; Wai, JS; Vacca, JP; Handt, L; Motzel, SL; Klein, HJ; Dornadula, G; Danovich, RM; Witmer, MV; Wilson, KAA; Tussey, L; Schleif, WA; Gabryelski, LS; Jin, LX; Miller, MD; Casimiro, DR; Emini, EA; Shiver, JW			Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques	SCIENCE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSCRIPTION; RESISTANCE; CELLS; HIV	We describe the efficacy of L-870812, an inhibitor of HIV-1 and SIV integrase, in rhesus macaques infected with the simian-human immunodeficiency virus (SHIV) 89.6P. When initiated before CD4 cell depletion, L-870812 therapy mediated a sustained suppression of viremia, preserving CD4 levels and permitting the induction of virus-specific cellular immunity. L-870812 was also active in chronic infection; however, the magnitude and durability of the effect varied in conjunction with the pretreatment immune response and viral load. These studies demonstrate integrase inhibitor activity in vivo and suggest that cellular immunity facilitates chemotherapeutic efficacy in retroviral infections.	Merck Res Labs, Dept Biol Chem, W Point, PA 19486 USA; Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA; Merck Res Labs, Dept Lab Anim Res, W Point, PA 19486 USA; Merck Res Labs, Dept Vaccine Res, W Point, PA 19486 USA; Merck Res Labs, Dept Drug Metab & Pharmaceut Res, W Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Hazuda, DJ (corresponding author), Merck Res Labs, Dept Biol Chem, POB 4, W Point, PA 19486 USA.	daria_hazuda@merck.com; steve_young@merck.com						ANTHONY NJ, 2002, Patent No. [00230931, 0230931]; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Fikkert V, 2003, J VIROL, V77, P11459, DOI 10.1128/JVI.77.21.11459-11470.2003; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; HASUDA DJ, UNPUB; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hogberg M, 2000, EXPERT OPIN THER PAT, V10, P1189, DOI 10.1517/13543776.10.8.1189; Jonckheere H, 2000, MED RES REV, V20, P129, DOI 10.1002/(SICI)1098-1128(200003)20:2<129::AID-MED2>3.0.CO;2-A; Lebon F, 2000, CURR MED CHEM, V7, P455, DOI 10.2174/0929867003375146; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	18	251	271	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					528	532		10.1126/science.1098632	http://dx.doi.org/10.1126/science.1098632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15247437				2022-12-01	WOS:000222828900043
J	Kalodimos, CG; Biris, N; Bonvin, AMJJ; Levandoski, MM; Guennuegues, M; Boelens, R; Kaptein, R				Kalodimos, CG; Biris, N; Bonvin, AMJJ; Levandoski, MM; Guennuegues, M; Boelens, R; Kaptein, R			Structure and flexibility adaptation in nonspecific and specific protein-DNA complexes	SCIENCE			English	Article							REPRESSOR-OPERATOR INTERACTION; LAC REPRESSOR; CRYSTAL-STRUCTURE; HEAT-CAPACITY; BINDING; RECOGNITION; DYNAMICS; SITES	Interaction of regulatory DNA binding proteins with their target sites is usually preceded by binding to nonspecific DNA. This speeds up the search for the target site by several orders of magnitude. We report the solution structure and dynamics of the complex of a dimeric lac repressor DNA binding domain with nonspecific DNA. The same set of residues can switch roles from a purely electrostatic interaction with the DNA backbone in the nonspecific complex to a highly specific binding mode with the base pairs of the cognate operator sequence. The protein DNA interface of the nonspecific complex is flexible on biologically relevant time scales that may assist in the rapid and efficient finding of the target site.	Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Utrecht University; University of Wisconsin System; University of Wisconsin Madison	Kaptein, R (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	kaptein@nmr.chem.uu.nl	Kalodimos, Charalampos/Q-9846-2018; Kalodimos, Charalampos/C-5380-2008; Bonvin, Alexandre M.J.J./A-5420-2009; Boelens, Rolf/B-4702-2009	Kalodimos, Charalampos/0000-0001-6354-2796; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Boelens, Rolf/0000-0002-6939-8913; Biris, Nikolaos/0000-0003-4055-5521	NIGMS NIH HHS [GM 23467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023467, R01GM023467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Falcon CM, 2001, BIOCHEMISTRY-US, V40, P15650, DOI 10.1021/bi0114067; Frank DE, 1997, J MOL BIOL, V267, P1186, DOI 10.1006/jmbi.1997.0920; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gowers DM, 2003, EMBO J, V22, P1410, DOI 10.1093/emboj/cdg125; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kalodimos CG, 2002, NAT STRUCT BIOL, V9, P193, DOI 10.1038/nsb763; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kalodimos CG, 2001, P NATL ACAD SCI USA, V98, P6039, DOI 10.1073/pnas.101129898; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Shimamoto N, 1999, J BIOL CHEM, V274, P15293, DOI 10.1074/jbc.274.22.15293; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Spronk CAEM, 1996, NAT STRUCT BIOL, V3, P916, DOI 10.1038/nsb1196-916; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; VONHIPPEL PH, 1994, SCIENCE, V263, P769, DOI 10.1126/science.8303292; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x	26	426	433	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2004	305	5682					386	389		10.1126/science.1097064	http://dx.doi.org/10.1126/science.1097064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256668	Green Submitted			2022-12-01	WOS:000222662400035
J	Xirodimas, DP; Saville, MK; Bourdon, JC; Hay, RT; Lane, DP				Xirodimas, DP; Saville, MK; Bourdon, JC; Hay, RT; Lane, DP			Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity	CELL			English	Article							PROTEASOME-MEDIATED DEGRADATION; PROTEIN MODIFICATION PATHWAY; TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN-LIGASE; MDM2-DEFICIENT MICE; EMBRYONIC LETHALITY; CELL-PROLIFERATION; IN-VIVO; MDM2; SYSTEM	The only reported role for the conjugation of the NEDD8 ubiquitin-like molecule is control of the activity of SCF ubiquitin ligase complexes. Here, we show that the Mdm2 RING finger E3 ubiquitin ligase can also promote NEDD8 modification of the p53 tumor suppressor protein. Mdm2 is itself modified with NEDD8 with very similar characteristics to the autoubiquitination activity of Mdm2. By using a cell line (TS-41) with a temperature-sensitive mutation in the NEDD8 conjugation pathway and a p53 mutant that cannot be NEDDylated (3NKR), we demonstrate that Mdm2-dependent NEDD8 modification of p53 inhibits its transcriptional activity. These findings expand the role for Mdm2 as an E3 ligase, providing evidence that Mdm2 is a common component of the ubiquitin and NEDD8 conjugation pathway and indicating the diverse mechanisms by which E3 ligases can control the function of substrate proteins.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland; Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland	University of Dundee; University of St Andrews	Lane, DP (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland.	d.p.lane@dundee.ac.uk	Hay, Ronald T/F-9338-2011; Lane, David P/C-4920-2008; Hay, Ronald/S-3233-2019; JC, Bourdon/A-4439-2008	Hay, Ronald T/0000-0001-7113-9024; Hay, Ronald/0000-0001-7113-9024; JC, Bourdon/0000-0003-4623-9386; Xirodimas, Dimitris/0000-0001-9275-1140; Lane, David/0000-0003-0551-3545				Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Cernac A, 1997, DEVELOPMENT, V124, P1583; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lain S, 2003, BIOCHEM SOC T, V31, P482, DOI 10.1042/BST0310482; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu C, 2002, MULT SCLER J, V8, P10; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; LUNA RMD, 1995, NATURE, V378, P203; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; STEPHEN CW, 1995, J MOL BIOL, V248, P58, DOI 10.1006/jmbi.1995.0202; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Woods Yvonne L, 2003, Hematol J, V4, P233, DOI 10.1038/sj.thj.6200260; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003	56	408	428	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2004	118	1					83	97		10.1016/j.cell.2004.06.016	http://dx.doi.org/10.1016/j.cell.2004.06.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242646	Bronze			2022-12-01	WOS:000222626800010
J	Tugwell, P; O'Connor, AM; Santesso, NA				Tugwell, P; O'Connor, AM; Santesso, NA			A 64 year old woman with knee pain: case outcome	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Ottawa, Dept Med, Ottawa, ON K1N 6N5, Canada; Ottawa Hosp, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Cochrane Musculoskeletal Review Grp, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Tugwell, P (corresponding author), Univ Ottawa, Dept Med, 202-1 Stewart St, Ottawa, ON K1N 6N5, Canada.	ptugwell@uottawa.ca	Tugwell, Peter/AFD-8076-2022	Tugwell, Peter/0000-0001-5062-0556				O'Connor AM, 2003, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2004	329	7456					38	38		10.1136/bmj.329.7456.38	http://dx.doi.org/10.1136/bmj.329.7456.38			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	836PP	15231621	Green Published			2022-12-01	WOS:000222568300021
J	Chang, C; Yu, TW; Bargmann, CI; Tessier-Lavigne, M				Chang, C; Yu, TW; Bargmann, CI; Tessier-Lavigne, M			Inhibition of netrin-mediated axon attraction by a receptor protein tyrosine phosphatase	SCIENCE			English	Article							GANGLION-CELL AXONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; FGF RECEPTOR; NERVE GROWTH; IN-VITRO; GUIDANCE; OUTGROWTH; UNC-5; MIGRATIONS	During axon guidance, the ventral guidance of the Caenorhabditis elegans anterior ventral microtubule axon is controlled by two cues, the UNC-6/ netrin attractant recognized by the UNC-40/DCC receptor and the SLT-1/slit repellent recognized by the SAX-3/robo receptor. We show here that loss-of-function mutations in clr-1 enhance netrin-dependent attraction, suppressing ventral guidance defects in slt-1 mutants. clr-1 encodes a transmembrane receptor protein tyrosine phosphatase ( RPTP) that functions in AVM to inhibit signaling through the DCC family receptor UNC-40 and its effector, UNC-34/enabled. The known effects of other RPTPs in axon guidance could result from modulation of guidance receptors like UNC-40/DCC.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	cori@itsa.ucsf.edu; marcH@gene.com	Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chang C. H., UNPUB; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Johnson KG, 2001, J NEUROBIOL, V49, P99, DOI 10.1002/neu.1068; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; Morse WR, 1998, J NEUROBIOL, V36, P53, DOI 10.1002/(SICI)1097-4695(199807)36:1<53::AID-NEU5>3.0.CO;2-9; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	32	57	71	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					103	106		10.1126/science.1096983	http://dx.doi.org/10.1126/science.1096983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232111				2022-12-01	WOS:000222386000046
J	Harris, RG; Herzog, EL; Bruscia, EM; Grove, JE; Van Arnam, JS; Krause, DS				Harris, RG; Herzog, EL; Bruscia, EM; Grove, JE; Van Arnam, JS; Krause, DS			Lack of a fusion requirement for development of bone marrow-derived epithelia	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; GIANT-CELL HEPATITIS; STEM-CELL; PURKINJE NEURONS; CRE RECOMBINASE; MUSCLE-FIBER; DIFFERENTIATION; HEPATOCYTES; REPORTER; EXCISION	Analysis of developmental plasticity of bone marrow - derived cells (BMDCs) is complicated by the possibility of cell-cell fusion. Here we demonstrate that epithelial cells can develop from BMDCs without cell-cell fusion. We use the Cre/lox system together with beta-galactosidase and enhanced green fluorescent protein expression in transgenic mice to identify epithelial cells in the lung, liver, and skin that develop from BMDCs without cell fusion.	Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA	Yale University	Krause, DS (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	diane.krause@yale.edu	Bruscia, Emanuela/C-4932-2012	Bruscia, Emanuela/0000-0003-2149-4057	NHLBI NIH HHS [T32-HL07778, HL63357, HL073742] Funding Source: Medline; NIDDK NIH HHS [DK61846] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007778, P01HL063357, R01HL073742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061846] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Badorf M, 2002, GENESIS, V33, P119, DOI 10.1002/gene.10099; Barraviera B, 1989, Rev Soc Bras Med Trop, V22, P5, DOI 10.1590/S0037-86821989000100002; Barraviera Benedito, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P63, DOI 10.1590/S0036-46651995000100008; HARRIS RH, UNPUB; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Heslop L, 2000, J CELL SCI, V113, P2299; Hicks J, 2001, ULTRASTRUCT PATHOL, V25, P65; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lerut JP, 1998, TRANSPLANT INT, V11, P320, DOI 10.1007/s001470050151; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; McTaggart Ryan A, 2004, Hepatology, V39, P1143, DOI 10.1002/hep.20192; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Yang YS, 2001, BIOTECHNIQUES, V31, P1036, DOI 10.2144/01315st03; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	23	308	330	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					90	93		10.1126/science.1098925	http://dx.doi.org/10.1126/science.1098925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232107				2022-12-01	WOS:000222386000042
J	Hedley, AA; Ogden, CL; Johnson, CL; Carroll, MD; Curtin, LR; Flegal, KM				Hedley, AA; Ogden, CL; Johnson, CL; Carroll, MD; Curtin, LR; Flegal, KM			Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRENDS	Context The prevalence of overweight and obesity has increased markedly in the last 2 decades in the United States. Objective To update the US prevalence estimates of overweight in children and obesity in adults, using the most recent national data of height and weight measurements. Design, Setting, and Participants As part of the National Health and Nutrition Examination Survey (NHANES), a complex multistage probability sample of the US non institutionalized civilian population, both height and weight measurements were obtained from 4115 adults and 4018 children in 1999-2000 and from 4390 adults and 4258 children in 2001-2002. Main Outcome Measure Prevalence of overweight (body mass index [BMI] greater than or equal to95th percentile of the sex-specific BMI-for-age growth chart) among children and prevalence of overweight (BMI, 25.0-29.9), obesity (BMI greater than or equal to30.0), and extreme obesity (BMI greater than or equal to40.0) among adults by sex, age, and racial/ethnic group. Results Between 1999-2000 and 2001-2002, there were no significant changes among adults in the prevalence of overweight or obesity (64.5% vs 65.7%), obesity (30.5% vs 30.6%), or extreme obesity (4.7% vs 5.1%), or among children aged 6 through 19 years in the prevalence of at risk for overweight or overweight (29.9% vs 31.5%) or overweight (15.0% vs 16.5%). Overall, among adults aged at least 20 years in 19992002, 65.1% were overweight or obese, 30.4% were obese, and 4.9% were extremely obese. Among children aged 6 through 19 years in 1999-2002, 31.0% were at risk for overweight or overweight and 16.0% were overweight. The NHANES results indicate continuing disparities by sex and between racial/ethnic groups in the prevalence of overweight and obesity. Conclusions There is no indication that the prevalence of obesity among adults and overweight among children is decreasing. The high levels of overweight among children and obesity among adults remain a major public health concern.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; Univ Calif Berkeley, Ctr Weight & Hlth, Berkeley, CA 94720 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley	Hedley, AA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4307, Hyattsville, MD 20782 USA.	ahedley@cdc.gov	Flegal, Katherine M/A-4608-2013; Kohn, Geoffrey P/A-9056-2009	Flegal, Katherine/0000-0002-0838-469X				Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hill JO, 1998, PEDIATRICS, V101, P570, DOI 10.1542/peds.101.3.570; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Kuczmarski RJ., 2000, CDC GROWTH CHARTS US; LUCAS JW, 2004, VITAL HLTH STAT, V10; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; *PHS, 2001, SURG GEN CALL ACT PR; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; US Department of Health and Human Services, 2000, HLTH PEOPL 2010	11	3120	3185	5	148	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2004	291	23					2847	2850		10.1001/jama.291.23.2847	http://dx.doi.org/10.1001/jama.291.23.2847			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GT	15199035	Bronze			2022-12-01	WOS:000221962500030
J	Seymour, B; O'Doherty, JP; Dayan, P; Koltzenburg, M; Jones, AK; Dolan, RJ; Friston, KJ; Frackowiak, RS				Seymour, B; O'Doherty, JP; Dayan, P; Koltzenburg, M; Jones, AK; Dolan, RJ; Friston, KJ; Frackowiak, RS			Temporal difference models describe higher-order learning in humans	NATURE			English	Article							NEURAL SUBSTRATE; HUMAN BRAIN; PREDICTION; DOPAMINE; REWARD; PAIN; EXPECTATION; EVENTS; FEAR	The ability to use environmental stimuli to predict impending harm is critical for survival. Such predictions should be available as early as they are reliable. In pavlovian conditioning, chains of successively earlier predictors are studied in terms of higher-order relationships, and have inspired computational theories such as temporal difference learning(1). However, there is at present no adequate neurobiological account of how this learning occurs. Here, in a functional magnetic resonance imaging ( fMRI) study of higher-order aversive conditioning, we describe a key computational strategy that humans use to learn predictions about pain. We show that neural activity in the ventral striatum and the anterior insula displays a marked correspondence to the signals for sequential learning predicted by temporal difference models. This result reveals a flexible aversive learning process ideally suited to the changing and uncertain nature of real-world environments. Taken with existing data on reward learning(2), our results suggest a critical role for the ventral striatum in integrating complex appetitive and aversive predictions to coordinate behaviour.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Gatsby Computat Neurosci Unit, London WC1N 3AR, England; UCL, Inst Child Hlth, London WC1N 1EH, England; Univ Manchester, Ctr Rheumat Dis, Hope Hosp, Manchester M6 8HD, Lancs, England; Fdn Santa Lucia, I-00179 Rome, Italy	University of London; University College London; University of London; University College London; University of London; University College London; University of Manchester; IRCCS Santa Lucia	Seymour, B (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	bseymour@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011; O'Doherty, John P/F-1204-2013; Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011; Koltzenburg, Martin/C-1349-2008	Friston, Karl/0000-0001-7984-8909; Frackowiak, Richard/0000-0002-3151-822X; Koltzenburg, Martin/0000-0001-9181-5966; Dayan, Peter/0000-0003-3476-1839; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X; Jones, Anthony/0000-0001-6944-9365				AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Barto A, 1998, REINFORCEMENT LEARNI, V1st; Barto A.G., 1990, LEARNING COMPUTATION, P539; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Beiser, 1995, MODELS INFORM PROCES, P215; Brandon SE, 2003, BEHAV PROCESS, V62, P5, DOI 10.1016/S0376-6357(03)00016-0; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dickinson A., 1980, CONT ANIMAL LEARNING; Dickinson A., 1979, MECH LEARNING MOTIVA, P203; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R.S., 1990, LEARNING COMPUTATION, P497; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135	30	439	441	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					664	667		10.1038/nature02581	http://dx.doi.org/10.1038/nature02581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190354	Green Published			2022-12-01	WOS:000221912600042
J	Azzouz, M; Ralph, GS; Storkebaum, E; Walmsley, LE; Mitrophanous, KA; Kingsman, SM; Carmeliet, P; Mazarakis, ND				Azzouz, M; Ralph, GS; Storkebaum, E; Walmsley, LE; Mitrophanous, KA; Kingsman, SM; Carmeliet, P; Mazarakis, ND			VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; LENTIVIRAL VECTORS; NERVOUS-SYSTEM; AXONAL-TRANSPORT; GENE-TRANSFER; MICE; DISEASE; EXPRESSION	Amyotrophic lateral sclerosis (ALS) causes adult-onset, progressive motor neuron degeneration in the brain and spinal cord, resulting in paralysis and death three to five years after onset in most patients(1). ALS is still incurable, in part because its complex aetiology remains insufficiently understood. Recent reports have indicated that reduced levels of vascular endothelial growth factor ( VEGF), which is essential in angiogenesis and has also been implicated in neuroprotection(2-4), predispose mice and humans to ALS(5,6). However, the therapeutic potential of VEGF for the treatment of ALS has not previously been assessed. Here we report that a single injection of a VEGF-expressing lentiviral vector into various muscles delayed onset and slowed progression of ALS in mice engineered to overexpress the gene coding for the mutated G93A form of the superoxide dismutase-1 (SOD1(G93A)) (refs 7-10), even when treatment was only initiated at the onset of paralysis. VEGF treatment increased the life expectancy of ALS mice by 30 per cent without causing toxic side effects, thereby achieving one of the most effective therapies reported in the field so far.	Oxford BioMed Plc, Oxford, England; Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Azzouz, M (corresponding author), Oxford BioMed Plc, Oxford Sci Pk,Medawar Ctr, Oxford, England.	m.azzouz@oxfordbiomedica.co.uk; n.mazarakis@oxfordbiomedica.co.uk	Carmeliet, Peter/AAQ-5140-2020; Azzouz, Mimoun/B-3979-2009; Storkebaum, Erik/B-5389-2017	Carmeliet, Peter/0000-0001-7961-1821; Azzouz, Mimoun/0000-0001-6564-5967; Storkebaum, Erik/0000-0002-9519-5642; Shaw, Pamela/0000-0002-8925-2567				Azzouz M, 2002, J NEUROSCI, V22, P10302; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; LAMBRECHTS D, 2003, NAT GENET, V34, P33; Martin-Rendon E, 2002, MOL THER, V5, P566, DOI 10.1006/mthe.2002.0576; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Mohammed SI, 2002, CANCER RES, V62, P356; Mulder D W, 1982, Adv Neurol, V36, P15; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Rohll JB, 2002, METHOD ENZYMOL, V346, P466; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sagot Y, 1998, J NEUROSCI, V18, P1132; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Wang LJ, 2002, J NEUROSCI, V22, P6920; Wong LF, 2004, MOL THER, V9, P101, DOI 10.1016/j.ymthe.2003.09.017	27	481	547	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2004	429	6990					413	417		10.1038/nature02544	http://dx.doi.org/10.1038/nature02544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164063				2022-12-01	WOS:000221644600039
J	Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG				Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG			Regulation through the secondary channel-structural framework for ppGpp-DksA synergism during transcription	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; RIBONUCLEIC-ACID; RNA; ELONGATION; PROTEIN; RPOS; IDENTIFICATION; SUPPRESSORS; MECHANISM	Bacterial transcription is regulated by the alarmone ppGpp, which binds near the catalytic site of RNA polymerase (RNAP) and modulates its activity. We show that the DksA protein is a crucial component of ppGpp-dependent regulation. The 2.0 Angstrom resolution structure of Escherichia coli DksA reveals a globular domain and a coiled coil with two highly conserved Asp residues at its tip that is reminiscent of the transcript cleavage factor GreA. This structural similarity suggests that DksA coiled coil protrudes into the RNAP secondary channel to coordinate a ppGpp bound Mg2+ ion with the Asp residues, thereby stabilizing the ppGpp-RNAP complex. Biochemical analysis demonstrates that DksA affects transcript elongation, albeit differently from GreA; augments ppGpp effects on initiation; and binds directly to RNAP, positioning the Asp residues near the active site. Substitution of these residues eliminates the synergy between DksA and ppGpp. Thus, the secondary channel emerges as a common regulatory entrance for transcription factors.	RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Stucturome Res Grp, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, High Throughput Factory, Sayo, Hyogo 6795148, Japan; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; RIKEN; University System of Ohio; Ohio State University; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Tahirov, Tahir/0000-0002-1238-0069				ABOUD M, 1975, J BIOL CHEM, V250, P2189; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; GALLANT J, 1967, J MOL BIOL, V25, P545, DOI 10.1016/0022-2836(67)90205-7; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mogull SA, 2001, INFECT IMMUN, V69, P5742, DOI 10.1128/IAI.69.9.5742-5751.2001; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Ohkubo S, 1997, J BACTERIOL, V179, P2089, DOI 10.1128/jb.179.6.2089-2091.1997; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEVA MN, 2004, IN PRESS ACTA CRYSTA; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	43	271	280	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					297	309		10.1016/j.cell.2004.06.030	http://dx.doi.org/10.1016/j.cell.2004.06.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294156	Bronze			2022-12-01	WOS:000223353100007
J	Wertz, IE; O'Rourke, KM; Zhou, HL; Eby, M; Aravind, L; Seshagiri, S; Wu, P; Wiesmann, C; Baker, R; Boone, DL; Ma, A; Koonin, EV; Dixit, VM				Wertz, IE; O'Rourke, KM; Zhou, HL; Eby, M; Aravind, L; Seshagiri, S; Wu, P; Wiesmann, C; Baker, R; Boone, DL; Ma, A; Koonin, EV; Dixit, VM			De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappa B signalling	NATURE			English	Article							ZINC-FINGER PROTEIN; TNF RECEPTOR; CELL-DEATH; DEUBIQUITINATING ENZYME; CYSTEINE PROTEASES; KINASE RIP; ACTIVATION; TRAF2; IKK; RECRUITMENT	NF-kappaB transcription factors mediate the effects of pro-inflammatory cytokines such as tumour necrosis factor-alpha and interleukin-1beta(1). Failure to downregulate NF-kappaB transcriptional activity results in chronic inflammation and cell death, as observed in A20-deficient mice(2). A20 is a potent inhibitor of NF-kappaB signalling, but its mechanism of action is unknown(2). Here we show that A20 downregulates NF-kappaB signalling through the cooperative activity of its two ubiquitin-editing domains. The amino-terminal domain of A20, which is a de-ubiquitinating (DUB) enzyme of the OTU (ovarian tumour) family(3), removes lysine-63 (K63)-linked ubiquitin chains from receptor interacting protein ( RIP), an essential mediator of the proximal TNF receptor 1 (TNFR1) signalling complex(4,5). The carboxy-terminal domain of A20, composed of seven C-2/C-2 zinc fingers(6), then functions as a ubiquitin ligase by polyubiquitinating RIP with K48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation. Here we define a novel ubiquitin ligase domain and identify two sequential mechanisms by which A20 downregulates NF-kappaB signalling. We also provide an example of a protein containing separate ubiquitin ligase and DUB domains, both of which participate in mediating a distinct regulatory effect.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; NCBI, Computat Biol Branch, Natl Lib Med, NIH, Bethesda, MD 20894 USA; Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Australian National University; John Curtin School of Medical Research; University of California System; University of California San Francisco	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Aravind, L/0000-0003-0771-253X; Wiesmann, Christian/0000-0002-4092-9880	NATIONAL LIBRARY OF MEDICINE [Z01LM092504, Z01LM000061, ZIALM000061] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kieser A, 1999, EMBO J, V18, P2511, DOI 10.1093/emboj/18.9.2511; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson KD, 2003, NATURE, V424, P738, DOI 10.1038/424738a; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	30	1416	1485	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					694	699		10.1038/nature02794	http://dx.doi.org/10.1038/nature02794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15258597				2022-12-01	WOS:000223085400050
J	Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR				Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR			Clinical predictors of bioterrorism-related inhalational anthrax	LANCET			English	Article							MANAGEMENT	Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.	Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles	Kyriacou, DN (corresponding author), 259 Erie St,Suite 100, Chicago, IL 60611 USA.	dkyriacou@aol.com		Yarnold, Paul/0000-0002-1648-739X; Handler, Jonathan/0000-0002-0304-7539				Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P984; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Hupert N, 2003, ANN INTERN MED, V139, P337, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00009; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892	7	31	32	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					449	452		10.1016/S0140-6736(04)16769-X	http://dx.doi.org/10.1016/S0140-6736(04)16769-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288744				2022-12-01	WOS:000222998600036
J	Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB				Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB			Synthetic mammalian prions	SCIENCE			English	Article							TRANSGENIC MICE; IN-VITRO; ALZHEIMERS-DISEASE; STRAIN VARIATION; SCRAPIE PRIONS; PROTEIN; CONFORMATION; INFECTIVITY; NEURODEGENERATION; ENCEPHALOPATHY	Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.	Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@itsa.ucsf.edu	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393	NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770, P01AG021601] Funding Source: NIH RePORTER; NIA NIH HHS [AG10770, AG021601, AG02132] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GAJDUSEK DC, 1993, BRIT MED BULL, V49, P913, DOI 10.1093/oxfordjournals.bmb.a072653; Gambetti P, 1999, NEW ENGL J MED, V340, P1675, DOI 10.1056/NEJM199905273402111; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; LEGNAME G, UNPUB; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Post K, 2000, ARCH VIROL, P265; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner Stanley B., 2004, VVolume 41, P187; Prusiner Stanley B., 2004, VVolume 41, P89; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Will Robert G., 2004, VVolume 41, P629; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X	41	827	851	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					673	676		10.1126/science.1100195	http://dx.doi.org/10.1126/science.1100195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286374				2022-12-01	WOS:000222992100050
J	Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE				Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE			Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR	NATURE			English	Article							TRANSITION-STATE; PROTEIN; DOMAIN; KINETICS	Many biochemical processes proceed through the formation of functionally significant intermediates(1,2). Although the identification and characterization of such species can provide vital clues about the mechanisms of the reactions involved, it is challenging to obtain information of this type in cases where the intermediates are transient or present only at low population(1-4). One important example of such a situation involves the folding behaviour of small proteins that represents a model for the acquisition of functional structure in biology(1). Here we use relaxation dispersion nuclear magnetic resonance (NMR) spectroscopy to identify, for two mutational variants of one such protein, the SH3 domain from Fyn tyrosine kinase(5), a low-population folding intermediate in equilibrium with its unfolded and fully folded states. By performing the NMR experiments at different temperatures, this approach has enabled characterization of the kinetics and energetics of the folding process as well as providing structures of the intermediates. A general strategy emerges for an experimental determination of the energy landscape of a protein by applying this methodology to a series of mutants whose intermediates have differing degrees of native-like structure.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Prot Engn Network Ctr Excellence, Toronto, ON M5S 1A8, Canada; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Cambridge	Kay, LE (corresponding author), Univ Toronto, Dept Mol & Med Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	cmd44@cam.ac.uk; kay@pound.med.utoronto.ca	Di Nardo, Ariel A/P-4442-2017; Vendruscolo, Michele/F-5901-2012; Salvatella, Xavier/C-7337-2008	Di Nardo, Ariel A/0000-0003-2944-488X; Vendruscolo, Michele/0000-0002-3616-1610; Salvatella, Xavier/0000-0002-8371-4185				BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Fersht A, 1999, STRUCTURE MECH PROTE; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; KAHN F, 2003, J MOL BIOL, V333, P169; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u; Press WH., 1988, NUMERICAL RECIPES C; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276	28	390	396	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					586	590		10.1038/nature02655	http://dx.doi.org/10.1038/nature02655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282609				2022-12-01	WOS:000222946100054
J	Wardle, DA; Walker, LR; Bardgett, RD				Wardle, DA; Walker, LR; Bardgett, RD			Ecosystem properties and forest decline in contrasting long-term chronosequences	SCIENCE			English	Article							NITROGEN-FIXATION; ISLAND AREA; NEW-ZEALAND; PHOSPHORUS; VEGETATION; LIMITATION; DYNAMICS; DISTRICT; ALASKA; HAWAII	During succession, ecosystem development occurs; but in the long-term absence of catastrophic disturbance, a decline phase eventually follows. We studied six long-term chronosequences, in Australia, Sweden, Alaska, Hawaii, and New Zealand; for each, the decline phase was associated with a reduction in tree basal area and an increase in the substrate nitrogen-to-phosphorus ratio, indicating increasing phosphorus limitation over time. These changes were often associated with reductions in litter decomposition rates, phosphorus release from litter, and biomass and activity of decomposer microbes. Our findings suggest that the maximal biomass phase reached during succession cannot be maintained in the long-term absence of major disturbance, and that similar patterns of decline occur in forested ecosystems spanning the tropical, temperate, and boreal zones.	Swedish Univ Agr Sci, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden; Landcare Res, Lincoln, New Zealand; Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA; Univ Lancaster, Inst Environm & Nat Sci, Lancaster LA1 4YQ, England	Swedish University of Agricultural Sciences; Landcare Research - New Zealand; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Lancaster University	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335				[Anonymous], 1979, PLANT STRATEGIES VEG; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Clements F., 1928, PLANT SUCCESSION IND; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Crews TE, 2000, ECOSYSTEMS, V3, P386, DOI 10.1007/s100210000034; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Jenkinson DS, 1981, SOIL BIOCH, V5, P415; MARK AF, 1988, J ROY SOC NEW ZEAL, V18, P29, DOI 10.1080/03036758.1988.10421692; NOBLE MG, 1984, BRYOLOGIST, V87, P119, DOI 10.2307/3243117; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; REDFIELD AC, 1958, AM SCI, V46, P205; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI 10.1515/9781400885695; THOMPSON CH, 1981, NATURE, V291, P59, DOI 10.1038/291059a0; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Walker J, 2001, ECOSYST HEALTH, V7, P7, DOI 10.1046/j.1526-0992.2001.007001007.x; WALKER LR, 1987, OIKOS, V50, P131, DOI 10.2307/3565409; Walker LR., 2003, PRIMARY SUCCESSION E; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WARD CM, 1988, J ROY SOC NEW ZEAL, V18, P1; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA., 2002, COMMUNITIES ECOSYSTE, P7; WILLIAMSON WB, UNPUB	29	696	838	18	517	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					509	513		10.1126/science.1098778	http://dx.doi.org/10.1126/science.1098778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15205475				2022-12-01	WOS:000222828900037
J	Nair, DT; Johnson, RE; Prakash, S; Prakash, L; Aggarwal, AK				Nair, DT; Johnson, RE; Prakash, S; Prakash, L; Aggarwal, AK			Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing	NATURE			English	Article							THYMINE-THYMINE DIMER; CRYSTAL-STRUCTURE; ERROR-PRONE; BYPASS; MECHANISM; EFFICIENT; FRAGMENT	Almost all DNA polymerases show a strong preference for incorporating the nucleotide that forms the correct Watson Crick base pair with the template base. In addition, the catalytic efficiencies with which any given polymerase forms the four possible correct base pairs are roughly the same. Human DNA polymerase-iota (hPoliota), a member of the Y family of DNA polymerases, is an exception to these rules. hPoli incorporates the correct nucleotide opposite a template adenine with a several hundred to several thousand fold greater efficiency than it incorporates the correct nucleotide opposite a template thymine, whereas its efficiency for correct nucleotide incorporation opposite a template guanine or cytosine is intermediate between these two extremes(1-5). Here we present the crystal structure of hPoliota bound to a template primer and an incoming nucleotide. The structure reveals a polymerase that is 'specialized' for Hoogsteen base-pairing, whereby the templating base is driven to the syn conformation. Hoogsteen base-pairing offers a basis for the varied efficiencies and fidelities of hPoliota opposite different template bases, and it provides an elegant mechanism for promoting replication through minor-groove purine adducts that interfere with replication.	Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77755 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	aggarwal@inka.mssm.edu	Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012; Nair, Deepak T/AAR-5234-2020	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444; Nair, Deepak/0000-0002-0677-9444				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 2003, MOL CELL BIOL, V23, P3008, DOI 10.1128/MCB.23.8.3008-3012.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	28	256	262	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2004	430	6997					377	380		10.1038/nature02692	http://dx.doi.org/10.1038/nature02692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254543				2022-12-01	WOS:000222631200047
J	Hobson, A				Hobson, A			A model for madness? Dream consciousness: our understanding of the neurobiology of sleep offers insight into abnormalities in the waking brain.	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hobson, A (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.		Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604				Hobson J. Allan, 2004, 13 DREAMS FREUD NEVE; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Snyder SH., 1996, DRUGS BRAIN; Solms M., 1997, NEUROPSYCHOLOGY DREA; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553	5	41	41	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2004	430	6995					21	21		10.1038/430021a	http://dx.doi.org/10.1038/430021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229582	Bronze			2022-12-01	WOS:000222356800023
J	Bukreyev, A; Lamirande, EW; Buchholz, UJ; Vogel, LN; Elkins, WR; St Claire, M; Murphy, BR; Subbarao, K; Collins, PL				Bukreyev, A; Lamirande, EW; Buchholz, UJ; Vogel, LN; Elkins, WR; St Claire, M; Murphy, BR; Subbarao, K; Collins, PL			Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS	LANCET			English	Article							ACUTE RESPIRATORY SYNDROME; HEMAGGLUTININ-NEURAMINIDASE; FUSION GLYCOPROTEINS; TYPE-3 PIV3; IMMUNOGENICITY; REPLICATION; INFECTION; VACCINE; BOVINE; IDENTIFICATION	Background The outbreak of severe acute respiratory syndrome (SARS) in 2002 was caused by a previously unknown coronavirus-SARS coronavirus (SARS-CoV). We have developed an experimental SARS vaccine for direct immunisation of the respiratory tract, the major site of SARS-coronavirus transmission and disease. Methods We expressed the complete SARS coronavirus envelope spike (S) protein from a recombinant attenuated parainfluenza virus (BHPIV3) that is being developed as a live attenuated, intranasal paediatric vaccine against human parainfluenza virus type 3 (HPIV3). We immunised eight African green monkeys, four with a single dose of BHPIV3/SARS-S and four with a control, BHPIV3/Ctrl, administered via the respiratory tract. A SARS-coronavirus challenge was given to all monkeys 28 days after immunisation. Findings Immunisation of animals with BHPIV3/SARS-S induced the production of SARS-coronavirus-neutralising serum antibodies, indicating that a systemic immune response resulted from mucosal immunisation. After challenge with SARS coronavirus, all monkeys in the control group shed SARS coronavirus, with shedding lasting 5-8 days. No viral shedding occurred in the group immunised with BHPIV3/SARS-S. Interpretation A vectored mucosal vaccine expressing the SARS-coronavirus S protein alone may be highly effective in a single-dose format for the prevention of SARS.	NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; Bioqual, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.	Bukreyev, A (corresponding author), NIAID, Infect Dis Lab, NIH, Bldg 50,Room 6505, Bethesda, MD 20892 USA.	AB176v@nih.gov	Buchholz, Ursula/AAA-4547-2022	Buchholz, Ursula/0000-0002-2329-3198; Subbarao, Kanta/0000-0003-1713-3056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938, ZIAAI000934, Z01AI000934, Z01AI000938] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Callebaut P, 1995, Adv Exp Med Biol, V380, P265; CLEMENTS ML, 1991, J CLIN MICROBIOL, V29, P1175, DOI 10.1128/JCM.29.6.1175-1182.1991; CROWE JE, 1993, VACCINE, V11, P1395, DOI 10.1016/0264-410X(93)90168-W; DANIEL C, 1990, VIROLOGY, V174, P87, DOI 10.1016/0042-6822(90)90057-X; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Durbin AP, 2000, J VIROL, V74, P6821, DOI 10.1128/JVI.74.15.6821-6831.2000; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Karron RA, 1996, PEDIATR INFECT DIS J, V15, P650, DOI 10.1097/00006454-199608000-00003; KARRON RA, 1995, J INFECT DIS, V172, P1445, DOI 10.1093/infdis/172.6.1445; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Murphy BR, 2002, J CLIN INVEST, V110, P21, DOI 10.1172/JCI200216077; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; *SARS, 2003, AY274119 SARS; Schmidt AC, 2000, J VIROL, V74, P8922, DOI 10.1128/JVI.74.19.8922-8929.2000; Schmidt AC, 2001, J VIROL, V75, P4594, DOI 10.1128/JVI.75.10.4594-4603.2001; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tang RS, 2003, J VIROL, V77, P10819, DOI 10.1128/JVI.77.20.10819-10828.2003; Tao T, 2000, J VIROL, V74, P6448, DOI 10.1128/JVI.74.14.6448-6458.2000; Tao T, 1998, J VIROL, V72, P2955, DOI 10.1128/JVI.72.4.2955-2961.1998; TUBOLY T, 1994, ARCH VIROL, V137, P55, DOI 10.1007/BF01311173; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5; World Health Organization, COMM DIS SURV RESP S; Zeng FY, 2003, EXP BIOL MED, V228, P866, DOI 10.1177/15353702-0322807-13	29	208	242	3	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2004	363	9427					2122	2127		10.1016/S0140-6736(04)16501-X	http://dx.doi.org/10.1016/S0140-6736(04)16501-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832LF	15220033	Green Published, Bronze			2022-12-01	WOS:000222268300008
J	Ding, H; Schertzer, M; Wu, XL; Gertsenstein, M; Selig, S; Kammori, M; Pourvali, R; Poon, S; Vulto, I; Chavez, E; Tam, PPL; Nagy, A; Lansdorp, PM				Ding, H; Schertzer, M; Wu, XL; Gertsenstein, M; Selig, S; Kammori, M; Pourvali, R; Poon, S; Vulto, I; Chavez, E; Tam, PPL; Nagy, A; Lansdorp, PM			Regulation of murine telomere length by Rtel: An essential gene encoding a helicase-like protein	CELL			English	Article							HUMAN-CHROMOSOMES; MAMMALIAN TELOMERES; HUMAN FIBROBLASTS; DNA-STRUCTURE; REPLICATION; CELLS; END; YEAST; INSTABILITY; INTERACTS	Little is known about the genes that regulate telomere length diversity between mammalian species. A candidate gene locus was previously mapped to a region on distal mouse Chr 2q. Within this region, we identified a gene similar to the dog-1 DNA helicase-like gene in C. elegans. We cloned this Regulator of telomere length (Rtel) gene and inactivated its expression in mice. Rtel(-/-) mice died between days 10 and 11.5 of gestation with defects in the nervous system, heart, vasculature, and extraembryonic tissues. Rtel(-/-) embryonic stem cells showed telomere loss and displayed many chromosome breaks and fusions upon differentiation in vitro. Crosses of Rtel(+/-) mice with Mus spretus showed that Rtel from the Mus musculus parent is required for telomere elongation of M. spretus chromosomes in F1 cells. We conclude that Rtel is an essential gene that regulates telomere length and prevents genetic instability.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Sydney, Childrens Med Res Inst, Embryol Unit, Westmead, NSW 2145, Australia; Rambam Med Ctr, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 4E3, Canada	British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Children's Medical Research Institute - Australia; University of Sydney; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Toronto; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	plansdor@bccrc.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Lansdorp, Peter/0000-0001-7435-1071				Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/417405a, 10.1038/ng928]; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Gertsenstein M, 2002, Methods Mol Biol, V185, P285; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Mieczkowski PA, 2003, P NATL ACAD SCI USA, V100, P10854, DOI 10.1073/pnas.1934561100; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Schmidt KH, 2002, J BIOL CHEM, V277, P45331, DOI 10.1074/jbc.M207263200; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Schulz VP, 1996, HUM GENET, V97, P750; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Vega LR, 2003, NAT REV MOL CELL BIO, V4, P948, DOI 10.1038/nrm1256; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.0.CO;2-#; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	54	253	259	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					873	886		10.1016/j.cell.2004.05.026	http://dx.doi.org/10.1016/j.cell.2004.05.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210109	Bronze			2022-12-01	WOS:000222300200006
J	Raser, JM; O'Shea, EK				Raser, JM; O'Shea, EK			Control of stochasticity in eukaryotic gene expression	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PHO5 PROMOTER; NOISE; CHROMATIN; ACTIVATION; NETWORKS; PRODUCT; YEAST; LOCUS	Noise, or random fluctuations, in gene expression may produce variability in cellular behavior. To measure the noise intrinsic to eukaryotic gene expression, we quantified the differences in expression of two alleles in a diploid cell. We found that such noise is gene-specific and not dependent on the regulatory pathway or absolute rate of expression. We propose a model in which the balance between promoter activation and transcription influences the variability in messenger RNA levels. To confirm the predictions of our model, we identified both cis- and trans-acting mutations that alter the noise of gene expression. These mutations suggest that noise is an evolvable trait that can be optimized to balance fidelity and diversity in eukaryotic gene expression.	Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	O'Shea, EK (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, 600 16th St,Room S472D, San Francisco, CA 94143 USA.	oshea@biochem.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051377, GM51377] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Arkin A, 1998, GENETICS, V149, P1633; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Schroedinger E., 1944, WHAT IS LIFE; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598	23	1054	1065	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1811	1814		10.1126/science.1098641	http://dx.doi.org/10.1126/science.1098641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15166317	Green Accepted			2022-12-01	WOS:000222089500048
J	Fox, CS; Parise, H; D'Agostino, RB; Lloyd-Jones, DM; Vasan, RS; Wang, TJ; Levy, D; Wolf, PA; Benjamin, EJ				Fox, CS; Parise, H; D'Agostino, RB; Lloyd-Jones, DM; Vasan, RS; Wang, TJ; Levy, D; Wolf, PA; Benjamin, EJ			Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLLOW-UP; FRAMINGHAM; ARRHYTHMIAS; PREVALENCE; IMPACT; ADULTS; STROKE; LOCUS	Context Atrial fibrillation (AF) is the most common cardiac dysrhythmia in the United States. Whereas rare cases of familial AF have been reported, it is unknown if AF among unselected individuals is a heritable condition. Objective To determine whether parental AF increases the risk for the development of offspring AF. Design, Setting, and Participants Prospective cohort study (1983-2002) within the Framingham Heart Study, a population-based epidemiologic study. Participants were 2243 offspring (1165 women, 1078 men) at least 30 years of age and free of AF whose parents had both been evaluated in the original cohort. Main Outcome Measures Development of new-onset AF in the offspring was prospectively examined in association with previously documented parental AF. Results Among 2243 offspring participants, 681 (30%) had at least 1 parent with documented AF; 70 offspring participants (23 women; mean age, 62 [range, 40-81] years) developed AF in follow-up. Compared with no parental AF, AF in at least 1 parent increased the risk of offspring AF (multivariable-adjusted odds ratio [OR], 1.85; 95% confidence interval [Cl], 1.12-3.06; P=.02). These results were stronger when age was limited to younger than 75 years in both parents and offspring (multivariable-adjusted OR, 3.23; 95% Cl, 1.87-5.58; P<.001) and when the sample was further limited to those without antecedent myocardial infarction, heart failure, or valve disease (multivariable-adjusted OR, 3.17; 95% Cl, 1.71-5.86; P<.001). Conclusions Parental AF increases the future risk for offspring AF, an observation supporting a genetic susceptibility to developing this dysrhythmia. Further research into the genetic factors predisposing to AF is warranted.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fox, CS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	foxca@nhlbi.nih.gov	Ramachandran, Vasan/Y-2527-2019; Lloyd-Jones, Donald M/C-5899-2009; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Benjamin, Emelia/0000-0003-4076-2336; Parise, Helen/0000-0001-7761-4973; Lloyd-Jones, Donald/0000-0003-0847-6110; Wolf, Philip/0000-0002-3628-301X	NHLBI NIH HHS [N01-HC-25195, K24-HL-04334, K23-HL-074077-01, K23-HL-04253] Funding Source: Medline; NINDS NIH HHS [5R01-NS-17950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, K23HL074077, K23HL004253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2000, SAS STAT US GUID VER; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Conway DSG, 2003, STROKE, V34, P413, DOI 10.1161/01.STR.0000051728.85133.32; CUPPLES LA, 1987, NIH PUBLICATION; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; HANSEN BC, 1995, DIABETES CARE, V18, pA2; Heath AC, 2001, BRIT J PSYCHIAT, V178, pS33, DOI 10.1192/bjp.178.40.s33; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Olgin JE, 2002, CARDIOVASC RES, V54, P280, DOI 10.1016/S0008-6363(02)00225-0; Psaty BM, 1997, CIRCULATION, V96, P2455; SHURTLEFF D, 1973, DHEW PUBLICATION; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229	28	449	459	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2004	291	23					2851	2855		10.1001/jama.291.23.2851	http://dx.doi.org/10.1001/jama.291.23.2851			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GT	15199036	Bronze			2022-12-01	WOS:000221962500031
J	Messaad, D; Sahla, H; Benahmed, S; Godard, P; Bousquet, J; Demoly, P				Messaad, D; Sahla, H; Benahmed, S; Godard, P; Bousquet, J; Demoly, P			Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction	ANNALS OF INTERNAL MEDICINE			English	Article							GENERAL-CONSIDERATIONS; DIAGNOSIS; ASPIRIN; ALLERGY; SKIN	Background: Drug hypersensitivity reactions are common and can be life-threatening. Confirmation of the diagnosis should be rigorous and based on clinical history and a physical examination, possibly followed by skin tests and drug provocation tests. Objective: To describe the outcome of drug provocation tests in evaluating patients with histories suggesting drug allergy. Design: Retrospective analysis of clinic case series. Setting: The department for drug allergy at a university hospital. Patients: 898 consecutive patients with suspected immediate drug allergy referred to the clinic between September 1996 and August 2001. Patients with severe skin reactions and those with positive results on skin tests for beta-lactams were excluded. Intervention: Single-blinded administration of increasing doses of the suspected drug, up to the usual daily dose, under strict hospital surveillance. Results: 1372 drug provocation tests were performed using various drugs, including beta-lactams (30.3%), aspirin (14.5%), other nonsteroidal anti-inflammatory drugs (11.7%), paracetamol (8.9%), macrolides (7.4%), and quinolones (2.4%). There were 241 (17.6%) positive drug provocation test results. Drug provocation reproduced the same symptoms, albeit milder and of a shorter duration, in the following patients: 13 (5.4%) with a history of anaphylactic shock, 17 (7.0%) with a history of anaphylaxis without shock, 10 (4.1%) with a history of laryngeal edema, 19 (7.9%) with a history of bronchospasm, 160 (66.4%) with a history of urticaria, and 22 (9.1%) with a history of maculopapular eruption. All adverse reactions were completely reversed by prednisolone, H-1-antihistamines, and epinephrine as needed. Limitations: Falsely negative results on drug provocation tests may have occurred because of loss of sensitization, rare cofactors not included in the diagnostic procedure, and tolerance induction during provocation. Conclusions: Drug provocation tests in individuals with suspected drug allergy performed in carefully controlled settings can confirm drug hypersensitivity.	CHU Montpellier, Hop Arnaud Villeneuve, INSERM, U454 IFR3, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Demoly, P (corresponding author), CHU Montpellier, Hop Arnaud Villeneuve, INSERM, U454 IFR3, F-34295 Montpellier, France.	demoly@montp.inserm.fr	Demoly, Pascal/Y-9938-2019	Demoly, Pascal/0000-0001-7827-7964				Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x; Brockow K, 2002, ALLERGY, V57, P45; Dahlen B, 2001, NEW ENGL J MED, V344, P142, DOI 10.1056/NEJM200101113440215; Demoly P, 1999, ALLERGY, V54, P999, DOI 10.1034/j.1398-9995.1999.00247.x; Demoly P, 2002, ALLERGY, V57, P37, DOI 10.1034/j.1398-9995.57.s72.7.x; DERNOLY P, 2001, CURR OPIN ALLERGY CL, V1, P305; Gruchalla RS, 2000, LANCET, V356, P1505, DOI 10.1016/S0140-6736(00)02885-3; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Kvedariene V, 2002, CLIN EXP ALLERGY, V32, P1366, DOI 10.1046/j.1365-2222.2002.01476.x; Primeau MN, 2001, CURR OPIN ALLERGY CL, V1, P337, DOI 10.1097/00130832-200108000-00009; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; STEVENSON DD, 1993, ANN ALLERGY, V71, P417; Torres MJ, 2002, CLIN EXP ALLERGY, V32, P270, DOI 10.1046/j.1365-2222.2002.01296.x	13	236	247	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2004	140	12					1001	1006		10.7326/0003-4819-140-12-200406150-00009	http://dx.doi.org/10.7326/0003-4819-140-12-200406150-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829NK	15197017				2022-12-01	WOS:000222055500003
J	van den Berg, B; Black, PN; Clemons, WM; Rapoport, TA				van den Berg, B; Black, PN; Clemons, WM; Rapoport, TA			Crystal structure of the long-chain fatty acid transporter FadL	SCIENCE			English	Article							COENZYME-A SYNTHETASE; ACYL-COA SYNTHETASE; ESCHERICHIA-COLI; OUTER-MEMBRANE; TRANSMEMBRANE MOVEMENT; PSEUDOMONAS-PUTIDA; GENE-PRODUCT; PROTEIN; BINDING; IDENTIFICATION	The mechanisms by which hydrophobic molecules, such as long-chain fatty acids, enter cells are poorly understood. In Gram-negative bacteria, the lipopolysaccharide layer in the outer membrane is an efficient barrier for fatty acids and aromatic hydrocarbons destined for biodegradation. We report crystal structures of the long-chain fatty acid transporter FadL from Escherichia coli at 2.6 and 2.8 angstrom resolution. FadL forms a 14-stranded beta barrel that is occluded by a central hatch domain. The structures suggest that hydrophobic compounds bind to multiple sites in FadL and use a transport mechanism that involves spontaneous conformational changes in the hatch.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Ordway Res Inst, Ctr Metab Dis, Albany, NY 12208 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Ordway Research Institute	van den Berg, B (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	lvandenberg@hms.harvard.edu	Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; van den Berg, Bert/0000-0003-1966-8804; Black, Paul/0000-0002-6272-6881				Abumrad N, 1998, J LIPID RES, V39, P2309; AZIZAN A, 1994, J BACTERIOL, V176, P6653, DOI 10.1128/JB.176.21.6653-6662.1994; Azizan A, 1999, ARCH BIOCHEM BIOPHYS, V365, P299, DOI 10.1006/abbi.1999.1171; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; BLACK PN, 1987, J BIOL CHEM, V262, P1412; BLACK PN, 1995, BIOCHEM J, V310, P389, DOI 10.1042/bj3100389; BLACK PN, 1990, BIOCHIM BIOPHYS ACTA, V1046, P97, DOI 10.1016/0005-2760(90)90099-J; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; BLACK PN, UNPUB; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; DiRusso CC, 1999, PROG LIPID RES, V38, P129, DOI 10.1016/S0163-7827(98)00022-8; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Kasai Y, 2001, J BACTERIOL, V183, P6662, DOI 10.1128/JB.183.22.6662-6666.2001; KORCHAK HM, 1994, J BIOL CHEM, V269, P30281; KUMAR GB, 1991, J BIOL CHEM, V266, P1348; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NUNN WD, 1986, J BIOL CHEM, V261, P167; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Reese AJ, 2004, J LIPID RES, V45, P232, DOI 10.1194/jlr.M300113-JLR200; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; WANG Y, 1995, MOL GEN GENET, V246, P570, DOI 10.1007/BF00298963; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	30	163	167	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2004	304	5676					1506	1509		10.1126/science.1097524	http://dx.doi.org/10.1126/science.1097524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178802				2022-12-01	WOS:000221795800046
J	Svensen, H; Planke, S; Malthe-Sorenssen, A; Jamtveit, B; Myklebust, R; Eidem, TR; Rey, SS				Svensen, H; Planke, S; Malthe-Sorenssen, A; Jamtveit, B; Myklebust, R; Eidem, TR; Rey, SS			Release of methane from a volcanic basin as a mechanism for initial Eocene global warming	NATURE			English	Article							VORING BASIN; MARGIN; SILLS; DISSOCIATION; END	A 200,000-yr interval of extreme global warming marked the start of the Eocene epoch about 55 million years ago. Negative carbon-and oxygen-isotope excursions in marine and terrestrial sediments show that this event was linked to a massive and rapid (similar to10,000 yr) input of isotopically depleted carbon(1,2). It has been suggested previously that extensive melting of gas hydrates buried in marine sediments may represent the carbon source(3,4) and has caused the global climate change. Large-scale hydrate melting, however, requires a hitherto unknown triggering mechanism. Here we present evidence for the presence of thousands of hydrothermal vent complexes identified on seismic reflection profiles from the Voring and More basins in the Norwegian Sea. We propose that intrusion of voluminous mantle-derived melts in carbon-rich sedimentary strata in the northeast Atlantic may have caused an explosive release of methane-transported to the ocean or atmosphere through the vent complexes-close to the Palaeocene/Eocene boundary. Similar volcanic and metamorphic processes may explain climate events associated with other large igneous provinces such as the Siberian Traps (similar to250 million years ago) and the Karoo Igneous Province (similar to183 million years ago).	Univ Oslo, N-0316 Oslo, Norway; Volcan Basin Petr Res, N-0349 Oslo, Norway; TGS NOPEC Geophys Co, N-3478 Naersnes, Norway	University of Oslo	Svensen, H (corresponding author), Univ Oslo, POB 1048 Blindern, N-0316 Oslo, Norway.	hsvensen@geo.uio.no; planke@vbpr.no	Planke, Sverre/AAE-1721-2021; Malthe-Sørenssen, Anders/C-2015-2015	Malthe-Sørenssen, Anders/0000-0001-8138-3995; Planke, Sverre/0000-0001-6128-2193; Jamtveit, Bjorn/0000-0001-5700-1803				BERGGREN WA, 1995, SEPM SPEC PUBL, V54, P212; Berndt C, 2000, J GEOPHYS RES-SOL EA, V105, P28443, DOI 10.1029/2000JB900217; Berndt C, 2001, J GEOL SOC LONDON, V158, P413, DOI 10.1144/jgs.158.3.413; Brekke H, 2000, GEOL SOC SPEC PUBL, V167, P327, DOI 10.1144/GSL.SP.2000.167.01.13; Brekke H., 1999, PETROLEUM GEOLOGY NW, P261, DOI DOI 10.1144/0050261; CALDEIRA K, 1991, GEOPHYS RES LETT, V18, P987, DOI 10.1029/91GL01237; Chevallier L, 1999, S AFR J GEOL, V102, P43; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; ECKHOFF EE, 1999, THESIS U OSLO; ELDHOLM O, 1994, J GEOPHYS RES-SOL EA, V99, P2955, DOI 10.1029/93JB02879; ELDHOLM O, 1993, EARTH PLANET SC LETT, V117, P319, DOI 10.1016/0012-821X(93)90087-P; Galushkin YI, 1997, ORG GEOCHEM, V26, P645, DOI 10.1016/S0146-6380(97)00030-2; HOPPER PR, 1997, AGU GEOPHYS MONOGR, V100, P1; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; IPCC, 2001, CLIMATE CHANGE 2001; JAMVEIT B, IN PRESS GEOL SOC LO; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KJELDSTAD A, 2003, ADV TOPICS COMPUTATI, P611; PLANKE S, IN PRESS PETROL GEOL; Schmitz B, 2003, GEOLOGY, V31, P689, DOI 10.1130/G19527.1; SKOGSEID J, 1992, GEOL SOC SPEC PUBL, P305; Smallwood Jr, 2002, GEOL SOC SPEC PUBL, V197, P271, DOI 10.1144/GSL.SP.2002.197.01.11; Svensen H, 2003, GEO-MAR LETT, V23, P351, DOI 10.1007/s00367-003-0141-2; Trude J, 2003, GEOLOGY, V31, P813, DOI 10.1130/G19559.1; WEINBERG RF, 1994, J GEOPHYS RES-SOL EA, V99, P9543, DOI 10.1029/93JB03461; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; WOODFORD AC, 2001, HYDROGEOLOGY MAIN KA; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zhang YX, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016658	31	673	703	6	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					542	545		10.1038/nature02566	http://dx.doi.org/10.1038/nature02566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175747				2022-12-01	WOS:000221767700034
J	Annas, GJ				Annas, GJ			Forcible medication for courtroom competence - The case of Charles Sell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GEORGE J., 2004, RIGHTS PATIENTS, P277; ANNAS GJ, 1990, HASTINGS CENT REP, V20, P28, DOI 10.2307/3563158; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; GRISSO T, 1998, ASSESSING COMPETENCE, P27; *INT DUAL LOYALTY, 2003, DUAL LOYALTY HUM RIG; SCHLAFLY P, 2002, EAGLE FORUM     0327; STONE A, 2003, PSYCHIAT TIMES  0901, V1	7	7	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2004	350	22					2297	2301		10.1056/NEJMlim033389	http://dx.doi.org/10.1056/NEJMlim033389			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823VP	15163782	Green Published			2022-12-01	WOS:000221641900014
J	Sehorn, MG; Sigurdsson, S; Bussen, W; Unger, VM; Sung, P				Sehorn, MG; Sigurdsson, S; Bussen, W; Unger, VM; Sung, P			Human meiotic recombinase Dmc1 promotes ATP-dependent homologous DNA strand exchange	NATURE			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; RECA PROTEIN; RAD51; MEIOSIS; HSDMC1; REPAIR; GENES; RING	Homologous recombination is crucial for the repair of DNA breaks and maintenance of genome stability(1-3). In Escherichia coli, homologous recombination is dependent on the RecA protein. In the presence of ATP, RecA mediates the homologous DNA pairing and strand exchange reaction that links recombin-letters ing DNA molecules. DNA joint formation is initiated through the nucleation of RecA onto single-stranded DNA (ssDNA) to form helical nucleoprotein filaments(4-6). Two RecA-like recombinases, Rad51 and Dmc1, exist in eukaryotes(1). Whereas Rad51 is needed for both mitotic and meiotic recombination events, the function of Dmc1 is restricted to meiosis(3,7). Here we examine human Dmc1 protein (hDmc1) for the ability to promote DNA strand exchange, and show that hDmc1 mediates strand exchange between paired DNA substrates over at least several thousand base pairs. DNA strand exchange requires ATP and is strongly dependent on the heterotrimeric ssDNA-binding molecule replication factor A (RPA). We present evidence that hDmc1-mediated DNA recombination initiates through the nucleation of hDmc1 onto ssDNA to form a helical nucleoprotein filament. The DNA strand exchange activity of hDmc1 is probably indispensable for repair of DNA double-strand breaks during meiosis and for maintaining the ploidy of meiotic chromosomes.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	Yale University; University of Texas System; University of Texas Health San Antonio	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058				Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; YOSHIDA N, 1998, REC RES DEV FERMEN 1, V1, P1; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	25	141	148	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					433	437		10.1038/nature02563	http://dx.doi.org/10.1038/nature02563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15164066				2022-12-01	WOS:000221644600043
J	Narbonne, GM				Narbonne, GM			Modular construction of early ediacaran complex life forms	SCIENCE			English	Article							SOUTHEASTERN NEWFOUNDLAND; MISTAKEN POINT; TRACE FOSSILS; EVOLUTION; RANGEA; BODY; SEA	Newly discovered, exceptionally preserved, soft-bodied fossils near Spaniard's Bay in eastern Newfoundland exhibit features not previously described from Ediacaran (terminal Neoproterozoic) fossils. All of the Spaniard's Bay taxa were composed of similar architectural elements-centimeter-scale frondlets exhibiting three orders of fracticality in branching. Frondlets were combined as modules atop semi-rigid organic skeletons to form a wide array of larger constructions, including frondose and plumose structures. This architecture and construction define the "rangeomorphs," a biological clade that dominated the Mistaken Point assemblage (575 to 560 million years ago) but does not appear to be ancestral to any Phanerozoic or modem organisms.	Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Narbonne, GM (corresponding author), Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada.		Narbonne, Guy M/I-7518-2012					ANDERSON MM, 1982, 3RD N AM PAL CONV P, V1, P1; BOWRING SA, NASA ASTR UN GEN M 2; Boynton H.E., 1995, Mercian Geologist, V13, P165; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Clapham ME, 2002, GEOLOGY, V30, P627, DOI 10.1130/0091-7613(2002)030<0627:EET>2.0.CO;2; Dzik J, 2002, J MORPHOL, V252, P315, DOI 10.1002/jmor.1108; Erwin D, 1997, AM SCI, V85, P126; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; FEDONKIN MA, 1990, VENDIAN SYSTEM, V1, P132; Ford T. D., 1958, Proceedings of the Yorkshire Geological Society, V31, P211; Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; JENKINS RJF, 1995, PRECAMBRIAN RES, V73, P51, DOI 10.1016/0301-9268(94)00071-X; JENKINS RJF, 1985, PALEOBIOLOGY, V11, P336, DOI 10.1017/S0094837300011635; Knoll AH, 2003, LIFE YOUNG PLANET 1; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; MISRA SB, 1969, GEOL SOC AM BULL, V80, P2133, DOI 10.1130/0016-7606(1969)80[2133:LPFFSN]2.0.CO;2; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 2001, B5 GEOL ASS CAN FIEL; Narbonne GM., 1998, GSA TODAY, V8, P1; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Wood DA, 2003, CAN J EARTH SCI, V40, P1375, DOI 10.1139/E03-048; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Zhuravlev Andrey Yu., 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V190, P299	28	166	171	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1141	1144		10.1126/science.1099727	http://dx.doi.org/10.1126/science.1099727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15256615				2022-12-01	WOS:000223557400044
J	Creighton, S; Sethi, G; Edwards, SG; Miller, R				Creighton, S; Sethi, G; Edwards, SG; Miller, R			Dispersal of HIV positive asylum seekers: national survey of UK healthcare providers	BRITISH MEDICAL JOURNAL			English	Article									Camden Primary Care Trust, Dept Genitourinary Med, Mortimer Market Ctr, London WC1E 6AU, England; St Marys Hosp, Dept Genitourinary Med, London W2 1NY, England; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England	Imperial College London; University of London; University College London	Creighton, S (corresponding author), Camden Primary Care Trust, Dept Genitourinary Med, Mortimer Market Ctr, London WC1E 6AU, England.	sarah.creighton@camdenpct.nhs.uk		Miller, Robert/0000-0003-2067-4291				*ALL PART PARL GRO, IMPR LIV BRIT; HEALTH T, 2003, ASYLUM STAT UK; Johnson R. D., 2003, ASYLUM SEEKERS DISPE	3	18	18	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					322	323		10.1136/bmj.38189.674213.79	http://dx.doi.org/10.1136/bmj.38189.674213.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15277294	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000223300300016
J	Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P				Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P		Athena Sci Team	Wind-related processes detected by the Spirit rover at Gusev Crater, Mars	SCIENCE			English	Article							ROCKS		Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Cornell Univ, Dept Astron, Ithaca, NY USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Honeybee Robot, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Colorado, Space Sci Inst, Boulder, CO 80301 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Orsted Lab, DK-2100 Copenhagen, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Deutsch Zentrum Luft & Raumfart, German Aerosp Ctr, Inst Space Simulat, D-51170 Cologne, Germany; NASA, Washington, DC 20546 USA	Arizona State University; Arizona State University-Tempe; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Greeley, R (corresponding author), Arizona State Univ, Dept Geol Sci, Box 871404, Tempe, AZ 85287 USA.	Greeley@asu.edu	Moersch, Jeffrey E/F-7189-2010; Haldemann, Albert F C/I-9224-2012; Madsen, Morten Bo/D-2082-2011; Whelley, Patrick/B-9560-2012; Farmer, Jack D/B-9343-2019	Moersch, Jeffrey E/0000-0003-3433-9419; Haldemann, Albert F C/0000-0003-3741-8841; Madsen, Morten Bo/0000-0001-8909-5111; Whelley, Patrick/0000-0003-3266-9772; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; Bridges NT, 2004, PLANET SPACE SCI, V52, P199, DOI 10.1016/j.pss.2003.08.026; Bridges NT, 1999, J GEOPHYS RES-PLANET, V104, P8595, DOI 10.1029/98JE02550; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; GREELEY R, 1987, GEOPHYS RES LETT, V14, P925, DOI 10.1029/GL014i009p00925; Greeley R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002491; GREELEY R, 1982, J GEOPHYS RES, V87, P9, DOI 10.1029/JB087iB12p10009; GREELEY R, 1979, J GEOPHYS RES, V84, P6248, DOI 10.1029/JB084iB11p06248; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Greeley R., 1992, MARS, P730; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Pollack J. B., 1977, Journal of Geophysical Research, V82, P4479, DOI 10.1029/JS082i028p04479; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; RAUPACH MR, 1992, BOUND-LAY METEOROL, V60, P375, DOI 10.1007/BF00155203; RAUPACH MR, 1993, J GEOPHYS RES-ATMOS, V98, P3023, DOI 10.1029/92JD01922; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; TOIGO D, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002064; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016	33	85	86	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					810	+		10.1126/science.1100108	http://dx.doi.org/10.1126/science.1100108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297660				2022-12-01	WOS:000223104900034
J	Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE				Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE			Mineralogy at Gusev crater from the Mossbauer spectrometer on the Spirit rover	SCIENCE			English	Article							ROCKS; MARS; SOILS; SPECTROSCOPY; HEMATITE	Mossbauer spectra measured on Mars by the Spirit rover during the primary mission are characterized by two ferrous iron doublets ( olivine and probably pyroxene) and a ferric iron doublet ( tentatively associated to nanophase ferric iron oxide). Two sextets resulting from nonstoichiometric magnetite are also present, except for a coating on the rock Mazatzal, where a hematite-like sextet is present. Greater proportions of ferric-bearing phases are associated with undisturbed soils and rock surfaces as compared to fresh rock surfaces exposed by grinding. The ubiquitous presence of olivine in soil suggests that physical rather than chemical weathering processes currently dominate at Gusev crater.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; IKI, Space Res Inst, Moscow, Russia; CVRD Grp, Vitoria, Brazil; CALTECH, Jet Prop Lab, Pasadena, CA USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Tech Univ Darmstadt, Darmstadt, Germany; Univ Alabama Birmingham, Birmingham, AL USA; Cornell Univ, Ithaca, NY USA; Washington Univ, St Louis, MO USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Johannes Gutenberg University of Mainz; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technical University of Darmstadt; University of Alabama System; University of Alabama Birmingham; Cornell University; Washington University (WUSTL)	Morris, RV (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	richard.v.morris@nasa.gov	de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008; Schröder, Christian/B-3870-2009	de Souza, Paulo/0000-0002-0091-8925; de Souza, Paulo A/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Renz, Franz/0000-0003-1494-1242				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BANDFIELD JL, 2002, J GEOPHYS RES, V107, P1626; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bishop J.L., 1996, SPEC PUBL GEOCHEM SO, V5, P337; BURNS RG, 1989, ACS SYM SER, V415, P262; BURNS RG, 1993, REMOTE GEOCHEMICAL A, P539; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Cornell R.M., 2003, IRON OXIDES STRUCTUR, DOI [DOI 10.1002/3527602097, 10.1002/3527602097, DOI 10.1002/]; DANIELS JM, 1969, J PHYS CHEM SOLIDS, V30, P1561, DOI 10.1016/0022-3697(69)90217-0; de Souza PA, 1999, LAB ROBOTICS AUTOMAT, V11, P3, DOI 10.1002/(SICI)1098-2728(1999)11:1<3::AID-LRA2>3.0.CO;2-F; DEGRAVE E, 1991, PHYS CHEM MINER, V18, P337, DOI 10.1007/BF00200191; Dyar MD, 2003, METEORIT PLANET SCI, V38, P1733, DOI 10.1111/j.1945-5100.2003.tb00012.x; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; MCCAMMON C, 1995, AGU REFERENCE SHELF, V2, P332; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MENZIES ON, 2001, LUNAR PLANET SCI, V32; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MYNENI SCB, 2000, REV MINERALOGY GEOCH, V40; SCHAEFER MW, 1983, NATURE, V303, P325, DOI 10.1038/303325a0; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stevens J. G., 1998, MOSSBAUER MINERAL HD; VIEIRA VWA, 1986, PHYS SCRIPTA, V33, P180, DOI 10.1088/0031-8949/33/2/016	30	205	208	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					833	836		10.1126/science.1100020	http://dx.doi.org/10.1126/science.1100020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297666				2022-12-01	WOS:000223104900039
J	Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M				Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M			GMAP-210 recruits gamma-tubulin complexes to cis-Golgi membranes and is required for Golgi ribbon formation	CELL			English	Article							MAMMALIAN-CELLS; MICROTUBULE DYNAMICS; INTERMEDIATE COMPARTMENT; PROTEIN COMPLEX; APPARATUS; CYCLE; OVEREXPRESSION; MITOCHONDRIA; CENTROSOME; CHAIN	Mammalian cells concentrate Golgi membranes around the centrosome in a microtubule-dependent manner. The mechanisms involved in generating a single Golgi ribbon in the periphery of the centrosome remain unknown. Here we show that GMAP-210, a cis-Golgi microtubule binding protein, recruits gamma-tubulin-containing complexes to Golgi membranes even in conditions where microtubule polymerization is prevented and independently of Golgi apparatus localization within the cell. Under overexpression conditions, very short microtubules, or tubulin oligomers, are stabilized on Golgi membranes. GMAP-210 depletion by RNA interference results in extensive fragmentation of the Golgi apparatus, supporting a role for GMAP-210 in Golgi ribbon formation. Targeting of GMAP-210 or its C terminus to mitochondria induces the recruitment of gamma-tubulin to their surface and redistribution of mitochondria to a pericentrosomal location. All our experiments suggest that GMAP-210 displays microtubule anchoring and membrane fusion activities, thus contributing to the assembly and maintenance of the Golgi ribbon around the centrosome.	Univ Sevilla, Fac Biol, Dept Microbiol, E-41080 Seville, Spain; CNRS, UMR 144, Inst Curie, Sect Rech, F-75248 Paris 05, France	University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite	Rios, RM (corresponding author), Univ Sevilla, Fac Biol, Dept Microbiol, Apdo 1095, E-41080 Seville, Spain.	rmrios@us.es	rios, rosa m/G-5742-2015	rios, rosa m/0000-0001-5778-6946				Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Grissom PM, 2002, MOL BIOL CELL, V13, P817, DOI 10.1091/mbc.01-08-0402; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lippincott-Schwartz J, 2000, HISTOCHEM CELL BIOL, V114, P93; Llanos R, 1999, BIOCHEMISTRY-US, V38, P15712, DOI 10.1021/bi990895w; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Moudjou M, 1996, J CELL SCI, V109, P875; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; Saoudi Y, 1998, J CELL BIOL, V142, P1519, DOI 10.1083/jcb.142.6.1519; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yoshimura S, 2001, J CELL SCI, V114, P4105	44	182	189	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 6	2004	118	3					323	335						13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294158				2022-12-01	WOS:000223353100009
J	Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A				Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A			The Spirit Rover's Athena Science Investigation at Gusev Crater, Mars	SCIENCE			English	Article							MAGNETIC-PROPERTIES EXPERIMENTS; MOSSBAUER SPECTROMETER; LANDING SITES; ROCKS; MISSION; SOILS	The Mars Exploration Rover Spirit and its Athena science payload have been used to investigate a landing site in Gusev crater. Gusev is hypothesized to be the site of a former lake, but no clear evidence for lacustrine sedimentation has been found to date. Instead, the dominant lithology is basalt, and the dominant geologic processes are impact events and eolian transport. Many rocks exhibit coatings and other characteristics that may be evidence for minor aqueous alteration. Any lacustrine sediments that may exist at this location within Gusev apparently have been buried by lavas that have undergone subsequent impact disruption.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; NASA, Ames SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Niels Bohr Inst, DK-2100 Copenhagen 0, Denmark; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Zentrum Luft & Raumfahrt, Inst Raumsimulat, D-51170 Cologne, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Space Sci Inst, Martinez, GA 30907 USA	Cornell University; Washington University (WUSTL); Max Planck Society; National Aeronautics & Space Administration (NASA); Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Copenhagen; Niels Bohr Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Farmer, Jack D/B-9343-2019; Lemmon, Mark/X-2333-2019; Sullivan, Robert/AAR-8193-2020; Madsen, Morten Bo/D-2082-2011; Smith, Michael/C-8875-2012; Lemmon, Mark T/E-9983-2010; Moersch, Jeffrey E/F-7189-2010	Lemmon, Mark/0000-0002-4504-5136; Madsen, Morten Bo/0000-0001-8909-5111; Lemmon, Mark T/0000-0002-4504-5136; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002006; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	32	298	304	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					794	799		10.1126/science.3050794	http://dx.doi.org/10.1126/science.3050794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297657				2022-12-01	WOS:000223104900031
J	McDermott, MM; Liu, K; Greenland, P; Guralnik, JM; Criqui, MH; Chan, CL; Pearce, WH; Schneider, JR; Ferrucci, L; Celic, L; Taylor, LM; Vonesh, E; Martin, GJ; Clark, E				McDermott, MM; Liu, K; Greenland, P; Guralnik, JM; Criqui, MH; Chan, CL; Pearce, WH; Schneider, JR; Ferrucci, L; Celic, L; Taylor, LM; Vonesh, E; Martin, GJ; Clark, E			Functional decline in peripheral arterial disease - Associations with the ankle brachial index and leg symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; 6-MINUTE WALK TEST; INTERMITTENT CLAUDICATION; CARDIOVASCULAR HEALTH; PHYSICAL-DISABILITY; TREADMILL WALKING; LOWER-EXTREMITIES; LONGITUDINAL DATA; VASCULAR-DISEASE; NATURAL COURSE	Context Among individuals with lower-extremity peripheral arterial disease (PAD), specific leg symptoms and the ankle brachial index (ABI) are cross-sectionally related to the degree of functional impairment. However, relations between these clinical characteristics and objectively measured functional decline are unknown. Objective To define whether PAD, ABI, and specific leg symptoms predict functional decline at 2-year follow-up. Design, Setting, and Participants Prospective cohort study among 676 consecutively identified individuals (aged greater than or equal to55 years) with and without PAD (n=417 and n=259, respectively), with baseline functional assessments occurring between October 1, 1998, and January 31, 2000, and follow-up assessments scheduled 1 and 2 years thereafter. PAD was defined as ABI less than 0.90, and participants with PAD were categorized at baseline into 1 of 5 mutually exclusive symptom groups. Main Outcome Measures Mean annual changes in 6-minute walk performance and in usual-paced and fast-paced 4-m walking velocity, adjusted for age, sex, race, prior-year functioning, comorbid diseases, body mass index, pack-years of cigarette smoking, and patterns of missing data. Results Lower baseline ABI values were associated with greater mean (95% confidence interval) annual decline in 6-minute walk performance (-73.0 [-142 to -4.2] ft for ABI <0.50 vs -58.8 [-83.5 to -34.0] ft for ABI 0.50 to <0.90 vs -12.6 [-40.3 to 15.1] ft for ABI 0.90-1.50, P=.02). Compared with participants without PAD, PAD participants with leg pain on exertion and rest at baseline had greater mean annual decline in 6-minute walk performance (-111 [-173 to -50.0] ft vs -8.67 [-36.9 to 19.5] ft, P=.004), usual-pace 4-meter walking velocity (-0.06 [-0.09 to -0.02] m/sec vs -0.01 (-0.03 to 0.003] m/sec, P=.02), and fastest-pace 4-meter walking velocity (-0.07 [-0.11 to -0.031 m/sec vs -0.02 [-0.04 to -0.006] m/sec, P=.046). Compared with participants without PAD, asymptomatic PAD was associated with greater mean annual decline in 6-minute walk performance (-76.8 (-135 to -18.61 ft vs -8.67 (-36.9 to 19.51 ft, P=.04) and an increased odds ratio for becoming unable to walk for 6 minutes continuously (3.63; 95% confidence interval, 1.58-8.36; P=.002). Conclusions Baseline ABI and the nature of leg symptoms predict the degree of functional decline at 2-year follow-up. Previously reported lack of worsening in claudication symptoms over time in patients with PAD may be more related to declining functional performance to than lack of disease progression.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Vasc Surg, Chicago, IL 60611 USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; NIA, Lab Clin Epidemiol, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; Evanston NW Hosp, Dept Surg, Div Vasc Surg, Evanston, IL USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Catholic Hlth Partners, Dept Surg, Div Vasc Surg, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; NorthShore University Health System; Oregon Health & Science University	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Greenland, Philip/ABD-5528-2021		NCRR NIH HHS [RR-00048] Funding Source: Medline; NHLBI NIH HHS [R01-HL58099, R01-HL64739] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064739, R01HL058099] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; BOYD AM, 1962, P ROY SOC MED, V55, P591, DOI 10.1177/003591576205500717; BRAUNWALD E, 2001, HEART DIS TXB CARDIV, P1467; Braunwald E, 2001, HARRISONS PRINCIPLES; Criqui M H, 1996, Vasc Med, V1, P65; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Gardner AW, 1998, ANGIOLOGY, V49, P327, DOI 10.1177/000331979804900501; GREIG C, 1993, J AM GERIATR SOC, V41, P15, DOI 10.1111/j.1532-5415.1993.tb05941.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; IMPARATO AM, 1975, SURGERY, V78, P795; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; MCALLISTER FF, 1976, AM J SURG, V132, P593, DOI 10.1016/0002-9610(76)90351-2; McDermott MM, 1998, J AM GERIATR SOC, V46, P1355, DOI 10.1111/j.1532-5415.1998.tb06001.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; OURIEL K, 1982, ARCH SURG-CHICAGO, V117, P1297; Papapetropoulou V, 1998, J CLIN NEUROPHYSIOL, V15, P447, DOI 10.1097/00004691-199809000-00009; Pasini FL, 1996, ANGIOLOGY, V47, P569, DOI 10.1177/000331979604700605; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413; RODRIGUEZSANCHEZ C, 1991, HISTOL HISTOPATHOL, V6, P63; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Simonsick EM, 2000, AGING-CLIN EXP RES, V12, P274, DOI 10.1007/BF03339847; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; SWINBURN CR, 1985, THORAX, V40, P581, DOI 10.1136/thx.40.8.581; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; [No title captured]; [No title captured]	48	439	452	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					453	461		10.1001/jama.292.4.453	http://dx.doi.org/10.1001/jama.292.4.453			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280343	Bronze			2022-12-01	WOS:000222900500022
J	Vestergaard, M; Hviid, A; Madsen, KM; Wohlfahrt, J; Thorsen, P; Schendel, D; Melbye, M; Olsen, J				Vestergaard, M; Hviid, A; Madsen, KM; Wohlfahrt, J; Thorsen, P; Schendel, D; Melbye, M; Olsen, J			MMR vaccination and febrile seizures - Evaluation of susceptible subgroups and long-term prognosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MUMPS-RUBELLA VACCINATION; ADVERSE EVENTS; RISK-FACTORS; MEASLES; CONVULSIONS; CHILDREN; SURVEILLANCE; IMMUNIZATION; PERTUSSIS; SELECTION	Context The rate of febrile seizures increases following measles, mumps, and rubella (MMR) vaccination but it is unknown whether the rate varies according to personal or family history of seizures, perinatal factors, or socioeconomic status. Furthermore, little is known about the long-term outcome of febrile seizures following vaccination. Objectives To estimate incidence rate ratios (RRs) and risk differences of febrile seizures following MMR vaccination within subgroups of children and to evaluate the clinical outcome of febrile seizures following vaccination. Design, Setting, and Participants A population-based cohort study of all children born in Denmark between January 1, 1991, and December 31, 1998, who were alive at 3 months; 537171 children were followed up until December 31, 1999, by using data from the Danish Civil Registration System and 4 other national registries. Main Outcome Measures incidence of first febrile seizure, recurrent febrile seizures, and subsequent epilepsy. Results A total of 439251 children (82%) received MMR vaccination and 17 986 children developed febrile seizures at least once; 973 of these febrile seizures occurred within 2 weeks of MMR vaccination. The RR of febrile seizures increased during the 2 weeks following MMR vaccination (2.75; 95% confidence interval [Cl], 2.55-2.97), and thereafter was close to the observed RR for nonvaccinated children. The RR did not vary significantly in the subgroups of children that had been defined by their family history of seizures, perinatal factors, or socioeconomic status. At 15 to 17 months, the risk difference of febrile seizures within 2 weeks following MMR vaccination was 1.56 per 1000 children overall (95% Cl, 1.44-1.68), 3.97 per 1000 (95% Cl, 2.90-5.40) for siblings of children with a history of febrile seizures, and 19.47 per 1000 (95% Cl, 16.05-23.55) for children with a personal history of febrile seizures. Children with febrile seizures following MMR vaccinations had a slightly increased rate of recurrent febrile seizures (RR, 1.19; 95% Cl, 1.01-1.41) but no increased rate of epilepsy (RR, 0.70; 95% Cl, 0.33-1.50) compared with children who were nonvaccinated at the time of their first febrile seizure. Conclusions MMR vaccination was associated with a transient increased rate of febrile seizures but the risk difference was small even in high-risk children. The long-term rate of epilepsy was not increased in children who had febrile seizures following vaccination compared with children who had febrile seizures of a different etiology.	Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; State Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Copenhagen, Denmark; N Atlantic Neuroepidemiol Alliances, Dept Epidemiol & Social Med, Aarhus, Denmark; Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA	Aarhus University; Aarhus University; Statens Serum Institut; Aarhus University; Centers for Disease Control & Prevention - USA	Vestergaard, M (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.	mv@soci.au.dk	Hviid, Anders/AAH-4319-2020; Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014	Hviid, Anders/0000-0002-7509-9127; Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Schendel, Diana/0000-0002-8588-1227; melbye, mads/0000-0001-8264-6785				AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Andersen TF, 1999, DAN MED BULL, V46, P263; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Clayton D., 1993, STAT MODELS EPIDEMIO; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; ELLENBERG JH, 1980, JAMA-J AM MED ASSOC, V243, P1337, DOI 10.1001/jama.243.13.1337; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GRIFFIN MR, 1991, PEDIATRICS, V88, P881; HIRTZ DG, 1983, J PEDIATR-US, V102, P14, DOI 10.1016/S0022-3476(83)80278-9; KNUDSEN FU, 1988, ACTA NEUROL SCAND, V78, P414, DOI 10.1111/j.1600-0404.1988.tb03678.x; Knudsen LB, 1998, DAN MED BULL, V45, P320; *LEADS MMWR, 1987, JAMA-J AM MED ASSOC, V257, P2894; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957; Malig C, 1996, TECH PAP INT I VITAL, V66, P1; MILLER C, 1989, PRACTITIONER, V233, P69; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; OFFRINGA M, 1994, J PEDIATR-US, V124, P574, DOI 10.1016/S0022-3476(05)83136-1; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Peltola H, 2000, JAMA-J AM MED ASSOC, V284, P2643, DOI 10.1001/jama.284.20.2643; PELTOLA H, 1986, LANCET, V1, P939; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Stafstrom CE, 2002, FEBRILE SEIZURES; Vestergaard M, 2002, EPIDEMIOLOGY, V13, P282, DOI 10.1097/00001648-200205000-00008; VESTERGAARD M, 2002, THESIS U AARHUS AARH; Watson J C, 1998, MMWR Recomm Rep, V47, P1; WHO, 2019, INT STAT CLASS DIS R, V10th; *WHO, 1967, MAN INT STAT CLASS D	32	115	118	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2004	292	3					351	357		10.1001/jama.292.3.351	http://dx.doi.org/10.1001/jama.292.3.351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838DL	15265850				2022-12-01	WOS:000222693500020
J	Hsu, CY; Vittinghoff, E; Lin, F; Shlipak, MG				Hsu, CY; Vittinghoff, E; Lin, F; Shlipak, MG			The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; 3RD NATIONAL-HEALTH; SERUM CREATININE; UNITED-STATES; PREDICTION	Background: The steady increase in end-stage renal disease (ESRD) incidence is a worldwide public health crisis. Objective: To determine whether the increasing incidence of ESRD in the United States is preceded by increased prevalence of chronic renal insufficiency. Design: Birth cohort analysis. Setting: Nationally representative Second and third National Health and Nutrition Examination Surveys (NHANES II [1976-1980] and III [1988-1994]) and nationally comprehensive U.S. Renal Data System registry. Patients: Adults, 20 to 74 years of age, surveyed in NHANES 11 (midpoint, 1978) and NHANES III (midpoint, 1991), and adults, 25 to 79 years of age, who developed ESRD in 1983 and 1996. Measurements: Prevalent chronic renal insufficiency (estimated glomerular filtration rate, 15 to 59 mL/min per 1.73 m(2)) and new ESRD cases. Results: From 1978 to 1991, the number of adults age 20 to 74 years with chronic renal insufficiency increased from 2.6 to 3.9 million, an increase in prevalence from 1970 to 2460 per 100 000 persons, However, the increased incidence of ESRD, was even greater during this period. For every 1000 adults with chronic renal insufficiency in 1978, 9 new cases of ESRD developed in 1983, but every 1000 adults with chronic renal insufficiency in 1991 produced 16 new cases of ESRD in 1996 (relative risk, 1.7 [95% CI, 1.1 to 2.7]). Limitations: We could not follow individual patients with chronic renal insufficiency for the development of ESRD, and we used estimated rather than measured glomerular filtration rate. Conclusions: During the period examined, growth in incident ESRD outpaced growth in prevalent chronic renal insufficiency, demonstrating that the ESRD epidemic in the United States is not merely a function of more cases of kidney disease. Future research should examine other potential contributors to ESRD, growth, such as improved survival from nonrenal diseases and more liberal entry into treatment programs.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hsu, CY (corresponding author), Univ Calif San Francisco, Div Nephrol, 513 Parnassus Ave,672 HSE,Box 0532, San Francisco, CA 94143 USA.	hsuchi@medicine.ucsf.edu		Hsu, Chi-yuan/0000-0001-8182-1238	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL068099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK061520] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68099] Funding Source: Medline; NIDDK NIH HHS [DK61520] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1997, Am J Kidney Dis, V30, pS67; [Anonymous], 2001, Am J Kidney Dis, V37, pS65; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feller W., 1957, INTRO PROBABILITY TH; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LITTLE RJ, 1987, STAT ANAL MISSING DA, P55; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; McDowell A, 1981, Vital Health Stat 1, P1; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753; [No title captured]; 2003, AM J KIDNEY DIS S2, V41, pS7	22	191	199	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2004	141	2					95	101		10.7326/0003-4819-141-2-200407200-00007	http://dx.doi.org/10.7326/0003-4819-141-2-200407200-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839BL	15262664				2022-12-01	WOS:000222758200002
J	Streubel, B; Chott, A; Huber, D; Exner, M; Jager, U; Wagner, O; Schwarzinger, I				Streubel, B; Chott, A; Huber, D; Exner, M; Jager, U; Wagner, O; Schwarzinger, I			Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-SITU HYBRIDIZATION; BONE-MARROW; FOLLICULAR LYMPHOMA; HORIZONTAL TRANSFER; TUMOR ANGIOGENESIS; APOPTOTIC BODIES; BLOOD-VESSELS; CHROMOSOME; TRANSLOCATION; MECHANISMS	BACKGROUND: The growth of most tumors depends on the formation of new blood vessels. In contrast to genetically unstable tumor cells, the endothelial cells of tumor vessels are considered to be normal diploid cells that do not acquire mutations. METHODS: Using a combined immunohistochemical and fluorescence in situ hybridization assay, we examined the endothelial cells in 27 B-cell lymphomas for cytogenetic alterations that are known to be present in the lymphoma cells. RESULTS: We found that 15 to 85 percent (median, 37 percent) of the microvascular endothelial cells in the B-cell lymphomas harbored lymphoma-specific chromosomal translocations. In addition, numerical chromosomal aberrations were shared by the lymphoma cells and the endothelial cells. CONCLUSIONS: Our findings suggest that microvascular endothelial cells in B-cell lymphomas are in part tumor-related and therefore reflect a novel aspect of tumor angiogenesis.	Med Univ Vienna, Vienna Gen Hosp, Inst Pathol, A-1090 Vienna, Austria; Med Univ Vienna, Vienna Gen Hosp, Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria; Med Univ Vienna, Vienna Gen Hosp, Ctr Excellence Clin & Expt Oncol, Lymphoma Program, A-1090 Vienna, Austria; Med Univ Vienna, Vienna Gen Hosp, Dept Internal Med 1, Div Hematol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Chott, A (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Inst Pathol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	andreas.chott@akh-wien.ac.at; oswald.wagner@meduniwien.ac.at						Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Gunsilius E, 2000, LANCET, V355, P1688, DOI 10.1016/S0140-6736(00)02241-8; HAMMERSEN F, 1985, INT J MICROCIRC, V4, P31; Helczynska K, 2003, CANCER RES, V63, P1441; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Horsman DE, 2001, GENE CHROMOSOME CANC, V30, P375, DOI 10.1002/gcc.1103; Jaffe ES, 2001, PATHOLOGY GENETICS T, V3; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Kurose K, 2002, NAT GENET, V32, P681, DOI 10.1038/ng1202-681b; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Moinfar F, 2000, CANCER RES, V60, P2562; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; Ott G, 1997, BLOOD, V89, P1421, DOI 10.1182/blood.V89.4.1421; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; PRAUSE JU, 1980, A GRAEF ARCH KLIN EX, V212, P261, DOI 10.1007/BF00410520; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Reynaud D, 2003, BLOOD, V101, P4313, DOI 10.1182/blood-2002-07-2085; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Takahashi N, 1998, BLOOD, V92, P4758, DOI 10.1182/blood.V92.12.4758; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vacca A, 2003, BLOOD, V102, P3340, DOI 10.1182/blood-2003-04-1338; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; WARREN BA, 1966, LAB INVEST, V15, P464; WEBERMATTHIESEN K, 1995, BLOOD, V86, P1464, DOI 10.1182/blood.V86.4.1464.bloodjournal8641464; Welzel N, 2001, CANCER RES, V61, P1629; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.3.CO;2-9; WILLIS RA, 1948, PATHOLOGY TUMOURS; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	42	253	267	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					250	259		10.1056/NEJMoa033153	http://dx.doi.org/10.1056/NEJMoa033153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254283	Bronze			2022-12-01	WOS:000222627200009
J	Bartlett, S				Bartlett, S			Fellowship of the rings	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					126	126		10.1016/S0140-6736(04)16654-3	http://dx.doi.org/10.1016/S0140-6736(04)16654-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246715				2022-12-01	WOS:000222612200008
J	Sheehan, PM; Harris, MT				Sheehan, PM; Harris, MT			Microbialite resurgence after the Late Ordovician extinction	NATURE			English	Article							MASS EXTINCTION; SOUTH CHINA; STROMATOLITES; CARBONATES; FACIES; BASIN; DECLINE; RECORD	Microbialites, including biogenic stromatolites, thrombolites and dendrolites, were formed by various microbial mats that trapped and bound sediments or formed the locus of mineral precipitation(1). Microbialites were common and diverse during the Proterozoic(2-4), but declined in abundance and morphological diversity when multicellular life diversified during the Cambrian Radiation. A second decline occurred during the Ordovician Radiation of marine animals, and from then until the present microbialites have been confined largely to high-stress environments where multicellular organisms are rare. The microbialite declines in the Phanerozoic are attributed to disruption of the mats by animals(2,5,6). A resurgence of stromatolite abundance and size during reduced animal diversity after the Permian extinction(7) has been documented anecdotally. Here we show, with statistical support, that a microbialite resurgence also occurred after the Late Ordovician extinction event in western North America. The resurgences were associated with loss of mat-inhibiting animals, providing insights into shallow-water community structures after extinction events.	Milwaukee Publ Museum, Dept Geol, Milwaukee, WI 53233 USA; Univ Wisconsin, Dept Geol Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Sheehan, PM (corresponding author), Milwaukee Publ Museum, Dept Geol, 800 W Wells St, Milwaukee, WI 53233 USA.	sheehan@uwm.edu						Awramik S. M., 1982, SCIENCE, V216, P171; Awramik S.M., 1999, HIST BIOL, V13, P241, DOI [10.1080/08912969909386584, DOI 10.1080/08912969909386584]; Bottjer DJ, 2001, EVOLUTIONARY PALEOECOLOGY, P35; Bottjer DJ, 1996, GEOL SOC SP, P1; BRENCHLEY PJ, 1994, GEOLOGY, V22, P295, DOI 10.1130/0091-7613(1994)022<0295:BAIEFA>2.3.CO;2; Browne KM, 2000, MICROBIAL SEDIMENTS, P233; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; GROTZINGER JP, 1990, AM J SCI, V290A, P80; HARRIS M. T., 1996, GEOLOGICAL SOC AM SP, P161, DOI DOI 10.1130/0-8137-2306-X.161; HARRIS MT, 1998, B NEW YORK STATE MUS, V491, P51; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Kershaw S, 1999, PALAEOGEOGR PALAEOCL, V146, P1, DOI 10.1016/S0031-0182(98)00139-4; Lehrmann DJ, 1998, J SEDIMENT RES, V68, P311, DOI 10.2110/jsr.68.311; MARTIN JM, 1994, SEDIMENT GEOL, V90, P257, DOI 10.1016/0037-0738(94)90042-6; Pope MC, 2000, J SEDIMENT RES, V70, P1139, DOI 10.1306/062099701139; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; SCHUBERT JK, 1995, PALAEOGEOGR PALAEOCL, V116, P1, DOI 10.1016/0031-0182(94)00093-N; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Sheehan Peter M., 1996, Geological Society of America Special Paper, V307, P477; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; SHEEHAN PM, 1997, EARLY PALEOZOIC BIOC, P85; Siegel S., 1956, NONPARAMETRIC STAT B; Stephens NP, 2003, SEDIMENTOLOGY, V50, P1283, DOI 10.1111/j.1365-3091.2003.00605.x; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WATSON RT, 2001, 3 INT PAN CLIM CHANG; Webby B.D., 2004, GREAT ORDOVICIAN BIO; WEBBY BD, 2001, ECOLOGY CAMBRIAN RAD; Wood R., 1999, REEF EVOLUTION	30	86	107	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					75	78		10.1038/nature02654	http://dx.doi.org/10.1038/nature02654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229600				2022-12-01	WOS:000222356800045
J	Zou, DJ; Feinstein, P; Rivers, AL; Mathews, GA; Kim, A; Greer, CA; Mombaerts, P; Firestein, S				Zou, DJ; Feinstein, P; Rivers, AL; Mathews, GA; Kim, A; Greer, CA; Mombaerts, P; Firestein, S			Postnatal refinement of peripheral olfactory projections	SCIENCE			English	Article							MICE DEFICIENT; NARIS CLOSURE; BULB; SYSTEM; EPITHELIUM; GLOMERULI; MOUSE; MAP; ORGANIZATION; SPECIFICITY	Axonal projections from the olfactory epithelium to the olfactory bulb are organized into glomeruli according to the expressed odorant receptor. Using gene-targeted mice, we show that glomerular maturation proceeds along different time courses for two similar receptors and requires sensory input during distinct sensitive periods. During early development, some glomeruli are innervated by axons of neurons that do not express the same receptor. These heterogeneous glomeruli normally disappear with age, but they persist in adults deprived of sensory input by unilateral and permanent naris closure. Persistence may be due, in part, to prolonged survival of olfactory sensory neurons.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Rockefeller Univ, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Columbia University; Rockefeller University; Yale University; Yale University	Zou, DJ (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	dz98@columbia.edu; sjf24@columbia.edu						Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BENSON TE, 1984, J NEUROSCI, V4, P638; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Conzelmann S, 2001, EUR J NEUROSCI, V14, P1623, DOI 10.1046/j.0953-816x.2001.01788.x; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klenoff JR, 1998, J COMP NEUROL, V390, P256; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Royal SJ, 1999, J NEUROSCI, V19, P9856; Tenne-Brown J, 1999, J COMP NEUROL, V410, P20, DOI 10.1002/(SICI)1096-9861(19990719)410:1<20::AID-CNE3>3.0.CO;2-T; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; ZOU D, UNPUB	26	177	180	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1976	1979		10.1126/science.1093468	http://dx.doi.org/10.1126/science.1093468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15178749				2022-12-01	WOS:000222241600048
J	Chapple, A; Ziebland, S; McPherson, A				Chapple, A; Ziebland, S; McPherson, A			Stigma, shame, and blame experienced by patients with lung cancer: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SMOKING-CESSATION	Objectives To draw on narrative interviews with patients with lung cancer and to explore their perceptions and experience of stigma. Design Qualitative study. Setting United Kingdom. Participants 45 patients with lung cancer recruited through several sources. Results Participants experienced stigma commonly felt by patients with other types of cancer, but, whether they smoked or not, they felt particularly stigmatised because the disease is so strongly associated with smoking. Interaction with family, friends, and doctors was often affected as a result, and many patients, particularly those who had stopped smoking years ago or who had never smoked, felt unjustly blamed for their illness. Those who resisted victim blaming maintained that the real culprits were tobacco companies with unscrupulous policies. Some patients concealed their illness, which sometimes had adverse financial consequences or made it hard for them to gain support from other people. Some indicated that newspaper and television reports may have added to the stigma: television advertisements aim to put young people off tobacco, but they usually portray a dreadful death, which may exacerbate fear and anxiety. A few patients were worried that diagnosis, access to care, and research into lung cancer might be adversely affected by the stigma attached to the disease and those who smoke. Conclusions Patients with lung cancer report stigmatisation with far reaching consequences. Efforts to help people quit smoking are important, but clinical and educational interventions should be presented with care so as not to add to the stigma experienced by patients with lung cancer and other smoking related diseases.	Univ Oxford, DIPEx Res Grp, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Chapple, A (corresponding author), Univ Oxford, DIPEx Res Grp, Dept Primary Hlth Care, Oxford OX3 7LF, England.	alison.chapple@dphpc.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859				Ablon J, 2002, EPILEPSY BEHAV, V3, pS2; ALBRECHT GL, 1982, SOC SCI MED, V16, P1319, DOI 10.1016/0277-9536(82)90027-2; BELLABY P, 1990, SOCIOL HEALTH ILL, V12, P47, DOI 10.1111/1467-9566.ep10844878; Chambers J, 1999, BMJ-BRIT MED J, V318, P1; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; *DEP HLTH, 1998, CMND3852; Douglas M., 2003, PURITY DANGER ANAL C; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Fowler G, 2000, EUR J PUBLIC HEALTH, V10, P3; Frank A., 1991, WILL BODY REFLECTION; Frank AW., 2013, WOUNDED STORYTELLER; Goffman E., 1963, STIGMA; MACDONALD L, 1988, LIVING CHRONIC ILLNE; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; MENEC VH, 1995, J AGING HEALTH, V7, P365, DOI 10.1177/089826439500700302; MOORE A, 2003, HLTH SERVICE J   FEB, P12; Morse JM, 1997, QUAL HEALTH RES, V7, P445, DOI 10.1177/104973239700700401; MURRAY E, 2003, BRIT MED J, V326, P368; MUZZIN LJ, 1994, SOC SCI MED, V38, P1201, DOI 10.1016/0277-9536(94)90185-6; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Richards L, 1993, USING COMPUTERS QUAL, P38; Rosman S, 2004, PATIENT EDUC COUNS, V52, P333, DOI 10.1016/S0738-3991(03)00040-5; SCAMBLER G, 1984, EXPERIENCE ILLNESS, P203; Schneider J.W., 1983, HAVING EPILEPSY EXPE; SILVERMAN D, 1994, INTERPRETING QUALITA; Sontag, 1978, ILLNESS METAPHOR, P64; Tesch R., 1991, QUALITATIVE RES ANAL; THE AM, 2002, PALLIATIVE CARE COMM; Waskul DD, 2002, SYMB INTERACT, V25, P487, DOI 10.1525/si.2002.25.4.487; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; White C, 2003, BRIT MED J, V326, P1417, DOI 10.1136/bmj.326.7404.1417-b; WILLIAMS S, 1987, SOCIOLOGICAL THEORY	33	480	490	3	68	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2004	328	7454					1470	1473		10.1136/bmj.38111.639734.7C	http://dx.doi.org/10.1136/bmj.38111.639734.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CK	15194599	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000222244600016
J	McPherson, JP; Lemmers, B; Chahwan, R; Pamidi, A; Migon, E; Matysiak-Zablocki, E; Moynahan, ME; Essers, J; Hanada, K; Poonepalli, A; Sanchez-Sweatman, O; Khokha, R; Kanaar, R; Jasin, M; Hande, MP; Hakem, R				McPherson, JP; Lemmers, B; Chahwan, R; Pamidi, A; Migon, E; Matysiak-Zablocki, E; Moynahan, ME; Essers, J; Hanada, K; Poonepalli, A; Sanchez-Sweatman, O; Khokha, R; Kanaar, R; Jasin, M; Hande, MP; Hakem, R			Involvement of mammalian Mus81 in genome integrity and tumor suppression	SCIENCE			English	Article							HOLLIDAY JUNCTIONS; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; ENDONUCLEASE; RESOLUTION; CELLS; REPLICATION; MECHANISM; STABILITY	Mus81-Eme1 endonuclease has been implicated in the rescue of stalled replication forks and the resolution of meiotic recombination intermediates in yeast. We used gene targeting to study the physiological requirements of Mus81 in mammals. Mus81(-/-) mice are viable and fertile, which indicates that mammalian Mus81 is not essential for recombination processes associated with meiosis. Mus81-deficient mice and cells were hypersensitive to the DNA cross-linking agent mitomycin C but not to gamma-irradiation. Remarkably, both homozygous Mus81(-/-) and heterozygous Mus81(-/-) mice exhibited a similar susceptibility to spontaneous chromosomal damage and a profound and equivalent predisposition to lymphomas and other cancers. These studies demonstrate a critical role for the proper biallelic expression of the mammalian Mus81 in the maintenance of genomic integrity and tumor suppression.	Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Univ Med Ctr, Erasmus MC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Univ Med Ctr, Erasmus MC, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands; Natl Univ Singapore, Dept Physiol, Fac Med, Singapore 117597, Singapore; Natl Univ Singapore, Oncol Res Inst, Fac Med, Singapore 117597, Singapore	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; National University of Singapore	Hakem, R (corresponding author), Ontario Canc Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.	rhakem@uhnres.utoronto.ca	Hande, M. Prakash/B-1645-2008; Pinheiro, Maísa/E-7424-2012; Chahwan, Richard/AAQ-9381-2021	Hande, M. Prakash/0000-0002-4511-6256; Chahwan, Richard/0000-0002-8672-7790; Moynahan, Mary Ellen/0000-0002-0167-1020; Hanada, Katsuhiro/0000-0003-0429-1899; Khokha, Rama/0000-0002-6028-1524; Hakem, Razqallah/0000-0001-5948-7931				Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Heyer WD, 2003, TRENDS BIOCHEM SCI, V28, P548, DOI 10.1016/j.tibs.2003.08.011; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; MCPHERSON J, UNPUB; Mullen JR, 2001, GENETICS, V157, P103; Ogrunc M, 2003, J BIOL CHEM, V278, P21715, DOI 10.1074/jbc.M302484200; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049	28	149	157	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1822	1826		10.1126/science.1094557	http://dx.doi.org/10.1126/science.1094557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205536				2022-12-01	WOS:000222089500051
J	Shav-Tal, Y; Darzacq, X; Shenoy, SM; Fusco, D; Janicki, SM; Spector, DL; Singer, RH				Shav-Tal, Y; Darzacq, X; Shenoy, SM; Fusco, D; Janicki, SM; Spector, DL; Singer, RH			Dynamics of single mRNPs in nuclei of living cells	SCIENCE			English	Article							MESSENGER-RNA; MOVEMENT; DIFFUSION; MOBILITY; VISUALIZATION; PROTEINS; BINDING	Understanding gene expression requires the ability to follow the fate of individual molecules. Here we use a cellular system for monitoring messenger RNA (mRNA) expression to characterize the movement in real time of single mRNA-protein complexes (mRNPs) in the nucleus of living mammalian cells. This mobility was not directed but was governed by simple diffusion. Some mRNPs were partially corralled throughout the nonhomogenous nuclear environment, but no accumulation at subnuclear domains was observed. Following energy deprivation, energy-independent motion of mRNPs was observed in a highly ATP-dependent nuclear environment; movements were constrained to chromatin-poor domains and excluded by newly formed chromatin barriers. This observation resolves a controversy, showing that the energetic requirements of nuclear mRNP trafficking are consistent with a diffusional model.	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cold Spring Harbor Laboratory	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rhsinger@aecom.yu.edu	shenoy, shailesh/AAD-4962-2020; Darzacq, Xavier/A-7546-2008	Darzacq, Xavier/0000-0003-2537-8395; Shav-Tal, Yaron/0000-0002-8017-948X; Shenoy, Shailesh/0000-0002-5132-7236	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB2060, R01 EB002060] Funding Source: Medline; NIGMS NIH HHS [GM42694, R01 GM042694] Funding Source: Medline; PHS HHS [DOE63056] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Calapez A, 2002, J CELL BIOL, V159, P795, DOI 10.1083/jcb.200203046; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Molenaar C, 2004, J CELL BIOL, V165, P191, DOI 10.1083/jcb.200310139; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Politz JC, 2000, J STRUCT BIOL, V129, P252, DOI 10.1006/jsbi.2000.4227; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; ZACHAR Z, 1993, J CELL BIOL, V121, P729, DOI 10.1083/jcb.121.4.729	18	372	381	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2004	304	5678					1797	1800		10.1126/science.1099754	http://dx.doi.org/10.1126/science.1099754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205532	Green Accepted			2022-12-01	WOS:000222089500044
J	Kalir, S; Alon, U				Kalir, S; Alon, U			Using a quantitative blueprint to reprogram the dynamics of the flagella gene network	CELL			English	Article							ESCHERICHIA-COLI; EXPRESSION; PROMOTERS; OPERONS	Detailed understanding and control of biological networks will require a level of description similar to that of electronic engineering blueprints. Currently, however, even the best-studied systems are usually described using qualitative arrow diagrams. A quantitative blueprint requires in vivo measurements of (1) the relative strength of the interactions (numbers on the arrows) and (2) the functions that integrate multiple inputs. Here, we address this using a well-studied system, the flagella biosynthesis transcription network in Escherichia coli. We use theory and high-resolution experiments to obtain a quantitative blueprint with (1) numbers on the arrows, finding different hierarchies of activation coefficients for the two regulators, FlhDC and FliA; and (2) cis-regulatory input functions, which summate the input from the two regulators (SUM gates). We then demonstrate experimentally how this blueprint can be used to reprogram temporal expression patterns in this system, using controlled expression of the regulators or point mutations in their binding sites. The present approach can be used to define blueprints of other gene networks and to quantitatively reprogram their dynamics.	Hebrew Univ Jerusalem, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Alon, U (corresponding author), Hebrew Univ Jerusalem, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il						Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ikebe T, 1999, MICROBIOL-SGM, V145, P1389, DOI 10.1099/13500872-145-6-1389; Ikebe T, 1999, GENES GENET SYST, V74, P179, DOI 10.1266/ggs.74.179; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KASHTAN N, 2004, IN PRESS PHYS REV E; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Lee E, 2004, PLOS BIOL, V2, P405, DOI 10.1371/journal.pbio.0020089; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wolf Denise M., 2002, OMICS A Journal of Integrative Biology, V6, P91, DOI 10.1089/15362310252780852; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	38	98	100	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					713	720		10.1016/j.cell.2004.05.010	http://dx.doi.org/10.1016/j.cell.2004.05.010			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186773	Bronze			2022-12-01	WOS:000222048400005
J	Maconochie, N; Doyle, P; Carson, C				Maconochie, N; Doyle, P; Carson, C			Infertility among male UK veterans of the 1990-1 Gulf War: reproductive cohort study	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-DEFECTS; HEALTH; POPULATION; CHILDREN; INFANTS; BORN	Objectives To examine the hypothesis that, theoretically at least, exposure to toxicants of the type present in the Gulf war could affect spermatogenesis, Which might be observed as increased levels of infertility. Design Retrospective reproductive cohort analysis. Setting Male UK Gulf war veterans and matched comparison group of non-deployed servicemen, surveyed by postal questionnaire. Participants 42 818 completed questionnaires were returned, representing response rates of 53% for Gulf veterans and 42% for non-Gulf veterans; 10465 Gulf veterans and 7376 non-Gulf veterans reported fathering or trying to father pregnancies after the Gulf war. Main outcome measures Failure to achieve conceptions (type I infertility) or live births (type II infertility) after the Gulf war, having tried for at least a year and consulted a doctor; time to conception among pregnancies fathered by men not reporting fertility problems. Results Risk of reported infertility was higher among Gulf war veterans than among non-Gulf veterans (odds ratio for type I infertility 1.41, 95% confidence interval 1.05 to 1.89; type II 1.50, 1.18 to 1.89). This small effect was constant over time since the war and was observed whether or riot the men had fathered pregnancies before the war. Results were similar when analyses were restricted to clinically confirmed diagnoses. Pregnancies fathered by Gulf veterans not reporting fertility problems also took longer to conceive (odds ratio for >1 year 1.18, 1.04 to 1.34). Conclusions We found some evidence of an association between Gulf war service and reported infertility Pregnancies fathered by Gulf veterans with no fertility problems also reportedly took longer to conceive.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Maconochie, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England.	noreen.maconochie@lshtin.ac.uk	Carson, Claire/F-1662-2011					Abou-Donia MB, 2003, J TOXICOL ENV HEAL A, V66, P57, DOI 10.1080/15287390306463; Araneta MRG, 1997, TERATOLOGY, V56, P244, DOI 10.1002/(SICI)1096-9926(199710)56:4<244::AID-TERA3>3.0.CO;2-Z; Araneta MRG, 2003, BIRTH DEFECTS RES A, V67, P246, DOI 10.1002/bdra.10033; Breslow NE, 1980, STAT METHODS CANC RE, V2; *CAN DEP NAT DEF, 1998, HLTH STUD CAN FORC P, V1; Cowan DN, 1997, NEW ENGL J MED, V336, P1650, DOI 10.1056/NEJM199706053362306; Doyle P, 2004, INT J EPIDEMIOL, V33, P74, DOI 10.1093/ije/dyh049; Ishoy T, 2001, DAN MED BULL, V48, P29; Kang H, 2001, ANN EPIDEMIOL, V11, P504, DOI 10.1016/S1047-2797(01)00245-9; Maconochie N, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-4; *MHRAG, 2003, MRC REV RES UK GULF; Penman AD, 1996, MIL MED, V161, P1; SIM M, 2003, AUSTR GULF VETERANS, V2; World Health Organization, 1992, WHO LAB MAN EX HUM S	14	26	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					196	200		10.1136/bmj.38163.620972.AE	http://dx.doi.org/10.1136/bmj.38163.620972.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15253919	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000222866900015
J	Risitano, AM; Maciejewski, JP; Green, S; Plasilova, M; Zeng, WH; Young, NS				Risitano, AM; Maciejewski, JP; Green, S; Plasilova, M; Zeng, WH; Young, NS			In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing	LANCET			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MYELODYSPLASTIC-SYNDROME; INTERFERON-GAMMA; STRUCTURAL BASIS; RECEPTOR; REPERTOIRE; EXPANSIONS; ANTIGEN; EPITOPE; CYTOTOXICITY	Background Aplastic anaemia is a bone-marrow-failure syndrome characterised by low blood-cell counts and fatty bone marrow. in most cases, no obvious aetiological factor can be identified. However, clinical responses to immunosuppression strongly suggest an immune pathophysiology. Methods To test the hypothesis that aplastic anaemia results from antigen-specific lymphocyte attack against haemopoietic tissue, we analysed effector immunity, seeking especially dominant specific T-cell responses. Blood samples from 54 patients with aplastic anaemia were subjected to flow cytometry to define T-cell-receptor Vbeta-chain usage and expansion of particular Vbeta subsets. We measured the size distribution of the complementarity-determining region 3 (CDR3) for expanded Vbeta subsets, then cloned and sequenced skewed, oligoclonal, or monoclonal peaks. Findings Expanded Vbeta subsets were identified in almost all the patients. Over-represented Vbeta subsets from CD8-positive cells showed oligoclonal or monoclonal CDR3 size patterns. The CDR3 sequence repertoire in aplastic anaemia showed much redundancy compared with healthy donors. We identified patient-specific putative pathogenetic clonotypes that were not detectable in controls. in selected patients who were assessed longitudinally, these clonotypes were quantitatively related to disease activity. Selective killing of autologous haemopoietic progenitors by the Vbeta-specific lymphocyte population was shown in one patient. These apparently pathogenetic CDR3 sequences showed homology between individuals, suggesting a role for a "semi-public" immune response in the pathophysiology of aplastic anaemia. Interpretation In-vivo dominant clonal immune response can be identified in many patients with aplastic anaemia, which is evidence for an underlying antigen-driven immune process. Longitudinal tracking by molecular techniques could inform individual clinical decisions and the development of new treatments in autoimmune diseases. Relevance to practice Although the target of the aberrant immune response is the haemopoietic stem cell, the triggering antigens remain unknown. We combined cell phenotypic, molecular biology, and functional analyses to study the effector arm of immunity in an attempt to establish an immune pathophysiology. Clinical application of such a model could broadly extend to other autoimmune diseases.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; Cleveland Clin Fdn, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation	Risitano, AM (corresponding author), Univ Naples Federico II, Div Hematol, Via Pansini 5, I-80131 Naples, Italy.	amrisita@unina.it			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073429, Z01HL002315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL73429] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Dunn DE, 1999, ANN INTERN MED, V131, P401, DOI 10.7326/0003-4819-131-6-199909210-00002; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; EVEN J, 1995, RES IMMUNOL, V146, P65, DOI 10.1016/0923-2494(96)80240-9; Feng XM, 2003, BLOOD, V102, p206A; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; HEIMPEL H, 1987, BLOOD, V70, P1718; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Hofbauer M, 2003, P NATL ACAD SCI USA, V100, P4090, DOI 10.1073/pnas.0236183100; Hong J, 1999, J IMMUNOL, V163, P3530; Karadimitris A, 2000, BLOOD, V96, P2613, DOI 10.1182/blood.V96.7.2613.h8002613_2613_2620; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kook H, 2002, BLOOD, V99, P3668, DOI 10.1182/blood.V99.10.3668; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; MACIEJEWSKI JP, 1995, BRIT J HAEMATOL, V91, P245, DOI 10.1111/j.1365-2141.1995.tb05277.x; Maciejewski JP, 2001, BLOOD, V98, P3513, DOI 10.1182/blood.V98.13.3513; Michalek J, 2003, LANCET, V361, P1183, DOI 10.1016/S0140-6736(03)12917-0; Michalek J, 2003, P NATL ACAD SCI USA, V100, P1180, DOI 10.1073/pnas.0337543100; Muraro PA, 2003, BRAIN, V126, P20, DOI 10.1093/brain/awg021; Nakao S, 1997, BLOOD, V89, P3691, DOI 10.1182/blood.V89.10.3691.3691_3691_3699; O'Keefe CL, 2004, J IMMUNOL, V172, P1960, DOI 10.4049/jimmunol.172.3.1960; Plasilova Magdalena, 2003, Hematology, V8, P173, DOI 10.1080/1024533031000107505; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Scotet E, 1999, EUR J IMMUNOL, V29, P973, DOI 10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.0.CO;2-P; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; Sospedra M, 2003, METHODS, V29, P236, DOI 10.1016/S1046-2023(02)00346-8; van den Beemd R, 2000, CYTOMETRY, V40, P336, DOI 10.1002/1097-0320(20000801)40:4<336::AID-CYTO9>3.0.CO;2-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Young N. S., 2000, BONE MARROW FAILURE, P1; Young NS, 2000, SEMIN HEMATOL, V37, P3, DOI 10.1016/S0037-1963(00)90026-X; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI200112687; ZOUMBOS NC, 1985, NEW ENGL J MED, V312, P257, DOI 10.1056/NEJM198501313120501	40	193	230	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					355	364		10.1016/S0140-6736(04)16724-X	http://dx.doi.org/10.1016/S0140-6736(04)16724-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276395				2022-12-01	WOS:000222853300034
J	Ruhl, HA; Smith, KL				Ruhl, HA; Smith, KL			Shifts in deep-sea community structure linked to climate and food supply	SCIENCE			English	Article							PORCUPINE ABYSSAL-PLAIN; BENTHIC BOUNDARY-LAYER; TIME-SERIES STATION; CALIFORNIA CURRENT; NORTH PACIFIC; NE PACIFIC; ONEIROPHANTA-MUTABILIS; EPIBENTHIC MEGAFAUNA; REPRODUCTIVE-BIOLOGY; ORGANIC-MATTER	A major change in the community structure of the dominant epibenthic megafauna was observed at 4100 meters depth in the northeast Pacific and was synchronous to a major El Nino/ La Nina event that occurred between 1997 and 1999. Photographic abundance estimates of epibenthic megafauna from 1989 to 2002 show that two taxa decreased in abundance after 1998 by 2 to 3 orders of magnitude, whereas several other species increased in abundance by 1 to 2 orders of magnitude. These faunal changes are correlated to climate fluctuations dominated by El Nino/La Nina. Megafauna even in remote marine areas appear to be affected by contemporary climatic fluctuations. Such faunal changes highlight the importance of an adequate temporal perspective in describing biodiversity, ecology, and anthropogenic impacts in deep-sea communities.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Ruhl, HA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	hruhl@ucsd.edu						Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; Beaulieu SE, 1998, DEEP-SEA RES PT II, V45, P781, DOI 10.1016/S0967-0645(98)00003-4; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett D.S.M., 1988, P421; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI [DOI 10.5670/0CEAN0G.1991.07, 10.5670/oceanog.1991.07, DOI 10.5670/OCEANOG.1991.07]; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; GOODAY AJ, 1988, NATURE, V332, P70, DOI 10.1038/332070a0; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hudson IR, 2003, PROG OCEANOGR, V59, P381, DOI 10.1016/j.pocean.2003.11.002; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Kahru M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014963; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Lauerman LML, 1996, DEEP-SEA RES PT I, V43, P1075, DOI 10.1016/0967-0637(96)00045-3; Lauerman LML, 1998, DEEP-SEA RES PT II, V45, P817, DOI 10.1016/S0967-0645(98)00004-6; Lauerman LML, 1997, LIMNOL OCEANOGR, V42, P589, DOI 10.4319/lo.1997.42.3.0589; Lavaniegos BE, 2003, DEEP-SEA RES PT II, V50, P2473, DOI 10.1016/S0967-0645(03)00132-2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Miller AJ, 2000, PROG OCEANOGR, V47, P355, DOI 10.1016/S0079-6611(00)00044-6; PFANNKUCHE O, 1993, DEEP-SEA RES PT I, V40, P727, DOI 10.1016/0967-0637(93)90068-E; Roberts D, 2001, PROG OCEANOGR, V50, P443, DOI 10.1016/S0079-6611(01)00065-9; Roberts D, 1997, BIODIVERS CONSERV, V6, P1487, DOI 10.1023/A:1018362319053; Smallwood BJ, 1999, NATURWISSENSCHAFTEN, V86, P320, DOI 10.1007/s001140050624; Smith CR, 2000, DEEP-SEA RES PT II, V47, P227, DOI 10.1016/S0967-0645(99)00108-3; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; SMITH KL, 1993, DEEP-SEA RES PT I, V40, P2307, DOI 10.1016/0967-0637(93)90106-D; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wigham BD, 2003, J MAR BIOL ASSOC UK, V83, P175, DOI 10.1017/S0025315403006957h; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7	33	197	202	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					513	515		10.1126/science.1099759	http://dx.doi.org/10.1126/science.1099759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273392				2022-12-01	WOS:000222828900038
J	Possick, SE; Barry, M				Possick, SE; Barry, M			Evaluation and management of the cardiovascular patient embarking on air travel	ANNALS OF INTERNAL MEDICINE			English	Review							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; ACUTE MYOCARDIAL-INFARCTION; DEEP-VEIN THROMBOSIS; LONG-HAUL FLIGHTS; PULMONARY-EMBOLISM; VENOUS THROMBOEMBOLISM; AMERICAN-COLLEGE; RANDOMIZED TRIAL; RISK-FACTORS	Almost 2 billion passengers embark on international and domestic air travel each year. An increasing number of travelers will have cardiovascular disease as the population continues to age and our ability to treat cardiac disease improves. Guidelines for safe air travel in this population vary and are supported by few concrete data from randomized trials. Although the overall risk for clinically significant myocardial ischemia and arrhythmia during flight seems to be low in the population with stable cardiovascular disease, certain groups may be at increased risk. In-flight venous thrombosis is an increasingly recognized potential complication of prolonged air travel. Travelers with cardiovascular disease may be at increased risk for venous thrombosis as a result of depressed ejection fraction or immobility. This case-based review describes the risks of air travel in a 65-year-old man with known cardiovascular disease. After reviewing the limited data on safe air travel after myocardial infarction and the common complications after both percutaneous intervention and coronary artery bypass grafting, we provide recommendations on safe air travel after myocardial infarction. We discuss the safety of both preflight screening and the in-flight environment with regard to pacemakers and implantable automatic defibrillators. We also review the literature on in-flight venous thrombosis and provide recommendations to prevent in-flight deep venous thrombosis.	Yale Univ, Sch Med, Off Int Hlth, New Haven, CT 06520 USA	Yale University	Barry, M (corresponding author), Yale Univ, Sch Med, Off Int Hlth, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	michele.barry@yale.edu						Alexander J K, 1995, Cardiol Clin, V13, P271; ALVAREZ D, 2003, AVIATION SPACE ENV M, V74, pA1; Ansell JE, 2001, NEW ENGL J MED, V345, P828, DOI 10.1056/NEJM200109133451110; Belcaro G, 2002, ANGIOLOGY, V53, P635, DOI 10.1177/000331970205300603; Belcaro G, 2001, ANGIOLOGY, V52, P369, DOI 10.1177/000331970105200601; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; COPPERMAN Y, 1988, PACE, V11, P1386, DOI 10.1111/j.1540-8159.1988.tb04985.x; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; Cox GR, 1996, AVIAT SPACE ENVIR MD, V67, P976; CUMMINS RO, 1988, JAMA-J AM MED ASSOC, V259, P1983, DOI 10.1001/jama.259.13.1983; Cutlip DE, 2001, CIRCULATION, V103, P1967; Dalen JE, 2003, ARCH INTERN MED, V163, P2674, DOI 10.1001/archinte.163.22.2674; De Rotte AA, 2002, AVIAT SPACE ENVIR MD, V73, P179; DeJohn CA, 2000, DOTFAAAM0013 OFF AV; DILLARD TA, 1989, ANN INTERN MED, V111, P362, DOI 10.7326/0003-4819-111-5-362; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; Fries R, 2002, CLIN CARDIOL, V25, P474, DOI 10.1002/clc.4960251007; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; GERTLER JP, 1993, J VASC SURG, V18, P939, DOI 10.1016/0741-5214(93)90548-Z; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GONG H, 1992, CHEST, V101, P1104, DOI 10.1378/chest.101.4.1104; Hannan EL, 2003, JAMA-J AM MED ASSOC, V290, P773, DOI 10.1001/jama.290.6.773; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Kaufmann PA, 2001, J NUCL CARDIOL, V8, P158, DOI 10.1067/mnc.2001.112537; Kazmers A, 1999, AM SURGEON, V65, P1124; Kolb C, 2003, J AM COLL CARDIOL, V41, P2054, DOI 10.1016/S0735-1097(03)00424-8; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; Kujanik S, 2000, PHYSIOL RES, V49, P285; Kujanik S, 2000, PHYSIOL RES, V49, P729; Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Levine BD, 1997, CIRCULATION, V96, P1224, DOI 10.1161/01.CIR.96.4.1224; Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424; MORGAN BJ, 1990, J WILDERNESS MED, V1, P147, DOI 10.1580/0953-9859-1.3.147; PAULTER N, 2000, 06020189 NIJ US DEP; Perez-Rodriguez E, 2003, ARCH INTERN MED, V163, P2766, DOI 10.1001/archinte.163.22.2766; POSSICK S, 2004, IN PRESS J TRAVEL ME; Rhoads JE, 1999, AM SURGEON, V65, P1127; Roby H, 2002, AVIAT SPACE ENVIR MD, V73, P91; RODENBERG H, 1988, AM FAM PHYSICIAN, V37, P263; Ryan TJ, 1996, CIRCULATION, V94, P2341, DOI 10.1161/01.CIR.94.9.2341; SCHWARTZ GB, 1982, JAMA-J AM MED ASSOC, V247, P1007; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6; Stoller JK, 1999, CHEST, V115, P991, DOI 10.1378/chest.115.4.991; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; *UK HOUS LORDS SEL, 5 UK HOUS LORDS SEL; WAKSMAN R, 1995, AM J CARDIOL, V75, P886, DOI 10.1016/S0002-9149(99)80681-X; Wyss CA, 2003, CIRCULATION, V108, P1202, DOI 10.1161/01.CIR.0000087432.63671.2E; Zahger D, 2000, AM HEART J, V140, P241, DOI 10.1067/mhj.2000.107998; TRAVELERS CONSUMERS	54	27	28	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2004	141	2					148	154		10.7326/0003-4819-141-2-200407200-00014	http://dx.doi.org/10.7326/0003-4819-141-2-200407200-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839BL	15262671				2022-12-01	WOS:000222758200009
J	Scherz, PJ; Harfe, BD; McMahon, AP; Tabin, CJ				Scherz, PJ; Harfe, BD; McMahon, AP; Tabin, CJ			The limb bud Shh-Fgf feedback loop is terminated by expansion of former ZPA cells	SCIENCE			English	Article							APICAL ECTODERMAL RIDGE; SONIC-HEDGEHOG; CHICK LIMB; VERTEBRATE LIMB; POLARIZING ACTIVITY; GROWTH; GREMLIN; ANTAGONISM; EXPRESSION; INDUCTION	Vertebrate limb outgrowth is driven by a positive feedback loop involving Sonic Hedgehog (Shh), Gremlin, and Fgf4. By overexpressing individual components of the loop at a time after these genes are normally down-regulated in chicken embryos, we found that Shh no longer maintains Gremlin in the posterior limb. Shh-expressing cells and their descendants cannot express Gremlin. The proliferation of these descendants forms a barrier separating the Shh signal from Gremlin-expressing cells, which breaks down the Shh-Fgf4 loop and thereby affects limb size and provides a mechanism explaining regulative properties of the limb bud.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	McMahon, Andrew P/ABE-7520-2020		NICHD NIH HHS [HD32443] Funding Source: Medline; NIGMS NIH HHS [5T32GM0719T6] Funding Source: Medline; NINDS NIH HHS [NS33642] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443, R01HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Driesch H., 1892, FDN EXPT ENBRYOLOGY, P584; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; Ganan Y, 1998, DEV BIOL, V196, P33, DOI 10.1006/dbio.1997.8843; Hafen E, 2003, PLOS BIOL, V1, P319, DOI 10.1371/journal.pbio.0000086; HARFE BD, IN PRESS CELL; HORNBRUCH A, 1970, NATURE, V226, P764, DOI 10.1038/226764a0; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Marigo V, 1996, DEVELOPMENT, V122, P1225; Merino R, 1999, DEVELOPMENT, V126, P5515; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pizette S, 1999, DEVELOPMENT, V126, P883; Richardson MK, 2004, EVOL DEV, V6, P1, DOI 10.1111/j.1525-142X.2004.04008.x; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	25	123	128	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2004	305	5682					396	399		10.1126/science.1096966	http://dx.doi.org/10.1126/science.1096966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837TE	15256670				2022-12-01	WOS:000222662400038
J	Spar, D				Spar, D			Business and medicine - The business of stem cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Spar, D (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.								0	4	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					211	213		10.1056/NEJMp048138	http://dx.doi.org/10.1056/NEJMp048138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254279				2022-12-01	WOS:000222627200003
J	Musallam, S; Corneil, BD; Greger, B; Scherberger, H; Andersen, RA				Musallam, S; Corneil, BD; Greger, B; Scherberger, H; Andersen, RA			Cognitive control signals for neural prosthetics	SCIENCE			English	Article							PREFRONTAL CORTEX; NEURONAL-ACTIVITY; EXPECTED REWARD; PARIETAL; PREMOTOR	Recent development of neural prosthetics for assisting paralyzed patients has focused on decoding intended hand trajectories from motor cortical neurons and using this signal to control external devices. In this study, higher level signals related to the goals of movements were decoded from three monkeys and used to position cursors on a computer screen without the animals emitting any behavior. Their performance in this task improved over a period of weeks. Expected value signals related to fluid preference, the expected magnitude, or probability of reward were decoded simultaneously with the intended goal. For neural prosthetic applications, the goal signals can be used to operate computers, robots, and vehicles, whereas the expected value signals can be used to continuously monitor a paralyzed patient's preferences and motivation.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Div Biol, Mail Code 216-76, Pasadena, CA 91125 USA.	andersen@vis.caltech.edu	Musallam, Sam/E-8064-2011; Corneil, Brian D/K-6401-2013	Corneil, Brian D/0000-0002-4702-7089; Greger, Bradley/0000-0002-6702-7596; Scherberger, Hansjorg/0000-0001-6593-2800				Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Mussa-Ivaldi FA, 2003, TRENDS NEUROSCI, V26, P329, DOI 10.1016/S0166-2236(03)00121-8; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roitman JD, 2002, J NEUROSCI, V22, P9475; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	29	503	527	5	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					258	262		10.1126/science.1097938	http://dx.doi.org/10.1126/science.1097938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247483				2022-12-01	WOS:000222501000057
J	Matsuura, I; Denissova, NG; Wang, GN; He, DM; Long, JY; Liu, F				Matsuura, I; Denissova, NG; Wang, GN; He, DM; Long, JY; Liu, F			Cyclin-dependent kinases regulate the antiproliferative function of Smads	NATURE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; C-MYC; RETINOBLASTOMA PROTEIN; TARGETED DISRUPTION; CDK INHIBITORS; CANCER; REPRESSION; P15(INK4B); SP1	Transforming growth factor-beta (TGF-beta) potently inhibits cell cycle progression at the G1 phase(1,2). Smad3 has a key function in mediating the TGF-beta growth-inhibitory response. Here we show that Smad3 is a major physiological substrate of the G1 cyclin-dependent kinases CDK4 and CDK2. Except for the retinoblastoma protein family(3,4), Smad3 is the only CDK4 substrate demonstrated so far. We have mapped CDK4 and CDK2 phosphorylation sites to Thr 8, Thr 178 and Ser 212 in Smad3. Mutation of the CDK phosphorylation sites increases Smad3 transcriptional activity, leading to higher expression of the CDK inhibitor p15. Mutation of the CDK phosphorylation sites of Smad3 also increases its ability to downregulate the expression of c-myc. Using Smad3(-/-) mouse embryonic fibroblasts and other epithelial cell lines, we further show that Smad3 inhibits cell cycle progression from G1 to S phase and that mutation of the CDK phosphorylation sites in Smad3 increases this ability. Taken together, these findings indicate that CDK phosphorylation of Smad3 inhibits its transcriptional activity and antiproliferative function. Because cancer cells often contain high levels of CDK activity(5,6), diminishing Smad3 activity by CDK phosphorylation may contribute to tumorigenesis and TGF-beta resistance in cancers.	Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Liu, F (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	fangliu@cabm.rutgers.edu	Long, Jianyin/H-8261-2013; Matsuura, Isao/E-3979-2010					Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Kim MJ, 2002, CANCER RES, V62, P2999; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuura I, 1996, J BIOL CHEM, V271, P5443, DOI 10.1074/jbc.271.10.5443; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Phelps DE, 1997, METHOD ENZYMOL, V283, P194; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SWIFT S, 1999, CURR PROTOCOLS IMM S, V31; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	30	386	410	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					226	231		10.1038/nature02650	http://dx.doi.org/10.1038/nature02650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241418	Bronze			2022-12-01	WOS:000222470600048
J	Knaden, M; Wehner, R				Knaden, M; Wehner, R			Path integration in desert ants controls aggressiveness	SCIENCE			English	Article									Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland	University of Zurich	Wehner, R (corresponding author), Univ Zurich, Dept Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	rwehner@zool.unizh.ch	Knaden, Markus/E-2151-2015	Knaden, Markus/0000-0002-6710-1071				Baier A, 2002, J EXP BIOL, V205, P1233; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Knaden M, 2003, J INSECT BEHAV, V16, P717, DOI 10.1023/B:JOIR.0000007706.38674.73; Kravitz EA, 2000, J COMP PHYSIOL A, V186, P221, DOI 10.1007/s003590050423; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Wehner Ruediger, 2003, P9	6	20	20	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					60	60		10.1126/science.1097165	http://dx.doi.org/10.1126/science.1097165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15232099				2022-12-01	WOS:000222386000032
J	Hallett, TB; Coulson, T; Pilkington, JG; Clutton-Brock, TH; Pemberton, JM; Grenfell, BT				Hallett, TB; Coulson, T; Pilkington, JG; Clutton-Brock, TH; Pemberton, JM; Grenfell, BT			Why large-scale climate indices seem to predict ecological processes better than local weather	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; POPULATION-DYNAMICS; COHORT VARIATION; RED DEER; DENSITY; FLUCTUATIONS; SURVIVAL	Large-scale climatic indices such as the North Atlantic Oscillation(1) are associated with population dynamics(2), variation in demographic rates(3) and values of phenotypic traits(4,5) in many species. Paradoxically, these large-scale indices can seem to be better predictors of ecological processes than local climate(5-8). Using detailed data from a population of Soay sheep(9,10), we show that high rainfall, high winds or low temperatures at any time during a 3-month period can cause mortality either immediately or lagged by a few days. Most measures of local climate used by ecologists fail to capture such complex associations between weather and ecological process, and this may help to explain why large-scale, seasonal indices of climate spanning several months can outperform local climatic factors. Furthermore, we show why an understanding of the mechanism by which climate influences population ecology is important. Through simulation we demonstrate that the timing of bad weather within a period of mortality can have an important modifying influence on intra-specific competition for food, revealing an interaction between climate and density dependence(11) that the use of large-scale climatic indices or inappropriate local weather variables might obscure.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Imperial College London; University of Cambridge; University of Edinburgh	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Coulson, Tim/AAL-8148-2021; Pemberton, Josephine M/F-3100-2010	Coulson, Tim/0000-0001-9371-9003; Hallett, Timothy/0000-0002-9681-0424				ALBON SD, 1983, J ZOOL, V200, P295; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Clutton-Brock TH, 2002, PHILOS T R SOC B, V357, P1285, DOI 10.1098/rstb.2002.1128; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; CLUTTONBROCK TH, 1992, J ANIM ECOL, V61, P381, DOI 10.2307/5330; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Elton CS, 1924, BR J EXP BIOL, V2, P119; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Gaillard JM, 1997, OECOLOGIA, V112, P502, DOI 10.1007/s004420050338; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ILLIUS AW, 2002, 38 S BES HERB PLANTS; Jewell P. A., 1974, ISLAND SURVIVORS ECO; KELLER LF, 1994, ARDEA, V82, P349; MILLONAS M, 1995, FLUCTUATIONS ORDER N; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Mysterud A, 2003, N ATLANTIC OSCILLATI, P235; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1998, J ANIM ECOL, V67, P537, DOI 10.1046/j.1365-2656.1998.00216.x; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Stenseth NC, 1999, P ROY SOC B-BIOL SCI, V266, P1645, DOI 10.1098/rspb.1999.0827; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	28	412	422	6	174	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					71	75		10.1038/nature02708	http://dx.doi.org/10.1038/nature02708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229599				2022-12-01	WOS:000222356800044
J	Dorak, MT; Tang, FM; Penman-Aguilar, A; Westfall, AO; Zulu, I; Lobashevsky, ES; Kancheya, NG; Schaen, MM; Allen, SA; Kaslow, RA				Dorak, MT; Tang, FM; Penman-Aguilar, A; Westfall, AO; Zulu, I; Lobashevsky, ES; Kancheya, NG; Schaen, MM; Allen, SA; Kaslow, RA			Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I; DISCORDANT COUPLES; RESISTANCE; INFECTION	Factors that might increase risk of HIV-1 transmission include age, sex, and amount of HIV-1 RNA in plasma, but findings for HLA allele-sharing are not in agreement. We tested the hypothesis that allele sharing at HLA loci is associated with increased risk of transmission of HIV-1 infection in cohabiting heterosexual Zambian couples. We studied 125 initially serodiscordant partners with sequence-confirmed interpartner HIV-1 transmission and 104 couples who were persistently serodiscordant, and we analysed relations with molecularly typed HLA-A, B, and C alleles by survival techniques. After adjustment for other genetic and non-genetic risk factors seen with heterosexual transmission of HIV-1 in this cohort, sharing of HLA-B alleles was independently associated with accelerated intracouple transmission (relative hazard 2.23, 95% Cl 1.52-3.26, p<0.0001). Selective pressure by HLA-B alleles on transmitted viruses accords with current understanding of the effect of B locus polymorphism in HIV-1 and perhaps other infections.	Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Zambia UAB HIV Res Project, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kaslow, RA (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	rkaslow@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486; Westfall, Andrew/0000-0002-0468-4695	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041530, R01AI041951, R01AI040951, P30AI027767] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI41530, R01-AI41951, R01-AI40951, P30-AI27767] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Liu CL, 2003, J INFECT DIS, V187, P1404, DOI 10.1086/374394; Lockett SF, 2001, J ACQ IMMUN DEF SYND, V27, P277, DOI 10.1097/00126334-200107010-00010; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002	11	48	50	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 26	2004	363	9427					2137	2139		10.1016/S0140-6736(04)16505-7	http://dx.doi.org/10.1016/S0140-6736(04)16505-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832LF	15220037				2022-12-01	WOS:000222268300012
J	Coplan, PM; Mitchnick, M; Rosenberg, ZF				Coplan, PM; Mitchnick, M; Rosenberg, ZF			Regulatory challenges in microbicide development	SCIENCE			English	Editorial Material							HIV; TRANSMISSION; INFECTION		Int Partnership Microbicides, Silver Spring, MD 20910 USA		Coplan, PM (corresponding author), Int Partnership Microbicides, Silver Spring, MD 20910 USA.	PCoplan@ipm-microbicides.org		Coplan, Paul/0000-0002-7078-7780				*DIV ANT DRUG PROD, 2003, MEM ANT DRUGS ADV CO; FARLEY T, 2003, FDA ANT DRUGS ADV CO; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; GUPTA GR, 2004, MICR 2004 C 28 31 MA; Milstien J, 2004, B WORLD HEALTH ORGAN, V82, P128; MILSTIEN J, 2002, DIVERGENCE VACCINE P; RAMJEE G, 2004, HIV PREV TRIALS NETW; *RWAND OFF NAT POP, 2001, DEM HLTH SURV 2000; Shattock R, 2004, LANCET, V363, P1002, DOI 10.1016/S0140-6736(04)15876-5; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; UNAIDS, 2003, AIDS EP UPD; Van Damme L, 2003, LANCET, V361, P786; Watts C, 2001, AIDS, V15, pS43, DOI 10.1097/00002030-200102001-00064; Weber J, 2001, AIDS, V15, P1563, DOI 10.1097/00002030-200108170-00014; *WHO, 2003, HIV AIDS EP SURV UPD; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840; WU T, 2004, MICR 2004 C 28 31 MA	18	26	27	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2004	304	5679					1911	1912		10.1126/science.1100441	http://dx.doi.org/10.1126/science.1100441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218130				2022-12-01	WOS:000222241600025
J	Kissel, J; Krueger, FR; Silen, J; Clark, BC				Kissel, J; Krueger, FR; Silen, J; Clark, BC			The Cometary and Interstellar Dust Analyzer at Comet 81P/Wild 2	SCIENCE			English	Article							ION FORMATION; HALLEY; PARTICLES; WILD-2; IMPACT	The CIDA (Cometary and Interstellar Dust Analyzer) instrument on the Stardust spacecraft is a time-of-flight mass spectrometer used to analyze ions formed when fast dust particles strike the instrument's target. In the spectra of 45 presumably interstellar particles, quinone derivates were identified as constituents in the organic component. The 29 spectra obtained during the flyby of Comet 81P/Wild 2 confirm the predominance of organic matter. In moving from interstellar to cometary dust, the organic material seems to lose most of its hydrogen and oxygen as water and carbon monoxide. These are now present in the comet as gas phases, whereas the dust is rich in nitrogen-containing species. No traces of amino acids were found. We detected sulfur ions in one spectrum, which suggests that sulfur species are important in cometary organics.	Max Planck Inst Aeron, D-37191 Katlenburg, Germany; Finnish Meteorol Inst, SF-00101 Helsinki, Finland; Lockheed Martin Aerosp, Denver, CO 80201 USA; Ingn Bur Krueger, D-64291 Darmstadt, Germany	Max Planck Society; Finnish Meteorological Institute; Lockheed Martin	Kissel, J (corresponding author), Max Planck Inst Aeron, Max Planck Str 2, D-37191 Katlenburg, Germany.							Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; CLARK BC, 1987, ASTRON ASTROPHYS, V187, P779; GREENBERG JM, 1984, SCI AM, V250, P124, DOI 10.1038/scientificamerican0684-124; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kissel J, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002091; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; Kissel J, 2001, RAPID COMMUN MASS SP, V15, P1713, DOI 10.1002/rcm.431; KISSEL J, 1987, APPL PHYS A-MATER, V42, P69, DOI 10.1007/BF00618161; KISSEL J, 1986, NATURE, V321, P336, DOI 10.1038/321336a0; KISSEL J, UNPUB; Krueger FR, 2004, RAPID COMMUN MASS SP, V18, P103, DOI 10.1002/rcm.1291; MCLAFFERTY FW, 1980, INTERPRETATION MASS, P3; SCHULZE H, 1992, METEORITICS, V27, P286; Tuzzolino AJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002086	14	116	117	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1774	1776		10.1126/science.1098836	http://dx.doi.org/10.1126/science.1098836			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205526				2022-12-01	WOS:000222089500037
J	Sekanina, Z; Brownlee, DE; Economou, TE; Tuzzolino, AJ; Green, SF				Sekanina, Z; Brownlee, DE; Economou, TE; Tuzzolino, AJ; Green, SF			Modeling the nucleus and jets of comet 81 P/Wild 2 based on the Stardust encounter data	SCIENCE			English	Article							ROTATION; COMA	We interpret the nucleus properties and jet activity from the Stardust spacecraft imaging and the onboard dust monitoring system data. Triangulation of 20 jets shows that 2 emanate from the nucleus dark side and 16 emanate from sources that are on slopes where the Sun's elevation is greater than predicted from the fitted triaxial ellipsoid. Seven sources, including five in the Mayo depression, coincide with relatively bright surface spots. Fitting the imaged jets, the spikelike temporal distribution of dust impacts indicates that the spacecraft crossed thin, densely populated sheets of particulate ejecta extending from small sources on the rotating nucleus, consistent with an emission cone model.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Univ Chicago, Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle; University of Chicago; Open University - UK	Sekanina, Z (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	zs@sek.jpl.nasa.gov	Green, Simon F/C-7408-2009	Green, Simon F/0000-0002-9153-9786				Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; FARNHAM TL, 2003, B AM ASTRON SOC, V35, P971; Ishiguro M, 2003, ASTROPHYS J, V589, pL101, DOI 10.1086/376440; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; LARSON S, 1978, B AM ASTRON SOC, V10, P589; McBride N, 1997, MON NOT R ASTRON SOC, V289, P535, DOI 10.1093/mnras/289.3.535; Sekanina Z, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002093; SEKANINA Z, 1979, ICARUS, V37, P420, DOI 10.1016/0019-1035(79)90006-X; Sekanina Z, 1998, ASTROPHYS J, V494, pL121, DOI 10.1086/311147; SEKANINA Z, 1981, ANNU REV EARTH PL SC, V9, P113, DOI 10.1146/annurev.ea.09.050181.000553; Sekanina Z., 1982, COMETS, P251; Sekanina Z., 1987, ESA SP, VSP-278, P315; Soderblom LA, 2004, ICARUS, V167, P4, DOI 10.1016/j.icarus.2003.07.008; Tuzzolino AJ, 2004, SCIENCE, V304, P1776, DOI 10.1126/science.1098759; VASUNDHARA R, COMMUNICATION; WHIPPLE FL, 1978, NATURE, V273, P134, DOI 10.1038/273134a0	16	92	92	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1769	1774		10.1126/science.1098388	http://dx.doi.org/10.1126/science.1098388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205525				2022-12-01	WOS:000222089500036
J	Sugrue, LP; Corrado, GS; Newsome, WT				Sugrue, LP; Corrado, GS; Newsome, WT			Matching behavior and the representation of value in the parietal cortex	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; DECISION; ATTENTION; REWARD; CHOICE; SPACE; LAW	Psychologists and economists have long appreciated the contribution of reward history and expectation to decision-making. Yet we know little about how specific histories of choice and reward lead to an internal representation of the "value" of possible actions. We approached this problem through an integrated application of behavioral, computational, and physiological techniques. Monkeys were placed in a dynamic foraging environment in which they had to track the changing values of alternative choices through time. In this context, the monkeys' foraging behavior provided a window into their subjective valuation. We found that a simple model based on reward history can duplicate this behavior and that neurons in the parietal cortex represent the relative value of competing actions predicted by this model.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Sugrue, LP (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	leo@monkeybiz.stanford.edu	Newsome, William T./W-7171-2019					[Anonymous], 2000, CHOICES VALUES FRAME; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Davison M, 2000, J EXP ANAL BEHAV, V74, P1, DOI 10.1901/jeab.2000.74-1; Davison M., 1988, MATCHING LAW RES REV; DEVILLIERS PA, 1976, PSYCHOL BULL, V83, P1131, DOI DOI 10.1037/0033-2909.83.6.1131; DORRIS MC, 2003, SOC NEUR ABSTR, V767, P1; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gallistel CR, 2001, J EXP PSYCHOL ANIM B, V27, P354, DOI 10.1037//0097-7403.27.4.354; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HARLEY CB, 1981, J THEOR BIOL, V89, P611, DOI 10.1016/0022-5193(81)90032-1; Herrnstein R. J., 1980, LIMITS ACTION ALLOCA, P143, DOI DOI 10.1016/B978-0-12-662650-6.50011-8; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HERRNSTEIN RJ, 1991, J ECON PERSPECT, V5, P137, DOI 10.1257/jep.5.3.137; HEYMAN GM, 1979, J EXP ANAL BEHAV, V31, P41, DOI 10.1901/jeab.1979.31-41; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; Maynard Smith J., 1982, pi; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rachlin H., 1997, RJ HERRNSTEIN MATCHI; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; STADDON JER, 1978, PSYCHOL REV, V85, P436, DOI 10.1037/0033-295X.85.5.436; Stephens D.W., 1986, pi	31	703	714	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1782	1787		10.1126/science.1094765	http://dx.doi.org/10.1126/science.1094765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205529				2022-12-01	WOS:000222089500040
J	Steinbrook, R				Steinbrook, R			The cost of admission - Tiered copayments for hospital use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Gabel J, 2003, HEALTH AFFAIR, V22, P117, DOI 10.1377/hlthaff.22.5.117; Kindig, 2004, HLTH LITERACY PRESCR; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; Levit K, 2004, HEALTH AFFAIR, V23, P147, DOI 10.1377/hlthaff.23.1.147; Newhouse JP., 1993, FREE ALL LESSONS RAN	5	11	11	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2004	350	25					2539	2542		10.1056/NEJMp048107	http://dx.doi.org/10.1056/NEJMp048107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829NE	15201407				2022-12-01	WOS:000222054700001
J	Hayashi, T; Boyko, EJ; Leonetti, DL; McNeely, MJ; Newell-Morris, L; Kahn, SE; Fujimoto, WY				Hayashi, T; Boyko, EJ; Leonetti, DL; McNeely, MJ; Newell-Morris, L; Kahn, SE; Fujimoto, WY			Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-FAT DISTRIBUTION; FASTING PLASMA-INSULIN; BLOOD-PRESSURE; ABDOMINAL OBESITY; HEART-DISEASE; PREVALENCE; RISK; MEN; TISSUE; HYPERINSULINEMIA	Background: Visceral adiposity is generally considered to play a key role in the metabolic syndrome. Objective: To examine the relationship between directly measured visceral adiposity and the risk for incident hypertension, independent of other adipose depots and fasting plasma insulin levels. Design: Community-based prospective cohort study with 10- to 11-year follow-up. Setting: King County, Washington. Participants: 300 Japanese Americans with a systolic blood pressure less than 140 mm Hg and a diastolic blood pressure less than 90 mm Hg who were not taking anti hypertensive medications, oral hypoglycemic medications, or insulin at study entry. Measurements: Abdominal, thoracic, and thigh fat areas were measured by using computed tomography. Total subcutaneous fat area was calculated as the sum of these fat areas excluding the intra-abdominal fat area. Hypertension during follow-up was defined as having a systolic blood pressure of 140 mm Hg or greater, having a diastolic blood pressure of 90 mm Hg or greater, or taking anti hypertensive medications. Results: There were 92 incident cases of hypertension during the follow-up period. The intra-abdominal fat area was associated with an increased risk for hypertension. Multiple-adjusted odds ratios of hypertension for quartiles of intra-abdominal fat area (1 = lowest; 4 = highest) were 5.07 (95% CI, 1.75 to 14.73) for quartile 3 and 3.48 (CI, 1.01 to 11.99) for quartile 4 compared with quartile 1 after adjustment for age, sex, fasting plasma insulin level, 2-hour plasma glucose level, body mass index, systolic blood pressure, alcohol consumption, smoking status, and energy expenditure through exercise (P = 0.003 for quadratic trend). The intra-abdominal fat area remained a significant risk factor for hypertension, even after adjustment for total subcutaneous fat area, abdominal subcutaneous fat area, or waist circumference; however, no measure of these fat areas was associated with risk for hypertension in models that contained the intra-abdominal fat area. Limitations: It is not known whether these results pertain to other ethnic groups. Conclusions: Greater visceral adiposity increases the risk for hypertension in Japanese Americans.	Vet Affairs Puget Sound Hlth Care Syst, Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Boyko, EJ (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Epidemiol Res & Informat Ctr, S-152E,1660 S Columbian Way, Seattle, WA 98108 USA.	eboyko@u.washington.edu	Hayashi, Tomoshige/N-8508-2015; Boyko, Edward J/G-2484-2017	Boyko, Edward J/0000-0002-3695-192X; Kahn, Steven/0000-0001-7307-9002	NCRR NIH HHS [RR-00037] Funding Source: Medline; NHLBI NIH HHS [HL-49293] Funding Source: Medline; NIDDK NIH HHS [DK-02654, DK-17047, DK-35816, DK-31170] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, R22DK031170, P30DK017047, R01DK031170, K24DK002654] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Boyko EJ, 1996, INT J OBESITY, V20, P801; BOYKO EJ, 1995, DIABETES CARE, V18, P174, DOI 10.2337/diacare.18.2.174; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Cardillo C, 1999, CIRCULATION, V100, P820, DOI 10.1161/01.CIR.100.8.820; Cassano Patricia A., 1990, Annals of Epidemiology, V1, P33; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; FOLSOM AR, 1990, STROKE, V21, P701, DOI 10.1161/01.STR.21.5.701; FOLSOM AR, 1989, INT J EPIDEMIOL, V18, P361, DOI 10.1093/ije/18.2.361; FUJIMOTO WY, 1994, DIABETOLOGIA, V37, P524, DOI 10.1007/s001250050142; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; FUJIMOTO WY, 1987, DIABETES, V36, P730, DOI 10.2337/diabetes.36.6.730; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gillum RF, 1998, INT J OBESITY, V22, P127, DOI 10.1038/sj.ijo.0800554; Glantz SA., 1990, PRIMER APPL REGRESSI, P181; GUPTA AK, 1992, HYPERTENSION, V19, pI78, DOI 10.1161/01.HYP.19.1_Suppl.I78; HAFFNER SM, 1992, DIABETES CARE, V15, P1277, DOI 10.2337/diacare.15.10.1277; Haffner SM, 1996, ARCH INTERN MED, V156, P1994, DOI 10.1001/archinte.156.17.1994; Han TS, 1997, INT J OBESITY, V21, P1161, DOI 10.1038/sj.ijo.0800530; Hayashi T, 2003, CIRCULATION, V108, P1718, DOI 10.1161/01.CIR.0000087597.59169.8D; Hosmer D.W., 2000, WILEY PS TX, DOI 10.1002/0471722146; JOHNSON D, 1992, INT J OBESITY, V16, P881; KANAI H, 1990, HYPERTENSION, V16, P484, DOI 10.1161/01.HYP.16.5.484; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; KLEINBAUM DG, 1994, LOGISTIC REGRESSION, P191; Landsberg L, 2001, J HYPERTENS, V19, P523, DOI 10.1097/00004872-200103001-00001; Leonetti Donna L., 1992, Ethnicity and Disease, V2, P326; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; McNeely MJ, 1999, OBES RES S1, V7, p47S; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; Okosun IS, 1999, J HUM HYPERTENS, V13, P425, DOI 10.1038/sj.jhh.1000862; Poli KA, 2000, CIRCULATION, V101, P264, DOI 10.1161/01.CIR.101.3.264; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; SHETTERLY SM, 1994, J HYPERTENS, V12, P1095; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; SHUMAN WP, 1986, INVEST RADIOL, V21, P483, DOI 10.1097/00004424-198606000-00007; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wannamethee SG, 2003, ARCH INTERN MED, V163, P1329, DOI 10.1001/archinte.163.11.1329; Warnick G R, 1986, Methods Enzymol, V129, P101	44	205	216	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2004	140	12					992	1000		10.7326/0003-4819-140-12-200406150-00008	http://dx.doi.org/10.7326/0003-4819-140-12-200406150-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829NK	15197016				2022-12-01	WOS:000222055500002
J	Papp, B; Pal, C; Hurst, LD				Papp, B; Pal, C; Hurst, LD			Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast	NATURE			English	Article							ESCHERICHIA-COLI MG1655; POST-GENOME ERA; SACCHAROMYCES-CEREVISIAE; GENETIC ROBUSTNESS; DUPLICATE GENES; NULL MUTATIONS; PATHWAYS; DATABASE	Under laboratory conditions 80% of yeast genes seem not to be essential for viability(1). This raises the question of what the mechanistic basis for dispensability is, and whether it is the result of selection for buffering or an incidental side product. Here we analyse these issues using an in silico flux model(2-5) of the yeast metabolic network. The model correctly predicts the knockout fitness effects in 88% of the genes studied(4) and in vivo fluxes. Dispensable genes might be important, but under conditions not yet examined in the laboratory. Our model indicates that this is the dominant explanation for apparent dispensability, accounting for 37 - 68% of dispensable genes, whereas 15 - 28% of them are compensated by a duplicate, and only 4 - 17% are buffered by metabolic network flux reorganization. For over one-half of those not important under nutrient-rich conditions, we can predict conditions when they will be important. As expected, such condition-specific genes have a more restricted phylogenetic distribution. Gene duplicates catalysing the same reaction are not more common for indispensable reactions, suggesting that the reason for their retention is not to provide compensation. Instead their presence is better explained by selection for high enzymatic flux.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary; Eotvos Lorand Univ, MTA, Ecol & Theoret Biol Res Grp, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Papp, Balazs/0000-0003-3093-8852				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Nakao, 1999, Genome Inform Ser Workshop Genome Inform, V10, P94; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x	29	273	279	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2004	429	6992					661	664		10.1038/nature02636	http://dx.doi.org/10.1038/nature02636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190353				2022-12-01	WOS:000221912600041
J	Hungate, BA; Stiling, PD; Dijkstra, P; Johnson, DW; Ketterer, ME; Hymus, GJ; Hinkle, CR; Drake, BG				Hungate, BA; Stiling, PD; Dijkstra, P; Johnson, DW; Ketterer, ME; Hymus, GJ; Hinkle, CR; Drake, BG			CO2 elicits long-term decline in nitrogen fixation	SCIENCE			English	Article							GROWTH		No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA; Univ S Florida, Dept Biol, Tampa, FL 33620 USA; Univ Nevada, Dept Biol, Reno, NV 89557 USA; Smithsonian Environm Res Ctr, Edgewater, MD 21038 USA; Dynamac Corp, Kennedy Space Ctr, FL 32899 USA	Northern Arizona University; Northern Arizona University; Northern Arizona University; State University System of Florida; University of South Florida; Nevada System of Higher Education (NSHE); University of Nevada Reno; Smithsonian Institution; Smithsonian Environmental Research Center; Dynamac Corporation	Hungate, BA (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	bruce.hungate@nau.edu	Hungate, Bruce/F-8991-2011	Hungate, Bruce/0000-0002-7337-1887				Gifford RM, 1996, PLANT SOIL, V187, P369, DOI 10.1007/BF00017101; HAFNER H, 1992, FERT RES, V31, P69, DOI 10.1007/BF01064229; Houghton J. T., 2001, CLIMATE CHANGE 2001; POORTER H, 1993, VEGETATIO, V104, P77, DOI 10.1007/BF00048146; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743	5	134	143	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2004	304	5675					1291	1291		10.1126/science.1095549	http://dx.doi.org/10.1126/science.1095549			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166370	Green Submitted			2022-12-01	WOS:000221669600044
J	Sordella, R; Bell, DW; Haber, DA; Settleman, J				Sordella, R; Bell, DW; Haber, DA; Settleman, J			Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE PROGRESSION; RAS/RAF/MEK/ERK PATHWAY; TYROSINE KINASE; INHIBITOR; ZD1839; TRIAL	Gefitinib (Iressa, AstraZeneca Pharmaceuticals) is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and induces dramatic clinical responses in nonsmall. cell lung cancers (NSCLCs) with activating mutations within the EGFR kinase domain. We report that these mutant EGFRS selectively activate Akt and signal transduction and activator of transcription (STAT) signaling pathways, which promote cell survival, but have no effect on extracellular signal-regulated kinase signaling which induces proliferation. NSCLC cells expressing mutant EGFRs underwent extensive apoptosis after small interfering RNA-mediated knockdown of the mutant EGFR or treatment with pharmacological inhibitors of Akt and STAT signaling and were relatively resistant to apoptosis induced by conventional chemotherapeutic drugs. Thus, mutant EGFRs selectively transduce survival signals on which NSCLCs become dependent, inhibition of those signals by gefitinib may contribute to the drug's efficacy.	Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Bldg 149,13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu			PHS HHS [P01 95281] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chang FM, 2003, INT J ONCOL, V22, P469; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kindler T, 2003, LEUKEMIA, V17, P999, DOI 10.1038/sj.leu.2402940; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paner GP, 2003, ANTICANCER RES, V23, P2253; SORDELLA R, UNPUB; Wakeling AE, 2002, CANCER RES, V62, P5749; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	19	1353	1450	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1163	1167		10.1126/science.1101637	http://dx.doi.org/10.1126/science.1101637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15284455				2022-12-01	WOS:000223557400051
J	Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB				Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB			Initial results from the Mini-TES experiment in Gusev crater from the Spirit rover	SCIENCE			English	Article							THERMAL EMISSION-SPECTROSCOPY; ROCKS; TERRESTRIAL	The Miniature Thermal Emission Spectrometer (Mini-TES) on Spirit has studied the mineralogy and thermophysical properties at Gusev crater. Undisturbed soil spectra show evidence for minor carbonates and bound water. Rocks are olivine-rich basalts with varying degrees of dust and other coatings. Dark-toned soils observed on disturbed surfaces may be derived from rocks and have derived mineralogy (+/- 5 to 10%) of 45% pyroxene (20% Ca-rich pyroxene and 25% pigeonite), 40% sodic to intermediate plagioclase, and 15% olivine (forsterite 45% +/- 5 to 10). Two spectrally distinct coatings are observed on rocks, a possible indicator of the interaction of water, rock, and airfall dust. Diurnal temperature data indicate particle sizes from 40 to 80 mum in hollows to similar to0.5 to 3 mm in soils.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Martinez, GA 30907 USA	Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Hawaii System; Cornell University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Rogers, A. Deanne/ABE-8469-2021; Glotch, Timothy/B-6829-2008; Blaney, Diana/M-1756-2019; Moersch, Jeffrey E/F-7189-2010; Smith, Michael/C-8875-2012; Johnson, Jeffrey R/F-3972-2015; Hayes, Alexander G/P-2024-2014; Rogers, Deanne/I-9737-2016	Rogers, A. Deanne/0000-0002-4671-2551; Blaney, Diana/0000-0002-4267-7939; Moersch, Jeffrey E/0000-0003-3433-9419; Johnson, Jeffrey R/0000-0002-5586-4901; Hayes, Alexander G/0000-0001-6397-2630; Rogers, Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bishop JL, 2004, ICARUS, V169, P311, DOI 10.1016/j.icarus.2003.12.025; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; CHRISTENSEN PR, 1993, J GEOPHYS RES-SOL EA, V98, P19819, DOI 10.1029/93JB00135; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2003, J GEOPHYS RES, V198; CICCOLLELA SM, 2003, P LUNAR PLANET SCI, V34, P1836; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1973, J GEOPHYS RES, V78, P4291, DOI 10.1029/JB078i020p04291; LANE MD, 2004, P LUNAR PLANET SCI, V35; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; Smith M.R., UNPUB; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	26	138	140	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					837	842		10.1126/science.1100564	http://dx.doi.org/10.1126/science.1100564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297667				2022-12-01	WOS:000223104900040
J	Fine, PVA; Mesones, I; Coley, PD				Fine, PVA; Mesones, I; Coley, PD			Herbivores promote habitat specialization by trees in amazonian forests	SCIENCE			English	Article							RAIN-FOREST; RECRUITMENT; VEGETATION; DIVERSITY; PATTERNS; STRESS; SHRUB	In an edaphically heterogeneous area in the Peruvian Amazon, clay soils and nutrient-poor white sands each harbor distinctive plant communities. To determine whether a trade-off between growth and antiherbivore defense enforces habitat specialization on these two soil types, we conducted a reciprocal transplant study of seedlings of 20 species from six genera of phylogenetically independent pairs of edaphic specialist trees and manipulated the presence of herbivores. Clay specialist species grew significantly faster than white-sand specialists in both soil types when protected from herbivores. However, when unprotected, white-sand specialists dominated in white-sand forests and clay specialists dominated in clay forests. Therefore, habitat specialization in this system results from an interaction of herbivore pressure with soil type.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Field Museum Nat Hist, Environm Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Conservat Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Nacl Amazonia Peruana, Dept Forestry, Iquitos, Peru	Utah System of Higher Education; University of Utah; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Universidad Nacional de la Amazonia Peruana	Fine, PVA (corresponding author), Univ Utah, Dept Biol, 257 S 1400 East, Salt Lake City, UT 84112 USA.	fine@biology.utah.edu		Fine, Paul/0000-0002-0550-5628				CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Cobb NS, 1997, OECOLOGIA, V109, P389, DOI 10.1007/s004420050098; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Coomes DA, 1996, VEGETATIO, V122, P167, DOI 10.1007/BF00044699; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Endler J.A., 1977, Monographs in Population Biology, pi; FINE PVA, UNPUB; GARCIAVILLACORT.R, 2002, FOLIA AMAZONICA, V14, P11; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gentry AH, 1986, CONSERVATION BIOL SC, P153; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; Harper J. L., 1977, Population biology of plants.; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Jorgensen P.M., 1999, CATALOGUE VASCULAR P; King RT, 2003, BIOTROPICA, V35, P462, DOI 10.1111/j.1744-7429.2003.tb00603.x; Louda S. M., 1990, Perspectives on plant competition., P413; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; LOUDA SM, 1983, ECOLOGY, V64, P511, DOI 10.2307/1939971; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Mark AF, 2001, AUSTRAL ECOL, V26, P423, DOI 10.1046/j.1442-9993.2001.01127.x; MCKEY D, 1978, SCIENCE, V202, P61; Medina E., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P217; Moran JA, 2000, BIOTROPICA, V32, P2, DOI 10.1111/j.1744-7429.2000.tb00442.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; PARKER MA, 1981, ECOLOGY, V62, P1390, DOI 10.2307/1937302; Proctor John, 1999, Botanical Journal of Scotland, V51, P1; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K., 1998, GEOECOLOGIA DESARROL, P253; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Vasquez R, 1997, FLORULA RESERVAS BIO; YOUNG KR, 1989, BRITTONIA, V41, P388, DOI 10.2307/2807552	38	391	407	6	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					663	665		10.1126/science.1098982	http://dx.doi.org/10.1126/science.1098982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286371				2022-12-01	WOS:000222992100046
J	Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC				Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC			Pinpointing the source of a lunar meteorite: Implications for the evolution of the moon	SCIENCE			English	Article							PROCELLARUM KREEP TERRANE; IMPACT-MELT BRECCIAS; ABSOLUTE AGES; SURFACE	The lunar meteorite Sayh al Uhaymir 169 consists of an impact melt breccia extremely enriched with potassium, rare earth elements, and phosphorus [thorium, 32.7 parts per million (ppm); uranium, 8.6 ppm; potassium oxide, 0.54 weight percent], and adherent regolith. The isotope systematics of the meteorite record four lunar impact events at 3909 +/- 13 million years ago (Ma), similar to 2800 Ma, similar to 200 Ma, and < 0.34 Ma, and collision with Earth sometime after 9.7 &PLUSMN; 1.3 thousand years ago. With these data, we can link the impact-melt breccia to Imbrium and pinpoint the source region of the meteorite to the Lalande impact crater.	Univ Bern, Inst Geol, CH-3012 Bern, Switzerland; Nat Hist Museum Burgergemeinde Bern, CH-3005 Bern, Switzerland; Univ Bern, Inst Phys, Abt Weltraumforsch & Planetol, CH-3012 Bern, Switzerland; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden; Univ Arizona, Natl Sci Fdn, Arizona Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Max Planck Inst Chem, Abt Kosmochem, D-55020 Mainz, Germany; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Bern; University of Bern; Swedish Museum of Natural History; National Science Foundation (NSF); University of Arizona; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society; University of Bern; Open University - UK	Gnos, E (corresponding author), Univ Bern, Inst Geol, Baltzerstr 1, CH-3012 Bern, Switzerland.	gnos@geo.unibe.ch	Lorenzetti, Silvio Rene/B-1188-2009; Whitehouse, Martin J/E-1425-2013; Gnos, Edwin/AAI-7477-2020	Lorenzetti, Silvio Rene/0000-0002-8339-8960; Whitehouse, Martin J/0000-0003-2227-577X; Gnos, Edwin/0000-0003-0940-8435; Greenwood, Richard/0000-0002-5544-8027; Hofmann, Beda/0000-0003-2738-8466				BALDWIN RB, 1985, ICARUS, V61, P63, DOI 10.1016/0019-1035(85)90156-3; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Dalrymple GB, 1996, J GEOPHYS RES-PLANET, V101, P26069, DOI 10.1029/96JE02806; ELPHIC RC, 2002, J GEOPHYS RES, V107, pE4; EUGSTER O, 1995, GEOCHIM COSMOCHIM AC, V59, P177, DOI 10.1016/0016-7037(94)00327-I; Feldman M., 2001, NATL IDENTITIES, V3, P5; Haskin LA, 2000, J GEOPHYS RES-PLANET, V105, P20403, DOI 10.1029/1999JE001128; Heiken G., 1991, LUNAR SOURCE BOOK US; HOHENBERG CM, 1978, P LUNAR PLANET SCI C, V9, P2311; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Jolliff BL, 1998, INT GEOL REV, V40, P916, DOI 10.1080/00206819809465245; Korotev RL, 2000, J GEOPHYS RES-PLANET, V105, P4317, DOI 10.1029/1999JE001063; Lawrence DJ, 1999, GEOPHYS RES LETT, V26, P2681, DOI 10.1029/1999GL008361; METZGER AE, 1973, SCIENCE, V179, P800, DOI 10.1126/science.179.4075.800; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Russell SS, 2003, METEORIT PLANET SCI, V38, pA189, DOI 10.1111/j.1945-5100.2003.tb00328.x; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; TUNIZ C, 1983, GEOPHYS RES LETT, V10, P804, DOI 10.1029/GL010i009p00804; WARREN PH, 1994, ICARUS, V111, P338, DOI 10.1006/icar.1994.1149; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348, P1	23	119	127	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					657	659		10.1126/science.1099397	http://dx.doi.org/10.1126/science.1099397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286369				2022-12-01	WOS:000222992100044
J	Reed, D				Reed, D			Paralysis, Roman Reed, and a ban on stem-cell research	LANCET			English	Editorial Material												diverdonreed@pacbell.net							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					219	219		10.1016/S0140-6736(04)16639-7	http://dx.doi.org/10.1016/S0140-6736(04)16639-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15246739				2022-12-01	WOS:000222612200037
J	Geisbrecht, ER; Montell, DJ				Geisbrecht, ER; Montell, DJ			A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration	CELL			English	Article							RHO-GTPASES; GERM-CELLS; PROTEIN; APOPTOSIS; SURVIVAL; DEATH; NUCLEATION; POLARITY; PROFILIN; MOTILITY	Border cell migration in the Drosophila ovary is a relatively simple and genetically tractable model for studying the conversion of epithelial cells to migratory cells. Like many cell migrations, border cell migration is inhibited by a dominant-negative form of the GTPase Rac. To identify new genes that function in Rac-dependent cell motility, we screened for genes that when overexpressed suppressed the migration defect caused by dominant-negative Rac. Overexpression of the Drosophila inhibitor of apoptosis 1 (DIAP1), which is encoded by the thread (th) gene, suppressed the migration defect. Moreover, loss-of-function mutations in th caused migration defects but, surprisingly, did not cause apoptosis. Mutations affecting the Dark protein, an activator of the upstream caspase Dronc, also rescued RacN17 migration defects. These results indicate an apoptosis-independent role for DIAP1-mediated Dronc inhibition in Rac-mediated cell motility.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046425, R01GM046425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRAND AH, 1993, DEVELOPMENT, V118, P401; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feldner JC, 2002, EXP CELL RES, V272, P93, DOI 10.1006/excr.2001.5385; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HARDEN N, 1995, DEVELOPMENT, V121, P903; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Settleman J, 1999, Prog Mol Subcell Biol, V22, P201; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208; Zhang BL, 2003, MOL CELL BIOL, V23, P5716, DOI 10.1128/MCB.23.16.5716-5725.2003; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang N, 1996, GENETICS, V143, P1231	54	151	155	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 9	2004	118	1					111	125		10.1016/j.cell.2004.06.020	http://dx.doi.org/10.1016/j.cell.2004.06.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837JW	15242648	Bronze			2022-12-01	WOS:000222626800012
J	Steinman, RM; Mellman, I				Steinman, RM; Mellman, I			Immunotherapy: Bewitched, bothered, and bewildered no more	SCIENCE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSES; SHEDDING LIGHT; CANCER; THERAPY; INTERLEUKIN-2; IMMUNOLOGY; STRATEGIES; CARCINOMA	The field of immunotherapy holds clear promise not only for the development of new approaches to cancer and other diseases, but also for providing fundamental insight into the human immune response. In order for this promise to be realized, however, the scientific community must overcome an array of challenges. These challenges reflect not only the difficulties inherent in conducting investigations in human patients, but also difficulties created by the culture and practice of our own institutions, reward structure, and funding mechanisms. We suggest steps to be taken to reinvigorate basic research in human subjects as part of the mainstream of science.	Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Rockefeller University; Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University	Steinman, RM (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10021 USA.	steinma@mail.rockefeller.edu	Mellman, Ira/ABG-5896-2020; Steinman, Ralph/F-7729-2012					Banchereau J, 2001, CELL, V106, P271, DOI 10.1016/S0092-8674(01)00448-2; Beck-Engeser GB, 2001, J EXP MED, V194, P285, DOI 10.1084/jem.194.3.285; Bell J, 2003, J EXP MED, V198, P1621, DOI 10.1084/jem.20031882; Bell J, 2003, BRIT MED J, V327, P1041, DOI 10.1136/bmj.327.7422.1041; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cerundolo V, 2004, NAT IMMUNOL, V5, P7, DOI 10.1038/ni0104-7; Coulie PG, 2003, CURR OPIN IMMUNOL, V15, P131, DOI 10.1016/S0952-7915(03)00009-8; Dhodapkar MV, 2003, J EXP MED, V198, P1753, DOI 10.1084/jem.20031030; Dhodapkar MV, 2002, P NATL ACAD SCI USA, V99, P13009, DOI 10.1073/pnas.202491499; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Finn OJ, 2003, J EXP MED, V198, P1623, DOI 10.1084/jem.20031787; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; Hall S. S., 1998, COMMOTION BLOOD; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Jager D, 2004, CANCER IMMUNOL IMMUN, V53, P144, DOI 10.1007/s00262-003-0470-z; Levitsky HI, 2000, CANCER J, V6, pS281; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; PARKINSON DR, 1990, J CLIN ONCOL, V8, P1630, DOI 10.1200/JCO.1990.8.10.1630; Perales MA, 2002, SEMIN CANCER BIOL, V12, P63, DOI 10.1006/scbi.2001.0397; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Rosenberg SA, 2004, NEW ENGL J MED, V350, P1461, DOI 10.1056/NEJMcibr045001; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; SPARANO JA, 1993, J CLIN ONCOL, V11, P1969, DOI 10.1200/JCO.1993.11.10.1969; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi T, 2003, INT REV CYTOL, V225, P1, DOI 10.1016/S0074-7696(05)25001-5; Triendl R, 2004, NAT REV IMMUNOL, V4, P72, DOI 10.1038/nri1259; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Yee C, 2002, NAT REV CANCER, V2, P409, DOI 10.1038/nrc820; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	37	106	118	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					197	200		10.1126/science.1099688	http://dx.doi.org/10.1126/science.1099688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247468				2022-12-01	WOS:000222501000039
J	Steinbrook, R				Steinbrook, R			Global health - The AIDS epidemic in 2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2004, WORLD HLTH REP 2004; CHASE M, 2004, WALL STREET J   0706, pA1; Joint United Nations Program on HIV/AIDS, 2004, 2004 REP GLOB AIDS E; LaFraniere S., 2004, NY TIMES, pA1	4	36	46	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2004	351	2					115	117		10.1056/NEJMp048156	http://dx.doi.org/10.1056/NEJMp048156			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835GM	15247349				2022-12-01	WOS:000222470700001
J	Brugha, R; Donoghue, M; Starling, M; Ndubani, P; Ssengooba, F; Fernandes, B; Walt, G				Brugha, R; Donoghue, M; Starling, M; Ndubani, P; Ssengooba, F; Fernandes, B; Walt, G			The Global Fund: managing great expectations	LANCET			English	Article								The Global Fund to fight AIDS, Tuberculosis, and Malaria was created to increase funds to combat these three devastating diseases. We report interim findings, based on interviews with 137 national-level respondents that track early implementation processes in four African countries. Country coordinating mechanisms (CCMs) are country-level partnerships, which were formed quickly to develop and submit grant proposals to the Global Fund. CCM members were often ineffective at representing their constituencies and encountered obstacles in participating in CCM processes. Delay in dissemination of guidelines from the Global Fund led to uncertainty among members about the function of these new partnerships. Respondents expressed most concern about the limited capacity of fund recipients-government and non-government-to meet Global Fund conditions for performance-based disbursement. Delays in payment of funds to implementing agencies have frustrated rapid financing of disease control interventions. The Global Fund is one of several new global initiatives superimposed on existing country systems to finance the control of HIV/AIDS. New and existing donors need to coordinate assistance to developing countries by bringing together funding, planning, management, and reporting systems if global goals for disease control are to be achieved.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth Policy, London WC1E 7HT, England; Univ Zambia, Inst Econ & Social Res, Lusaka, Zambia; Makerere Univ, Inst Publ Hlth, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of Zambia; Makerere University	Brugha, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth Policy, Keppel St, London WC1E 7HT, England.	Ruairi.brugha@lshtm.ac.uk	Ndubani, Phillimon/AAB-3724-2020; Brugha, Ruairi/C-8420-2012	Brugha, Ruairi/0000-0003-0729-0197; Ssengooba, Freddie/0000-0003-3489-0745				[Anonymous], TUB MAL; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Cassels A, 1998, LANCET, V352, P1777, DOI 10.1016/S0140-6736(98)05350-1; *COMM MACR HLTH, 2002, DEV ASS HLTH REP WOR; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; *GAO, 2003, TB MAL ADV KEY AR DI; *GLOB FUND FIGHT A, 2003, TUB MAL PARTN PREV T; *GLOB FUND FIGHT A, 2003, TUB MAL GUID PERF BA; *GLOB FUND FIGHT A, 2002, 1 BOARD M JAN 28 29; *GLOB FUND FIGHT A, 2003, TUB MAL GUID PURP ST; *GLOB FUND FIGHT A, 2004, GFB73 GLOB FUND FIGH; GRACE C, 2003, GLOBAL FUND COUNTRY; Hanson K, 2003, J INT DEV, V15, P1, DOI DOI 10.1002/JID.963; OECD, 2003, DAC GUID REF SER HAR; VENETSANOU E, 2003, UNPUB IN DEPTH ASSES	15	77	78	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	2004	364	9428					95	100		10.1016/S0140-6736(04)16595-1	http://dx.doi.org/10.1016/S0140-6736(04)16595-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234862				2022-12-01	WOS:000222392900037
J	Dujon, B; Sherman, D; Fischer, G; Durrens, P; Casaregola, S; Lafontaine, I; de Montigny, J; Marck, C; Neuveglise, C; Talla, E; Goffard, N; Frangeul, L; Aigle, M; Anthouard, V; Babour, A; Barbe, V; Barnay, S; Blanchin, S; Beckerich, JM; Beyne, E; Bleykasten, C; Boisrame, A; Boyer, J; Cattolico, L; Confanioleri, F; de Daruvar, A; Despons, L; Fabre, E; Fairhead, C; Ferry-Dumazet, H; Groppi, A; Hantraye, F; Hennequin, C; Jauniaux, N; Joyet, P; Kachouri, R; Kerrest, A; Koszul, R; Lemaire, M; Lesur, I; Ma, L; Muller, H; Nicaud, JM; Nikolski, M; Oztas, S; Ozier-Kalogeropoulos, O; Pellenz, S; Potier, S; Richard, GF; Straub, ML; Suleau, A; Swennen, D; Tekaia, F; Wesolowski-Louvel, M; Westhof, E; Wirth, B; Zeniou-Meyer, M; Zivanovic, I; Bolotin-Fukuhara, M; Thierry, A; Bouchier, C; Caudron, B; Scarpelli, C; Gaillardin, C; Weissenbach, J; Wincker, P; Souciet, JL				Dujon, B; Sherman, D; Fischer, G; Durrens, P; Casaregola, S; Lafontaine, I; de Montigny, J; Marck, C; Neuveglise, C; Talla, E; Goffard, N; Frangeul, L; Aigle, M; Anthouard, V; Babour, A; Barbe, V; Barnay, S; Blanchin, S; Beckerich, JM; Beyne, E; Bleykasten, C; Boisrame, A; Boyer, J; Cattolico, L; Confanioleri, F; de Daruvar, A; Despons, L; Fabre, E; Fairhead, C; Ferry-Dumazet, H; Groppi, A; Hantraye, F; Hennequin, C; Jauniaux, N; Joyet, P; Kachouri, R; Kerrest, A; Koszul, R; Lemaire, M; Lesur, I; Ma, L; Muller, H; Nicaud, JM; Nikolski, M; Oztas, S; Ozier-Kalogeropoulos, O; Pellenz, S; Potier, S; Richard, GF; Straub, ML; Suleau, A; Swennen, D; Tekaia, F; Wesolowski-Louvel, M; Westhof, E; Wirth, B; Zeniou-Meyer, M; Zivanovic, I; Bolotin-Fukuhara, M; Thierry, A; Bouchier, C; Caudron, B; Scarpelli, C; Gaillardin, C; Weissenbach, J; Wincker, P; Souciet, JL			Genome evolution in yeasts	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR EVOLUTION; INTERACTION NETWORK; GENE ORDER; SEQUENCE; DUPLICATION; ARABIDOPSIS; FEATURES; REGIONS; RICE	Identifying the mechanisms of eukaryotic genome evolution by comparative genomics is often complicated by the multiplicity of events that have taken place throughout the history of individual lineages, leaving only distorted and superimposed traces in the genome of each living organism. The hemiascomycete yeasts, with their compact genomes, similar lifestyle and distinct sexual and physiological properties, provide a unique opportunity to explore such mechanisms. We present here the complete, assembled genome sequences of four yeast species, selected to represent a broad evolutionary range within a single eukaryotic phylum, that after analysis proved to be molecularly as diverse as the entire phylum of chordates. A total of approximately 24,200 novel genes were identified, the translation products of which were classified together with Saccharomyces cerevisiae proteins into about 4,700 families, forming the basis for interspecific comparisons. Analysis of chromosome maps and genome redundancies reveal that the different yeast lineages have evolved through a marked interplay between several distinct molecular mechanisms, including tandem gene repeat formation, segmental duplication, a massive genome duplication and extensive gene loss.	Univ Strasbourg, Lab Dynam Evolut & Express Genomes Microorganisme, CNRS, FRE 2326, F-67000 Strasbourg, France; Univ Paris 06, CNRS, UFR 927, Unite Genet Mol Levures, F-75724 Paris 15, France; Univ Paris 06, CNRS, URA 2171, Unite Genet Mol Levures, F-75724 Paris 15, France; Pasteur Genopole Ile de France, Plate Forme Genom, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, Unite Genet Interact Macormol, F-75724 Paris 15, France; Inst Pasteur, Grp Logiciels & Banques Donnees, F-75724 Paris 15, France; LaBRI, CNRS, UMR 5800, F-33405 Talence, France; Univ Bordeaux 2, Ctr Bioinformat Bordeaux, F-33076 Bordeaux, France; Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; INAPG, INRA, UMR 216, Collect Levures Interet Biotechnol, F-78850 Thiverval Grignon, France; INAPG, INRA, UMR 216, Lab Genet Mol & Cellulaire, F-78850 Thiverval Grignon, France; INAPG, CNRS, URA 1925, F-78850 Thiverval Grignon, France; CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France; CNRS, UMR 8030, F-91057 Evry, France; Univ Paris 11, Inst Genet Mol, CNRS, UMR 8621, F-91405 Orsay, France; CNRS, UPR 9002, IBMC, F-67000 Strasbourg, France; Univ Lyon 1, CNRS, UMR 5122, Lab Genet Levures, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dujon, B (corresponding author), Univ Strasbourg, Lab Dynam Evolut & Express Genomes Microorganisme, CNRS, FRE 2326, 28 Rue Goethe, F-67000 Strasbourg, France.	bdujon@pasteur.fr; souciet@gem.u-strasbg.fr	Fischer, Gilles/Q-4603-2019; Dujon, Bernard A/F-4971-2010; Fairhead, Cecile/D-9011-2014; Tekaia, Fredj/H-4553-2012; Goffard, Nicolas/A-1759-2011; BRIAND-SULEAU, Audrey/A-9956-2019; Lafontaine, Ingrid/F-4588-2017; Frangeul, Lionel/G-3617-2015; NICAUD, Jean-marc/ABA-9076-2021; Nicaud, jean marc/G-4204-2016; Hennequin, Christophe/AAF-2755-2021; Briand-Suleau, Audrey/O-8620-2017; Richard, Guy-Franck/ABB-9185-2021; Dujon, Bernard/AAL-8410-2021; Fischer, Gilles/G-6654-2016; Swennen, Dominique/T-4544-2017	Fischer, Gilles/0000-0001-5732-2682; Lafontaine, Ingrid/0000-0003-4544-8055; Nicaud, jean marc/0000-0002-6679-972X; Hennequin, Christophe/0000-0002-4528-927X; Dujon, Bernard/0000-0003-4661-3534; Bolotin-Fukuhara, Monique/0000-0002-5285-5006; Fairhead, Cecile/0000-0002-0456-0377; Swennen, Dominique/0000-0002-9370-5717; Despons, Laurence/0000-0002-9414-7585; Sherman, David James/0000-0002-2316-1005; Koszul, Romain/0000-0002-3086-1173; FABRE, Emmanuelle/0000-0002-0009-4604; Lionel, Frangeul/0000-0002-0992-8775; Groppi, Alexis/0000-0002-3341-8281; Tekaia, Fredj/0000-0003-1934-2396; Neuveglise, Cecile/0000-0001-5017-7830; TALLA, Emmanuel/0000-0002-7775-8296; Richard, Guy-Franck/0000-0002-8233-3532; Babour, Anna/0000-0002-0212-3528; Barnay-Verdier, Stephanie/0000-0002-4615-3059				AMANATIDES PG, 2000, SCIENCE, V287, P2185; [Anonymous], 1998, YEASTS TAXONOMIC STU; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bon E, 2003, NUCLEIC ACIDS RES, V31, P1121, DOI 10.1093/nar/gkg213; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; Frangeul L, 2004, BIOINFORMATICS, V20, P790, DOI 10.1093/bioinformatics/btg490; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; LALO D, 1993, CR ACAD SCI III-VIE, V316, P367; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STEPHEN A, 2002, SCIENCE, V296, P92; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	34	1216	4329	8	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2004	430	6995					35	44		10.1038/nature02579	http://dx.doi.org/10.1038/nature02579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	833RP	15229592				2022-12-01	WOS:000222356800036
J	Lilley, BN; Ploegh, HL				Lilley, BN; Ploegh, HL			A membrane protein required for dislocation of misfolded proteins from the ER	NATURE			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; TO-CYTOSOL DISLOCATION; I HEAVY-CHAINS; QUALITY-CONTROL; RETRO-TRANSLOCATION; SIGNAL PEPTIDE; PROTEASOME; TRANSPORT; REVEALS; YEAST	After insertion into the endoplasmic reticulum ( ER), proteins that fail to fold there are destroyed. Through a process termed dislocation such misfolded proteins arrive in the cytosol, where ubiquitination, deglycosylation and finally proteasomal proteolysis dispense with the unwanted polypeptides. The machinery involved in the extraction of misfolded proteins from the ER is poorly defined. The human cytomegalovirus-encoded glycoproteins US2 and US11 catalyse the dislocation of class I major histocompatibility complex (MHC) products, resulting in their rapid degradation. Here we show that US11 uses its transmembrane domain to recruit class I MHC products to a human homologue of yeast Der1p, a protein essential for the degradation of a subset of misfolded ER proteins. We show that this protein, Derlin-1, is essential for the degradation of class I MHC molecules catalysed by US11, but not by US2. We conclude that Derlin-1 is an important factor for the extraction of certain aberrantly folded proteins from the mammalian ER.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ploegh, HL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	ploegh@hms.harvard.edu						Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; GREEN N, 1998, CURRENT PROTOCOLS CE; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kinter M., 2000, PROTEIN SEQUENCING I; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; PLOEGH HL, 1995, CURRENT PROTOCOLS SC; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; SAWIN KE, 1992, J CELL SCI, V101, P303; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsukahara M, 2001, DEV GROWTH DIFFER, V43, P285; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; YE Y, NATURE; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ying H, 2001, BIOCHEM BIOPH RES CO, V286, P394, DOI 10.1006/bbrc.2001.5390	48	542	555	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2004	429	6994					834	840		10.1038/nature02592	http://dx.doi.org/10.1038/nature02592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	831RE	15215855				2022-12-01	WOS:000222213000032
J	Balague, F				Balague, F			Do not dismiss intense pain	LANCET			English	Editorial Material									Hop Cantonal Fribourg, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland		Balague, F (corresponding author), Hop Cantonal Fribourg, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 19	2004	363	9426					2021	2021		10.1016/S0140-6736(04)16450-7	http://dx.doi.org/10.1016/S0140-6736(04)16450-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830YJ	15207951				2022-12-01	WOS:000222159800007
J	Jordan, MB; Mills, DM; Kappler, J; Marrack, P; Cambier, JC				Jordan, MB; Mills, DM; Kappler, J; Marrack, P; Cambier, JC			Promotion of B cell immune responses via an alum-induced myeloid cell population	SCIENCE			English	Article							CLASS-II MOLECULES; ACTIVATION; IL-4; PROLIFERATION; LYMPHOCYTES; RECEPTOR	Exposure of naive B cells to the cytokine interleukin-4 (IL-4) and/or antigen leads to a state of "priming," in which subsequent aggregation of major histocompatibility complex class II molecules induces the mobilization of calcium ions and cell proliferation. However, it is not clear how critical this priming is for immune responses or how it is normally induced in vivo. Injection of mice with the commonly used adjuvant alum led to priming of splenic B cells and to the accumulation in the spleen of a previously unknown population of IL-4-producing, Gr1(+) cells. These cells and IL-4 were both required for in vivo priming and expansion of antigen-specific B cells, as well as for optimal production of antibody. These studies reveal a key role for a previously unknown accessory myeloid cell population in the generation of humoral immune responses.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	cambierj@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Cambier, John/0000-0002-7803-242X	NIAID NIH HHS [AI-18785, AI-20519, AI-22295, AI-50802, AI-52225, AI-17134] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018785, R01AI020519, R01AI018785, R01AI017134, P01AI022295, R56AI017134, R01AI052225, K08AI050802, R37AI017134, R37AI018785] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; CHEN ZZ, 1987, J IMMUNOL, V138, P2345; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Jordan M.D., UNPUB; LANE PJL, 1990, J IMMUNOL, V144, P3684; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; STPIERRE Y, 1991, J IMMUNOL, V147, P2875	14	184	195	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1808	1810		10.1126/science.1089926	http://dx.doi.org/10.1126/science.1089926			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205534				2022-12-01	WOS:000222089500047
J	Bowman, GD; O'Donnell, M; Kuriyan, J				Bowman, GD; O'Donnell, M; Kuriyan, J			Structural analysis of a eukaryotic sliding DNA clamp-clamp loader complex	NATURE			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; CRYSTAL-STRUCTURE; HELICASE-PRIMASE; GAMMA COMPLEX; DELTA-SUBUNIT; POLYMERASE; MECHANISM; DOMAIN; PROTEINS	Sliding clamps are ring-shaped proteins that encircle DNA and confer high processivity on DNA polymerases. Here we report the crystal structure of the five-protein clamp loader complex ( replication factor-C, RFC) of the yeast Saccharomyces cerevisiae, bound to the sliding clamp ( proliferating cell nuclear antigen, PCNA). Tight interfacial coordination of the ATP analogue ATP-gamma S by RFC results in a spiral arrangement of the ATPase domains of the clamp loader above the PCNA ring. Placement of a model for primed DNA within the central hole of PCNA reveals a striking correspondence between the RFC spiral and the grooves of the DNA double helix. This model, in which the clamp loader complex locks onto primed DNA in a screw-cap-like arrangement, provides a simple explanation for the process by which the engagement of primer-template junctions by the RFC: PCNA complex results in ATP hydrolysis and release of the sliding clamp on DNA.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab DNA Replicat, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066586] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM066586-02, F32 GM066586-01, F32 GM066586] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Goedken ER, 2004, J MOL BIOL, V336, P1047, DOI 10.1016/j.jmb.2003.12.074; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gonzalez A, 2003, ACTA CRYSTALLOGR D, V59, P1935, DOI 10.1107/S0907444903017700; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Hortnagel K, 1999, J MOL BIOL, V286, P1097, DOI 10.1006/jmbi.1998.2515; HUANG CC, 1981, J BIOL CHEM, V256, P4087; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LAFORTELLE ED, 1997, METHOD ENZYMOL, V276, P476; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; LEE SH, 1991, J BIOL CHEM, V266, P594; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; MIYATA T, IN PRESS NATURE STRU; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Saenger W, 2013, PRINCIPLES NUCL ACID; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.0.CO;2-#; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Xiong Y, 2000, NUCLEIC ACIDS RES, V28, P2171, DOI 10.1093/nar/28.10.2171; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	49	332	344	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2004	429	6993					724	730		10.1038/nature02585	http://dx.doi.org/10.1038/nature02585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201901				2022-12-01	WOS:000222059900029
J	He, DZZ; Jia, SP; Dallos, P				He, DZZ; Jia, SP; Dallos, P			Mechanoelectrical transduction of adult outer hair cells studied in a gerbil hemicochlea	NATURE			English	Article							GUINEA-PIG COCHLEA; INTRACELLULAR-RECORDINGS; MECHANICAL RESPONSES; MOTOR PROTEIN; MOUSE COCHLEA; PRESTIN; CURRENTS; CONDUCTANCE; ADAPTATION; MEMBRANE	Sensory receptor cells of the mammalian cochlea are morphologically and functionally dichotomized. Inner hair cells transmit auditory information to the brain, whereas outer hair cells (OHC) amplify the mechanical signal, which is then transduced by inner hair cells(1). Amplification by OHCs is probably mediated by their somatic motility(2,3) in a mechanical feedback process. OHC motility in vivo is thought to be driven by the cell's receptor potential. The first steps towards the generation of the receptor potential are the deflection of the stereociliary bundle(4), and the subsequent flow of transducer current through the mechanosensitive transducer channels located at their tips(5). Quantitative relations between transducer currents and basilar membrane displacements are lacking, as well as their variation along the cochlear length. To address this, we simultaneously recorded OHC transducer currents (or receptor potentials) and basilar membrane motion in an excised and bisected cochlea, the hemicochlea(6). This preparation permits recordings from adult OHCs at various cochlear locations while the basilar membrane is mechanically stimulated. Furthermore, the stereocilia are deflected by the same means of stimulation as in vivo. Here we show that asymmetrical transducer currents and receptor potentials are significantly larger than previously thought, they possess a highly restricted dynamic range and strongly depend on cochlear location.	Creighton Univ, Dept Biomed Sci, Hair Cell Biophys Lab, Omaha, NE 68175 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Northwestern Univ, Dept Neurobiol & Physiol, Hugh Knowles Ctr, Auditory Lab, Evanston, IL 60208 USA; Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA	Creighton University; Boys Town National Research Hospital; Northwestern University; Northwestern University	He, DZZ (corresponding author), Creighton Univ, Dept Biomed Sci, Hair Cell Biophys Lab, Omaha, NE 68175 USA.	hed@creighton.edu	Dallos, Peter/Q-9360-2019	Dallos, Peter/0000-0002-9731-6591; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [R01 DC004696, R21 DC006039] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASHMORE JF, 1993, BIOPHYSICS HAIR CELL, P151; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CHEATHAM MA, 2004, ASS RES OT ABSTR, V1248; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; DALLOS P, 1982, SCIENCE, V218, P582, DOI 10.1126/science.7123260; DALLOS P, 1986, HEARING RES, V22, P185, DOI 10.1016/0378-5955(86)90095-X; DALLOS P, 1985, J NEUROSCI, V5, P1591; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1992, J NEUROSCI, V12, P4575; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; He DZZ, 2003, J NEUROSCI, V23, P9089; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Richter CP, 1998, J NEUROPHYSIOL, V79, P2255, DOI 10.1152/jn.1998.79.5.2255; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; RUSSELL IJ, 1983, J PHYSIOL-LONDON, V338, P179, DOI 10.1113/jphysiol.1983.sp014668; RUSSELL IJ, 1986, NATURE, V321, P517, DOI 10.1038/321517a0; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	31	102	107	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2004	429	6993					766	770		10.1038/nature02591	http://dx.doi.org/10.1038/nature02591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829OS	15201911				2022-12-01	WOS:000222059900040
J	Oh, P; Li, Y; Yu, JY; Durr, E; Krasinska, KM; Carver, LA; Testa, JE; Schnitzer, JE				Oh, P; Li, Y; Yu, JY; Durr, E; Krasinska, KM; Carver, LA; Testa, JE; Schnitzer, JE			Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy	NATURE			English	Article							IN-VIVO; MONOCLONAL-ANTIBODIES; CANCER-THERAPY; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL EXPRESSION; DRUG DISCOVERY; PHAGE DISPLAY; GENE DELIVERY; ANNEXIN-I; CELLS	The molecular complexity of tissues and the inaccessibility of most cells within a tissue limit the discovery of key targets for tissue-specific delivery of therapeutic and imaging agents in vivo. Here, we describe a hypothesis-driven, systems biology approach to identifying a small subset of proteins induced at the tissue - blood interface that are inherently accessible to antibodies injected intravenously. We use subcellular fractionation, subtractive proteomics and bioinformatics to identify endothelial cell surface proteins exhibiting restricted tissue distribution and apparent tissue modulation. Expression profiling and gamma-scintigraphic imaging with antibodies establishes two of these proteins, aminopeptidase- P and annexin A1, as selective in vivo targets for antibodies in lungs and solid tumours, respectively. Radio-immunotherapy to annexin A1 destroys tumours and increases animal survival. This analytical strategy can map tissue- and disease-specific expression of endothelial cell surface proteins to uncover novel accessible targets useful for imaging and therapy.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA		Schnitzer, JE (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.	jschnitzer@skcc.org						Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Anzick SL, 2002, ONCOLOGY-NY, V16, P7; AUERBACH R, 1987, CANCER RES, V47, P1492; Bredow S, 2000, EUR J CANCER, V36, P675, DOI 10.1016/S0959-8049(99)00335-4; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Cavenee WK, 2002, CARCINOGENESIS, V23, P683, DOI 10.1093/carcin/23.5.683; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Farah RA, 1998, CRIT REV EUKAR GENE, V8, P321, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.50; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; HENNIKER AJ, 1990, DIS MARKERS, V8, P179; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hu ZW, 2001, P NATL ACAD SCI USA, V98, P12180, DOI 10.1073/pnas.201420298; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; Huber LA, 2003, NAT REV MOL CELL BIO, V4, P74, DOI 10.1038/nrm1007; Jain RK, 1998, NAT MED, V4, P655, DOI 10.1038/nm0698-655; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; McKanna JA, 1997, J HISTOCHEM CYTOCHEM, V45, P527, DOI 10.1177/002215549704500405; Oh P, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P34; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Schnitzer J. E., 1997, VASCULAR ENDOTHELIUM, P77; Schnitzer JE, 1998, NEW ENGL J MED, V339, P472, DOI 10.1056/NEJM199808133390711; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SCHNITZER JE, 1992, AM J PHYSIOL, V262, pH246, DOI 10.1152/ajpheart.1992.262.1.H246; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; St Croix B, 2000, SCIENCE, V289, P1197; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Workman P, 2001, CURR CANCER DRUG TAR, V1, P33, DOI 10.2174/1568009013334269	46	388	446	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					629	635		10.1038/nature02580	http://dx.doi.org/10.1038/nature02580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15190345				2022-12-01	WOS:000221912600032
J	Lobb, E; Meiser, B				Lobb, E; Meiser, B			Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer	LANCET			English	Editorial Material							INCREASED RISK; MASTECTOMY; COMMUNICATION; CONSULTATIONS; OOPHORECTOMY; CARRIERS; IMPACT; BRCA2		Edith Cowan Univ, WA Ctr Canc & Palliat Care, Perth, WA 6018, Australia; Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia	Edith Cowan University	Lobb, E (corresponding author), Edith Cowan Univ, WA Ctr Canc & Palliat Care, Perth, WA 6018, Australia.	e.lobb@ecu.edu.au	Meiser, Bettina/AAG-5480-2021					Armstrong K, 2004, J CLIN ONCOL, V22, P1045, DOI 10.1200/JCO.2004.06.090; Hallowell N., 1999, HEALTH RISK SOC, V1, P267, DOI DOI 10.1080/13698579908406316; Hartmann LC, 2004, J CLIN ONCOL, V22, P981, DOI 10.1200/JCO.2004.01.925; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; Lobb EA, 2004, BRIT J CANCER, V90, P321, DOI 10.1038/sj.bjc.6601502; Lobb EA, 2002, BRIT J CANCER, V87, P502, DOI 10.1038/sj.bjc.6600484; Meiser B, 2000, J CLIN ONCOL, V18, P2250, DOI 10.1200/JCO.2000.18.11.2250; Mild Y, 1994, SCIENCE, V266, P66; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Tiller K, 2002, GYNECOL ONCOL, V86, P212, DOI 10.1006/gyno.2002.6737; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	11	9	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 5	2004	363	9424					1841	1842		10.1016/S0140-6736(04)16393-9	http://dx.doi.org/10.1016/S0140-6736(04)16393-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826IH	15183619				2022-12-01	WOS:000221822300005
J	Hays, GC; Houghton, JDR; Myers, AE				Hays, GC; Houghton, JDR; Myers, AE			Endanqered species - Pan-Atlantic leatherback turtle movements	NATURE			English	Editorial Material							DERMOCHELYS-CORIACEA		Univ Coll Swansea, Sch Biol Sci, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales	Swansea University	Hays, GC (corresponding author), Univ Coll Swansea, Sch Biol Sci, Inst Environm Sustainabil, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	g.hays@swan.ac.uk		Hays, Graeme/0000-0002-3314-8189				Brongersma L.D., 1972, Zoologische Verh Leiden, VNo. 121, P1; ECKERT SA, 1986, HERPETOLOGICA, V42, P381; ECKERT SA, 1998, NOAA TECHNICAL MEMOR, V415, P46; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; *NOAA, 2001, NOAA NE DIST FISH EX; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; YOKAWA K, 2003, COL VOL SCI PAP ICCA, V55, P475	11	131	145	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					522	522		10.1038/429522a	http://dx.doi.org/10.1038/429522a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175742				2022-12-01	WOS:000221767700029
J	de Onis, M; Blossner, M; Borghi, E; Frongillo, EA; Morris, R				de Onis, M; Blossner, M; Borghi, E; Frongillo, EA; Morris, R			Estimates of global prevalence of childhood underweight in 1990 and 2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESCHOOL-CHILDREN; MALNUTRITION; GROWTH; SURVIVAL; OBESITY; TRENDS	Context One key target of the United Nations Millennium Development goals is to reduce the prevalence of underweight among children younger than 5 years by half between 1990 and 2015. Objective To estimate trends in childhood underweight by geographic regions of the world. Design, Setting, and Participants Time series study of prevalence of underweight, defined as weight 2 SDs below the mean weight for age of the National Center for Health Statistics and World Health Organization (WHO) reference population. National prevalence rates derived from the WHO Global Database on Child Growth and Malnutrition, which includes data on approximately 31 million children younger than 5 years who participated in 419 national nutritional surveys in 139 countries from 1965 through 2002. Main Outcome Measures Linear mixed-effects modeling was used to estimate prevalence rates and numbers of underweight children by region in 1990 and 2015 and to calculate the changes (ie, increase or decrease) to these values between 1990 and 2015. Results Worldwide, underweight prevalence was projected to decline from 26.5% in 1990 to 17.6% in 2015, a change of -34% (95% confidence interval [CI], -43% to -23%). In developed countries, the prevalence was estimated to decrease from 1.6% to 0.9%, a change of -41% (95% CI, -92% to 343%). In developing regions, the prevalence was forecasted to decline from 30.2% to 19.3%, a change of -36% (95% CI, -45% to -26%). In Africa, the prevalence of underweight was forecasted to increase from 24.0% to 26.8%, a change of 12% (95% CI, 8%-16%). In Asia, the prevalence was estimated to decrease from 35.1% to 18.5%, a change of -47% (95% CI, -58% to -34%). Worldwide, the number of underweight children was projected to decline from 163.8 million in 1990 to 113.4 million in 2015, a change of -31% (95% CI, -40% to -20%). Numbers are projected to decrease in all subregions except the subregions of sub-Saharan, Eastern, Middle, and Western Africa, which are expected to experience substantial increases in the number of underweight children. Conclusions An overall improvement in the global situation is anticipated; however, neither the world as a whole, nor the developing regions, are expected to achieve the Millennium Development goals. This is largely due to the deteriorating situation in Africa where all subregions, except Northern Africa, are expected to fail to meet the goal.	WHO, Dept Nutr, CH-1211 Geneva 27, Switzerland; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England	World Health Organization; Cornell University; University of London; University College London; UCL Medical School	de Onis, M (corresponding author), WHO, Dept Nutr, CH-1211 Geneva 27, Switzerland.	deonism@who.int		Morris, Richard/0000-0001-7240-4563				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; CAULFIELD LE, IN PRESS AM J CLIN N; Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; *DEP EC SOC AFF UN, 2001, WORLD POP PROSP SEX; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th, DOI DOI 10.1002/9780470973394; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; Sakamoto N, 2001, INT J OBESITY, V25, P389, DOI 10.1038/sj.ijo.0801477; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; UN, MILL DEV GOALS; UNICEF, 2004, STAT WORLDS CHILDR 2; Verbeke G., 2000, LINEAR MIXED MODELS, P41; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227; *WHO EXP COMM REP, 1995, WHO TECHN REP SER, V854	22	155	161	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2004	291	21					2600	2606		10.1001/jama.291.21.2600	http://dx.doi.org/10.1001/jama.291.21.2600			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825EM	15173151	Bronze			2022-12-01	WOS:000221738800023
J	Ebers, GC; Sadovnick, AD; Dyment, DA; Yee, IML; Willer, CJ; Risch, N				Ebers, GC; Sadovnick, AD; Dyment, DA; Yee, IML; Willer, CJ; Risch, N			Parent-of-origin effect in multiple sclerosis: observations in half-siblings	LANCET			English	Article								Multiple sclerosis is a complex trait in which occurrence rates in offspring are 20-50-fold greater than in the general population. Parent-of-origin effects have been difficult to screen for, since most cases are sporadic. We have compared recurrence risks in half-siblings with respect to their parent in common. Of the 1567 index cases with half-siblings in multiple sclerosis clinics across Canada, we recorded 3436 half-siblings and 2706 full-siblings. Age-adjusted full-sibling risk was 3.11%. By contrast, half-sibling risk in the same families was significantly lower at 1.89% (chi(2) test, p=0.006), but higher than expected if familial risk was simply polygenic. For maternal half-siblings, the risk was 2.35% (34 affected siblings of 1859), and 1.31% for paternal half-siblings (15 of 1577), (p=0.048). The difference in risk suggests a maternal parent-of-origin effect in multiple sclerosis susceptibility.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC, Canada; Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA	University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of British Columbia; University of British Columbia; Stanford University	Ebers, GC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	george.ebers@clinical-neurology.oxford.ac.uk		Ebers, George/0000-0003-4771-4177; Sadovnick, Dessa/0000-0003-2987-2008; Willer, Cristen/0000-0001-5645-4966				DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; Sadovnick AD, 1998, CAN J NEUROL SCI, V25, P216, DOI 10.1017/S0317167100034041; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	5	193	196	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 29	2004	363	9423					1773	1774		10.1016/S0140-6736(04)16304-6	http://dx.doi.org/10.1016/S0140-6736(04)16304-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824SD	15172777				2022-12-01	WOS:000221705800012
J	Dobson, CM				Dobson, CM			In the footsteps of alchemists	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; PEPTIDE		Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk						Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dalton R, 2004, NATURE, V427, P5, DOI 10.1038/427005b; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Ghani AC, 2003, P ROY SOC B-BIOL SCI, V270, P689, DOI 10.1098/rspb.2002.2313; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6	16	61	63	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2004	304	5675					1259	+		10.1126/science.1093078	http://dx.doi.org/10.1126/science.1093078			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15166354				2022-12-01	WOS:000221669600028
J	Leutgeb, S; Leutgeb, JK; Treves, A; Moser, MB; Moser, EI				Leutgeb, S; Leutgeb, JK; Treves, A; Moser, MB; Moser, EI			Distinct ensemble codes in hippocampal areas CA3 and CA1	SCIENCE			English	Article							SPATIAL FIRING PATTERNS; COMPLEX-SPIKE CELLS; PLACE CELLS; COMPUTATIONAL CONSTRAINTS; NMDA RECEPTORS; MEMORY; CONTEXT; ENVIRONMENT; RATS; REPRESENTATIONS	The hippocampus has differentiated into an extensively connected recurrent stage (CA3) followed by a feed-forward stage (CA1). We examined the function of this structural differentiation by determining how cell ensembles in rat CA3 and CA1 generate representations of rooms with common spatial elements. In CA3, distinct subsets of pyramidal cells were activated in each room, regardless of the similarity of the testing enclosure. In CA1, the activated populations overlapped, and the overlap increased in similar enclosures. After exposure to a novel room, ensemble activity developed slower in CA3 than CA1, suggesting that the representations emerged independently.	Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Trieste, Italy	International School for Advanced Studies (SISSA)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no	Treves, Alessandro/B-2318-2009	Leutgeb, Jill/0000-0002-2014-842X; TREVES, Alessandro/0000-0001-7246-5673				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Freeman JH, 1996, J NEUROSCI, V16, P1538; Hebb D.O., 2002, CLIN PSYCHOL; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; JARRARD LE, 1975, J COMP PHYSIOL PSYCH, V89, P400, DOI 10.1037/h0077049; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2002, NEUROSCIENCE, V112, P655, DOI 10.1016/S0306-4522(02)00101-X; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tanila H, 1999, HIPPOCAMPUS, V9, P235, DOI 10.1002/(SICI)1098-1063(1999)9:3<235::AID-HIPO4>3.0.CO;2-3; Treves A, 2004, HIPPOCAMPUS, V14, P539, DOI 10.1002/hipo.10187; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINOCUR G, 1978, J COMP PHYSIOL PSYCH, V92, P312, DOI 10.1037/h0077468	33	507	514	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1295	1298		10.1126/science.1100265	http://dx.doi.org/10.1126/science.1100265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15272123				2022-12-01	WOS:000223624600043
J	Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH				Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH			The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography	SCIENCE			English	Article							CONFORMATION-ACTIVITY RELATIONSHIPS; POLYKETIDE NATURAL-PRODUCTS; COMMON PHARMACOPHORE; BIOLOGICAL-ACTIVITY; BETA-TUBULIN; CHEMICAL-SYNTHESIS; PACLITAXEL; MUTATIONS; TAXOL; STABILITY	The structure of epothilone A, bound to alpha, beta-tubulin in zinc-stabilized sheets, was determined by a combination of electron crystallography at 2.89 angstrom resolution and nuclear magnetic resonance-based conformational analysis. The complex explains both the broad-based epothilone structure-activity relationship and the known mutational resistance pro. le. Comparison with Taxol shows that the longstanding expectation of a common pharmacophore is not met, because each ligand exploits the tubulin-binding pocket in a unique and independent manner.	Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Emory University; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Snyder, JP (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	snyder@euch4e.chem.emory.edu; khdowning@lbl.gov		Nettles, James/0000-0002-5683-8481; Li, Huilin/0000-0001-8085-8928				BOLLAG DM, 1995, CANCER RES, V55, P2325; Carlomagno T, 2003, ANGEW CHEM INT EDIT, V42, P2511, DOI 10.1002/anie.200351276; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guastalla JP, 2003, BRIT J CANCER, V89, pS16, DOI 10.1038/sj.bjc.6601496; Hardt IH, 2001, J NAT PROD, V64, P847, DOI 10.1021/np000629f; He LF, 2000, BIOCHEMISTRY-US, V39, P3972, DOI 10.1021/bi992518p; He LF, 2001, MOL CANCER THER, V1, P3; HOFLE G, 1993, CHEM ABSTR 52841, V120; Jimenez-Barbero Jesus, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P91, DOI 10.2174/1568011023354416; Johnson J, 2000, ORG LETT, V2, P1537, DOI 10.1021/ol0058240; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Nicolaou KC, 2000, CHEM BIOL, V7, P593, DOI 10.1016/S1074-5521(00)00006-5; Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P2015, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2; Nicolaou KC, 2003, ANGEW CHEM INT EDIT, V42, P3515, DOI 10.1002/anie.200351819; Nicolaou KC, 2001, J AM CHEM SOC, V123, P9313, DOI 10.1021/ja011338b; Nicolaou KC, 2001, CHEM COMMUN, P1523, DOI 10.1039/b104949f; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Regueiro-Ren A, 2002, ORG LETT, V4, P3815, DOI 10.1021/ol026589j; Regueiro-Ren A, 2001, ORG LETT, V3, P2693, DOI 10.1021/ol016273w; Rivkin A, 2003, J AM CHEM SOC, V125, P2899, DOI 10.1021/ja029695p; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Taylor RE, 2004, ORG BIOMOL CHEM, V2, P127, DOI 10.1039/b312213c; Taylor RE, 2003, J AM CHEM SOC, V125, P26, DOI 10.1021/ja028196l; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Wang MM, 2000, J ORG CHEM, V65, P1059, DOI 10.1021/jo9916075; Wang MM, 1999, ORG LETT, V1, P43, DOI 10.1021/ol990521v; Wartmann M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P123, DOI 10.2174/1568011023354489	32	359	369	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					866	869		10.1126/science.1099190	http://dx.doi.org/10.1126/science.1099190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297674				2022-12-01	WOS:000223104900049
J	Ricklefs, RE				Ricklefs, RE			Cladogenesis and morphological diversification in passerine birds	NATURE			English	Article							ADAPTIVE RADIATION; EVOLUTION; TEMPO; MODE; SPECIATION; FINCHES	Morphological diversity tends to increase within evolving lineages over time(1,2), but the relative roles of gradual evolutionary change (anagenesis)(3) and abrupt shifts associated with speciation events (cladogenesis, or 'punctuated equilibrium')(4) have not been resolved for most groups of organisms(5). However, these two modes of evolution can be distinguished by the fact that morphological variance increases in proportion to time under anagenesis(6), and in proportion to the logarithm of the number of species under cladogenesis(7). Although species and time are themselves correlated, multiple regression analysis provides a statistical framework for partitioning their relative contributions. In this study, I use multiple regressions to evaluate the effects of time and species number on morphological diversity within clades of passerine birds. The results show clearly that number of species exerts a strong influence on morphological variance independent of time, but that time has no unique effect. Thus, morphological evolution in birds seems to be associated with cladogenesis. How lineage splitting promotes morphological diversification poses an important challenge to ecologists and evolutionary biologists.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	ricklefs@umsl.edu						Abouheif E, 1999, EVOL ECOL RES, V1, P895; Benkman CW, 2003, EVOLUTION, V57, P1176; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Eldredge N., 1972, P82; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Foote Mike, 1996, P62; GOULD S J, 1977, Paleobiology, V3, P115; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; RAUP DM, 1974, SYST ZOOL, V23, P305, DOI 10.2307/2412538; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; RICKLEFS RE, 1980, AUK, V97, P321; Ricklefs Robert E., 1994, P13; SCHLUTER D, 1984, EVOLUTION, V38, P921, DOI 10.1111/j.1558-5646.1984.tb00363.x; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; [No title captured], DOI DOI 10.1086/285901)	20	86	88	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2004	430	6997					338	341		10.1038/nature02700	http://dx.doi.org/10.1038/nature02700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254535				2022-12-01	WOS:000222631200038
J	Sandel, MJ				Sandel, MJ			Embryo ethics - The moral logic of stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	61	65	0	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2004	351	3					207	209		10.1056/NEJMp048145	http://dx.doi.org/10.1056/NEJMp048145			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837KA	15254277				2022-12-01	WOS:000222627200001
J	Bulteau, AL; O'Neill, HA; Kennedy, MC; Ikeda-Saito, M; Isaya, G; Szweda, LI				Bulteau, AL; O'Neill, HA; Kennedy, MC; Ikeda-Saito, M; Isaya, G; Szweda, LI			Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity	SCIENCE			English	Article							FE-S CLUSTER; YEAST FRATAXIN; FRIEDREICH ATAXIA; SACCHAROMYCES-CEREVISIAE; PROCESSING PEPTIDASE; BINDING PROPERTIES; SCAFFOLD PROTEIN; HOMOLOG; INACTIVATION; BIOSYNTHESIS	Numerous degenerative disorders are associated with elevated levels of pro-oxidants and declines in mitochondrial aconitase activity. Deficiency in the mitochondrial iron-binding protein frataxin results in diminished activity of various mitochondrial iron-sulfur proteins including aconitase. We found that aconitase can undergo reversible citrate-dependent modulation in activity in response to pro-oxidants. Frataxin interacted with aconitase in a citrate-dependent fashion, reduced the level of oxidant-induced inactivation, and converted inactive [3Fe-4S](1+) enzyme to the active [4Fe-4S](2+) form of the protein. Thus, frataxin is an iron chaperone protein that protects the aconitase [4Fe-4S](2+) cluster from disassembly and promotes enzyme reactivation.	Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; Gannon Univ, Dept Chem, Erie, PA USA; Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Case Western Reserve University; Mayo Clinic; Mayo Clinic; Tohoku University	Szweda, LI (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	lxs54@po.cwru.edu	Ikeda-Saito, Masao/A-5992-2008; bulteau, anne-laure/AAN-4004-2020; Ikeda-Saito, Masao/K-2703-2015		NIA NIH HHS [AG-16339, AG-15709] Funding Source: Medline; NINR NIH HHS [NRSA 44748] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015709, R01AG016339] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bolis D, 2004, J MOL BIOL, V336, P203, DOI 10.1016/j.jmb.2003.11.056; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; ONEILL HA, 2004, UNPUB; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Wilson RB, 2003, J NEUROL SCI, V207, P103, DOI 10.1016/S0022-510X(02)00432-X; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	31	295	313	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					242	245		10.1126/science.1098991	http://dx.doi.org/10.1126/science.1098991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247478				2022-12-01	WOS:000222501000052
J	Lee, SY; MacKinnon, R				Lee, SY; MacKinnon, R			A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom	NATURE			English	Article							DEPENDENT K+ CHANNEL; GATING MODIFIER TOXINS; POTASSIUM CHANNEL; PEPTIDE INHIBITOR; RECEPTOR; DIFFUSION; HANATOXIN; SURFACE; CHARYBDOTOXIN; NEUROTOXIN	Venomous animals produce small protein toxins that inhibit ion channels with high affinity. In several well-studied cases the inhibitory proteins are water-soluble and bind at a channel's aqueous-exposed extracellular surface(1-4). Here we show that a voltage-sensor toxin (VSTX1) from the Chilean Rose Tarantula (Grammostola spatulata) reaches its target by partitioning into the lipid membrane. Lipid membrane partitioning serves two purposes: to localize the toxin in the membrane where the voltage sensor resides and to exploit the free energy of partitioning to achieve apparent high-affinity inhibition. VSTX1, small hydrophobic poisons and anaesthetic molecules reveal a common theme of voltage sensor inhibition through lipid membrane access. The apparent requirement for such access is consistent with the recent proposal that the sensor in voltage-dependent K+ channels is located at the membrane-protein interface(5,6).	Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu						Almeida P.F.F., 1995, HDB BIOL PHYS A&B, V1, P305, DOI 10.1016/S1383-8121(06)80023-0; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, ION CHANNELS EXCITAB, P635; HUGUES M, 1982, P NATL ACAD SCI-BIOL, V79, P1308, DOI 10.1073/pnas.79.4.1308; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; JIANG QX, 2001, THESIS YALE U; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; MANOLERAS N, 1994, BIOCHEMISTRY-US, V33, P11051, DOI 10.1021/bi00203a001; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MILLER C, 1990, BIOCHEMISTRY-US, V29, P5320, DOI 10.1021/bi00474a016; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SCHURR JM, 1970, BIOPHYS J, V10, P717, DOI 10.1016/S0006-3495(70)86331-7; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Wang JL, 2003, BIOPHYS J, V84, p218A; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637	30	236	239	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2004	430	6996					232	235		10.1038/nature02632	http://dx.doi.org/10.1038/nature02632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241419				2022-12-01	WOS:000222470600049
J	Skop, AR; Liu, HB; Yates, J; Meyer, BJ; Heald, R				Skop, AR; Liu, HB; Yates, J; Meyer, BJ; Heald, R			Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms	SCIENCE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; CAENORHABDITIS-ELEGANS; FISSION YEAST; LIPID RAFTS; CELL-DIVISION; HUMAN HOMOLOG; CLEAVAGE; MITOSIS; PROTEINS; EXPRESSION	Cytokinesis is the essential process that partitions cellular contents into daughter cells. To identify and characterize cytokinesis proteins rapidly, we used a functional proteomic and comparative genomic strategy. Midbodies were isolated from mammalian cells, proteins were identified by multidimensional protein identification technology ( MudPIT), and protein function was assessed in Caenorhabditis elegans. Of 172 homologs disrupted by RNA interference, 58% displayed defects in cleavage furrow formation or completion, or germline cytokinesis. Functional dissection of the midbody demonstrated the importance of lipid rafts and vesicle trafficking pathways in cytokinesis, and the utilization of common membrane cytoskeletal components in diverse morphogenetic events in the cleavage furrow, the germline, and neurons.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Scripps Research Institute	Skop, AR (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019	Skop, Ahna Renee/0000-0003-3522-4939; Meyer, Barbara/0000-0002-6530-4588; Heald, Rebecca/0000-0001-6671-6528	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064159] Funding Source: NIH RePORTER; NCRR NIH HHS [RR1823, P41 RR011823] Funding Source: Medline; NIGMS NIH HHS [F32 GM064159-01, F32 GM064159-02, F32 GM064159, F32 GM064159-03, F32 GM64159-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; BASU J, 1988, BIOCHIM BIOPHYS ACTA, V945, P121, DOI 10.1016/0005-2736(88)90474-9; Bednarek SY, 2002, TRAFFIC, V3, P621, DOI 10.1034/j.1600-0854.2002.30904.x; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; BIELIAVSKY N, 1990, J SUBMICR CYTOL PATH, V22, P445; Brandt R, 2001, CELL TISSUE RES, V305, P255, DOI 10.1007/s004410000334; BRAWLEY SH, 1977, J CELL SCI, V24, P275; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chang F, 2001, CELL STRUCT FUNCT, V26, P539, DOI 10.1247/csf.26.539; DAN K, 1990, ANN NY ACAD SCI, V582, P108; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Flemming W., 1891, ARCH MIKROSK ANAT, V37, P685, DOI [DOI 10.1007/BF02954311, 10.1007/BF02954311]; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jiang M, 2003, BIOCHEM BIOPH RES CO, V309, P196, DOI 10.1016/S0006-291X(03)01559-6; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KOCH GLE, 1987, J CELL SCI, V87, P491; Kuwabara PE, 2000, GENE DEV, V14, P1933; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LoTurco JJ, 2003, CEREB CORTEX, V13, P588, DOI 10.1093/cercor/13.6.588; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; Osman MA, 1998, J CELL BIOL, V142, P443, DOI 10.1083/jcb.142.2.443; Paweletz N, 2001, NAT REV MOL CELL BIO, V2, P72, DOI 10.1038/35048077; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PICKETTHEAPS J, 1981, EUR J CELL BIOL, V25, P150; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Seidl P, 2002, INT J CANCER, V102, P129, DOI 10.1002/ijc.10675; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; Sharp DJ, 1997, J CELL SCI, V110, P2373; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sisson JC, 1999, CELL BIOL INT, V23, P871, DOI 10.1006/cbir.1999.0484; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Staehlin LA, 1996, CELL, V84, P821, DOI 10.1016/S0092-8674(00)81060-0; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Velichkova M, 2002, CELL MOTIL CYTOSKEL, V51, P147, DOI 10.1002/cm.10025; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Walling HW, 1998, J NEUROSCI RES, V54, P301, DOI 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Won M, 2001, BIOCHEM BIOPH RES CO, V282, P10, DOI 10.1006/bbrc.2001.4535	66	368	499	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2004	305	5680					61	66		10.1126/science.1097931	http://dx.doi.org/10.1126/science.1097931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BG	15166316	Green Accepted			2022-12-01	WOS:000222386000033
J	Sutton, MA; Wall, NR; Aakalu, GN; Schuman, EM				Sutton, MA; Wall, NR; Aakalu, GN; Schuman, EM			Regulation of dendritic protein synthesis by miniature synaptic events	SCIENCE			English	Article							LONG-TERM FACILITATION; HIPPOCAMPAL-NEURONS; SYNAPSES; RELEASE; GLUTAMATE; VISUALIZATION; TRANSMISSION; POTENTIATION; TRANSMITTER; PLASTICITY	We examined dendritic protein synthesis after a prolonged blockade of action potentials alone and after a blockade of both action potentials and miniature excitatory synaptic events ( minis). Relative to controls, dendrites exposed to a prolonged blockade of action potentials showed diminished protein synthesis. Dendrites in which both action potentials and minis were blocked showed enhanced protein synthesis, suggesting that minis inhibit dendritic translation. When minis were acutely blocked or stimulated, an immediate increase or decrease, respectively, in dendritic translation was observed. Taken together, these results reveal a role for miniature synaptic events in the acute regulation of dendritic protein synthesis in neurons.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Sutton, Michael/C-6264-2011; Schuman, Erin M/D-6204-2011	Wall, Nicholas/0000-0003-2039-8258; Sutton, Michael/0000-0002-0692-6459				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johnson OL, 2004, BRAIN RES, V996, P89, DOI 10.1016/j.brainres.2003.10.011; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; POULAIN B, 1995, CLOSTRIDIAL NEUROTOX, P243; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1	29	196	198	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2004	304	5679					1979	1983		10.1126/science.1096202	http://dx.doi.org/10.1126/science.1096202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15218151				2022-12-01	WOS:000222241600049
J	Joffe, S; Harrington, DP; George, SL; Emanuel, EJ; Budzinski, LA; Weeks, JC				Joffe, S; Harrington, DP; George, SL; Emanuel, EJ; Budzinski, LA; Weeks, JC			Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; EQUIPOISE; ETHICS; PERSPECTIVE; ONCOLOGY; THERAPY; REASONS; SURGERY	Objective To assess whether publicly funded adult cancer trials satisfy the uncertainty principle, which states that physicians should enrol a patient in a trial only if they are substantially uncertain which of the treatments in the trial is most appropriate for the patient. This principle is violated if trials systematically favour either the experimental or the standard treatment. Design Retrospective cohort study of completed cancer trials, with randomisation as the unit of analysis. Setting Two cooperative research groups in the United States. Studies included 93 phase III randomised trials (103 randomisations) that completed recruitment of patients between 1981 and 1995. Main outcome measures Whether the randomisation favoured the experimental treatment, the standard treatment, or neither treatment; effect size (outcome of the experimental treatment compared with outcome of the standard treatment) for each randomisation. Results Three randomisations (3%) favoured the standard treatment, 70 (68%) found no significant difference between treatments, and 30 (29%) favoured the experimental treatment. The average effect size was 1.20 (95% confidence interval 1.13 to 1.28), reflecting a slight advantage for the experimental treatment. Conclusions In cooperative group trials in adults with cancer, there is a measurable average improvement in disease control associated with assignment to the experimental rather than the standard arm. However, the heterogeneity of outcomes and the small magnitude of the advantage suggest that, as a group, these trials satisfy the uncertainty principle.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Durham, NC 27710 USA; Lesley Coll, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Ctr Stat, Canc & Leukemia Grp B, Durham, NC 27710 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; Harvard University; Dana-Farber Cancer Institute	Joffe, S (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	steven_joffe@dfci.harvard.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384	NATIONAL CANCER INSTITUTE [K01CA096872, U10CA033601, U10CA023318] Funding Source: NIH RePORTER; NCI NIH HHS [CA96872, CA33601, CA23318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alderson P, 1996, J MED ETHICS, V22, P135, DOI 10.1136/jme.22.3.135; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; CHLEBOWSKI RT, 1994, J CLIN ONCOL, V12, P1789, DOI 10.1200/JCO.1994.12.9.1789; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Edwards SJ, 1998, HLTH TECHNOLOGY ASSE, V2, p[i, 1]; ENKIN MW, 2000, BMJ-BRIT MED J, V321, P757; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fried C., 1974, MED EXPT PERSONAL IN; GILBERT JP, 1977, SCIENCE, V198, P684, DOI 10.1126/science.333585; GOTAY CC, 1991, SOC SCI MED, V33, P569, DOI 10.1016/0277-9536(91)90214-W; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; HUNTER CP, 1987, CANCER TREAT REP, V71, P559; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lee SJ, 2000, STAT SCI, V15, P95; Lilford RJ, 2003, BRIT MED J, V326, P980, DOI 10.1136/bmj.326.7396.980; Machin D, 1997, Clin Oncol (R Coll Radiol), V9, P100; MARQUIS D, 1983, HASTINGS CENT REP, V13, P40, DOI 10.2307/3561721; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; Ubel PA, 1997, J INVEST MED, V45, P561; Welch HG, 2002, BMJ-BRIT MED J, V324, P1088, DOI 10.1136/bmj.324.7345.1088	24	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2004	328	7454					1463	1466		10.1136/bmj.38118.685289.55	http://dx.doi.org/10.1136/bmj.38118.685289.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CK	15163611	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000222244600014
J	Chasman, DI; Posada, D; Subrahmanyan, L; Cook, NR; Stanton, VP; Ridker, PM				Chasman, DI; Posada, D; Subrahmanyan, L; Cook, NR; Stanton, VP; Ridker, PM			Pharmacogenetic study of statin therapy and cholesterol reduction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-E; GENE; PRAVASTATIN	Context Polymorphisms in genes involved in cholesterol synthesis, absorption, and transport may affect statin efficacy. Objective To evaluate systematically whether genetic variation influences response to pravastatin therapy. Design, Setting, and Population The DNA of 1536 individuals treated with pravastatin, 40 mg/d, was analyzed for 148 single-nucleotide polymorphisms (SNPs) within 10 candidate genes related to lipid metabolism. Variation within these genes was then examined for associations with changes in lipid levels observed with pravastatin therapy during a 24-week period. Main Outcome Measure Changes in lipid levels in response to pravastatin therapy. Results Two common and tightly linked SNPs (linkage disequilibrium r(2) = 0.90; heterozygote prevalence = 6.7% for both) were significantly associated with reduced efficacy of pravastatin therapy. Both of these SNPs were in the gene coding for 3-hydroxy-3methylglutaryl-coenzyme A (HMG-CoA) reductase, the target enzyme that is inhibited by pravastatin. For example, compared with individuals homozygous for the major allele of one of the SNPs, individuals with a single copy of the minor allele had a 22% smaller reduction in total cholesterol (-32.8 vs -42.0 mg/dL [-0.85 vs -1.09 mmol/L]; P = .001; absolute difference, 9.2 mg/dL [95% confidence interval {Cl}, 3.8-14.6 mg/dL]) and a 19% smaller reduction in low-density lipoprotein (LDL) cholesterol (-27.7 vs -34.1 mg/dL [-0.72 vs -0.88 mmol/L]; P = .005; absolute difference, 6.4 mg/dL [95% Cl, 2.2-10.6 mg/dL]). The association for total cholesterol reduction persisted even after adjusting for multiple tests on all 33 SNPs evaluated in the HMG-CoA reductase gene as well as for all 148 SNPs evaluated was similar in magnitude and direction among men and women and was present in the ethnically diverse total cohort as well as in the majority subgroup of white participants. No association for either SNP was observed for the change in high-density lipoprotein (HDL) cholesterol (P > .80) and neither was associated with baseline lipid levels among those actively treated or among those who did not receive the drug. Among the remaining genes, less robust associations were found for squalene synthase and change in total cholesterol, apolipoprotein E and change in LDL cholesterol, and cholesteryl ester transfer protein and change in HDL cholesterol, although none of these met our conservative criteria for purely pharmacogenetic effects. Conclusion Individuals heterozygous for a genetic variant in the HMG-CoA reductase gene may experience significantly smaller reductions in cholesterol when treated with pravastatin.	Harvard Univ, Brigham & Womens Hosp,Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA; Variagen Inc, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp,Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org	Posada, David/C-4502-2008	Posada, David/0000-0003-1407-3406; Stanton, Vincent/0000-0002-2205-6000				Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; [Anonymous], ONLINE MENDELIAN INH; Brorholt-Petersen JU, 2001, CLIN GENET, V59, P397, DOI 10.1034/j.1399-0004.2001.590604.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; GOTTO AM, 2002, DYSLIPOPROTEINEMIAS; HANSEN PS, 1994, CLIN INVESTIGATOR, V72, P1065, DOI 10.1007/BF00577757; Kokoris M, 2000, MOL DIAGN, V5, P329; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; ORDOVAS JM, 1995, ATHEROSCLEROSIS, V113, P157, DOI 10.1016/0021-9150(94)05439-P; Ordovas JM, 2002, CURR OPIN LIPIDOL, V13, P113, DOI 10.1097/00041433-200204000-00001; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Roses AD, 2002, NAT REV DRUG DISCOV, V1, P541, DOI 10.1038/nrd840; Schmitz G, 2003, CLIN CHEM LAB MED, V41, P581, DOI 10.1515/CCLM.2003.088; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TEMPLETON AR, 1987, GENETICS, V117, P343; TSIMIKAS S, 2002, MOL BIOL LIPOPROTEIN; WATANABE J, 1993, DIABETES RES CLIN PR, V20, P21, DOI 10.1016/0168-8227(93)90018-Z; Westfall PH., 1993, RESAMPLING BASED MUL	20	334	358	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2004	291	23					2821	2827		10.1001/jama.291.23.2821	http://dx.doi.org/10.1001/jama.291.23.2821			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828GT	15199031				2022-12-01	WOS:000221962500026
J	Navas-Acien, A; Peruga, A; Breysse, P; Zavaleta, A; Blanco-Marquizo, A; Pitarque, R; Acuna, M; Jimenez-Reyes, K; Colombo, VL; Gamarra, G; Stillman, FA; Samet, J				Navas-Acien, A; Peruga, A; Breysse, P; Zavaleta, A; Blanco-Marquizo, A; Pitarque, R; Acuna, M; Jimenez-Reyes, K; Colombo, VL; Gamarra, G; Stillman, FA; Samet, J			Secondhand tobacco smoke in public places in Latin America, 2002-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	12th World Conference on Tobacco or Health	AUG 03-08, 2003	Helsinki, FINLAND				EXPOSURE; SCIENCE; HEALTH	Context The success of measures to restrict smoking in indoor environments and the intensity of enforcement vary among countries around the world. In 2001, the Pan American Health Organization (PAHO) launched the Smoke-Free Americas Initiative to build capacity to achieve smoke-free environments in Latin America and the Caribbean. Objective To assess secondhand smoke concentrations in public places in the capital cities of Argentina, Brazil, Chile, Costa Rica, Paraguay, Peru, and Uruguay in conjunction with the Smoke-Free Americas Initiative. Design and Setting Multicountry assessment of vapor-phase nicotine concentrations using a common protocol in all 7 Latin American countries. A total of 633 sampling devices were placed for 7 to 14 days in 1 hospital, 2 secondary schools, 1 city government building, 1 airport (2 in Argentina), and restaurants and bars in each country. Main Outcome Measure Concentrations of airborne nicotine. Results Airborne nicotine was detected in most (94%) of the locations surveyed. By country, Argentina and Uruguay had the highest median concentrations in most environments (eg, in hospitals: 1.33 [interquartile range {IQR), 0.51-3.12] mug/m(3) and 0.8 [IQR, 0.30-1.69] mug/m(3), respectively). Overall, bars and restaurants had the highest median concentrations (3.65 [IQR, 1.55-5.121 mug/m(3) and 1.24 [IQR, 0.41-2.48] mug/m(3), respectively). Nicotine concentrations were also found in a number of key, sentinel buildings, including 95% (155/163) of hospital samples (in the physicians' and nurses' stations the median was 0.27 [IQR, 0.02-1.94] mug/m(3)), schools, government buildings, and/or airports in most countries. Conclusions The finding of airborne nicotine in critical locations in Latin America provides a basis for enforcing smoke-free initiatives and for strengthening the protection of the public from unwanted exposure to secondhand smoke.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Global Tobacco Control, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Pan Amer Hlth Org, Washington, DC USA; Univ Peruana Cayetano Heredia, Dept Biochem Mol Biol & Pharmacol, Lima, Peru; CEDRO, Lima, Peru; Intendencia Municipal, Montevideo, Uruguay; Minist Hlth, Buenos Aires, DF, Argentina; Minist Salud, Tobacco Unit, Santiago, Chile; IAFA, San Jose, Costa Rica; INCA, Rio De Janeiro, Brazil; Minist Hlth, Tobacco Unit, Asuncion, Paraguay	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pan American Health Organization; Universidad Peruana Cayetano Heredia; National Cancer Institute (Inca)	Navas-Acien, A (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Global Tobacco Control, 615 N Wolfe St,Room W6027, Baltimore, MD 21205 USA.	anavasac@jhsph.edu	ZAVALETA, ALFONSO/AAS-9595-2020; Peruga, Armando/G-9739-2019; Peruga, Armando/M-5455-2017	Peruga, Armando/0000-0002-1138-3292				AGUINAGABIALOUS S, 2002, PROFITS PEOPLE TOBAC; Akbar-Khanzadeh F, 2003, ARCH ENVIRON HEALTH, V58, P97, DOI 10.3200/AEOH.58.2.97-103; [Anonymous], 2002, WORLD HLTH REP 2002; *CDCP, 1986, HLTH CONS INV SMOK R; *CDCP WHO, GLOB YOUTH TOB SURV; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; HAMMOND SK, 1987, ENVIRON SCI TECHNOL, V21, P494, DOI 10.1021/es00159a012; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; HAMMOND SK, 1993, SAMPLING ANAL AIRBOR, P319; Jane M, 2002, TOB CONTROL, V11, P83, DOI 10.1136/tc.11.1.83; Jenkins R.A., 2000, CHEM ENV TOBACCO SMO; LAMBERT WE, 1993, AM J PUBLIC HEALTH, V83, P1339, DOI 10.2105/AJPH.83.9.1339; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; OEI TPS, 1992, J DRUG EDUC, V22, P155, DOI 10.2190/DWLW-UGVB-R1Y4-DQA4; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; Samet J. M., 2000, Environmental toxicants: human exposures and their health effects., P319; Schorp MK, 2002, ENVIRON INT, V27, P567, DOI 10.1016/S0160-4120(01)00110-6; Shafey O, 2003, TOBACCO CONTROL COUN; SIEGEL M, 1993, JAMA-J AM MED ASSOC, V270, P490, DOI 10.1001/jama.270.4.490; STILLMAN FA, 1990, JAMA-J AM MED ASSOC, V264, P1565, DOI 10.1001/jama.264.12.1565; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	22	92	103	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2004	291	22					2741	2745		10.1001/jama.291.22.2741	http://dx.doi.org/10.1001/jama.291.22.2741			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	826XH	15187056				2022-12-01	WOS:000221862300029
J	Little, AF; van Oppen, MJH; Willis, BL				Little, AF; van Oppen, MJH; Willis, BL			Flexibility in algal endosymbioses shapes growth in reef corals	SCIENCE			English	Article							MONTASTRAEA-ANNULARIS; ZOOXANTHELLAE; SYMBIODINIUM; DIVERSITY; ECOLOGY; SPECIFICITY; SYMBIOSIS; ACROPORA; PATTERNS	The relation between corals and their algal endosymbionts has been a key to the success of scleractinian (stony) corals as modern reef-builders, but little is known about early stages in the establishment of the symbiosis. Here, we show that initial uptake of zooxanthellae by juvenile corals during natural infection is nonspecific (a potentially adaptive trait); the association is flexible and characterized by a change in ( dominant) zooxanthella strains over time; and growth rates of experimentally infected coral holobionts are partly contingent on the zooxanthella strain harbored, with clade C - infected juveniles growing two to three times as fast as those infected with clade D.	James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; Australian Institute of Marine Science	Willis, BL (corresponding author), James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia.	Bette.Willis@jcu.edu.au	van Oppen, Madeleine JH/C-3261-2008	van Oppen, Madeleine/0000-0003-4607-0744				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Carlos AA, 2000, MAR ECOL PROG SER, V195, P93, DOI 10.3354/meps195093; Fitt W.K., 1985, PROC 5 TH INT CORAL, V6, P131; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LOH W, 1997, P ACRS 17 ANN C HER, P87; Rodriguez-Lanetty M, 2001, MAR BIOL, V138, P1175; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; VANOPPEN M, UNPUB; WILLIS BL, 1997, CORAL REEFS S, V16, P53	21	412	423	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1492	1494		10.1126/science.1095733	http://dx.doi.org/10.1126/science.1095733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15178799				2022-12-01	WOS:000221795800041
J	Vinicor, F; Jack, L				Vinicor, F; Jack, L			25 years and counting: Centers for Disease Control and Prevention identifies opportunities and challenges for diabetes prevention and control	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGEMENT		CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Vinicor, F (corresponding author), CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Woodcock Blvd,Room 2044, Atlanta, GA 30341 USA.	FVinicor@cdc.gov						Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Feudtner C., 2003, BITTER SWEET DIABETE; Fisher L, 2000, J FAM PRACTICE, V49, P561; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Glasgow RE, 1999, ANN BEHAV MED, V21, P159, DOI 10.1007/BF02908297; Hirsch IB, 2003, PRIMARY CARE, V30, P499, DOI 10.1016/S0095-4543(03)00031-9; Institute of Medicine, 2001, CROSSING QUALITY CHA; JACK L, 2003, J PUBLIC HLTH MANA S, pS64; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Larme AC, 2001, DIABETES CARE, V24, P1728, DOI 10.2337/diacare.24.10.1728; LEONARD J, 2003, J PUBLIC HLTH MANA S, pS5; Lteif Amale A, 2003, Cardiol Rev, V11, P262, DOI 10.1097/01.crd.0000086892.07437.05; Nathan DM, 2002, AM J MED, V113, P339, DOI 10.1016/S0002-9343(02)01219-6; Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Safran Marc A, 2003, J Public Health Manag Pract, V9, P58; Schroeder SA, 2001, NEW ENGL J MED, V344, P847, DOI 10.1056/NEJM200103153441113; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soltesz G, 2003, DIABETOLOGIA, V46, P447, DOI 10.1007/s00125-003-1101-0; Taylor R, 2004, NEW ENGL J MED, V350, P639, DOI 10.1056/NEJMp038239; VALK GD, 2001, COCHRANE DB SYST REV; Vinicor F, 2003, LANCET, V361, P544, DOI 10.1016/S0140-6736(03)12561-5; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x	24	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2004	140	11					943	944		10.7326/0003-4819-140-11-200406010-00034	http://dx.doi.org/10.7326/0003-4819-140-11-200406010-00034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824IS	15172918				2022-12-01	WOS:000221680600024
J	Yoo, HY; Kumagai, A; Shevchenko, A; Shevchenko, A; Dunphy, WG				Yoo, HY; Kumagai, A; Shevchenko, A; Shevchenko, A; Dunphy, WG			Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase	CELL			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAK; CELL-FREE-EXTRACTS; DAMAGE CHECKPOINT; CHK1; ATR; ARREST; PHOSPHORYLATION; PROTEIN; MRC1	The checkpoint mediator protein Claspin is essential for the ATR-dependent activation of Chk1 in Xenopus egg extracts containing aphidicolin-induced DNA replication blocks. We show that, during this checkpoint response, Claspin becomes phosphorylated on threonine 906 (T906), which creates a docking site for Plx1, the Xenopus Polo-like kinase. This interaction promotes the phosphorylation of Claspin on a nearby serine (S934) by Plx1. After a prolonged interphase arrest, aphidicolin-treated egg extracts typically undergo adaptation and enter into mitosis despite the presence of incompletely replicated DNA. In this process, Claspin dissociates from chromatin, and Chk1 undergoes inactivation. By contrast, aphidicolin-treated extracts containing mutants of Claspin with alanine substitutions at positions 906 or 934 (T906A or S934A) are unable to undergo adaptation. Under such adaptation-defective conditions, Claspin accumulates on chromatin at high levels, and Chk1 does not decrease in activity. These results indicate that the Plx1-dependent inactivation of Claspin results in termination of a DNA replication checkpoint response.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	California Institute of Technology; Max Planck Society	Dunphy, WG (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NIGMS NIH HHS [GM43974] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043974, R01GM043974] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(05)00092-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Liu QH, 2000, GENE DEV, V14, P1448; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5	36	179	182	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					575	588		10.1016/S0092-8674(04)00417-9	http://dx.doi.org/10.1016/S0092-8674(04)00417-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163406	Bronze			2022-12-01	WOS:000221857900005
J	Jagsi, R; Lehmann, S				Jagsi, R; Lehmann, S			The ethics of medical education	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEGAL IMPLICATIONS; INFORMED CONSENT; STUDENT DOCTOR; CARE; RESIDENTS; ATTITUDES; PATIENT		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lehmann, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.	llehmann1@partners.org		Jagsi, Reshma/0000-0001-6562-1228				ANNAS GJ, 1980, B NEW YORK ACAD MED, V56, P403; BASSON MD, 1982, HASTINGS CENT REP, V12, P27; BEATTY ME, 1995, ACAD MED, V70, P175, DOI 10.1097/00001888-199503000-00002; Brody BA, 1998, ETHICS BIOMEDICAL RE; Butters JM, 1996, ACAD MED, V71, P583, DOI 10.1097/00001888-199606000-00008; COHEN DL, 1987, J MED EDUC, V62, P789; COHEN DL, 1988, J MED EDUC, V63, P821; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Diekema DS, 1996, AM J EMERG MED, V14, P6, DOI 10.1016/S0735-6757(96)90002-9; Doyal L, 2001, BRIT MED J, V322, P685, DOI 10.1136/bmj.322.7288.685; Frank SH, 1997, JAMA-J AM MED ASSOC, V278, P712, DOI 10.1001/jama.278.9.712; Hicks LK, 2001, BRIT MED J, V322, P709, DOI 10.1136/bmj.322.7288.709; KAPP MB, 1983, J MED EDUC, V58, P293; KING D, 1992, MED EDUC, V26, P360, DOI 10.1111/j.1365-2923.1992.tb00186.x; Magrane D, 1996, OBSTET GYNECOL, V88, P298, DOI 10.1016/0029-7844(96)00191-3; Marracino RK, 1998, J GEN INTERN MED, V13, P266, DOI 10.1046/j.1525-1497.1998.00078.x; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; Vinicky J K, 1991, J Clin Ethics, V2, P35; WILLIG C, 1992, J COMMUNITY APPL SOC, V2, P217, DOI 10.1002/casp.2450020306	19	28	30	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					332	334		10.1136/bmj.329.7461.332	http://dx.doi.org/10.1136/bmj.329.7461.332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	846FF	15297341	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000223300300024
J	Xiong, Y; Steitz, TA				Xiong, Y; Steitz, TA			Mechanism of transfer RNA maturation by CCA-adding enzyme without using an oligonucleotide template	NATURE			English	Article							DNA-POLYMERASE-BETA; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; POLYMERIZATION; COMPLEXES; ATP	Transfer RNA nucleotidyltransferases (CCA-adding enzymes) are responsible for the maturation or repair of the functional 30 end of tRNAs by means of the addition of the essential nucleotides CCA. However, it is unclear how tRNA nucleotidyltransferases polymerize CCA onto the 30 terminus of immature tRNAs without using a nucleic acid template. Here we describe the crystal structure of the Archaeoglobus fulgidus tRNA nucleotidyltransferase in complex with tRNA. We also present ternary complexes of this enzyme with both RNA duplex mimics of the tRNA acceptor stem that terminate with the nucleotides C74 or C75, as well as the appropriate incoming nucleoside 5'-triphosphates. A single nucleotide-binding pocket exists whose specificity for both CTP and ATP is determined by the protein side chain of Arg 224 and backbone phosphates of the tRNA, which are non-complementary to and thus exclude UTP and GTP. Discrimination between CTP or ATP at a given addition step and at termination arises from changes in the size and shape of the nucleotide binding site that is progressively altered by the elongating 30 end of the tRNA.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009					AEBI M, 1990, J BIOL CHEM, V265, P16216; Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yue DX, 1996, RNA, V2, P895; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	26	98	103	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					640	645		10.1038/nature02711	http://dx.doi.org/10.1038/nature02711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295590				2022-12-01	WOS:000223085400035
J	Sampath, SC; Ohi, R; Leismann, O; Salic, A; Pozniakovski, A; Funabiki, H				Sampath, SC; Ohi, R; Leismann, O; Salic, A; Pozniakovski, A; Funabiki, H			The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly	CELL			English	Article							INNER CENTROMERE PROTEIN; MITOTIC-SPINDLE; AURORA-B; CELL-CYCLE; RAN-GTP; SELF-ORGANIZATION; IMPORTIN-BETA; INCENP; DYNAMICS; CENTROSOME	In cells lacking centrosomes, such as those found in female meiosis, chromosomes must nucleate and stabilize microtubules in order to form a bipolar spindle. Here we report the identification of Dasra A and Dasra B, two new components of the vertebrate chromosomal passenger complex containing Incenp, Survivin, and the kinase Aurora B, and demonstrate that this complex is required for chromatin-induced microtubule stabilization and spindle formation. The failure of microtubule stabilization caused by depletion of the chromosomal passenger complex was rescued by codepletion of the microtubule-depolymerizing kinesin MCAK, whose activity is negatively regulated by Aurora B. By contrast, we present evidence that the RanGTP pathway of chromatin-induced microtubule nucleation does not require the chromosomal passenger complex, indicating that the mechanisms of microtubule assembly by these two pathways are distinct. We propose that the chromosomal passenger complex regulates local MCAK activity to permit spindle formation via stabilization of chromatin-associated microtubules.	Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Rockefeller University; Harvard University; Harvard Medical School; Max Planck Society	Funabiki, H (corresponding author), Rockefeller Univ, Lab Chromosome & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	funabih@rockefeller.edu	Salic, Adrian/GXG-1611-2022	Funabiki, Hironori/0000-0003-4831-4087	NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BEDDINGTON R, 2002, PRINCIPLES DEV; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; CAMINCI P, 2000, GENOME RES, V10, P1617; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Faruki S, 2002, CELL MOTIL CYTOSKEL, V52, P107, DOI 10.1002/cm.10036; Field CM, 1998, METHOD ENZYMOL, V298, P525, DOI 10.1016/S0076-6879(98)98043-0; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heald R, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P326; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; OHI R, 2004, IN PRESS MOL BIOL CE; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359	49	330	352	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2004	118	2					187	202		10.1016/j.cell.2004.06.026	http://dx.doi.org/10.1016/j.cell.2004.06.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	841XQ	15260989	Bronze			2022-12-01	WOS:000222966000008
J	Ramchandani, P				Ramchandani, P			A question of balance	NATURE			English	Editorial Material							MAJOR DEPRESSION; CONTROLLED TRIAL; ADOLESCENTS; CHILDREN; EFFICACY		Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Ramchandani, P (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.		Ramchandani, Paul/O-5340-2014	Ramchandani, Paul/0000-0003-3646-2410				Aynsley-Green A, 2000, BRIT MED J, V321, P229, DOI 10.1136/bmj.321.7255.229; Brent DA, 2004, J AM ACAD CHILD PSY, V43, P379, DOI 10.1097/01.chi.0000120018.48166.57; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	8	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					401	402		10.1038/430401a	http://dx.doi.org/10.1038/430401a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269742				2022-12-01	WOS:000222801400018
J	Hiiragi, T; Solter, D				Hiiragi, T; Solter, D			First cleavage plane of the mouse egg is not predetermined but defined by the topology of the two apposing pronuclei	NATURE			English	Article							POSTIMPLANTATION DEVELOPMENT; CLEAVAGE DIVISION; CELL-DIVISION; BLASTOMERES; EMBRYO; FERTILIZATION; SPERM; AXIS; MICROTUBULES; ORGANIZATION	Studies of experimentally manipulated embryos(1-4) have led to the long-held conclusion that the polarity of the mouse embryo remains undetermined until the blastocyst stage. However, recent studies(5-7) reporting that the embryonic - abembryonic axis of the blastocyst arises perpendicular to the first cleavage plane, and hence to the animal - vegetal axis of the zygote, have led to the claim that the axis of the mouse embryo is already specified in the egg. Here we show that there is no specification of the axis in the egg. Time-lapse recordings show that the second polar body does not mark a stationary animal pole, but instead, in half of the embryos, moves towards a first cleavage plane. The first cleavage plane coincides with the plane defined by the two apposing pronuclei once they have moved to the centre of the egg. Pronuclear transfer experiments confirm that the first cleavage plane is not determined in early interphase but rather is specified by the newly formed topology of the two pronuclei. The microtubule networks that allow mixing of parental chromosomes before dividing into two may be involved in these processes.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Max Planck Society	Hiiragi, T (corresponding author), Max Planck Inst Immunbiol, D-79108 Freiburg, Germany.	hiiragi@immunbio.mpg.de	Solter, Davor/Q-5476-2019	Solter, Davor/0000-0002-8438-347X; Hiiragi, Takashi/0000-0003-4964-7203				Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; JOHNSON MH, 1975, NATURE, V257, P321, DOI 10.1038/257321a0; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; PAWELETZ N, 1987, EUR J CELL BIOL, V44, P205; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2002, DEVELOPMENT, V129, P5803, DOI 10.1242/dev.00170; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; SCHATTEN G, 1981, DEV BIOL, V86, P426, DOI 10.1016/0012-1606(81)90201-3; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SCHATTEN H, 1986, P NATL ACAD SCI USA, V83, P105, DOI 10.1073/pnas.83.1.105; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; ZAMBONI L, 1972, BIOL REPROD, V7, P170, DOI 10.1093/biolreprod/7.2.170	25	120	129	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2004	430	6997					360	364		10.1038/nature02595	http://dx.doi.org/10.1038/nature02595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837LG	15254539				2022-12-01	WOS:000222631200043
J	Bhatt, DH; Otto, SJ; Depoister, B; Fetcho, JR				Bhatt, DH; Otto, SJ; Depoister, B; Fetcho, JR			Cyclic AMP-induced repair of zebrafish spinal circuits	SCIENCE			English	Article							AXON REGENERATION; GROWTH; CELL; INHIBITION; GOLDFISH; RECEPTOR; NEURONS; ABILITY; ESCAPE; REVEAL	Neurons in the human central nervous system (CNS) are unable to regenerate, as a result of both an inhibitory environment and their inherent inability to regrow. In contrast, the CNS environment in fish is permissive for growth, yet some neurons still cannot regenerate. Fish thus offer an opportunity to study molecules that might surmount the intrinsic limitations they share with mammals, without the complication of an inhibitory environment. We show by in vivo imaging in zebra fish that post-injury application of cyclic adenosine monophosphate can transform severed CNS neurons into ones that regenerate and restore function, thus overcoming intrinsic limitations to regeneration in a vertebrate.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Fetcho, JR (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	Jfetcho@notes.cc.sunysb.edu		Bhatt, D/0000-0002-7646-0981	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026539, R01NS026539, R29NS026539] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [R01 NS026539, R01 NS026539-25, NS 26539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 1998, J NEUROSCI, V18, P5789; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Buffo A, 1997, J NEUROSCI, V17, P8778; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; FETCHO JR, 1992, J NEUROPHYSIOL, V67, P1574, DOI 10.1152/jn.1992.67.6.1574; Gao Y, 2003, J NEUROSCI, V23, P11770; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Takami T, 2002, J NEUROSCI, V22, P6670; Udvadia AJ, 2001, DEVELOPMENT, V128, P1175; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; ZOTTOLI SJ, 1994, PROG BRAIN RES, V103, P219	31	141	145	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					254	258		10.1126/science.1098439	http://dx.doi.org/10.1126/science.1098439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247482				2022-12-01	WOS:000222501000056
J	Hogbom, M; Stenmark, P; Voevodskaya, N; McClarty, G; Graslund, A; Nordlund, P				Hogbom, M; Stenmark, P; Voevodskaya, N; McClarty, G; Graslund, A; Nordlund, P			The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; ESCHERICHIA-COLI; ELECTRON-TRANSFER; TRACHOMATIS; COFACTOR; PROTEIN; MECHANISM; CLUSTER; EPR; ACTIVATION	Ribonucleotide reductase (RNR) synthesizes the deoxyribonucleotides for DNA synthesis. The R2 protein of normal class I ribonucleotide reductases contains a diiron site that produces a stable tyrosyl free radical, essential for enzymatic activity. Structural and electron paramagnetic resonance studies of R2 from Chlamydia trachomatis reveal a protein lacking a tyrosyl radical site. Instead, the protein yields an iron-coupled radical upon reconstitution. The coordinating structure of the diiron site is similar to that of diiron oxidases/monoxygenases and supports a role for this radical in the RNR mechanism. The specific ligand pattern in the C. trachomatis R2 metal site characterizes a new group of R2 proteins that so far has been found in eight organisms, three of which are human pathogens.	Stockholm Univ, Albanova Univ Ctr, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Stockholm Univ, Arrhenius Labs Nat Sci A3, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada; Hlth Canada, Natl Microbiol Lab, Winnipeg, MB R3E 0W3, Canada	Stockholm University; Stockholm University; University of Manitoba; Health Canada	Nordlund, P (corresponding author), Stockholm Univ, Albanova Univ Ctr, Dept Biochem & Biophys, Roslagstullsbacken 15, SE-10691 Stockholm, Sweden.	par.nordlund@dbb.su.se		Hogbom, Martin/0000-0001-5574-9383; Stenmark, Pal/0000-0003-4777-3417				Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8024, DOI 10.1021/ja00097a009; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Burdi D, 1998, J AM CHEM SOC, V120, P12910, DOI 10.1021/ja9824270; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Elleingand E, 1998, EUR J BIOCHEM, V258, P485, DOI 10.1046/j.1432-1327.1998.2580485.x; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; Guittet O, 1999, CELL MOL LIFE SCI, V55, P1054, DOI 10.1007/s000180050356; HENRIKSEN MA, 1994, J AM CHEM SOC, V116, P9773, DOI 10.1021/ja00100a062; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MCCLARTY G, 1991, J BACTERIOL, V173, P4922, DOI 10.1128/jb.173.16.4922-4931.1991; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Perry LL, 1998, INFECT IMMUN, V66, P1265, DOI 10.1128/IAI.66.3.1265-1269.1998; Potsch S, 1999, J BIOL CHEM, V274, P17696, DOI 10.1074/jbc.274.25.17696; Ramsey KH, 1998, INFECT IMMUN, V66, P835, DOI 10.1128/IAI.66.2.835-838.1998; Riggs-Gelasco PJ, 1998, J AM CHEM SOC, V120, P849, DOI 10.1021/ja9718230; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Sturgeon BE, 1996, J AM CHEM SOC, V118, P7551, DOI 10.1021/ja960399k; TIPPLES G, 1993, MOL MICROBIOL, V8, P1105, DOI 10.1111/j.1365-2958.1993.tb01655.x; TIPPLES G, 1991, J BACTERIOL, V173, P4932, DOI 10.1128/jb.173.16.4932-4940.1991; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Yun D, 2002, BIOCHEMISTRY-US, V41, P981, DOI 10.1021/bi011797p	33	123	124	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2004	305	5681					245	248		10.1126/science.1098419	http://dx.doi.org/10.1126/science.1098419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835QQ	15247479				2022-12-01	WOS:000222501000053
J	Freeman, C; Fenner, N; Ostle, NJ; Kang, H; Dowrick, DJ; Reynolds, B; Lock, MA; Sleep, D; Hughes, S; Hudson, J				Freeman, C; Fenner, N; Ostle, NJ; Kang, H; Dowrick, DJ; Reynolds, B; Lock, MA; Sleep, D; Hughes, S; Hudson, J			Export of dissolved organic carbon from peatlands under elevated carbon dioxide levels	NATURE			English	Article							TERRESTRIAL EXPORT; METHANE EMISSIONS; CLIMATE-CHANGE; BOREAL LAKES; CO2; DEPOSITION; GROWTH; MATTER; ENRICHMENT; ECOSYSTEMS	Peatlands represent a vast store of global carbon(1). Observations of rapidly rising dissolved organic carbon concentrations in rivers draining peatlands have created concerns that those stores are beginning to destabilize(2,3). Three main factors have been put forward as potential causal mechanisms, but it appears that two alternatives-warming(2,4) and increased river discharge(3)-cannot offer satisfactory explanations(5). Here we show that the third proposed mechanism, namely shifting trends in the proportion of annual rainfall arriving in summer(6), is similarly unable to account for the trend. Instead we infer that a previously unrecognized mechanism-carbon dioxide mediated stimulation of primary productivity-is responsible. Under elevated carbon dioxide levels, the proportion of dissolved organic carbon derived from recently assimilated carbon dioxide was ten times higher than that of the control cases. Concentrations of dissolved organic carbon appear far more sensitive to environmental drivers that affect net primary productivity than those affecting decomposition alone.	Univ Coll N Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster LA1 4AP, England; Ctr Ecol & Hydrol, Bangor LL57 2UP, Gwynedd, Wales; Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Bangor University; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH)	Freeman, C (corresponding author), Univ Coll N Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	c.freeman@bangor.ac.uk	Ostle, Nicholas J/E-4847-2014; Kang, Hojeong/C-7208-2011; Reynolds, Brian/G-6292-2011; Ostle, Nick J/K-6891-2012; Hughes, Steven/G-3596-2011	Ostle, Nicholas J/0000-0003-3263-3702; 				AERTS R, 1992, J ECOL, V80, P131, DOI 10.2307/2261070; Berendse F, 2001, GLOBAL CHANGE BIOL, V7, P591, DOI 10.1046/j.1365-2486.2001.00433.x; DACEY JWH, 1994, NATURE, V370, P47, DOI 10.1038/370047a0; Evans CD, 2002, NATURE, V415, P862, DOI 10.1038/415862a; FORSBERG C, 1992, HYDROBIOLOGIA, V229, P51, DOI 10.1007/BF00006990; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hudson JJ, 2003, HYDROL EARTH SYST SC, V7, P390, DOI 10.5194/hess-7-390-2003; HUTCHIN PR, 1995, GLOB CHANGE BIOL, V1, P125, DOI 10.1111/j.1365-2486.1995.tb00012.x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Megonigal JP, 1997, BIOGEOCHEMISTRY, V37, P77, DOI 10.1023/A:1005738102545; Mitsch W. J, 2011, WETLANDS; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; Schindler DW, 1997, BIOGEOCHEMISTRY, V36, P9, DOI 10.1023/A:1005792014547; Strom L, 2003, GLOBAL CHANGE BIOL, V9, P1185, DOI 10.1046/j.1365-2486.2003.00655.x; Tipping E, 1999, ENVIRON INT, V25, P83, DOI 10.1016/S0160-4120(98)00098-1; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Van der Heijden E, 2000, J BRYOL, V22, P175, DOI 10.1179/jbr.2000.22.3.175; Waddington JM, 1997, J HYDROL, V191, P122, DOI 10.1016/S0022-1694(96)03075-2; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; WOODIN S, 1992, NEW PHYTOL, V122, P635; Worrall F, 2003, BIOGEOCHEMISTRY, V64, P165, DOI 10.1023/A:1024924216148; ZANGERL AR, 1984, OECOLOGIA, V62, P412, DOI 10.1007/BF00384276; Ziska LH, 1998, GLOBAL CHANGE BIOL, V4, P657, DOI 10.1046/j.1365-2486.1998.00186.x	30	464	497	4	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2004	430	6996					195	198		10.1038/nature02707	http://dx.doi.org/10.1038/nature02707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835GL	15241411				2022-12-01	WOS:000222470600040
J	Asamoah-Odei, E; Calleja, JMG; Boerma, JT				Asamoah-Odei, E; Calleja, JMG; Boerma, JT			HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences	LANCET			English	Article							POPULATION; WOMEN	Background Expansion of HIV surveillance systems in sub-Saharan Africa is leading to downward adjustments to the size of the AIDS epidemic. However, only analysis of surveillance data from the same populations over time can provide insight into trends of HIV prevalence. We have used data from the same antenatal clinics to document recent empirical trends. Methods We collated data from antenatal clinics on HIV prevalence between 1997 and 2003. Data were obtained from 140 000 pregnant women attending more than 300 antenatal clinics in 22 countries in sub-Saharan Africa. Additionally, long-term trend data are available for 57 urban areas and provinces. Findings Median HIV prevalence in 148 antenatal clinic sites in southern Africa increased from 21.3% (IQR 11.5-28.2%) in 1997/98 to 23.8% (15.6-29.2%) in 2002. At more than half the sites (58%) an increase of at least one-tenth was noted, but at a fifth of sites, prevalence dropped by at least one-tenth. In eastern Africa, median HIV prevalence decreased from 12.9% (7.0-16.9%) in 1997/98 to 8.5% (5.3-13.0%) in 2002, with prevalence rising in four (7%) sites, but falling at 25 (43%) sites. In west Africa, median HIV prevalence was 3.5% (2.2-5.9%) and 3.2% (2.3-6.1%) for 1997/98 and 2002, respectively, with reductions and increases in prevalence being noted in equal proportions. The long-term trends in urban areas in sub-Saharan Africa show a similar pattern, with increasing evidence of stabilisation during the past 2-3 years compared with the previous decade. Interpretation Evidence from surveillance of mostly urban antenatal clinic attendees indicates that the growth in the AIDS epidemic in sub-Saharan Africa has levelled off since the late 1990s but only eastern Africa shows a decline in HIV prevalence. Very large differences persist between subregions. Workers planning a response to the AIDS epidemic must take more careful consideration of these variations to allow locally appropriate responses to the epidemic.	WHO, HIV Dept, CH-1211 Geneva, Switzerland; WHO Reg Off Africa, Harare, Zimbabwe	World Health Organization	Boerma, JT (corresponding author), WHO, Dept Measurement & Hlth Informat Syst, 20 Ave Appia, CH-1211 Geneva, Switzerland.	boermat@who.int						Agresti A, 1990, CATEGORICAL DATA ANA, P100; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; *CEFORMI, 2002, ENQ NAT SER INF VIH; Cellule de Planification et de Statistique Ministere de la Sante Direction Nationale de la Statistique et de l'Informatique (DNSI) and ORC Macro, 2002, HIV TEST MAL FIND 20; [Central Bureau of Statistics Ministry of health ORC Macro], 2004, KEN DEM HLTH SURV 20; LOUBOUTINCROC JP, 2002, ENQUETE NATL SEROPRE; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; *MIN HLTH, 2002, ENQ NAT SER VIH SIDA; *MIN HLTH CHILD WE, 2002, ZIMB YOUNG AD SURV 2; Pettifor Audrey, 2004, HIV SEXUAL BEHAV YOU; Shisana O., 2002, N MANDELA HSRC STUDY; UNAIDS, 2002, MON DECL COMM HIV AI; *UNAIDS WHO, 2003, EP UPD 2003; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; *WHO REG OFF AFR, 2003, HIV AIDS EP SURV UPD; *WHO UNAIDS, 2001, GUID US HIV TEST TEC; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; Zaba B, 1998, AIDS, V12, pS41; [No title captured]	20	99	101	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					35	40		10.1016/S0140-6736(04)16587-2	http://dx.doi.org/10.1016/S0140-6736(04)16587-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234854				2022-12-01	WOS:000222392900029
J	Barouch, DH; Letvin, NL				Barouch, DH; Letvin, NL			HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?	LANCET			English	Editorial Material							VIRAL ESCAPE; DISEASE PROGRESSION; RHESUS-MONKEYS; CELL RESPONSES; IN-VIVO; AIDS; TRANSMISSION; VACCINATION; PREVENTION; REVERSION		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019					Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Goudsmit J, 1997, J VIROL, V71, P4479, DOI 10.1128/JVI.71.6.4479-4484.1997; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; van Ballegooijen M, 2003, JAIDS-J ACQ IMM DEF, V34, P214, DOI 10.1097/00126334-200310010-00012	16	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2004	364	9428					10	11		10.1016/S0140-6736(04)16609-9	http://dx.doi.org/10.1016/S0140-6736(04)16609-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DX	15234837				2022-12-01	WOS:000222392900008
J	Hallem, EA; Ho, MG; Carlson, JR				Hallem, EA; Ho, MG; Carlson, JR			The molecular basis of odor coding in the drosophila antenna	CELL			English	Article							OLFACTORY SENSORY MAP; RECEPTOR EXPRESSION; MAXILLARY PALP; TASTE NEURONS; FLY BRAIN; MELANOGASTER; INFORMATION; ORGANIZATION; RESPONSES; SYSTEM	We have undertaken a functional analysis of the odorant receptor repertoire in the Drosophila antenna. Each receptor was expressed in a mutant olfactory receptor neuron (ORN) used as a "decoder," and the odor response spectrum conferred by the receptor was determined in vivo by electrophysiological recordings. The spectra of these receptors were then matched to those of defined ORNs to establish a receptor-to-neuron map. In addition to the odor response spectrum, the receptors dictate the signaling mode, i.e., excitation or inhibition, and the response dynamics of the neuron. An individual receptor can mediate both excitatory and inhibitory responses to different odorants in the same cell, suggesting a model of odorant receptor transduction. Receptors vary widely in their breadth of tuning, and odorants vary widely in the number of receptors they activate. Together, these properties provide a molecular basis for odor coding by the receptor repertoire of an olfactory organ.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Ho, Michael/0000-0002-4893-3016; Hallem, Elissa/0000-0003-0260-3174	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174, R01DC004729] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02174, DC04729] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Elmore T, 2003, J NEUROSCI, V23, P9906; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Strange PG, 2002, TRENDS PHARMACOL SCI, V23, P89, DOI 10.1016/S0165-6147(02)01993-4; *TNO, 2004, VOL COMP FOOD QUAL Q; UMANO K, 1992, J AGR FOOD CHEM, V40, P599, DOI 10.1021/jf00016a014; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	49	594	621	3	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2004	117	7					965	979		10.1016/j.cell.2004.05.012	http://dx.doi.org/10.1016/j.cell.2004.05.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	832XE	15210116	Bronze			2022-12-01	WOS:000222300200013
J	Laffort, C; Le Deist, F; Favre, M; Caillat-Zucman, S; Radford-Weiss, I; Debre, M; Fraitag, S; Blanche, S; Cavazzana-Calvo, M; Saint Basile, GD; de Villartay, JP; Giliani, S; Orth, G; Casanova, JL; Bodemer, C; Fischer, A				Laffort, C; Le Deist, F; Favre, M; Caillat-Zucman, S; Radford-Weiss, I; Debre, M; Fraitag, S; Blanche, S; Cavazzana-Calvo, M; Saint Basile, GD; de Villartay, JP; Giliani, S; Orth, G; Casanova, JL; Bodemer, C; Fischer, A			Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gamma c cytokine receptor subunit or JAK-3 deficiency	LANCET			English	Article							COMBINED IMMUNODEFICIENCY; MUTATIONS	Haemopoietic stem-cell transplantation is a life-saving treatment for severe combined immune deficiency. However, there has been little long-term follow-up of this treatment. There is evidence for the persistance of partial immunodeficiency associated with significant infections, including severe human papillomavirus (HPV) disease. We did a retrospective analysis of severe HPV disease in a group of 41 patients with severe combined immune deficiency from one centre who were alive 10 years or longer after haemopoietic stem-cell transplantation. Nine of the 41 patients had extensive chronic HPV disease limited to the skin, with a median onset at 8 years after transplantation. Four had lesions typical of epidermodysplasia verruciformis, a rare genodermatosis. Transplant characteristics, immune status, and chimerism of these nine patients did not differ significantly from those of the other patients. The nine patients with HPV disease had severe combined immune deficiency associated with either common gammac receptor cytokine subunit or Janus kinase-3 (JAK-3) deficiency. By contrast, patients with other forms of severe combined immune deficiency did not have any signs of HPV disease. That genetic causes are the only predisposing factor to be identified for severe combined immune deficiency, suggests that natural-killer cells or gammac/JAK-3-dependent signalling in keratinocytes could have a role in anti-HPV immunity.	Hop Necker Enfants Malad, INSERM, U429, F-75743 Paris 15, France; Hop Necker Enfants Malad, Unite Immunol Hematol & Rhumatol Pediat, F-75743 Paris 15, France; Hop Necker Enfants Malad, CHU, INSERM, U550, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Dermatol Pediat, F-75743 Paris 15, France; Hop Necker Enfants Malad, Immunol Lab, F-75743 Paris 15, France; Hop Necker Enfants Malad, Lab Cytogenet, F-75743 Paris 15, France; Hop Necker Enfants Malad, Lab Anatomopathol, F-75743 Paris 15, France; Hop Necker Enfants Malad, Dept Biotherapie, F-75743 Paris 15, France; Univ Brescia, Inst Med Mol Angelo Nocivelli, I-25121 Brescia, Italy; Inst Pasteur, Unite Papillomavirus, Paris, France; Hop Necker Enfants Malad, Lab Immunol Pediat, F-75743 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Brescia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Le Deist, F (corresponding author), Hop Necker Enfants Malad, INSERM, U429, 149 Rue Sevres, F-75743 Paris 15, France.	ledeist@necker.fr	de Villartay, jean pierre/H-9353-2017; Giliani, Silvia/AAX-8843-2020; ORTH, Gérard C/C-2518-2009; Casanova, Jean-Laurent/I-3418-2017; de Saint Basile, Genevieve/G-9731-2017	de Villartay, jean pierre/0000-0001-5987-0463; Giliani, Silvia/0000-0001-8137-4642; Caillat-Zucman, Sophie/0000-0002-4535-3550; de Saint Basile, Genevieve/0000-0002-1913-5269; Casanova, Jean-Laurent/0000-0002-7782-4169				Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Ruckert R, 2000, J IMMUNOL, V165, P2240, DOI 10.4049/jimmunol.165.4.2240	7	111	112	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2004	363	9426					2051	2054		10.1016/S0140-6736(04)16457-X	http://dx.doi.org/10.1016/S0140-6736(04)16457-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830YJ	15207958				2022-12-01	WOS:000222159800014
J	Tuzzolino, AJ; Economou, TE; Clark, BC; Tsou, P; Brownlee, DE; Green, SF; McDonnell, JAM; McBride, N; Colwell, MTSH				Tuzzolino, AJ; Economou, TE; Clark, BC; Tsou, P; Brownlee, DE; Green, SF; McDonnell, JAM; McBride, N; Colwell, MTSH			Dust measurements in the coma of comet 81P/Wild 2 by the Dust Flux Monitor Instrument	SCIENCE			English	Article							P/HALLEY; ENCOUNTER; NUCLEUS	We present measurements of the dust particle flux and mass distribution from the Stardust Dust Flux Monitor Instrument (DFMI) throughout the flyby of comet 81P/Wild 2. In the particle mass regime from 10(-14) to 10(-7) kilograms, the spacecraft encountered regions of intense swarms of particles, together with bursts of activity corresponding to clouds of particles only a few hundred meters across. This fine-scale structure can be explained by particle fragmentation. We estimate that 2800+/-500 particles of diameter 15 micrometers or larger impacted the aerogel collectors, the largest being similar to6x10(-7) kilograms, which dominates the total collected mass.	Univ Chicago, Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; Lockheed Martin Astronaut, Denver, CO 80201 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Washington, Dept Astron & Astrophys, Seattle, WA 98195 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Chicago; Lockheed Martin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle; Open University - UK	Economou, TE (corresponding author), Univ Chicago, Enrico Fermi Inst, Lab Astrophys & Space Res, 9333 E 56th St, Chicago, IL 60637 USA.	tecon@tecon.uchicago.edu	Green, Simon F/C-7408-2009	Green, Simon F/0000-0002-9153-9786				CLARK BC, UNPUB; Crifo JF, 2002, EARTH MOON PLANETS, V90, P227, DOI 10.1023/A:1021501509992; Crifo JF, 1999, ICARUS, V138, P85, DOI 10.1006/icar.1999.6051; Fulle M, 2000, ASTRON J, V119, P1968, DOI 10.1086/301285; HANNER M, COMMUNICATION; Levasseur-Regourd AC, 1999, ASTRON ASTROPHYS, V348, P636; MAZETS EP, 1987, ASTRON ASTROPHYS, V187, P699; MCDONNELL JAM, 1987, ASTRON ASTROPHYS, V187, P719; MCDONNELL JAM, 1991, COMETS POST HALLEY E, V2, P1043; NEWBURN RL, UNPUB; Rodionov AV, 2002, PLANET SPACE SCI, V50, P983, DOI 10.1016/S0032-0633(02)00047-8; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; SIMKPSON JA, 1987, EUROPEAN SPACE AGENC, V278, P391; SIMPSON JA, 1986, NATURE, V321, P278, DOI 10.1038/321278a0; SIMPSON JA, 1987, ASTRON ASTROPHYS, V187, P742; Soderblom LA, 2004, ICARUS, V167, P4, DOI 10.1016/j.icarus.2003.07.008; THOMAS N, 1987, ASTRON ASTROPHYS, V187, P843; Tsou P, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002109; Tuzzolino AJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002086; VAISBERG OL, 1987, ASTRON ASTROPHYS, V187, P753	20	128	130	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1776	1780		10.1126/science.1098759	http://dx.doi.org/10.1126/science.1098759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15205527				2022-12-01	WOS:000222089500038
J	An, W; Kim, J; Roeder, RG				An, W; Kim, J; Roeder, RG			Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53	CELL			English	Article							HISTONE H3; PROTEIN METHYLTRANSFERASE; DNA-BINDING; METHYLATION; ACETYLATION; CHROMATIN; COACTIVATORS; PHOSPHORYLATION; RECRUITMENT; CBP	Transcriptional coactivators that modify histones represent an increasingly important group of regulatory factors, although their ability to modify other factors as well precludes common assumptions that they necessarily act by histone modification. In an extension of previous studies showing a role for acetyltransferase p300/CBP in p53 function, we have used systems reconstituted with recombinant chromatin templates and (co)activators to demonstrate (1) the additional involvement of protein arginine methyltransferases PRMT1 and CARM1 in p53 function; (2) both independent and ordered cooperative functions of p300, PRMT1, and CARM1; and (3) mechanisms that involve direct interactions with p53 and, most importantly, obligatory modifications of corresponding histone substrates. ChIP analyses have confirmed the ordered accumulation of these (and other) coactivators and cognate histone modifications on the GADD45 gene following ectopic p53 expression and/or UV irradiation. These studies thus define diverse cofactor functions, as well as underlying mechanisms involving distinct histone modifications, in p53-dependent gene activation.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	roeder@mail.rockefeller.edu	Kim, Jaehoon/G-2711-2011; zhang, shijun/K-3688-2013	Kim, Jaehoon/0000-0003-4035-0438; 				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; An WJ, 2004, METHOD ENZYMOL, V377, P460; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Scolnick DM, 1997, CANCER RES, V57, P3693; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	38	393	409	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2004	117	6					735	748		10.1016/j.cell.2004.05.009	http://dx.doi.org/10.1016/j.cell.2004.05.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	829KY	15186775	Bronze			2022-12-01	WOS:000222048400007
J	Forsgren, E; Amundsen, T; Borg, AA; Bjelvenmark, J				Forsgren, E; Amundsen, T; Borg, AA; Bjelvenmark, J			Unusually dynamic sex roles in a fish	NATURE			English	Article							POTENTIAL REPRODUCTIVE RATES; PARENTAL INVESTMENT; MATING SYSTEM; MATE CHOICE; SELECTION; COMPETITION; EVOLUTION; CARE; POPULATION; DIRECTION	Sex roles are typically thought of as being fixed for a given species. In most animals males compete for females, whereas the females are more reluctant to mate. Therefore sexual selection usually acts most strongly on males(1,2). This is explained by males having a higher potential reproductive rate than females, leading to more males being sexually active (a male-biased operational sex ratio)(3,4). However, what determines sex roles and the strength of sexual selection is a controversial and much debated question(3,5-10). In this large-scale field study, we show a striking temporal plasticity in the mating competition of a fish (two-spotted goby, Gobiusculus flavescens). Over the short breeding season fierce male-male competition and intensive courtship behaviour in males were replaced by female-female competition and actively courting females. Hence, sex role reversal occurred rapidly. This is the first time that a shift in sex roles has been shown in a vertebrate. The shift might be explained by a large decline in male abundance, strongly skewing the sex ratio towards females. Notably, the sex role reversal did not occur at an equal operational sex ratio, contrary to established sex role theory(3,4).	Univ Gothenburg, Dept Marine Ecol, Kristineberg Marine Res Stn, SE-45034 Fiskebackskil, Sweden; Norwegian Univ Sci & Technol, Dept Biol, NO-7491 Trondheim, Norway	University of Gothenburg; Norwegian University of Science & Technology (NTNU)	Forsgren, E (corresponding author), Univ Gothenburg, Dept Marine Ecol, Kristineberg Marine Res Stn, SE-45034 Fiskebackskil, Sweden.	elisabet.forsgren@bio.ntnu.no		Amundsen, Trond/0000-0003-4261-0555				AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; Ahnesjo I, 2001, BEHAV ECOL, V12, P397, DOI 10.1093/beheco/12.4.397; ALMADA VC, 1995, ANIM BEHAV, V49, P1125, DOI 10.1006/anbe.1995.0142; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Andersson Malte, 1994; Bjelvenmark J, 2003, BEHAVIOUR, V140, P55, DOI 10.1163/156853903763999890; Borg AA, 2002, OIKOS, V98, P105, DOI 10.1034/j.1600-0706.2002.980111.x; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Darwin C., 1871, P423; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; Godwin J, 1995, B MAR SCI, V57, P637; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; Gwynne DT, 1998, BEHAV ECOL SOCIOBIOL, V42, P157, DOI 10.1007/s002650050426; Kokita T, 1998, J ETHOL, V16, P81, DOI 10.1007/BF02769286; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; KVARNEMO C, 1994, P ROY SOC B-BIOL SCI, V256, P151, DOI 10.1098/rspb.1994.0063; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; KYNARD BE, 1978, BEHAVIOUR, V67, P178, DOI 10.1163/156853978X00323; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; MARCONATO A, 1993, BEHAV ECOL SOCIOBIOL, V32, P229; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P315, DOI 10.1098/rspb.1996.0048; Trivers R., 1972, SEXUAL SELECTION DES, P139; VINCENT A, 1992, TRENDS ECOL EVOL, V7, P237, DOI 10.1016/0169-5347(92)90052-D; Vincent A, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P209; Wade MJ, 2002, AM NAT, V160, P285, DOI 10.1086/341520	30	209	210	2	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					551	554		10.1038/nature02562	http://dx.doi.org/10.1038/nature02562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15175750				2022-12-01	WOS:000221767700037
J	Vollaard, AM; Ali, S; van Asten, HAGH; Widjaja, S; Visser, LG; Surjadi, C; van Dissel, JT				Vollaard, AM; Ali, S; van Asten, HAGH; Widjaja, S; Visser, LG; Surjadi, C; van Dissel, JT			Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEKONG-DELTA; CHILDREN; VACCINE; IMMUNIZATION; COMMUNITY; EPIDEMIC; VIETNAM; INDIA	Context The proportion of paratyphoid fever cases to typhoid fever cases may change due to urbanization and increased dependency on food purchased from street vendors. For containment of paratyphoid a different strategy may be needed than for typhoid, because risk factors for disease may not coincide and current typhoid vaccines do not protect against paratyphoid fever. Objective To determine risk factors for typhoid and paratyphoid fever in an endemic area. Design, Setting, and Participants Community-based case-control study conducted from June 2001 to February 2003 in hospitals and outpatient health centers in Jatinegara district, Jakarta, Indonesia. Enrolled participants were 1019 consecutive patients with fever lasting 3 or more days, from which 69 blood culture-confirmed typhoid cases, 24 confirmed paratyphoid cases, and 289 control patients with fever but without Salmonella bacteremia were interviewed, plus 378 randomly selected community controls. Main Outcome Measures Blood culture-confirmed typhoid or paratyphoid fever; risk factors for both diseases. Results In 1019 fever patients we identified 88 (9%) Salmonella typhi and 26 (3%) Salmonella paratyphi A infections. Paratyphoid fever among cases was independently associated with consumption of food from street vendors (comparison with community controls: odds ratio [OR], 3.34; 95% confidence interval [CI], 1.41-7.91; with fever controls: OR, 5.17; 95% CI, 2.12-12.60) and flooding (comparison with community controls: OR, 4.52; 95% CI, 1.90-10.73; with fever controls: OR, 3.25; 95% CI, 1.31-8.02). By contrast, independent risk factors for typhoid fever using the community control group were mostly related to the household, ie, to recent typhoid fever in the household (OR, 2.38; 95% CI, 1.03-5.48); no use of soap for handwashing (OR, 1.91; 95% CI, 1.06-3.46); sharing food from the same plate (OR, 1.93; 95% CI, 1.10-3.37), and no toilet in the household (OR, 2.20; 95% CI, 1.06-4.55). Also, typhoid fever was associated with young age in years (OR, 0.96; 95% CI, 0.94-0.98). In comparison with fever controls; risk factors for typhoid fever were use of ice cubes (OR 2.27; 95% CI, 1.31-3.93) and female sex (OR, 1.79;95% CI, 1.04-3.06). Fecal contamination of drinking water was not associated with typhoid or paratyphoid fever. We did not detect fecal carriers among food handlers in the households. Conclusions In Jakarta, typhoid and paratyphoid fever are associated with distinct routes of transmission, with the risk factors for disease either mainly within the household (typhoid) or outside the household (paratyphoid).	Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands; Atma Jaya Catholic Univ, Fac Med, Dept Biol, Jakarta, Indonesia; Atma Jaya Catholic Univ, Ctr Hlth Res, Jakarta, Indonesia; Atma Jaya Catholic Univ, Dept Internal Med, Jakarta, Indonesia; Univ Med Ctr Nijmegen, Inst Int Hlth, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University Katolik Indonesia Atma Jaya; University Katolik Indonesia Atma Jaya; University Katolik Indonesia Atma Jaya; Radboud University Nijmegen	van Dissel, JT (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, C5-P,POB 9600, NL-2300 RC Leiden, Netherlands.	j.t.van_dissel@lumc.nl	Visser, Leo/AAH-5755-2021; van Asten, Henri/AID-4234-2022	Ali, Soegianto/0000-0002-9972-8696; Visser, Leo/0000-0002-3600-9782				Arya SC, 1995, VACCINE, V13, P1727, DOI 10.1016/0264-410X(96)81276-X; Bhan MK, 2002, J INFECT DIS, V186, P1857, DOI 10.1086/345762; BLACK RE, 1985, B WORLD HEALTH ORGAN, V63, P899; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Castillo M. T. G., 1995, SE ASIAN J TROP M S2, V26, P39; Christie AB, 1987, INFECT DIS EPIDEMIOL, V4th; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; DICKENS DL, 1985, JAMA-J AM MED ASSOC, V253, P3141, DOI 10.1001/jama.253.21.3141; Estrada-Garcia T, 2002, EPIDEMIOL INFECT, V129, P223, DOI 10.1017/S0950268802007070; FERRECCIO C, 1984, J PEDIATR-US, V104, P899, DOI 10.1016/S0022-3476(84)80492-8; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; KING CC, 1989, INT J EPIDEMIOL, V18, P254, DOI 10.1093/ije/18.1.254; Koo D, 1996, EPIDEMIOL INFECT, V116, P121, DOI 10.1017/S0950268800052341; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Luby SP, 1998, EPIDEMIOL INFECT, V120, P129, DOI 10.1017/S0950268897008558; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Parry CM, 1999, J CLIN MICROBIOL, V37, P2882, DOI 10.1128/JCM.37.9.2882-2886.1999; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Saha MR, 2002, INDIAN J MED RES, V115, P46; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Swaddiwudhipong Witaya, 2001, Journal of the Medical Association of Thailand, V84, P1513; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Velema JP, 1997, TROP MED INT HEALTH, V2, P1088, DOI 10.1046/j.1365-3156.1997.d01-179.x; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; WHO, 1997, GUID DRINK WAT QUAL, V2nd edn	32	184	201	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2004	291	21					2607	2615		10.1001/jama.291.21.2607	http://dx.doi.org/10.1001/jama.291.21.2607			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825EM	15173152	Bronze			2022-12-01	WOS:000221738800024
J	Hertzog, M; van Heijenoort, C; Didry, D; Gaudier, M; Coutant, J; Gigant, B; Didelot, G; Preat, T; Knossow, M; Guittet, E; Carlier, MF				Hertzog, M; van Heijenoort, C; Didry, D; Gaudier, M; Coutant, J; Gigant, B; Didelot, G; Preat, T; Knossow, M; Guittet, E; Carlier, MF			The beta-thymosin/WH2 domain: Structural basis for the switch from inhibition to promotion of actin assembly	CELL			English	Article							CYCLASE-ASSOCIATED PROTEIN; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; F-ACTIN; ATP HYDROLYSIS; SACCHAROMYCES-CEREVISIAE; ACANTHAMOEBA ACTOBINDIN; THYMOSIN BETA(4); BINDING PROTEINS; ATOMIC-STRUCTURE	The widespread beta-thymosin/WH2 actin binding domain has versatile regulatory properties in actin dynamics and motility. beta-thymosins (isolated WH2 domain) maintain monomeric actin in a "sequestered" nonpolymerizable form. In contrast, when repeated in tandem or inserted in modular proteins, the beta-thymosin/WH2 domain promotes actin assembly at filament barbed ends, like profilin. The structural basis for these opposite functions is addressed using ciboulot, a three beta-thymosin repeat protein. Only the first repeat binds actin and possesses the function of ciboulot. The region that shows the strongest interaction with actin is an amphipathic N-terminal alpha helix, present in all beta-thymosin/WH2 domains, which recognizes the ATP bound actin structure and uses the shear motion of actin linked to ATP hydrolysis to control polymerization. Crystallographic (H-1, N-15), NMR, and mutagenetic data reveal that the weaker interaction of the C-terminal region of beta-thymosin/WH2 domain with actin accounts for the switch in function from inhibition to promotion of actin assembly.	CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; CNRS, Inst Alfred Fessard, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	VAN HEIJENOORT, Carine/N-1986-2016; van Heijenoort, Carine/AAX-1041-2021	VAN HEIJENOORT, Carine/0000-0002-2839-1037; van Heijenoort, Carine/0000-0002-2839-1037; Guittet, Eric/0000-0002-8368-6719; Gigant, Benoit/0000-0002-5946-6759; Preat, Thomas/0000-0001-9976-1763				Barrero RA, 2002, PLANT CELL, V14, P149, DOI 10.1105/tpc.010301; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Bubb MR, 1998, CELL MOTIL CYTOSKEL, V39, P134, DOI 10.1002/(SICI)1097-0169(1998)39:2<134::AID-CM4>3.0.CO;2-6; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; CARLIER MF, 1993, P NATL ACAD SCI USA, V90, P5034, DOI 10.1073/pnas.90.11.5034; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Crow T, 2003, J NEUROSCI, V23, P3415; CZISCH M, 1993, EUR J BIOCHEM, V218, P335, DOI 10.1111/j.1432-1033.1993.tb18382.x; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; DOMANSKI M, 2004, IN PRESS J BIOL CHEM; Eadie JS, 2000, J CELL BIOCHEM, V77, P277, DOI 10.1002/(SICI)1097-4644(20000501)77:2<277::AID-JCB10>3.0.CO;2-Q; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hertzog M, 2002, J BIOL CHEM, V277, P14786, DOI 10.1074/jbc.M112064200; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Hudson AM, 2002, ANNU REV GENET, V36, P455, DOI 10.1146/annurev.genet.36.052802.114101; Irobi E, 2003, FEBS LETT, V552, P86, DOI 10.1016/S0014-5793(03)00934-7; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otterbein LR, 2002, P NATL ACAD SCI USA, V99, P8003, DOI 10.1073/pnas.122126299; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; ROUSSEL A, 1991, TURBO FRODO SILICON; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; SAFER D, 1994, BIOESSAYS, V16, P590; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Simenel C, 2000, EUR J BIOCHEM, V267, P3530, DOI 10.1046/j.1432-1327.2000.01380.x; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Van Troys M, 1999, BBA-MOL CELL RES, V1448, P323, DOI 10.1016/S0167-4889(98)00152-9; VANCOMPERNOLLE K, 1991, J BIOL CHEM, V266, P15427; VanTroys M, 1996, EMBO J, V15, P201, DOI 10.1002/j.1460-2075.1996.tb00350.x; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; Yarmola EG, 2000, J BIOL CHEM, V275, P28120	65	176	186	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2004	117	5					611	623		10.1016/S0092-8674(04)00403-9	http://dx.doi.org/10.1016/S0092-8674(04)00403-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	826VP	15163409	Bronze			2022-12-01	WOS:000221857900008
